0001835378-23-000022.txt : 20230303 0001835378-23-000022.hdr.sgml : 20230303 20230303161647 ACCESSION NUMBER: 0001835378-23-000022 CONFORMED SUBMISSION TYPE: 10-K PUBLIC DOCUMENT COUNT: 118 CONFORMED PERIOD OF REPORT: 20221231 FILED AS OF DATE: 20230303 DATE AS OF CHANGE: 20230303 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Innovid Corp. CENTRAL INDEX KEY: 0001835378 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-PREPACKAGED SOFTWARE [7372] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 10-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-40048 FILM NUMBER: 23704195 BUSINESS ADDRESS: STREET 1: 30 IRVING PLACE, 12TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10003 BUSINESS PHONE: 2129667555 MAIL ADDRESS: STREET 1: 30 IRVING PLACE, 12TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10003 FORMER COMPANY: FORMER CONFORMED NAME: ION Acquisition Corp 2 Ltd. DATE OF NAME CHANGE: 20201207 10-K 1 ctv-20221231.htm 10-K ctv-20221231
00018353782022FYFalsehttp://innovid.com/20221231#WarrantLiabilityNoncurrenthttp://innovid.com/20221231#WarrantLiabilityNoncurrenthttp://fasb.org/us-gaap/2022#OtherLiabilitiesNoncurrenthttp://fasb.org/us-gaap/2022#OtherLiabilitiesNoncurrentP3Y00018353782022-01-012022-12-310001835378us-gaap:CommonStockMember2022-01-012022-12-310001835378us-gaap:WarrantMember2022-01-012022-12-3100018353782022-06-30iso4217:USD00018353782023-03-01xbrli:shares00018353782022-12-3100018353782021-12-31iso4217:USDxbrli:shares00018353782021-01-012021-12-3100018353782020-01-012020-12-31xbrli:pure00018353782019-12-310001835378us-gaap:CommonStockMember2019-12-310001835378us-gaap:TreasuryStockCommonMember2019-12-310001835378us-gaap:AdditionalPaidInCapitalMember2019-12-310001835378us-gaap:RetainedEarningsMember2019-12-310001835378us-gaap:AdditionalPaidInCapitalMember2020-01-012020-12-310001835378us-gaap:RetainedEarningsMember2020-01-012020-12-310001835378us-gaap:CommonStockMember2020-01-012020-12-3100018353782020-12-310001835378us-gaap:CommonStockMember2020-12-310001835378us-gaap:TreasuryStockCommonMember2020-12-310001835378us-gaap:AdditionalPaidInCapitalMember2020-12-310001835378us-gaap:RetainedEarningsMember2020-12-310001835378us-gaap:AdditionalPaidInCapitalMember2021-01-012021-12-310001835378us-gaap:RetainedEarningsMember2021-01-012021-12-310001835378us-gaap:CommonStockMember2021-01-012021-12-310001835378us-gaap:TreasuryStockCommonMember2021-01-012021-12-310001835378us-gaap:CommonStockMember2021-12-310001835378us-gaap:TreasuryStockCommonMember2021-12-310001835378us-gaap:AdditionalPaidInCapitalMember2021-12-310001835378us-gaap:RetainedEarningsMember2021-12-310001835378us-gaap:CommonStockMember2022-01-012022-12-310001835378us-gaap:AdditionalPaidInCapitalMember2022-01-012022-12-310001835378us-gaap:RetainedEarningsMember2022-01-012022-12-310001835378us-gaap:CommonStockMember2022-12-310001835378us-gaap:TreasuryStockCommonMember2022-12-310001835378us-gaap:AdditionalPaidInCapitalMember2022-12-310001835378us-gaap:RetainedEarningsMember2022-12-3100018353782021-01-012021-11-300001835378ctv:TVSquaredMember2022-02-282022-02-280001835378ctv:TVSquaredMember2022-02-280001835378srt:ScenarioPreviouslyReportedMember2022-01-012022-12-310001835378srt:RestatementAdjustmentMember2022-01-012022-12-310001835378srt:ScenarioPreviouslyReportedMember2021-01-012021-12-310001835378srt:RestatementAdjustmentMember2021-01-012021-12-310001835378srt:ScenarioPreviouslyReportedMember2020-01-012020-12-310001835378srt:RestatementAdjustmentMember2020-01-012020-12-310001835378us-gaap:GeographicDistributionForeignMember2022-12-310001835378us-gaap:GeographicDistributionForeignMember2021-12-310001835378us-gaap:ComputerEquipmentMember2022-01-012022-12-310001835378ctv:OfficeFurnitureAndEquipmentMembersrt:MinimumMember2022-01-012022-12-310001835378ctv:OfficeFurnitureAndEquipmentMembersrt:MaximumMember2022-01-012022-12-310001835378us-gaap:SoftwareAndSoftwareDevelopmentCostsMember2022-01-012022-12-310001835378us-gaap:SoftwareAndSoftwareDevelopmentCostsMember2021-01-012021-12-310001835378us-gaap:SoftwareAndSoftwareDevelopmentCostsMember2022-07-012022-09-300001835378us-gaap:SoftwareAndSoftwareDevelopmentCostsMember2020-01-012020-12-31ctv:reportingUnit0001835378us-gaap:CustomerRelationshipsMember2022-01-012022-12-310001835378us-gaap:TechnologyBasedIntangibleAssetsMember2022-01-012022-12-310001835378us-gaap:TradeNamesMember2022-01-012022-12-310001835378us-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel1Member2022-12-310001835378us-gaap:FairValueInputsLevel2Memberus-gaap:FairValueMeasurementsRecurringMember2022-12-310001835378us-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel3Member2022-12-310001835378us-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel1Member2021-12-310001835378us-gaap:FairValueInputsLevel2Memberus-gaap:FairValueMeasurementsRecurringMember2021-12-310001835378us-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel3Member2021-12-310001835378ctv:WarrantsLiabilityMemberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel3Member2021-12-310001835378ctv:WarrantsLiabilityMemberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel3Member2020-12-310001835378ctv:WarrantsLiabilityMemberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel3Member2022-01-012022-12-310001835378ctv:WarrantsLiabilityMemberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel3Member2021-01-012021-12-310001835378ctv:WarrantsLiabilityMemberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel3Member2022-12-310001835378ctv:PublicMemberus-gaap:FairValueInputsLevel1Member2022-12-310001835378ctv:PublicMemberus-gaap:FairValueInputsLevel1Member2021-12-310001835378us-gaap:PrivatePlacementMember2022-01-012022-12-310001835378us-gaap:PrivatePlacementMember2021-01-012021-12-310001835378us-gaap:PostemploymentRetirementBenefitsMember2022-01-012022-12-310001835378us-gaap:PostemploymentRetirementBenefitsMember2021-01-012021-12-310001835378us-gaap:PostemploymentRetirementBenefitsMember2020-01-012020-12-310001835378us-gaap:EmployeeSeveranceMember2022-01-012022-12-310001835378us-gaap:SalesRevenueNetMemberctv:CustomerAMemberus-gaap:CustomerConcentrationRiskMember2022-01-012022-12-310001835378us-gaap:SalesRevenueNetMemberus-gaap:CustomerConcentrationRiskMemberctv:CustomerBMember2022-01-012022-12-310001835378us-gaap:SalesRevenueNetMemberus-gaap:CustomerConcentrationRiskMemberctv:CustomerBMember2020-01-012020-12-310001835378us-gaap:RealEstateMemberus-gaap:AccountingStandardsUpdate201602Member2022-01-010001835378ctv:CarsMemberMemberus-gaap:AccountingStandardsUpdate201602Member2022-01-010001835378us-gaap:AccountingStandardsUpdate201602Member2022-01-010001835378ctv:IONMember2021-11-300001835378ctv:PIPEInvestorsMemberctv:SecondarySaleMember2021-11-302021-11-300001835378ctv:InnovidCorpMember2021-11-302021-11-300001835378ctv:InnovidCorpMember2021-01-010001835378ctv:IONMemberus-gaap:IPOMember2021-11-302021-11-300001835378ctv:IONMemberus-gaap:IPOMember2021-11-300001835378ctv:PIPEInvestorsMember2021-12-010001835378ctv:IONMember2021-11-302021-11-300001835378ctv:IONMember2021-01-012021-12-310001835378ctv:PIPEInvestorsMember2021-01-012021-12-3100018353782021-11-300001835378us-gaap:CommonStockMember2021-11-300001835378ctv:PublicWarrantsMemberus-gaap:CommonStockMember2021-11-302021-11-300001835378us-gaap:CommonStockMemberctv:PrivatePlacementWarrantsMember2021-11-302021-11-3000018353782021-11-302021-11-300001835378ctv:TVSquaredMemberus-gaap:TechnologyBasedIntangibleAssetsMember2022-02-280001835378ctv:TVSquaredMemberus-gaap:CustomerRelationshipsMember2022-02-280001835378ctv:TVSquaredMemberus-gaap:TradeNamesMember2022-02-280001835378ctv:TVSquaredMemberus-gaap:TechnologyBasedIntangibleAssetsMember2022-02-282022-02-280001835378ctv:TVSquaredMemberus-gaap:CustomerRelationshipsMember2022-02-282022-02-280001835378ctv:TVSquaredMemberus-gaap:TradeNamesMember2022-02-282022-02-280001835378ctv:TVSquaredMember2022-01-012022-12-310001835378ctv:TVSquaredMember2021-01-012021-12-310001835378us-gaap:CustomerRelationshipsMember2022-12-310001835378us-gaap:TechnologyBasedIntangibleAssetsMember2022-12-310001835378us-gaap:TradeNamesMember2022-12-310001835378us-gaap:SoftwareAndSoftwareDevelopmentCostsMember2022-12-310001835378us-gaap:SoftwareAndSoftwareDevelopmentCostsMember2021-12-310001835378us-gaap:ComputerEquipmentMember2022-12-310001835378us-gaap:ComputerEquipmentMember2021-12-310001835378ctv:OfficeFurnitureAndEquipmentMember2022-12-310001835378ctv:OfficeFurnitureAndEquipmentMember2021-12-310001835378us-gaap:LeaseholdImprovementsMember2022-12-310001835378us-gaap:LeaseholdImprovementsMember2021-12-310001835378us-gaap:RealEstateMember2022-12-310001835378ctv:CarsMemberMember2022-12-310001835378ctv:RentalOfPremisesMember2021-12-310001835378ctv:LeaseOfMotorVehiclesMember2021-12-310001835378ctv:PublicWarrantsMember2022-12-310001835378ctv:PrivateWarrantsMember2022-12-310001835378ctv:InnovidCorpMember2022-01-012022-12-310001835378ctv:InnovidCorpMember2022-12-310001835378ctv:RedemptionOfWarrantPricePerShareEqualsOrExceeds1800Memberctv:InnovidCorpMember2021-12-300001835378ctv:RedemptionOfWarrantPricePerShareEqualsOrExceeds1800Memberctv:InnovidCorpMember2021-12-302021-12-300001835378ctv:InnovidCorpMember2021-12-300001835378ctv:RedemptionOfWarrantPricePerShareEqualsOrExceeds1000Memberctv:InnovidCorpMember2021-12-300001835378ctv:RedemptionOfWarrantPricePerShareEqualsOrExceeds1000Memberctv:InnovidCorpMember2021-12-302021-12-300001835378ctv:PrivatePlacementWarrantsMember2022-12-310001835378ctv:PrivatePlacementWarrantsMember2021-12-310001835378us-gaap:RevolvingCreditFacilityMember2022-08-030001835378us-gaap:RevolvingCreditFacilityMember2022-08-040001835378srt:MaximumMemberus-gaap:RevolvingCreditFacilityMember2022-08-042022-08-040001835378us-gaap:RevolvingCreditFacilityMember2022-08-042022-08-040001835378srt:ScenarioForecastMemberus-gaap:RevolvingCreditFacilityMember2023-08-042023-08-040001835378us-gaap:LineOfCreditMemberctv:AmendedCreditAgreementMaturingDecember2020Member2022-12-310001835378us-gaap:RevolvingCreditFacilityMember2022-12-310001835378us-gaap:LineOfCreditMember2020-01-012020-12-310001835378us-gaap:LineOfCreditMember2022-10-012022-12-310001835378us-gaap:LineOfCreditMemberctv:AmendedCreditAgreementMaturingDecember2020Member2022-04-012022-06-300001835378us-gaap:SubsequentEventMember2023-01-012023-01-310001835378us-gaap:LineOfCreditMemberus-gaap:PrimeRateMembersrt:MinimumMemberctv:AmendedCreditAgreementMaturingOctober2018Member2020-12-292020-12-290001835378us-gaap:LineOfCreditMemberus-gaap:PrimeRateMemberctv:AmendedCreditAgreementMaturingOctober2018Membersrt:MaximumMember2020-12-292020-12-290001835378srt:SubsidiariesMember2022-12-310001835378ctv:IsraeliSubsidiaryMember2022-12-31ctv:vote0001835378ctv:HolderMember2022-12-310001835378ctv:HolderMember2010-02-250001835378ctv:IncentivePlanMember2021-11-300001835378ctv:IncentivePlanMember2021-11-302021-11-300001835378srt:MinimumMemberctv:LegacyPlanMember2022-01-012022-12-310001835378ctv:LegacyPlanMember2022-01-012022-12-310001835378ctv:LegacyPlanAnd2021PlanMemberMemberus-gaap:ShareBasedPaymentArrangementEmployeeMemberus-gaap:CostOfSalesMember2022-01-012022-12-310001835378ctv:LegacyPlanAnd2021PlanMemberMemberus-gaap:ShareBasedPaymentArrangementEmployeeMemberus-gaap:CostOfSalesMember2021-01-012021-12-310001835378ctv:LegacyPlanAnd2021PlanMemberMemberus-gaap:ShareBasedPaymentArrangementEmployeeMemberus-gaap:CostOfSalesMember2020-01-012020-12-310001835378us-gaap:ResearchAndDevelopmentExpenseMemberctv:LegacyPlanAnd2021PlanMemberMemberus-gaap:ShareBasedPaymentArrangementEmployeeMember2022-01-012022-12-310001835378us-gaap:ResearchAndDevelopmentExpenseMemberctv:LegacyPlanAnd2021PlanMemberMemberus-gaap:ShareBasedPaymentArrangementEmployeeMember2021-01-012021-12-310001835378us-gaap:ResearchAndDevelopmentExpenseMemberctv:LegacyPlanAnd2021PlanMemberMemberus-gaap:ShareBasedPaymentArrangementEmployeeMember2020-01-012020-12-310001835378ctv:LegacyPlanAnd2021PlanMemberMemberus-gaap:ShareBasedPaymentArrangementEmployeeMemberus-gaap:SellingAndMarketingExpenseMember2022-01-012022-12-310001835378ctv:LegacyPlanAnd2021PlanMemberMemberus-gaap:ShareBasedPaymentArrangementEmployeeMemberus-gaap:SellingAndMarketingExpenseMember2021-01-012021-12-310001835378ctv:LegacyPlanAnd2021PlanMemberMemberus-gaap:ShareBasedPaymentArrangementEmployeeMemberus-gaap:SellingAndMarketingExpenseMember2020-01-012020-12-310001835378ctv:LegacyPlanAnd2021PlanMemberMemberus-gaap:ShareBasedPaymentArrangementEmployeeMemberus-gaap:GeneralAndAdministrativeExpenseMember2022-01-012022-12-310001835378ctv:LegacyPlanAnd2021PlanMemberMemberus-gaap:ShareBasedPaymentArrangementEmployeeMemberus-gaap:GeneralAndAdministrativeExpenseMember2021-01-012021-12-310001835378ctv:LegacyPlanAnd2021PlanMemberMemberus-gaap:ShareBasedPaymentArrangementEmployeeMemberus-gaap:GeneralAndAdministrativeExpenseMember2020-01-012020-12-310001835378ctv:LegacyPlanAnd2021PlanMemberMemberus-gaap:ShareBasedPaymentArrangementEmployeeMember2022-01-012022-12-310001835378ctv:LegacyPlanAnd2021PlanMemberMemberus-gaap:ShareBasedPaymentArrangementEmployeeMember2021-01-012021-12-310001835378ctv:LegacyPlanAnd2021PlanMemberMemberus-gaap:ShareBasedPaymentArrangementEmployeeMember2020-01-012020-12-310001835378us-gaap:ShareBasedPaymentArrangementNonemployeeMember2022-01-012022-12-310001835378us-gaap:ShareBasedPaymentArrangementNonemployeeMember2021-01-012021-12-310001835378us-gaap:ShareBasedPaymentArrangementNonemployeeMember2020-01-012020-12-310001835378srt:MinimumMember2022-01-012022-12-310001835378srt:MaximumMember2022-01-012022-12-310001835378us-gaap:ShareBasedPaymentArrangementEmployeeMember2021-12-310001835378us-gaap:ShareBasedPaymentArrangementEmployeeMember2021-01-012021-12-310001835378us-gaap:ShareBasedPaymentArrangementEmployeeMember2022-01-012022-12-310001835378us-gaap:ShareBasedPaymentArrangementEmployeeMember2022-12-310001835378us-gaap:ShareBasedPaymentArrangementNonemployeeMember2021-12-310001835378us-gaap:ShareBasedPaymentArrangementNonemployeeMember2022-12-310001835378srt:MinimumMemberus-gaap:RestrictedStockUnitsRSUMember2022-01-012022-12-310001835378srt:MaximumMemberus-gaap:RestrictedStockUnitsRSUMember2022-01-012022-12-310001835378us-gaap:ShareBasedPaymentArrangementEmployeeMemberus-gaap:RestrictedStockUnitsRSUMember2021-12-310001835378us-gaap:ShareBasedPaymentArrangementEmployeeMemberus-gaap:RestrictedStockUnitsRSUMember2022-01-012022-12-310001835378us-gaap:ShareBasedPaymentArrangementEmployeeMemberus-gaap:RestrictedStockUnitsRSUMember2022-12-310001835378us-gaap:ShareBasedPaymentArrangementNonemployeeMemberus-gaap:RestrictedStockUnitsRSUMember2021-12-310001835378us-gaap:ShareBasedPaymentArrangementNonemployeeMemberus-gaap:RestrictedStockUnitsRSUMember2022-01-012022-12-310001835378us-gaap:ShareBasedPaymentArrangementNonemployeeMemberus-gaap:RestrictedStockUnitsRSUMember2022-12-310001835378us-gaap:RestrictedStockUnitsRSUMember2022-12-310001835378us-gaap:RestrictedStockUnitsRSUMember2022-01-012022-12-310001835378ctv:EmployeeStockPurchasePlanMember2021-11-300001835378ctv:EmployeeStockPurchasePlanMember2021-11-302021-11-300001835378ctv:EmployeeStockPurchasePlanMembersrt:MaximumMember2021-11-300001835378ctv:EmployeeStockPurchasePlanMember2022-01-012022-12-310001835378us-gaap:WarrantMember2022-01-012022-12-310001835378us-gaap:WarrantMember2021-01-012021-12-310001835378ctv:PaycheckProtectionProgramMember2022-01-012022-12-310001835378ctv:PaycheckProtectionProgramMember2021-01-012021-12-310001835378ctv:PaycheckProtectionProgramMember2020-01-012020-12-310001835378us-gaap:DomesticCountryMember2022-12-310001835378us-gaap:DomesticCountryMember2021-12-310001835378us-gaap:StateAndLocalJurisdictionMember2022-12-310001835378us-gaap:StateAndLocalJurisdictionMember2021-12-310001835378us-gaap:ForeignCountryMember2022-12-310001835378us-gaap:ForeignCountryMember2021-12-310001835378ctv:TVSquaredMember2022-12-31ctv:segment0001835378country:US2022-01-012022-12-310001835378country:US2021-01-012021-12-310001835378country:US2020-01-012020-12-310001835378country:CA2022-01-012022-12-310001835378country:CA2021-01-012021-12-310001835378country:CA2020-01-012020-12-310001835378srt:AsiaPacificMember2022-01-012022-12-310001835378srt:AsiaPacificMember2021-01-012021-12-310001835378srt:AsiaPacificMember2020-01-012020-12-310001835378us-gaap:EMEAMember2022-01-012022-12-310001835378us-gaap:EMEAMember2021-01-012021-12-310001835378us-gaap:EMEAMember2020-01-012020-12-310001835378srt:LatinAmericaMember2022-01-012022-12-310001835378srt:LatinAmericaMember2021-01-012021-12-310001835378srt:LatinAmericaMember2020-01-012020-12-310001835378country:IL2022-12-310001835378country:IL2021-12-310001835378country:US2022-12-310001835378country:US2021-12-310001835378ctv:RestOfTheWorldMember2022-12-310001835378ctv:RestOfTheWorldMember2021-12-310001835378ctv:PreferredStocksMember2022-01-012022-12-310001835378ctv:PreferredStocksMember2021-01-012021-12-310001835378ctv:PreferredStocksMember2020-01-012020-12-310001835378us-gaap:EmployeeStockOptionMember2022-01-012022-12-310001835378us-gaap:EmployeeStockOptionMember2021-01-012021-12-310001835378us-gaap:EmployeeStockOptionMember2020-01-012020-12-310001835378us-gaap:RestrictedStockUnitsRSUMember2022-01-012022-12-310001835378us-gaap:RestrictedStockUnitsRSUMember2021-01-012021-12-310001835378us-gaap:RestrictedStockUnitsRSUMember2020-01-012020-12-310001835378us-gaap:WarrantMember2022-01-012022-12-310001835378us-gaap:WarrantMember2021-01-012021-12-310001835378us-gaap:WarrantMember2020-01-012020-12-31
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 10-K
xAnnual Report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
For the fiscal year ended December 31, 2022
¨TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the transition period from _____ to _____
Commission file number 001-40048
Innovid Corp.
(Exact name of registrant as specified in its charter)
____________________________
Delaware87-3769599
(State or other jurisdiction of incorporation or organization)(I.R.S. Employer Identification Number)
30 Irving Place, 12th Floor
New York, New York 10003
(Address of Principal Executive Offices, including Zip Code)
Registrant's telephone number, including area code: +1 (212) 966-7555
Securities registered pursuant to Section 12(b) of the Act:
Title of each classTrading Symbol(s)Name of each exchange on which registered
Common stock, par value $0.0001 per shareCTVNew York Stock Exchange
Warrants to purchase one share of common stock, each at an exercise price of $11.50 per shareCTVWSNew York Stock Exchange
Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act.Yes ¨ No x
Indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.Yes ¨ No x
Indicate by check mark whether the registrant: (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports); and (2) has been subject to such filing requirements for the past 90 days.Yes x No ¨
Indicate by check mark whether the registrant has submitted electronically and posted on its corporate web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). Yes x No ¨
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See the definitions of “large accelerated filer,” “accelerated filer” and “smaller reporting company” in Rule 12b-2 of the Exchange Act. (Check one):
Large accelerated filer¨Accelerated filerx
Non-accelerated filer¨Smaller reporting companyx
Emerging growth companyx
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ¨¨
Indicate by check mark whether the registrant has filed a report on and attestation to its management’s assessment of the effectiveness of its internal control over financial reporting under Section 404(b) of the Sarbanes-Oxley Act (15 USC. 7262(b)) by the registered public accounting firm that prepared or issued its audit report. ☐
If securities are registered pursuant to Section 12(b) of the Act, indicate by check mark whether the financial statements of the registrant included in the filing reflect the correction of an error to previously issued financial statements. ☐
Indicate by check mark whether any of those error corrections are restatements that required a recovery analysis of incentive-based compensation received by any of the registrant’s executive officers during the relevant recovery period pursuant to § 240.10D-1(b). ☐
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Act). Yes ¨ No x
The aggregate market value of voting and non-voting stock held by non-affiliates of Innovid Corp. on June 30, 2022, based on the closing price of $1.66 for shares of common stock, was approximately $220 million. Shares of common stock beneficially owned by each executive officer, director, and holder of more than 10% of our common stock have been excluded in that such persons may be deemed to be affiliates.
The registrant had outstanding 136,281,196 shares of common stock as of March 1, 2023.
DOCUMENTS INCORPORATED BY REFERENCE
Portions of the registrant’s definitive Proxy Statement for its 2023 Annual Meeting of Stockholders are incorporated by reference into Part III of this Annual Report on Form 10-K.

TABLE OF CONTENTS
Page
Item 6. [Reserved]
F-1
2
CAUTIONARY STATEMENT REGARDING FORWARD-LOOKING STATEMENTS
This Annual Report on Form 10-K contains forward-looking statements. These forward-looking statements include, without limitation, statements relating to expectations for future financial performance, business strategies or expectations for our business. These statements are based on the beliefs and assumptions of the management of Innovid. Although Innovid believes that its plans, intentions and expectations reflected in or suggested by these forward-looking statements are reasonable, it cannot assure you that it will achieve or realize these plans, intentions or expectations. These statements constitute projections, forecasts and forward-looking statements, and are not guarantees of performance. Such statements can be identified by the fact that they do not relate strictly to historical or current facts. When used in this prospectus, words such as “anticipate,” “believe,” “can,” “continue,” “could,” “estimate,” “expect,” “forecast,” “intend,” “may,” “might,” “plan,” “possible,” “potential,” “predict,” “project,” “seek,” “should,” “strive,” “target,” “will,” “would” and similar expressions may identify forward-looking statements, but the absence of these words does not mean that a statement is not forward-looking.
Should one or more of a number of known and unknown risks and uncertainties materialize, or should any of our assumptions prove incorrect, our actual results or performance may be materially different from those expressed or implied by these forward-looking statements. Some factors that could cause actual results to differ include, but are not limited to:
• our public securities’ potential liquidity and trading;
• our ability to raise financing in the future;
• our success in retaining or recruiting, or changes required in, our officers, key employees or directors;
• changes in applicable laws or regulations;
• our ability to maintain and expand relationships with advertisers;
• decreases and/or changes in CTV audience viewership behavior;
• Innovid’s ability to make the right investment decisions and to innovate and develop new solutions;
• the accuracy of Innovid’s estimates of market opportunity, forecasts of market growth and projections of future financial performance;
• the extent of investment required in Innovid’s sales and marketing efforts;
• Innovid’s ability to effectively manage its growth;
• sustained overall demand for advertising;
• the impact of the COVID-19 pandemic;
• the continued acceptance of digital advertising by consumers and the impact of opt-in, opt-out or ad-blocking technologies;
• Innovid’s ability to scale its platform and infrastructure to support anticipated growth and transaction volume;
• the impact of increasing competition in the digital advertising space, including with competitors who have significantly more resources;
• other risks and uncertainties indicated in this prospectus, including those set forth under the section titled “Risk Factors.”
These forward-looking statements are based on information available as of the date of this Annual Report on Form 10-K and current expectations, forecasts and assumptions, and involve a number of judgments, risks and uncertainties. Accordingly, forward-looking statements should not be relied upon as representing our views as of any subsequent date, and we do not undertake any obligation to update forward-looking statements to reflect events or circumstances after the date they were made, whether as a result of new information, future events or otherwise, except as may be required under applicable securities laws.
As a result of a number of known and unknown risks and uncertainties, our actual results or performance may be materially different from those expressed or implied by these forward-looking statements. You should not place undue reliance on these forward-looking statements.
3
SUMMARY OF THE RISK FACTORS
Innovid’s business is subject to numerous risks and uncertainties, including those highlighted in the section titled Item 1A. “Risk Factors” below, that represent challenges that Innovid faces in connection with the successful implementation of our strategy and the growth of our business. In particular, the following considerations, among others, may offset our competitive strengths or have a negative effect on our business strategy, which could cause a decline in the price of shares of our common stock or warrants and result in a loss of all or a portion of your investment:
• Innovid has a history of net losses in the previous years, and it anticipates increasing operating expenses in the future, and it may not be able to achieve and, if achieved, maintain profitability;
• Decrease and/or changes in CTV audience viewership behavior may adversely affect Innovid’s business and growth potential;
• If Innovid fails to make the right investment decisions, or if it fails to innovate and develop new solutions that are adopted by advertisers, it may not attract advertisers, which could have an adverse effect on Innovid’s business, results of operations and financial condition;

• Innovid’s estimates of market opportunity, forecasts of market growth and projections of future financial performance may prove to be inaccurate;
• Innovid’s sales and marketing efforts may require significant investments and, in certain cases, involve long sales cycles, and may not yield the results Innovid seeks;
• If Innovid does not manage its growth effectively, the quality of its platform and solutions may suffer, and its business, results of operations, and financial condition may be adversely affected;

• Innovid’s revenue and results of operations are highly dependent on the overall demand for advertising;
• Innovid’s business depends on a limited number of advertising agencies and advertisers;
• If the use of digital advertising is rejected by consumers, through opt-in, opt-out or ad-blocking technologies or other means, it could have an adverse effect on Innovid’s business, results of operations, and financial condition;
• The extent to which the COVID-19 pandemic, including the resulting global economic uncertainty, and measures taken in response to the pandemic, may continue adversely to affect Innovid’s business. results of operations, and financial condition remains uncertain and difficult to predict;
• If the ability to collect, use, and disclose data is limited by consumer tools, regulatory restrictions or technology limitations, certain advertising offerings could be impacted and Innovid’s business may be adversely affected;
• Market pressure may reduce Innovid’s revenue per impression;
• Innovid must scale its platform infrastructure to support anticipated growth and transaction volume and it may fail to do so;
• If advertisers, publishers and data providers do not obtain necessary and requisite consents from consumers for Innovid to process their personal data, Innovid could be subject to fines and liability;
• Innovid faces intense and increasing competition for employee talent, and if it does not retain and continue to attract highly skilled talent or retain its senior management team and other key employees, it may not be able to sustain its growth or achieve its business objectives;
• Seasonal fluctuations in advertising activity could have a negative impact on Innovid’s revenue, cash flow and operating results;
• Innovid is subject to payment-related risks, and if its ability to accurately and timely collect payments is impaired, it’s business, financial condition and results of operations may be adversely affected;
• Any interruptions or delays in services from third parties, including data center hosting facilities, cloud computing platform providers and other hardware and software vendors, or disruptions from Innovid’s inability to adequately plan for and manage service failures or infrastructure capacity requirements, could impair the delivery of Innovid’s services and harm its business;
4
• Innovid’s software platform could be susceptible to errors, defects, or unintended performance problems that could adversely affect its business, results of operations, and financial condition;
• If CTV, mobile devices or their operating systems and Internet browsers develop in ways that prevent advertisements from being delivered to consumers, Innovid’s business, results of operations, and financial condition generally, could be adversely affected;
• The market in which Innovid participates is intensely competitive, and Innovid may not be able to compete successfully with its current or future competitors;
• Innovid relies on advertisers and publishers to abide by contractual requirements and relevant laws, rules, and regulations when using its platform. Legal claims or enforcement actions resulting from their actions could expose Innovid to liabilities, damage its reputation, and be costly to defend. In addition, in certain instances Innovid’s campaigns are dependent upon the performance of third-parties hired by its clients. Any failure of such parties to meet expected performance benchmarks could have a negative impact on the success of Innovid’s services;
• Innovid’s platform relies on third-party open source software components, any failure to comply with the terms of underlying open source software licenses could negatively impact Innovid’s business;
• Innovid relies on integrations with demand- and supply-side advertising platforms, ad servers and social platform over which we exercise very limited control. A decrease in demand for advertising and public criticism of digital advertising technology in the US and internationally, could adversely affect the demand for and use of Innovid’s solutions;
• Changes in tax laws or tax rulings could materially affect Innovid’s effective tax rates, financial position and results of operations;
• Innovid Innovid experiences fluctuations in its results of operations due to a number of factors, which make Innovid’s future results difficult to predict and could cause its operating results to fall below expectations or guidance;
• If we fail to maintain an effective system of internal controls over financial reporting in the future we may not be able to accurately or timeously report our financial condition or results of operations;
• Innovid is subject to legislation related to data privacy and data protection in a variety of jurisdictions, failure to comply with such laws may adversely affect Innovid’s business;
• An assertion from a third party that Innovid is infringing its intellectual property rights, whether such assertion is valid or not, could subject it to costly and time-consuming litigation, expensive licenses or other impacts to its business;
• Innovid’s intellectual property rights may be difficult to enforce and protect, which could enable others to copy or use aspects of its technology without compensation, thereby eroding its competitive advantages and having an adverse effect on its business, results of operations, and financial condition;
• Any failure of Innovid’s platform to operate as expected, including as a result of system failures, security breaches or cyberattacks, may adversely affect Innovid’s business;
• In the future, Innovid may need to obtain additional financing that may not be available or may reduce its profitability or result in dilution to its stockholders;
• The price of our common stock and warrants was and may be volatile in the future; and
• We do not intend to pay cash dividends for the foreseeable future.



5
WHERE TO FIND MORE INFORMATION
Our website address is www.innovid.com. We may use our website as a means of disclosing material non-public information. Such disclosures will be included on our website in the “Investors” section or at investors.innovid.com. We may also use certain social media channels, such as LinkedIn, Facebook or Twitter, as a means of disclosing information about us and our business to our colleagues, customers, investors and the public. While not all of the information that the Company posts to the Innovid website or to social media accounts is of a material nature, some information could be deemed to be material. Accordingly, investors should monitor our website and certain of our social media channels, in addition to following our press releases, SEC filings and public conference calls and webcasts. However, information contained on, or that can be accessed through, these communications channels do not constitute a part of this Annual Report and are not incorporated by reference herein. Our SEC filings are available to you on the SEC’s website at http://www.sec.gov. This site contains reports and other information regarding issuers that file electronically with the SEC. The information on that website is not part of this Annual Report and is not incorporated by reference herein.

6
Part I
Item 1. Business
Innovid Corp. together with its consolidated subsidiaries ( the “Company,” “we,” “us,” “our,” and “Innovid”), is a leading independent software platform that provides ad serving, measurement and creative services for the creation, delivery, and measurement of TV ads across connected TV (“CTV”), mobile TV and desktop TV environments to advertisers, publishers and media agencies.
Vision
Innovid’s vision is to reimagine TV advertising. Our name stands for innovation in video, and originated from our desire to change how the world engages with TV and video advertisements. Our mission is to provide the infrastructure empowering advertisers to connect with consumers in a more personalized, data-driven and interactive manner and to measure the impact of advertising across linear and CTV and digital.
About Innovid
CTV is a large and growing industry with significant upside potential, but it also has its own set of challenges. Innovid’s solutions are designed to solve three core areas of disruption for large advertisers shifting investment to CTV; the streaming and delivery of creative, personalization of creative, and measurement. Our solutions starts with the workflow for personalizing and delivering ads, a process that allows us to receive signals to enable measurement of advertising. In the middle of this workflow loop is a complex ecosystem of providers that Innovid supports through collaboration and integration, but does not compete with. This includes Demand Side Platforms who enable programmatic ad buying.
Overview
We are a leading independent software platform that provides critical technology infrastructure for the creation, delivery, and measurement of TV/video ads across CTV, linear TV, mobile and desktop TV environments. As of December 31, 2022, over 50% of the top 200 advertisers by TV US advertising spend according to Kantar Media are utilizing our platform in their advertisement delivery infrastructure. Innovid’s revenue has grown alongside the growth of CTV advertising. We believe our open platform and purpose-built technology for CTV, combined with our position as a media-independent provider, has allowed us to win a large and growing market share, while the growth of CTV combined with our usage-based revenue model has further contributed to our rapid growth. CTV accounted for 51%, 46% and 40% of all video impressions served by Innovid during the years ended December 31, 2022, 2021 and 2020, respectively. During the year ended December 31, 2022, this represented a year-over-year increase of 28%. An impression is the metric used to quantify the number of views of an advertisement. Impressions are measured by cost per mille (“CPM”), where mille refers to 1,000 impressions (or cost per thousand). For example, a CTV ad might have a CPM of $25, meaning that the content owner receives $25 every time an ad is displayed 1,000 times within a designated program. Ad servers, such as Innovid, provide a pixel that is implemented within an ad. When an ad with that pixel loads, an impression is counted. Counting impressions is essential to how digital advertising is measured, accounted and paid for. We serve many of the top TV advertisers, including Anheuser-Busch InBev, CVS Pharmacy, Kellogg’s, Mercedes-Benz, Target, Sanofi, and many more, with such clients representing the key verticals we serve.

A key driver of CTV growth has been the evolving preferences of consumers. Consumers are increasingly cutting the cord and streaming TV content over-the-top (“OTT”) through internet-connected devices rather than traditional broadcast, satellite or cable TV. We believe OTT content, which is typically delivered on-demand, seeks to provide a better user experience, and often saves the consumer money over traditional paid TV services. Advertisers seeking to engage these audiences are rapidly shifting dollars away from traditional TV mediums towards increasing budgets for CTV. Advertisers can also benefit from the shift to CTV as the digitally delivered ads can be personalized and measured in real time, similar to other digital advertising mediums such as internet browser-based formats. As a result, TV advertisers have better transparency, control and ultimately potential return on investment from their CTV advertising.
7
Innovid’s purpose-built CTV infrastructure platform comprises three key offerings: Ad Serving Solutions, Creative Personalization Solutions and Measurement Solutions. Our software-based platform provides an open technology infrastructure that tightly integrates with the highly fragmented advertising technology and media ecosystem including Demand Side Platforms such as The Trade Desk and Amobee; supply side platforms such as Magnite and Verizon Media; publishers such as Hulu and Peacock; and end user devices such as Amazon Fire and Samsung Smart TV. Our offerings encompass independent global ad serving, data-driven personalization, and new forms of measurement designed to connect all channels in a clean, comparable, and privacy-compliant manner. Although we work closely with the vendors who buy and sell media, our platform only facilitates the creation, delivery and measurement of advertisements and campaigns and we do not make purchasing decisions of advertisement inventory. Because we do not make ad buying or selling decisions we are able to maintain our independence and remain free of potential buying conflicts.
Our target clients comprise the largest global TV advertisers. In addition, we work closely with top advertising agency holding companies such as WPP, Publicis Groupe, Omnicom, Interpublic Group of Cos. and Dentsu. Our clients are diversified across all major industry verticals, including consumer packaged goods, pharmaceutical and healthcare, retail, financial services, automotive and technology. We believe Innovid’s independence is critical to advertisers seeking an interoperable and open partner that is primarily focused on technology infrastructure. We define core clients as advertisers or publishers that generate at least $100,000 of annual revenue. Prior to our acquisition of TVS, our definition of a core client included only advertisers that generated at least $100,000 of annual revenue but publishers are now included as well due to their meaningful contribution to our client base we have a history of strong growth in our core client base, with 174 core clients as of December 31, 2022, including 41 core clients added from the acquisition of TVS. No individual core client represented more than 12% of 2022 revenue. In 2022 we had 174 core clients that generated approximately 88% of the total company revenue, which includes TVS core clients and the combination of advertisers and publishers. In the years ended December 31, 2021 and 2020 we had 109 and 95 core clients, respectively, (which did not include publishers) that generated 89% and 91% of total company revenue, respectively. Innovid serves customers globally, including the US, Germany, UK, Mexico, Argentina, Colombia, Israel, Singapore, Japan and Australia. In 2022 approximately 10% of Innovid’s revenue was generated by our customers outside of the US.

Our revenue model is based on impressions volume and the cost per impression for our various ad serving services. For our core ad serving platform, we generate revenue from our advertising customers based on the volume of advertising impressions delivered, enabling us to grow as our customers increase their digital ad spend and corresponding ad impressions. We also provides measurement services to brand and agencies, enterprise clients (networks) and publishers. The measurement service provide analysis on and track performance of advertisement campaigns. The measurement service provides insights into the effectiveness of TV and digital advertising. Revenues related to the measurement services platform are recognized over time, since the customer simultaneously receives and consumes the benefits provided by the Company’s performance. Revenues for these measurement services are recognized over the service period. Additionally, we generate revenue from creative services based on flat fee per projects. As we introduce new products such as advanced measurement and creative capabilities including personalization and interactivity, we expect to be able to charge higher prices per impression volume.
The Innovid Platform
Innovid powers many of the leading TV advertisers globally through its integrated solutions across CTV, linear TV, mobile TV, desktop TV, display and other channels. The Innovid platform consists of three core offerings: Ad Serving, Creative Personalization and Measurement. Together, these offerings allow brands and advertisers to effectively deliver personalized ads to audiences and measure effectiveness across all major TV mediums.
Ad Serving Solutions
Innovid’s ad serving platform consists of three primary offerings:
•Campaign Submission Form - Our CSF is a web-based portal used by clients to submit all advertising campaign information and creative assets. The CSF allows marketers to upload assets, which are then automatically validated and subjected to QA procedures to ensure compliance with approximately 55 different delivery format specifications. Validated assets are then automatically encoded to deliver multiple publisher-specific versions of a single base asset delivered by our customers. The CSF also allows advertisers to submit relevant vendor integrations (e.g., viewability and verification) and to set up creative ad rotation and swap strategies. We integrate with third-party APIs to seamlessly pass ad creative where third-party ad serving is not allowed.
8
•Campaign Management Tool - The CMT is our platform portal for campaign implementation and management. The CMT is our central hub for managing partner integrations, publisher tag generation, click-through and tracking management, as well as supporting QA. This workflow tool leverages multiple integrations and verification partners to streamline day-to-day operations, eliminate unnecessary work, expedite campaign launches and minimize reporting discrepancies.
•Analytics Dashboard - Our analytics dashboard provides a unified visualization of ad performance filterable by delivery, audience reach, device breakdown, viewability, verification and more. Within the UI, our custom report building feature allows users to customize and save their own templated reports, scheduling them for automatic delivery if desired. Our platform also provides several templates to guide users in their report building as well as integrating with third-party data visualization partners.
Creative Personalization Solutions
Our dynamic creative optimization (“DCO”) solution enables advertisers to generate millions of personalized ad versions from a single asset. Multiple tools within our creative optimization solution are proprietary to Innovid.
•Software Development Kit (“SDK”) - Our proprietary SDK allows CTV publishers to execute advanced video formats across all CTV devices and enables advanced measurement. The Innovid SDK is integrated with many of the leading CTV apps and devices, including a device-level integration in the Roku Ad Framework, a direct integration with Hulu and Paramount APAC, as well as integrations with a growing list of publishers and app developers, providing advanced video capabilities into more than 100 apps on all the leading devices.
•Creative Composer Suite: We provide flexibility for designers and developers to author ads through any combination of internal, external, and/or code-based tools. Our ad authoring solutions allow clients to handle the design and development of interactive and personalized templates in tandem, which saves time and allows focus on the creative. Our proprietary suite features CTV Composer, an intuitive tool that enables the design of custom or templated interactive and dynamic CTV ads. We also offer Adobe and Google Web Designer plug-ins to streamline ad creation and data feed mapping, in addition to an open creative API for a code-based solution.
•Decision Trees. Our decision trees provide flexibility to create and visualize strategies using boolean logic across multiple data sets. Users can combine and prioritize across first-and third-party data sets such as geo, weather, date/time, audience, frequency, sequencing, publisher data, retargeting, and ISP. Within each decision tree branch, creatives can be managed via ad rotation, sequencing, and optimization. We can also connect directly to client APIs to build a custom strategy.
•Dynamic Rendering Engine. Our proprietary dynamic rendering engine is robust, and uses automation to streamline workflows. It is designed to seamlessly pre-render dynamic static images, animations, and videos. These ads are assembled server-side (cloud) and in real-time upon ad request. Our proactive certification includes automated specifications compliance and video encoding, ensuring that ads are served at the highest possible quality across all publishers and devices, including 4K CTV.
Measurement Solutions
Our measurement solutions are designed to provide holistic and granular household-level analysis for the TV and digital ecosystem. In addition to standard measurement and reporting included within Innovid’s ad serving solutions, we provide converged TV measurement through InnovidXP. Innovid acquired TVSquared (“TVS”), an independent global measurement and attribution platform for converged TV, in Q1 2022, establishing a global, independent measurement platform for linear TV, CTV, and digital. InnovidXP measures across the TV universe, enabling accurate, always-on, identity-enabled measurement and attribution, at scale, for advertisers everywhere – driving brand growth and maximizing audience reach.
•Measure Reach and Frequency: Provides a holistic view of total TV media investment with cross-platform measurement, inclusive of incremental reach and ad delivery across linear and streaming campaigns.
•Impression measurement across channels and audiences;
◦Accurate reach and frequency metrics;
◦Optimal reach and frequency for the greatest efficiency;
◦Incremental reach beyond linear and across streaming platforms;
9
•Quantify TV Impact and Business Outcomes: Measures the immediate and longer-term business impact of converged TV campaigns with full-funnel analytics and rapid speed to insight.
◦Online and offline outcomes;
◦KPIs that matter – sales, registrations, app activities, web visits, in-store traffic and more;
◦Complete TV ROI, from total campaign to individual publishers and media channels;
•Inform Activation with Audience Analytics: Link authenticated household-level viewing data along the customer journey for advanced audience analytics that inform activation.
◦Audience reach and response across channels, platforms and screens;
◦Campaign optimization for audiences most likely to convert;
◦First- and third-party audience data tied to ad exposure for identity resolution.
Growth Strategy
We intend to continue penetrating the advertising market through the following key growth areas, which we believe will help us continue to gain market share in the markets we serve.
Growing with Our Current Customers
As TV investment continues to shift from linear to CTV, we expect to continue to benefit from the natural volume growth of CTV impressions. We have driven consistently positive net revenue retention of our core client base, those that spend $100,000 or more annually, largely through increased CTV advertising volume. As legacy TV budgets migrate from linear TV to CTV we anticipate there will be significant growth upside in the coming years.
Cross-Sell and Upsell Additional Products and Solutions to Our Existing Customers
We will continue to invest in cross-selling and upselling existing customers. We cross-sell our personalized creative solutions to primary ad serving customers, who, for example, launch with standard TV ads then introduce personalized formats over time. We cross-sell our advanced converged TV measurement solution to provide real-time metrics to inform optimization of cross-platform campaigns while in market, a departure from the traditional delayed post-campaign reporting widely available in market.
Expand to New Customer Groups
The acquisition of TVSquared, brought a portfolio of publisher and mid-market brand customers (such as Direct to Consumer brands). As TV investment and consumer behavior continues to shift from linear to CTV, we have identified the opportunity for our total addressable market to be larger than just Enterprise top TV advertising spenders and we intend to drive growth among these segments.
Expand Our International Presence
The majority of our clients are global advertisers and operate at a significant scale. We intend to continue to grow our footprint in international markets in order to meet the needs of our global customer base and accelerate new customer acquisition in key geographies outside of North America.
Win New Client Accounts
We intend to continue targeting new brand, media agency and digital publisher customers who are currently utilizing solutions provided by our competitors or point solutions. We see a significant opportunity to grow our customer base by introducing enhanced capabilities with an emphasis on data, identity resolution and cross-channel measurement.
10
Pursue M&A Opportunities
Our management team has a proven track record of identifying, evaluating, executing and integrating strategic acquisitions. Innovid completed the acquisition of TVSquared, a leading independent global measurement and attribution platform for converged TV, in 2022. Through this acquisition we expanded our technology and solutions offerings to encompass real-time, cross-platform analysis, including outcomes such as reach, frequency and unduplicated reach, as well as performance metrics. Additionally, the acquisition added approximately 145 employees with expertise in measurement and attribution while broadening our geographic footprint in Europe and expanding measurement capabilities to over 75 countries. We maintain an active pipeline of potential M&A targets and intend to continue evaluating add-on opportunities to bolster our current solutions suite and complement our organic growth initiatives.
Partnerships and Integrations
In a market that has been trending towards walled garden consolidation, we believe our independence allows us to work with any publisher or partner, without media bias or ad-buying conflicts of interest. Because of this open platform approach, we have been able to develop deep integrations with partners across the ad tech ecosystem.
Innovid’s integrations are designed to automate workflow and streamline the development and distribution of advertisements, all the while saving marketers time and money. Innovid integrations include:
•Campaign Workflow Integrations - Campaign management and trafficking integrations with DSPs like The Trade Desk, digital asset management vendors such as AdStream for example, streamline day-to-day workflow by eliminating unnecessary work, expediting campaign launches, and minimizing reporting discrepancies.
•Brand Safety and Ad Fraud Integrations - Innovid supports deep verification, viewability, and ad blocking capabilities with vendors such as Moat, IAS, DV, and Comscore.
•Media Providers and Walled Garden Integrations - Innovid’s independent third-party ad tags are accepted by media providers and content platforms globally. Innovid is a Google Preferred Measurement Partner and is fully integrated with Google’s Ads Data Hub. Innovid is also a Preferred Creative Partner of Facebook and Instagram.
•Data and Creative Personalization Integrations - Innovid maintains server-to-server integrations to enable ad decisioning from audience segments and/or IDs passed from partners. We integrate with leading Data Management Platforms (“DMP”) such as LiveRamp, Oracle, Neustar, Salesforce, and Adobe. Innovid also supports creative decision-making based on audience data passed directly from the brand’s choice of Demand Side Platform . Examples include, but are not limited to Adobe, Verizon Media and The Trade Desk.
•Creative Ad Authoring Integrations - Innovid provides full flexibility for designers and developers to curate ads through any combination of internal, external, and/or code-based tools. Integrations include Adobe Photoshop, After Effects, and Google Web Designer.
•Brand Research and Attribution Integrations - Brand study partners directly integrated with Innovid include Comscore, Nielsen DAR, and Kantar (Millward Brown). Innovid is also able to implement third-party pixels to support direct tracking or pursue deeper integrations with other third-party measurement providers.
•Data Visualization Integrations - Third-party data processing and analytics tools can tap into Innovid’s Data API or connect to a raw data feed to receive Innovid data for further analysis.
•Third Party Ad Server Integrations - Innovid enables brands to leverage the power of our omni-channel ad serving and analytics platform through 1x1 pixels, while continuing to use other ad servers to manage their search campaigns and multi-touch attribution goals.
Certifications and Accreditations
As an independent ad server, Innovid is deeply invested in ensuring the accuracy of our ad delivery and measurement on behalf of our clients. Proactive publisher certification prior to campaign launch can significantly reduce the number of data discrepancies and/or errors with the rendering of tags.
11
Innovid’s publisher certification process is supported via a dedicated certification team that maintains a database of thousands of publishers, networks, and exchanges. The process is made up of both a functional and discrepancy test to ensure all ads are rendered at their highest possible quality, all pixels are firing correctly, and reporting is as expected. Our team certifies publishers pre-campaign, verifying compliance with Interactive Advertising Bureau (“IAB”) and MRC standards. When ads are uploaded to our platform our system automatically references Innovid’s publisher certification database. Our automatic encoding engine then instantly resizes ads to individual publisher specs, from a single asset, to meet the requirements for each partner on a media plan.
Innovid also holds industry-leading MRC accreditations, a common standard for media transacting with leading advertisers, spanning CTV, video and display ad formats. The MRC establishes industry standards for valid, reliable and effective media measurement. Innovid has been accredited with the MRC since 2013 for impressions and viewable impressions on desktops, mobile webs, and mobile apps. In 2018, the MRC granted Innovid the first ever MRC accreditation for OTT video ad impression measurement, cementing an important milestone in the industry’s ongoing evolution in this space. As a result of this accreditation, Innovid’s accredited metrics and methodologies have been independently vetted by the MRC to confirm they are valid, reliable and effective.
Customers
During 2022 Innovid served as the ad delivery platform for over 50% of the top 200 TV advertisers in the US including Anheuser-Busch InBev, Kellogg’s, Mercedes-Benz, and many more, with such clients representing key verticals we serve and Anheuser-Busch InBev, and Kellogg’s, each a core client (brand/advertiser). Our clients are comprised of the largest TV advertisers, with the majority of our customers typically coming from large global enterprises. We define a customer as an entity that generates revenue during a certain period of time. A single organization with multiple divisions, segments or subsidiaries is treated as a single customer, even though we may enter into commercial agreements with multiple parties within that organization.
We define a core client as an advertiser or publisher that generates at least $100,000 of annual revenue. Looking at our core clients on an annual basis and presenting related metrics only on an annual basis rather than also on an interim basis helps us avoid overstating or understating the importance of certain customers to our overall business based on their spending in any particular period. Together our core clients typically generated more than 84% of our annual revenue from 2020 through 2022, demonstrating our continued focus on large enterprise customers while we diversify our client base.
The number of clients that generated more than $100,000 of annual revenue has increased sequentially year-over-year, driven by our existing customers’ retention as a result of their continued success using our solutions and the growing adoption of our business platform by existing customers for additional use cases. Additionally, we experienced growth in the number of new clients customers that contributed more than $100,000 of revenue.
Our clients are diversified across all major industry verticals, including consumer packaged goods, pharmaceutical and healthcare, retail, financial services, automotive and technology. No single client accounted for more than 12% of our revenue in 2022, with such advertisers or publishers representing brands that contract with us directly, or through third party agencies and publishers, or some combination thereof.
Industry Overview
As consumers rapidly shift their viewing from traditional linear TV to streaming TV, marketers and agencies are recognizing the need to make CTV a strategic focus. We believe that our business benefits from many of the most significant trends in converged TV advertising.
Advertisers see the opportunity of CTV and are investing in it.
•Consumers Are “Cutting the Cord” and Adopting Streaming Services with Advertisers Quickly Following Suit. According to eMarketer, US CTV advertising spending is expected to reach $21.3B in 2022, which is 23.8% of total US TV ad spending, up from just 3.8% five years ago. The CTV ad market is projected to more than double by 2026, demonstrating significant upside.
12
•Rise of Advertising-Supported Content. According to eMarketer, more than half of all US internet users will be watching content via AVOD services in 2023. In addition, AVOD viewers seem to be using multiple AVOD services at a time rather than limiting themselves to a single offering; for example, The Roku Channel, Pluto TV and Tubi each have over 50 million viewers in 2022. Large streaming services have been adopting hybrid models, offering both ad-supported and ad-free, subscription tiers. For example, streaming services such as Netflix and Disney+ are adopting this hybrid approach, entering a market that includes Hulu, HBO Max, Paramount+ and Peacock. According to S&P Global Market Intelligence, 7 in 10 Peacock and Hulu users are on ad-supported plans, and a recent Kantar survey estimates about a quarter of existing subscribers would opt for the ad-supported tier of Disney+. As more streaming services adopt ads, this will increase the amount of available advertising inventory in the marketplace.
•Digitalization of TV Advertising. The advertising industry continues to see traditional mediums such as linear TV, radio, and out-of-home (“OOH”) transition to digital channels and platforms. This has created a new environment where the operational silos that existed historically between linear and digital are being removed with new open software and technology platforms enabling this evolution. In particular, according to Dentsu, TV advertising is gravitating toward CTV due to its ability to provide the reach, addressability, interactivity, and measurability most commonly associated with digital media.
But advertisers are challenged to be able to unify and optimize across linear TV, CTV and digital video.
•Fragmentation is increasing. As of December 2022, there were more than 200 streaming services in the market, according to Gazette, presenting a significant challenge for advertisers trying to reach a large audience at scale. The growing ecosystem of disparate partners, each with their own unique formats, infrastructure and operating procedures has fueled increased demand for open and independent technology platforms that are able to connect and simplify workflows across the various closed ecosystems, or walled gardens, that restrict access to applications, content and/or media and an increasing universe of other media providers.
•Cross-platform measurement for linear and CTV is still being defined. Television networks and advertisers have relied on traditional metrics such as age, gender and specific air times for linear TV measurement. As viewership continues to fragment and shift towards CTV, data and technology enables advertisers and publishers to capture ad exposures and measure content consumption and ad engagement in new ways. Almost nine in ten advertisers anticipate a converged linear TV/CTV marketplace in the coming years, according to the Interactive Advertising Bureau (“IAB”) May 2022 report “2021 Video Ad Spend & 2022 Outlook”.. However, the process of standardizing measurement across both linear and CTV ads is a key challenge. More than half of advertisers cited accuracy of cross-platform TV measurement and attribution as the top challenge, according to a 2021 TVSquared by Innovid survey. And more than half the marketers reported that inconsistent measurement was a challenge of CTV advertising, according to a May 2021 Innovid and Digiday survey. In addition, almost half of advertisers cite measuring incremental reach across platforms and publishers as the top CTV challenge, according to IAB.
•Ensuring a consistently good user experience across screens is complex. Untargeted ads served at a high frequency have lost favor to a new model focused on fewer, better ads. Marketers are adopting data-driven advertising strategies to improve creative relevance through personalized ads while at the same time optimizing ad delivery against key metrics such as reach and frequency in real-time. It was found that the second most prevalent challenge across 250+ brands and agencies was converged TV creative personalization at scale, according to an Innovid study across 250+ brands and agencies. To do this successfully, at scale, and across a fragmented landscape of publishers, all with different specs, is hard. Technology plays a critical role in empowering advertisers to leverage data to improve relevance and provide the infrastructure for real-time optimization of ad delivery based on accurate measures.
Competition
We operate in multiple competitive markets with different types of competitors. Our primary competition in ad serving and creative personalization solutions is Google. In addition, there are several vendors that provide point solutions addressing creative personalization solutions and DCO such as Jivox. Lastly, we compete with providers of audience and advertising measurement, which are evolving with the marketplace and advertising measurement startups such as iSpot.
To be competitive in our industry, we believe we must focus on:
•the ability to reach and engage with viewers in CTV environments enabled through unique premium publisher partnerships and proprietary SDK technology;
13
•the ability to holistically manage the personalization and delivery of ads dynamically across all addressable formats and channels;
•the ability to automate the ad delivery workflow to reduce rejection rates and decrease manual resources required to deliver TV and other digital ads into addressable environments;
•the ability to provide unified and consistent measurement of linear, CTV, and digital video ads across all available formats and channels;
•the ability to innovate and adapt product offerings to emerging addressable media technologies and offer products that meet changing customer needs;
•the ability to support large, global customers and develop and maintain complex integrations with key partners across the advertising ecosystem;
•the ability to achieve and maintain industry accreditations;
•the ability to collect advertising data across platforms and provide independent measurement to our customers;
•the ability to provide always-on, accurate measurement across linear and CTV for reach & frequency and outcomes at scale, across platforms, including walled gardens.
Talent and Culture
Employees
As of December 31, 2022, we had 531 full time employees across 13 offices in 9 countries, with 198 employees in research and development and related activities. In response to the COVID-19 pandemic, we implemented changes that we determined were in the best interest of our employees and the communities in which we operate, and which comply with government regulations. This includes enabling the vast majority of our employees to work from home, while implementing additional safety measures for employees continuing on-site work where legally possible.
Talent Acquisition and Development
We are focused on recruiting and retaining talented employees across the organization, with a particular focus on unique talent in CTV, product, analytics and many other areas that are critical to our success. We continue to invest to hire and retain top talent in all of our offices. We were included in both Inc. magazine’s and Ad Age Best workplaces for 2022 in the U.S and the DUNS 100 Best HighTech Companies to work for. Our strong reputation has contributed to over 15,000 candidates applying to work at Innovid in 2022. For new hires, we have a robust onboarding program tailored towards individual roles and responsibilities. On an ongoing basis, we invest in training and development programs that help our employees achieve their career goals and build management skills. We have two formal career feedback discussions per year where managers and their employees discuss progress and feedback for each other. We believe in developing and promoting top talent from within: in 2022, approximately one out of every seven of our employees was offered an opportunity for career advancement within the Company.
Diversity, Equity and Inclusion
Innovid is committed to fostering, cultivating and preserving a culture of diversity, equity and inclusion. We embrace and encourage our employees’ differences in age, color, disability, ethnicity, family or marital status, gender identity or expression, language, national origin, physical and mental ability, race, religion, sexual orientation, socio-economic status, veteran status, and other characteristics that make our employees unique.
Innovid’s policies are applicable, but not limited, to our practices and policies on recruitment and selection, compensation and benefits, professional development and training, promotions, transfers, social and recreational programs, layoffs, terminations, and the ongoing development of a work environment built on the premise of diversity equity and inclusion that encourages and enforces:
•Respectful communication and cooperation among all employees;
•Teamwork and employee participation, permitting the representation of all individuals and employee perspectives;
•Work/life balance through flexible work schedules to accommodate employees’ varying needs; and
14
•Contributions to the communities we serve to promote a greater understanding and respect for diversity, equity and inclusion.
All employees of Innovid have a responsibility to treat others with dignity and respect at all times. All employees deserve a work environment free from all forms of discrimination. Innovid similarly prohibits retaliation against employees who file complaints under this policy or who participate in complaint investigations. Any employee found to have exhibited any inappropriate conduct or behavior against others may be subject to disciplinary action. Employees who believe they have been subjected to any kind of discrimination are required to advise HR, their department’s VP or a member of the management team.
Innovid’s commitment to diversity, equity, and inclusion achieved measurable results in 2022. New U.S employees hired during 2022 were 33% BIPOC and 55% women. Existing employee promotions across 2022 were granted to women 53% of the time globally and Black and Indigenous people of color (BIPOC) employees 21% of the time in the US. Additionally several other diversity-focused initiatives including behaviors of inclusion training, compensation audits and a paid internship program were implemented during calendar year 2022.
Regulatory Matters
Data Privacy and Data Protection Laws
Data privacy and data protection legislation and regulation play a significant role in our business. We and our clients use personal data about internet users collected through our platform to manage and execute digital advertising campaigns in a variety of ways, including delivering advertisements to internet users based on their particular geographic locations, the type of device they are using, or their interests as inferred from their web browsing or app usage activity. We do not use this data to further identify specific individuals, and we do not seek to associate this data with information that can be used to further identify specific individuals. We take all required steps to comply with applicable data protection and privacy laws, which continue to evolve. As a result, our platform and business practices must be assessed regularly in each jurisdiction where we do business to avoid violating applicable legislation and regulation.
Data Privacy Regulation in the US
In the United States (“US”), at both the federal and state level, there are laws that govern activities such as the collection and use of data by companies. At the federal level, online advertising activities are subject to regulation by the Federal Trade Commission (“FTC”), which has primarily relied upon Section 5 of the FTC Act, which prohibits companies from engaging in “unfair” or “deceptive” trade practices, including alleged violations of representations concerning privacy protections and acts that allegedly violate individuals’ privacy interests. There are also other data privacy laws that apply. For example, we send marketing emails and are therefore subject to the Controlling the Assault of Non-Solicited Pornography and Marketing Act of 2003, or the CAN SPAM Act, which established specific requirements for commercial email messages, specifies penalties for the transmission of commercial email messages that are intended to deceive the recipient as to source or content, and obligates, among other things, the sender of commercial emails to provide recipients with the ability to opt out of receiving future commercial emails from the sender.
There has been increased regulation of data privacy and security in the United States, particularly at the state level. Some proposed and newly enacted legislation at state level has affected and will continue to affect, our operations and those of our industry partners. For example, the California Consumer Privacy Act (“CCPA”), which came into effect in January 2020, defines “personal information” broadly enough to include online identifiers provided by individuals’ devices, such as IP addresses, and establishes a new privacy framework for covered businesses. The CCPA expanded privacy rights and consumer protection for residents of California and imposes more stringent obligations on companies regarding the level of information and control they provide to users about the collection and sharing of their data. Moreover, the California Privacy Rights Act (“CPRA”), was approved by California voters in November 2020 and will further modify and expand the CCPA, including by expanding consumers’ rights with respect to certain personal information and creating a new state agency to oversee implementation and enforcement efforts. The CPRA came into effect on January 1, 2023. Further, Virginia has adopted a new state data protection act referred to as the Virginia Consumer Data Protection Act, which also came into effect on January 1, 2023. Additionally, Colorado has adopted a new state data protection act titled the Colorado Privacy Act, which is set to take effect on July 1, 2023.
15
Data Privacy Regulation in Europe
Our business activities are also subject to foreign legislation and regulation. In the European Economic Area (“EEA”), separate laws and regulations (and member states’ implementations thereof) govern the processing of personal data, and these laws and regulations continue to impact us. We are subject to the EEA General Data Protection Regulation (“GDPR”) and also the United Kingdom (“UK”) GDPR, which, together with the amended UK Data Protection Act 2018, retains the GDPR in UK national law. The relationship between the United Kingdom and the European Union (“EU”) in relation to certain aspects of data protection law remains unclear, and it is unclear how UK data protection laws and regulations will develop in the medium to longer term, and how data transfers to and from the United Kingdom will be regulated in the long term. These changes may lead to additional costs and increase our overall risk exposure.
In any event, we are subject to laws, rules, and regulations regarding cross-border transfers of personal data, including laws relating to the transfer of personal data outside the EEA and the UK. Recent legal developments in the EEA and the UK have created complexity and uncertainty regarding transfers of personal information from the EEA and the UK to “third countries,” especially the United States. As supervisory authorities issue further guidance on personal data transfer mechanisms, we could suffer additional costs, complaints and/or regulatory investigations or fines, and/or injunctions against processing personal data from the EEA and UK, and if we are otherwise unable to transfer personal data between and among countries and regions in which we operate, it could affect the manner in which we provide our services, the geographical location or segregation of our relevant systems and operations, and could adversely affect our financial results.
We are also subject to evolving EEA and UK privacy laws on cookies and e-marketing which require informed consent for the placement of most cookies or similar technologies on a user’s device and for direct electronic marketing. In the EEA and the UK, regulators are increasingly focusing on compliance with these requirements in the online behavioral advertising ecosystem and are increasingly taking action to enforce them. The EEA GDPR and UK GDPR also impose conditions on obtaining valid consent, such as a prohibition on pre-checked consents and a requirement to ensure separate consents are sought for each type of cookie or similar technology.
Data Privacy Regulation in the Asia-Pacific Region
Our business activities are also subject to legislation and regulation in the Asia-Pacific region. Following the implementation of the GDPR, many jurisdictions have moved to amend, release, review and strengthen their existing data privacy and cyber-security laws, and there has been a progressive effort in the region to work towards coordinating their otherwise disparate laws.
Innovid’s data protection program is largely rooted in the GDPR and Sevice Organization Control Type 2 (“SOC2”) security standards, and any international data transfers from the Asia-Pacific region are governed by direct contractual agreements between the regional entities and Innovid’s US parent corporate entity, Innovid, Corp. Otherwise, our compliance team works to oversee compliance with these Asia-Pacific regional requirements and to address compliance with our region-specific clients and business teams.
Innovid’s General Data Protection and Consumer Privacy Practices
Innovid is dedicated to a high standard of consumer privacy and data protection, while maintaining quality online Advertising Services to various advertisers, agencies, publishers and other businesses across various third party websites and online media.
Innovid has restrictive policies for the collection, use and sharing of consumer data. We maintain membership with the Network Advertising Initiative (“NAI”), a self-regulatory association dedicated to responsible data collection and its use for digital advertising, and the Digital Advertising Aliance (“DAA”), an independent organization led by advertising and marketing trade associations that has established self-regulatory principles enforcing responsible privacy practices for digital advertising and consumer transparency. Innovid also maintains accreditation with the MRC.
Innovid’s collection of consumer data generally consists of basic data elements associated with advertisements served or measured by Innovid, such as impressions, clicks, viewing duration, IP address, date and time of interaction, information about the general geographical location from which a consumer is viewing an advertisement, device type, and other generic identifiers made available by the browser or device. Innovid collects these data elements on behalf of its clients in a data privacy-compliant manner, in order to effectively measure and evaluate the performance of the client’s advertising campaigns, deliver, schedule and sequence ads, administer the client’s account, and provide the client with engagement analysis.
16
At a client’s request, Innovid may assist the client with targeting its ads based on the client’s first-party data or based on data from the client’s selected data management platform. Innovid also offers frequency and ad personalization features such as ad sequencing and creative decisioning based on factors such as general geographic location. Innovid receives user segments from its customers to conduct real-time ad decisioning, but does not create or retain such segments itself. Innovid also does not collect any categories of data deemed sensitive under applicable laws or NAI standards. In a limited number of use cases, the client also has the option to have Innovid collect consumer email addresses or phone numbers on its behalf from selected advertising formats; in these cases, such opt-in data is used solely to fulfill the client’s request.
Innovid upholds consumer choice. Innovid believes consumers should have the right to control how they are targeted across online media. Innovid respects the consumer’s choice to opt-out of interest-based advertising.
Data Security and Compliance with Applicable Laws and Regulations
Innovid is committed to data security and takes a variety of measures in line with industry practice to safeguard the data in its possession from unauthorized alteration, destruction, access or misuse. We maintain tight controls over all the data we collect, retaining it in firewalled and secured databases with strictly limited and controlled access rights, designed to ensure that the data is secure. Additional security measures include encryption of personal information at rest and in transit, maintaining a strict password policy, the use of multi-factor authentication for key systems, maintaining antivirus measures and vulnerability management policies, and the use of various security technologies designed to prevent unauthorized activity.
Innovid maintains compliance with the EU GDPR and UK GDPR. Innovid has in place the EU-approved standard contractual clauses with data exporters from the EU. Innovid has appointed a data protection officer, has a process for responding in a timely manner to data subjects seeking to exercise their rights under GDPR, and takes a proactive approach to putting the necessary contractual provisions in place with its vendors and clients.
Innovid has taken a comprehensive approach to compliance with State privacy laws and will continue to monitor and adjust its approach as the law continues to evolve, to ensure we maintain compliance with the latest regulations, requirements and best practices. As between Innovid and its clients, Innovid is a service provider and does not sell personal information as contemplated under CCPA.
Data policy and privacy regulations are dynamic and constantly changing. In addition to performing yearly internal audits, Innovid continues to monitor its compliance with applicable laws and regulations.
Intellectual Property
We consider our trademarks, trade dress, copyrights, trade secrets, patent and other intellectual property rights, including those in our know-how and the software code of our proprietary technology, to be important components of our success. We rely on intellectual property laws, including trade secret, copyright and trademark laws in the United States and abroad, and use contracts, confidentiality procedures, non-disclosure agreements, employee disclosure and invention assignment agreements and other contractual rights to protect our intellectual property.
As of February 1, 2023, we had 14 granted patents, zero pending patent applications, and seven registered trademark applications covering a variety of interactive and contextual analysis capabilities. We have also registered domain names for websites that we use in our business, such as www.innovid.com.
We design, test and update our products, services and websites regularly, and we have developed our proprietary solutions in-house. Our know-how is an important element of our intellectual property. The development and management of our platform requires sophisticated coordination among many specialized employees. We take steps to protect our know-how, trade secrets and other confidential information, in part, by entering into confidentiality agreements with our employees, consultants, developers and vendors who have access to our confidential information, and generally limiting access to and distribution of our confidential information. To protect our technology against unauthorized access, we also implement multiple layers of security. Access to our platform, other than to obtain basic information, requires system usernames and passwords.
We intend to pursue additional intellectual property protection to the extent we believe it would advance our business objectives and maintain our competitive position.
17
Seasonality
See Item 7. “Management’s Discussion and Analysis of Financial Condition and Results of Operations - Key Factors Affecting Our Performance”
Corporate History and Background
ION Acquisition Corp 2 Ltd. (“ION”) was initially incorporated on November 23, 2020, as a Cayman Islands exempted company formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses. Innovid Inc. was incorporated on June 21, 2007 as a Delaware corporation.
On June 24, 2021, ION, Innovid Inc., Merger Sub 1 and Merger Sub 2 entered into and agreement and plan of merger, the “Merger Agreement”. On November 30, 2021, as contemplated by the Merger Agreement, ION consummated the merger transaction contemplated by the Merger Agreement (the “Transaction”).
As a result of the Transaction, ION changed its name to Innovid Corp. and we became an SEC-registered and NYSE-listed company.
Our Corporate Information
Our principal executive offices are located at 30 Irving Place, 12th Floor, New York, NY 10003 and our telephone number is +1 (212) 966-7555.
Our corporate website address is www.innovid.com. The information contained in, or accessible through, our website is not incorporated by reference into this Annual Report and you should not consider information on our website to be a part of this Annual Report. We have included our website address in this Annual Report solely as an inactive textual reference.
Executive Officers and Directors of the Registrant
Ken Markus and David Helmreich were appointed as executive officers by the Company’s Board on February 23, 2023.This reflects their growing roles in the leadership functions of the Company. Tal Chalozin, while no longer serving as an executive officer, retains his title as Chief Technology Officer. Mr Chalozin will continue to concentrate on working with the executive team to support the formulation and execution of the Company’s future strategy and may also seek out new opportunities in addition to his role with Innovid.
The Executive Officers and Directors are therefore as follows:

NameAgePosition
Zvika Netter50Chief Executive Officer; Director
Tanya Andreev-Kaspin45Chief Financial Officer
David Helmreich52Chief Commercial Officer
Ken Markus48Chief Operating Officer
Gilad Shany(2)(3)
46Director
Brian Hughes (1)
64Director
Michael DiPiano(1)(2)
64Director
Rachel Lam(1)(3)
55Director
Jonathan Saacks(3)
54Director
(1)    Member of the audit committee
(2)    Member of the compensation committee
(3)    Member of the nominating and corporate governance committee
18
Zvika Netter. Mr. Netter serves as CEO of the Company and as a member of the Company’s Board. Mr. Netter has served as the Company’s CEO since the inception of Innovid Inc., and was selected by TIME as one of the “Tech Pioneers Who Will Change Your Life.” Mr. Netter was also named as a World Economic Forum “Technology Pioneer,” as one of “Europe’s Young Entrepreneurs” by Businessweek, and as a 2016 SmartCEO Magazine Fast 50 CEO and he was featured in Business Insider’s 19 Most Interesting Ad-Tech Startups of 2017. Prior to co-founding Innovid, Inc. in 2007, Mr. Netter served in an elite computer unit in the Israeli Defense Forces, and co-founded the non-profit organization GarageGeeks, an innovation hub with more than 8,000 members. Mr. Netter has authored several patents, and has spoken on stage at several industry events including IAB Innovation Days at Internet Week, IAB Digital Video Marketplace, The Israel Conference, and ILovation.
Tanya Andreev-Kaspin. Ms. Andreev-Kaspin serves as CFO of the Company. Ms. Andreev-Kaspin has served as the CFO of Innovid Inc. since January 2020 and prior to that served as Senior Vice President of Global Finance from 2016 and as Vice President of Finance from 2012 through 2015. Prior to joining Innovid, Ms. Andreev-Kaspin held finance leadership positions in a number of tech startup companies after starting her career as a public auditor at PricewaterhouseCoopers. Ms. Andreev-Kaspin received an MBA, Finance Management from Tel Aviv University and BA, Economics and Accounting from Tel Aviv University.
David Helmreich. Mr. Dave Helmreich serves as Chief Commercial Officer ("CCO") of the company as of December 13, 2022. Prior to this role, Mr. Helmreich served as the Chief Revenue Officer for Stackline, Chief Revenue Officer and Group Vice President for Oracle Marketing cloud, Chief Operating Officer for LiveIntent, CEO for Audience Partners, SVP and GM, Marketing and Advertising solutions for Neustar and more. Mr. Helmreich is a decorated US Navy veteran and holds a B.S. in Computer Science from the United States Naval Academy in Annapolis and an MBA from the Robert H. Smith School of Business at the University of Maryland.
Ken Markus. Ken Markus serves as Chief Operating Officer (“COO”) of the company as of February 7, 2023. Prior to his role as COO, Mr. Markus served as the Company’s Chief Client Officer since January 2019. From October 2015 until January 2019, Mr. Markus served as the Company’s Senior Vice President of Global Operations and Client Services. Prior to joining the Company, Mr. Markus served as the Head of Scale Operations and Services for gTech Ads at Google and held positions at Condé Nast, SiriusXM Satellite Radio, and Time Inc. Mr. Markus received an Executive MBA from Columbia and London Business School, an MS in Data Analytics from City University of New York, and a BS and BAS from the University of Pennsylvania.
Gilad Shany. Mr. Shany co-founded ION Crossover Partners, an Israeli-based crossover fund, where he currently serves as the Managing Partner. Prior to co-founding ION Crossover Partners, Mr. Shany served as General Partner of Magma Venture Partners. Mr. Shany previously served as Vice President of Baron Capital, where he gained more than 10 years of experience investing in innovative growth companies in public and private markets. Mr. Shany led investments with various international companies, including Tesla Inc. (NASDAQ: TSLA), Mobileye N.V. (NYSE: MBLY) (acquired by Intel Corporation (NASDAQ: INTC) $15.3BN), Mellanox Technologies (acquired by Nvidia $6.9BN), Varonis Systems Inc. (NASDAQ: VRNS), Fiverr (NYSE: FVRR), BlueVine Capital Inc. and Monday.com Ltd, among others. Prior to that Mr. Shany spent 14 years with the Israel Air Force and served as Head of Aerial Defense in the Israel Air Force from 2007 to 2008. Mr. Shany holds a B.S. in Physics, Astronomy and Philosophy from Tel Aviv University in Israel and an MBA from the Wharton School at the University of Pennsylvania in Philadelphia, Pennsylvania.
Brian Hughes. Mr. Hughes currently serves as a Director of Bentley Systems (Nasdaq: BSY) and CompoSecure, Inc. (Nasdaq: CMPO). Mr. Hughes was previously an audit partner, the national private markets group leader, and venture capital co-leader at KPMG LLP where he worked from 2002 to 2019 and an audit partner at Arthur Andersen where he worked from 1981 to 2002. Mr. Hughes received a Master’s in Business Administration and a Bachelor of Science in Economics and Accounting from the Wharton School, University of Pennsylvania.
Michael DiPiano. Since December 2001, Mr. DiPiano has been the Chairman of NewSpring Capital where he manages the firm’s investment decisions. Mr. DiPiano currently serves as a director for a number of private companies, including aPriori, Dstillery, Energage, and Interactions where he provides oversight for corporate governance and other business matters. Previously, Mr. DiPiano also served on the Governance and Compensation Committees of NutriSystems. Mr. DiPiano holds a B.S. in Marketing from Penn State University and an MBA from New York University.
19
Rachel Lam. Ms. Lam is the Co-Founder and Managing Partner of Imagination Capital, an early-stage venture capital firm founded in 2017. From 2003 to 2017, Ms. Lam served as SVP and Group Managing Director of the Time Warner Investments Group, the strategic investing arm of Time Warner Inc. Ms. Lam managed Time Warner’s investments in numerous digital media companies and served on the board of directors of privately held Maker Studios and Bluefin Labs prior to their sales to the Walt Disney Company and Twitter, respectively. Ms. Lam has previously served on 20 boards of directors over the years and currently serves on the board of Magnite (NASDAQ: MGNI), the world’s largest independent sell-side ad platform, as well as on the board of Porch Group, Inc. (NASDAQ: PRCH), the vertical software platform for the home, where she is also the Chair of the Nominating & Governance Committee. Ms. Lam also spent several years in investment banking within the M&A group at Morgan Stanley and the Media and Telecommunications group at Credit Suisse. Ms. Lam received a B.S. in industrial engineering and operations research from U.C. Berkeley in 1989 and an M.B.A. from Harvard Business School in 1994.
Jonathan Saacks. Mr. Saacks is currently Managing Partner of F2 Venture Capital. Mr. Saacks was Managing Partner at Genesis Partners and brings extensive early stage investment experience from his roles at operational companies and venture capital funds. Mr. Saacks invested and served on the boards of many successful Israeli companies including Monday.com, PrimeSense and Neebula. Mr. Saacks also served for 10 years in the Intelligence Corps of the Israeli Defense Forces where he commanded large operational teams. Mr. Saacks was a Lieutenant Colonel in the Israeli Defense Forces and holds an MBA from Oxford University and a BA in Economics and Management from Tel Aviv University.
Additional Information
We file electronically with the SEC our annual reports on Form 10-K, quarterly reports on Form 10-Q, current reports on Form 8-K, proxy statements and other information. Our SEC filings are available to the public over the Internet at the SEC's website at www.sec.gov. We make available on our website at investors.innovid.com, free of charge, copies of these reports and any amendments as soon as reasonably practicable after filing or furnishing them with the SEC.
20

Item 1A. Risk Factors
An investment in Innovid involves a high degree of risk and uncertainty. You should carefully consider the risks and uncertainties described below together with all of the other information contained in this prospectus, including the financial statements and the related notes appearing at the end of this prospectus, before deciding whether to purchase our common stock. Additional risks and uncertainties, that we do not presently consider to be material or of which we are not presently aware, may also become important factors that affect our business, results of operations or financial condition, that may materially and adversely affect the investment of Innovid stockholders. See the section titled “Cautionary Statement Regarding Forward-Looking Statements.”
Risks Relating to Innovid’s Business and Industry
Innovid’s business depends on its ability to maintain and expand relationships with advertisers and agencies and continued resilience of ad-spend among existing customers. If Innovid fails to grow its advertiser base or experience continued levels of ad-spend among existing customers, its business may be adversely affected. Similarly, if Innovid’s services or employees fail to perform as expected, it may lose advertisers and its business, results of operations, and financial condition may be adversely affected.
Innovid’s business depends on its ability to maintain and expand relationships with advertisers and agencies. Innovid depends on advertisers and agencies to specify and utilize its offering. Innovid currently relies on, and expects to continue to rely on, approximately 174 core clients calculated according to a new methodology to include publishers described elsewhere in this Form 10-K. This amount may include multiple paying customers. These core clients accounted for 88% of our 2022 revenue, with no single client accounting for more than 12% of our 2022 revenue. To support Innovid’s continued growth, it will seek to add additional advertisers to its platform and expand current utilization with its existing advertisers. However, there are no assurances it will be able to do so. Innovid has few advertising customers with minimum commitments so there is no guarantee that existing advertiser relationships will persist. Any disruptions in Innovid’s relationships with advertisers could adversely affect its business, results of operations and financial condition. If Innovid cannot retain or add individual advertisers, or if existing advertisers reduce their use of its offering, it could adversely affect Innovid’s business, results of operations, and financial condition. Additionally, if Innovid’s offerings do not meet the current or future expectations of its advertisers or agencies or if Innovid’s services or employees fail to perform as expected, such advertisers or agencies may seek alternative options and Innovid’s results may suffer. Furthermore, if existing advertisers significantly reduce their ad-spend in response to continued supply change disruptions, labor shortages or other macroeconomic trends, Innovid’s results will suffer.
Innovid and Legacy Innovid have a history of net losses in the previous years, and it anticipates increasing operating expenses in the future, and may not be able to achieve and, if achieved, maintain profitability.
We incurred net losses of $18.4 million, $11.5 million and $0.8 million in fiscal years 2022, 2021 and 2020, respectively. Innovid may not achieve or maintain profitability in the future. Because the market for CTV advertisement, and the management and analytics tools Innovid offers, is rapidly evolving, it is difficult for Innovid to predict its future results of operations or the limits of its market opportunity. Innovid expects its operating expenses to increase over the next several years as it hires additional personnel, particularly in research and development and sales and marketing, expands it partnerships, operations, and infrastructure, both domestically and internationally and continues to develop and expand its platform’s features and capabilities. Innovid also intends to continue to build and enhance its platform through both internal research and development as well as selectively pursuing acquisitions that can uniquely contribute to its platform’s features and capabilities. In addition, now that Innovid has become a public company, it will incur additional significant legal, accounting, and other expenses that it did not incur as a private company. If Innovid’s revenue does not increase to offset the expected increases in its operating expenses, it will not be profitable in future periods. In future periods, Innovid’s revenue growth could slow or its revenue could decline for a number of reasons, including any failure to increase the number of advertisers using its platform or to increase its volume of impressions or as a result of a decrease in the growth of its overall market, its failure, for any reason, to continue to capitalize on growth opportunities, slowing demand for CTV advertising or for its management and analytics tools, additional regulatory burdens, or increasing competition. As a result, our past financial performance may not be indicative of its future performance. Any failure by Innovid to achieve or sustain profitability on a consistent basis could cause the value of our common stock to decline.
21
Decrease and/or changes in CTV audience viewing behavior may adversely affect Innovid’s business and growth potential.
Technology and competition in Innovid’s industry continue to evolve rapidly. Changes to competitor’s products and solutions, which may differ from Innovid’s current offerings could have a material impact on Innovid. Also, consumer behavior relating to changes in content distribution and technological innovation may affect Innovid’s economic model and viewership in ways that are not entirely predictable. Innovid’s growth is dependent upon the continued growth of CTV, and to the extent consumer behavior regarding CTV were to change in ways that reduce the effectiveness of Innovid’s offering, its growth prospects would be significantly impacted.
If Innovid fails to make the right investment decisions, or if it fails to innovate and develop new solutions that are adopted by advertisers, it may not attract advertisers, which could have an adverse effect on Innovid’s business, results of operations and financial condition.
Innovid faces intense competition in the marketplace and is confronted by rapidly changing technology, industry standards, consumer preferences, and regulatory requirements, which require it to adapt and respond quickly. Innovid needs to continuously update its platform by investing and developing in new technology in order to attract advertisers and anticipate changes in technology, evolving industry standards and regulatory requirements. Innovid’s platform is complex and new solutions can require a significant investment of time and resources to develop, test, introduce, and enhance. These activities can take longer than expected. Moreover, Innovid may not make the right decisions regarding these investments. New formats and channels related to CTV advertising present unique challenges that Innovid must address in order to succeed. Innovid’s success depends upon its ability to integrate its platform with these new formats and channels. If Innovid’s solutions are not widely adopted by advertisers, it may not attract or retain advertisers. In addition, evolving demands from advertisers, superior offerings by competitors, changes in technology, and new industry standards or regulatory requirements could render Innovid’s platform or its existing solutions less effective and require Innovid to make unanticipated changes to its platform or business model. Innovid’s failure to adapt to a rapidly changing market or failure to anticipate advertiser demand and attract advertisers could cause its revenue or revenue growth rate to decline, and may adversely affect its business, results of operations, and financial condition.
While Innovid is working on a number of innovations and enhancements designed to improve the value to its clients, these innovations may prove to be unsuccessful which could have a material impact on Innovid’s business. Also, Innovid may need to restructure or expand its sales efforts in order to maintain or increase revenues from new and existing customers and to further penetrate the market. If such efforts are ineffective, this may have a material impact on Innovid’s operations.
Innovid’s estimates of market opportunity, forecasts of market growth and projections of future financial performance may prove to be inaccurate. If such forecasts related to market growth and market opportunity prove inaccurate, Innovid may not hire or staff appropriately and its business, results of operations, and financial condition may be adversely affected.
Innovid operates in a rapidly evolving industry. Innovid’s ability to forecast its future operating results is subject to a number of uncertainties, including its ability to plan for and model future growth in both its business and the digital advertising market. The extent to which the COVID-19 pandemic may impact the Company’s operational and financial performance remains uncertain and will depend on many factors outside the Company’s control. Innovid is subject to risks and uncertainties frequently experienced by growing companies in rapidly evolving industries, including challenges in forecasting accuracy, determining the appropriate nature and levels of investments, assessing appropriate returns on investments, achieving market acceptance of its existing and future offerings, managing buyer implementations, and developing new solutions. If Innovid’s assumptions regarding these uncertainties, which it regularly uses to plan, are incorrect or fail to appropriately capture market changes, or if Innovid does not address these risks successfully, its operating and financial results could differ materially from its expectations and its business could suffer. Innovid’s past revenue growth is not indicative of its future performance. In future periods, Innovid’s revenue could decline or grow more slowly than it expects. Innovid believes the growth of its revenue depends on a number of factors, including its ability to:
•attract new advertisers, and retain and expand its relationships with existing advertisers;
•leverage the growth of OTT advertising and the proliferation of OTT advertising platforms, while remaining agile to advertisers’ needs or the possibility that OTT advertisers will revert to traditional advertising modes;
•hire or staff appropriately according to its growth needs;
•broaden its solutions portfolio to include additional marketing and monetization goals for advertisers;
22
•adapt its offering to meet evolving needs, including to address market trends such as (i) the migration of consumers from desktop to mobile and from websites to mobile applications, (ii) the increasing percentage of sales that involve multiple digital devices, (iii) the growing adoption by consumers of “ad-blocking” software on web browsers on desktop and/or on mobile devices and the use or consumption by consumers of advertising-free services, (iv) changes in the marketplace for and supply of advertising inventory, including the shift toward header bidding, (v) changes in the overall ecosystem such as Apple’s introduction of its Intelligent Tracking Prevention feature into its Safari browser, Microsoft’s Tracking Prevention feature in its Edge browser, and Mozilla’s introduction of Enhanced Tracking Protection into its Firefox browser; and (vi) changes in consumer acceptance of tracking technologies for targeted or behavioral advertising purposes; and
•continue to adapt to a changing regulatory landscape governing data protection and privacy matters.
Innovid’s sales and marketing efforts may require significant investments and, in certain cases, involve long sales cycles, and may not yield the results it seeks.
Innovid’s sales and marketing teams educate prospective advertisers about the use, technical capabilities, and benefits of its platform. Innovid’s sales cycle, from initial contact to contract execution and implementation, can take significant time with certain advertisers and agencies. Some of Innovid’s customers undertake an evaluation process that involves reviewing the offerings of Innovid’s competitors in addition to its platform. As a result, it is difficult to predict when a prospective customer will decide to execute an agreement and begin generating revenue for Innovid. Innovid is often required to explain how its platform can optimize the value of a premium publisher’s ad impressions or how a Demand Side Platform can discover valuable ad impressions. Innovid may spend substantial time and resources searching for new business or responding to requests for proposals from potential advertisers and such efforts may not result in revenue. Following contract execution and implementation, ongoing sales cycles and account management can take significant time. Innovid is often required to explain how an additional platform integration can enhance incremental demand or engage multiple trading teams within an advertising agency to source ad campaigns and create additional demand. Innovid may not succeed in attracting new advertisers and agencies despite its significant investment in its business development, sales and marketing organizations. It may also be difficult to predict when new advertisers will begin generating revenue through Innovid’s platform, and the extent of that revenue. Innovid may not succeed in expanding relationships with existing advertisers, despite its significant investment in its sales, account management, and marketing organizations. Further, it may be difficult to predict when additional products will generate revenue through Innovid’s platform, and the extent of that revenue.
If Innovid does not manage its growth effectively, the quality of its platform and solutions may suffer, and its business, results of operations, and financial condition may be adversely affected.
The continued growth in Innovid’s business may place demands on its infrastructure and its operational, managerial, administrative, and financial resources. Innovid’s success will depend on the ability of its management to manage growth effectively. Among other things, this will require Innovid at various times to:
•strategically invest in the development and enhancement of its platform and data center infrastructure;
•improve coordination among Innovid’s engineering, product, operations, and other support organizations;
•manage multiple relationships with various partners, customers, and other third parties;
•manage international operations;
•develop its operating, administrative, legal, financial, and accounting systems and controls; and
•recruit, hire, train, and retain personnel.
If Innovid does not manage its growth well, the efficacy and performance of its platform may suffer, which could harm its reputation, reduce demand for its platform and solutions and have an adverse effect on its business, results of operations, and financial condition.
23
Innovid’s revenue and results of operations are highly dependent on the overall demand for advertising. Factors that affect the amount of advertising spending, such as economic downturns and the COVID-19 pandemic, can make it difficult to predict Innovid’s revenue and could adversely affect its business, results of operations, and financial condition.
Innovid’s business depends on global economic conditions, the overall demand for digital advertising spending and on the economic health of its current and prospective customers that benefit from our platform. Unstable market conditions make it difficult for our customers and us to accurately forecast and plan future business activities and there is no assurance that the digital advertising market will experience the growth we anticipate
The market for internet advertising solutions is highly competitive and rapidly changing. New technologies and methods of advertising present a dynamic competitive challenge as market participants develop and offer multiple new products and services aimed at facilitating and/or capturing advertising spending. With the introduction of new technologies and the influx of new entrants to the market, including large established companies and companies that Innovid does not yet know about or do not yet exist, Innovid expects competition to persist and intensify in the future, which could harm its ability to increase sales and maintain its profitability. Large and established internet and technology companies may have the power to significantly change the very nature of the digital advertising marketplaces in ways that could materially disadvantage Innovid. These companies could leverage their positions to make changes to their web browsers, mobile operating systems, platforms, exchanges, networks or other solutions or services that could be significantly harmful to Innovid’s business and results of operations. These companies also have significantly larger resources than Innovid does, and in many cases have advantageous competitive positions in popular products and services like Gmail, YouTube, Chrome, Facebook and Instagram, which they can use to their advantage.
Furthermore, Innovid’s competitors include large and established internet and technology companies that have invested substantial resources in innovation, which could lead to technological advancements that change the competitive dynamics of Innovid’s business in ways that it may not be able to predict. Competition could also hinder the success of new advertising solutions that Innovid offers in the future. If any of these risks were to materialize, Innovid’s ability to compete effectively could be significantly compromised and its results of operations could be harmed. Any of these developments would make it more difficult for Innovid to sell its offerings and could result in increased pricing pressure, reduced gross margins, increased sales and marketing expense and/or the loss of market share.
Also, various macroeconomic factors could cause advertisers to reduce the advertising budgets of Innovid’s customers, including adverse economic conditions, pandemics (for example COVID-19), terrorism, and general uncertainty about economic recovery or growth, particularly in North America, Europe, and Asia, where Innovid does most of its business, instability in political or market conditions generally, and any changes in the tax treatment of advertising expenses and the deductibility thereof. Reductions in overall advertising spending as a result of these factors could make it difficult to predict Innovid’s revenue and could adversely affect its business, results of operations, and financial condition. During the course of the pandemic supply chain disruptions and concerns regarding the continued pace of economic recovery led some advertisers in certain industries to reduce advertising spending and similar disruptions could recur in the future.
The extent to which the COVID-19 pandemic, including the resulting global economic uncertainty, and measures taken in response to the pandemic, may continue adversely to affect Innovid’s business, results of operations, and financial condition remains uncertain and difficult to predict.
COVID-19 had a significant impact around the world, prompting governments and businesses to take unprecedented measures in response. Such measures included restrictions on travel and business operations, temporary closures of businesses, and quarantine and shelter-in-place orders. The COVID-19 pandemic at times significantly curtailed global economic activity and caused significant volatility and disruption in global financial markets. The extent to which the COVID-19 pandemic may continue to impact the Company’s operational and financial performance remains uncertain and will depend on many factors outside the Company’s control,
The COVID-19 pandemic also led to an increase in CTV viewership, which caused an increase in advertising spending and thus, Innovid’s financial results. Any increase to financial metrics such as revenues, operating margins, net income, net cash provided by operating activities and other financial and operating data, may not be indicative of results for future periods.
24
Innovid’s business depends on a limited number of advertising agencies and advertisers.
Innovid derives a substantial portion of its revenue from a limited number of advertising agencies and advertisers. There are inherent risks whenever a large percentage of revenues within any specific market or solution are concentrated within a limited number of advertising agencies and advertisers. Innovid cannot predict the future level of demand for its services and products that will be generated by these advertising agencies and advertisers. In addition, revenue from these advertising agencies and advertisers may fluctuate from time to time. Further, some of Innovid’s contracts with key advertising holding groups may permit such groups to terminate use of its products at any time (subject to notice and certain other provisions). If any of these advertising agencies and advertisers terminate or reduce their use of Innovid’s products, its revenues or specific solutions may be negatively impacted.
If the use of digital advertising is rejected by consumers, through opt-in, opt-out or ad-blocking technologies or other means, it could have an adverse effect on Innovid’s business, results of operations, and financial condition.
Consumers can, with increasing ease, implement technologies that limit Innovid’s ability to collect and use data to deliver advertisements, or otherwise limit the effectiveness of its platform. Cookies may be deleted or blocked by consumers. Cookies have not been available on iPhone, nor across Safari or Firefox browsers for several years and we anticipate that other browsers, including Google Chrome and others will follow suit. While such limitations have not, to date, impacted Innovid’s business as a result of Innovid’s cross-channel, cross-device dynamic creative campaigns, which are not solely reliant on cookies or device IDs, Innovid’s ability to continue to respond to changes in ad-blocking technologies will have an impact on its business, results of operations, and financial condition.
To the extent cookies remain relevant to Innovid’s business, most commonly used internet browsers allow consumers to modify their browser settings to block first-party cookies (placed directly by the publisher or website owner that the consumer intends to interact with) or third-party cookies (placed by parties, like us, that have no direct relationship with the consumer), and some browsers block third-party cookies by default. For example, Apple recently announced its intention to move to “opt-in” privacy models, requiring users to voluntarily choose to receive targeted ads, which may reduce the value of ad impressions on its iOS mobile application platform. Many applications and other devices allow consumers to avoid receiving advertisements by paying for subscriptions or other downloads. Mobile devices using Android and iOS operating systems limit the ability of cookies to track consumers while they are using applications other than their web browser on the device. As a consequence, fewer of Innovid’s cookies or publishers’ cookies may be set in browsers or be accessible in mobile devices, which may adversely affect Innovid’s business. Some consumers also download free or paid “ad blocking” software on their computers or mobile devices, not only for privacy reasons, but also to counteract the adverse effect advertisements can have on the consumer experience, including increased load times, data consumption, and screen overcrowding. Ad-blocking technologies and other global privacy controls may prevent some third-party cookies, or other tracking technologies, from being stored on a consumer’s computer or mobile device.
If more consumers adopt these measures, and Innovid’s alternative approaches prove unsuccessful, Innovid’s business, results of operations, and financial condition could be adversely affected. Ad-blocking technologies could have an adverse effect on Innovid’s business, results of operations, and financial condition if they reduce the volume, effectiveness or value of advertising. In addition, some ad blocking technologies block only ads that are targeted through use of third-party data, while allowing ads based on first-party data (i.e., data owned by the publisher). Even if ad blockers do not ultimately have an adverse effect on Innovid’s business, investor concerns about ad blockers could cause Innovid’s stock price to decline.
If the ability to collect, use, and disclose data is limited by consumer tools, regulatory restrictions or technology limitations, certain advertising offerings could be impacted and Innovid’s business may be adversely affected.
As Innovid processes transactions through its platform, it collects large amounts of data about advertisements and where they are placed, such as advertiser preferences for media and advertising content. Innovid collects data on consumers that does not identify the individual, including browser, device location and characteristics, online browsing behavior, exposure to and interaction with advertisements, and inferential data about purchase intentions, and preferences. Innovid collects this data through various means, including from its own platform and measurement tracking capabilities. Innovid’s advertisers, publishers, and data providers may choose to provide Innovid with their proprietary data about consumers. Innovid aggregates this data and analyzes it in order to enhance its services, including the pricing, placement, and scheduling of advertisements.
25
As part of Innovid’s real-time analytics service offering, it also shares the data, or analyses based on it, with its advertisers. There are many technical challenges relating to Innovid’s ability to collect, aggregate and associate the data, and Innovid cannot assure that it will be able to do so effectively. Evolving regulatory standards could place restrictions on the collection, management, aggregation and use of information, which could result in a material increase in the cost of collecting or otherwise obtaining certain kinds of data and could limit the ways in which Innovid may use or disclose information. Internet users can, with increasing ease, implement practices or technologies that may limit Innovid’s ability to collect and use data to deliver advertisements, or otherwise inhibit the effectiveness of its platform. Although Innovid’s advertisers generally permit it to aggregate and use data from advertising placements, subject to certain restrictions, advertisers might decide to restrict Innovid’s collection or use of their data. Any limitations on this ability could impair Innovid’s ability to deliver certain advertising offerings, which could adversely affect its business, results of operations, and financial condition.
If the use of third-party “cookies,” mobile device IDs or other tracking technologies is restricted without similar or better alternatives, certain offerings could be impacted and Innovid’s business may be adversely affected.
Innovid uses “cookies,” or small text files placed on consumer devices when an internet browser is used, as well as mobile device identifiers, to gather data that enables its platform to be more effective. Innovid’s cookies and mobile device IDs do not identify consumers directly, but record information such as when a consumer views or clicks on an advertisement, when a consumer uses a mobile app, the consumer’s location, and browser or other device information. Publishers, advertisers and partners may also choose to share their information about consumers’ interests or give Innovid permission to use their cookies and mobile device IDs. Without cookies, mobile device IDs, and other tracking technology data, transactions processed through Innovid’s platform would be executed with less insight into consumer activity, reducing the precision of advertisers’ decisions about which impressions to purchase for an advertising campaign. This could make placement of advertising through Innovid’s platform less valuable, and harm its revenue. If Innovid’s ability to use cookies, mobile device IDs or other tracking technologies is limited, it may be required to develop or obtain additional applications and technologies to compensate for the lack of cookies, mobile device IDs and other tracking technology data, which could be time consuming or costly to develop, less effective, and subject to additional regulation.
Market pressure may reduce Innovid’s revenue per impression.
Innovid’s revenue may be affected by market changes, new demands by advertisers, and competitors and we may need to change our pricing models to compete successfully. Innovid’s solutions may be priced too high or too low, either of which may carry adverse consequences. Innovid may receive requests from agencies and advertisers for volume discounts, fee revisions, and rebates. Any of these developments could adversely affect Innovid’s business, results of operations, or financial condition. Any failure of Innovid’s pricing approaches to gain acceptance could adversely affect its business, results of operations, and financial condition.
Innovid must scale its platform infrastructure to support anticipated growth and transaction volume. If Innovid fails to do so, it may limit its ability to process ad impressions, and it may lose revenue.
Innovid’s business depends on processing ad impressions in milliseconds, and it must handle an increasingly large volume of such transactions. The addition of new solutions, such as header bidding in mobile and the CTV and OTT formats, support for evolving advertising formats, handling, and use of increasing amounts of data, and overall growth in impressions, place growing demands upon Innovid’s platform infrastructure. If Innovid is unable to grow its platform to support substantial increases in the number of transactions and in the amount of data it processes, on a high-performance, cost-effective basis, its business, results of operations, and financial condition could be adversely affected. Innovid expects to continue to invest in its platform in order to meet these requirements, and that investment may adversely affect its business, results of operations, and financial condition.
If advertisers, publishers and data providers do not obtain the necessary and requisite consents from consumers for Innovid to process their personal data, Innovid could be subject to fines and liability.
Because Innovid does not have direct relationships with consumers, it relies on advertisers, publishers and data providers, as applicable, to obtain the consent of the consumer on its behalf to process their data and deliver interest-based advertisements, and to implement any notice or choice mechanisms required under applicable laws, but if advertisers, publishers, or data providers do not follow this process (including as the legal requirements in this area continue to evolve and develop), Innovid could be subject to fines and liability. Innovid may not have adequate insurance or contractual indemnity arrangements to protect itself against any such claims and losses.
26
Advertisements on websites, applications and other digital media properties of publishers serviced through Innovid’s platform are viewed by consumers visiting the publishers’ digital media properties. Publishers often have terms of use in place with their consumers that disclaim or limit their potential liabilities to consumers, or pursuant to which consumers waive rights to bring class actions against the publishers. Innovid generally does not have terms of use in place with such consumers, so it cannot disclaim or limit potential liabilities to them through terms of use, which may expose it to greater liabilities than certain of its competitors.
Innovid faces intense and increasing competition for employee talent, and if it does not retain and continue to attract highly skilled talent or retain its senior management team and other key employees, it may not be able to sustain its growth or achieve its business objectives.
Innovid is led by a strong management team that has extensive experience leading technology and digital marketing companies. Innovid’s success and future growth depends to a significant degree on the leadership, knowledge, skills and continued services of its senior management team and other key personnel. The loss of any of these persons could adversely affect Innovid’s business.
Innovid’s future success also depends on its ability to retain, attract and motivate highly skilled technical, managerial, marketing, and customer service personnel. Innovid expects to continue its growth in the near term. Innovid may incur significant costs to attract and retain qualified employees, including significant expenditures related to salaries and benefits and compensation expenses related to equity awards. New employees often require significant training and Innovid may lose new or existing employees to its competitors or other companies before it realizes the benefit of its investment in recruiting and training them. Competition for personnel is intense, particularly in the technology and software industries. A substantial majority of Innovid’s workforce are at-will employees, and Innovid may experience a loss of productivity due to the departure of key personnel and the associated loss of institutional knowledge. Innovid’s inability to retain and attract the necessary personnel could adversely affect its business, financial condition and results of operations.
Seasonal fluctuations in advertising activity could have a negative impact on Innovid’s revenue, cash flow and operating results.
Innovid’s revenue, cash flow, operating results and other key operating and performance metrics may vary from quarter to quarter due to the seasonal nature of its customers spending on advertising campaigns. For example, advertisers typically allocate the largest portion of their media budgets to the fourth quarter of the calendar year in order to coincide with increased holiday purchasing. As a result, the fourth quarter of the year typically reflects Innovid’s highest level of measurement activity while the first quarter reflects the lowest level of such activity. Innovid’s historical revenue growth has masked the impact of seasonality, but if its growth rate declines or seasonal spending becomes more pronounced, seasonality could have a more significant impact on its revenue, cash flow and operating results from period to period.
Innovid is subject to payment-related risks, and if its ability to accurately and timely collect payments is impaired, it’s business, financial condition and results of operations may be adversely affected.
Innovid has a large and diverse customer and integration partner base. At any given time, one or more of Innovid’s customers or partners may experience financial difficulty, file for bankruptcy protection or cease operations. Unfavorable economic and financial conditions could result in an increase in customer financial difficulties which could adversely affect Innovid. The direct impact on Innovid could include reduced revenues and write-offs of accounts receivable and expenditures billable to customers, and if these effects were severe enough, the indirect impact could include impairments of intangible assets and reduced liquidity. Furthermore, the payment risks Innovid faces are heightened since some of the media agencies with which Innovid deals collect payments from their advertiser customers and then remit to Innovid such amounts on behalf of those advertiser customers, each of whom is subject to independent billing and payment risks as well. Although no core client (brand/advertiser) accounted for more than 12% of Innovid’s revenue in 2022, our approximately 174 core clients accounted for in excess of 88% of Innovid’s total revenue in 2022.
27
Any interruptions or delays in services from third parties, including data center hosting facilities, cloud computing platform providers and other hardware and software vendors, or disruptions from Innovid’s inability to adequately plan for and manage service failures or infrastructure capacity requirements, could impair the delivery of Innovid’s services and harm its business.
Innovid currently serves its customers from third-party data center hosting facilities and cloud computing platform providers located in the United States and Europe. Innovid also relies on computer hardware purchased or leased, if any, from, software licensed from, and cloud computing platforms provided by, third parties in order to offer its services, including database software, hardware and data from a variety of vendors. Any disruption or damage to, or failure of Innovid’s systems generally, including the systems of its third-party platform providers, could result in interruptions in its services. Innovid has from time to time experienced interruptions in its services and such interruptions may occur in the future. Also, Innovid may contract with other third-party data centers outside of the United States and Europe, which may carry risks that Innovid does not, or may not be able to, anticipate. In addition, the COVID-19 pandemic disrupted the supply chain of hardware needed to maintain these third-party systems or to run Innovid’s business and such disruptions may recur again in future.. As Innovid increases its reliance on these third-party systems, particularly with respect to third-party cloud computing platforms, its exposure to damage from service interruptions may increase.
Innovid does not control the operation of any of these facilities, and it may be vulnerable to damage or interruption from earthquakes, floods, fires, power loss, telecommunications failures and similar events. Innovid may also be subject to break-ins, sabotage, intentional acts of vandalism and similar misconduct, as well as local administrative actions (including shelter-in-place or similar orders), changes to legal or permitting requirements and litigation to stop, limit or delay operation. Despite precautions taken at these facilities, such as disaster recovery and business continuity arrangements, the occurrence of a natural disaster or pandemic (including the COVID-19 pandemic), an act of terrorism, a decision to close the facilities without adequate notice or other unanticipated problems at these facilities could result in lengthy interruptions in Innovid’s services.
These hardware, software, data and cloud computing platforms may not continue to be available at reasonable prices, on commercially reasonable terms or at all. Any loss of the right to use any of these hardware, software or cloud computing platforms could significantly increase Innovid’s expenses and otherwise result in delays of its services until equivalent technology is either developed by Innovid, or is obtained through purchase or license and integrated into Innovid’s services.
Additionally, improving Innovid’s platform’s infrastructure and expanding its capacity in anticipation of growth in new channels and formats, as well as implementing technological enhancements to its platform to improve its efficiency and cost-effectiveness are key components of its business strategy, and if Innovid’s data centers are unable to keep up with its growing needs for capacity, this could have an adverse effect on its business. Any changes in third-party service levels at Innovid’s data centers or any errors, defects, disruptions, or other performance problems could adversely affect its reputation, expose it to liability, cause it to lose customers, or otherwise adversely affect its business, results of operations, and financial condition. Service interruptions might reduce Innovid’s revenue, trigger refunds, subject Innovid to potential liability, or adversely affect its business, results of operations, and financial condition.
If Innovid does not accurately plan for its infrastructure capacity requirements and it experiences significant strains on its data center capacity, its clients could experience performance degradation or service outages that may subject Innovid to financial liabilities, result in customer losses and harm its reputation and business. As Innovid adds data centers and capacity and continues to move to cloud computing platform providers, it may move or transfer its data and its customers’ data. Despite precautions taken during this process, any unsuccessful data transfers may impair the delivery of Innovid’s services, which may damage its business.
28
Innovid’s software platform could be susceptible to errors, defects, or unintended performance problems that could adversely affect its business, results of operations, and financial condition.
Innovid depends upon the sustained and uninterrupted performance of its platform to operate its business. Software bugs, faulty algorithms, technical or infrastructure problems, or system updates could lead to an inability to process data to place advertisements or price inventory effectively, or cause advertisements to display improperly or be placed in proximity to inappropriate content, which could adversely affect Innovid’s business, results of operations, and financial condition. These risks are compounded by the complexity of Innovid’s technology and the large amounts of data Innovid utilizes. Because Innovid’s software is complex, undetected material defects, errors and failures may occur. Despite testing, errors or bugs in Innovid’s software may not be found until the software is in its live operating environment. Errors or failures in Innovid’s solution, even if caused by the implementation of changes by advertisers, publishers, or partners to their systems, could also result in negative publicity, damage to its reputation, loss of or delay in market acceptance of its solution, increased costs, loss of revenue or loss of competitive position. In such an event, Innovid may be required or choose to expend additional resources to help mitigate any problems resulting from defects, errors and failures in its software. As a result, defects or errors in Innovid’s products or services could harm its reputation, result in significant costs, impair the ability of advertisers to sell and impair its ability to fulfill obligations with its clients. Any significant interruptions could adversely affect Innovid’s business, results of operations, and financial condition.
If CTV, mobile devices or their operating systems and Internet browsers develop in ways that prevent advertisements from being delivered to consumers, Innovid’s business, results of operations and financial condition generally, could be adversely affected.
Innovid’s success in the mobile advertising industry depends upon the ability of its platform to provide advertising for mobile connected devices, the major operating systems or internet browsers that run on them, and the thousands of applications that are downloaded onto them. The design of mobile devices and operating systems or browsers is controlled by third parties that may also introduce new devices and operating systems or modify existing ones, and network carriers may affect Innovid’s ability to access specified content on mobile devices. For example, Apple recently announced its intent to eliminate the Identifier for advertisers, which Innovid and other advertising firms have used to deliver targeted advertisements to consumers.
While the effects of this development are uncertain and would not prevent Innovid from operating its header bidding technology on Apple products, it could reduce the value of the ad impressions it offers. If Innovid’s platform cannot operate effectively with popular devices, operating systems or Internet browsers, including Apple devices and iOS, its business, results of operations, and financial condition could be adversely affected.
Also, as online video advertising continues to scale and evolve, the amount of online video advertising being bought and sold programmatically has increased dramatically. The online video advertising market continues to grow with the increased popularity of CTV. However, despite the opportunities created by programmatic advertising, programmatic solutions for CTV and OTT publishers are still nascent compared to desktop and mobile video solutions. Many CTV publishers have backgrounds in cable or broadcast television and have limited experience with digital advertising, and in particular programmatic advertising. For these publishers, it is extremely important to protect the quality of the viewer experience to maintain brand goodwill and ensure online advertising efforts do not create sales channel conflicts or otherwise detract from their direct sales force. In this regard, programmatic advertising presents a number of potential challenges, including the ability to ensure ads are brand safe, comply with business rules around competitive separation, are not overly repetitive, are played at the appropriate volume, and do not cause delays in load-time of content. Innovid believes its platform is well-positioned to allow publishers the opportunity to achieve these goals and also reliably achieve “ad potting,” or the placement of the desired number of advertisements in commercial breaks. While Innovid believes programmatic advertising will continue to grow as a percentage of overall CTV advertising, there can be no assurance that CTV publishers will adopt programmatic solutions such as Innovid’s, or the rate at which they may adopt such solutions, which could adversely affect Innovid’s business, results of operations, and financial condition.
29
The market in which Innovid participates is intensely competitive, and it may not be able to compete successfully with its current or future competitors.
Innovid’s industry and business is subject to rapid and frequent changes in technology, evolving client demands and frequent competitors with new and enhanced offerings. Innovid competes for both supply and demand with larger, well-established companies that may have technological advantages stemming from their experience in the market. Innovid’s future success will depend on its ability to continuously enhance and improve its offerings to meet client needs and address technological and industry advancements. If Innovid is unable to enhance its solutions to meet market demand in a timely manner, it may not be able to maintain its existing clients or attract new clients. Innovid has made, and intends to continue to make, substantial investments in order to further advance its brand and scale its technology capabilities. However, these investments are inherently risky and may not be successful. Addressing broader marketing and monetization goals, is relatively new to Innovid and it has had to invest in substantial resources to adapt its model, pricing and organization to support this expansion. Similarly, Innovid does not have a long or established track record of competing successfully in this space. If Innovid is not successful in expanding its solutions along broader marketing goals, its results of operations could be adversely affected. Furthermore, Innovid believes the importance of brand recognition will increase as competition in its market increases. However, if Innovid is unable to continuously enhance and improve its offerings, it may be unable to respond effectively to changes in its industry, technology or user preferences, and its solutions may become less competitive or obsolete. Furthermore, brand promotion activities may not yield any increased revenue, and even if they do, any increased revenue may not offset the expenses Innovid incurred in building its brand.
Innovid’s business depends on the overall demand for advertising and on the economic health of Innovid’s current and prospective advertisers. The market for digital advertising solutions is highly competitive and rapidly changing. New technologies and methods of advertising present a dynamic competitive challenge as market participants develop and offer multiple new products and services aimed at facilitating and/or capturing advertising spending. With the introduction of new technologies and the influx of new entrants to the market, including large established companies and companies that Innovid does not yet know about or do not yet exist, Innovid expects competition to persist and intensify in the future, which could harm its ability to increase sales and maintain its profitability. Large and established internet and technology companies may have the power to significantly change the very nature of the digital advertising marketplaces in ways that could materially disadvantage Innovid. These companies could leverage their positions to make changes to their web browsers, mobile operating systems, platforms, exchanges, networks or other solutions or services that could be significantly harmful to Innovid’s business and results of operations.
These companies also have significantly larger resources than Innovid does, and in many cases have advantageous competitive positions in popular products and services like Gmail, YouTube, Chrome, Facebook and Instagram, which they can use to their advantage. Furthermore, Innovid’s competitors include large and established internet and technology companies that have invested substantial resources in innovation, which could lead to technological advancements that change the competitive dynamics of Innovid’s business in ways that it may not be able to predict. Competition could also hinder the success of new advertising solutions that Innovid offers in the future. If any of these risks were to materialize, Innovid’s ability to compete effectively could be significantly compromised and its results of operations could be harmed. Any of these developments would make it more difficult for Innovid to sell its offerings and could result in increased pricing pressure, reduced gross margins, increased sales and marketing expense and/or the loss of market share.
Innovid relies on advertisers and publishers to abide by contractual requirements and relevant laws, rules, and regulations when using its platform. Legal claims or enforcement actions resulting from their actions could expose Innovid to liabilities, damage its reputation, and be costly to defend. In addition, in certain instances Innovid’s campaigns are dependent upon the performance of third-parties hired by its clients. Any failure of such parties to meet expected performance benchmarks could have a negative impact on the success of Innovid’s services.
The advertisers and publishers engaging in transactions through Innovid’s platform impose various requirements upon each other, and Innovid and the underlying advertisers are subject to regulatory requirements by governments and standards bodies applicable to their activities. Innovid may assume responsibility for satisfying or facilitating the satisfaction of some of these requirements through the contracts it enters into with advertisers or publishers transacting business through its platform under applicable laws, regulations or common law duties, even if Innovid has not assumed responsibility contractually. These responsibilities could expose Innovid to significant liabilities, perhaps without the ability to impose effective mitigating controls upon, or to recover from, advertisers and publishers and our contractual indemnities and limitations of liability may not protect us adequately.
30
Innovid contractually requires its advertisers, publishers and data providers to abide by relevant laws, rules and regulations, and restrictions by their counterparties, when transacting on Innovid’s platform, and it generally attempts to obtain representations from advertisers that the advertising they place through its platform complies with applicable laws and regulations and does not violate third-party intellectual property rights. Innovid also generally receives representations from advertisers, publishers and data providers about their data privacy practices and compliance with applicable laws and regulations, including their maintenance of adequate privacy policies that disclose and permit Innovid’s data collection practices. Nonetheless, there are many circumstances in which it is difficult or impossible for Innovid to monitor or evaluate its compliance. For example, Innovid cannot control the content of advertisers and/or publisher’s media properties.
If advertisers, publishers or data providers fail to abide by relevant laws, rules and regulations, or contract requirements when transacting over Innovid’s platform or after such a transaction is completed, or if such parties fail to provide proper notice to and obtain proper consent from individuals that permit Innovid’s data collection practices where applicable, Innovid could potentially face liability to consumers for such misuse. Further, Innovid could face potential liability to consumers in the event such parties engage in malicious activities, such as the introduction of malware into consumers’ computers through advertisements served through Innovid’s platform, and code that redirects consumers to sites other than the ones consumers sought to visit, potentially resulting in malware downloads or use charges from the redirect site. Advertisers often have terms of use in place with their consumers that disclaim or limit their potential liabilities to such consumers, or pursuant to which consumers waive rights to bring class-action lawsuits against the publishers related to advertisements, which could make Innovid a more likely target for certain lawsuits. Similarly, if such misconduct results in enforcement action by a regulatory body or other governmental authority, Innovid could become involved in a potentially time-consuming and costly investigation, or it could be subject to some form of sanction or penalty and face reputational damage. Innovid may not have adequate indemnities to protect itself against, and its policies of insurance may not cover, all such claims and losses.
If advertisers or publishers or data providers do not have sufficient rights to the content, technology, data or other material that they provide or make available to Innovid, Innovid’s business and reputation may be harmed.
If advertisers or publishers or data providers do not have sufficient rights to the content, technology, data, or other material that they provide or make available to Innovid or if they subsequently lose such rights, or if it infringes or is alleged to infringe the intellectual property rights of third parties, Innovid could be subject to claims from those third parties, which could adversely affect its business, results of operations, and financial condition. For example, channel partners may aggregate ad impressions across several publishers, and Innovid may not be able to verify that these aggregators own or have rights to all of their digital ad impressions. As a result, Innovid may face potential liability for copyright, patent, trademark or other intellectual property infringement, or other claims. Litigation to defend these claims could be costly and have an adverse effect on Innovid’s business, results of operations, and financial condition. While Innovid does include indemnity provisions covering customer content in its service agreements, it can provide no assurance that it is adequately insured to cover claims related to customer content or that its indemnification provisions will be adequate to mitigate all liability that may be imposed on it as a result of claims related to customer content.
Innovid’s platform relies on third-party open source software components. Failure to comply with the terms of the underlying open source software licenses could expose Innovid to liabilities, and the combination of open source software with code that it develops could compromise the proprietary nature of its platform.
Innovid’s platform utilizes software licensed to it by third-party authors under “open source” licenses, and Innovid expects to continue to utilize open source software in the future. The use of open source software may entail greater risks than the use of third-party commercial software, as open source licensors generally do not provide warranties or other contractual protections regarding infringement claims or the quality of the code. To the extent that Innovid’s platform depends upon the successful operation of the open source software it uses, any undetected errors or defects in this open source software could prevent the deployment or impair the functionality of Innovid’s platform, delay new solutions introductions, result in a failure of its platform, and injure its reputation. For example, undetected errors or defects in open source software could render Innovid vulnerable to breaches or security attacks, and, in conjunction, make its systems more vulnerable to data breaches. Furthermore, some open source licenses contain requirements that Innovid make available source code for modifications or derivative works Innovid creates based upon the type of open source software Innovid uses. If Innovid combines its proprietary software with open source software in a specific manner, it could, under some open source licenses, be required to release the source code of its proprietary software to the public. This would allow Innovid’s competitors to create similar solutions with lower development effort and time and ultimately put Innovid at a competitive disadvantage.
31
Although Innovid monitors its use of open source software, it cannot be sure that the process for controlling the use of open source software in its platform will be effective. If Innovid is held to have breached the terms of an open source software license, it could be required to seek licenses from third parties to continue operating using its solutions on terms that are not economically feasible, to re-engineer its solutions or the supporting computational infrastructure, to discontinue use of the code or to make generally available, in source code form, portions of its proprietary code.
Innovid’s business is subject to the risk of catastrophic events such as pandemics, earthquakes, flooding, fire, and power outages, and to interruption by man-made problems such as terrorism.
Innovid’s business is vulnerable to damage or interruption from pandemics, earthquakes, flooding, fire, power outages, telecommunications failures, terrorist attacks, acts of war, human errors, break-ins and similar events. In particular, a pandemic such as the recent COVID-19 pandemic, including the reactions of governments, markets, and the general public,could result in a number of adverse consequences for Innovid’s business, results of operations, and financial condition, many of which would be beyond Innovid’s control. A significant natural disaster could have a material adverse effect on Innovid’s business, results of operations, and financial condition, and Innovid’s insurance coverage may be insufficient to compensate Innovid for losses that may occur. In addition, acts of terrorism, which may be targeted at metropolitan areas that have higher population density than rural areas, could cause disruptions in Innovid’s or its customers businesses or the economy as a whole. Innovid may also be subject to cyber security incidents – see “Risks Relating to Information Technology, Cybersecurity and Intellectual Property—System failures, security breaches, or cyberattacks could interrupt the operation of Innovid’s platform and data centers and significantly harm its business, financial condition and results of operations” below for more details. Innovid may not have sufficient protection or recovery plans in some circumstances, such as natural disasters affecting areas in which it operates. As Innovid relies heavily on technology such as computers, communications systems and the Internet to conduct its business and provide high-quality customer service, these disruptions could negatively impact Innovid’s ability to run its business and either directly or indirectly disrupt its customers businesses, which could have an adverse effect on Innovid’s business, results of operations and financial condition.
Innovid relies on integrations with demand- and supply-side advertising platforms, ad servers and social platform over which we exercise very limited control. A decrease in demand for advertising and public criticism of digital advertising technology in the US and internationally, could adversely affect the demand for and use of Innovid’s solutions.
Innovid’s business depends, in part, on the demand for digital advertising technology. The digital advertising industry has been and may in the future be subject to reputational harm, negative media attention and public complaint relating to, among other things, the alleged lack of transparency and anti-competitive behavior among advertising technology companies. This public criticism could result in increased data privacy and anti-trust regulation in the digital advertising industry in the US and internationally. In addition, Innovid’s services are delivered in web browsers, mobile apps and other software environments where online advertising is displayed, and certain of these environments have announced future plans to phase out or end the use of cookies and other third-party tracking technology on their operating systems in order to provide more consumer data privacy. While Innovid’s technology and solutions do not rely on persistent identifiers or cookie-based or cross-site tracking, these changes and other updates to software functionality in these environments could hurt Innovid’s ability to effectively deliver its services.
Innovid may not be able to accurately predict changes in overall advertiser demand for the channels in which it operates, and cannot assure that its investment in formats will correspond to any such changes. Advertisers may change the fees they charge users or otherwise change their business model in a manner that slows the widespread acceptance of advertisements. In order for Innovid’s services to be successful, there must be a large base of advertisers to deliver content. Innovid has limited or no control over the availability or acceptance of those advertisements, and any change in the licensing terms, costs, availability or user acceptance of these advertisements could adversely affect its business. Any decrease in the use of mobile, display, and video advertising, whether due to customers losing confidence in the value or effectiveness of such channels, regulatory restrictions, public criticism or other causes, or any inability to further penetrate CTV or enter new and emerging advertising channels, could adversely affect Innovid’s business, results of operations, and financial condition. Any change or decrease in the demand for digital advertising, including on social media platforms as a result of avoidance campaigns or similar events, may negatively affect the demand for and use of Innovid’s solutions. If Innovid’s customers significantly reduce or eliminate their digital ad spend in response to the public criticism of the digital advertising industry or its related effects, its business, financial condition and results of operations could be adversely affected.
32
Innovid’s international operations and expansion expose it to several risks.
Innovid’s current global operations and future initiatives involve a variety of risks, including, in addition to risks described elsewhere in this section:
•operational and execution risk, including localization of the product interface and systems, translation into foreign languages, adaptation for local practices, adequate coordination of timing to onboard local clients and advertisers, difficulty of maintaining Innovid’s corporate culture, challenges inherent to hiring and efficiently managing an increased number of employees over large geographic distances, and the increasing complexity of the organizational structure required to support expansion and operations into multiple geographies and regulatory systems;
•insufficient, or insufficiently coordinated, demand for and supply of advertising inventory in specific geographic markets, which could impair Innovid’s ability to accurately predict user engagement in that market;
•compliance with (and liability for failure to comply with) applicable local laws and regulations, including, among other things, laws and regulations with respect to data protection, data/user privacy, tax and withholding, labor regulations, anti-corruption, consumer protection, spam and content, which laws and regulations may be inconsistent across jurisdictions;
•intensity of local competition for digital advertising budgets and internet display inventory;
•changes in a specific country’s or region’s political or economic conditions. For example, we have one of our four main offices in Tel Aviv. The Israeli government is currently pursuing extensive changes to Israel’s judicial system and in response to this, certain leading international financial institutions, including investment banks, investors and key economists, have indicated several causes for concern, including that such proposed changes, if adopted, may cause a downgrade to Israel’s sovereign credit rating and Israel’s international standing, which would adversely affect the macroeconomic condition in which we operate as we have extensive operations in Israel, and also potentially deter foreign investment into Israel, which may hinder our ability to raise additional funds;
•risks related to pricing structure, payment and currency, including aligning Innovid’s pricing model and payment terms with local norms, higher levels of credit risk and payment fraud, difficulties in invoicing and collecting in foreign currencies and associated foreign currency exposure, restrictions on foreign ownership and investments, and difficulties in repatriating or transferring funds from or converting; currencies; and
•limited or unfavorable intellectual property protection.
Innovid currently operates in Europe through a subsidiary located in the United Kingdom and may expand to other global regions including China, other South Asian countries as well as Latin America. The withdrawal of the United Kingdom from the EU (“Brexit”) may continue adversely to affect economic conditions in the United Kingdom, EU and elsewhere across the globe, and could contribute to volatility in foreign exchange markets with respect to the British Pound and Euro, which Innovid may not be able to effectively manage, and its financial results could be adversely affected. Further, Brexit may add additional complexity to potential European operations. Accordingly, Innovid cannot predict the additional expense, impact on revenue, or other business impact that may stem from Brexit. Additionally, operating in international markets also requires significant management attention and financial resources. Innovid cannot be certain that the investment and additional resources required in establishing operations in other countries will produce desired levels of revenue or profitability. Foreign currency exchange risk exposure also arises from intra-company transactions and financing with subsidiaries that have a functional currency different than the euro. While Innovid may engage in hedging transactions to minimize the impact of uncertainty in future exchange rates on intra-company transactions and financing, it may not hedge all of its foreign currency exchange rate risk. In addition, hedging transactions, to the extent Innovid may engage in hedging, carries its own risks and costs, and could expose it to additional risks that could harm its financial condition and operating results.
33
Changes in tax laws or tax rulings could materially affect Innovid’s effective tax rates, financial position and results of operations.
We are subject to taxation in multiple jurisdictions as a result of the international scope of our operations and our corporate entity structure . Any adverse development in the tax law of any of these jurisdictions or any disagreement with our tax positions could have a material adverse effect on our business, financial condition or results of operations. The tax regimes Innovid is subject to or operates under may be subject to significant change. Changes in tax laws or changes in interpretations of existing laws could cause Innovid to be subject to additional income-based taxes and non-income based taxes (such as payroll, sales, use, value-added, digital services and excise, net worth, property, and goods and services taxes), which in turn could materially affect Innovid’s financial position and results of operations. In addition, many countries in the EU, as well as a number of other countries and organizations such as the Organization for Economic Cooperation and Development, have recently proposed or recommended changes to existing tax laws or have enacted new laws that could impact Innovid’s tax obligations. Any significant changes to Innovid’s future effective tax rate may materially and adversely affect Innovid’s business, financial condition, results of operations, or cash flows.
Innovid could be required to collect additional sales, value added or similar taxes or be subject to other tax liabilities that may adversely affect its results of operations.
One or more countries or US states may seek to impose incremental or new sales, value added taxes or use or other tax collection obligations on Innovid. An increasing number of states have considered or adopted laws that impose sales tax collection obligations on out-of-state companies. This is also the case in respect of the EU, where value added taxes may be imposed on non-EU companies making digital sales to consumers within the EU. In addition, the US Supreme Court ruled in South Dakota v. Wayfair, Inc., or Wayfair, that online sellers can be required to collect sales and use tax despite not having a physical presence in the customer’s state. In response to Wayfair, or otherwise, state and local governments may adopt, or begin to enforce, laws requiring Innovid to calculate, collect and remit sales taxes in their jurisdictions. Similarly, many foreign jurisdictions have considered or adopted laws that impose value added, digital services or similar indirect taxes on companies despite not having a physical presence in the foreign jurisdiction.
A successful assertion by one or more states, or other countries or jurisdictions, requiring Innovid to collect taxes where it presently does not do so, or to collect more taxes in a jurisdiction in which it currently collects some taxes, could result in substantial liabilities, including taxes on past sales as well as penalties and interest. Innovid continually monitors the ever-evolving tax landscape in the jurisdictions in which it operates and those jurisdictions where its customers reside. The requirement to collect sales, value added or similar indirect taxes by foreign, state or local governments for sellers that do not have a physical presence in the jurisdiction could also create additional administrative burdens for Innovid, put it at a competitive disadvantage if they do not impose similar obligations on its competitors or decrease its future sales, which may materially and adversely affect its business and results of operations.
Innovid may have exposure to greater than anticipated tax liabilities.
Innovid’s income tax obligations are based in part on its corporate operating structure and intercompany arrangements. The tax laws applicable to Innovid’s business, including the laws of the US and other jurisdictions, are subject to interpretation, and certain jurisdictions are aggressively interpreting their laws in new ways in an effort to raise additional tax revenue. Innovid’s existing corporate structure and intercompany arrangements have been implemented in a manner Innovid believes is in compliance with current prevailing tax laws. However, the taxing authorities of the jurisdictions in which Innovid operates may challenge Innovid’s methodologies for intercompany arrangements, which could impact Innovid’s worldwide effective tax rate and harm its financial position and results of operations. In addition, changes to Innovid’s corporate structure and intercompany agreements, including through acquisitions, could impact Innovid’s worldwide effective tax rate and harm its financial position and results of operation.
34
Innovid may not be able to effectively integrate the businesses it acquires, which may adversely affect its ability to achieve its growth and business objectives.
Innovid explores, on an ongoing basis, potential acquisitions of additional businesses, products, solutions, technologies or teams. If Innovid identifies an appropriate acquisition candidate, it may not be successful in negotiating the terms and/or financing of the acquisition, and its due diligence may fail to identify all of the problems, liabilities or other shortcomings or challenges of an acquired business, product, solution or technology, including issues related to intellectual property, product quality or architecture, employees or clients, regulatory compliance practices or revenue recognition or other accounting practices. Any acquisition or investment may require Innovid to use significant amounts of cash, issue potentially dilutive equity securities or incur debt, contingent liabilities or amortization of expenses, or impairment of goodwill and/or purchased long-lived assets, and restructuring charges, any of which could harm its financial condition or results. In addition, acquisitions, including Innovid’s recent acquisitions, involve numerous risks, any of which could harm its business, including:
•difficulties in integrating the operations, technologies, services and personnel of acquired businesses, especially if those businesses operate outside of Innovid’s core competency;
•the need to integrate operations across different geographies, cultures and languages and to address the particular economic, currency, political and regulatory risks associated with specific countries;
•cultural challenges associated with integrating employees from the acquired company into Innovid’s organization;
•ineffectiveness, lack of scalability or incompatibility of acquired technologies or services;
•potential loss of key employees of acquired businesses;
•inability to maintain the key business relationships and the reputation of acquired businesses;
•failure to successfully further develop the acquired technology in order to recoup Innovid’s investment;
•unfavorable reputation and perception of the acquired product or technology by the general public;
•diversion of management’s attention from other business concerns;
•liability or litigation for activities of the acquired business, including claims from terminated employees, clients, former shareholders or other third parties;
•implementation or remediation of controls, practices, procedures and policies at acquired businesses, including the costs necessary to establish and maintain effective internal controls; and
•increased fixed costs.
There can be no assurance that Innovid will be able to successfully integrate the businesses that it acquires or that it will be able to leverage the acquired commercial relationships, products or technologies in the manner it anticipates. If Innovid is unable to successfully integrate the businesses it has acquired or any business, product, solution or technology it acquires in the future, its business and results of operations could suffer, and it may not be able to achieve its business and growth objectives.
Innovid has substantial client concentration in certain local markets and solutions, with a limited number of clients accounting for a substantial portion of its revenues in those areas.
Although Innovid’s overall customer base is well-diversified, in certain of its local markets and specific solutions, it derives a substantial portion of revenues from a limited number of clients. There are inherent risks whenever a large percentage of revenues within any specific market or solution are concentrated within a limited number of clients. Innovid cannot predict the future level of demand for its services and products that will be generated by these clients. In addition, revenues from these clients may fluctuate from time to time. Further, some of Innovid’s contracts with these clients may permit them to terminate use of its products at any time (subject to notice and certain other provisions). If any of these clients terminate or reduce use of Innovid’s products, its revenues within local markets or specific solutions may be negatively impacted.
35
Innovid experiences fluctuations in its results of operations due to a number of factors, which make Innovid’s future results difficult to predict and could cause its operating results to fall below expectations or guidance.
Innovid’s quarterly and annual results of operations fluctuate due to a variety of factors, many of which are outside of its control. As a result, comparing Innovid’s results of operations on a period-to-period basis may not be meaningful. Fluctuations in Innovid’s results of operations could cause its performance to fall below the expectations of analysts and investors, and adversely affect the price of its services. Innovid’s past results are not an indication of its future performance. Factors that may affect Innovid’s quarterly results of operations include:
•the nature of Innovid’s clients’ products or services, including the seasonal nature of its clients’ advertising spending;
•lengthy implementation cycles resulting in substantial expenses incurred without any guarantee of revenue generation;
•demand for Innovid’s offering and the size, scope and timing of digital advertising campaigns;
•the relative lack of long-term agreements with Innovid’s clients and advertisers;
•client and advertisers retention rates;
•market acceptance of Innovid’s offering and future solutions and services (i) in current industry verticals and new industry verticals, (ii) in new geographic markets, (iii) in new advertising channels, or (iv) for broader marketing goals;
•the timing of large expenditures related to expansion into new solutions, new geographic markets, new industry verticals, acquisitions and/or capital projects;
•the timing of adding support for new digital devices, platforms and operating systems;
•Innovid’s clients’ budgeting cycles;
•changes in the competitive dynamics of Innovid’s industry, including consolidation among competitors;
•consumers’ response to Innovid’s clients’ advertisements, to online advertising in general and to tracking technologies for targeted or behavioral advertising purposes;
•Innovid’s ability to control costs, including its operating expenses;
•network outages, errors in Innovid’s technology or security breaches and any associated expense and collateral effects;
•foreign currency exchange rate fluctuations, as some of Innovid’s foreign sales and costs are denominated in its local currencies;
•failure to successfully manage any acquisitions; and
•general economic and political conditions in Innovid’s domestic and international markets.
As a result, Innovid may have a limited ability to forecast the amount of future revenue and expense, and its results of operations may from time to time fall below its estimates or the expectations of public market analysts and investors.
Risks Relating to Compliance with Law, Government Regulation and Litigation
Innovid is subject to anti-bribery, anti-corruption, and similar laws and non-compliance with such laws can subject it to criminal penalties or significant fines and harm its business and reputation.
Innovid is subject to anti-bribery and similar laws, such as the U.S. Foreign Corrupt Practice Act of 1977 (“FCPA”), the US domestic bribery statute contained in 18 USC. § 201, the USA PATRIOT Act, US Travel Act, the U.K. Bribery Act 2010 and the Proceeds of Crime Act 2002, and possibly other anti-corruption, anti-bribery and anti-money laundering laws in countries in which it conducts activities. Anti-corruption laws have been enforced with great rigor in recent years and are interpreted broadly and prohibit companies and their employees and their agents from making or offering improper payments or other benefits to government officials and others in the private sector. The FCPA or other applicable anti-corruption laws may also hold Innovid liable for acts of corruption or bribery committed by its third-party business partners, representatives, and agents, even if Innovid does not authorize such activities. As Innovid increases its international sales and business, and increases its use of third parties, Innovid’s risks under these laws will increase.
36
Innovid operates in jurisdictions that present a high risk for bribery and corruption according to the Transparency International Corruption Perceptions Index, and Innovid’s current policies and procedures may not be sufficient to mitigate Innovid’s anti-corruption risks. As a public company, the FCPA separately requires that Innovid keep accurate books and records and maintain internal accounting controls sufficient to assure management’s control, authority, and responsibility over its assets. Innovid has adopted policies and procedures and conducted training designed to prevent improper payments and other corrupt practices prohibited by applicable laws, but cannot guarantee that improprieties will not occur. Noncompliance with these laws could subject Innovid to investigations, sanctions, settlements, prosecution, other enforcement actions, disgorgement of profits, significant fines, damages, other civil and criminal penalties or injunctions, suspension and/or debarment from contracting with specified persons, the loss of export privileges, reputational harm, adverse media coverage, and other collateral consequences. Any investigations, actions, and/or sanctions could have an adverse effect on Innovid’s business, results of operations and financial condition.
Innovid is subject to economic and trade sanctions laws and regulations and export and import controls that could impair its ability to compete in international markets or subject it to liability if it is not in compliance with applicable laws
Innovid is subject to various US export control laws and regulations, including the Export Administration Regulations administered by the US Department of Commerce, and trade and economic sanctions laws and regulations, including those administered by the US Department of the Treasury’s Office of Foreign Assets Control, the US Department of State, and the US Department of Commerce (collectively, “Trade Controls”). US Trade Controls prohibit or restrict transactions and dealings, including the shipment of products and the provision of services to or involving certain countries, territories, governments, and persons. Although Innovid endeavors to conduct its business in compliance with Trade Controls, its failure to successfully comply may expose it to negative legal and business consequences, including civil or criminal penalties, governmental investigations, loss of export privileges, disgorgement of profits, significant fines, damages, suspension and/or debarment from contracting with certain persons, adverse media coverage, and other reputational harm.
Furthermore, if Innovid exports its technology or software, such exports may require authorization from US regulators, including prior licensing from the US Department of Commerce or other appropriate government authorization. Obtaining such authorization and otherwise complying with Trade Controls may be time-consuming and may result in the delay or loss of opportunities.
In addition, various countries regulate the import of encryption technology, including the imposition of import permitting and licensing requirements, and have enacted laws that could limit Innovid’s ability to offer its platform or could limit its customers’ ability to use Innovid’s platform in those countries. Changes in Innovid’s platform or future changes in export and import regulations may create delays in the introduction of Innovid’s platform in international markets or prevent Innovid’s customers with international operations from deploying its platform globally. Any change in export or import regulations, economic sanctions or related legislation, or change in the countries, governments, persons, or technologies targeted by such regulations, could result in decreased use of Innovid’s platform by, or in its decreased ability to export its technology and services to, existing or potential customers. Any decreased use of Innovid’s platform or limitation on its ability to export its platform would likely adversely affect its business, results of operations, and financial condition.
If we fail to maintain an effective system of internal controls over financial reporting in the future we may not be able to accurately or timeously report our financial condition or results of operations.
If our internal control over financial reporting is not effective, it may adversely affect investor confidence in us and in the price of our common stock.
Failure to comply with applicable legislation and regulation on data privacy and data protection and changes in laws and regulations that result in changes to Innovid’s data collection and storage practices may adversely affect its business.
Privacy and data protection laws and regulation of digital advertising may cause Innovid to incur additional or unexpected costs, subject it to enforcement actions for compliance failures or cause it to change our platform or business model, which may have a material adverse effect on our business.
37
There are a growing number of data privacy and protection laws and regulations in the digital advertising industry that apply to Innovid’s business. Innovid has dedicated, and expects to continue to dedicate, significant resources in its efforts to comply with such laws and regulations. For example, Innovid has implemented policies and procedures to comply with applicable data privacy laws and regulations, and relies on contractual representations made to it by customers and partners that the information they provide to it and their use of its solutions do not violate these laws and regulations or their own privacy policies. If Innovid’s customers’ and partners’ representations are false or inaccurate, or if its customers and partners do not otherwise comply with applicable privacy laws, Innovid could face adverse publicity and possible legal or regulatory action. Conversely, Innovid’s partners and communications services providers have adopted their own policies based on their own perceptions of legal requirements or other policy determinations, and these policies have in the past temporarily prevented Innovid, and may again in the future prevent it, from operating on their platforms and possibly result in loss of business or litigation. The application, interpretation and enforcement of data privacy and protection laws and regulations are often uncertain and continue to evolve, particularly in the new and rapidly evolving industry in which Innovid operates, and may be interpreted and applied inconsistently between states within a country or between countries, and Innovid’s current policies and practices may be found not to comply.
In the US, federal and state laws impose limits on, or requirements regarding the collection, distribution, use, security and storage of personal information of individuals. For example, the Children’s Online Privacy Protection Act applies to websites and other online services that collect personal information about children under 13 years of age. The FTC Act grants the FTC authority to enforce against unfair or deceptive practices, which the FTC has interpreted to require companies’ practices with respect to personal information comply with the commitments posted in their privacy policies. With respect to the use of personal information for direct marketing purposes, the Controlling the Assault of Non-Solicited Pornography and Marketing Act of 2003, establishes specific requirements for commercial email messages and specifies penalties for the transmission of commercial email messages that are intended to deceive the recipient as to source or content, and obligates, among other things, the sender of commercial emails to provide recipients with the ability to opt out of receiving future commercial emails from the sender. Further, the Telephone Consumer Protection Act restricts telemarketing and the use of technologies that enable automatic calling and/or messaging without proper customer consent, and is a particularly highly litigated issue.
There has also been increased regulation of data privacy and security in the US particularly at the state level. For example, in 2018, California enacted the CPA, which came into effect in January 2020 and places increased obligations on businesses. The CCPA gives California residents expanded rights to access and delete their personal information, opt out of certain personal information sharing, and receive detailed information about how their personal information is used. The CCPA provides for civil penalties for violations, as well as a private right of action for data breaches that is expected to increase data breach litigation. Further, in November 2020, California voters passed the CPRA, which significantly expands the CCPA. The CPRA took effect January 1, 2023 (and applies to data collected during the prior year), introduced additional obligations such as data minimization and storage limitations, granting additional rights to consumers, such as correction of personal information and additional opt-out rights, and creates a new entity, the California Privacy Protection Agency, to implement and enforce the law. The CCPA has marked the beginning of a trend toward more stringent state data privacy legislation in the US, which could increase Innovid’s potential liability and adversely affect its business. For example, Virginia has adopted a new state data protection act referred to as the Virginia Consumer Data Protection Act, or CDPA, which also took effect on January 1, 2023. Further, Colorado has adopted a new state data protection act titled the Colorado Privacy Act, which is set to take effect on July 1, 2023. The potential effects of legislation are far-reaching and may require Innovid to modify its processing practices and policies and to incur substantial costs and expenses in an effort to comply.
38
Further, foreign data privacy laws are also rapidly changing and have become more stringent in recent years. In the EEA and the UK, the EEA GDPR, the UK General Data Protection Regulation, and the UK Data Protection Act 2018 impose strict obligations on the ability to collect, analyze, use, transfer and otherwise process personal data. This includes requirements with respect to accountability, transparency, obtaining individual consent, international data transfers, security and confidentiality and personal data breach notifications, which may restrict our processing activities. Separate, restrictive obligations relating to electronic marketing and the use of cookies which may limit our ability to advertise or analyze user behavior online. In the EU and UK, informed consent is required for the placement of most cookies or similar technologies on a user’s device and for direct electronic marketing. The EEA privacy laws on cookies and e-marketing are also subject to change as they are likely to be replaced by the European Commission’s Regulation on Privacy and Electronic Communications, or the ePrivacy Regulation. The ePrivacy Regulation may introduce more stringent requirements for using cookies and similar technologies for direct marketing and significantly increase fines for non-compliance in-line with the GDPR. In addition, there is an increasing regulatory focus on cookies in Europe recently following a recent court decision, privacy activists’ campaigns and various guidance issued by supervisory authorities, which has in some cases led to significant monetary penalties. If regulators start to enforce the strict approach in recent guidance, this could lead to substantial costs, require significant systems changes, limit the effectiveness of our marketing activities, divert the attention of our technology personnel, adversely affect our margins, increase costs, and subject us to additional liabilities.
Innovid expects that there will continue to be new proposed laws, regulations, and industry standards concerning data privacy, data protection, and information security in the United States and other jurisdictions at all levels of legislature, governance, and applicability. These federal, state and foreign laws and regulations, which in some cases can be enforced by private parties in addition to government entities, are increasingly restricting the collection, processing and use of personal data. Innovid continues to monitor changes in laws and regulations, and the costs of compliance with, and the other burdens imposed by, these and other new laws or regulatory actions increase our costs. Although Innovid takes reasonable efforts to comply with all applicable laws and regulations, laws are constantly evolving, can be subject to significant change or interpretive application, and may be inconsistent from one jurisdiction to another.
Any perception of Innovid’s practices, platform or solutions delivery as a violation of data privacy rights may subject it to public criticism, loss of customers or partners, loss of goodwill, class action lawsuits, reputational harm, or investigations or claims by regulators, industry groups or other third parties, any of which could significantly disrupt its business and expose it to liability in ways that negatively affect its business, results of operations and financial condition. Innovid or its third-party service providers could be adversely affected if legislation or regulations are expanded to require changes in Innovid’s or its third-party service providers’ business practices or if governing jurisdictions interpret or implement their legislation or regulations in ways that negatively affect Innovid’s or Innovid’s third-party service providers’ business, results of operations or financial condition.
In addition, failure to comply with these and other laws and regulations may result in, among other things, administrative enforcement actions and significant fines, individual or class action lawsuits, significant legal fees, and civil or criminal liability. Any regulatory or civil action that is brought against Innovid, even if unsuccessful, may distract its management’s attention, divert its resources, negatively affect its public image or reputation among its customers and partners and within its industry, and, consequently, harm its business, results of operations and financial condition.
Legal uncertainty and industry unpreparedness for new regulations may mean substantial disruption and inefficiency, demand constraints, and reduced value.
Some of Innovid’s advertisers may be unprepared to comply with evolving regulatory guidance under the CCPA, CPRA, CDPA, GDPR, or other new regulations, and may therefore remove personal data from their inventory before passing it into the bid stream, at least temporarily. This may lower customer inventory, resulting in loss of ad spend and revenue for Innovid. Further, since Innovid does not have direct relationships with end users, it relies on advertisers to obtain such consents as required. Even well-prepared advertisers may be confronted with difficult choices and administrative and technical hurdles as they implement their compliance programs and integrate with multiple other parties in the ecosystem. While Innovid can and does provide training and guidance on compliance, the nature of the ecosystem and technology does not support 100% verification that consent from end users has been obtained, when required, and it may unknowingly pass on consumer personal information when it should not. This exposes Innovid to potential regulatory scrutiny, investigations, fines, penalties, and other legal and financial exposure. Additionally, data privacy and data protection laws are evolving, and it is possible that these laws may be interpreted and applied in a manner that is inconsistent with Innovid’s safeguards and practices that could result in fines, lawsuits and other penalties, and significant changes to its client’s businesses practices and inventory.
39
Further, compliance program design and implementation will be an ongoing process as understanding of new regulations increase and industry compliance standards evolve. The resulting process friction could result in substantial inefficiency and loss of inventory and demand, as well as increased burdens upon Innovid’s organization as it seeks to assist customers and adapt its own technology and processes as necessary to comply with the law and industry practice. The uncertain regulatory environment may disadvantage Innovid in comparison to large, integrated competitors such as Google and Facebook, which have greater compliance resources and can take advantage of their direct relationships with end users to secure consents. Changes in the business practices of such large integrated competitors could impose additional requirements with respect to the retention and security of Innovid’s handling or ability to handle customer and end user data, could limit its marketing and core business activities, and have an adverse effect on its business, results of operations, and financial condition.
Risks Relating to Information Technology, Cybersecurity and Intellectual Property
An assertion from a third party that Innovid is infringing its intellectual property rights, whether such assertion is valid or not, could subject it to costly and time-consuming litigation, expensive licenses or other impacts to its business.
There is significant intellectual property development activity in the measurement and authentication of digital ads. Third-party intellectual property rights may cover significant aspects of Innovid’s technologies or business methods or block Innovid from expanding its platform and delivering new solutions, and it cannot be certain that its current operations do not infringe the rights of a third party. Innovid has on one occasion received and may in the future receive allegations and/or claims from third parties that Innovid’s technology infringes or violates such third parties’ intellectual property rights. The cost of defending against such claims, whether or not the claims have merit, is significant and could divert the attention of management, technical personnel and other employees from Innovid’s business operations. Litigation regarding intellectual property rights is inherently uncertain due to the complex issues involved, and Innovid may not be successful in defending itself in such matters.
Additionally, Innovid may be obligated to indemnify its customers or partners in connection with any such litigation. Intellectual property claims could harm Innovid’s relationships with its customers and deter future customers from buying its solutions or expose Innovid to litigation. If Innovid is found to infringe intellectual property rights, it could potentially be subject to injunctive or other relief that could affect Innovid’s ability to provide its solutions. Innovid may also be required to develop alternative non-infringing technology and may be unable to do so, or such development may require significant time and expense and may not be successful. In addition, Innovid could be required to pay royalty payments, either as a one-time fee or ongoing, as well as damages for past use that was deemed to be infringing. If Innovid cannot license or develop technology for any allegedly infringing aspect of its business, this may limit its platform and solutions, and Innovid may be unable to compete effectively. Any of these results could adversely affect Innovid’s business, financial condition and results of operations.
Innovid’s intellectual property rights may be difficult to enforce and protect, which could enable others to copy or use aspects of its technology without compensation, thereby eroding its competitive advantages and having an adverse effect on its business, results of operations, and financial condition.
Innovid relies upon a combination of trade secrets, third-party confidentiality, non-disclosure agreements, contractual restrictions on disclosure and use, and trademark, copyright, patent, and other intellectual property laws to establish and protect its proprietary technology and intellectual property rights. Innovid currently owns trademark registrations and applications for the “Innovid” name and variants thereof and other product-related marks in the United States and certain foreign countries. Innovid has also registered numerous Internet domain names related to its business.
Innovid also relies on copyright laws to protect computer programs related to its platform and its proprietary technologies, although to date Innovid has not registered for statutory copyright protection. In order to bring a copyright infringement lawsuit in the United States, the copyright must be registered. Accordingly, the remedies and damages available to Innovid for unauthorized use of its software may be limited. Some of Innovid’s proprietary technology, technology architecture, trade secrets and engineering roadmap have not been patented. As a result, Innovid cannot look to patent enforcement rights to protect some of Innovid’s proprietary technology. Furthermore, Innovid’s patent strategy is still in its early stages. Innovid may not be able to obtain any further patents, and Innovid’s pending application may not result in the issuance of a patent. Any issued patents may be challenged, invalidated, or circumvented, and any rights granted under these patents may not actually provide adequate defensive protection or competitive advantages to Innovid. Additionally, the process of obtaining patent protection is expensive and time-consuming, and Innovid may not be able to prosecute all necessary or desirable patent applications at a reasonable cost or in a timely manner.
40
While it is Innovid’s policy to protect and defend its rights to its intellectual property, it cannot predict whether steps taken by it to protect its intellectual property will be adequate to prevent infringement, misappropriation, dilution, or other violations of its intellectual property rights. Third parties may knowingly or unknowingly infringe Innovid’s intellectual property rights, third parties may challenge intellectual property rights held by Innovid, and pending and future trademark and patent applications may not be approved. These claims may result in restrictions on Innovid’s use of its intellectual property or the conduct of its business. In any of these cases, Innovid may be required to expend significant time and expense to prevent infringement or to enforce its rights. Innovid also cannot guarantee that others will not independently develop technology with the same or similar functions to any proprietary technology Innovid relies on to conduct its business and differentiate itself from its competitors. Unauthorized parties may also attempt to copy or obtain and use Innovid’s technology to develop applications with the same functionality as its solutions, and policing unauthorized use of its technology and intellectual property rights is difficult and may not be effective. In addition, the laws of some foreign countries may not be as protective of intellectual property rights as those of the United States, and mechanisms for enforcement of Innovid’s intellectual property rights in such countries may be inadequate. If Innovid is unable to protect its intellectual property rights (including in particular, the proprietary aspects of its platform) Innovid may find itself at a competitive disadvantage to others who have not incurred the same level of expense, time and effort to create, and protect their intellectual property.
Innovid’s customer agreements generally restrict the use of its confidential information solely to use in connection with the use of its services and restrict the reverse engineering of its technology. In spite of such limitations, reverse engineering Innovid’s software or the theft or misuse of Innovid’s confidential information could occur by customers or other third parties who have access to its technology. Innovid also endeavors to enter into agreements with its employees and contractors in order to limit access to and disclosure of its confidential information, as well as to clarify rights to intellectual property and technology associated with Innovid’s business. These agreements may not effectively grant all necessary rights to any inventions that may have been developed by the employees or consultants party thereto. In addition, these agreements may not effectively prevent unauthorized use or disclosure of Innovid’s confidential information, intellectual property or technology and may not provide an adequate remedy in the event of unauthorized use or disclosure of Innovid’s confidential information, intellectual property, or technology.
Furthermore, protecting Innovid’s intellectual property is particularly challenging after its employees or its contractors end their relationship with Innovid, and, in some cases, decide to work for Innovid’s competitors. Also, enforceability of the non-compete agreements that Innovid has in place is not guaranteed, and contractual restrictions could be breached without discovery or adequate remedies.
Innovid relies on licenses to use the intellectual property rights of third parties to conduct its business.
Innovid relies on products, technologies, and intellectual property that it licenses from third parties, for use in operating its business. Innovid cannot assure that these third-party licenses, or support for such licensed products and technologies, will continue to be available to Innovid on commercially reasonable terms, if at all. Innovid cannot be certain that its licensors are not infringing the intellectual property rights of others or that its suppliers and licensors have sufficient rights to the technology in all jurisdictions in which Innovid may operate. Some of Innovid’s license agreements may be terminated by its licensors for convenience. If Innovid is unable to obtain or maintain rights to any of this technology because of intellectual property infringement claims brought by third parties against its suppliers and licensors or against it, or if Innovid is unable to continue to obtain the technology or enter into new agreements on commercially reasonable terms, its ability to operate and expand its business could be harmed.
41
If Innovid fails to adequately maintain the security of and prevent unauthorized access into its systems or devices, advertisers could lose confidence in its platform, and Innovid could face legal claims that could adversely affect its business, results of operations, and financial condition.
Innovid may be subject to fraudulent or malicious activities undertaken by persons seeking to use its platform for improper purposes. For example, someone may attempt to divert or artificially inflate advertiser purchases through Innovid’s platform, or to disrupt or divert the operation of the systems, and devices of its advertisers, and their consumers in order to misappropriate information, generate fraudulent billings or stage cyberattacks, or for other illicit purposes. For example, sophisticated bot-nets and other complex forms of click fraud might be used to generate fraudulent impressions and divert advertising revenue from legitimate websites of publishers. Those activities could also introduce malware through Innovid’s platform in order to commandeer or gain access to information on consumers’ computers. Innovid uses third-party tools and proprietary technology to identify non-human traffic and malware, and it may reduce or terminate relationships with advertisers that Innovid finds to be engaging in such activities. Although Innovid continuously assesses the quality and performance of advertising on digital media properties, it may be difficult to detect fraudulent or malicious activity, and Innovid relies on its own and third-party tools, as well as the controls of advertisers. Further, perpetrators of fraudulent impressions and malware frequently change their tactics and may become more sophisticated over time, requiring both Innovid and third parties to improve processes for assessing the quality of advertiser inventory and controlling fraudulent activity. If Innovid fails to prevent such unauthorized access or our platform is compromised its services may be disrupted or perceived as insecure. As a result, its reputation could be damaged, advertisers may contest payment, demand refunds, or fail to give Innovid future business, or Innovid could face legal claims from advertisers.
System failures, security breaches or cyberattacks could interrupt the operation of Innovid’s platform and data centers and significantly harm its business, financial condition and results of operations.
Innovid’s success depends on the efficient and uninterrupted operation of its platform. In delivering Innovid’s solutions, it is dependent on the operation of third-party data and cloud computing platforms centers, which are vulnerable to damage or interruption from computer viruses, computer denial of service attacks, unidentified security vulnerabilities, exploitation of encryption technology, or other attempts to harm Innovid’s system and similar events. In the future, in particular due to the increasingly evolving methods of bad actors, Innovid may need to expand its systems at a significant cost and at a more rapid pace than Innovid has to date. Innovid may be unable to provide its solutions on a timely basis or experience performance issues with its platform if Innovid fails to adequately expand or maintain its system capabilities to meet future requirements and address future threats. Some of Innovid’s systems are not fully redundant, and its disaster recovery planning cannot account for all eventualities. The occurrence of any issues or failures at Innovid’s data centers could result in interruptions in the delivery of its solutions to its customers. Additionally, certain of Innovid’s third-party service providers and other vendors have access to portions of its IT system. Performance failures or acts of negligence by these service providers may cause material disruptions to Innovid’s IT systems. A failure or disruption of Innovid’s computer systems, or those of its demand-side integration partners, could impede access to its platform, interfere with its data analytics and prevent the timely delivery of Innovid’s solutions.
The techniques used by criminals to obtain unauthorized access to systems or proprietary information or sensitive, personal or confidential data change frequently and often are not recognized until after being launched against a target, and accordingly, we may be unable to anticipate these techniques or implement adequate preventative measures and there may be a significant delay between the initiation of an attack on our systems and our recognition of the attack. The occurrence of inadvertent or intentional acts of our employees, third-party service providers and other vendors, or business partners may result in a compromise or breach of our networks, or those of third parties with whom we do business. Outside parties may also attempt in the future to fraudulently induce Innovid’s employees or users of its platform to disclose sensitive information via illegal electronic spamming, phishing, or other tactics. Any actual or perceived breach of Innovid’s security measures or Innovid’s third party service providers and other vendors with access to Innovid’s IT system, or the accidental loss, inadvertent disclosure or unauthorized dissemination of proprietary information or sensitive, personal or confidential data about us, our employees, customers or integration partners, or our advertisers and their consumers, including the potential loss or disclosure of such information or data as a result of hacking, fraud, trickery or other forms of deception, could expose Innovid, our employees, our customers or integration partners, or our advertisers and their consumers to risks of loss or misuse of this information.
42
Any such breach, loss, disclosure or dissemination may also result in potential liability or fines, governmental inquiry or oversight, enforcement actions, injunctive relief, litigation, public statements against us by advocacy groups or others, or a loss of customer confidence, any of which could harm Innovid’s business and damage its reputation, possibly impeding its ability to retain and attract new customers, and cause a material adverse effect on Innovid’s operations and financial condition. The cost of investigating, mitigating and responding to potential security breaches and complying with applicable breach notification obligations to individuals, regulators, partners and others can be significant and the risk of legal claims in the event of a security breach is increasing. For example, the CCPA creates a private right of action for certain data breaches. Further, defending a suit, regardless of its merit, could be costly, divert management attention and harm Innovid’s reputation. The successful assertion of one or more large claims against Innovid that exceed available insurance coverage, or the occurrence of changes in its insurance policies, including premium increases or the imposition of large deductibles or co-insurance requirements, could adversely affect Innovid’s reputation, business, financial condition, results of operations and cash flows. Any material disruption or slowdown of Innovid’s systems or those of its third-party vendors or business partners, could have a material adverse effect on Innovid’s business, financial condition, results of operations and cash flows.
Risks Relating to Innovid’s Capital Resources
Restrictions and financial covenants in our current revolving credit facility impose the risk of default and could adversely affect our business, financial condition and results of operations

In the future, Innovid may need to obtain additional financing that may not be available or may reduce its profitability or result in dilution to its stockholders.
Innovid may require additional capital in the future to develop and execute Innovid’s long-term growth strategy. Innovid may need to raise additional funds in the future in order to, among other things:
•finance working capital requirements, capital investments, or refinance existing or future indebtedness;
•acquire complementary businesses, technologies, or products;
•develop or enhance its technological infrastructure and its existing platform and solutions;
•fund strategic relationships; and
•respond to competitive pressures.
If Innovid incurs additional indebtedness, its profitability may be reduced. Any future indebtedness could be at higher interest rates and may require Innovid to comply with restrictive covenants, which could place limitations on its business operations. Further, Innovid may not be able to maintain sufficient cash flows from its operating activities to service its existing and any future indebtedness. If Innovid’s operating results are not sufficient to service any future indebtedness, it will be forced to take actions such as reducing or delaying its business activities, investments or capital expenditures, selling assets or issuing equity. If Innovid issues additional equity securities, its stockholders may experience significant dilution and the price of our common stock may decline. Alternatively, if adequate funds are not available or are not available on acceptable terms, Innovid’s ability to fund its strategic initiatives, take advantage of unanticipated opportunities, develop or enhance its technology or services, or otherwise respond to competitive pressures could be significantly limited.
Additional Risks Related to Ownership of Our Common Stock
The price of our common stock and warrants was and may be volatile in the future.
The price of our common stock, as well as our warrants, fluctuated in the past and may continue to fluctuate due to a variety of factors, including:
•changes in the industries in which we and our customers operate;
•developments involving our competitors;
•changes in laws and regulations affecting our business;
•variations in our operating performance and the performance of our competitors in general;
•actual or anticipated fluctuations in our quarterly or annual operating results;
43
•publication of research reports by securities analysts about us or our competitors or our industry;
•the public’s reaction to our press releases, our other public announcements and our filings with the SEC;
•actions by stockholders, including the sale by the PIPE Investors (as defined in Item 7. Management’s Discussion and Analysis, Transaction, of this Annual Report on the Form 10-K) of any of their shares of our common stock;
•additions and departures of key personnel;
•commencement of, or involvement in, litigation involving our company;
•changes in our capital structure, such as future issuances of securities or the incurrence of additional debt;
•the volume of shares of our common stock available for public sale; and
•general economic and political conditions, such as the effects of the recent COVID-19 outbreak, recessions, interest rates, local and national elections, fuel prices, international currency fluctuations, corruption, political instability and acts of war or terrorism including the conflict between Russia and Ukraine.
These market and industry factors may materially reduce the market price of our common stock and warrants regardless of our operating performance.
We do not intend to pay cash dividends for the foreseeable future.
We currently intend to retain our future earnings, if any, to finance the further development and expansion of our business and do not intend to pay cash dividends in the foreseeable future. Any future determination to pay dividends will be at the discretion of our board of directors and will depend on our financial condition, results of operations, capital requirements, restrictions contained in future agreements and financing instruments, business prospects and such other factors as our board of directors deems relevant.
If analysts do not publish research about our business or if they publish inaccurate or unfavorable research, our stock price and trading volume could decline.
The trading market for our common stock depends in part on the research and reports that analysts publish about our business. We do not have any control over these analysts. If one or more of the analysts who cover us downgrade our common stock or publish inaccurate or unfavorable research about our business, the price of our common stock would likely decline. If few analysts cover us, demand for our common stock could decrease and our common stock price and trading volume may decline. Similar results may occur if one or more of these analysts stop covering us in the future or fail to publish reports on us regularly.
We are an “emerging growth company” and we expect to elect to comply with reduced public company reporting requirements which could make our common stock less attractive to investors.
We are an “emerging growth company” as defined in the Jumpstart Our Business Startups Act of 2012 (“JOBS Act”). For so long as we continue to be an emerging growth company we are eligible for certain exemptions from various public company reporting requirements.
We may be subject to securities litigation, which is expensive and could divert management attention.
The market price of our common stock may be volatile and, in the past, companies that have experienced volatility in the market price of their stock have been subject to securities class action litigation. We may be the target of this type of litigation in the future. Securities litigation against us could result in substantial costs and divert management’s attention from other business concerns, which could seriously harm our business.
Our certificate of incorporation designates the Court of Chancery of the State of Delaware will be the sole and exclusive forum for certain litigation that may be initiated by our stockholders and the federal district courts of the United States as the exclusive forum for litigation arising under the Securities Act of 1933 as amended which could limit our stockholders’ ability to obtain a favorable judicial forum for disputes with us.
44
Future resales of common stock may cause the market price of our securities to drop significantly, even if our business is doing well.
Following the expiration of the lock-up arrangements relating tot he Transaction, there are no contractual restrictions on selling shares of our common stock held by them, other than by applicable securities laws. As such, sales of a substantial number of shares of our common stock in the public market could occur at any time. These sales, or the perception in the market that the holders of a large number of shares intend to sell shares, could have the effect of increasing the volatility in our share price or could reduce the market price of our common stock. Such sales, or the possibility that such sales may occur, also might make it more difficult for us to sell equity securities in the future at a time and at a price that we deem appropriate.
General Risk Factors
We may have to constrain our business activities to avoid being deemed an investment company under the Investment Company Act.
In general, a company that is or holds itself out as being engaged primarily in the business of investing, reinvesting, or trading in securities may be deemed to be an investment company under the Investment Company Act. The Investment Company Act contains substantive legal requirements that regulate the manner in which “investment companies” are permitted to conduct their business activities. The Company believes it has conducted, and intends to continue to conduct, its business in a manner that does not result in the Company being characterized as an investment company. To avoid being deemed an investment company, the Company may decide not to broaden its offerings, which could require the Company to forgo attractive opportunities. If the Company is deemed to be an investment company under the Investment Company Act, it may be required to institute burdensome compliance requirements and its activities may be restricted, which would adversely affect the Company’s business, financial condition, and results of operations. In addition, the Company may be forced to make changes to its management team if it is required to register as an investment company under the Investment Company Act.
Our business and operations could be negatively affected if we become subject to any securities litigation or shareholder activism, which could cause us to incur significant expense, hinder execution of business and growth strategy and impact our stock price.
In the past, following periods of volatility in the market price of a company’s securities, securities class action litigation has often been brought against that company. Shareholder activism, which could take many forms or arise in a variety of situations, has been increasing recently. Volatility in the stock price of our common stock or other reasons may in the future cause it to become the target of securities litigation or shareholder activism. Securities litigation and shareholder activism, including potential proxy contests, could result in substantial costs and divert management’s and the Board’s attention and resources from the Company’s business. Additionally, such securities litigation and shareholder activism could give rise to perceived uncertainties as to the Company’s future, adversely affect its relationships with service providers and make it more difficult to attract and retain qualified personnel. Also, the Company may be required to incur significant legal fees and other expenses related to any securities litigation and activist shareholder matters.
Further, our stock price could be subject to significant fluctuation or otherwise be adversely affected by the events, risks and uncertainties of any securities litigation and shareholder activism.
Item 1B. Unresolved Staff Comments
N/A.
Item 2. Properties
Our corporate headquarters is located in New York, New York and consists of approximately 17,000 square feet of space. Our other main offices are in Edinburgh, Tel Aviv and Buenos Aires We also maintain offices and/or shared work spaces in Los Angeles, Chicago, Detroit, London, Edinburgh, Sydney and Bogota. We lease all of our facilities and do not own any real property. Leases on these facilities expire at various dates from 2022 to 2025, excluding any options for renewal. We may add facilities as we grow our employee base and expand geographically. We believe that our facilities are sufficient to meet our needs for the immediate future, and that, should it be needed, suitable additional space will be available to accommodate expansion of our operations.
45
Item 3. Legal Proceedings
We are not presently party to any legal proceedings or aware of any claims which we believe would have, individually or in the aggregate, a material adverse effect on our consolidated business prospects, financial condition, liquidity, results of operation, cash flows, or capital levels. We may from time to time be party to litigation and subject to claims incident to the ordinary course of business.
On March 4, 2022, a lawsuit was filed in the United States District Court for the Western District of Texas by Nielsen, LLC against TVS alleging infringement of US Patent No. 10,063,378. On January 18, 2023 the Texas Court granted TVS’s motion to transfer venue to the Southern District of New York. It is expected that the Southern District of New York will issue a scheduling order detailing the next steps in the case in March 2023. The plaintiff has not specified the amount sought in the litigation.
Item 4. Mine Safety Disclosures
N/A.
Part II
Item 5. Market for Registrant's Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities
Market Information
Our common stock trades on the NYSE under the ticker symbol “CTV” and our warrants trade on NYSE under the ticker symbol “CTV.WS.”
Holders
As of March 1, 2023, there were approximately 100 holders of record of our common stock and approximately 2 holders of record of our warrants.
Issuer purchases of equity securities
There were no purchases of common stock for the year ended December 31, 2022.
Dividends
We have not paid any cash dividends on our common stock to date. The payment of cash dividends in the future will be dependent upon our revenues and earnings, if any, capital requirements and general financial condition. The payment of any cash dividends, if any, will be within the discretion of our board of directors. Our ability to declare dividends may be limited by the terms of financing or other agreements entered into by us or our subsidiaries from time to time.
Recent Sales of Unregistered Securities
There were no sales of unregistered equity securities for the year ended December 31, 2022.
Securities Authorized for Issuance under Equity Compensation Plans
Refer to Item 12. Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters of this Annual Report on Form 10-K.
Use of Proceeds
On November 30, 2021, Innovid, Inc. consummated the Merger Agreement dated June 24, 2021, with Innovid surviving the merger. Approximately $149.3 million in cash proceeds were received net of transaction costs paid. For greater detail, see Note 3, Transaction to our audited consolidated financial statements included under Item 8, Financial Statements and Supplementary Data.
Item 6.
[Reserved.]
46
Item 7. Management’s Discussion and Analysis of Financial Condition and Results of Operations
The following discussion and analysis should be read in conjunction with the audited consolidated financial statements and related notes of Innovid included in Item 8. “Financial Statements and Supplementary Data” “Financial Statements and Supplemental Data”. This discussion contains forward-looking statements reflecting our current expectations, estimates and assumptions concerning events and financial trends that may affect our future operating results or financial position. Actual results and timing of events may differ materially from those contained in these forward-looking statements due to a number of factors, including those discussed in the sections in this Annual Report on Form 10-K titled “Risk Factors” and “Cautionary Statement Regarding Forward-Looking Statements.”
Company Overview
Overview
We are a leading independent software platform that provides critical technology infrastructure for the creation, delivery, and measurement of TV/video ads across CTV, linear TV, mobile and desktop TV environments. As of December 31, 2022, over 50% of the top 200 advertisers by TV US advertising spend according to Kantar Media are utilizing our platform in their advertisement delivery infrastructure. Innovid’s revenue has grown alongside the growth of CTV advertising. We believe our open platform and purpose-built technology for CTV, combined with our position as a media-independent provider, has allowed us to win a large and growing market share, while the growth of CTV combined with our usage-based revenue model has further contributed to our rapid growth. CTV accounted for 51%, 46% and 40% of all video impressions served by Innovid during the years ended December 31, 2022, 2021 and 2020, respectively. During the year ended December 31, 2022, this represented a year-over-year increase of 28%. The balance of video impressions served by Innovid during such periods were attributable to Mobile, 36%, 39% and 43%, respectively, and PC, 13%, 15%, 16% respectively. In 2022, the year-over-year change in video impressions was an increase of 5% for mobile TV and 2% for desktop TV. An impression is the metric used to quantify the number of views of an advertisement. Impressions are measured by cost per mille (“CPM”), where mille refers to 1,000 impressions (or cost per thousand). For example, a CTV ad might have a CPM of $25, meaning that the content owner receives $25 every time an ad is displayed 1,000 times within a designated program. Ad servers, such as Innovid, provide a pixel that is implemented within an ad. When an ad with that pixel loads, an impression is counted. Counting impressions is essential to how digital advertising is measured, accounted and paid for. We serve many of the top TV advertisers, including Anheuser-Busch InBev, CVS Pharmacy, Kellogg’s, Mercedes-Benz, Target, Sanofi, and many more, with such clients representing the key verticals we serve.

We believe CTV is a large and growing industry with significant upside potential, but it also has its own set of challenges. Innovid’s solutions are designed to solve three core areas of disruption for large advertisers shifting investment to CTV; the streaming and delivery of creative, personalization of creative, and measurement. Our solutions starts with the workflow for personalizing and delivering ads, a process that allows us to receive signals to enable measurement of advertising. In the middle of this workflow loop is a complex ecosystem of providers that Innovid supports through collaboration and integration, but does not compete with. This includes Demand Side Platforms who enable programmatic ad buying.

A key driver of CTV growth has been the evolving preferences of consumers. Consumers are increasingly cutting the cord and streaming TV content over-the-top (“OTT”) through internet-connected devices rather than traditional broadcast, satellite or cable TV. We believe OTT content, which is typically delivered on-demand, seeks to provide a better user experience, and often saves the consumer money over traditional paid TV services. Advertisers seeking to engage these audiences are rapidly shifting dollars away from traditional TV mediums towards increasing budgets for CTV. Advertisers can also benefit from the shift to CTV as the digitally delivered ads can be personalized and measured in real time, similar to other digital advertising mediums such as internet browser-based formats. As a result, TV advertisers have better transparency, control and ultimately potential return on investment from their CTV advertising.
Innovid’s purpose-built CTV infrastructure platform comprises three key offerings: Ad Serving Solutions, Creative Personalization Solutions and Measurement Solutions. Our software-based platform provides an open technology infrastructure that tightly integrates with the highly fragmented advertising technology and media ecosystem including Demand Side Platforms such as The Trade Desk and Amobee; supply side platforms such as Magnite and Verizon Media; publishers such as Hulu and Peacock; and end user devices such as Amazon Fire and Samsung Smart TV. Our offerings encompass independent global ad serving, data-driven personalization, and new forms of measurement designed to connect all channels in a clean, comparable, and privacy-compliant manner. Although we work closely with the vendors who buy and sell media, our platform only facilitates the creation, delivery and measurement of advertisements and campaigns and we do not make purchasing decisions of advertisement inventory. Because we do not make ad buying or selling decisions we are able to maintain our independence and remain free of potential buying conflicts.
47
Our target clients comprise the largest global TV advertisers. In addition, we work closely with top advertising agency holding companies such as WPP, Publicis Groupe, Omnicom, Interpublic Group of Cos. and Dentsu. Our clients are diversified across all major industry verticals, including consumer packaged goods, pharmaceutical and healthcare, retail, financial services, automotive and technology. We believe Innovid’s independence is critical to advertisers seeking an interoperable and open partner that is primarily focused on technology infrastructure. We define core clients as advertisers or publishers that generated at least $100,000 of annual revenue. Prior to our acquisition of TVS, our definition of a core client included only advertisers that generates at least $100,000 of annual revenue. We have a history of strong growth in our core client base, with 174 core clients as of December 31, 2022 using the new definition, including 41 core clients added from the acquisition of TVS. No individual core client represented more than 12% of 2022 revenue. In 2022 our 174 core clients that generated approximately 88% of the total company revenue.. In the years ended December 31, 2020 and 2021 we had 95 and 109 core clients (which did not include publishers) that generated 89% and 91% of the total company revenue. Innovid serves customers globally, including the US, Germany, UK, Mexico, Argentina, Colombia, Israel, Singapore, Japan and Australia. In 2022 approximately 10% of Innovid’s revenue was generated by our customers outside of the US.

Our revenue model is based on impressions volume and the cost per impression for our various ad serving services. For our core ad serving platform, we generate revenue from our advertising customers based on the volume of advertising impressions delivered, enabling us to grow as our customers increase their digital ad spend and corresponding ad impressions. We also provide measurement services to brand and agencies, enterprise clients (networks) and publishers. Our measurement services provide analysis on and track performance of advertisement campaigns and in this way provide insights into the effectiveness of TV and digital advertising. The measurement service provides insights into the effectiveness of TV and digital advertising. Revenues related to the measurement services platform are recognized over time, since the customer simultaneously receives and consumes the benefits provided by the Company’s performance. Revenues for these measurement services are recognized over the service period. Additionally, we generate revenue from creative services based on flat fee per projects. As we introduce new products such as advanced measurement and creative capabilities including personalization and interactivity, we expect to be able to charge higher prices per impression volume.
The Transaction
Innovid Corp. was originally incorporated as ION Acquisition Corp. 2 Ltd., a special purpose acquisition company, in Cayman Islands on November 23, 2020 for the purpose of entering into a merger, share exchange, asset acquisition, stock purchase, recapitalization or other similar business combination with one or more businesses or entities.
On November 30, 2021 ION and Innovid Inc. closed the transaction as described below. Through several mergers and a name change, Innovid Corp. was formed. ION entered into certain subscription agreements in June and October 2021 (“PIPE Investment”). The Mergers and PIPE Investment are collectively referred to as “the Transaction”. Innovid Corp. is the public company entity which continues Legacy Innovid’s operating activity.
The Company common stock and warrants commenced trading on the NYSE under the symbols “CTV” and “CTVWS,” respectively, on December 1, 2021.
Acquisition
On February 28, 2022, the Company completed the acquisition of TVS. TVS is an independent global measurement and attribution platform for converged TV and a private company limited by shares incorporated under the laws of Scotland. The Company acquired all the equity of TVS for an aggregate amount of $100,000 in cash, 11,549,465 shares of the Company common stock at fair value of $3.80 per share, and the issuance of 949,893 fully vested stock option of the Company at weighted average fair value of $3.49, subject to certain adjustments as defined in the Stock Purchase Agreement.
Use of Estimates
The preparation of the consolidated financial statements in conformity with US GAAP requires us to make estimates, judgments and assumptions. We believe that the estimates, judgments and assumptions used are reasonable based upon information available at the time they are made. These estimates, judgments and assumptions can affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the dates of the financial statements, and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.
48
We have considered the impact of these factors on our estimates and assumptions and determined that there were no material adverse impacts on the consolidated financial statements for the periods ended December 31, 2022 and 2021. As events continue to evolve and additional information becomes available, our estimates and assumptions may change materially in future periods.
Key Factors Affecting Our Performance
There are a number of factors that have impacted, and we believe will continue to impact, our results of operations and growth. These factors include:
Continued market demand. Our performance is dependent on continued global demand across the advertising ecosystem for independent third-party ad serving and measurement of digital ads. Advertisers, programmatic platforms, social media channels and digital publishers are collectively placing increased emphasis on the quality and effectiveness of digital ad spend across all channels, formats and devices.
Our growth is primarily driven by the fastest growing segments of digital ad spend, mostly CTV, and our results depend on our ability to capture continued market growth.
Growth of volume of CTV ad impressions of existing customers. Our results also depend on our ability to retain our existing customers and on our customers’ continued investment in CTV advertising. Customer retention will continue to impact our results as TV investment continues to shift from linear to CTV and the volume of CTV impressions grows.
Upsell of additional services. An additional contributor to our efforts in expanding revenue generated by our customers is our investment in cross-selling our solutions. We cross-sell our personalized creative solutions to primary ad serving customers, who, for example, begin using our services with standard TV ads and then introduce personalized formats over time. We also have cross-selling efforts related to our advanced measurement solutions, which provide real-time metrics to inform optimization of TV campaigns while in market. The success of these efforts will impact our results of operations.
Global expansion
The majority of our clients are global advertisers and operate at a significant scale. Innovid serves customers globally through a delivery footprint covering the US, the UK, Mexico, Argentina, Colombia, Israel, Singapore, Japan, and Australia. In 2022, approximately 10% of Innovid’s revenue was generated outside of the US.
We intend to continue to grow our footprint in international markets in order to meet the needs of our global customer base and to accelerate new customer acquisition in key geographies outside of North America. Our results of operations will be impacted by the success of our geographic expansion, and whether the expected ad spend growth in these markets materializes.
New client accounts: We intend to continue targeting new brand, media agency and digital publisher customers who are currently utilizing solutions provided by our competitors or point solutions. Our results of operations will be impacted by our ability to attract new customers.
Seasonality: We experience fluctuations in revenues that coincide with seasonal fluctuations in the digital ad spending of our customers, in particular television ad spending patterns. Advertisers often allocate the largest portion of their media budgets to the fourth quarter of the calendar year in order to coincide with increased holiday purchasing. As a result, the fourth quarter of the year typically reflects our highest level of revenues while the first quarter typically reflects our lowest level of revenues. We expect our revenues to continue to fluctuate based on seasonal factors that affect the advertising industry as a whole and for these seasonal fluctuations in ad spend to impact quarter-over-quarter results. We believe that the year-over-year comparison of results more appropriately reflects the overall performance of our business. However, this traditional seasonality may also be impacted by certain external factors or major events that impact traditional television advertising patterns, such as global events described above. In the year ended December 31, 2022 we observed more traditional seasonality in television advertising spend relative to the corresponding period in 2021.
Public company costs: We are incurring additional legal, accounting and other expenses that we did not previously incur, including costs associated with SEC reporting and corporate governance requirements. These requirements include compliance with the Sarbanes-Oxley Act as well as other rules implemented by the SEC and the NYSE. Our financial statements reflect the impact of these expenses.
49
Components of Results of Operations
The period to period comparisons of our results of operations have been prepared using the historical periods included in our consolidated financial statements. The following discussion should be read in conjunction with the audited consolidated financial statements and related notes included in Item 8. “Financial Statements and Supplementary Data”.
Revenues
We generate the majority of our revenues from providing Ad serving services to advertisers, media agencies and publishers. We focus on standard, interactive and data driven digital video advertising. Ad serving services relate to utilizing Innovid’s platform to serve advertising impressions to various digital publishers across CTV, mobile TV, desktop TV, display, and other channels.
We also have a new offering, InnovidXP, which is focused on measurement of the efficiency of CTV advertising and in-flight optimizations for TV marketers. We plan to further develop and scale it in the future.
We provide creative services related to the design and development of interactive data-driven and dynamic ad formats by adding data, interactivity and dynamic features to standard ad units.
We generate the majority of our revenues from the sale and delivery of our products within the US. For information with respect to sales by geographic markets, refer to Note 18, Segment Reporting to the Consolidated Financial Statements included under Item 8, Financial Statements and Supplementary Data. Our chief operating decision maker (our CEO) does not evaluate the profit or loss from any separate geography.
We anticipate that revenues from our US sales will continue to constitute a substantial portion of our revenues in future periods.
Cost of revenues
Cost of revenues consists primarily of costs to run our ad serving, creative and measurement services. These costs include hosting fees, personnel costs including stock-based compensation, professional services costs and facility related costs. We allocate overhead, including rent and other facility related costs and communication costs, based on headcount.
Research and development
Research and development expenses consist primarily of personnel costs, including stock-based compensation, professional services costs, hosting and facility related costs. We allocate overhead including rent and other facility related costs and communication costs based on headcount. We expect research and development expenses to increase in future periods to support our growth, including continuing to invest in optimization, accuracy and reliability of our platform and other technology improvements to support and drive efficiency in our operations. These expenses may vary from period to period as a percentage of revenue, depending primarily upon when we choose to make more significant investments.
Research and development costs are charged to the consolidated statements of operations as incurred. ASC 350-40, Internal-Use Software (“ASC 350-40”), requires the capitalization of certain costs incurred only during the application development stage.
Sales and marketing
Sales and marketing expenses consist primarily of personnel costs, including commissions, stock-based compensation, professional services costs and facility related costs, as well as costs related to advertising, promotional materials, public relations, other sales and marketing programs. We allocate overhead, including rent and other facility related costs and communication costs based on headcount.
General and administrative
General and administrative expenses consist primarily of personnel costs, including stock-based compensation, for executive management, finance, accounting, human capital, legal and other administrative functions as well as professional services costs and facility related costs. We allocate overhead, including rent and other facility related costs, and communication costs based on headcount.
50
Prior period reclassification
Beginning in the second quarter 2022, we present depreciation, amortization and impairment expenses as a separate line item on our consolidated statements of operations. All prior periods have been adjusted. Depreciation and amortization expenses were previously included in cost of sales and other operating expenses depending on the underlying asset’s function. Additionally, we no longer present gross profit as a subtotal on our consolidated statements of operations. In accordance with generally accepted accounting principles, all periods presented below have been retrospectively adjusted to reflect the reclassification of cost of revenue and other operating expenses exclusive of depreciation, amortization and impairment. The period-to-period comparisons of our results of operations have been prepared using the historical periods included in our consolidated financial statements, adjusted for this reclassification. Refer toNote 2, Summary of Significant Accounting Policies to the Consolidated Financial Statements included under Item 8, Financial Statements and Supplementary Data for further information on prior period reclassification.
Results of Operations
The period to period comparisons of our results of operations have been prepared using the historical periods included in our audited consolidated financial statements. The following discussion should be read in conjunction with the audited consolidated financial statements and related notes included elsewhere in this Form 10-K. We have derived this data from our annual audited consolidated financial statements included in Item 8. “Financial Statements and Supplementary Data”.
Year ended December 31,
20222021
(in thousands)% of Revenue(in thousands)% of Revenue
Revenues$127,117 

100.0 %$90,291 100.0 %
Cost of revenues30,187 

23.7 %17,698 19.6 %
Research and development31,118 

24.5 %24,299 26.9 %
Sales and marketing50,266 

39.5 %32,841 36.4 %
General and administrative39,144 

30.8 %20,641 22.9 %
Depreciation, amortization and impairment6,143 4.8 %661 0.7 %
Operating loss
(29,741)

(23.4)%(5,849)(6.5)%
Finance expenses (income), net(13,348)

(10.5)%4,386 4.9 %
Loss before taxes
(16,393)(12.9)%(10,235)(11.3)%
Taxes on income2,017 

1.6 %1,237 1.4 %
Net loss
$(18,410)

(14.5)%$(11,472)(12.7)%
Revenues
The growth and scaling of CTV was the key driver of Innovid’s revenue growth. As TV ad spend continues to shift from linear to CTV, we continue to benefit from the natural volume growth of CTV impressions we delivered for our existing and new customers. We have driven consistent positive net revenue retention of our core client base, largely through increased CTV advertising volume, as legacy TV budgets migrate from linear TV to CTV.
Total revenue increased by 41% year-over-year, from $90.3 million in the year ended December 31, 2021 to $127.1 million in the year ended December 31, 2022. 19% of total 2022 revenue, $23.6 million, was attributed to TVS.

Revenue, excluding TVS, was $103.5 million in the year ended December 31, 2022, an increase of 15% from the year ended December 31, 2021. The increases are driven primarily by growth in ad impressions delivered on our platform for both existing and new clients. A significant contributor to our revenue growth is the ongoing conversion of advertising investment from linear TV to CTV, both in the market and among our clients.

There was no meaningful impact of changes in average cost per impression on total revenue.
51
Cost of revenues (exclusive of depreciation and amortization shown below)
Year ended December 31,
20222021
(in thousands)% of Revenue(in thousands)% of Revenue$ Variance% Variance
Cost of revenues$30,187 

23.7 %$17,698 19.6 %$12,489 70.6 %
Cost of revenue increased by $12.5 million, or 71%, from $17.7 million in the year ended December 31, 2021 to $30.2 million in the year ended December 31, 2022. This is driven by a $6.1 million increase predominantly related to inclusion of data costs for our measurement services included in our operations following TVS acquisition. In addition, we had a $4.9 million increase in personnel costs due to a higher headcount due to TVS acquisition and to support increased activity volume.
Research and development (exclusive of depreciation, amortization and impairment shown below)
Year ended December 31,
20222021
(in thousands)% of Revenue(in thousands)% of Revenue$ Variance% Variance
Research and development$31,118 

24.5 %$24,299 26.9 %$6,819 28.1 %
Research and development expenses increased by $6.8 million, or 28%, from $24.3 million in the year ended December 31, 2021 to $31.1 million in the year ended December 31, 2022. The increase was primarily due to an increase of $8.1 million in personnel costs following the TVS acquisition and an increase of $1.1 million in technology infrastructure and hosting fees, both to support our platform maintenance work as well as our product research efforts. In addition, there was a $4.3 million increase in share-based compensation mostly due to increase in headcount and RSUs that were granted to employees. These increases were partially offset by an increase of $7.4 million for capitalization of research and development expenses related to our development of new products and our platform enhancements.
Sales and marketing (exclusive of depreciation and amortization shown below)
Year ended December 31,
20222021
(in thousands)% of Revenue(in thousands)% of Revenue$ Variance% Variance
Sales and marketing$50,266 

39.5 %$32,841 36.4 %$17,425 53.1 %
Sales and marketing expenses increased by $17.4 million, or 53%, from $32.8 million in the year ended December 31, 2021 to $50.3 million in the year ended December 31, 2022. The increase was driven primarily by an increase in personnel costs of $9.9 million following the TVS acquisition and an increase in marketing costs of $1.6 million, both to support our long-term growth strategy. In addition, there was a $4.3 million increase in share-based compensation due to increase in headcount and RSUs that were granted to employees and a $0.4 million increase in commissions due to higher revenues.
General and administrative (exclusive of depreciation, amortization and impairment shown below)
Year ended December 31,
20222021
(in thousands)% of Revenue(in thousands)% of Revenue$ Variance% Variance
General and administrative$39,144 

30.8 %$20,641 22.9 %$18,503 89.6 %
General and administrative expenses increased by $18.5 million, or 90%, from $20.6 million in the year ended December 31, 2021 to $39.1 million in the year ended December 31, 2022. The increase was primarily due an increase in personnel costs of $2.3 million related to the expansion of our operations following the TVS acquisition and a $3.3 million increase in Directors and Officers insurance expense during the period. In addition, there was an increase in professional fees primarily consisting of $4.9 million related to the TVS Acquisition, $1.9 million for accounting and audit services in connection with being a public company and $0.8 million for legal services related to SEC reporting. Further, we incurred $1.5 million in litigation related professional fees.
52
In addition, there was a $2.2 million increase in share-based compensation mostly due to RSUs that were granted to employees and an increase in headcount.
Depreciation, amortization and impairment
Year ended December 31,
20222021
(in thousands)% of Revenue(in thousands)% of Revenue$ Variance% Variance
Depreciation, amortization and impairment$6,143 4.8 %$661 0.7 %$5,482 829.4 %
Depreciation, amortization and impairment expenses increased by $5.5 million, or 829%, from $0.7 million in the year ended December 31, 2021 to $6.1 million in the year ended December 31, 2022. The increase was driven primarily by amortization of $3.8 million related to acquired intangible assets associated with our acquisition of TVS and an impairment charge of $0.5 million related to the abandonment of certain projects associated with our internal software development.
Finance expenses (income), net
Year ended December 31,
20222021
(in thousands)% of Revenue(in thousands)% of Revenue$ Variance% Variance
Finance expenses (income), net$(13,348)

(10.5)%$4,386 4.9 %$(17,734)(404.3)%
Finance expenses (income), net decreased by $17.7 million, or 404%, from $4.4 million expense in the year ended December 31, 2021 to $13.3 million income in the year ended December 31, 2022. The decrease was driven primarily by a decline in the fair value of our Public and Private Warrants issued as a part of the Transaction. The fair value of the warrants is influenced by market volatility impacting Company’s share price which is an underlying input for the valuation.
Taxes on income
Year ended December 31,
20222021
(in thousands)% of Revenue(in thousands)% of Revenue$ Variance% Variance
Taxes on income$2,017 

1.6 %$1,237 1.4 %$780 63.1 %
Tax expense increased by $0.8 millions, or 63%, from $1.2 million in the year ended December 31, 2021 to $2.0 million in the year ended December 31, 2022. The increase is primarily due to changes in US state and foreign income taxes, changes in uncertain tax positions related to our Israel subsidiary, and changes to deferred taxes associated with the acquisition of TVS.
Liquidity and Capital Resources
We have financed our operations and capital expenditures primarily through utilization of cash generated from operations, as well as borrowings under our credit facilities.
As of December 31, 2022, we had cash, cash equivalents and restricted cash of $38.0 million and net working capital, consisting of current assets less current liabilities, of $72.6 million. We paid net cash consideration of approximately $99.1 million for the acquisition of TVS. As of December 31, 2022, we had an accumulated deficit of $150.9 million, $76.0 million thereof results from the cumulative accretion of preferred stock to redemption value prior to the conversion of all preferred stock into our common stock upon the closing of the Transaction.
We believe our existing cash and cash equivalents and anticipated net cash provided by operating activities, together with available borrowings under our credit facility, will be sufficient to meet our cash needs and working capital requirements for at least the next 12 months. However, if our operating performance during the next 12 months is below our expectations, our liquidity and ability to operate our business could be adversely affected. We are closely monitoring the effect that current economic conditions may have on our working capital requirements. To date, the global events have not had a material negative impact on our cash flow or liquidity. Our future capital requirements and the adequacy of available funds will depend on many factors.
53
Sources of Liquidity
Revolving Line of Credit
On August 4, 2022, two of our wholly owned subsidiaries, Innovid LLC and TV Squared Inc, entered into an amended and restated loan and security agreement with Silicon Valley Bank (the “2022 A&R Agreement”), to increase the revolving line of credit from $15.0 million to $50.0 million (the “New Revolving Credit Facility”). The interest for the New Revolving Credit Facility is payable monthly in arrears. The New Revolving Credit Facility bears interest at an annual rate which is the greater of (a) WSJ Prime Rate plus 0.75% or (b) 4.25%, on the aggregate outstanding balance. Additional fees include fees in an amount of 0.20% per annum of the average unused portion of the New Revolving Credit Facility to be paid quarterly in arrears. The maturity date of the 2022 A&R Agreement is June 30, 2024. The New Revolving Credit Facility is subject to certain customary conditions precedent to the credit extension as stated in the 2022 A&R Agreement.
The New Revolving Credit Facility requires us to comply with all covenants, primarily maintaining an adjusted quick ratio of at least 1.30 to 1.00. As defined in the 2022 A&R Agreement “adjusted quick ratio” is the ratio of (a) quick assets to (b) current liabilities minus the current portion of deferred revenue. “Quick assets” determines as our unrestricted cash plus accounts receivable, net, determined according to accounting principles generally accepted in the United States of America (“US GAAP”). We are also required to maintain the minimum quarterly adjusted EBITDA as defined in the 2022 A&R Agreement if we do not maintain the quarterly adjusted quick ratio of at least 1.50 to 1.00.
As of December 31, 2022, we were in compliance with all covenants.
As of December 31, 2022, the Company utilized $20.0 million of the $50.0 million credit line, $6.0 million of which was drawn during 2020, $5.0 million was drawn during the fourth quarter 2022 and $9.0 million was drawn during the second quarter of 2022. In January 2023, the Company repaid $5.0 million under the credit line.
Prior to the 2022 A&R Agreement, the credit installments bore US dollar denominated interest at an annual rate equal to 0.75%-1% plus a prime rate on the outstanding principal of each credit installment.
We recognized interest expenses in “Finance expenses (income), net” in the consolidated statements of operations. Interest expenses for the years ended December 31, 2022 and 2021 were $0.7 million and $0.3 million, respectively.
Uses of Liquidity
We utilize short-term certificates of deposit in order to maximize the use of cash on hand. As of December 31, 2022 we had one short-term certificate of deposit of $10 million with an original maturity greater than 90 days. This deposit is expected to mature within 180 days from it’s date of issuance.
Cash Flows
Year ended December 31, 2022 compared to year ended December 31, 2021
The following table summarizes our cash flows for the periods presented:
Year ended December 31,
20222021
Net cash used in operating activities$(11,561)$(2,421)
Net cash used in investing activities(119,426)(3,687)
Net cash provided by financing activities11,800 147,174 
(Decrease) increase in cash, cash equivalents and restricted cash
$(119,187)$141,066 
Operating Activities
Our cash flows from operating activities are primarily influenced by growth in our operations, increases or decreases in collections from our customers and payments to our vendors, as well as increases in personnel related expenses as we scale up our business. The timing of cash receipts from customers and payments to vendors and providers can significantly impact our cash flows from operating activities. In addition, we expect seasonality to impact quarterly cash flows from operating activities.
54
Cash used in operating activities is calculated by adjusting our net loss for changes in working capital, as well as by excluding non-cash items such as depreciation, amortization and impairment, stock-based compensation and changes in fair value of warrants.
For the year ended December 31, 2022, net cash used in operating activities was $11.6 million compared to net cash used in operating activities of $2.4 million for the year ended December 31, 2021. The increase in net cash used in operating activities during 2022 as compared to 2021 was primarily attributable to increased loss from operations, an increase in account receivable because of the expansion of our operations offset by decreased non-cash adjustments.
The changes in our working capital compared to the prior period were the result of an increase in trade receivables due to increased revenue and operating activities. The changes in working capital were also related to an increase in accrued liabilities due to accrual and the timing of payments for personnel costs, prepaid software subscription fees and changes due to the acquisition of TVS.
Our non-cash adjustments decreased mostly driven by decrease in valuation of warrants due to changes in our stock market price, offset by an increase in stock-based compensation as a result of RSUs granted in 2022 and amortization of intangible assets related to TVS acquisition.
Investing Activities
For the year ended December 31, 2022, we used $119.4 million of net cash in investing activities, primarily driven by cash consideration of $99.1 million paid to acquire TVS. In addition, an increase of $7.4 million comparing to the prior period relates to investment in internal software development work. Further, we invested $10.0 million in short-term deposit in the fourth quarter of 2022 with maturity of no more than 180 days.
For the year ended December 31, 2021, we used $3.7 million of net cash in investing activities, primarily driven by the investment in internal software development work of $2.6 million and the loan in the amount of $0.5 million issued to our founder.
Financing Activities
For the year ended December 31, 2022, net cash provided by financing activities of $11.8 million was due to drawdown of credit facility of $14.0 million and proceeds received for exercises of options in the amount of $1.0 million, partially offset by payment of SPAC merger transaction costs of $3.2 million.
For the year ended December 31, 2021, net cash provided by financing activities of $147.2 million was primarily due to $149.3 million of net cash proceeds in connection with the closing of the Transaction. The increase in financing cash flow was also due to proceeds received for exercises of options in the amount of $1.1 million, and partially offset by repayment of the Paycheck Protection Program Loan (“PPP loan”) in the amount of $3.0 million.
Contractual Obligations and Known Future Cash Requirements
Lease Commitments
We rent our facilities and certain motor vehicles under operating lease agreements that expire on various dates, the latest of which is in 2025 excluding any options for renewal. The minimum rental payments under operating leases for rental of premises as of December 31, 2022 for the next five years totaled $3.9 million, which is comprised of $2.2 million and $1.7 million in the next 12 months and more than 12 months, respectively. Other operating leases are immaterial.
Pledges and Bank Guarantees
In connection with the first loan agreement with with Silicon Valley Bank, we pledged 65,000 shares of common stock of our Israeli subsidiary, NIS 0.01 par value each.
We have a total of $0.8 million of pledged bank deposits as of December 31, 2022. We obtained bank guarantees in an aggregate amount of $0.3 million in connection with our office lease agreements in the US as of December 31, 2022.
55
Key Metrics and Non-GAAP Financial Measures
Adjusted EBITDA
In addition to our results determined in accordance with US GAAP, we believe that certain non-GAAP financial measures, including Adjusted earnings before interest, taxes, depreciation and amortization (“EBITDA”) and Adjusted EBITDA Margin are useful in evaluating our business. The following table presents a reconciliation of Adjusted EBITDA, a non-GAAP financial measure, to the most directly comparable financial measure prepared in accordance with GAAP.
Year ended December 31,
(in thousands)202220212020
Net loss$(18,410)$(11,472)$(812)
Net loss margin(14.5)%(12.7)%(1.2)%
Depreciation, amortization and impairment (a)6,143 661 730 
Stock-based compensation13,878 3,273 584 
Finance expense (income), net (b)(13,348)4,386 734 
Transaction related expenses (c)393 7,200 153 
Acquisition related expenses (d)4,971 161 — 
Retention bonus expenses (e)3,152 — — 
Legal claims 1,506 — — 
Other (f)923 — — 
Taxes on income2,017 1,237 1,200 
Adjusted EBITDA
$1,225 $5,446 $2,589 
Adjusted EBITDA margin
1.0 %6.0 %3.8 %
(a) In third quarter, 2022, the Company recorded impairment charges of $0.5 million related to the abandonment of certain projects related to our internal software development.
(b) Finance expense (income), net consists mostly of remeasurement related to revaluation of our warrants, remeasurement of our foreign subsidiary’s monetary assets, liabilities and operating results, and our interest expense. In a prior period it also included transaction costs allocated to warrants.
(c) Transaction related expenses consist of one-time, non-recurring bonus payments to certain members of management, professional fees associated with the SPAC merger transaction and SEC filings.
(d) Acquisition related expenses consists of professional fees associated with the acquisition of TVS.
(e) Retention bonus expenses consists of retention bonus for TVS employees.
(f) Other consists predominantly of exit costs for a former TVS employees.
We use Adjusted EBITDA and Adjusted EBITDA Margin as measures of operational efficiency to understand and evaluate our core business operations. We believe that these non-GAAP financial measures are also useful to investors for period to period comparisons of our core business. Additionally, these figures provide an understanding and evaluation of our trends when comparing our operating results, on a consistent basis, by excluding items that we do not believe are indicative of our core operating performance.
These non-GAAP financial measures have limitations as analytical tools and should not be considered in isolation or as substitutes for an analysis of our results as reported under GAAP. Some of the limitations of these measures are:
•they do not reflect changes in, or cash requirements for, our working capital needs;
•Adjusted EBITDA does not reflect our capital expenditures or future requirements for capital expenditures or contractual commitments;
•they do not reflect costs of acquiring and integrating businesses, which will continue to be a part of our growth strategy;
•they do not reflect one-time, non-recurring, bonus costs and third party costs associated with the SPAC merger transaction and regulatory filings;
56
•they do not reflect income tax expense or the cash requirements to pay income taxes;
•they do not reflect our interest expense or the cash requirements necessary to service interest or principal payments on our debt; and
•although depreciation and amortization are non-cash charges related mainly to intangible assets, certain assets being depreciated and amortized will have to be replaced in the future, and Adjusted EBITDA does not reflect any cash requirements for such replacements.
Other companies in our industry may calculate these non-GAAP financial measures differently than we do, limiting their usefulness as a comparative measure. You should compensate for these limitations by relying primarily on our US GAAP results and using the non-GAAP financial measures only supplementally. We calculate Adjusted EBITDA Margin as Adjusted EBITDA divided by total revenue.
Operational Metrics
In addition, Innovid’s management considers net revenue retention and core client retention in evaluating the performance of the business. Net revenue retention is defined as the percentage of revenue retained from existing core customers as compared to the prior year period. Prior to our acquisition of TVS in 2022, our definition of a core client included only advertisers that generated at least $100,000 of annual revenue. Following our acquisition of TVS, we have included publishers as core clients. Innovid’s management believes that net revenue retention is a useful metric for management and investors in evaluating Innovid’s value proposition to customers and its ability to retain customers.
Innovid’s management believes that core client retention is a useful metric for management and investors in evaluating the strength of core customer relationships. Core client retention is defined as the percentage of core clients retained by Innovid as compared to the prior year period. We define core clients as advertisers or publishers that generated at least $100,000 of annual revenue. Prior to our acquisition of TVS, our definition of a core client included only advertisers that generates at least $100,000 of annual revenue. For the year ended December 31, 2022, our net revenue retention was 111%. Our core client retention was 90%.
For the years ended December 31, 2021 and 2020, our net revenue retention based on prior methodology, which did not include publishers, was 127% and 121%, respectively. Our core client retention was 97% and 94%, respectively.
Off-Balance Sheet Arrangements
As of December 31, 2022, we did not have any relationships with unconsolidated organizations or financial partnerships, such as structured finance or special purpose entities that would have been established for the purpose of facilitating off-balance sheet arrangements or other contractually narrow or limited purposes.
Critical Accounting Policies and Estimates
Our discussion and analysis of our financial condition and results of operations are based on our audited consolidated financial statements, which have been prepared in accordance with GAAP. The preparation of these financial statements requires us to make estimates, assumptions and judgments that affect the amounts reported in our consolidated financial statements and the accompanying notes to consolidated financial statements. We base our estimates on historical experience and on various other assumptions that we believe to be reasonable under the circumstances, including the ongoing and potential impacts of global events such as raising inflation, war in Ukraine and COVID-19 pandemic. Actual results may differ from these estimates.
While our significant accounting policies are described in more detail in Note 2, Summary of Significant Accounting Policies included in Item 8. Financial Statements and Supplementary Data, we believe the following accounting policies to be the most critical to the judgments and estimates used in the preparation of our consolidated financial statements.
Revenue Recognition
The majority of Company’s revenues is derived from providing Ad serving services to advertisers, publishers, and media agencies. The services focus on standard, interactive and data driven digital video advertising. Ad serving services relate to utilizing Innovid’s platform to serve advertising impressions to various digital publishers across CTV, mobile TV, desktop TV, display, and other channels.

The Company also provides measurement services to brand and agencies, enterprise clients (networks) and publishers. The measurement service provide analysis on and track performance of advertisement campaigns. The measurement service provides insights into the effectiveness of TV and digital advertising.
57

Creative services relate to the design and development of interactive data-driven and dynamic ad formats by adding data, interactivity and dynamic features to standard ad units.

The Company recognizes revenue when its customer obtains control of promised services in an amount that reflects the consideration that the Company expects to receive in exchange for those services. The Company recognizes revenue in accordance with ASC Topic 606, Revenue from contracts with customers (“ASC 606”) and determines revenue recognition through the following steps: (1) identify the contract with a customer, (2) identify the performance obligations in the contract, (3) determine the transaction price, (4) allocate the transaction price to the performance obligations in the contract, and (5) recognize revenue when a performance obligation is satisfied.
For arrangements with multiple performance obligations, which represent promises within an arrangement that are capable of being distinct and are separately identifiable, the Company allocates the contract consideration to all distinct performance obligations based on their relative standalone selling price (“SSP”). SSP is typically estimated based on observable transactions when these services are sold on a standalone basis.

Revenues related to ad serving services are recognized when impressions are delivered. The Company recognizes revenue from the display of impression-based ads in the contracted period in which the impressions are delivered. Impressions are considered delivered when an ad is displayed to users.
Revenues related to the measurement services platform are recognized over time, since the customer simultaneously receives and consumes the benefits provided by the Company’s performance. Revenues for these measurement services are recognized over the service period.
Revenues related to creative projects are recognized at a point in time. Creative services projects are usually delivered within a week.
The Company’s accounts receivable, consist primarily of receivables related to providing ad serving, measurement and creative services, for which the Company’s contracted performance obligations have been satisfied, the amount has been billed and the Company has an unconditional right to payment. The Company typically bills customers monthly based on actual delivery. The payment terms vary, mainly with terms of 60 days or less.
The typical contract term is 12 months or less for ASC 606 purposes. Most of the Company’s contracts can be cancelled without a cause. The Company has the unconditional right to payment for the services provided as of the date of the termination of the contracts.
The Company applies the practical expedient in ASC 606 and does not adjust the promised amount of consideration for the effects of a significant financing component if the Company expects, at contract inception, that the period between when the Company transfers a promised good or service to a customer and when the customer pays for that good or service will be one year or less.
Deferred revenues represent mostly unrecognized fees billed or collected for measurement platform services. Deferred revenues are recognized as (or when) we perform under the contract.
Costs to obtain a contract
Contract costs include commission programs to compensate sales employees for generating sales orders with new customers or for new services with existing customers. Most commissions are commensurate. The Company elected to apply the practical expedient and recognize incremental costs of obtaining a contract as an expense when incurred if the amortization period of the asset that the Company otherwise would have recognized is one year or less. If commissions are not commensurate, the Company capitalizes these commissions. The term of amortization of capitalized commissions is three years.
Warrants
The Company accounts for warrants as either equity-classified or liability-classified instruments based on an assessment of the warrant’s specific terms and applicable authoritative guidance. The assessment considers whether the warrants are freestanding financial instruments, meet the definition of a liability under ASC 480, and meet all of the requirements for equity classification, including whether the warrants are indexed to the Company’s own common stock and whether the warrant holders could potentially require “net cash settlement” in a circumstance outside of the Company’s control, among other conditions for equity classification. This assessment, which requires the use of professional judgment, is conducted at the time of warrant issuance and as of each subsequent reporting period end date while the warrants are outstanding.
58
Warrants that meet all the criteria for equity classification, are required to be recorded as a component of additional paid-in capital. Warrants that do not meet all the criteria for equity classification, are required to be recorded as liabilities at their initial fair value on the date of issuance and remeasured to fair value at each balance sheet date thereafter. The liability-classified warrants are recorded under non-current liabilities. Changes in the estimated fair value of the warrants are recognized in “Financial expenses (income), net” in the consolidated statements of operations.
Fair value of financial instruments
The Company applies a fair value framework to measure and disclose its financial assets and liabilities. Fair value is defined as the exchange price that would be received for an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. The fair value hierarchy requires an entity to maximize the use of observable inputs, where available, and minimize the use of unobservable inputs when measuring fair value. There are three levels of inputs that may be used to measure fair value:
Level 1 - Observable inputs that reflect quoted prices (unadjusted) for identical assets or liabilities in active markets.
Level 2 - Includes other inputs that are directly or indirectly observable in the marketplace.
Level 3 - Unobservable inputs which are supported by little or no market activity.
The Company’s financial instruments consist of cash and cash equivalents, short-term deposits, restricted deposits, trade receivables, net, trade payables, employees and payroll accruals, accrued expenses and other current liabilities and current portion of long term debts. Their historical carrying amounts are approximate fair values due to the short-term maturities of these instruments.
The Company measures its investments in money market funds classified as cash equivalents and warrants liability at fair value.
Certificates of deposit represent our deposits with certain financial institutions with maturities ranging from 90 to 180 days. These amounts are included in Cash equivalents and Short-term deposits on our consolidated balance sheet and are carried at cost, which approximates fair value.
The Private Placement Warrants are classified as Level 3 as of December 31, 2022 and continue to be valued based on a Black-Scholes option pricing model. Gains and losses from the remeasurement of the Private Warrants’liability is recognized in finance expenses (income), net in the consolidated statements of operations.
Fair value estimates are made at a specific point in time, based on relevant market information and information about the financial instruments. These estimates are subjective in nature and involve uncertainties and matters of significant judgment and, therefore, cannot be determined with precision. Changes in assumptions could significantly affect these estimates.
Stock-based compensation
The Company estimates the fair value of stock-based awards on the date of grant. The fair value of stock options with only service conditions is determined using the Black-Scholes option pricing model. The grant date fair value of the stock-based awards with graded vesting is recognized on a straight-line basis over the requisite service period. The determination of the fair value of the Company’s stock option awards is based on a variety of factors including Company’s common stock price, risk-free interest rate, expected volatility, expected life of awards and dividend yield. The Company has limited option exercise history and has elected to estimate the expected life of the stock option awards using the “simplified method” with the continued use of this method extended until such time that the Company has sufficient exercise history. The expected volatility of the price of such stocks is based on volatility of similar companies whose stock prices are publicly available over a historical period equivalent to the option’s expected term. The dividend yield is based on the Company’s historical and future expectation of dividends payouts. Historically, the Company has not paid cash dividends. Risk-free interest rates are based on the yield from US Treasury zero-coupon bonds with a term equivalent to the expected term of the options.
The Company accounts for forfeitures as they occur.
59
Goodwill and intangible assets
Goodwill represents the excess of purchase price over the fair value of tangible net assets and identifiable intangible assets of the businesses acquired. Goodwill deemed to have an indefinite life is not amortized. Intangible assets determined to have finite lives are amortized over their useful lives. Goodwill with indefinite lives are subject to impairment testing annually as of October 1, or whenever events or changes in circumstances indicate that the carrying amount may not be fully recoverable, using the guidance and criteria described ASC 350, Intangibles—Goodwill and other (“ASC 350”). This testing compares carrying values to fair values and, when appropriate, the carrying value of these assets is reduced to fair value.
The Company has one reporting unit. There are many assumptions and estimates used that directly impact the results of impairment testing, including an estimate of future expected revenues, net income, EBITDA, EBITDA margins and cash flows, useful lives, discount rates and an estimate of value using multiples derived from the stock prices of publicly traded guideline companies applied to such expected cash flows and market approaches in order to estimate fair value. The determination of whether or not goodwill or indefinite-lived acquired intangible assets have become impaired involves a significant level of judgment in the assumptions and estimates underlying the approach used to determine the value of our reporting unit. Changes in our strategy or market conditions could significantly impact these judgments and require an impairment to be recorded to intangible assets and goodwill. There have been no goodwill impairment indicators subsequent to the impairment test performed as of October 1, 2022.
The Company allocates the fair value of the purchase consideration to the tangible assets acquired, liabilities assumed and intangible assets acquired based on their estimated fair values. The excess of the fair value of the purchase consideration over the fair values of these identifiable assets and liabilities is recorded as goodwill. Such valuations require management to make significant estimates and assumptions, especially with respect to intangible assets. The estimates used in valuing the intangible assets are determined with the assistance of third-party specialists, a discounted cash flow analysis and estimates made by management. Management’s estimates of fair value are based upon assumptions believed to be reasonable, but which are inherently uncertain and unpredictable and, as a result, actual results may differ from estimates. During the measurement period, which is not to exceed one year from the acquisition date, the Company may record adjustments to the assets acquired and liabilities assumed, with the corresponding offset primarily made to goodwill. Upon the conclusion of the measurement period, any subsequent adjustments are recorded to earnings.
Capitalized software development costs
Software development costs, which are included in property and equipment, net, consists of capitalized costs related to purchase and develop internal-use software. The Company uses such software to provide services to its customers. The costs to purchase and develop internal-use software are capitalized from the time that the preliminary project stage is completed, and it is considered probable that the software will be used to perform the function intended. These costs include personnel and personnel-related employee benefits for employees directly associated with the software development and external costs of the materials or services consumed in developing the software. Any costs incurred for upgrades and functionality enhancements of the software are also capitalized. Once this software is ready for use in providing the Company's services, these costs are amortized on a straight-line basis over the three-year estimated useful life. The amortization is presented within depreciation and amortization in the consolidated statements of operations.
During the years ended December 31, 2022 and 2021, the Company capitalized internal-use software cost of $11,143 and $2,594, respectively. In the third quarter of 2022, the Company recorded impairment charges included in depreciation, amortization and impairment in the consolidated statement of operations of $547 related to the abandonment of certain projects. There were no impairment of capitalized software costs for the year ended December 31, 2021 and 2020.
Income taxes and tax contingencies
Income taxes are computed using a balance sheet approach reflecting both current and deferred taxes. Current and deferred taxes reflect the tax impact of all of the events included in the financial statements. The basic principles employed in the balance sheet approach are to reflect a current tax liability or asset that is recognized for the estimated taxes payable or refundable on tax returns for the current and prior years, a deferred tax liability or asset that is recognized for the estimated future tax effects attributable to temporary differences and carryforwards, the measurement of current and deferred tax liabilities and assets is based on provisions of the enacted tax law of which the effects of future changes in tax laws or rates are not anticipated, and the measurement of deferred tax assets is reduced, if necessary, by the amount of any tax benefits that, based on available evidence, are not expected to be realized. There are certain situations in which deferred taxes are not provided. Some basis differences are not temporary differences because their reversals are not expected to result in taxable or deductible amounts.
60
The Company regularly evaluates deferred tax assets for future realization and establishes a valuation allowance to the extent that a portion is not more likely than not to be realized. The Company considers whether it is more likely than not that the deferred tax assets will be realized, including existing cumulative losses in recent years, expectations of future taxable income, carryforward periods, and other relevant quantitative and qualitative factors. The recoverability of the deferred tax assets is evaluated by assessing the adequacy of future expected taxable income from all sources, including reversal of taxable temporary differences, forecasted operating earnings and available tax planning strategies. These sources of income rely on estimates.
ASC 740, Income Taxes (“ASC 740”) contains a two-step approach to recognizing and measuring a liability for uncertain tax positions. The first step is to evaluate the tax position taken or expected to be taken in a tax return by determining if the weight of available evidence indicates that it is more likely than not that, on an evaluation of the technical merits, the tax position will be sustained on audit, including resolution of any related appeals or litigation processes. The second step is to measure the tax benefit as the largest amount that is more than 50% (cumulative basis) likely to be realized upon ultimate settlement. The Company classifies interest related to unrecognized tax benefits in taxes on income.
On December 20, 2017, Congress passed the “US Tax Act”. The US Tax Act requires complex computations to be performed that were not previously required by US tax law, significant judgments to be made in interpretation of the provisions of the US Tax Act, significant estimates in calculations, and the preparation and analysis of information not previously relevant or regularly produced the Act provides that a person who is a US shareholder of any CFC is required to include its GILTI in gross income for the tax year in a manner generally similar to that for Subpart F inclusions. The term “global intangible low-taxed income” is defined as the excess (if any) of the US shareholder’s net CFC tested income for that tax year, over the US shareholder’s net deemed tangible income return for that tax year. The Company’s policy is to treat GILTI as a period expense in the provision for income taxes.
Functional currency
A majority of the Company’s revenues are generated in US dollars. In addition, a substantial portion of the Company’s costs are incurred in US dollars. The Company’s management believes that the US dollar is the currency of the primary economic environment in which the Company and each of its subsidiaries operate. Thus, the functional and reporting currency of the Company and its subsidiaries is the US dollar. Accordingly, accounts maintained in currencies other than the US dollar are re-measured into US dollars. All translation gains and losses resulting from the re-measurement of monetary assets and liabilities that are not denominated in the functional currency are recorded in Financial expenses, net on the consolidated statements of operations.
Recent Accounting Pronouncements
See Note 2, Summary of Significant Accounting Policies in our audited consolidated financial statements included in this Form 10-K, for recently adopted accounting pronouncements and recently issued accounting pronouncements not yet adopted.
Item 7A. Quantitative and Qualitative Disclosures About Market Risk
As a smaller reporting company, as defined by Rule 12b-2 of the Securities Exchange Act of 1934, as amended, we are not required to provide this information.
61
Item 8. Financial Statements and Supplementary Data



























F-1



ctv-20221231_g1.jpg
Report of Independent Registered Public Accounting Firm
To the Stockholders and the Board of Directors of
INNOVID CORP.
Opinion on the Financial Statements
We have audited the accompanying consolidated balance sheets of Innovid Corp. and its subsidiaries (the Company) as of December 31, 2022 and 2021, the related consolidated statements of operations, changes in temporary equity and stockholders' equity (deficit), and cash flows for each of the three years in the period ended December 31, 2022, and the related notes (collectively referred to as the “consolidated financial statements”). In our opinion, the consolidated financial statements present fairly, in all material respects, the financial position of the Company as of December 31, 2022 and 2021, and the results of its operations and its cash flows for each of the three years in the period ended December 31, 2022, in conformity with US generally accepted accounting principles.
Basis for Opinion
These consolidated financial statements are the responsibility of the Company’s management. Our responsibility is to express an opinion on the Company’s consolidated financial statements based on our audits. We are a public accounting firm registered with the Public Company Accounting Oversight Board (United States) (“PCAOB”) and are required to be independent with respect to the Company in accordance with the US federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.
We conducted our audits in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the financial statements are free of material misstatements, whether due to error or fraud. The Company is not required to have, nor were we engaged to perform, an audit of its internal control over financial reporting. As part of our audits we are required to obtain an understanding of internal control over financial reporting but not for the purpose of expressing an opinion on the effectiveness of the Company’s internal control over financial reporting. Accordingly, we express no such opinion.
Our audits included performing procedures to assess the risks of material misstatement of the consolidated financial statements, whether due to error or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the consolidated financial statements. Our audits also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the consolidated financial statements. We believe that our audits provide a reasonable basis for our opinion.
We have served as the Company’s auditor since 2007.
Tel-Aviv, Israel
KOST FORER GABBAY & KASIERER
March 3, 2023
A Member of Ernst & Young Global

F-2

INNOVID, CORP. AND ITS SUBSIDIARIES
CONSOLIDATED BALANCE SHEETS
(In thousands, except stock and per stock data)

December 31,

20222021
ASSETS


Cash and cash equivalents$37,541 $156,696 
Short-term bank deposit10,000 — 
Trade receivables, net of reserves of $65 at December 31, 2022 and $81 at December 31, 2021
43,653 35,422 
Prepaid expenses and other current assets2,640 3,131 
Total current assets
93,834 195,249 
Long-term deposit277 310 
Long-term restricted deposits430 462 
Property and equipment, net14,322 4,840 
Goodwill116,976 4,555 
Operating lease right of use asset2,910 — 
Intangible assets29,918 — 
Other non-current assets 938 116 
Total non-current assets$165,771 $10,283 
TOTAL ASSETS
$259,605 $205,532 
LIABILITIES AND STOCKHOLDER’ EQUITY
Trade payables3,361 5,026 
Employee and payroll accruals10,165 7,742 
Current portion of long-term debt— 6,000 
Lease liabilities - current portion2,186 — 
Accrued expenses and other current liabilities5,474 3,082 
Total current liabilities
21,186 21,850 
Long-term debt20,000 — 
Lease liabilities - non-current portion1,636 — 
Other non-current liabilities6,554 3,455 
Warrants liability4,301 18,972 
Total non-current liabilities
32,491 22,427 
TOTAL LIABILITIES
53,677 44,277 
COMMITMENTS AND CONTINGENT LIABILITIES (Note 13)
STOCKHOLDERS’ EQUITY:
Common stock of $0.0001 par value - Authorized: 500,000,000 at December 31, 2022 and December 31, 2021; Issued and outstanding: 133,882,414 and 119,017,380 at December 31, 2022 and December 31, 2021, respectively
13 12 
Additional paid-in capital356,801 293,719 
Accumulated deficit(150,886)(132,476)
TOTAL STOCKHOLDERS’ EQUITY205,928 161,255 
TOTAL LIABILITIES AND STOCKHOLDERS’ EQUITY$259,605 $205,532 
The accompanying notes are an integral part of the consolidated financial statements.

F-3

INNOVID, CORP. AND ITS SUBSIDIARIES
CONSOLIDATED STATEMENTS OF OPERATIONS
(In thousands, except stock and per stock data)

Year ended December 31,

202220212020
Revenues$127,117 $90,291 $68,801 
Cost of revenues (1)30,187 17,698 12,311 
Research and development (1)31,118 24,299 18,014 
Sales and marketing (1)50,266 32,841 28,521 
General and administrative (1)39,144 20,641 8,103 
Depreciation, amortization and impairment6,143 661 730 
Operating (loss) profit
(29,741)(5,849)1,122 
Finance expenses (income), net(13,348)4,386 734 
(Loss) profit before taxes
(16,393)(10,235)388 
Taxes on income2,017 1,237 1,200 
Net loss(18,410)(11,472)(812)
Accretion of preferred stock to redemption value— (77,063)(7,297)
Net loss attributable to common stockholders$(18,410)$(88,535)$(8,109)
Net loss per stock attributable to common stockholders (2) –
Basic and diluted$(0.14)$(3.31)$(0.51)
Weighted-average number of stocks used in computing net loss per stock attributable to common stockholders (2) –
Basic and diluted130,756,484 26,745,020 16,028,560 
The accompanying notes are an integral part of the consolidated financial statements.
(1) Exclusive of depreciation, amortization and impairment presented separately.
(2) Prior period results have been adjusted to reflect the exchange of Innovid Inc’s common stock for Innovid Corp’s common stock at an exchange ratio of approximately 1.337 because of the Transaction. See Note 3, Transaction for further details.
F-4

INNOVID, CORP. AND ITS SUBSIDIARIES
STATEMENTS OF CHANGES IN TEMPORARY EQUITY AND STOCKHOLDERS’ EQUITY (DEFICIT)
(In thousands, except stock data)



Temporary equity
Common stocks
Treasury stocks
Additional paid-in capital
Accumulated deficit
Total stockholders’ equity (deficit)
Number
Amount
Number
Amount
Number
Amount
Balance as of December 31, 2019
73,690,340 $79,700 15,969,260 $2 1,914,328 $(1,629)$3,058 $(44,218)$(42,787)
Accretion of preferred stocks to redemption value— 7,297 — — — — (4,214)(3,083)(7,297)
Capital contribution— — — — — — 504 — 504 
Stock-based compensation— — — — — — 584 — 584 
Stock options exercised— — 306,349 *— — 78 — 78 
Net loss— — — — — — — (812)(812)
Balance as of December 31, 2020
73,690,340 $86,997 16,275,609 $2 1,914,328 $(1,629)$10 $(48,113)$(49,730)
Accretion of preferred stocks to redemption value— 77,063 — — — — (4,172)(72,891)(77,063)
Conversion of redeemable convertible preferred stock into common stock(73,690,340)(164,060)73,690,340 7 — — 164,053 — 164,060 
Reverse recapitalization, net— — 25,154,340 3 (1,914,328)1,629 124,394 — 126,026 
Conversion of Legacy Innovid Warrants— — 507,994 *— — 5,080 — 5,080 
Warrant exercised**— — 132,392 *— — — — — 
Stock-based compensation— — — — — — 3,273 — 3,273 
Stock options exercised— — 3,256,705 *— — 1,081 — 1,081 
Net loss— — — — — — — (11,472)(11,472)
Balance as of December 31, 2021
— $— 119,017,380 $12 — $— $293,719 $(132,476)$161,255 
Common stock and equity awards issued for acquisition of TVS— — 11,549,465 1 — — 47,151 — 47,152 
Stock-based compensation— — — — — — 14,945 — 14,945 
Stock options exercised and RSUs vested— — 3,315,569 *— — 986 — 986 
Net loss— — — — — — — (18,410)(18,410)
Balance as of December 31, 2022
— $— 133,882,414 $13 — $— $356,801 $(150,886)$205,928 
The accompanying notes are an integral part of the consolidated financial statements.
*Represents an amount less than $1.
** The warrant was exercised in November 2021 and was net share settled.

F-5

INNOVID, CORP. AND ITS SUBSIDIARIES
CONSOLIDATED STATEMENTS OF CASH FLOWS
(In thousands, except stock and per stock data)
Year ended December 31,
2022

20212020
Cash flows from operating activities:


Net loss$(18,410)$(11,472)$(812)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation, amortization and impairment6,143 661 730 
Stock-based compensation13,781 3,273 584 
Loss on sale of property and equipment— — 127 
Change in fair value of warrants(14,671)762 86 
Founders notes forgiven— 459 — 
Transaction costs allocated to warrants— 2,750 — 
Non-cash interest expense— — 22 
Changes in operating assets and liabilities
Increase in trade receivables, net(4,045)(618)(8,372)
(Increase)/ decrease in prepaid expenses and other assets755 (1,823)78 
Decrease in operating lease right of use assets1,831 — — 
Increase/ (decrease) in trade payables(622)1,500 (545)
Increase in employees and payroll accruals1,710 1,236 1,914 
Decrease in operating lease liabilities(2,335)— — 
Increase in accrued expenses and other liabilities4,302 851 2,029 
Net cash used in operating activities
$(11,561)$(2,421)$(4,159)
Cash flows from investing activities:
Acquisitions of businesses, net of cash acquired$(99,097)$— $— 
Internal use software capitalization(9,961)(2,594)— 
Purchase of property and equipment(488)(549)(1,030)
Founders’ note receivable— (459)— 
Proceeds from sale of property and equipment— — 6 
Change in short-term bank deposits(10,000)— — 
Other deposits120 (85)76 
Net cash used in investing activities
$(119,426)$(3,687)$(948)
Cash flows from financing activities:
Proceeds from reverse recapitalization, net*$— $149,252 $— 
Capital contributions— — 504 
Proceeds from loans14,000 — 15,516 
Loan repayment— (3,033)(6,504)
Repayment of acquisition liability— (126)(592)
Payment of SPAC merger transaction costs(3,185)— — 
Proceeds from exercise of options985 1,081 78 
Net cash provided by financing activities
$11,800 $147,174 $9,002 
(Decrease) increase in cash, cash equivalents and restricted cash(119,187)141,066 3,895 
Cash, cash equivalents and restricted cash at the beginning of the year157,158 16,092 12,197 
Cash, cash equivalents and restricted cash at the end of the year $37,971 $157,158 $16,092 
Supplemental disclosure of cash flows activities:
(1) Cash paid during the year for:
Income taxes paid, net of tax refunds$785 $535 $421 
Interest$675 $259 $272 
(2) Non-cash transactions:
Conversion of redeemable convertible preferred stock into common stock$— $164,060 $— 
Conversion of Legacy Innovid Warrants$— $5,080 $— 
Accrued acquisition liability$— $— $126 
Accretion of preferred stocks to redemption value$— $77,063 $7,297 
Accrued transaction cost, not yet paid$— $3,185 $— 
Business combination consideration paid in stock$47,152 $— $— 
Reconciliation of cash, cash equivalents, and restricted cash reported within the statement of financial position
Cash and cash equivalents$37,541 $156,696 $15,645 
Long-term restricted deposits430 462 447 
Total cash, cash equivalents, and restricted cash shown in the consolidated statements of cash flows$37,971 $157,158 $16,092 
* Refer to Note 3, Transaction for details
The accompanying notes are an integral part of the consolidated financial statements.
F-6
INNOVID, CORP.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(In thousands, except stock and per stock data)

1. DESCRIPTION OF BUSINESS
Innovid Corp. together with its consolidated subsidiaries, the “Company” or “Innovid”, is a leading independent software platform that provides ad serving and creative services for the creation, delivery, and measurement of TV ads across connected TV (“CTV”), mobile TV and desktop TV environments to advertisers, publishers and media agencies.
Innovid Corp. was originally incorporated as ION Acquisition Corp. 2 Ltd. (“ION”), a special purpose acquisition company, on November 23, 2020.
On November 30, 2021, ION and Innovid Inc. closed the mergers as described below (the “Transaction”). Through several merges and name changes Innovid Corp. was established and continues the operations of Innovid Inc.
On November 30, 2021, ION consummated a series of merger transactions, whereby it acquired the business of Innovid Inc. Immediately following these mergers, ION changed its name to “Innovid Corp.” In addition, ION entered into certain subscription agreements (“PIPE Investment”). Further, in connection with the closing of the Transaction, PIPE investors purchased equity securities of Innovid Inc. stockholders (the “Secondary Sale Transaction”) for an aggregate purchase price of $68,855 (the “Secondary Sale Amount”). See Note 3, Transaction for further details.
On February 28, 2022, the Company completed the acquisition of all outstanding shares of TVSquared (“TVS”), an independent global measurement and attribution platform for converged TV and a private company limited by shares incorporated under the laws of the Scotland. The Company acquired all of the equity of TVSquared for an aggregate amount of $100,000 in cash, 11,549,465 shares of the Company common stock at fair value of $3.80 per share, and the issuance of 949,893 fully vested stock options of the Company at a weighted average fair value of $3.49, subject to certain adjustments as defined in the Stock Purchase Agreement. See Note 4, Acquisition for further details.
Innovid Corp.’s common stock and warrants commenced trading on the NYSE under the symbols “CTV” and “CTV.WS,” respectively, on December 1, 2021.
2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
Basis of Presentation
The accompanying Consolidated Financial Statements and Notes to the Consolidated Financial Statements included in this Annual Report on Form 10-K are prepared in accordance with generally accepted accounting principles in the United States ("GAAP") for annual financial information and the instructions to Form 10-K and Article 10 of Regulation S-X. The accompanying Consolidated Financial Statements include our accounts and those of our wholly-owned subsidiaries; all intercompany activity and balances have been eliminated. The Consolidated Financial Statements reflect all adjustments, which are, in the opinion of management, necessary for a fair presentation of the consolidated balance sheets of the Company as of December 31, 2022 and 2021 and the consolidated results of operations and cash flows for the years ended December 31, 2022, 2021 and 2020.
Prior Period Reclassification
During the second quarter of 2022, we presented depreciation, amortization and impairment expenses as a separate line item on our consolidated statements of operations and all prior periods have been adjusted.
Depreciation, amortization and impairment expenses were previously included in cost of sales and other operating expenses depending on the underlying asset’s function. Additionally, we no longer present gross profit as a subtotal on our consolidated statements of operations.
The reclassification is to better reflect the financial performance of transactions with customers as our business has evolved and reflects a better representation of our current operations, which include those of our most recent acquisition. The change provides more clarity about changes in cost of revenue and other operating expenses exclusive of depreciation, amortization and impairment.
F-7
INNOVID, CORP.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(In thousands, except stock and per stock data)
In accordance with US GAAP, all periods presented below have been retrospectively adjusted to reflect the reclassification of cost of revenue and other operating expenses exclusive of depreciation and amortization. There was no net impact to loss from operations, net loss attributable to common stockholders or net loss per stock for any periods presented. The consolidated balance sheets, statements of changes in temporary equity and stockholders’ equity, and the consolidated statements of cash flows are not affected by this reclassification. The effect of the change is as follows:

Year ended December 31, 2022Year ended December 31, 2021Year ended December 31, 2020
Under previous classificationEffect of changeAs reportedPreviously reportedEffect of changeAs adjustedPreviously reportedEffect of changeAs adjusted
Cost of revenues$33,265 $(3,078)$30,187 $17,785 $(87)$17,698 $12,365 $(54)$12,311 
Operating expenses:
Research and development31,932 (814)31,118 24,619 (320)24,299 18,283 (269)18,014 
Sales and marketing52,226 (1,960)50,266 33,056 (215)32,841 28,810 (289)28,521 
General and administrative39,435 (291)39,144 20,680 (39)20,641 8,221 (118)8,103 
Depreciation, amortization and impairment$— $6,143 $6,143 $— $661 $661 $— $730 $730 
Use of Estimates
The preparation of the consolidated financial statements in conformity with US GAAP requires management to make estimates, judgments and assumptions. The Company’s management believes that the estimates, judgments and assumptions used are reasonable based upon information available at the time they are made. These estimates, judgments and assumptions can affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the dates of the financial statements, and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.
The Company has considered the impact of these factors on its estimates and assumptions and determined that there were no material adverse impacts on the consolidated financial statements for the periods ended December 31, 2022, 2021, and 2020. As events continue to evolve and additional information becomes available, the Company’s estimates and assumptions may change materially in future periods.
Accounting Policies
Functional currency
A majority of the Company’s revenues are generated in US dollars. In addition, a substantial portion of the Company’s costs are incurred in US dollars. The Company’s management believes that the US dollar is the currency of the primary economic environment in which the Company and each of its subsidiaries operate. Thus, the functional and reporting currency of the Company and its subsidiaries is the US dollar. Accordingly, accounts maintained in currencies other than the US dollar are re-measured into US dollars. All translation gains and losses resulting from the re-measurement of monetary assets and liabilities that are not denominated in the functional currency are recorded in Financial expenses, net on the consolidated statements of operations.
Cash and cash equivalents
Cash equivalents are short-term highly liquid investments that are readily convertible to cash with original maturities of three months or less, at the date acquired.
Short-term bank deposits
The Company utilizes short-term deposits in order to maximize the use of cash on hand. As of December 31, 2022 we had deposits of $10,000 with original maturities greater than 90 days at 4.1% interest. These deposits are expected to mature within no more than 180 days with an interest rate of 4.1%.
F-8
INNOVID, CORP.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(In thousands, except stock and per stock data)
Restricted deposits and restricted cash
Restricted deposits presented in Prepaid expenses and other current assets and in Long-term restricted deposits are deposits used as security for the Company’s credit cards and for the rental of premises. As of December 31, 2022 and 2021, the Company’s restricted deposits are denominated in New Israeli Shekels (“NIS”) and bore interest at weighted average interest rates of 0.01% and 0.01%, respectively. Restricted deposits are presented at their cost, including accrued interest.
Property and equipment, net
Property and equipment are stated at cost, net of accumulated depreciation. Depreciation is calculated by the straight-line method over the estimated useful lives of the assets, at the following annual rates:

Years
Computers and peripheral equipment
3
Office furniture and equipment
5-7
Lease improvementsThe shorter of the lease term or the useful life of the asset
Internal-use software3
Software development costs
Software development costs, which are included in property and equipment, net, consists of capitalized costs related to purchase and develop internal-use software. The Company uses such software to provide services to its customers. The costs to purchase and develop internal-use software are capitalized from the time that the preliminary project stage is completed, and it is considered probable that the software will be used to perform the function intended. These costs include personnel and personnel-related employee benefits for employees directly associated with the software development and external costs of the materials or services consumed in developing or obtaining the software.
Any costs incurred for upgrades and functionality enhancements of the software are also capitalized. Once this software is ready for use in providing the Company's services, these costs are amortized on a straight-line basis over the three-year estimated useful life. The amortization is presented within depreciation and amortization in the consolidated statements of operations. During the years ended December 31, 2022 and 2021, the Company capitalized internal-use software cost of $11,143 and $2,594, respectively. In the third quarter of 2022, the Company recorded impairment charges included in depreciation, amortization and impairment in the consolidated statement of operations of $547 related to the abandonment of certain projects. There were no impairment of capitalized software costs for the year ended December 31, 2021 and 2020.
Impairment of long-lived assets
Long-lived assets, including property and equipment and finite-lived intangible assets, are reviewed for impairment whenever facts or circumstances either internally or externally may indicate that the carrying value of an asset may not be recoverable. If there are indications of an impairment, the Company tests for recoverability by comparing the estimated undiscounted future cash flows expected to result from the use of the asset to the carrying amount of the asset or asset group. If the asset or asset group is determined to be impaired, any excess of the carrying value of the asset or asset group over its estimated fair value is recognized as an impairment loss.
For the year ended December 31, 2022, we recognized impairment expense of $547. For the years ended December 31, 2021, and 2020 no impairments of long-lived assets were recorded.
Business combinations
The Company accounts for business combinations by applying the provisions of ASC 805, “Business Combination” (“ASC 805”) and allocates the fair value of purchase consideration to the tangible assets acquired, liabilities assumed, and intangible assets acquired based on their estimated fair values. The excess of the fair value of purchase consideration over the fair values of these identifiable assets and liabilities is recorded as goodwill. When determining the fair values of assets acquired and liabilities assumed, management makes significant estimates and assumptions, especially with respect to intangible assets.
F-9
INNOVID, CORP.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(In thousands, except stock and per stock data)
Acquisition-related expenses are expensed as incurred.
Goodwill and acquired intangible assets
Goodwill and acquired intangible assets have been recorded in the Company's financial statements resulting from     various business combinations. Goodwill represents the excess of the purchase price in a business combination over the fair value of identifiable tangible and intangible assets acquired and liabilities assumed. Goodwill is subject to an annual impairment test.
The Company allocates goodwill to reporting units based on the expected benefit from the business combination. Reporting units are evaluated when changes in the Company’s operating structure occur, and if necessary, goodwill is reassigned using a relative fair value allocation approach. The Company currently has one reporting unit.
ASC 350, Intangibles—Goodwill and other (“ASC 350”) requires goodwill to be tested for impairment at least annually and, in certain circumstances, between annual tests. The accounting guidance gives the option to perform a qualitative assessment to determine whether further impairment testing is necessary. The qualitative assessment considers events and circumstances that might indicate that a reporting unit's fair value is less than its carrying amount. If it is determined, as a result of the qualitative assessment, that it is more likely than not that the fair value of a reporting unit is less than its carrying amount, a quantitative test is performed. The Company operates as one reporting unit. The Company elects to perform an annual impairment test of goodwill as of October 1 of each year, or more frequently if impairment indicators are present. For the years ended December 31, 2022, 2021 and 2020 no impairments of goodwill were recorded.
Separately acquired intangible assets are measured on initial recognition at cost including directly attributable costs. Intangible assets acquired in a business combination are measured at fair value at the acquisition date.
Customer relationships, acquired technology and trade name are being amortized over the estimated useful life of approximately 11 years, 6 years, and 4 years, respectively, using straight-line amortization method.
The amortization of customer relationships, acquired technology and trade name is presented within depreciation, amortization and impairment in the consolidated statement of operations.
Leases
Innovid's lease portfolio primarily consists of real estate properties and cars. Short-term leases with a term of 12 months or less are not recorded on the balance sheet. Innovid does not separate lease components from non-lease components.
The Company is a lessee in all its lease agreements. The Company records lease liabilities based on the present value of lease payments over the lease term. Innovid generally uses an incremental borrowing rate to discount its lease liabilities, as the rate implicit in the lease is typically not readily determinable. Certain lease agreements include renewal options that are under the Company's control. Innovid includes optional renewal periods in the lease term only when it is reasonably certain that Innovid will exercise its option.
Variable lease payments are primarily related to payments to lessors for taxes, maintenance, insurance, and other operating costs. The Company's lease agreements do not contain any significant residual value guarantees or restrictive covenants.
Fair value of financial instruments
The Company applies a fair value framework to measure and disclose its financial assets and liabilities. Fair value is defined as the exchange price that would be received for an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. The fair value hierarchy requires an entity to maximize the use of observable inputs, where available, and minimize the use of unobservable inputs when measuring fair value. There are three levels of inputs that may be used to measure fair value:
Level 1 - Observable inputs that reflect quoted prices (unadjusted) for identical assets or liabilities in active markets.
Level 2 - Includes other inputs that are directly or indirectly observable in the marketplace.
Level 3 - Unobservable inputs which are supported by little or no market activity.
F-10
INNOVID, CORP.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(In thousands, except stock and per stock data)
The Company’s financial instruments consist of cash and cash equivalents, short term deposits, restricted deposits, trade receivables, net, trade payables, employees and payroll accruals, accrued expenses and other current liabilities and current portion of long term debts. Their historical carrying amounts are approximate fair values due to the short-term maturities of these instruments.
The Company measures its investments in money market funds classified as cash equivalents and warrants liability at fair value.
The following table presents information about the Company’s financial instruments that are measured at fair value on a recurring basis:

December 31, 2022

Level 1
Level 2
Level 3
Assets:
Money market funds$18,948 $— $— 
Certificates of deposit— 20,000 — 
Liabilities:
Warrants liability$1,265 $— $3,036 

December 31, 2021

Level 1
Level 2
Level 3
Assets:
Money market funds$4,515 $— $— 
Liabilities:
Warrants liability$3,510 $— $15,462 
The change in the fair value of the Level 3 warrant liability is summarized below:

December 31,

2022

2021
Beginning of the year
$15,462 $499 
Additions*— 18,427 
Change in fair value(12,426)1,616 
Conversion of Legacy Innovid Warrants on the Closing of the Transaction— (5,080)
End of the year$3,036 $15,462 
* Additions during the year ended December 31, 2021 represent Company Warrant liability assumed in the Transaction. See Note 11, Warrants for further detail.

Certificates of deposit represent our deposits with certain financial institutions with maturities ranging from 90 to 180 days. These amounts are included in Cash equivalents and Short-term deposits on our consolidated balance sheet and are carried at cost, which approximates fair value.
As of December 31, 2022, the Company’s warrant liability includes the Warrants, refer to Note 11, Warrants, that were originally issued in connection with ION’s initial public offering, the “ION IPO”, which were transferred to the Company as part of the Transaction. The Company’s Warrants are recorded on the balance sheet at fair value with changes in fair value recognized through earnings. This valuation is subject to re-measurement at each balance sheet date. With each re-measurement the valuation will be adjusted to fair value, with the change in fair value recognized in the Company’s statement of operations. ASC 820, Fair Value Measurements, indicates that the fair value should be determined “from the perspective of a market participant that holds the identical item” and “use the quoted price in an active market held by another party, if that price is available.”
F-11
INNOVID, CORP.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(In thousands, except stock and per stock data)
The Company has determined that the fair value of the Public Warrants, refer to Note 11, Warrants, at a specific date is determined by the closing price of the Company’s warrants, and are within Level 1 of the fair value hierarchy. The closing price of the warrants was $0.40 and $1.11 as of December 31, 2022 and 2021, respectively. The fair value of the warrants was $1,265 and $3,510 as of December 31, 2022 and 2021, respectively. Gains and losses from the remeasurement of the Public Warrants’ liability is recognized in finance expenses, net in the consolidated statements of operations.
The Private Warrants are classified as Level 3 as of December 31, 2022 and continue to be valued based on a Black-Scholes option pricing model. Gains and losses from the remeasurement of the Private Warrants’ refer to Note 11, Warrants liability is recognized in finance expenses, net in the consolidated statements of operations.
The key inputs into the Black-Scholes model for the Private Warrants were as follows:

December 31,December 31,

20222021

Risk-free interest rate
4.07 %1.24 %
Expected dividends— %— %
Expected term (years)
3.94.9
Expected volatility85 %55 %
Fair value estimates are made at a specific point in time, based on relevant market information and information about the financial instruments.
Trade receivable, net
The Company records trade receivable for amounts invoiced and yet unbilled invoices. The Company maintains an allowance for doubtful accounts to reserve for potentially uncollectible receivables. The expectation of collectability is based on a review of credit profiles of customers, contractual terms and conditions, current economic trends, and historical payment experience. The Company regularly reviews the adequacy of the allowance for doubtful accounts by considering the age of each outstanding invoice and the collection history of each customer to determine the appropriate amount of allowance for doubtful accounts. Trade receivables deemed uncollectible are charged against the allowance for doubtful accounts when identified.
Accrued post-employment benefits
401(k) profit sharing plans:
The Company has a 401(k) retirement savings plan with a safe harbor employer match with a maximum of 4% employer contribution for its eligible employees in the US. During the years ended December 31, 2022, 2021 and 2020 the Company recorded expenses for matching contributions in the amount of $1,182, $961 and $705, respectively.
Severance pay:
The Israeli Severance Pay Law, 1963 (“Severance Pay Law”), specifies that employees are entitled to severance payment, following the termination of their employment. Under the Severance Pay Law, the severance payment is calculated as one-month salary for each year of employment, or a portion thereof.
The Israeli Subsidiary’s liability for all of its Israeli employees is covered by the provisions of Section 14 of the Severance Pay Law (“Section 14”). Under Section 14 employees are entitled to monthly deposits, at a rate of 8.33% of their monthly salary, continued on their behalf to their insurance funds. Payments in accordance with Section 14 release the Company from any future severance payments in respect of those employees. As a result, the Company does not recognize any liability for severance pay due to these employees and the deposits under Section 14 are not recorded as an asset in the Company’s balance sheets.
Severance pay expenses for the years ended December 31, 2022, 2021 and 2020, amounted to approximately $946, $755 and $600, respectively.
F-12
INNOVID, CORP.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(In thousands, except stock and per stock data)
Income taxes and tax contingencies
Income taxes are computed using a balance sheet approach reflecting both current and deferred taxes. Current and deferred taxes reflect the tax impact of all of the events included in the financial statements. The basic principles employed in the balance sheet approach are to reflect a current tax liability or asset that is recognized for the estimated taxes payable or refundable on tax returns for the current and prior years, a deferred tax liability or asset that is recognized for the estimated future tax effects attributable to temporary differences and carryforwards, the measurement of current and deferred tax liabilities and assets is based on provisions of the enacted tax law of which the effects of future changes in tax laws or rates are not anticipated, and the measurement of deferred tax assets is reduced, if necessary, by the amount of any tax benefits that, based on available evidence, are not expected to be realized. There are certain situations in which deferred taxes are not provided. Some basis differences are not temporary differences because their reversals are not expected to result in taxable or deductible amounts.
The Company regularly evaluates deferred tax assets for future realization and establishes a valuation allowance to the extent that a portion is not more likely than not to be realized. The Company considers whether it is more likely than not that the deferred tax assets will be realized, including existing cumulative losses in recent years, expectations of future taxable income, carryforward periods, and other relevant quantitative and qualitative factors. The recoverability of the deferred tax assets is evaluated by assessing the adequacy of future expected taxable income from all sources, including reversal of taxable temporary differences, forecasted operating earnings and available tax planning strategies. These sources of income rely on estimates.
ASC 740, Income Taxes (“ASC 740”) contains a two-step approach to recognizing and measuring a liability for uncertain tax positions. The first step is to evaluate the tax position taken or expected to be taken in a tax return by determining if the weight of available evidence indicates that it is more likely than not that, on an evaluation of the technical merits, the tax position will be sustained on audit, including resolution of any related appeals or litigation processes. The second step is to measure the tax benefit as the largest amount that is more than 50% (cumulative basis) likely to be realized upon ultimate settlement. The Company classifies interest related to unrecognized tax benefits in taxes on income.
On December 20, 2017, Congress passed the “US Tax Act”. The US Tax Act requires complex computations to be performed that were not previously required by US tax law, significant judgments to be made in interpretation of the provisions of the US Tax Act, significant estimates in calculations, and the preparation and analysis of information not previously relevant or regularly produced the Act provides that a person who is a US shareholder of any CFC is required to include its GILTI in gross income for the tax year in a manner generally similar to that for Subpart F inclusions. The term “global intangible low-taxed income” is defined as the excess (if any) of the US shareholder’s net CFC tested income for that tax year, over the US shareholder’s net deemed tangible income return for that tax year. The Company’s policy is to treat GILTI as a period expense in the provision for income taxes.
Concentrations of credit risks
Financial instruments that potentially subject the Company to concentrations of credit risk consist principally of cash and cash equivalents, deposits and trade receivables, net.
The majority of the Company’s cash and cash equivalents are invested in deposits with major banks in US, Israel and UK. Generally, these investments may be redeemed upon demand and, therefore, bear minimal risk.
The Company’s trade receivables, net are mainly derived from sales to customers located in the US, APAC, EMEA, and LATAM. The Company mitigates its credit risks by performing an ongoing credit evaluations of its customers’ financial conditions.
The Company has no off-balance-sheet concentration of credit risk such as foreign exchange contracts, option contracts or other foreign hedging arrangements.
F-13
INNOVID, CORP.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(In thousands, except stock and per stock data)
During the years ended December 31, 2022, 2021 and 2020, two of the Company’s customers accounted for more than 10% of the Company’s total revenues as presented below:

Year ended December 31,

202220212020
Customer A
11 %**
Customer B
10 %*10 %
* less than 10%
Stock-based compensation
The Company estimates the fair value of stock-based awards on the date of grant. The fair value of stock options with only service conditions is determined using the Black-Scholes option pricing model. The grant date fair value of the stock-based awards with graded vesting is recognized on a straight-line basis over the requisite service period. The determination of the fair value of the Company’s stock option awards is based on a variety of factors including Company’s common stock price, risk-free interest rate, expected volatility, expected life of awards and dividend yield. The Company has limited option exercise history and has elected to estimate the expected life of the stock option awards using the “simplified method” with the continued use of this method extended until such time that the Company has sufficient exercise history. The expected volatility of the price of such stocks is based on volatility of similar companies whose stock prices are publicly available over a historical period equivalent to the option’s expected term. The dividend yield is based on the Company’s historical and future expectation of dividends payouts. Historically, the Company has not paid cash dividends. Risk-free interest rates are based on the yield from US Treasury zero-coupon bonds with a term equivalent to the expected term of the options.
The Company accounts for forfeitures as they occur.
Warrants
The Company accounts for warrants as either equity-classified or liability-classified instruments based on an assessment of the warrant’s specific terms and applicable authoritative guidance. The assessment considers whether the warrants are freestanding financial instruments, meet the definition of a liability under ASC 480, and meet all of the requirements for equity classification, including whether the warrants are indexed to the Company’s own common stock and whether the warrant holders could potentially require “net cash settlement” in a circumstance outside of the Company’s control, among other conditions for equity classification. This assessment, which requires the use of professional judgment, is conducted at the time of warrant issuance and as of each subsequent reporting period end date while the warrants are outstanding.
Warrants that meet all the criteria for equity classification, are required to be recorded as a component of additional paid-in capital. Warrants that do not meet all the criteria for equity classification, are required to be recorded as liabilities at their initial fair value on the date of issuance and remeasured to fair value at each balance sheet date thereafter. The liability-classified warrants are recorded under non-current liabilities. Changes in the estimated fair value of the warrants are recognized in “Financial expenses, net” in the consolidated statements of operations.
Revenue recognition
The majority of Company’s revenues is derived from providing Ad serving services to advertisers, publishers, and media agencies. The services focus on standard, interactive and data driven digital video advertising. Ad serving services relate to utilizing Innovid’s platform to serve advertising impressions to various digital publishers across CTV, mobile TV, desktop TV, display, and other channels.
The Company also provides measurement services to brand and agencies, enterprise clients (networks) and publishers. The measurement service provide analysis on and track performance of advertisement campaigns. The measurement service provides insights into the effectiveness of TV and digital advertising.
Creative services relate to the design and development of interactive data-driven and dynamic ad formats by adding data, interactivity and dynamic features to standard ad units.
F-14
INNOVID, CORP.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(In thousands, except stock and per stock data)
The Company recognizes revenue when its customer obtains control of promised services in an amount that reflects the consideration that the Company expects to receive in exchange for those services. The Company recognizes revenue in accordance with ASC Topic 606, Revenue from contracts with customers (“ASC 606”) and determines revenue recognition through the following steps: (1) identify the contract with a customer, (2) identify the performance obligations in the contract, (3) determine the transaction price, (4) allocate the transaction price to the performance obligations in the contract, and (5) recognize revenue when a performance obligation is satisfied.
For arrangements with multiple performance obligations, which represent promises within an arrangement that are capable of being distinct and are separately identifiable, the Company allocates the contract consideration to all distinct performance obligations based on their relative standalone selling price (“SSP”). SSP is typically estimated based on observable transactions when these services are sold on a standalone basis.
Revenues related to ad serving services are recognized when impressions are delivered. The Company recognizes revenue from the display of impression-based ads in the contracted period in which the impressions are delivered. Impressions are considered delivered when an ad is displayed to users.
Revenues related to the measurement services platform are recognized over time, since the customer simultaneously receives and consumes the benefits provided by the Company’s performance. Revenues for these measurement services are recognized over the service period.
Revenues related to creative projects are recognized at a point in time when the Company delivers an ad unit. Creative services projects are usually delivered within a week.
The Company’s accounts receivable, consist primarily of receivables related to providing ad serving, measurement and creative services, for which the Company’s contracted performance obligations have been satisfied, the amount has been billed and the Company has an unconditional right to payment. The Company typically bills customers monthly based on actual delivery. The payment terms vary, mainly with terms of 60 days or less.
The typical contract term is 12 months or less for ASC 606 purposes. Most of the Company’s contracts can be cancelled without a cause. The Company has the unconditional right to payment for the services provided as of the date of the termination of the contracts.
The Company applies the practical expedient in ASC 606 and does not adjust the promised amount of consideration for the effects of a significant financing component if the Company expects, at contract inception, that the period between when the Company transfers a promised good or service to a customer and when the customer pays for that good or service will be one year or less.
Deferred revenues represent mostly unrecognized fees billed or collected for measurement platform services. Deferred revenues are recognized as (or when) we perform under the contract.
Ad serving services were 76.7%, 93.6%, and 96.5% of the Company’s revenues for the years ended December 31, 2022, 2021 and 2020, respectively. Measurement services were 19.7%, 1.6% and 0.7% of the Company’s revenues for the years ended December 31, 2022, 2021 and 2020, respectively. Creative services were 3.6%, 4.8% and 2.8% of the Company’s revenues for the years ended December 31, 2022, 2021 and 2020, respectively.
Costs to obtain a contract
Contract costs include commission programs to compensate sales employees for generating sales orders with new customers or for new services with existing customers. Most commissions are commensurate. The Company elected to apply the practical expedient and recognize incremental costs of obtaining a contract as an expense when incurred if the amortization period of the asset that the Company otherwise would have recognized is one year or less. If commissions are not commensurate, the Company capitalizes these commissions. The term of amortization of capitalized commissions is three years. The amount of commissions capitalized as of December 31, 2022 is immaterial.
Cost of revenues
Cost of revenues consists primarily of costs to run the ad serving, creative and measurement services. These costs include hosting fees, cost to access data and personnel costs including stock-based compensation, professional services costs and facility related costs. The Company allocates overhead including rent and other facility related costs, communication costs based on headcount.
F-15
INNOVID, CORP.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(In thousands, except stock and per stock data)
Research and development
Research and development expenses consist primarily of personnel costs, including stock-based compensation, professional services costs, hosting and facility related costs. We allocate overhead including rent and other facility related costs and communication costs based on headcount. We expect research and development expenses to increase in future periods to support our growth, including continuing to invest in optimization, accuracy and reliability of our platform and other technology improvements to support and drive efficiency in our operations. These expenses may vary from period to period as a percentage of revenue, depending primarily upon when we choose to make more significant investments.
Research and development costs are charged to the consolidated statements of operations as incurred. ASC 350-40, Internal-Use Software (“ASC 350-40”), requires the capitalization of certain costs incurred only during the application development stage.
Sales and marketing
Sales and marketing expenses consist primarily of personnel costs, including stock-based compensation, professional services costs and facility related costs as well as costs related to advertising, product management, promotional materials, public relations, other sales and marketing programs. The Company allocates overhead including rent and other facility related costs, communication costs based on headcount.
General and administrative
General and administrative expenses consist primarily of personnel costs, including stock-based compensation, for executive management, finance, accounting, human capital, legal and other administrative functions as well as professional services costs and facility related costs. The Company allocates overhead including rent and other facility related costs, communication costs based on headcount.
Net loss per common stock
Prior to the Company’s SPAC merger, the Company computed net loss per stock using the two-class method required for participating securities. The two-class method requires income available to common stockholders for the period to be allocated between common stocks and participating securities based upon their respective rights to receive dividends as if all income for the period had been distributed. The Company considered its preferred stocks to be participating securities as the holders of the preferred stocks would be entitled to dividends that would be distributed to the holders of common stocks, on a pro-rata basis assuming conversion of all preferred stocks into common stocks.
These participating securities do not contractually require the holders of such stocks to participate in the Company’s losses. As such, net loss for the periods presented was not allocated to the Company’s participating securities.
Following the SPAC merger, basic net loss per stock share is computed by dividing net income (loss) for each reporting period by the weighted-average number of ordinary shares outstanding during that period. Diluted net loss per stock is computed by dividing net income (loss) for each reporting period by the weighted average number of ordinary shares outstanding during the period, plus dilutive potential ordinary shares considered outstanding during the period. Diluted net loss per stock is the same as basic net loss per stock in periods when the effects of potentially dilutive stock of common stock are anti-dilutive.
All outstanding warrants, options and RSUs for the years ended December 31, 2022, 2021 and 2020 have been excluded from the calculation of the diluted net loss per share, because all such securities are anti-dilutive for all periods presented. Preferred stocks were converted and treasury stocks were cancelled as of December 31, 2021. For further information see Note 19 Basic and Diluted Net Loss Per Share.
F-16
INNOVID, CORP.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(In thousands, except stock and per stock data)
Recently Adopted Accounting Pronouncements
In February 2016, the FASB issued the ASU No. 2016-02, Leases (Topic 842). The standard outlines a comprehensive lease accounting model that supersedes the previous lease guidance and requires lessees to recognize lease liabilities and corresponding right-of-use (“ROU”) assets for all leases with lease terms greater than 12 months. The guidance also changes the definition of a lease and expands the disclosure requirements of lease arrangements. Innovid adopted the standard in the first quarter of 2022 using the modified retrospective method. Results for reporting periods beginning after December 31, 2021, have been presented in accordance with the standard, while results for prior periods have not been adjusted and continue to be reported in accordance with the Company's historical accounting. The cumulative effect of initially applying the new leases standard was recognized as an adjustment to the opening consolidated balance sheet as of January 1, 2022.
The Company elected a package of practical expedients for leases that commenced prior to January 1, 2022, and did not reassess historical conclusions on: (i) whether any expired or existing contracts are or contain leases; (ii) lease classification for any expired or existing leases; and (iii) initial direct costs capitalization for any existing leases.
This standard has a significant impact on our consolidated balance sheet but did not have a significant impact on the Company’s consolidated statements of operations. The most significant effects relate to the recognition ROU assets and lease liabilities on interim consolidated balance sheet for real estate and cars operating leases.
Upon adoption, the Company recognized lease liabilities and corresponding ROU assets, adjusted for the accrued rent and remaining lease incentives received on the adoption date, as follows:
January 1, 2022
ROU assetsLease liabilities
Real Estate$3,928 $5,482 
Cars50 50 
Total operating leases$3,978 $5,532 
See Note 8, Leases for further details.
In December 2019, the FASB issued ASU 2019-12, Income Taxes (Topic 740): Simplifying the Accounting for Income Taxes (“ASU 2019-12”). The new guidance eliminates certain exceptions related to the approach for intraperiod tax allocation, the methodology for calculating income taxes in an interim period and the recognition of deferred tax liabilities for outside basis differences. It also clarifies and simplifies other aspects of the accounting for income taxes. Innovid adopted the standard in the first quarter of 2022. The adoption of the guidance did not have a material impact on the Company’s consolidated financial statements.
In October 2021, the FASB issued ASU 2021-08, Business Combinations (Topic 805), Accounting for Contract Assets and Contract Liabilities from Contracts with Customers, which requires contract assets and contract liabilities (i.e., deferred revenue) acquired in a business combination to be recognized and measured by the acquirer on the acquisition date in accordance with ASC 606, Revenue from Contracts with Customers. This new guidance will result in the acquirer recognizing contract assets and contract liabilities at the same amounts recorded by the acquiree. Historically, such amounts were recognized by the acquirer at fair value in acquisition accounting. The Company adopted the standard effective in the first quarter of 2022. The adoption of the guidance did not have a material impact on the Company’s consolidated financial statements.
Recently issued accounting pronouncements not yet adopted by the Company
As an “emerging growth company,” the JOBS Act allows the Company to delay adoption of new or revised accounting pronouncements applicable to public companies until such pronouncements are made applicable to private companies. The Company has elected to use this extended transition period under the JOBS Act. The adoption dates discussed below reflect this election.
F-17
INNOVID, CORP.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(In thousands, except stock and per stock data)
In August 2020, the FASB issued ASU 2020-06, Debt — Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging — Contracts in Entity’s Own Equity (Subtopic 815-40): Accounting for Convertible Instruments and Contracts in an Entity’s Own Equity (“ASU 2020-06”). The final guidance issued by the FASB for convertible instruments eliminates two of the three models in ASC 470-20 that require separate accounting for embedded conversion features. Separate accounting is still required in certain cases. Additionally, among other changes, the guidance eliminates some of the conditions for equity classification in ASC 815-40-25 for contracts in an entity’s own equity. The guidance also requires entities to use the if-converted method for all convertible instruments in the diluted earnings per share calculation and include the effect of share settlement for instruments that may be settled in cash or shares, except for certain liability-classified share-based payment awards. ASU 2020-06 is effective for fiscal years beginning after December 15, 2023, and interim periods within those fiscal years. The Company evaluated the potential impact of this guidance on its consolidated financial statements and determined that it will not have an impact on the consolidated financial statements.
In June 2016, the FASB issued ASU 2016-13, Financial Instruments – Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments (“ASU 2016-13”). ASU 2016-13 requires the measurement of all expected credit losses for financial assets held at the reporting date based on historical experience, current conditions, and reasonable and supportable forecasts. ASU 2016-13 requires enhanced qualitative and quantitative disclosures to help investors and other financial statement users better understand significant estimates and judgments used in estimating credit losses, as well as the credit quality and underwriting standards of an organization’s portfolio. ASU 2016-13 is effective for fiscal years beginning after December 15, 2022, and interim periods within those fiscal years. The Company has evaluated the impact of this accounting standard update and has determined that its adoption will impact how the Company assesses its estimates for credit losses, but will not have an impact on the consolidated financial statements.

Other guidance that has been issued since the end of our previous reporting period is not expected to have an impact on the Company’s consolidated financial statements.
3. TRANSACTION
On November 30, 2021, the Transaction was closed. The Transaction was accounted for as a reverse recapitalization. Under this method of accounting, ION who was the legal acquirer, was treated as the acquired company for accounting purposes and the Transaction was treated as the equivalent of Innovid Corp. issuing stock for the net assets of ION. The net assets of ION are stated at historical cost, with no goodwill or other intangible assets recorded.
Upon the consummation of the Transaction all outstanding shares of Innovid Inc. common stock, Innovid Inc. redeemable convertible preferred stock, Innovid Inc. warrants, and Secondary Sale Transaction of 6,885,486 shares to PIPE investors, were exchanged for 93,787,278 shares of common stock in Innovid Corp.

Number of shares
Legacy Innovid common stock of January 1, 202116,275,609 
Warrant exercised132,392 
Stock option exercised3,180,943 
Conversion of redeemable convertible preferred stock into common stock73,690,340 
Conversion of Legacy Innovid Warrants507,994 
Exchanged into Innovid Corp. common stock on November 30, 202193,787,278 
Holders of 19,585,174 shares of ION’s Class A common stock sold in its initial public offering (the “Initial Shares”) exercised their right to have such shares redeemed for a full pro rata portion of the trust account holding the proceeds from ION IPO, which was approximately $10.00 per share, or $195,888 in the aggregate. The remaining shares of ION Class A common stock, including total shares of ION Class B common stock converted to ION Class A common stock immediately prior to the Domestication, were automatically converted to 12,039,826 shares of common stock in Innovid Corp.
After giving effect to the Transaction, the redemption of Initial Shares as described above and the consummation of the PIPE Investment, there were 118,941,618 shares of common stock issued and outstanding after the close of the Transaction.
Innovid Corp. received approximately $149,252 in cash proceeds, net of transaction costs paid. The Company paid an accrued liability of $3,185 directly related to the Transaction as of December 31, 2021.
F-18
INNOVID, CORP.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(In thousands, except stock and per stock data)

The following table reconciles the elements of the Transaction to the Consolidated statement of cash flows and the Consolidated Statement of Changes in Temporary Equity and Stockholders’ Equity for the year ended December 31, 2021.

Total value
Cash - ION trust account and cash, net of redemptions
$55,466 
Cash - PIPE Investment, net of Secondary Sale Amount of $68,855
131,145 
Less: Transaction costs paid
(31,160)
Less: Deferred underwriting fee paid(6,199)
Proceeds from reverse recapitalization, net
149,252 
Less: Accrued transaction costs not yet paid*
(3,185)
Less: Company Warrant assumed as part of the Transaction
(22,791)
Plus: Transaction costs allocated to Company Warrant2,750 
Reverse recapitalization, net
$126,026 
* These amounts were paid in 2022.
As a result of the Transaction, each share of Innovid Inc. redeemable convertible preferred stock and common stock was converted into the right to receive approximately 1.337 shares of the common stock of the Company.
The consolidated assets, liabilities and results of operations prior to the Transaction are those of Innovid Inc.. The stocks and corresponding capital amounts and losses per stock, prior to the Transaction, have been retroactively restated based on stocks reflecting the exchange ratio established in the Transactions.
The equity structure has been recast in all comparative periods up to the Closing Date to reflect the number of shares of the Company’s common stock, $0.0001 par value per share, issued to Innovid Inc.’s stockholders in connection with the Transaction. As such, the shares and corresponding capital amounts and earnings per share related to Innovid Inc. redeemable convertible preferred stock and Innovid Inc.'s common stock prior to the Transaction have been retroactively recast as shares reflecting the exchange ratio of 1.337 established in the Transaction.
Public Warrants and Private Placement Warrants
As a result of the Transaction, the Company assumed the outstanding Public Warrants to purchase 3,162,500 shares of the Company’s common stock and the outstanding Private Warrants to purchase 7,060,000 shares of the Company’s common stock. Each whole Warrant entitles the registered holder to purchase one share of the Company’s common stock at a price of $11.50 per share, at any time commencing 30 days after the closing of the Transaction. The warrants expire five years after the completion of the Transaction. Refer to Note 11, Warrants for further discussion.

4. ACQUISITION
On February 28, 2022, the Company completed the acquisition of TVS. TVS is an independent global measurement and attribution platform for converged TV and a private company limited by shares incorporated under the laws of Scotland. The Company acquired all the equity of TVS for an aggregate amount of approximately $100,000 in cash, 11,549,465 shares of the Company common stock at fair value of $3.80 per share, and the issuance of 949,893 fully vested stock option of the Company at weighted average fair value of $3.49, subject to certain adjustments as defined in the Stock Purchase Agreement.
The Company, through this acquisition, added a real-time, cross-platform service to its offerings, including measurement outcomes such as frequency and unique unduplicated reach and performance metrics. The combination of ad serving, and cross-platform measurement enables the buy- and sell-sides to solve fragmentation by unlocking a complete picture of advertising across the linear TV, CTV and digital video marketplaces.
F-19
INNOVID, CORP.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(In thousands, except stock and per stock data)
The acquisition of TVS has been accounted for as a business combination using the acquisition method of accounting. The acquisition method requires that assets acquired and liabilities assumed in a business combination be recognized at their fair values as of the acquisition date. The valuation of assets acquired and liabilities assumed have been finalized as of December 31, 2022. The Company finalized the purchase accounting for the TVS acquisition during the fourth quarter of fiscal 2022.
The following table summarizes the fair value of assets acquired and liabilities assumed as of the acquisition date:

Total value
Cash and cash equivalents
$5,318 
Accounts receivables
4,186
Other current assets1,173
Property and equipment154
Total tangible assets
10,831 
Technology15,075
Customer relationships
16,700
Trade name
2,000
Goodwill
112,421
Total assets acquired
157,027 
Less: Deferred tax liabilities(1,677)
Less: Other assumed liabilities
(3,782)
Net assets acquired
$151,568 
Intangible assets related to technology, customer relationship and trade name are being amortized over the estimated useful life of approximately 6 years, 11 years, and 4 years, respectively. The estimated fair values of identifiable intangible assets were determined using the "income approach", which is a valuation technique that provides an estimate of the fair value of an asset based on market participant expectations of the cash flows an asset would generate over its remaining useful life. Some of the more significant assumptions inherent in the development of these asset valuations include the estimated net cash flows for each year for the appropriate discount rate necessary to measure the risk inherent in each future cash flow stream, the life cycle of each asset, competitive trends impacting the asset and each cash flow stream, as well as other factors.
Goodwill was calculated as the excess of the consideration transferred over the net assets recognized and represents the future economic benefits arising from the other assets acquired that could not be individually identified and separately recognized. Specifically, the goodwill recognized from the acquisition of TVS represents the value of additional growth potential of the revenue base from the creation of a single combined global organization and synergies related to combined IT efforts for enhancement of the existing and acquired technologies. The goodwill is not deductible for tax purposes.
In addition to the purchase consideration, the Company entered cash compensation arrangements with certain employees, which amounted to $9,700 in aggregate and are subject to certain performance and employment conditions following the acquisition date.
The Company incurred approximately $5.0 million in total transaction costs for the acquisition. Acquisition related transaction costs include legal, accounting fees and other professional costs directly related to the acquisition and are recognized in “general and administrative” in the consolidated statements of operations.
F-20
INNOVID, CORP.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(In thousands, except stock and per stock data)
Unaudited Pro Forma Financial Information
The following table presents the unaudited pro forma combined results of Innovid and TVS for the year ended December 31, 2022, and 2021 as if the acquisition of TVS had occurred on January 1, 2021:
Twelve months ended December 31,
2022

2021
(Unaudited)(Unaudited)
Revenues$131,433 $112,147 
Net loss(14,634)(37,195)
The unaudited pro forma combined financial information was prepared using the acquisition method of accounting and was based on the historical financial information of Innovid and TVS. In order to reflect the occurrence of the acquisition on January 1, 2021, the unaudited pro forma financial information includes adjustments to reflect incremental amortization expense to be incurred based on the current preliminary fair values of the identifiable intangible assets acquired and the reclassification of acquisition-related costs incurred during the three months and twelve months ended December 31, 2022 to the three months and twelve months ended December 31, 2021. The unaudited pro forma financial information is not necessarily indicative of what the consolidated results of operations would have been had the acquisition been completed on January 1, 2021. In addition, the unaudited pro forma financial information is not a projection of future results of operations of the combined company.
5. INTANGIBLE ASSETS, NET
The Company amortizes intangible assets on a straight line basis over their estimated useful lives. The estimated useful life, gross carrying amounts and accumulated amortization totals related to our identifiable intangible assets are as follows:
December 31, 2022
Estimated Useful LifeGross Carrying AmountAccumulated AmortizationNet Carrying Amount
Customer relationships11 years$16,898 $(1,469)$15,429 
Acquired technology6 years15,275 (2,367)12,907 
Trade name4 years2,000 (418)1,582 
Total$34,173 $(4,254)$29,918 
The weighted average useful life of our intangible assets at December 31, 2022 was 7.64 years. As described in Note 4, Acquisition, we acquired several intangible assets as part of the TVS acquisition. The Company assesses intangible assets for indicators of impairment on an annual basis, including an evaluation of our useful lives to determine if events and circumstances warrant a revision to the remaining period of amortization. If indicators of impairment are present, amortizable intangible assets are tested for impairment by comparing the carrying value to undiscounted cash flows and, if impaired, written down to fair value based on discounted cash flows. The company have not identified an impairment, nor a material change to the estimated remaining useful lives of its intangible assets during fiscal years 2022 and 2021. The intangible assets have no assigned residual values.
Amortization expense recorded for intangible assets was $3,850, $33, and $199 during fiscal years 2022, 2021, and 2020, respectively.
F-21
INNOVID, CORP.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(In thousands, except stock and per stock data)
As of December 31, 2022, estimated intangible asset amortization expense for each of the next five years and thereafter are as follows:
Fiscal YearAmortization Expense
2023$4,518 
20244,518 
20254,518 
20264,081 
20274,018 
Thereafter8,265 
Total$29,918 
6. PREPAID AND OTHER CURRENT ASSETS
Prepaid and other current assets consist of the following:

December 31,

2022

2021
Prepaid expenses$1,721 $2,333 
Deposits99 142 
Government authorities204 153 
Other current assets616 503 
Total
$2,640 $3,131 
7. PROPERTY AND EQUIPMENT, NET
Property and equipment consist of the following:

December 31,

2022

2021
Cost:


Software development costs$13,190 $2,594 
Computers and peripheral equipment2,283 1,779 
Office furniture and equipment665 661 
Leasehold improvements2,167 2,164 

18,305 7,198 
Accumulated depreciation(3,983)(2,358)
Depreciated cost$14,322 $4,840 
The depreciation expense for the years ended December 31, 2022, 2021 and 2020 was $1,626, $630 and $531, respectively.
F-22
INNOVID, CORP.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(In thousands, except stock and per stock data)
8. LEASES
The Company has the following operating ROU assets and lease liabilities:
December 31, 2022
ROU assetsLease liabilities
Real Estate$2,886 $3,801 
Cars24 21 
Total operating leases$2,910 $3,822 
December 31, 2022
Lease liabilities
Current lease liabilities$2,186 
Non-current lease liabilities1,636 
Total lease liabilities$3,822 
The following table summarizes the lease costs recognized in the consolidated statement of operations:
Year ended
December 31, 2022
Operating lease cost$1,889 
Short term lease cost973 
Variable lease cost48 
Total lease cost$2,910 
As of December 31, 2022, the weighted-average remaining lease term and weighted-average discount rate for operating leases are 2.2 years and 3.6%, respectively.
The following table presents supplementary cash flow information regarding the company's operating leases:
Year ended
December 31, 2022
Cash paid for amounts included in the measurement of lease liabilities$2,162 
Right of use assets obtained in exchange for operating lease liabilities upon lease modification$610 

The following table summarizes the future payments of Innovid for its operating lease liabilities:
December 31, 2022
2023$2,219 
20241,018 
2025669 
Total undiscounted lease payments$3,906 
Less: Interest(84)
Total lease liabilities - operating$3,822 

F-23
INNOVID, CORP.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(In thousands, except stock and per stock data)
Lease Disclosures Related to Periods Prior to the Adoption of ASU 2016-02 are as follows:
Operating lease expenses for the years ended December 31, 2021 and 2020 were $2,072 and, $2,215, respectively.
Future minimum lease commitments under non-cancelable operating leases as of December 31, 2021, are as follows:
Year ended December 31, 2021
Rental of premisesLease of motor vehicles
2022$2,486 $8 
20231,844 — 
2024826 — 
2025770 — 
Total
$5,926 $8 

9. ACCRUED EXPENSES AND OTHER CURRENT LIABILITIES
Accrued expenses and other current liability consist of the following:
December 31,
2022

2021
Accrued expenses$3,544 $2,485 
Tax payables1,325 39 
Deferred revenue426 — 
Accrued lease liability, current portion— 420 
Other current liabilities179 138 
Total
$5,474 $3,082 
10. OTHER NON-CURRENT LIABILITIES
Other non-current liabilities consist of the following:

December 31,
2022

2021
Accrued lease liability$— $996 
Uncertain tax position3,865 2,459 
Deferred tax liability489 — 
Other non-current liabilities2,200 — 
Total
$6,554 $3,455 
11. WARRANTS
As of December 31, 2022, the Company had 3,162,500 Public Warrants and 7,060,000 Private Warrants outstanding.
Public Warrants
Warrants may only be exercised for a whole number of shares. No fractional shares will be issued upon exercise of the Public Warrants. The Public Warrants will become exercisable on the later of (a) 30 days after the completion of the Transaction and (b) one year from the closing of the Initial Public Offering. The Public Warrants will expire five years from the completion of the Transaction or earlier upon redemption or liquidation.
F-24
INNOVID, CORP.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(In thousands, except stock and per stock data)
Redemption of warrants when the price per share of Innovid Corp. common stock equals or exceeds $18.00.
Once the warrants become exercisable, the Company may redeem the outstanding warrants (except as described with respect to the Private Placement Warrants):
•in whole and not in part.
•at a price of $0.01 per warrant.
•upon a minimum of 30 days’ prior written notice of redemption to each warrant holder; and
•if, and only if, the closing price of the Innovid Corp. common stock equals or exceeds $18.00 per share (as adjusted) for any 20 trading days within a 30-trading day period ending three business days before the Company sends the notice of redemption to the warrant holders.
When the warrants become redeemable by the Company, the Company may exercise its redemption right even if it is unable to register or qualify the underlying securities for sale under all applicable state securities laws.
The Company has established the last of the redemption criterion discussed above to prevent a redemption call unless there is at the time of the call a significant premium to the warrant exercise price. If the foregoing conditions are satisfied and the Company issues a notice of redemption of the warrants, each warrant holder will be entitled to exercise the warrant prior to the scheduled redemption date. However, the price of the Company’s common shares may fall below the $18.00 redemption trigger price (as adjusted for share sub-divisions, share capitalization, reorganization, recapitalization and the like) as well as the $11.50 warrant exercise price after the redemption notice is issued.
Redemption of warrants when the price per share of Innovid Corp. common stock equals or exceeds $10.00.
Once the warrants become exercisable, the Company may redeem the outstanding warrants:
•in whole and not in part.
•at a price of $0.10 per warrant.
•upon a minimum of 30 days’ prior written notice of redemption; if holders will be able to exercise their warrants on a cashless basis prior to redemption and receive that number of shares determined based on the redemption date and the fair market value of the Innovid Corp. common stock; and
•if, and only if, the closing price of the Innovid Corp. ordinary shares equals or exceeds $10.00 per share (as adjusted) for any 20 trading days within a 30-trading day period ending three business days before the Company sends the notice of redemption to the warrant holders.
If the Company calls these Public Warrants for redemption, as described above, its management will have the option to require any holder that wishes to exercise the Public Warrants to do so on a “cashless basis,” as described in the warrant agreement. The exercise price and number of ordinary shares issuable upon exercise of the Public Warrants may be adjusted in certain circumstances including in the event of a share dividend, extraordinary dividend or recapitalization, reorganization, merger, or consolidation. However, except as described below, the Public Warrants will not be adjusted for issuances of ordinary shares at a price below their exercise price. Additionally, in no event will the Company be required to net cash settle the Public Warrants.
Private Placement Warrants
The Private Placement Warrants are identical to the Public Warrants, except that the Private Placement Warrants and the Innovid Corp. ordinary shares issuable upon the exercise of the Private Placement Warrants will not be transferable, assignable or salable until 30 days after the completion of the Transaction subject to certain limited exceptions. Additionally, the Private Placement Warrants will be exercisable on a cashless basis and be non-redeemable, except as described above, so long as they are held by the initial purchaser or its permitted transferees.
F-25
INNOVID, CORP.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(In thousands, except stock and per stock data)
The Company evaluated the Company Warrants (Public Warrants and Private Placement Warrants) in accordance with ASC 480, “Distinguishing Liabilities from Equity” and ASC 815-40, “Derivatives and Hedging — Contracts in Entity’s Own Equity” and concluded that the warrants do not meet all the conditions to be classified as equity pursuant to ASC 815-40. As the warrants do not meet all the requirements for equity classification, the Company Warrants are recorded as liabilities on the Balance Sheets and measured at fair value with changes in fair value recognized in the Statements of Operations in the period of change. The Company Warrants’ fair value as of December 31, 2022 and 2021 was $4,301 and $18,972, respectively.

12. LONG-TERM DEBT
2022 A&R Agreement
On August 4, 2022, two wholly owned subsidiaries of the Company, Innovid LLC and TV Squared Inc, entered an amended and restated loan and security agreement with Silicon Valley Bank (the “2022 A&R Agreement”), to increase the revolving line of credit from $15,000 to $50,000 (the “New Revolving Credit Facility”). The interest for the New Revolving Credit Facility is payable monthly in arrears. The New Revolving Credit Facility bears interest at an annual rate which is the greater of (a) WSJ Prime Rate plus 0.75% or (b) 4.25%, on the aggregate outstanding balance. Additional fees include fees in an amount of 0.20% per annum of the average unused portion of the New Revolving Credit Facility to be paid quarterly in arrears. The Company will also pay non-refundable commitment fees of $40 and $75 at inception and first anniversary date, respectively. The maturity date of the 2022 A&R Agreement is June 30, 2024. The New Revolving Credit Facility is subject to certain customary conditions precedent to the credit extension as stated in the 2022 A&R Agreement.
The New Revolving Credit Facility requires the Company to comply with all covenants, primarily maintaining an adjusted quick ratio of at least 1.30 to 1.00. As defined in the 2022 A&R Agreement “adjusted quick ratio” is the ratio of (a) quick assets to (b) current liabilities minus the current portion of deferred revenue. “Quick assets” are determined as the Company’s unrestricted cash plus accounts receivable, net, and is determined according to US GAAP. The Company is also required to maintain the minimum quarterly adjusted EBITDA as defined in the 2022 A&R Agreement if the Company does not maintain the quarterly adjusted quick ratio of at least 1.50 to 1.00.
As of December 31, 2022, the Company utilized $20,000 of the $50,000 credit line, $6,000 of which was drawn during 2020, $5,000 was drawn during the fourth quarter 2022 and $9,000 was drawn during the second quarter of 2022. In January 2023, the Company repaid $5,000 under the credit line.
As of December 31, 2022, the Company is in compliance with all the covenants.
Prior to the 2022 A&R Agreement, the credit installments bore US dollar denominated interest at an annual rate equal to 0.75%-1% plus a prime rate on the outstanding principal of each credit installment.

13. COMMITMENTS AND CONTINGENT LIABILITIES
Pledges and bank guarantees:
1.In conjunction with the 2022 A&R Agreement (see Note 12, Long-term Debt), Innovid LLC. pledged 65,000 common stocks of its Israeli Subsidiary, NIS 0.01 par value each.
2.The Israeli Subsidiary pledged bank deposits in an aggregate amount of $629 in connection with an office rent agreement and credit cards.
3.Innovid Inc. obtained bank guarantees in an aggregate amount of $231 in connection with its office lease agreements.
Legal contingencies:
On March 4, 2022, a lawsuit was filed in the United States District Court for the Western District of Texas on March 4, 2022, by Nielsen, LLC against TVS alleging infringement of US Patent No. 10,063,378. On January 18, 2023 the Texas Court granted TVS’s motion to transfer venue to the Southern District of New York. It is expected that the Southern District of New York will issue a scheduling order detailing the next steps in the case in March 2023. The plaintiff has not specified the amount sought in the litigation.
F-26
INNOVID, CORP.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(In thousands, except stock and per stock data)
14. STOCKHOLDERS’ EQUITY
Stockholders’ equity:
AuthorizedIssuedOutstanding
December 31,December 31,December 31,
2022

20212022

2021

20222021
Stocks of $0.0001, par value each:
Common stocks500,000,000 500,000,000 133,882,414 119,017,380 133,882,414 119,017,380 
The shares of the Company’s common stock, prior to the Transaction (as discussed in Note 3, Transaction) have been retrospectively adjusted to reflect the exchange ratio of 1.337 established in the Transaction.
i.Common stocks:
The rights and privileges of the common stocks are as follows:
Voting Rights - The holders of the common stocks are entitled to one vote for each share of common stocks.
Dividend Rights - Subject to preferences that may be applicable to dividends of any outstanding preferred stocks, dividends may be paid on the common stocks as and when declared by the Board of Directors. Such dividends will be distributed among the holders of common stocks pro rata in proportion of the number of common stocks held by each.
Liquidation Rights - In the event of any voluntary or involuntary liquidation, dissolution or winding up of the Company’s affairs, the holders of the Company common stock are entitled to share ratably in all assets remaining after payment of the Company’s debts and other liabilities, subject to prior distribution rights of the Company preferred stock or any class or series of stock having a preference over the Company common stock, then outstanding, if any.
Redemption Rights - The common stocks are not redeemable.
Options outstanding and options available for future option grants have been retroactively adjusted to give effect to the exchange ratio.
ii.Treasury stocks: As of December 31, 2022 there are no treasury stock issued or outstanding
iii.Equity classified warrants:
The Company issued 133,725 warrants to American Friends of Tmura, Inc. (the “Holder”) on February 25, 2010 to purchase an aggregate of 133,725 shares of the Company’s common stock, $0.001 par value each, with an exercise price of $0.07 which is subject to an adjustment on the occurrence of certain events. The warrants are exercisable until March 1, 2029. The warrants were recorded within equity based on their fair value on the date of issuance. These warrants are not remeasured. All equity classified warrants were exercised in November 2021 on a non-cash basis.
15. STOCK-BASED COMPENSATION
The Innovid Corp. Incentive Plan (“2021 Incentive Plan”)
A total number of Company common stock equal to 10% of the fully-diluted shares outstanding following the closing of the Transaction will initially be authorized and reserved for issuance under the 2021 Incentive Plan, which is 15,617,049 shares of Company common stock. The number of shares authorized and reserved for issuance will be subject to an annual increase for 10 years on the first day of each calendar year beginning January 1, 2022, equal to the lesser of (A) 5% of the aggregate number of shares of Company common stock outstanding on the final day of the immediately preceding calendar year and (B) such smaller number of shares as is determined by the board of directors of Innovid Corp. The maximum number of shares of Company common stock that may be issued pursuant to the exercise of incentive stock options granted under the 2021 Incentive Plan will be equal to 30% of the total number of issued and outstanding shares of Company common stock on a fully diluted basis as of the closing of the Transaction, see Note 3, Transaction.
F-27
INNOVID, CORP.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(In thousands, except stock and per stock data)
If shares covered by an award are not purchased or are forfeited or expire, or otherwise terminate without delivery of any shares subject thereto, then such shares will, to the extent of any such forfeiture, termination, cash-settlement or expiration, be available for future grant under the 2021 Incentive Plan. The payment of dividend equivalent rights in cash in conjunction with any outstanding awards will not be counted against the shares available for issuance under the 2021 Incentive Plan, and shares tendered by a participant, repurchased by the Company using proceeds from the exercise of stock options or withheld by the Company in payment of the exercise price of a stock option or to satisfy any tax withholding obligation for an award will not again be available for future awards.
Innovid Stock Plan (“Innovid Stock Plan")
Under the Innovid Stock Plan, options may be granted to officers, directors, employees and non-employee consultants of the Company. Each option granted under the Plan expires no later than 10 years from the date of grant. The options vest usually over four years from commencement of employment or services. Any options, which are forfeited or not exercised before expiration, become available for future grants. From and after the effectiveness of the 2021 Incentive Plan, no additional awards will be granted under the Innovid Stock Plan. Upon the effectiveness of the Transaction, all outstanding stock options under the Innovid Stock Plan, whether vested or unvested, were converted into options to purchase a number of shares of common stock of the Company. Awards previously granted under the Innovid Stock Plan will continue to be subject to the provisions thereof.
Stock-based compensation expense
Stock-based compensation expense is related to awards issued to employees pursuant to the Innovid Stock Plan and the 2021 Incentive Plan, summarized as follows:

Year ended December 31,

202220212020
Cost of goods sold
$1,171 $43 $11 
Research and development
3,489 501 121 
Sales and marketing
4,685 470 196 
General and administrative
3,342 1,997 92 
Total
$12,687 $3,011 $420 
In connection with the options granted to service providers and non-employee consultants, during the twelve months ended December 31, 2022, 2021 and 2020, the Company recorded stock compensation expenses in the amount of $1,190, $262 and $162, respectively. The majority of these expenses were recorded in general and administrative.
During the twelve months ended December 31, 2022 the Company capitalized stock-based compensation expense of $1,165 in internal-use software cost. The Company stock-based compensation expense related to internal-use software cost for the same period in 2021 were immaterial.
Stock Options
Stock options may be granted to officers, directors, employees, and non-employee consultants of the Company. Each option granted under the Plan expires no later than 10 years from the date of grant. The options vest usually over four years from commencement of employment or services. Any options, which are forfeited or not exercised before expiration, become available for future grants.
In connection with the TVS acquisition, Innovid issued 949,893 stock options to holders of TVS options for replacement options. These options were fully vested upon issuance due to acceleration upon acquisition and therefore do not require future service for vesting. The Company attributed a total amount of $152 to post acquisition service and recorded it as stock compensation expenses immediately after the acquisition closed. See Note 4, Acquisition for further details.
F-28
INNOVID, CORP.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(In thousands, except stock and per stock data)
A summary of the employees’ stock option activity under the Innovid Stock Plan and the 2021 Incentive Plan for the years ended December 31, 2022 is as follows:

Year ended
December 31, 2022

Amount
of
options
Weighted
average
exercise
price
Weighted
average
remaining contractual term
(in years)
Aggregate intrinsic value (in thousands)
Outstanding at beginning of year
11,122,648 $0.82 6.87$64,818 
Transfer between employee and consultant40,118 0.64 
Granted2,105,258 2.10 
Granted in acquisition949,893 0.31 
Forfeited(355,998)1.60 
Expired(26,089)1.37 
Exercised(3,149,387)0.30 
Outstanding at end of year
10,686,443 $1.15 6.85$5,923 
Exercisable options at end of year
6,687,488 $0.75 5.77$6,409 

A summary of the consultants’ stock option activity under the Innovid Stock Plan for the year ended December 31, 2022 is as follows:

Year ended
December 31, 2022

Amount
of
options
Weighted
average
exercise
price
Weighted
average
remaining contractual term
(in years)
Aggregate intrinsic value (in thousands)
Outstanding at beginning of year
179,627 $0.31 2.34$1,139 
Consultant has become employee(40,118)0.64 
Granted— — 
Forfeited(460)2.81 
Expired(209)2.81 
Exercised(69,298)0.30 
Outstanding at end of year
69,542 $0.47 4.21$86 
Exercisable options at end of year
64,524 $0.46 3.93$81 
As of December 31, 2022, the Company had approximately $4,536 of total unrecognized compensation cost related to non-vested stock-based compensation. That cost is expected to be recognized over a weighted-average period of 1.8 years years.
The Company estimated the fair value of each option on the date of grant using the Black-Scholes option pricing model applying the weighted-average assumptions in the following table:

Year ended December 31,

2022

20212020
Expected volatility
69%-71%
65 %79 %
Expected dividends
— %— %— %
Expected term (in years)
4.316.026.11
Risk free interest
2.84%-3.81%
1.06%-1.11%
0.62%-0.82%
F-29
INNOVID, CORP.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(In thousands, except stock and per stock data)
Restricted Stock Units
In connection with the Company’s transition to its next life-cycle stage post Transaction, Restricted Stock Units (“RSUs”) may be granted to officers, directors, employees, and non-employee consultants of the Company, and generally vest over a three- or four-year period.
A summary of the employees’ RSU activity under the 2021 Incentive Plan for the year ended December 31, 2022 is as follows:

Number of share units
Weighted
average
grant date
fair value
Outstanding at beginning of year
— — 
Granted9,329,639 5.65 
Released(96,884)5.90 
Forfeited(1,246,382)5.97 
Outstanding at end of year
7,986,373 $5.60 
A summary of the consultants’ RSU activity under the 2021 Incentive Plan for the year ended December 31, 2022 is as follows:

Number of share units
Weighted
average
grant date
fair value
Outstanding at beginning of year
— — 
Granted176,151 6.52 
Forfeited(45,883)6.28 
Outstanding at end of year
130,268 $6.60 
The weighted-average grant-date fair value of RSUs generally is determined based on the number of units granted and the quoted price of Innovid’s common stock on the date of grant.
As of December 31, 2022, $33,165 of unrecognized compensation cost related to RSUs is expected to be recognized as expense over the weighted average period of 2.0 years.
The Innovid Corp. Employee Stock Purchase Plan
On November 30, 2021, the ESPP became effective. A total of 2,868,438 shares of Company common stock were initially reserved for issuance under the ESPP. The compensation committee of our board of directors is the plan administrator of the ESPP and has the authority to interpret the terms of the ESPP and determine eligibility of participants. On the first day of each calendar year beginning on January 1, 2022 and ending on (and including) January 1, 2031, the number of shares available for issuance under the ESPP will be increased by a number of shares equal to the lesser of (i) 1% of the shares outstanding on the final day of the immediately preceding calendar year, and (ii) such smaller number of shares as determined by the board of directors. If any right granted under the ESPP terminates for any reason without having been exercised, the shares subject thereto that are not purchased under such right will again be available for issuance under the ESPP. Notwithstanding the foregoing, no more than 17,383,002 shares of Company Common Stock may be issued under the Section 423 Component of the ESPP.
As of December 31, 2022, the Company had not granted any options under the Innovid Corp. Employee Stock Purchase Plan.
F-30
INNOVID, CORP.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(In thousands, except stock and per stock data)
NOTE 16. FINANCE EXPENSES (INCOME), NET
The Company recognizes the gains and losses from the remeasurement of the warrants liability related to Public Warrants and Private Placement Warrants in “Finance expenses (income), net” in the consolidated statements of operations. The unrealized gain from changes in the fair value of the Company Warrants for the years ended December 31, 2022 and 2021 was $14,671 and $3,819, respectively.
The Company also recognized interest expenses in “Finance expenses (income), net” in the consolidated statements of operations. Interest expenses for the years ended December 31, 2022, 2021 and 2020 were $675, $259 and $328, respectively.
17. INCOME TAXES
Income (loss) before taxes on income is comprised as follows:
Year ended December 31,
2022

20212020
Domestic$(7,910)$(11,098)$1,241 
Foreign(8,483)863 (853)
Total income (loss) before income taxes
$(16,393)$(10,235)$388 
Income taxes are comprised as follows:
Year ended December 31,
2022

20212020
Current income tax provision (benefit):  
Domestic$1,048 $(8)$96 
Foreign2,129 1,245 1,104 
Total current income tax (benefit) provision
$3,177 $1,237 $1,200 
Year ended December 31,
2022

20212020
Deferred income tax provision (benefit):  
Domestic$— $— $— 
Foreign(1,160)— — 
Total deferred income tax (benefit) provision
$(1,160)$— $— 
Total income tax (benefit) provision$2,017 $1,237 $1,200 
F-31
INNOVID, CORP.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(In thousands, except stock and per stock data)
A reconciliation of the U. S. statutory income tax rate to the Company’s effective income tax rate for continuing operations is as follows:
Year ended December 31,
 202220212020
Total income (loss) before income taxes
$(16,393)$(10,235)$388 
US statutory rate21 %21 %21 %
Income taxed computed at U. S. federal statutory rate$(3,443)$(2,149)$81 
Foreign rate differential101 (14)(155)
State and local income taxes, net(239)(359)207 
Other non-deductible items546 (37)140 
GILTI2,892 308 — 
Change in valuation allowance2,305 1,493 159 
Tax credits(474)(338)(469)
Changes in uncertain tax positions1,202 881 956 
Transaction costs1,427 578 — 
Warrants - MTM(3,081)160 (5)
Other781 714 286 
Total income tax provision
$2,017 $1,237 $1,200 
Effective income tax rate
(12.3)%(12.1)%309.0 %
The Company’s effective tax rate is subject to significant variations due to several factors, including variability in pre-tax and taxable income (loss) and the mix of jurisdictions to which they relate, intercompany transactions, mergers and acquisitions, the applicability of special tax regimes, changes in the Company’s currently established valuation allowance, foreign currency gains (losses), and other laws and accounting rules in various jurisdictions.
Significant factors that impacted the Company’s effective tax rate between 2022 and 2021 were related to the acquisition of TVS, GILTI, uncertain tax positions, and increase in valuation allowance.
The Company’s effective tax rate between 2021 and 2020 was primarily reflects a pre-tax loss in 2021 compared to pre-tax income in 2020, offset by increases in non-deductible expenses, GILTI, uncertain tax positions and increase in valuation allowance.
F-32
INNOVID, CORP.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(In thousands, except stock and per stock data)
Deferred income taxes are provided for the effects of temporary differences between assets and liabilities recognized for financial reporting purposes and the amounts recognized for income tax purposes. Significant components of deferred tax assets and deferred tax liabilities consisted of the following:
 December 31,
 20222021
Deferred tax assets  
Loss carryforwards$11,093 $10,201 
Tax credits1,271 1,128 
Interest limitation carryforwards— 25 
R&D capitalization costs7,497 — 
Accrued expenses1,157 597 
Share-based compensation4,398 127 
Fixed assets147 180 
Lease liabilities700 — 
Other28 187 
Total deferred tax assets, gross
26,291 12,445 
Valuation allowance(18,697)(12,445)
Total deferred tax assets, net
$7,594 $— 
Deferred tax liabilities
Intangibles$(7,239)$— 
Right-of-use asset(654)— 
Other(190)— 
Total deferred tax liability, net
$(8,083)$— 
Total deferred tax asset (liability)$(489)$— 
A valuation allowance is provided when it is more likely than not that the deferred tax assets will not be realized. The Company has established a valuation allowance to offset its deferred tax assets, excluding the newly acquired TVS UK which is in a net deferred tax liability position due primarily to acquisition accounting, at December 31, 2022 and 2021 due to the uncertainty of realizing future tax benefits from its net operating loss carryforwards and other deferred tax assets.
The Israeli corporate tax rate was 23% in 2022, 2021 and 2020. The Company’s production facilities in Israel have been granted the status of a “preferred enterprise” under the Law for the Encouragement of Capital Investments Law, 1959. According to the provisions of the Encouragement of Capital Investments Law, 1959, the Company has been granted a reduced tax rate for certain research and development activities the Company performs in Israel. A preferred enterprise located in development area A will be subject to a tax rate of 7.5% instead of 9%. The tax rate applicable to preferred enterprises located in other areas remains at 16%.
Foreign withholding taxes and Internal Revenue Code Section 986(c) gains and losses have not been recorded on permanently reinvested earnings of certain subsidiaries aggregating $12,888 and $8,720 as of December 31, 2022 and 2021, respectively. The amount of deferred international withholding taxes and Internal Revenue Code Section 986(c) gains and losses relating to these subsidiaries is approximately $1,237 and $1,224 as of December 31, 2022 and 2021, respectively.
F-33
INNOVID, CORP.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(In thousands, except stock and per stock data)
The Company’s gross NOLs for tax return purposes are as follows:
 
Year ended December 31,
 20222021
Domestic NOLs (federal)$11,881 $36,817 
Domestic NOLs (state and local)10,992 36,245 
Foreign NOLs30,804 1,136 
Total
$53,677 $74,198 
Domestic (federal and state) NOLs expire in various year starting from 2030 through an indefinite period. Foreign NOLs expire starting from 2026 (Argentina) through an indefinite period (Germany, UK). A portion of domestic (federal and state) NOLs are subject to Internal Revenue Code Section 382 or similar provisions, but the net operating loss carryforwards are expected to be fully realized. The table above reflects gross NOLs for tax return purposes which are different than financial statement NOLs, as the Company’s intention is to settle additional income taxes from tax contingencies with NOLs. The other tax credit carryforwards expire in various years beginning in 2033. The Company’s intention is to settle the tax contingencies associated with the research and development credits with the attribute.
The Company’s unrecognized tax benefits are reconciled as follows:
December 31,
202220212020
Gross unrecognized tax benefits as of January 1
$3,162 $2,373 $1,438 
Increases - prior year tax positions60 508 — 
Decreases - prior year tax positions(231)(410)— 
Increases - current year tax positions2,562 691 935 
Position expiration(97)— — 
Gross unrecognized tax benefits as of December 31
$5,456 $3,162 $2,373 
The balances of unrecognized tax benefits of $5,456 and $3,162 as of December 31, 2022 and 2021, respectively, represent amounts that, if recognized, would impact the effective income tax rate in future periods, of which $1,495 relates to the Company’s acquisition of TVS.
The Company recognized interest and penalties related to unrecognized tax benefits in its income tax provision. The Company accrued $471 and $136 for interest and penalties as of December 31, 2022 and 2021, respectively.
The Company is subject to income taxes in the US and several foreign jurisdictions including Australia, Argentina, Germany, the UK and Israel. Significant judgment is required in evaluating the Company’s tax positions and determining the Company’s provision for income taxes. During the ordinary course of business there are many transactions and calculations for which the ultimate tax determination is uncertain. The Company establishes reserves for tax related uncertainties based on estimates of whether, and the extent to which, additional taxes will be due. These reserves are established when we believe that certain positions might be challenged despite the belief that the Company’s tax return positions are fully supportable. The Company adjusts these reserves in light of changing facts and circumstances, such as the outcome of tax audits. The provision for income taxes includes the impact of reserve provisions and changes to reserves that are considered appropriate.
The Company’s Israeli Subsidiary is currently under examination by the taxing authorities for 2017 to 2019 tax periods. The last tax assessment that was received by the Company related to tax years through 2014 in Israel.

18. SEGMENT REPORTING
The Company operates as one operating segment, which primarily focuses on ad serving, measurement and creative services. Our CEO is the chief operating decision-maker, manages and allocates resources to the operations of the Company on an entity-wide basis.
F-34
INNOVID, CORP.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(In thousands, except stock and per stock data)
Revenue by geographical location are as follows:

December 31,

202220212020
US$114,528 $81,882 $62,760 
Canada1,266 1,039 518 
APAC4,249 3,151 2,636 
EMEA6,030 2,515 1,463 
LATAM1,044 1,704 1,424 
Total revenues
$127,117 $90,291 $68,801 
The Company’s property and equipment, net and ROU assets commencing January 1, 2022 by geographical location are as follows:
Year ended December 31,
20222021
Israel$2,707 $1,495 
US14,065 3,051 
Rest of the World 460 294 
Total
$17,232 $4,840 
19. BASIC AND DILUTED NET LOSS PER SHARE
Basic and diluted net loss per share attributable to common stockholders was calculated as follows:
Year ended December 31,
202220212020
Numerator:
Net loss$(18,410)$(11,472)$(812)
Accretion of preferred stocks to redemption value— (77,063)(7,297)
Net loss attributable to common stockholders - basic and diluted
$(18,410)$(88,535)$(8,109)
Denominator:
Weighted-average number of stocks used in computing net loss per stock attributable to common stockholders
130,756,484 26,745,020 16,028,560 
Net loss per stock attributable to common stockholders – basic and diluted
$(0.14)$(3.31)$(0.51)
Net loss per share calculations and potentially dilutive security amounts for all periods prior to the Transaction have been retrospectively adjusted to the equivalent number of shares outstanding immediately after the Transaction to effect the reverse recapitalization. Historically reported weighted average shares outstanding have been multiplied by the exchange ratio of 1.337.
The Company’s potentially dilutive securities have been excluded from the computation of diluted net loss per share as the effect would be to reduce the net loss per share attributable to common stockholders. Therefore, the weighted average number of common shares outstanding used to calculate both basic and diluted net loss per share attributable to common stockholders is the same.
F-35
INNOVID, CORP.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(In thousands, except stock and per stock data)
The Company excluded the following potential common shares, presented based on amounts outstanding at each period end, from the computation of diluted net loss per share attributable to common stockholders for the periods indicated because including them would have had an anti-dilutive effect:
Year ended December 31,
202220212020
Preferred stocks— — 73,690,340 
Options outstanding10,755,985 11,302,275 13,204,528 
RSUs outstanding8,116,641 — — 
Warrants outstanding10,222,500 10,222,500 680,271 
Preferred stocks, options outstanding and warrant outstanding have been retroactively adjusted to give effect to the exchange ratio.
F-36
Item 9. Changes in and Disagreements With Accountants on Accounting and Financial Disclosures
None.
Item 9A. Controls and Procedures
Limitations on Effectiveness of Controls and Procedures
In designing and evaluating our disclosure controls and procedures, management recognizes that any controls and procedures, no matter how well designed and operated, can provide only reasonable assurance of achieving the desired control objectives. In addition, the design of disclosure controls and procedures must reflect the fact that there are resource constraints, and that management is required to apply judgment in evaluating the benefits of possible controls and procedures relative to their costs.
Evaluation of Disclosure Controls and Procedures
Our management, with the participation of our CEO and CFO, conducted an evaluation of the effectiveness of our disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e)) under the Exchange Act as of December 31, 2022.
Based upon that evaluation, our CEO and CFO concluded that our disclosure controls and procedures were effective at the reasonable assurance level as of December 31, 2022.
Management Report on Internal Control Over Financial Reporting
Management is responsible for establishing and maintaining adequate internal control over financial reporting, as such term is defined in Rule 13a-15(f) under the Securities Exchange Act of 1934, as amended.
Our management conducted an assessment of the effectiveness of our internal control over financial reporting based on the criteria set forth in "Internal Control—Integrated Framework (2013)" issued by the Committee of Sponsoring Organizations of the Treadway Commission. Based on this assessment, management concluded that, as of December 31, 2022, our internal control over financial reporting was effective.
The scope of management's assessment of the effectiveness of our internal control over financial reporting included all of our consolidated operations except for the operations of TVS, which we acquired in February 2022. TVS’s assets excluding business combination related intangibles represented approximately 3% of our consolidated total assets as of December 31, 2022. TVS’s operations excluding amortization of the business combination related intangibles represented 19% and 34% of our consolidated revenue and net loss, respectively, for the year ended December 31, 2022.
This annual report does not include an attestation report of our independent registered public accounting firm on internal control over financial reporting due to an exemption established by the JOBS Act for "emerging growth companies".
Changes in Internal Control over Financial Reporting
There were no changes in our internal control over financial reporting (as defined in Rules 13a-15(f) and 15d-15(f) under the Exchange Act) during the year ended December 31, 2022 that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.
Item 9B. Other Information
None.
Item 9C. Disclosure Regarding Foreign Jurisdictions that Prevent Inspections
None.
59
Part III
Item 10. Directors, Executive Officers and Corporate Governance
The information required to be furnished by this Item 10 is incorporated herein by reference to our Notice of Annual Meeting of Stockholders and Proxy Statement to be filed within 120 days of December 31, 2022 (the "Proxy Statement").
Pursuant to General Instruction G(3) of Form 10-K, the information required by this item relating to our executive officers is included in Item 1. Executive Officers of the Registrant of this Annual Report on Form 10-K.
Item 11. Executive Compensation
The information required to be furnished by this Item 11 is incorporated herein by reference to our Proxy Statement.
Item 12. Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters
The information required to be furnished by this Item 12 is incorporated herein by reference to our Proxy Statement.
Item 13. Certain Relationships and Related Transactions, and Director Independence
The information required to be furnished by this Item 13 is incorporated herein by reference to our Proxy Statement.
Item 14. Principal Accounting Fees and Services
The information required to be furnished by this Item 14 is incorporated herein by reference to our Proxy Statement.
60
Part IV
Item 15. Exhibits and Financial Statement Schedules.
1.Financial Statements
The information required by this item is included in Item 8. Financial Statements and Supplementary Data, of this Annual Report on Form 10-K which is incorporated herein.
2.Financial Statements’ Schedules
Financial statement schedules have been omitted because they are either not required or not applicable or the information is included in the consolidated financial statements or the notes thereto.
3. Exhibits
See the Exhibit Index in Item 15(b) below.
Exhibit NumberDescription
2.1
3.1
3.2
4.1
4.2
4.3
4.4
10.1
10.2
10.3
10.4
10.5
10.6
10.7
10.8#
10.9
10.10
61
10.11
10.12
10.13
10.14#
10.15#
10.16#
10.17*
10.18*
10.19*
10.20*
21.1*
23.1*
31.1*
31.2*
32.1**
32.2**
101.INS
Inline XBRL Instance Document – the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document.
Inline XBRL Instance Document – the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document.
101.SCHInline XBRL Taxonomy Extension Schema Document.
101.CALXBRL Taxonomy Extension Calculation Linkbase Document.
101.DEFXBRL Taxonomy Extension Definition Linkbase Document.
101.LABXBRL Taxonomy Extension Label Linkbase Document.
101.PREXBRL Taxonomy Extension Presentation Linkbase Document.
104Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101)
* Filed herewith.
**Furnished herewith.
# Indicates management contract or compensatory plan.
Item 16. Form 10-K Summary
None.
62
SIGNATURES
Pursuant to the requirements of the Securities Act, the registrant has duly caused this registration statement to be signed on its behalf by the undersigned, thereunto duly authorized, in the City of New York, State of New York, on March 3, 2023.
Innovid Corp.
By:/s/ Zvika Netter
Name: Zvika Netter
Title: Chief Executive Officer
By:/s/ Tanya Andreev-Kaspin
Name: Tanya Andreev-Kaspin
Title: Chief Financial Officer

POWER OF ATTORNEY
Each person whose signature appears below constitutes and appoints each of Zvika Netter and Tanya Andreev-Kaspin, and each of them acting alone, as his or her true and lawful attorney-in-fact and agent, with full power of substitution and resubstitution, for such person and in his or her name, place, and stead, in any and all capacities, to sign any or all further amendments to this Annual Report on Form 10-K, and to file the same, with all exhibits thereto, and other documents in connection therewith, with the Securities and Exchange Commission, granting unto said attorney-in-fact and agents, and each of them, full power and authority to do and perform each and every act and thing requisite and necessary to be done in and about the premises, as fully to all intents and purposes as he might or could do in person, hereby ratifying and confirming all that said attorney-in-fact and agent, or his or her substitute or substitutes, may lawfully do or cause to be done by virtue hereof.
Pursuant to the requirements of the Securities Act, this registration statement has been signed by the following persons in the capacities and on March 3, 2023.
SignatureTitleDate
/s/ Zvika Netter
Chief Executive Officer and Director
(Principal Executive Officer)		March 3, 2023
Zvika Netter
/s/ Tanya Andreev-Kaspin
Chief Financial Officer
(Principal Financial Officer and Principal Accounting Officer)
March 3, 2023
Tanya Andreev-Kaspin
/s/ Gilad Shany
DirectorMarch 3, 2023
Gilad Shany
/s/ Brian Hughes
DirectorMarch 3, 2023
Brian Hughes
/s/ Michael DiPiano
DirectorMarch 3, 2023
Michael DiPiano
/s/ Rachel Lam
DirectorMarch 3, 2023
Rachel Lam
/s/ Jonathan Saacks
DirectorMarch 3, 2023
Jonathan Saacks
63
 EX-10.17 2 a1017innovidcorpformofstoc.htm EX-10.17 Document

INNOVID CORP.
2021 OMNIBUS INCENTIVE PLAN
STOCK OPTION GRANT NOTICE
Capitalized terms not specifically defined in this Stock Option Grant Notice (the “Grant Notice”) have the meanings given to them in the 2021 Omnibus Incentive Plan (as amended from time to time, the “Plan”) of Innovid Corp. (the “Company”).
The Company has granted to the participant listed below (“Participant”) the stock option described in this Grant Notice (the “Option”), subject to the terms and conditions of the Plan and the Stock Option Agreement attached as Exhibit A (the “Agreement”), both of which are incorporated into this Grant Notice by reference.
Participant:
Grant Date:
Exercise Price per Share:
Shares Subject to the Option:
Final Expiration Date:
Vesting Commencement Date:
Vesting Schedule:
Type of Option
By Participant’s signature below, Participant agrees to be bound by the terms of this Grant Notice, the Plan and the Agreement. Participant has reviewed the Plan, this Grant Notice and the Agreement in their entirety, has had an opportunity to obtain the advice of counsel prior to executing this Grant Notice and fully understands all provisions of the Plan, this Grant Notice and the Agreement. Participant hereby agrees to accept as binding, conclusive and final all decisions or interpretations of the Administrator upon any questions arising under the Plan, this Grant Notice or the Agreement.
INNOVID CORP.PARTICIPANT
By:
Name:
Title:



Exhibit A
STOCK OPTION AGREEMENT
Capitalized terms not specifically defined in this Agreement have the meanings specified in the Grant Notice or, if not defined in the Grant Notice, in the Plan.
ARTICLE I.
GENERAL
1.1Grant of Option. The Company has granted to Participant the Option effective as of the grant date set forth in the Grant Notice (the “Grant Date”).
1.2Incorporation of Terms of Plan. The Option is subject to the terms and conditions set forth in this Agreement and the Plan, which is incorporated herein by reference. In the event of any inconsistency between the Plan and this Agreement, the terms of the Plan will control.
ARTICLE II.
PERIOD OF EXERCISABILITY
1.1Commencement of Exercisability. The Option will vest and become exercisable according to the vesting schedule in the Grant Notice (the “Vesting Schedule”) except that any fraction of a Share as to which the Option would be vested or exercisable will be accumulated and will vest and become exercisable only when a whole Share has accumulated. Notwithstanding anything in the Grant Notice, the Plan or this Agreement to the contrary, unless the Administrator otherwise determines, the Option will immediately expire and be forfeited as to any portion that is not vested and exercisable as of Participant’s Termination of Service for any reason.
1.2Duration of Exercisability. The Vesting Schedule is cumulative. Any portion of the Option which vests and becomes exercisable will remain vested and exercisable until the Option expires. The Option will be forfeited immediately upon its expiration.
1.3Expiration of Option. The Option may not be exercised to any extent by anyone after, and will expire on, the first of the following to occur:
(a)The final expiration date in the Grant Notice;
(b)Except as the Administrator may otherwise approve, the expiration of three (3) months from the date of Participant’s Termination of Service, unless Participant’s Termination of Service is for Cause or by reason of Participant’s death or Disability;
(c)Except as the Administrator may otherwise approve, the expiration of one (1) year from the date of Participant’s Termination of Service by reason of Participant’s death or Disability; and
(d)Except as the Administrator may otherwise approve, Participant’s Termination of Service for Cause.
ARTICLE III.
EXERCISE OF OPTION
1.1Person Eligible to Exercise. During Participant’s lifetime, only Participant may exercise the Option. After Participant’s death, any exercisable portion of the Option may, prior to the time the Option expires, be exercised by Participant’s Designated Beneficiary as provided in the Plan.
1.2Partial Exercise. Any exercisable portion of the Option or the entire Option, if then wholly exercisable, may be exercised, in whole or in part, according to the procedures in the Plan at any time prior to the time the Option or portion thereof expires, except that the Option may only be exercised for whole Shares.




1.3Tax Withholding.
(a)The Company has the right and option, but not the obligation, to treat Participant’s failure to provide timely payment in accordance with the Plan of any withholding tax arising in connection with the Option as Participant’s election to satisfy all or any portion of the withholding tax by requesting the Company retain Shares otherwise issuable under the Option.
(b)Participant acknowledges that Participant is ultimately liable and responsible for all taxes owed in connection with the Option, regardless of any action the Company or any Subsidiary takes with respect to any tax withholding obligations that arise in connection with the Option. Neither the Company nor any Subsidiary makes any representation or undertaking regarding the treatment of any tax withholding in connection with the awarding, vesting or exercise of the Option or the subsequent sale of Shares. The Company and the Subsidiaries do not commit and are under no obligation to structure the Option to reduce or eliminate Participant’s tax liability.
ARTICLE IV.
OTHER PROVISIONS
1.1Adjustments. Participant acknowledges that the Option is subject to adjustment, modification and termination in certain events as provided in this Agreement and the Plan.
1.2Notices. Any notice to be given under the terms of this Agreement to the Company must be in writing and addressed to the Company in care of the Company’s Secretary at the Company’s principal office or the Secretary’s then-current email address or facsimile number. Any notice to be given under the terms of this Agreement to Participant must be in writing and addressed to Participant (or, if Participant is then deceased, to the person entitled to exercise the Option) at Participant’s last known mailing address, email address or facsimile number in the Company’s personnel files. By a notice given pursuant to this Section, either party may designate a different address for notices to be given to that party. Any notice will be deemed duly given when actually received, when sent by email, when sent by certified mail (return receipt requested) and deposited with postage prepaid in a post office or branch post office regularly maintained by the United States Postal Service, when delivered by a nationally recognized express shipping company or upon receipt of a facsimile transmission confirmation.
1.3Titles. Titles are provided herein for convenience only and are not to serve as a basis for interpretation or construction of this Agreement.
1.4Conformity to Securities Laws. Participant acknowledges that the Plan, the Grant Notice and this Agreement are intended to conform to the extent necessary with all Applicable Laws and, to the extent Applicable Laws permit, will be deemed amended as necessary to conform to Applicable Laws.
1.5Successors and Assigns. The Company may assign any of its rights under this Agreement to single or multiple assignees, and this Agreement will inure to the benefit of the successors and assigns of the Company. Subject to the restrictions on transfer set forth in the Plan, this Agreement will be binding upon and inure to the benefit of the heirs, legatees, legal representatives, successors and assigns of the parties hereto.
1.6Limitations Applicable to Section 16 Persons. Notwithstanding any other provision of the Plan or this Agreement, if Participant is subject to Section 16 of the Exchange Act, the Plan, the Grant Notice, this Agreement and the Option will be subject to any additional limitations set forth in any applicable exemptive rule under Section 16 of the Exchange Act (including any amendment to Rule 16b-3) that are requirements for the application of such exemptive rule. To the extent Applicable Laws permit, this Agreement will be deemed amended as necessary to conform to such applicable exemptive rule.
1.7Entire Agreement. The Plan, the Grant Notice and this Agreement (including any exhibit hereto) constitute the entire agreement of the parties and supersede in their entirety all prior undertakings and agreements of the Company and Participant with respect to the subject matter hereof.
A-2



1.8Agreement Severable. In the event that any provision of the Grant Notice or this Agreement is held illegal or invalid, the provision will be severable from, and the illegality or invalidity of the provision will not be construed to have any effect on, the remaining provisions of the Grant Notice or this Agreement.
1.9Limitation on Participant’s Rights. Participation in the Plan confers no rights or interests other than as herein provided. This Agreement creates only a contractual obligation on the part of the Company as to amounts payable and may not be construed as creating a trust. Neither the Plan nor any underlying program, in and of itself, has any assets. Participant will have only the rights of a general unsecured creditor of the Company with respect to amounts credited and benefits payable, if any, with respect to the Option, and rights no greater than the right to receive the Shares as a general unsecured creditor with respect to the Option, as and when exercised pursuant to the terms hereof.
1.10Not a Contract of Employment. Nothing in the Plan, the Grant Notice or this Agreement confers upon Participant any right to continue in the employ or service of the Company or any Subsidiary or interferes with or restricts in any way the rights of the Company and its Subsidiaries, which rights are hereby expressly reserved, to discharge or terminate the services of Participant at any time for any reason whatsoever, with or without Cause, except to the extent expressly provided otherwise in a written agreement between the Company or a Subsidiary and Participant.
1.11Counterparts. The Grant Notice may be executed in one or more counterparts, including by way of any electronic signature, subject to Applicable Law, each of which will be deemed an original and all of which together will constitute one instrument.
1.12Incentive Stock Options. If the Option is designated as an Incentive Stock Option:
(a)Participant acknowledges that to the extent the aggregate fair market value of shares (determined as of the time the option with respect to the shares is granted) with respect to which stock options intended to qualify as “incentive stock options” under Section 422 of the Code, including the Option, are exercisable for the first time by Participant during any calendar year exceeds $100,000 or if for any other reason such stock options do not qualify or cease to qualify for treatment as “incentive stock options” under Section 422 of the Code, such stock options (including the Option) will be treated as non-qualified stock options. Participant further acknowledges that the rule set forth in the preceding sentence will be applied by taking the Option and other stock options into account in the order in which they were granted, as determined under Section 422(d) of the Code. Participant acknowledges that amendments or modifications made to the Option pursuant to the Plan that would cause the Option to become a Non-Qualified Stock Option will not materially or adversely affect Participant’s rights under the Option, and that any such amendment or modification shall not require Participant’s consent. Participant also acknowledges that if the Option is exercised more than three (3) months after Participant’s Termination of Service as an Employee, other than by reason of death or disability, the Option will be taxed as a Non-Qualified Stock Option.
(b)Participant will give prompt written notice to the Company of any disposition or other transfer of any Shares acquired under this Agreement if such disposition or other transfer is made (a) within two (2) years from the Grant Date or (b) within one (1) year after the transfer of such Shares to Participant. Such notice will specify the date of such disposition or other transfer and the amount realized, in cash, other property, assumption of indebtedness or other consideration, by Participant in such disposition or other transfer.
* * * * *

A-3

 EX-10.18 3 a1018innovidcorpformofrest.htm EX-10.18 Document

INNOVID CORP.
2021 OMNIBUS INCENTIVE PLAN
RESTRICTED STOCK UNIT GRANT NOTICE
Capitalized terms not specifically defined in this Restricted Stock Unit Grant Notice (the “Grant Notice”) have the meanings given to them in the 2021 Omnibus Incentive Plan (as amended from time to time, the “Plan”) of Innovid Corp. (the “Company”).
The Company has granted to the participant listed below (“Participant”) the Restricted Stock Units described in this Grant Notice (the “RSUs”), subject to the terms and conditions of the Plan and the Restricted Stock Unit Agreement attached as Exhibit A (the “Agreement”), both of which are incorporated into this Grant Notice by reference.
Participant:
Grant Date:
Number of RSUs:
Vesting Commencement Date:
Vesting Schedule:
By Participant’s signature below, Participant agrees to be bound by the terms of this Grant Notice, the Plan and the Agreement. Participant has reviewed the Plan, this Grant Notice and the Agreement in their entirety, has had an opportunity to obtain the advice of counsel prior to executing this Grant Notice and fully understands all provisions of the Plan, this Grant Notice and the Agreement. Participant hereby agrees to accept as binding, conclusive and final all decisions or interpretations of the Administrator upon any questions arising under the Plan, this Grant Notice or the Agreement.
INNOVID CORP.PARTICIPANT
By:
Name:
Title:


Exhibit A
RESTRICTED STOCK UNIT AGREEMENT
Capitalized terms not specifically defined in this Agreement have the meanings specified in the Grant Notice or, if not defined in the Grant Notice, in the Plan.
Article I.
GENERAL
1.1Award of RSUs and Dividend Equivalents.
(a)The Company has granted the RSUs to Participant effective as of the grant date set forth in the Grant Notice (the “Grant Date”). Each RSU represents the right to receive one Share, as set forth in this Agreement. Participant will have no right to the distribution of any Shares until the time (if ever) the RSUs have vested.
(b)The Company hereby grants to Participant, with respect to each RSU, a Dividend Equivalent for ordinary cash dividends paid to substantially all holders of outstanding Shares with a record date after the Grant Date and prior to the date the applicable RSU is settled, forfeited or otherwise expires. Each Dividend Equivalent entitles Participant to receive the equivalent value of any such ordinary cash dividends paid on a single Share. The Company will establish a separate Dividend Equivalent bookkeeping account (a “Dividend Equivalent Account”) for each Dividend Equivalent and credit the Dividend Equivalent Account (without interest) on the applicable dividend payment date with the amount of any such cash paid.
1.2Incorporation of Terms of Plan. The RSUs are subject to the terms and conditions set forth in this Agreement and the Plan, which is incorporated herein by reference. In the event of any inconsistency between the Plan and this Agreement, the terms of the Plan will control.
1.3Unsecured Promise. The RSUs and Dividend Equivalents will at all times prior to settlement represent an unsecured Company obligation payable only from the Company’s general assets.
Article II.
VESTING; FORFEITURE AND SETTLEMENT
1.1Vesting; Forfeiture. The RSUs will vest according to the vesting schedule in the Grant Notice except that any fraction of an RSU that would otherwise be vested will be accumulated and will vest only when a whole RSU has accumulated. In the event of Participant’s Termination of Service for any reason, all unvested RSUs will immediately and automatically be cancelled and forfeited, except as otherwise determined by the Administrator or provided in a binding written agreement between Participant and the Company. Dividend Equivalents (including any Dividend Equivalent Account balance) will vest or be forfeited, as applicable, upon the vesting or forfeiture of the RSU with respect to which the Dividend Equivalent (including the Dividend Equivalent Account) relates.
1.2Settlement.
(a)RSUs will be paid in Shares, and Dividend Equivalents (including any Dividend Equivalent Account balance) will be paid in Shares or cash, at the Company’s option, in each case, as soon as administratively practicable after the vesting of the applicable RSU, but in no event more than sixty (60) days after the RSU’s vesting date. Notwithstanding the foregoing, the Company may delay any payment under this Agreement that the Company reasonably determines would violate Applicable Law until the earliest date the Company reasonably determines the making of the payment will not cause such a violation (in accordance with Treasury Regulation Section 1.409A-2(b)(7)(ii)), provided the Company reasonably believes the delay will not result in the imposition of excise taxes under Section 409A.
(b)If a Dividend Equivalent is paid in Shares, the number of Shares paid with respect to the Dividend Equivalent will equal the quotient, rounded down to the nearest whole Share, of


the Dividend Equivalent Account balance divided by the Fair Market Value of a Share on the day immediately preceding the payment date.
Article III.
TAXATION AND TAX WITHHOLDING
1.1Representation. Participant represents to the Company that Participant has reviewed with Participant’s own tax advisors the tax consequences of this Award and the transactions contemplated by the Grant Notice and this Agreement. Participant is relying solely on such advisors and not on any statements or representations of the Company or any of its agents.
1.2Tax Withholding.
(a)The Company has the right and option, but not the obligation, to treat Participant’s failure to provide timely payment in accordance with the Plan of any withholding tax arising in connection with the RSUs or Dividend Equivalents as Participant’s election to satisfy all or any portion of the withholding tax by requesting the Company retain Shares otherwise issuable under the Award.
(b)Participant acknowledges that Participant is ultimately liable and responsible for all taxes owed in connection with the RSUs and the Dividend Equivalents, regardless of any action the Company or any Subsidiary takes with respect to any tax withholding obligations that arise in connection with the RSUs or Dividend Equivalents. Neither the Company nor any Subsidiary makes any representation or undertaking regarding the treatment of any tax withholding in connection with the awarding, vesting or payment of the RSUs or the Dividend Equivalents or the subsequent sale of Shares. The Company and the Subsidiaries do not commit and are under no obligation to structure the RSUs or Dividend Equivalents to reduce or eliminate Participant’s tax liability.
Article IV.
OTHER PROVISIONS
1.1Adjustments. Participant acknowledges that the RSUs, the Shares subject to the RSUs and the Dividend Equivalents are subject to adjustment, modification and termination in certain events as provided in this Agreement and the Plan.
1.2Notices. Any notice to be given under the terms of this Agreement to the Company must be in writing and addressed to the Company in care of the Company’s Secretary at the Company’s principal office or the Secretary’s then-current email address or facsimile number. Any notice to be given under the terms of this Agreement to Participant must be in writing and addressed to Participant at Participant’s last known mailing address, email address or facsimile number in the Company’s personnel files. By a notice given pursuant to this Section, either party may designate a different address for notices to be given to that party. Any notice will be deemed duly given when actually received, when sent by email, when sent by certified mail (return receipt requested) and deposited with postage prepaid in a post office or branch post office regularly maintained by the United States Postal Service, when delivered by a nationally recognized express shipping company or upon receipt of a facsimile transmission confirmation.
1.3Titles. Titles are provided herein for convenience only and are not to serve as a basis for interpretation or construction of this Agreement.
1.4Conformity to Securities Laws. Participant acknowledges that the Plan, the Grant Notice and this Agreement are intended to conform to the extent necessary with all Applicable Laws and, to the extent Applicable Laws permit, will be deemed amended as necessary to conform to Applicable Laws.
1.5Successors and Assigns. The Company may assign any of its rights under this Agreement to single or multiple assignees, and this Agreement will inure to the benefit of the successors and assigns of the Company. Subject to the restrictions on transfer set forth in the Plan, this Agreement will be binding upon and inure to the benefit of the heirs, legatees, legal representatives, successors and assigns of the parties hereto.
A-2


1.6Limitations Applicable to Section 16 Persons. Notwithstanding any other provision of the Plan or this Agreement, if Participant is subject to Section 16 of the Exchange Act, the Plan, the Grant Notice, this Agreement, the RSUs and the Dividend Equivalents will be subject to any additional limitations set forth in any applicable exemptive rule under Section 16 of the Exchange Act (including any amendment to Rule 16b-3) that are requirements for the application of such exemptive rule. To the extent Applicable Laws permit, this Agreement will be deemed amended as necessary to conform to such applicable exemptive rule.
1.7Entire Agreement. The Plan, the Grant Notice and this Agreement (including any exhibit hereto) constitute the entire agreement of the parties and supersede in their entirety all prior undertakings and agreements of the Company and Participant with respect to the subject matter hereof.
1.8Agreement Severable. In the event that any provision of the Grant Notice or this Agreement is held illegal or invalid, the provision will be severable from, and the illegality or invalidity of the provision will not be construed to have any effect on, the remaining provisions of the Grant Notice or this Agreement.
1.9Limitation on Participant’s Rights. Participation in the Plan confers no rights or interests other than as herein provided. This Agreement creates only a contractual obligation on the part of the Company as to amounts payable and may not be construed as creating a trust. Neither the Plan nor any underlying program, in and of itself, has any assets. Participant will have only the rights of a general unsecured creditor of the Company with respect to amounts credited and benefits payable, if any, with respect to the RSUs and Dividend Equivalents, and rights no greater than the right to receive cash or the Shares, as applicable, as a general unsecured creditor with respect to the RSUs and/or Dividend Equivalents, as applicable, as and when settled pursuant to the terms of this Agreement.
1.10Not a Contract of Employment. Nothing in the Plan, the Grant Notice or this Agreement confers upon Participant any right to continue in the employ or service of the Company or any Subsidiary or interferes with or restricts in any way the rights of the Company and its Subsidiaries, which rights are hereby expressly reserved, to discharge or terminate the services of Participant at any time for any reason whatsoever, with or without Cause, except to the extent expressly provided otherwise in a written agreement between the Company or a Subsidiary and Participant.
1.11Counterparts. The Grant Notice may be executed in one or more counterparts, including by way of any electronic signature, subject to Applicable Law, each of which will be deemed an original and all of which together will constitute one instrument.
* * * * *
A-3

 EX-10.19 4 a1019executiveseveranceplan.htm EX-10.19 Document

Innovid, Inc.
Executive Severance Plan
ARTICLE I. Establishment, Term, and Purpose

1.1Establishment of the Plan. Innovid, Inc. (the “Company”) hereby establishes a severance plan for key executives, to be known as the Innovid, Inc. Executive Severance Plan (the “Plan”).

1.2Plan Participants. The Plan provides Severance Benefits (as described below) to certain employees of the Company, its Subsidiaries and Affiliates who incur a Qualifying Termination (as defined below) and who are listed in Attachment A or who have received a Participation Letter in the form shown on Attachment B (as it may be amended from time to time) (each a “Participant”).

1.3Purpose of Plan. The Company considers it essential to provide competitive compensation to attract and retain its management team. The Company has determined that competitive compensation should include severance benefits payable to key executives who are terminated under certain circumstances not related to performance. Accordingly, the Board of Directors of the Company (“Board”) has determined that the adoption of this Plan is necessary to provide a competitive level of severance benefits to key executives.

1.4Effective Date. The effective date of this Plan is June 29, 2021.

ARTICLE II: Definitions

Whenever used in this Plan, the following terms shall have the meanings set forth below and, when the meaning is intended, the initial letter of the word is capitalized.
1.1“Accrued Obligation” means an amount equal to the Participant’s accrued and unpaid Base Salary and, to the extent provided for under applicable law or the applicable policies of the Company in effect from time to time, earned but not taken vacation pay through the Participant’s Effective Date of Termination.

1.2“Affiliate” means any entity that, directly or indirectly, controls, is controlled by, or is under common control with, the Company.

1.3“Base Salary” means the annual rate of base salary paid by the Company, a Subsidiary or Affiliate to a Participant (including amounts that the Participant could have received in cash had he or she not elected to contribute to an employee benefit plan or a deferred compensation program maintained by the Company, any Subsidiary or Affiliate).

1.4“Cause” means:

(A)The Participant’s failure to substantially perform his/her duties with the Company or Participant’s material underperformance of his or her job duties, as determined in the discretion of the Company’s Chief Executive Officer;

(B)The Participant’s willfully engaging in conduct which is demonstrably and materially injurious to the Company, monetarily or otherwise;

(C)The Participant’s conviction or plea of guilty or nolo contendere to a felony:
1



(D)The Participant’s material violation of the Company’s Code of Business Conduct and Ethics;

(E)The Participant’s commission of an act of theft, fraud or dishonesty against the Company, any Affiliate or any Subsidiary;

(F)The Participant’s noncompliance with any restrictive covenant applicable to the Participant; or

(G)The Participant’s material breach or violation of the terms of any agreement to which Participant and the Company, or any Subsidiary or Affiliate are party.

1.5“Code” means the United States Internal Revenue Code of 1986, as amended, and any successors thereto.

1.6“Committee” means the Compensation Committee of the Board or any other committee appointed by the Board to perform the functions of the Compensation and Benefits Committee.

1.7“Company” means Innovid, Inc., a Delaware corporation, or any successor thereto as provided in Article VI herein.

1.8“Continuation of Benefits Period” means, subject to adjustment by the Company’s Chief Executive Officer in his discretion, the number of months (as disclosed in Attachment A or as set forth in a Participation Letter) used to calculate a Participant’s lump sum payment, in lieu of continuation of the Participant’s benefits following a Qualifying Termination.

1.9“Disability” means “permanent and total disability” within the meaning of Code Section 22(e)(3).

1.10“Effective Date” means the date of this Plan set forth above.

1.11“Effective Date of Termination” means the effective date of a Participant’s termination of employment with the Company, all Subsidiaries and Affiliates, regardless of reason.

1.12“Notice of Termination” shall mean a written notice which shall indicate the specific termination provision in this Plan relied upon, and shall set forth in reasonable detail the facts and circumstances claimed to provide a basis for termination of the Participant’s employment under the provision so indicated.

1.13“Participation Letter” means a letter delivered to a Participant acknowledging his or her participation in the Plan in substantially the form shown as Attachment B hereto, as such form may be amended, modified or supplemented from time to time.

1.14“Qualifying Termination” means the involuntary termination of the Participant’s employment by the Company for reasons other than Cause pursuant to a Notice of Termination delivered to the Participant by the Company. A termination of Participant’s employment by reason of Disability shall not be considered a Qualifying Termination

2


1.15“Severance Benefits” means the severance benefits and compensation payable to a Participant under Sections 3.3(A) and (B) herein, subject to adjustment in accordance with Section 4.2.

1.16“Subsidiary” means any corporation or other entity, whether domestic or foreign, in which the Company has or obtains, directly or indirectly, ownership of more than fifty percent (50%) of the total combined voting power of all classes of stock.

ARTICLE III. Participation and Severance Benefits

1.1Participation. Upon the Board’s designation of an employee as a Participant, such employee shall be provided a Participation Letter and shall become a Participant in the Plan.

1.2Termination of Participation. A Participant shall cease to be a Participant in the Plan and therefore shall cease to be eligible to receive Severance Benefits under the Plan upon the occurrence of any one of the following circumstances, subject as applicable to Article VII:

(A)The Participant’s employment with the Company ends due to death or Disability;

(B)The Company terminates the Participant’s employment for Cause:

(C)The Company terminates the Participant’s Participation Letter; or

(D)The Company terminates the Plan.

1.3Severance Benefits Payable upon a Qualifying Termination. If a Participant has incurred a Qualifying Termination, the Company shall pay to the Participant: (i) a cash lump sum equal to the Participant’s Accrued Obligation within sixty (60) days of such Qualifying Termination and (ii) the following Severance Benefits, with the payment or provision of such Severance Benefits conditioned upon the Participant’s compliance with Section 3.7:

(A)Cash Severance. A cash lump sum payment equal to the product of (i) the Participant’s Base Salary and (ii) the Participant’s Severance Multiple as set forth in Attachment A or as set forth in a Participation Letter, with such payment made no later than the sixtieth (60th) day following the Participant’s Effective Date of Termination.

(B)Medical and Life Insurance Benefits. A cash lump sum payment equal to the product of
(i) the Participant’s Benefits Continuation Period and (ii) 105% of the monthly premium paid by the Company for the Participant’s medical, dental, optical and group term-life insurance coverage in effect on the Participant’s Effective Date of Termination, with such payment made no later than the sixtieth (60th) day following the Participant’s Effective Date of Termination. For purposes of calculating this amount, the monthly premium shall be based on the same coverage level as in effect immediately prior to Participant’s Effective Date of Termination.

1.4Termination due to Disability. If the Participant’s employment is terminated due to Disability, the Company shall pay the Participant (i) a cash lump sum equal to the Participant’s Accrued Obligations within sixty (60) days of such termination and (ii) any other payments or benefits the Participant may be entitled to under the Company’s disability, retirement, insurance, and other applicable plans and programs then in effect and in accordance with their terms. In addition, such
3


Participant shall not be entitled to the Severance Benefits described in Section 3.3 and the Company shall have no further obligations to the Participant under this Plan.

1.5Termination due to Death. If a Participant’s employment is terminated due to death, the Company shall pay the Participant’s estate, beneficiary or other designated legal representative (i) a cash lump sum equal to the Participant’s Accrued Obligations within sixty (60) days of the Participant’s death and (ii) any other payments or benefits the Participant may be entitled to under the Company’s disability, retirement, insurance, and other applicable plans and programs then in effect and in accordance with their terms. In addition, such Participant shall not be entitled to Severance Benefits described in Section 3.3 and the Company shall have no further obligations to the Participant under this Plan.

1.6Termination for Cause or Voluntary Termination. If a Participant’s employment is terminated by the Company for Cause or voluntarily terminated by the Participant, the Company shall pay the Participant (i) a cash lump sum equal to the Participant’s Accrued Obligations within sixty (60) days of such termination and (ii) any other payments or benefits the Participant may be entitled to under the Company’s disability, retirement, insurance, and other applicable plans and programs then in effect and in accordance with their terms. In addition, such Participant shall not be entitled to Severance Benefits described in Section 3.3 and the Company shall have no further obligations to the Participant under this Plan.

1.7Release and Waiver of Claims. The payment of Severance Benefits pursuant to Section 3.3 to a Participant, is conditioned upon the Participant’s execution (and not revocation) of a release of claims in favor of the Company (and its current and former directors, officers, employees, agents, stockholders, etc.) substantially in a form acceptable to the Company (the “Release”), and the Release becomes effective and irrevocable prior to the sixtieth (60th) day following the Participant’s Effective Date of Termination. If (i) the Release does not become effective and irrevocable prior to the sixtieth (60th) day following the Participant’s Effective Date of Termination or if the Participant otherwise fails to comply with this Section 3.7, (ii) the Participant revokes all or any portion of the Release within any applicable revocation period or (iii) otherwise fails to comply with the requirements of this Section 3.7, the Company shall have no obligation to pay or provide any Severance Benefits to the Participant under Section 3.3.

ARTICLE IV. Reduction in Severance Benefits; No Duplication

1.1Other Arrangements. It is the express intent of the Company that the Severance Benefits provided hereunder shall not duplicate any severance, notice, termination or similar payments or benefits that may be provided to a Participant under any other agreement, plan or arrangement of the Company or that may be required to be provided to a Participant under any applicable law or regulation (collectively, “Other Severance”). Therefore, notwithstanding any provision herein to the contrary, the Severance Benefits payable hereunder shall be reduced (on a dollar for dollar basis) by the amount of such Other Severance, such that a Participant who is entitled to receive Severance Benefits hereunder receives, in the aggregate, not more than the amount of Severance Benefits that would be provided hereunder if there were no arrangements providing for any Other Severance. Any such reduction in Severance Benefits provided hereunder shall be implemented in such manner as is determined by the Company in compliance with all applicable laws, including Section 409A of the Code, if applicable, without changing the time or form of payment of any Other Severance.

4


1.2Discretionary Adjustments. Notwithstanding any provision herein to the contrary, except with respect to the Company’s Chief Executive Officer, payment of any Severance Benefits to any Participant is subject to the prior approval of the Company’s Chief Executive Officer or his delegate and the Company’s Chief Executive Officer may, in his sole discretion, reduce, enhance or eliminate the amount of any Severance Benefits that may be provided to a Participant hereunder, taking into account such facts, circumstances and considerations as may be deemed relevant at the time of the Participant’s Qualifying Termination. All determinations of the Company’s Chief Executive Officer hereunder shall be final and binding on all Participants.

1.3No Duplication of Benefits Provided under Change in Control Plan. In no event will any benefits be provided under this Plan if the Participant receives any benefits under the Innovid, Inc. Executive Change in Control Severance Plan or any successor plan thereto.

ARTICLE V. Restrictive Covenants

1.1Forfeiture and Clawback. Any entitlement of a Participant to Severance Benefits hereunder is expressly conditioned on the Participant’s continued compliance with any non-competition, non-solicitation, confidentiality, non-disparagement, assignment of inventions or other restrictive covenants to which such Participant is subject (“Restrictive Covenants”). In the event a Participant breaches or otherwise fails to comply with any such Restrictive Covenants, Participant (i) shall forfeit any unpaid portion of the payments or benefits provided pursuant to this Plan and/or (ii) shall repay to the Company any amounts previously paid to the Participant pursuant to this Plan.

ARTICLE VI. Successors and Assignment

1.1Successors to the Company. The Company will require any successor (whether direct or indirect, by purchase, merger, consolidation, or otherwise) of all or substantially all of the business and/or assets of the Company or of any division or subsidiary thereof to expressly assume and agree to perform the Company’s obligations under this Plan in the same manner and to the same extent that the Company would be required to perform them if no such succession had taken place.

1.2Assignment by the Participant. This Plan shall inure to the benefit of and be enforceable by the Participant’s personal or legal representatives, executors, administrators, successors, heirs, distributees, devisees and legatees. If the Participant dies while any amounts would still be payable to the Participant under the Plan had the Participant continued to live, all such amounts, unless otherwise provided herein, shall be paid in accordance with the terms of this Plan to the Participant’s Beneficiary. If the Participant has not named a Beneficiary, then such amounts shall be paid to the Participant’s devisee, legatee, or other designee, or if there is no such designee, to the Participant’s estate.

ARTICLE VII. Termination and Amendment

1.1Amendment and Termination of the Plan. Subject to Section 7.2, the Board of Directors may terminate or amend the Plan or any outstanding Participation Letter at any time.

1.2Participant Rights. Notwithstanding any provision of the Plan to the contrary, no termination or amendment of the Plan or any outstanding Participation Letter made after the Participant incurs a Qualifying Termination may have the effect of reducing or otherwise impairing the rights and
5


benefits of such Participant under the Plan or the Participant’s Participation Letter, without the Participant’s written consent.

ARTICLE VIII. Miscellaneous
1.1Withholding of Taxes. The Company shall be entitled to withhold from any amounts payable under this Plan, all taxes as legally shall be required (including, without limitation, any United States federal taxes, any other state, city, or local taxes). The Company, its Subsidiaries and Affiliates shall have the power to deduct or withhold from any amounts payable under the Plan, or require the Participant to remit to the Company, its Subsidiaries or its Affiliates, any amount deemed sufficient to satisfy U.S. Federal, state, local and non-U.S. tax withholding requirements, as deemed necessary or appropriate by the Company.

1.2Unfunded Status. The Plan shall be unfunded and all costs of the Plan shall be paid from the Company’s general assets. Neither the Company nor the Board shall be required to segregate any assets that may at any time be represented by benefits under the Plan. Neither the Company nor the Board shall be deemed to be a trustee of any amounts to be paid under the Plan. Any liability of the Company to any Participant with respect to any benefit shall be based solely upon any contractual obligations created by the Plan and the Participation Letter; no such obligation shall be deemed to be secured by any pledge or any encumbrance on any property of the Company.

1.3No Mitigation. The Participant shall not be obligated to seek other employment in mitigation of the amounts payable or arrangements made under any provision of this Plan, and the obtaining of any such other employment shall in no event effect any reduction of the Company’s obligations to make the payments and arrangements required to be made under this Plan.

1.4Employment Status. Except as may be provided under any other agreement between the Participant and the Company, the employment of the Participant by the Company is “at will” and may be terminated by either the Participant or the Company at any time, subject to applicable law.

1.5Beneficiaries. The Participant may designate one or more persons or entities as the primary and/or contingent Beneficiaries of any Severance Benefits owing to the Participant under this Plan. Such designation must be in the form of a signed writing acceptable to the Committee. The Participant may make or change such designations at any time.

1.6Severability. In the event any provision of this Plan shall be held illegal or invalid for any reason, the illegality or invalidity shall not affect the remaining parts of the Plan, and the Plan shall be construed and enforced as if the illegal or invalid provision had not been included. Further, the captions of this Plan are not part of the provisions hereof and shall have no force and effect.

1.7Applicable Law. To the extent not preempted by the laws of the United States, the laws of the state of New York shall be the controlling law in all matters relating to this Plan.

1.8Code Section 409A. The Severance Benefits and other benefits under this Plan are intended to comply with Section 409A of the Code or to otherwise be exempt therefrom.

(A)Notwithstanding anything herein to the contrary, if the Participant is a “specified employee” as determined pursuant to Section 409A of the Code as of the date of the
6


Participant’s “separation from service” (within the meaning of Treas. Reg. 1.409A-1(h)) and if any Severance Benefits or other payment or benefit provided for in this Plan or otherwise both (i) constitutes a “deferral of compensation” within the meaning of Section 409A of the Code and (ii) cannot be paid or provided in the manner otherwise provided without subjecting the Participant to “additional tax”, interest or penalties under Section 409A of the Code, then any such Severance Benefits or other payment or benefit that is payable during the first six (6) months following the Participant’s “separation from service” shall be paid or provided to the Participant in a cash lump sum on the first (1st) business day of the seventh (7th) calendar month following the month in which the Participant’s “separation from service” occurs. Any payment or benefit due upon a termination of the Participant’s employment that represents a “deferral of compensation” within the meaning of Section 409A shall only be paid or provided to the Participant upon a “separation from service.”

(B)Notwithstanding anything to the contrary in Section 3.3 of this Plan or elsewhere, any payment or benefit under Section 3.3 or otherwise that is exempt from Section 409A pursuant to Treas. Reg. 1.409A-1 (b)(9)(v)(A) or (C) shall be paid or provided to the Participant only to the extent that the expenses are not incurred, or the benefits are not provided, beyond the last day of the second (2nd) taxable year of the Participant following the taxable year of the Participant in which the “separation from service” occurs; and provided further that such expenses are reimbursed no later than the last day of the third (3rd) taxable year following the taxable year of the Participant in which the “separation from service” occurs.

(C)To the extent any expense reimbursement or the provision of any in-kind benefit under this Plan is determined to be subject to Section 409A of the Code, the amount of any such expenses eligible for reimbursement, or the provision of any in-kind benefit, in one calendar year shall not affect the expenses eligible for reimbursement in any other taxable year (except for any life-time or other aggregate limitation applicable to medical expenses), in no event shall any expenses be reimbursed after the last day of the calendar year following the calendar year in which the Participant incurred such expenses, and in no event shall any right to reimbursement or the provision of any in-kind benefit be subject to liquidation or exchange for another benefit. For the purposes of this Plan, each payment made pursuant to Section 3.3 shall be deemed to be separate payments, amounts payable under Section 3.3 of this Plan shall be deemed not to be a “deferral of compensation” subject to Section 409A of the Code to the extent provided in the exceptions in Treas. Reg. Sections 1.409A-1(b)(4) (“short-term deferrals”) and (b)(9) (“separation pay plans,” including the exception under subparagraph (iii)) and other applicable provisions of Treas. Reg. Section 1.409A-1 through A-6.

(D)In no event may a Participant, directly or indirectly, designate the calendar year of any payment under this Plan, and to the extent required by Section 409A of the Code, any payment that may be paid in more than one taxable year (depending on the time that Participant executes the Release Agreement) shall be paid in the later taxable year.


7


ATTACHMENT A
INNOVID, INC.
EXECUTIVE SEVERANCE PLAN
Participant NameTitleSeverance MultipleBenefits Continuation Period
(# of months)
Zvika NetterChief Executive Officer1.0x12
Tanya Andreev-KaspinChief Financial Officer0.5x6
Tim BrazExecutive Vice President, Global Sales 0.5x6
Guy KupermanChief Strategy Officer0.5x6
Dale OlderChief Product Officer0.5x6
Ken MarkusChief Operating Officer0.5x6
Tal ChalozinChief Technology Officer0.5x6
Liel GolanExecutive Vice President, Human Resources0.5x6
Yuval PemperChief Engineering Officer0.5x6
Michal LivnyExecutive Vice President, People Operations, EMEA & APAC0.5x6
Stephen CookGeneral Counsel 0.5x6
David HelmreichChief Commercial Officer0.5x6


8


ATTACHMENT B

INNOVID, INC.
EXECUTIVE SEVERANCE PLAN

FORM OF PARTICIPATION LETTER

We are pleased to inform you that you have been designated as a Participant in the Innovid, Inc. (“Company”) Executive Severance Plan (the “Plan”). Your participation in the Plan is subject to the terms and conditions of the Plan. A copy of the Plan is attached hereto as Annex A and is incorporated herein and deemed to be part of this Participation Letter for all purposes. Unless otherwise defined herein, capitalized terms used in this Participation Letter shall have the meanings set forth in the Plan.
Pursuant to your participation in the Plan, you are eligible to receive Severance Benefits in accordance with and subject to the terms of the Plan.
Please understand that the Plan and this Participation Letter supersede all prior severance benefit policies, plans and arrangements of the Company, if any, with the intent that, to the maximum extent permitted by law, any such prior policies, plans, arrangements and communications are null and void and of no further force and effect with respect to your participation therein.
Please further understand that your participation in the Plan is subject to your continued compliance with all Restrictive Covenants pursuant to all agreements and arrangements between you and the Company and its subsidiaries. In the event you do not comply with any such Restrictive Covenants, you will not be eligible for any Severance Benefits under the Plan. Severance Benefits, if any, are also subject to the execution and non-revocation of a release of claims upon any Qualifying Termination, as set forth in the Plan.
Thank you for your service to the Company.

INNOVID, INC.
By:___________________________________
Printed Name:__________________________
Title:__________________________________
Date:_________________________________

9

 EX-10.20 5 a1020executivechangeinctrl.htm EX-10.20 Document

Innovid, Inc.
Executive Change in Control Severance Plan
ARTICLE I. Establishment, Term, and Purpose

1.1Establishment of the Plan. Innovid, Inc. (the “Company”) hereby establishes a severance plan for key executives, to be known as the Innovid, Inc. Executive Change in Control Severance Plan (the “Plan”).

1.2Plan Participants. The Plan provides Severance Benefits (as described below) to certain employees of the Company, its Subsidiaries and Affiliates who incur a Qualifying Termination (as defined below) and who are listed in Attachment A or who have received a Participation Lettter shown on Attachment B (as it may be amended from time to time) (each a “Participant”).

1.3Purpose of Plan. The purpose of this Plan is to assure the Company that it will have the continued dedication of, and the availability of objective advice and counsel from, key executives of the Company notwithstanding the possibility, threat, or occurrence of a change of control of the Company. In the event the Company receives any proposal from a third party concerning a possible business combination with the Company, or acquisition of the Company’s equity securities, or otherwise considers or pursues a transaction that could lead to a change of control, the Board of Directors of the Company (“Board”) believes it imperative that the Company and the Board be able to rely upon key executives to continue in their positions and be available for advice, if requested, without concern that those individuals might be distracted by the personal uncertainties and risks created by such circumstances. Should the Company receive or consider any such proposal or transaction, in addition to their regular duties, such key executives may be called upon to assist in the assessment of the proposal or transaction, to advise management and the Board as to whether the proposal or transaction would be in the best interest of the Company and its stockholders, and to take such other actions as the Board might determine to be appropriate.

1.4Effective Date. The Plan shall become effective (the “Effective Date”) on the date on which any equity securities of the Company (or any affiliate or successor) are first listed on a national securities exchange.

ARTICLE II: Definitions

Whenever used in this Plan, the following terms shall have the meanings set forth below and, when the meaning is intended, the initial letter of the word is capitalized.
1.1“Accrued Obligation” means an amount equal to the Participant’s accrued and unpaid Base Salary and, to the extent provided for under applicable law or the applicable policies of the Company in effect from time to time, earned but not taken vacation pay through the Participant’s Effective Date of Termination.

1.2“Affiliate” means any entity that, directly or indirectly, controls, is controlled by, or is under common control with, the Company.

1.3“Base Salary” means the annual rate of base salary paid by the Company, a Subsidiary or Affiliate to a Participant (including amounts that the Participant could have received in cash had he or she not elected to contribute to an employee benefit plan or a deferred compensation program
1


maintained by the Company, any Subsidiary or Affiliate). For purposes of the Plan, Base Salary shall mean the higher of (i) the Participant’s Base Salary as in effect immediately prior to the Change in Control and (ii) the Participant’s highest Base Salary in effect at any time thereafter (without regard to any material reduction in such Base Salary giving rise to Good Reason).

1.4“Beneficial Owner” shall have the meaning ascribed to such term in Rule 13d-3 of the General Rules and Regulations under the Exchange Act.

1.5“Beneficiary” means the persons or entities designated or deemed designated by the Participant pursuant to Section 7.2.

1.6“Cause” means:

(A)The Participant’s willful and continued failure to substantially perform his/her duties with the Company (other than any such failure resulting from Disability), after a written demand for substantial performance is delivered to the Participant that specifically identifies the manner in which the Company believes that the Participant has willfully failed to substantially perform his/her duties, and after the Participant has failed to resume substantial performance of his/her duties on a continuous basis within thirty (30) calendar days of receiving such demand;

(B)The Participant’s willfully engaging in conduct which is demonstrably and materially injurious to the Company, monetarily or otherwise;

(C)The Participant’s conviction or plea of guilty or nolo contendere to a felony:

(D)The Participant’s material violation of the Company’s Code of Business Conduct and Ethics;

(E)The Participant’s commission of an act of theft, fraud or dishonesty against the Company, any Affiliate or any Subsidiary;

(F)The Participant’s material breach or violation of the terms of any agreement to which Participant and the Company, or any Subsidiary or Affiliate are party.

1.7“Change in Control” means any of the following events:

(A)A transaction or series of transactions (other than an offering of equity securities to the general public through a registration statement filed with the Securities and Exchange Commission or a transaction or series of transactions that meets the requirements of clauses (i) and (ii) of subsection (c) below) whereby any “person” or related “group” of “persons” (as such terms are used in Sections 13(d) and 14(d)(2) of the Exchange Act) (other than the Company, any of its Subsidiaries, an employee benefit plan maintained by the Company or any of its Subsidiaries or a “person” that, prior to such transaction or series of transactions, directly or indirectly controls, is controlled by, or is under common control with, the Company) directly or indirectly acquires beneficial ownership (within the meaning of Rule 13d-3 under the Exchange Act) of securities of the Company possessing more than 50% of the total combined voting power of the Company’s securities outstanding immediately after such acquisition; or
2


(B)During any period of two consecutive years, individuals who, at the beginning of such period, constitute the Board together with any new director(s) (other than a director designated by a person who shall have entered into an agreement with the Company to effect a transaction described in subsections (a) or (c)) whose election by the Board or nomination for election by the Company’s shareholders was approved by a vote of at least two-thirds of the directors then still in office who either were Directors at the beginning of the two-year period or whose election or nomination for election was previously so approved, cease for any reason to constitute a majority thereof; or
(C)The consummation by the Company (whether directly involving the Company or indirectly involving the Company through one or more intermediaries) of (x) a merger, consolidation, reorganization, or business combination, (y) a sale or other disposition of all or substantially all of the Company’s assets in any single transaction or series of related transactions or (z) the acquisition of assets or stock of another entity, in each case other than a transaction:
(i)which results in the Company’s voting securities outstanding immediately before the transaction continuing to represent (either by remaining outstanding or by being converted into voting securities of the Company or the person that, as a result of the transaction, controls, directly or indirectly, the Company or owns, directly or indirectly, all or substantially all of the Company’s assets or otherwise succeeds to the business of the Company (the Company or such person, the “Successor Entity”)) directly or indirectly, at least a majority of the combined voting power of the Successor Entity’s outstanding voting securities immediately after the transaction, and
(ii)after which no person or group beneficially owns voting securities representing 50% or more of the combined voting power of the Successor Entity; provided, however, that no person or group shall be treated for purposes of this clause (ii) as beneficially owning 50% or more of the total combined voting power of the Successor Entity solely as a result of the voting power held in the Company prior to the consummation of the transaction.
Notwithstanding anything in this Plan to the contrary, to the extent any provision of this Plan would cause a payment or benefit not exempt from the requirements of Code Section 409A to be made because of the occurrence of a Change in Control, then such payment or benefit shall not be made unless such Change in Control also constitutes a “change in ownership”, “change in effective control” or “change in ownership of a substantial portion of the Company’s assets” within the meaning of Code Section 409A. Further, in no event shall a Change in Control be deemed to have occurred in connection with a business combination transaction involving the Company and any special purpose acquisition company or similar entity.
1.8“Code” means the United States Internal Revenue Code of 1986, as amended, and any successors thereto.

1.9“Committee” means the Compensation Committee of the Board or any other committee appointed by the Board to perform the functions of the Compensation and Benefits Committee.

1.10“Company” means Innovid, Inc., a Delaware corporation, or any successor thereto as provided in Article VIII herein.

1.11“Continuation of Benefits Period” means the number of months (as disclosed in Attachment A or as set forth in a Participation Letter) used to calculate a Participant’s lump sum payment, in lieu of continuation of the Participant’s benefits following a Qualifying Termination.

1.12“Disability” means “permanent and total disability” within the meaning of Code Section 22(e)(3).

1.13“Effective Date” means the date of this Plan set forth above.

3


1.14“Effective Date of Termination” means the effective date of a Participant’s termination of employment with the Company, all Subsidiaries and Affiliates, regardless of reason.

1.15“Exchange Act” means the United States Securities Exchange Act of 1934, as amended.

1.16“Good Reason” means, without the Participant’s express written consent, the occurrence of any one or more of the following:

(A)The assignment of the Participant to duties materially inconsistent with the Participant’s authorities, duties, responsibilities, and status (including offices and reporting requirements) as an employee of the Company, or a material reduction or alteration in the nature or status of the Participant’s authorities, duties, or responsibilities relative to those in effect immediately preceding the Change in Control;

(B)The Company’s requiring the Participant to be based at a location which is at least fifty (50) miles further from the Participant’s current primary residence than is such residence from the Company’s current headquarters, except for required travel related to the Company’s business to an extent substantially consistent with the Participant’s business obligations as of the Effective Date;

(C)A material reduction in the Participant’s Base Salary or Target Bonus as in effect at the time of the Change in Control;

(D)The failure of the Company to obtain a satisfactory agreement from any successor to the Company to assume and agree to perform this Plan, as contemplated in Section 7.1 herein;

(E)Any material breach of any of the terms of the Plan by the Company or any successor entity; or

(F)Any termination of the Participant’s employment by the Company that is not effected pursuant to a Notice of Termination.
For purposes of this Plan, the Participant shall not be entitled to assert that a termination is for Good Reason unless (i) the Participant gives the Board written notice of the event or events which are the basis for such assertion within ninety (90) days after the event or events occur (“Event Date”), (ii) the Company has not cured or fully remedied such event or events within thirty (30) days after receiving such written notice and (iii) the Participant’s Effective Date of Termination is no later than one-hundred twenty (120) days after the Event Date.
1.17“Notice of Termination” shall mean a written notice which shall indicate the specific termination provision in this Plan relied upon, and shall set forth in reasonable detail the facts and circumstances claimed to provide a basis for termination of the Participant’s employment under the provision so indicated.

1.18“Participation Letter” means a letter delivered to a Participant acknowledging his or her participation in the Plan.

1.19“Qualifying Termination” means the occurrence of any one of the following events:
4



(A)An involuntary termination of the Participant’s employment by the Company for reasons other than Cause within twenty-four (24) months following a Change in Control pursuant to a Notice of Termination delivered to the Participant by the Company; or

(B)A voluntary termination by the Participant for Good Reason within twenty-four (24) months following a Change in Control pursuant to a Notice of Termination delivered to the Company by the Participant.

1.20“Severance Benefits” means the severance benefits and compensation payable to a Participant under Sections 3.3(A), (B) and (C) herein.

1.21“Subsidiary” means any corporation or other entity, whether domestic or foreign, in which the Company has or obtains, directly or indirectly, ownership of more than fifty percent (50%) of the total combined voting power of all classes of stock.

1.22“Target Bonus” means the Participant’s annual bonus opportunity, assuming the achievement of target performance under any Company-maintained annual incentive plan in effect on the date of the Participant’s Qualified Termination of Employment or, if greater, in effect on the date of a Change in Control; provided, however, if the Participant’s annual bonus is discretionary, then the Participant’s Target Bonus shall be deemed equal to the average of the Participant’s last three annual bonuses (or lesser number of annual bonuses for which Participant has been eligible if employed for less than three full years).

ARTICLE III. Participation and Severance Benefits

1.1Participation. Upon the Board’s designation of an employee as a Participant, such employee shall be offered a Participation Letter and such employee shall become a Participant in the Plan.

1.2Termination of Participation. A Participant shall cease to be a Participant in the Plan and therefore shall cease to be eligible to receive Severance Benefits under the Plan upon the occurrence of any one of the following circumstances, subject as applicable to Article VIII:

(A)The Participant’s employment with the Company ends due to death or Disability;

(B)The Participant voluntarily terminates employment with the Company without Good Reason;

(C)The Company terminates the Participant’s employment for Cause;

(D)The Company terminates the Participant’s Participation Letter; or

(E)The Company terminates the Plan in accordance with the terms hereof.

1.3Severance Benefits Payable upon a Qualifying Termination. If a Participant has incurred a Qualifying Termination, the Company shall pay to the Participant: (i) a cash lump sum equal to the Participant’s Accrued Obligation within sixty (60) days of such Qualifying Termination and (ii) the following Severance Benefits, with the payment or provision of such Severance Benefits conditioned upon the Participant’s compliance with Section 3.7:
5



(A)Cash Severance. A cash lump sum payment equal to the product of (i) the sum of the Participant’s Base Salary and Target Bonus and (ii) the Participant’s Severance Multiple as set forth in Attachment A (or as provided under a Participation Letter), with such payment made no later than the sixtieth (60th) day following the Participant’s Effective Date of Termination.

(B)Pro Rata Target Bonus. A cash lump sum payment equal to the Participant’s Target Bonus, adjusted on a pro rata basis based on the number of days Participant was actually employed during the applicable annual performance period in which Participant incurred a Qualifying Termination, with such payment made no later than the sixtieth (60th) day following the Participant’s Effective Date of Termination.

(C)Medical and Life Insurance Benefits. A cash lump sum payment equal to the product of
(i) the Participant’s Benefits Continuation Period and (ii) 105% of the monthly premium paid by the Company for the Participant’s medical, dental, optical and group term-life insurance coverage in effect on the Participant’s Effective Date of Termination, with such payment made no later than the sixtieth (60th) day following the Participant’s Effective Date of Termination. For purposes of calculating this amount, the monthly premium shall be based on the same coverage level as in effect immediately prior to Participant’s Effective Date of Termination.

(D)Vesting of Outstanding Equity Awards. All of the Participant’s outstanding and unvested equity or equity-based awards that were granted prior to the date of the Change in Control shall become immediately 100% vested, provided, that, unless a provision more favorable to the Participant is included in an applicable award agreement, any such awards that are subject to performance-based vesting conditions shall only be payable subject to the attainment of the performance measures for the applicable performance period as provided under the terms of the applicable award agreement.

1.4Termination due to Disability. If the Participant’s employment is terminated due to Disability upon or following a Change in Control, the Company shall pay the Participant (i) a cash lump sum equal to the Participant’s Accrued Obligations within sixty (60) days of such termination and (ii) any other payments or benefits the Participant may be entitled to under the Company’s disability, retirement, insurance, and other applicable plans and programs then in effect and in accordance with their terms. In addition, such Participant shall not be entitled to the Severance Benefits described in Section 3.3 and the Company shall have no further obligations to the Participant under this Plan.

1.5Termination due to Death. If a Participant’s employment is terminated due to death upon or following a Change in Control, the Company shall pay the Participant’s estate, beneficiary or other designated legal representative (i) a cash lump sum equal to the Participant’s Accrued Obligations within sixty (60) days of the Participant’s death and (ii) any other payments or benefits the Participant may be entitled to under the Company’s disability, retirement, insurance, and other applicable plans and programs then in effect and in accordance with their terms. In addition, such Participant shall not be entitled to Severance Benefits described in Section 3.3 and the Company shall have no further obligations to the Participant under this Plan.

6


1.6Termination for Cause or Voluntary Termination Other Than for Good Reason. If a Participant’s employment is terminated by the Company for Cause or by the Participant other than for Good Reason upon or following a Change in Control, the Company shall pay the Participant (i) a cash lump sum equal to the Participant’s Accrued Obligations within sixty (60) days of such termination and (ii) any other payments or benefits the Participant may be entitled to under the Company’s disability, retirement, insurance, and other applicable plans and programs then in effect and in accordance with their terms. In addition, such Participant shall not be entitled to Severance Benefits described in Section 3.3 and the Company shall have no further obligations to the Participant under this Plan.

1.7Release and Waiver of Claims. The payment of Severance Benefits pursuant to Section 3.3 to a Participant, is conditioned upon the Participant’s execution (and not revocation) of a customary release of claims in favor of the Company (and its current and former directors, officers, employees, agents, stockholders, etc.) substantially in a form reasonably acceptable to the Company (the “Release”), and the Release becomes effective and irrevocable prior to the sixtieth (60th) day following the Participant’s Effective Date of Termination. If (i) the Release does not become effective and irrevocable prior to the sixtieth (60th) day following the Participant’s Effective Date of Termination or if the Participant otherwise fails to comply with this Section 3.7, (ii) the Participant revokes all or any portion of the Release within any applicable revocation period or (iii) otherwise fails to comply with the requirements of this Section 3.7, the Company shall have no obligation to pay or provide any Severance Benefits to the Participant under Section 3.3. The Release shall not include any additional Restrictive Covenants, cooperation obligations or other affirmative obligations of Participant and shall not require Participant to release any claims with respect to Participant’s vested equity securities in the Company (including in respect of any equity securities that vest in connection with the Qualifying Termination).

ARTICLE IV. Excise Tax Equalization Payment

1.1280G Net-Better Cut Back. Notwithstanding anything in this Plan to the contrary, in the event it shall be determined that (i) any payment, award, benefit or distribution (or any acceleration of any payment, award, benefit or distribution) by the Company (or any of its affiliated entities) or any entity which effectuates a Change in Control (or any of its affiliated entities) to or for the benefit of the Participant (whether pursuant to the terms of this Plan or otherwise) (the “Payment” or “Payments”) would be subject to the excise tax imposed by Section 4999 of the Code (the “Excise Tax”), and (ii) the reduction of the amounts payable to the Participant under this Plan to the maximum amount that could be paid to the Participant without giving rise to the Excise Tax (the “Safe Harbor Cap”) would provide the Participant with a greater after tax amount than if such amounts were not reduced, then the amounts payable to the Participant under this Plan shall be reduced (but not below zero) to the Safe Harbor Cap. The reduction of the amounts payable hereunder, if applicable, shall be made by reducing first the payments under Section 3.3(A), then the payments under Section 3.3(B) and then the payments under Section 3.3(C). For purposes of reducing the Payments to the Safe Harbor Cap, only amounts payable under this Plan (and no other Payments) shall be reduced. If the reduction of the amounts payable hereunder would not result in a greater after tax result to the Participant, no amounts payable under this Plan shall be reduced pursuant to this provision.

1.2Determination by Accounting Firm. All determinations required to be made under this Article IV shall be made by the public accounting firm that is retained by the Company as of the date immediately prior to the Change in Control (the “Accounting Firm”) which shall provide detailed
7


supporting calculations both to the Company and the Participant within fifteen (15) business days of the receipt of notice from the Company or the Participant that there has been a Payment, or such earlier time as is requested by the Company. Notwithstanding the foregoing, in the event (i) the Board shall determine prior to the Change in Control that the Accounting Firm is precluded from performing such services under applicable auditor independence rules or (ii) the Audit Committee of the Board determines that it does not want the Accounting Firm to perform such services because of auditor independence concerns or (iii) the Accounting Firm is serving as accountant or auditor for the individual, entity or group effecting the Change in Control, the Board shall appoint another nationally recognized public accounting firm to make the determinations required hereunder (which accounting firm shall then be referred to as the Accounting Firm hereunder). If payments are reduced to the Safe Harbor Cap, the Accounting Firm shall provide a reasonable opinion to the Participant that he or she is not required to report any Excise Tax on his or her federal income tax return. All fees, costs and expenses (including, but not limited to, the costs of retaining experts) of the Accounting Firm shall be borne by the Company. If the Accounting Firm determines that no Excise Tax is payable by the Participant, it shall furnish the Participant with a written opinion to such effect, and to the effect that failure to report the Excise Tax, if any, on the Participant’s applicable federal income tax return will not result in the imposition of a negligence or similar penalty. In the event the Accounting Firm determines that the Payments shall be reduced to the Safe Harbor Cap, it shall furnish the Participant with a written opinion to such effect. The determination by the Accounting Firm shall be binding upon the Company and the Participant (except as provided in Section 4.3).

1.3Subsequent Recalculation. In the event the Internal Revenue Service adjusts the tax computations made by the Accounting Firm under Section 4.2 so that the Participant did not receive the greatest net benefit, the Company shall reimburse the Participant for the full amount necessary to make the Participant whole, plus a market rate of interest, as determined by the Committee, within thirty (30) days after such adjustment.

ARTICLE V. Reduction in Severance Benefits; No Duplication

1.1Other Arrangements. It is the express intent of the Company that the Severance Benefits provided hereunder shall not duplicate any severance, notice, termination or similar payments or benefits that may be provided to a Participant under any other agreement, plan or arrangement of the Company or that may be required to be provided to a Participant under any applicable law or regulation (collectively, “Other Severance”). Therefore, notwithstanding any provision herein to the contrary, the Severance Benefits payable hereunder shall be reduced (on a dollar for dollar basis) by the amount of such Other Severance, such that a Participant who is entitled to receive Severance Benefits hereunder receives, in the aggregate, not more than the amount of Severance Benefits that would be provided hereunder if there were no arrangements providing for any Other Severance. Any such reduction in Severance Benefits provided hereunder shall be implemented in such manner as is determined by the Company in compliance with all applicable laws, including Section 409A of the Code, if applicable, without changing the time or form of payment of any Other Severance.

1.2No Duplication of Benefits Provided under Severance Plan. In the event the Participant receives Severance Benefits under this Plan, Participant will not receive any benefits under the Innovid, Inc. Executive Severance Plan.

ARTICLE VI. Restrictive Covenants
8



1.1Forfeiture and Clawback. Any entitlement of a Participant to Severance Benefits hereunder is expressly conditioned on the Participant’s continued compliance with any non-competition, non-solicitation, confidentiality, non-disparagement, assignment of inventions or other restrictive covenants to which such Participant is subject (“Restrictive Covenants”). In the event a Participant breaches or otherwise fails to comply with any such Restrictive Covenants, Participant (i) shall forfeit any unpaid portion of the payments or benefits provided pursuant to this Plan and/or (ii) shall repay to the Company any amounts previously paid to the Participant pursuant to this Plan.

ARTICLE VII. Successors and Assignment

1.1Successors to the Company. The Company will require any successor (whether direct or indirect, by purchase, merger, consolidation, or otherwise) of all or substantially all of the business and/or assets of the Company or of any division or subsidiary thereof to expressly assume and agree to perform the Company’s obligations under this Plan in the same manner and to the same extent that the Company would be required to perform them if no such succession had taken place. The date on which any such succession becomes effective shall be deemed to be the date of the Change in Control.

1.2Assignment by the Participant. This Plan shall inure to the benefit of and be enforceable by the Participant’s personal or legal representatives, executors, administrators, successors, heirs, distributees, devisees and legatees. If the Participant dies while any amounts would still be payable to the Participant under the Plan had the Participant continued to live, all such amounts, unless otherwise provided herein, shall be paid in accordance with the terms of this Plan to the Participant’s Beneficiary. If the Participant has not named a Beneficiary, then such amounts shall be paid to the Participant’s devisee, legatee, or other designee, or if there is no such designee, to the Participant’s estate.

ARTICLE VIII. Termination and Amendment

1.1Amendment and Termination of the Plan. Subject to Section 8.2, the Board of Directors may terminate or amend the Plan or any outstanding Participation Letter at any time, provided, however, that the Plan and any outstanding Participation Letter may not be amended or terminated without the written consent of the affected Participant at any time when a transaction that would reasonably be likely to result in a Change in Control is under active consideration by the Board.

1.2Participant Rights. Notwithstanding any provision of the Plan to the contrary, no termination or amendment of the Plan or any outstanding Participation Letter made (i) after the Participant incurs a Qualifying Termination may have the effect of reducing or otherwise impairing the rights and benefits of such Participant under the Plan or the Participant’s Participation Letter, without the Participant’s written consent, and (ii) on or after the date of a Change of Control may be effective prior to the second anniversary of such Change of Control.

ARTICLE IX. Miscellaneous

1.1Withholding of Taxes. The Company shall be entitled to withhold from any amounts payable under this Plan, all taxes as legally shall be required (including, without limitation, any United States
9


federal taxes, any other state, city, or local taxes). The Company, its Subsidiaries and Affiliates shall have the power to deduct or withhold from any amounts payable under the Plan, or require the Participant to remit to the Company, its Subsidiaries or its Affiliates, any amount deemed sufficient to satisfy U.S. Federal, state, local and non-U.S. tax withholding requirements, as deemed necessary or appropriate by the Company.

1.2Unfunded Status. The Plan shall be unfunded and all costs of the Plan shall be paid from the Company’s general assets. Neither the Company nor the Board shall be required to segregate any assets that may at any time be represented by benefits under the Plan. Neither the Company nor the Board shall be deemed to be a trustee of any amounts to be paid under the Plan. Any liability of the Company to any Participant with respect to any benefit shall be based solely upon any contractual obligations created by the Plan and the Participation Letter; no such obligation shall be deemed to be secured by any pledge or any encumbrance on any property of the Company.

1.3No Mitigation. The Participant shall not be obligated to seek other employment in mitigation of the amounts payable or arrangements made under any provision of this Plan, and the obtaining of any such other employment shall in no event effect any reduction of the Company’s obligations to make the payments and arrangements required to be made under this Plan.

1.4Employment Status. Except as may be provided under any other agreement between the Participant and the Company, the employment of the Participant by the Company is “at will” and may be terminated by either the Participant or the Company at any time, subject to applicable law.

1.5Beneficiaries. The Participant may designate one or more persons or entities as the primary and/or contingent Beneficiaries of any Severance Benefits owing to the Participant under this Plan. Such designation must be in the form of a signed writing acceptable to the Committee. The Participant may make or change such designations at any time.

1.6Severability. In the event any provision of this Plan shall be held illegal or invalid for any reason, the illegality or invalidity shall not affect the remaining parts of the Plan, and the Plan shall be construed and enforced as if the illegal or invalid provision had not been included. Further, the captions of this Plan are not part of the provisions hereof and shall have no force and effect.

1.7Applicable Law. To the extent not preempted by the laws of the United States, the laws of the state of New York shall be the controlling law in all matters relating to this Plan.

1.8Code Section 409A. The Severance Benefits and other benefits under this Plan are intended to comply with Section 409A of the Code or to otherwise be exempt therefrom.

(A)Notwithstanding anything herein to the contrary, if the Participant is a “specified employee” as determined pursuant to Section 409A of the Code as of the date of the Participant’s “separation from service” (within the meaning of Treas. Reg. 1.409A-1(h)) and if any Severance Benefits or other payment or benefit provided for in this Plan or otherwise both (i) constitutes a “deferral of compensation” within the meaning of Section 409A of the Code and (ii) cannot be paid or provided in the manner otherwise provided without subjecting the Participant to “additional tax”, interest or penalties under Section 409A of the Code, then any such Severance Benefits or other payment or benefit that is
10


payable during the first six (6) months following the Participant’s “separation from service” shall be paid or provided to the Participant in a cash lump sum on the first (1st) business day of the seventh (7th) calendar month following the month in which the Participant’s “separation from service” occurs. Any payment or benefit due upon a termination of the Participant’s employment that represents a “deferral of compensation” within the meaning of Section 409A shall only be paid or provided to the Participant upon a “separation from service.”

(B)Notwithstanding anything to the contrary in Section 3.3 of this Plan or elsewhere, any payment or benefit under Section 3.3 or otherwise that is exempt from Section 409A pursuant to Treas. Reg. 1.409A-1 (b)(9)(v)(A) or (C) shall be paid or provided to the Participant only to the extent that the expenses are not incurred, or the benefits are not provided, beyond the last day of the second (2nd) taxable year of the Participant following the taxable year of the Participant in which the “separation from service” occurs; and provided further that such expenses are reimbursed no later than the last day of the third (3rd) taxable year following the taxable year of the Participant in which the “separation from service” occurs.

(C)To the extent any expense reimbursement or the provision of any in-kind benefit under this Plan is determined to be subject to Section 409A of the Code, the amount of any such expenses eligible for reimbursement, or the provision of any in-kind benefit, in one calendar year shall not affect the expenses eligible for reimbursement in any other taxable year (except for any life-time or other aggregate limitation applicable to medical expenses), in no event shall any expenses be reimbursed after the last day of the calendar year following the calendar year in which the Participant incurred such expenses, and in no event shall any right to reimbursement or the provision of any in-kind benefit be subject to liquidation or exchange for another benefit. For the purposes of this Plan, each payment made pursuant to Section 3.3 shall be deemed to be separate payments, amounts payable under Section 3.3 of this Plan shall be deemed not to be a “deferral of compensation” subject to Section 409A of the Code to the extent provided in the exceptions in Treas. Reg. Sections 1.409A-1(b)(4) (“short-term deferrals”) and (b)(9) (“separation pay plans,” including the exception under subparagraph (iii)) and other applicable provisions of Treas. Reg. Section 1.409A-1 through A-6.

(D)In no event may a Participant, directly or indirectly, designate the calendar year of any payment under this Plan, and to the extent required by Section 409A of the Code, any payment that may be paid in more than one taxable year (depending on the time that Participant executes the Release Agreement) shall be paid in the later taxable year.


11


ATTACHMENT A
INNOVID, INC.
EXECUTIVE CHANGE IN CONTROL SEVERANCE PLAN
Participant NameTitleSeverance MultipleContinuation of Benefits Period
(# of months)
Zvika NetterChief Executive Officer1.0x12
Tanya Andreev-KaspinChief Financial Officer0.5x6
Tim BrazExecutive Vice President, Global Sales 0.5x6
Guy KupermanChief Strategy Officer0.5x6
Dale OlderChief Product Officer0.5x6
Ken MarkusChief Operating Officer0.5x6
Tal ChalozinChief Technology Officer0.5x6
Liel GolanExecutive Vice President, Human Resources0.5x6
Yuval PemperChief Engineering Officer0.5x6
Michal LivnyExecutive Vice President, People Operations, EMEA & APAC0.5x6
Stephen CookGeneral Counsel 0.5x6
David HelmreichChief Commercial Officer0.5x6


12


ATTACHMENT B

INNOVID, INC.
EXECUTIVE CHANGE IN CONTROL SEVERANCE PLAN

FORM OF PARTICIPATION LETTER

We are pleased to inform you that you have been designated as a Participant in the Innovid, Inc. (“Company”) Executive Change in Control Severance Plan (the “Plan”). Your participation in the Plan is subject to the terms and conditions of the Plan. A copy of the Plan is attached hereto as Annex A and is incorporated herein and deemed to be part of this Participation Letter for all purposes. Unless otherwise defined herein, capitalized terms used in this Participation Letter shall have the meanings set forth in the Plan.
Pursuant to your participation in the Plan, you are eligible to receive Severance Benefits in accordance with and subject to the terms of the Plan.
Please understand that the Plan and this Participation Letter supersede all prior severance benefit policies, plans and arrangements of the Company, if any, with the intent that, to the maximum extent permitted by law, any such prior policies, plans, arrangements and communications are null and void and of no further force and effect with respect to your participation therein.
Please further understand that your participation in the Plan is subject to your continued compliance with all Restrictive Covenants pursuant to all agreements and arrangements between you and the Company and its subsidiaries. In the event you do not comply with any such Restrictive Covenants, you will not be eligible for any Severance Benefits under the Plan. Severance Benefits, if any, are also subject to the execution and non-revocation of a release of claims upon any Qualifying Termination, as set forth in the Plan.
Thank you for your service to the Company.

INNOVID, INC.
By:___________________________________
Printed Name:__________________________
Title:__________________________________
Date:_________________________________

13

 EX-21.1 6 a211listofsubsidiariesofth.htm EX-21.1 Document

Exhibit 21.1
Subsidiaries of Innovid Corp. as of December 31, 2022

NameJurisdiction of Incorporation
Innovid LLCDelaware
TV Squared IncDelaware
TV Squared LimitedUnited Kingdom
TV Squared GmbHGermany
Innovid Holdings LLCDelaware
Innovid AU Pty LtdAustralia
Innovid EU LimitedUnited Kingdom
Innovid Media Ltd.Israel
Innovid Argentina SRLArgentina


 EX-23.1 7 a231consentofernstyoungglo.htm EX-23.1 Document
Exhibit 23.1

 
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
 
We consent to the incorporation by reference in the following Registration Statements:
1.Registration Statement (Form S-1 No. 333-261784) of Innovid Corp.,
2.Registration Statement (Form S-1 No. 333-264324) of Innovid Corp., and
3.Registration Statement (Form S-8 No. 333-262537) pertaining to the Innovid Corp. 2021 Incentive Award Plan, the Innovid Corp. 2021 Employee Stock Purchase Plan and Global Share Incentive Plan (2008)
of our report dated March 3, 2023, with respect to the consolidated financial statements of Innovid Corp. included in this Annual Report (Form 10-K) for the year ended December 31, 2022.

/s/ Kost Forer Gabbay & Kasierer
A Member of Ernst & Young Global

Tel-Aviv, Israel
March 3, 2023


 EX-31.1 8 a311certificationofceosect.htm EX-31.1 Document
Exhibit 31.1

CERTIFICATION
PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002
I, Zvika Netter, certify that:
1.I have reviewed this Annual Report on Form 10-K of Innovid Corp.;

2.
Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which
such statements were made, not misleading with respect to the period covered by this report;
 

3.
Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
 

4.
The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:
 

(a)
Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
 

(b)
Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
 

(c)
Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
 

(d)
Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and
 

5.
The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):
 


Exhibit 31.1

(a)
All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and
 

(b)Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.
Date: March 3, 2023
/s/ Zvika Netter
Zvika Netter
Chief Executive Officer


 EX-31.2 9 a312certificationofcfosect.htm EX-31.2 Document
Exhibit 31.2

CERTIFICATION
PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002
I, Tanya Andreev-Kaspin, certify that:
1.I have reviewed this Annual Report on Form 10-K of Innovid Corp.;

2.
Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which
such statements were made, not misleading with respect to the period covered by this report;
 

3.
Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
 

4.
The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:
 

(a)
Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
 

(b)
Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
 

(c)
Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
 

(d)
Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and
 

5.
The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):
 


Exhibit 31.2

(a)
All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and
 

(b)Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.
Date: March 3, 2023
/s/ Tanya Andreev-Kaspin    
Tanya Andreev-Kaspin
Chief Financial Officer


 EX-32.1 10 a321certificationofceo18us.htm EX-32.1 Document
Exhibit 32.1

CERTIFICATION PURSUANT TO
18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

    In connection with the Annual Report on Form 10-K of Innovid Corp. (the “Company”) for the period ended December 31, 2022, as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that, to my knowledge:

    (i)    the Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

    (ii)    the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.



Dated: March 3, 2023                        /s/ Zvika Netter            
        Zvika Netter
        Chief Executive Officer

The foregoing certification is being furnished solely to accompany the Report pursuant to 18 U.S.C. Section 1350, and is not being filed for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, and is not to be incorporated by reference into any filing of the Company, whether made before or after the date hereof, regardless of any general incorporation language in such filing.


 EX-32.2 11 a322certificationofcfo18us.htm EX-32.2 Document
Exhibit 32.2

CERTIFICATION PURSUANT TO
18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

    In connection with the Annual Report on Form 10-K of Innovid Corp. (the “Company”) for the period ended December 31, 2022, as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that, to my knowledge:

    (i)    the Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

    (ii)    the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company..



Dated: March 3, 2023                        /s/ Tanya Andreev-Kaspin    
        Tanya Andreev-Kaspin
        Chief Financial Officer

The foregoing certification is being furnished solely to accompany the Report pursuant to 18 U.S.C. Section 1350, and is not being filed for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, and is not to be incorporated by reference into any filing of the Company, whether made before or after the date hereof, regardless of any general incorporation language in such filing.



 EX-101.SCH 12 ctv-20221231.xsd XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT 0000001 - Document - Cover Page link:presentationLink link:calculationLink link:definitionLink 0000002 - Document - Audit Information link:presentationLink link:calculationLink link:definitionLink 0000003 - Statement - CONSOLIDATED BALANCE SHEETS link:presentationLink link:calculationLink link:definitionLink 0000004 - Statement - CONDENSED BALANCE SHEETS (Parenthetical) link:presentationLink link:calculationLink link:definitionLink 0000005 - Statement - CONSOLIDATED STATEMENTS OF OPERATIONS link:presentationLink link:calculationLink link:definitionLink 0000006 - Statement - CONSOLIDATED STATEMENTS OF OPERATIONS (Parenthetical) link:presentationLink link:calculationLink link:definitionLink 0000007 - Statement - STATEMENTS OF CHANGES IN TEMPORARY EQUITY AND STOCKHOLDERS’ EQUITY (DEFICIT) link:presentationLink link:calculationLink link:definitionLink 0000008 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS link:presentationLink link:calculationLink link:definitionLink 0000009 - Disclosure - DESCRIPTION OF BUSINESS link:presentationLink link:calculationLink link:definitionLink 0000010 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES link:presentationLink link:calculationLink link:definitionLink 0000011 - Disclosure - TRANSACTION link:presentationLink link:calculationLink link:definitionLink 0000012 - Disclosure - ACQUISITION link:presentationLink link:calculationLink link:definitionLink 0000013 - Disclosure - INTANGIBLE ASSETS, NET link:presentationLink link:calculationLink link:definitionLink 0000014 - Disclosure - PREPAID AND OTHER CURRENT ASSETS link:presentationLink link:calculationLink link:definitionLink 0000015 - Disclosure - PROPERTY AND EQUIPMENT, NET link:presentationLink link:calculationLink link:definitionLink 0000016 - Disclosure - LEASES link:presentationLink link:calculationLink link:definitionLink 0000017 - Disclosure - ACCRUED EXPENSES AND OTHER CURRENT LIABILITIES link:presentationLink link:calculationLink link:definitionLink 0000018 - Disclosure - OTHER NON-CURRENT LIABILITIES link:presentationLink link:calculationLink link:definitionLink 0000019 - Disclosure - WARRANTS link:presentationLink link:calculationLink link:definitionLink 0000020 - Disclosure - LONG-TERM DEBT link:presentationLink link:calculationLink link:definitionLink 0000021 - Disclosure - COMMITMENTS AND CONTINGENT LIABILITIES link:presentationLink link:calculationLink link:definitionLink 0000022 - Disclosure - STOCKHOLDERS’ EQUITY link:presentationLink link:calculationLink link:definitionLink 0000023 - Disclosure - STOCK-BASED COMPENSATION link:presentationLink link:calculationLink link:definitionLink 0000024 - Disclosure - FINANCE EXPENSES (INCOME), NET link:presentationLink link:calculationLink link:definitionLink 0000025 - Disclosure - INCOME TAXES link:presentationLink link:calculationLink link:definitionLink 0000026 - Disclosure - SEGMENT REPORTING link:presentationLink link:calculationLink link:definitionLink 0000027 - Disclosure - BASIC AND DILUTED NET LOSS PER SHARE link:presentationLink link:calculationLink link:definitionLink 0000028 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies) link:presentationLink link:calculationLink link:definitionLink 0000029 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables) link:presentationLink link:calculationLink link:definitionLink 0000030 - Disclosure - TRANSACTION (Tables) link:presentationLink link:calculationLink link:definitionLink 0000031 - Disclosure - ACQUISITION (Tables) link:presentationLink link:calculationLink link:definitionLink 0000032 - Disclosure - INTANGIBLE ASSETS, NET (Tables) link:presentationLink link:calculationLink link:definitionLink 0000033 - Disclosure - PREPAID AND OTHER CURRENT ASSETS (Tables) link:presentationLink link:calculationLink link:definitionLink 0000034 - Disclosure - PROPERTY AND EQUIPMENT, NET (Tables) link:presentationLink link:calculationLink link:definitionLink 0000035 - Disclosure - LEASES (Tables) link:presentationLink link:calculationLink link:definitionLink 0000036 - Disclosure - ACCRUED EXPENSES AND OTHER CURRENT LIABILITIES (Tables) link:presentationLink link:calculationLink link:definitionLink 0000037 - Disclosure - OTHER NON-CURRENT LIABILITIES (Tables) link:presentationLink link:calculationLink link:definitionLink 0000038 - Disclosure - STOCKHOLDERS’ EQUITY (Tables) link:presentationLink link:calculationLink link:definitionLink 0000039 - Disclosure - STOCK-BASED COMPENSATION (Tables) link:presentationLink link:calculationLink link:definitionLink 0000040 - Disclosure - INCOME TAXES (Tables) link:presentationLink link:calculationLink link:definitionLink 0000041 - Disclosure - SEGMENT REPORTING (Tables) link:presentationLink link:calculationLink link:definitionLink 0000042 - Disclosure - BASIC AND DILUTED NET LOSS PER SHARE (Tables) link:presentationLink link:calculationLink link:definitionLink 0000043 - Disclosure - DESCRIPTION OF BUSINESS (Details) link:presentationLink link:calculationLink link:definitionLink 0000044 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Schedule of Reclassification (Details) link:presentationLink link:calculationLink link:definitionLink 0000045 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Narrative) (Details) link:presentationLink link:calculationLink link:definitionLink 0000046 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Schedule of Property, Plant and Equipment) (Details) link:presentationLink link:calculationLink link:definitionLink 0000047 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis) (Details) link:presentationLink link:calculationLink link:definitionLink 0000048 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Schedule of Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation) (Details) link:presentationLink link:calculationLink link:definitionLink 0000049 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Schedule of Warrants Follows at Initial Measurement) (Details) link:presentationLink link:calculationLink link:definitionLink 0000050 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Schedule of Concentration Risk) (Details) link:presentationLink link:calculationLink link:definitionLink 0000051 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Schedule of Operating Lease Liabilities and ROU Assets (Details) link:presentationLink link:calculationLink link:definitionLink 0000052 - Disclosure - TRANSACTION - Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 0000053 - Disclosure - TRANSACTION - Common Stock in Innovid Corp (Details) link:presentationLink link:calculationLink link:definitionLink 0000054 - Disclosure - TRANSACTION - Transaction to Cash Flow and Changes in Temporary Equity and Stockholders’ Equity (Details) link:presentationLink link:calculationLink link:definitionLink 0000055 - Disclosure - ACQUISITION - Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 0000056 - Disclosure - ACQUISITION - Fair Values of the Assets Acquired and Liabilities Assumed (Details) link:presentationLink link:calculationLink link:definitionLink 0000057 - Disclosure - ACQUISITION - Unaudited Pro Forma Financial Information (Details) link:presentationLink link:calculationLink link:definitionLink 0000058 - Disclosure - INTANGIBLE ASSETS, NET - Intangible Assets (Details) link:presentationLink link:calculationLink link:definitionLink 0000059 - Disclosure - INTANGIBLE ASSETS, NET - Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 0000060 - Disclosure - INTANGIBLE ASSETS, NET - Intangible Assets Amortization Expense (Details) link:presentationLink link:calculationLink link:definitionLink 0000061 - Disclosure - PREPAID AND OTHER CURRENT ASSETS (Details) link:presentationLink link:calculationLink link:definitionLink 0000062 - Disclosure - PROPERTY AND EQUIPMENT, NET (Details) link:presentationLink link:calculationLink link:definitionLink 0000063 - Disclosure - LEASES (Schedule of operating ROU assets and lease liabilities) (Details) link:presentationLink link:calculationLink link:definitionLink 0000064 - Disclosure - LEASES (Schedule of lease liability) (Details) link:presentationLink link:calculationLink link:definitionLink 0000065 - Disclosure - LEASES (Schedule Of Lease Costs Recognized In The Consolidated Statement Of Earnings) (Details) link:presentationLink link:calculationLink link:definitionLink 0000066 - Disclosure - LEASES (Narrative) (Details) link:presentationLink link:calculationLink link:definitionLink 0000067 - Disclosure - LEASE (Supplementary Cash Flow Information) (Details) link:presentationLink link:calculationLink link:definitionLink 0000068 - Disclosure - LEASES (Schedule of Operating Lease Liability Maturities) (Details) link:presentationLink link:calculationLink link:definitionLink 0000068 - Disclosure - LEASES (Schedule of Operating Lease Liability Maturities) (Details) link:presentationLink link:calculationLink link:definitionLink 0000069 - Disclosure - LEASES (Schedule Of Commitments Under Non-Cancelable Operating Leases) (Details) link:presentationLink link:calculationLink link:definitionLink 0000070 - Disclosure - ACCRUED EXPENSES AND OTHER CURRENT LIABILITIES (Details) link:presentationLink link:calculationLink link:definitionLink 0000071 - Disclosure - OTHER NON-CURRENT LIABILITIES (Details) link:presentationLink link:calculationLink link:definitionLink 0000072 - Disclosure - WARRANTS (Details) link:presentationLink link:calculationLink link:definitionLink 0000073 - Disclosure - LONG-TERM DEBT (Details) link:presentationLink link:calculationLink link:definitionLink 0000074 - Disclosure - COMMITMENTS AND CONTINGENT LIABILITIES (Details) link:presentationLink link:calculationLink link:definitionLink 0000075 - Disclosure - STOCKHOLDERS’ EQUITY (Common Shares Activity) (Details) link:presentationLink link:calculationLink link:definitionLink 0000076 - Disclosure - STOCKHOLDERS’ EQUITY (Narrative) (Details) link:presentationLink link:calculationLink link:definitionLink 0000077 - Disclosure - STOCK-BASED COMPENSATION (Narrative) (Details) link:presentationLink link:calculationLink link:definitionLink 0000078 - Disclosure - STOCK-BASED COMPENSATION ( Stock Option Activity Under Plan) (Details) link:presentationLink link:calculationLink link:definitionLink 0000079 - Disclosure - STOCK-BASED COMPENSATION ( Stock Option Activity) (Details) link:presentationLink link:calculationLink link:definitionLink 0000080 - Disclosure - STOCK-BASED COMPENSATION ( Fair Value of Each Option on The Date of Grant) (Details) link:presentationLink link:calculationLink link:definitionLink 0000081 - Disclosure - STOCK-BASED COMPENSATION - Restricted Stock Unit Activity (Details) link:presentationLink link:calculationLink link:definitionLink 0000082 - Disclosure - FINANCE EXPENSES (INCOME), NET (Details) link:presentationLink link:calculationLink link:definitionLink 0000083 - Disclosure - INCOME TAXES - Income before Income Tax, Domestic and Foreign (Details) link:presentationLink link:calculationLink link:definitionLink 0000084 - Disclosure - INCOME TAXES - Income Tax Expense (Benefit) (Details) link:presentationLink link:calculationLink link:definitionLink 0000085 - Disclosure - INCOME TAXES - Effective Income Tax Rate Reconciliation (Details) link:presentationLink link:calculationLink link:definitionLink 0000086 - Disclosure - INCOME TAXES - Deferred Tax Assets and Liabilities (Details) link:presentationLink link:calculationLink link:definitionLink 0000087 - Disclosure - INCOME TAXES - Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 0000088 - Disclosure - INCOME TAXES - Operating Loss Carryforwards (Details) link:presentationLink link:calculationLink link:definitionLink 0000089 - Disclosure - INCOME TAXES - Income Tax Contingencies (Details) link:presentationLink link:calculationLink link:definitionLink 0000090 - Disclosure - SEGMENT REPORTING - Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 0000091 - Disclosure - SEGMENT REPORTING (Revenue and Property and Equipment, by Geographical Areas) (Details) link:presentationLink link:calculationLink link:definitionLink 0000092 - Disclosure - BASIC AND DILUTED NET LOSS PER SHARE (Basic and Diluted Net loss Per Share) (Details) link:presentationLink link:calculationLink link:definitionLink 0000093 - Disclosure - BASIC AND DILUTED NET LOSS PER SHARE (Narrative) (Details) link:presentationLink link:calculationLink link:definitionLink 0000094 - Disclosure - BASIC AND DILUTED NET LOSS PER SHARE (Securities Excluded from Computation of Earnings Per Share) (Details) link:presentationLink link:calculationLink link:definitionLink EX-101.CAL 13 ctv-20221231_cal.xml XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT EX-101.DEF 14 ctv-20221231_def.xml XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT EX-101.LAB 15 ctv-20221231_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT Business Acquisition [Axis] Business Acquisition [Axis] Revision of Prior Period [Axis] Revision of Prior Period [Axis] Increase (Decrease) in Stockholders' Equity [Roll Forward] Increase (Decrease) in Stockholders' Equity [Roll Forward] Foreign Current Foreign Tax Expense (Benefit) Fractional shares issued upon exercise (in shares) Fractional Shares Issued Upon Exercise Fractional Shares Issued Upon Exercise Total undiscounted lease payments Lessee, Operating Lease, Liability, to be Paid Functional currency Foreign Currency Transactions and Translations Policy [Policy Text Block] Entity Address, Postal Zip Code Entity Address, Postal Zip Code Schedule of Stockholders Equity Schedule of Stockholders Equity [Table Text Block] Property, Plant and Equipment [Abstract] Deferred income tax provision (benefit): Deferred Income Tax Expense (Benefit), Continuing Operations [Abstract] Reconciliation of Unrecognized Tax Benefits, Excluding Amounts Pertaining to Examined Tax Returns [Roll Forward] Reconciliation of Unrecognized Tax Benefits, Excluding Amounts Pertaining to Examined Tax Returns [Roll Forward] Government authorities Government Contract Receivable, Current Government Contract Receivable, Current Business combinations Business Combinations Policy [Policy Text Block] Debt Instrument [Axis] Debt Instrument [Axis] Total cost Property, Plant and Equipment, Gross Finance expenses (income), net Finance Expenses (Income), Net Finance Expenses (Income), Net Income Tax Disclosure [Abstract] Software development costs Software and Software Development Costs [Member] Sales and marketing Sales and Marketing [Policy Text Block] Sales and Marketing Number of issued and outstanding shares of common stock fully diluted basis Number of Issued and Outstanding Shares of Common Stock Fully Diluted Basis Number of Issued and Outstanding Shares of Common Stock Fully Diluted Basis Fair value of financial instruments Fair Value of Financial Instruments, Policy [Policy Text Block] Other Income and Expenses [Abstract] Additional paid-in capital Additional Paid in Capital Debt instrument, variable rate Debt Instrument, Basis Spread on Variable Rate Long-term restricted deposits Long Term Restricted Deposit Long Term Restricted Deposit Statistical Measurement [Domain] Statistical Measurement [Domain] Depreciation Depreciation Schedule of Future Minimum Lease Commitments Schedule of Future Minimum Rental Payments for Operating Leases [Table Text Block] Commitments and Contingencies [Line Items] Commitments and Contingencies [Line Items] Commitments and Contingencies Stock options exercised (in shares) Stock options exercised (in shares) Exercised (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period Total deferred tax asset (liability) Deferred Tax Assets, Net Operating lease, weighted average discount rate, percent Operating Lease, Weighted Average Discount Rate, Percent Schedule of Revenue and Property and Equipment, by Geographical Areas Schedule of Revenue from External Customers and Long-Lived Assets, by Geographical Areas [Table Text Block] Share-Based Payment Arrangement [Abstract] Israeli Subsidiary Israeli Subsidiary [Member] Israeli Subsidiary [Member] Conversion of redeemable convertible preferred stock into common stock Stock Issued During Period, Value, Conversion of Convertible Securities Long-lived tangible assets Long-Lived Assets Amended Credit Agreement Maturing October 2018 Amended Credit Agreement Maturing October 2018 [Member] Amended Credit Agreement Maturing October 2018 Conversion of Legacy Innovid Warrants Conversion of Legacy Innovid Warrants Conversion of Legacy Innovid Warrants Stock Issued During Period, Shares, Acquisitions (in shares) Stock Issued During Period, Shares, Acquisitions Domestic NOLs (federal) Domestic Tax Authority [Member] Derivative Liability, Statement of Financial Position [Extensible Enumeration] Derivative Liability, Statement of Financial Position [Extensible Enumeration] Beginning balance (in shares) Ending balance (in shares) Temporary Equity, Shares Outstanding Net loss Net loss Net Income (Loss) Attributable to Parent Condensed Income Statement Condensed Income Statement [Table Text Block] Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] Securities excluded from computation of earnings per share (in shares) Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount Long-term deposit Long Term Lease Deposit Long Term Lease Deposit Document Information [Line Items] Document Information [Line Items] Subsequent Event Type [Axis] Subsequent Event Type [Axis] Temporary Equity [Line Items] Temporary Equity [Line Items] Equity Component [Domain] Equity Component [Domain] Subsequent Event Type [Domain] Subsequent Event Type [Domain] Scenario [Axis] Scenario [Axis] Change in valuation allowance Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Amount Increases - current year tax positions Unrecognized Tax Benefits, Increase Resulting from Current Period Tax Positions Class of Warrant or Right [Line Items] Class of Warrant or Right [Line Items] LEASES Lessee, Operating Leases [Text Block] Related Party [Domain] Related Party [Domain] Plan Name [Axis] Plan Name [Axis] Share price (in dollars per share) Business Acquisition, Share Price Weighted average interest rate of time deposits, three months or less Weighted Average Interest Rate of Time Deposits, $100,000 or More, Three Months or Less Software development costs Research, Development, and Computer Software, Policy [Policy Text Block] Supplemental disclosure of cash flows activities: Supplemental Cash Flow Information [Abstract] Forfeited (in USD per share) Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price Intangibles Deferred Tax Liabilities, Goodwill and Intangible Assets Number of operating segments Number of Operating Segments Accrued acquisition liability Noncash or Part Noncash Acquisition, Value of Liabilities Assumed Plan Name [Domain] Plan Name [Domain] Cars Cars Member [Member] Cars Member Total non-current liabilities Liabilities, Noncurrent Statement of Cash Flows [Abstract] Statement of Cash Flows [Abstract] Line of credit outstanding Long-Term Line of Credit Entity Address, State or Province Entity Address, State or Province Level 1 Fair Value, Inputs, Level 1 [Member] 2023 Operating Leases, Future Minimum Payments, Due in Two Years Outstanding option, weighted average remaining contractual term (in years) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term Conversion of Legacy Innovid Warrants on the Closing of the Transaction Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Conversion of Warrants Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Conversion of Warrants Award Type [Axis] Award Type [Axis] Weighted Average Number of Shares Outstanding, Basic [Abstract] Weighted Average Number of Shares Outstanding, Basic [Abstract] New Accounting Pronouncements or Change in Accounting Principle [Line Items] New Accounting Pronouncements or Change in Accounting Principle [Line Items] Net cash used in operating activities Net Cash Provided by (Used in) Operating Activities Non-cash interest expense Noncash Interest Expense Noncash Interest Expense Lease liabilities - current portion Current lease liabilities Operating Lease, Liability, Current Expired (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Expirations in Period Share-based Payment Arrangement, Expensed and Capitalized, Amount [Table] Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Table] Employee Stock Purchase Plan Employee Stock Purchase Plan [Member] Employee Stock Purchase Plan Adjustments to reconcile net loss to net cash used in operating activities: Adjustments, Noncash Items, to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract] Released (in USD per share) Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Released In Period Weighted Average Grant Date Fair Value Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Released In Period Weighted Average Grant Date Fair Value Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table] Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table] Lease liabilities Deferred Tax Assets, Lease Liabilities Deferred Tax Assets, Lease Liabilities Maximum annual contributions per employee, percent Defined Contribution Plan, Maximum Annual Contributions Per Employee, Percent Forfeited (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures in Period Accounts receivables Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets, Receivables Property and equipment Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Property, Plant, and Equipment Document Annual Report Document Annual Report Bank deposits pledged Bank Deposits, Pledged Bank Deposits, Pledged Legal Entity [Axis] Legal Entity [Axis] Liability Class [Axis] Liability Class [Axis] Interest rate during period Line of Credit Facility, Interest Rate During Period Long-term debt Long-Term Debt, Excluding Current Maturities Subsidiaries Subsidiaries [Member] TOTAL LIABILITIES Liabilities Operating lease, weighted average remaining lease term Operating Lease, Weighted Average Remaining Lease Term Geographical [Axis] Geographical [Axis] Share-based Compensation Arrangement by Share-based Payment Award [Line Items] Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items] Cash flows from investing activities: Net Cash Provided by (Used in) Investing Activities [Abstract] Additions Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Additions Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Additions Cash and cash equivalents Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Cash and Equivalents Technology Acquired technology Technology-Based Intangible Assets [Member] Increase in accrued expenses and other liabilities Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities Transfer between employee and consultant (in shares) Share-based Compensation Arrangement by Share-based Payment Award, Options, Transfer Between Employee And Consultant Share-based Compensation Arrangement by Share-based Payment Award, Options, Transfer Between Employee And Consultant Increase (Decrease) in Temporary Equity [Roll Forward] Increase (Decrease) in Temporary Equity [Roll Forward] Warrants liability Warrant Liability, Noncurrent Warrant Liability, Noncurrent Operating Leased Assets [Line Items] Operating Leased Assets [Line Items] Entity Common Stock, Shares Outstanding Entity Common Stock, Shares Outstanding Fair Value Hierarchy and NAV [Domain] Fair Value Hierarchy and NAV [Domain] Conversion of stock (in shares) Conversion of Stock, Shares Converted Revolving Credit Facility Revolving Credit Facility [Member] Schedule of Property, Plant and Equipment Property, Plant and Equipment [Table Text Block] Revenue recognition and Cost of revenues Revenue from Contract with Customer [Policy Text Block] Current income tax provision (benefit): Current Income Tax Expense (Benefit), Continuing Operations [Abstract] Schedule of Related Party Transactions, by Related Party [Table] Schedule Of Reverse Recapitalization [Table] Schedule Of Reverse Recapitalization Document Type Document Type Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Abstract] Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Abstract] Years Property, Plant and Equipment, Useful Life Stock options exercised and RSUs vested Share Based Compensation Arrangement By Share Based Payment Award, Stock Options Exercised And Restricted Stock Units Vested In Period, Value Share Based Compensation Arrangement By Share Based Payment Award, Stock Options Exercised And Restricted Stock Units Vested In Period, Value Number of share units Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward] Concentration Risk Benchmark [Domain] Concentration Risk Benchmark [Domain] Stock options exercised and RSUs vested (in shares) Share Based Compensation Arrangement By Share Based Payment Award, Stock Options Exercised And Restricted Stock Units Vested In Period, Shares Share Based Compensation Arrangement By Share Based Payment Award, Stock Options Exercised And Restricted Stock Units Vested In Period, Shares Number of common stock equal to the fully-diluted shares outstanding Number of Common Stock Equal to the Fully-Diluted Shares Outstanding Number of Common Stock Equal to the Fully-Diluted Shares Outstanding Assets: Assets, Fair Value Disclosure [Abstract] Public Public [Member] Public [Member] Restructuring Type [Axis] Restructuring Type [Axis] Finite-Lived Intangible Assets, Major Class Name [Domain] Finite-Lived Intangible Assets, Major Class Name [Domain] Weighted average interest rate Weighted Average Rate, Interest-Bearing Foreign Deposits, Point in Time Severance costs Severance Costs Outstanding at the beginning of the year (in USD per share) Outstanding at the ending of the year (in USD per share) Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value LONG-TERM DEBT FINANCE EXPENSES (INCOME), NET Debt Disclosure [Text Block] Product and Service [Domain] Product and Service [Domain] Entity Shell Company Entity Shell Company Total deferred income tax (benefit) provision Deferred Income Tax Expense (Benefit) Decreases - prior year tax positions Unrecognized Tax Benefits, Decrease Resulting from Prior Period Tax Positions Concentration Risk [Table] Concentration Risk [Table] 2023 Lessee, Operating Lease, Liability, to be Paid, Year One Shares issued as consideration (in shares) Business Acquisition, Equity Interest Issued or Issuable, Number of Shares OTHER NON-CURRENT LIABILITIES Other Liabilities Disclosure [Text Block] Operating Lease, Liability, Noncurrent, Statement of Financial Position [Extensible Enumeration] Operating Lease, Liability, Noncurrent, Statement of Financial Position [Extensible Enumeration] Subsequent Event Subsequent Event [Member] Revenue Benchmark Revenue Benchmark [Member] Consultants Share-Based Payment Arrangement, Nonemployee [Member] Document Period End Date Document Period End Date Legacy Plan Legacy Plan [Member] Legacy Plan TOTAL ASSETS Assets Redemption Of Warrant Price Per Share Equals Or Exceeds 18.00 Redemption Of Warrant Price Per Share Equals Or Exceeds 18.00 [Member] Redemption Of Warrant Price Per Share Equals Or Exceeds 18.00 Debt Disclosure [Abstract] Quarterly adjusted quick ratio Quarterly Adjusted Quick Ratio Quarterly Adjusted Quick Ratio Earnings Per Share [Abstract] Summary of Significant Accounting Policies [Line Items] Summary of Significant Accounting Policies [Line Items] Summary of Significant Accounting Policies [Line Items] Trade receivable, net Accounts Receivable [Policy Text Block] Income Statement Location [Axis] Income Statement Location [Axis] Antidilutive Securities [Axis] Antidilutive Securities [Axis] Shares issued (in shares) Shares, Issued Accrued expenses and other current liabilities Total Accrued Liabilities, Current Current portion of long-term debt Long-Term Debt, Current Maturities Exercised (in USD per share) Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price Net cash provided by financing activities Net Cash Provided by (Used in) Financing Activities Warrants - MTM Effective Income Tax Rate Reconciliation, Warrants Effective Income Tax Rate Reconciliation, Warrants Accounting Policies [Abstract] Accounting Policies [Abstract] Debt related interest expense Interest Expense, Debt Employee and payroll accruals Employee-related Liabilities, Current Line of Credit Line of Credit [Member] Variable lease cost Variable Lease, Cost Beginning balance Ending balance Temporary Equity, Carrying Amount, Attributable to Parent (Loss) profit before taxes Total income (loss) before income taxes Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest STOCKHOLDERS’ EQUITY: Stockholders' Equity Attributable to Parent [Abstract] Prepaid expenses and other current assets Total Prepaid Expense and Other Assets, Current BASIC AND DILUTED NET LOSS PER SHARE Earnings Per Share [Text Block] Other Deferred Tax Liabilities, Other Customer [Axis] Customer [Axis] Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions Schedule of Share-Based Payment Award, Stock Options, Valuation Assumptions [Table Text Block] Major Property Class [Axis] Major Property Class [Axis] Decrease in operating lease liabilities Increase (Decrease) in Operating Lease Liability Related Party Transaction [Line Items] Related Party Transaction [Line Items] Schedule of Components of Income Tax Expense (Benefit) Schedule of Components of Income Tax Expense (Benefit) [Table Text Block] Award Type [Domain] Award Type [Domain] Grantee Status [Axis] Grantee Status [Axis] Number of securities callable by warrants (in shares) Class of Warrant or Right, Number of Securities Called by Warrants or Rights Other deposits Proceeds From (Payments For) Other Deposits, Investing Activities Proceeds From (Payments For) Other Deposits, Investing Activities Period for cost yet to be recognized Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition Outstanding exercisable, weighted average remaining contractual term (in years) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Remaining Contractual Term Schedule of Finite-Lived Intangible Assets Schedule of Finite-Lived Intangible Assets [Table Text Block] Computers and peripheral equipment Computer Equipment [Member] Payments to acquire business Payments to Acquire Businesses, Gross Total assets acquired Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Assets Acquired Including Goodwill Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Assets Acquired Including Goodwill Conversion of redeemable convertible preferred stock into common stock Temporary Equity Conversion of Redeemable Convertible Preferred Stock Into Common Stock Temporary Equity Conversion of Redeemable Convertible Preferred Stock Into Common Stock Entity Registrant Name Entity Registrant Name Exchange ratio Preferred Stock, Convertible, Conversion Ratio Expected dividends Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Dividend Rate Redemption of warrants, reference price (in dollars per share) Class Of Warrant Or Right, Redemption Of Warrants Or Rights, Reference Price Class Of Warrant Or Right, Redemption Of Warrants Or Rights, Reference Price Changes in uncertain tax positions Effective Income Tax Rate Reconciliation, Change in Uncertain Tax Positions, Amount Effective Income Tax Rate Reconciliation, Change in Uncertain Tax Positions, Amount Customer relationships Customer Relationships [Member] Entity Address, City or Town Entity Address, City or Town EMEA EMEA [Member] Commitments and Contingencies [Table] Commitments and Contingencies [Table] Commitments and Contingencies Leases [Abstract] Creative serving services Revenue Recognition, Creative Serving, Percentage Revenue Recognition, Creative Serving, Percentage Operating expenses: Operating Expenses [Abstract] Geographic Distribution [Domain] Geographic Distribution [Domain] Loss carryforwards Deferred Tax Assets, Operating Loss Carryforwards Employees Share-Based Payment Arrangement, Employee [Member] Weighted average fair value (in dollars per share) Business Acquisition, Fully Vested Stock Option, Weighted Average Fair Value Business Acquisition, Fully Vested Stock Option, Weighted Average Fair Value Public Warrants Public Warrants [Member] Public Warrants [Member] Minimum Minimum [Member] Statement of Financial Position [Abstract] Statement of Financial Position [Abstract] Entity Emerging Growth Company Entity Emerging Growth Company PIPE Investors PIPE Investors [Member] PIPE Investors Common stock, par value (in dollars per share) Ordinary shares, par value (in dollars per share) Common Stock, Par or Stated Value Per Share Interest on income taxes accrued Unrecognized Tax Benefits, Interest on Income Taxes Accrued Commitments and Contingencies Disclosure [Abstract] Commitments and Contingencies Disclosure [Abstract] Treasury stocks Treasury Stock, Common [Member] Auditor Name Auditor Name Accounting Standards Update [Axis] Accounting Standards Update [Axis] Geographic Distribution, Foreign Geographic Distribution, Foreign [Member] Initial public offering per share (in dollars per share) Share Price Operating loss carryforwards Operating Loss Carryforwards Accrued lease liability, current portion Accrued Rent, Current Postemployment Retirement Benefits Postemployment Retirement Benefits [Member] PREPAID AND OTHER CURRENT ASSETS Other Assets Disclosure [Text Block] Trading Symbol Trading Symbol Entity File Number Entity File Number Real Estate Real Estate [Member] INTANGIBLE ASSETS, NET Intangible Assets Disclosure [Text Block] Beginning balance (in shares) Ending balance (in shares) Treasury Stock, Common, Shares 2026 Finite-Lived Intangible Asset, Expected Amortization, Year Four Research and development Research and Development Expense Canada CANADA Increases - prior year tax positions Unrecognized Tax Benefits, Increase Resulting from Prior Period Tax Positions Less: Deferred underwriting fee paid Payments for Underwriting Expense Deferred revenue Deferred Revenue, Current Foreign Deferred Foreign Income Tax Expense (Benefit) Fair Value by Liability Class [Domain] Fair Value by Liability Class [Domain] Granted (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period Restricted Stock Units (RSUs) RSUs outstanding Restricted Stock Units (RSUs) [Member] Effective income tax rate Effective Income Tax Rate Reconciliation, Percent Summary of Operating Loss Carryforwards Summary of Operating Loss Carryforwards [Table Text Block] Proceeds from line of credit Proceeds from Lines of Credit Concentration Risk Benchmark [Axis] Concentration Risk Benchmark [Axis] Use of Estimates Use of Estimates, Policy [Policy Text Block] Money market funds Cash and Cash Equivalents, Fair Value Disclosure ACQUISITION Business Combination Disclosure [Text Block] Capital contributions Proceeds from Contributed Capital Increase/ (decrease) in trade payables Increase (Decrease) in Accounts Payable Net assets acquired Business Combination, Recognized Identifiable Assets Acquired, Goodwill, and Liabilities Assumed, Net Fair value of warrant Beginning of the year End of the year Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value Prime Rate Prime Rate [Member] Concentration risk, percentage Concentration Risk, Percentage Stock Option Plan Legacy Plan And2021 Plan Member [Member] Legacy Plan And2021 Plan Member Issued, fully vested stock option (in shares) Issued, fully vested stock option (in shares) Business Acquisition, Equity Interest Issued or Issuable, Fully Vested Stock Option Business Acquisition, Equity Interest Issued or Issuable, Fully Vested Stock Option Net losses Business Acquisition, Pro Forma Net Income (Loss) Annual increase period Common Shares Authorized and Reserved For Issuance Annual Increase Period Common Shares Authorized and Reserved For Issuance Annual Increase Period INCOME TAXES Income Tax Disclosure [Text Block] Credit Facility [Domain] Credit Facility [Domain] Amortization of intangible assets Amortization of Intangible Assets Accretion of preferred stock to redemption value Preferred Stock Redemption Premium Exercise price per share (in dollars per share) Class of Warrant or Right, Exercise Price of Warrants or Rights Interest Interest Paid, Excluding Capitalized Interest, Operating Activities Net loss per stock attributable to common stockholders – basic (in dollars per share) Earnings Per Share, Basic 2025 Lessee, Operating Lease, Liability, to be Paid, Year Three ION ION [Member] ION Revenues from External Customers and Long-Lived Assets [Line Items] Revenues from External Customers and Long-Lived Assets [Line Items] Accounting Standards Update and Change in Accounting Principle [Table] Accounting Standards Update and Change in Accounting Principle [Table] Concentration Risk Type [Domain] Concentration Risk Type [Domain] Counterparty Name [Domain] Counterparty Name [Domain] Sales and marketing Selling and Marketing Expense TOTAL STOCKHOLDERS’ EQUITY Balance Balance Stockholders' Equity Attributable to Parent Prepaid expenses Prepaid Expense, Current WARRANTS Derivative Instruments and Hedging Activities Disclosure [Text Block] Forfeited (in USD per share) Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value Line of Credit Facility [Line Items] Line of Credit Facility [Line Items] Tax credits Deferred Tax Assets, Tax Credit Carryforwards Other Deferred Tax Assets, Other Entity Interactive Data Current Entity Interactive Data Current Shares issued in transaction (in shares) Sale of Stock, Number of Shares Issued in Transaction Accumulated Amortization Finite-Lived Intangible Assets, Accumulated Amortization Israel ISRAEL Property, Plant and Equipment [Table] Property, Plant and Equipment [Table] Changes in operating assets and liabilities Increase (Decrease) in Operating Capital [Abstract] Numerator: Net Income (Loss) Attributable to Parent [Abstract] 2025 Finite-Lived Intangible Asset, Expected Amortization, Year Three Customer B Customer B [Member] Customer B Schedule of Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table Text Block] Accumulated deficit Retained Earnings [Member] Total lease cost Lease, Cost Common stock, par value $0.0001 per share Common stocks Common Stock [Member] Schedule Share Based Compensation Expenses Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Table Text Block] Short-term bank deposits Short-Term Bank Deposits [Policy Text Block] Short-Term Bank Deposits Rest of the World Rest Of The World [Member] Rest of the World [Member] Summary of Lease Cost Lease, Cost [Table Text Block] Class of Stock [Axis] Class of Stock [Axis] Income taxes and tax contingencies Income Tax, Policy [Policy Text Block] Operating Loss Carryforwards [Line Items] Operating Loss Carryforwards [Line Items] Statement [Table] Statement [Table] Less: Company Warrant assumed as part of the Transaction Warrant Assumed as Part of Transaction Warrant Assumed as Part of Transaction Common stock and equity awards issued for acquisition of TVS Stock Issued During Period, Value, Acquisitions Lease liabilities - non-current portion Non-current lease liabilities Operating Lease, Liability, Noncurrent Schedule of Key Inputs for Valuation of Private Placement Warrants Fair Value Measurement Inputs and Valuation Techniques [Table Text Block] Statistical Measurement [Axis] Statistical Measurement [Axis] Defined contribution plan, cost Defined Contribution Plan, Cost Leasehold improvements Leasehold Improvements [Member] Grantee Status [Domain] Grantee Status [Domain] Cash compensation arrangement for certain employees Business Combination, Post Closing Compensation Expense Business Combination, Post Closing Compensation Expense Change in fair value Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Period Increase (Decrease) Accumulated deficit Retained Earnings (Accumulated Deficit) Trade receivables, net of reserves of $65 at December 31, 2022 and $81 at December 31, 2021 Accounts Receivable, after Allowance for Credit Loss, Current Bank guarantees Bank Guarantees In connection With Office Lease Agreement Bank Guarantees In connection With Office Lease Agreement Schedule of Finite-Lived Intangible Assets [Table] Schedule of Finite-Lived Intangible Assets [Table] Equity Components [Axis] Equity Components [Axis] Scenario [Domain] Scenario [Domain] Major Property Class [Domain] Major Property Class [Domain] Reverse recapitalization, net Reverse Recapitalization, Value, Net Reverse Recapitalization, Value, Net Cash - PIPE Investment, net of Secondary Sale Amount of $68,855 Proceeds from Issuance of Private Placement Fair Value, Recurring Fair Value, Recurring [Member] Exercisable exercise price at the end of the period (in USD per share) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Exercise Price Business Acquisition, Unaudited Pro Forma Information Business Acquisition, Pro Forma Information [Table Text Block] Expired (in USD per share) Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Expirations in Period, Weighted Average Exercise Price Revision of Prior Period [Domain] Revision of Prior Period [Domain] Document Fiscal Year Focus Document Fiscal Year Focus Total Operating Leases, Future Minimum Payments Due Cash flows from operating activities: Net Cash Provided by (Used in) Operating Activities [Abstract] Statement [Line Items] Statement [Line Items] Expiration term of warrant (in years) Warrants and Rights Outstanding, Term Fair Value Measurement Inputs and Valuation Techniques [Table] Fair Value Measurement Inputs and Valuation Techniques [Table] R&D capitalization costs Deferred Tax Assets, in Process Research and Development Outstanding at the beginning of the year (in shares) Outstanding at the ending of the year (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number Proceeds from reverse recapitalization, net Proceeds From Reverse Recapitalization, Net Proceeds From Reverse Recapitalization, Net Variable Rate [Domain] Variable Rate [Domain] 2022 Operating Leases, Future Minimum Payments Due, Next 12 Months Gross Carrying Amount Finite-Lived Intangible Assets, Gross Fair Value Hierarchy and NAV [Axis] Fair Value Hierarchy and NAV [Axis] Total current income tax (benefit) provision Current Income Tax Expense (Benefit) Exchanged into Innovid Corp. common stock on November 30, 2021 (in shares) Stock Issued During Period, Shares, Reverse Recapitalization Stock Issued During Period, Shares, Reverse Recapitalization Operating lease right of use asset ROU assets Operating Lease, Right-of-Use Asset Number of votes for each share Number of Votes for Each Share Number of Votes for Each Share Impairment of long-lived assets Impairment or Disposal of Long-Lived Assets, Policy [Policy Text Block] Auditor Firm ID Auditor Firm ID Line of credit quick ratio Line Of Credit Quick Ratio Line Of Credit Quick Ratio Customer A Customer A [Member] Customer A Type of Restructuring [Domain] Type of Restructuring [Domain] Document Transition Report Document Transition Report Foreign NOLs Foreign Tax Authority [Member] Local Phone Number Local Phone Number Schedule of Share Based Payment Arrangement, Option, Activity Share-Based Payment Arrangement, Option, Activity [Table Text Block] Operating (loss) profit Operating Income (Loss) Recently Adopted Accounting Pronouncements and Recently issued accounting pronouncements not yet adopted by the Company New Accounting Pronouncements, Policy [Policy Text Block] Accretion of preferred stocks to redemption value Noncash Preferred Stock, Accretion Of Redemption Value Noncash Preferred Stock, Accretion Of Redemption Value Other non-current liabilities Other Sundry Liabilities, Noncurrent Share-based compensation Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-Based Compensation Cost (Increase)/ decrease in prepaid expenses and other assets Increase (Decrease) in Prepaid Expense and Other Assets Document Information [Table] Document Information [Table] Domestic NOLs (state and local) State and Local Jurisdiction [Member] Accrued expenses Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals, Accrued Liabilities Common stock, shares outstanding (in shares) Beginning balance (in shares) Ending balance (in shares) Common stock, shares outstanding (in shares) Common Stock, Shares, Outstanding Goodwill Goodwill Goodwill Long-Lived Tangible Asset [Axis] Long-Lived Tangible Asset [Axis] Foreign rate differential Effective Income Tax Rate Reconciliation, Foreign Income Tax Rate Differential, Amount Amount of unrecognized deferred tax liability, undistributed earnings of foreign subsidiaries Deferred Tax Liability Not Recognized, Amount of Unrecognized Deferred Tax Liability, Undistributed Earnings of Foreign Subsidiaries Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items] Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items] Taxes on income Total income tax (benefit) provision Income Tax Expense (Benefit) Geographical [Domain] Geographical [Domain] Valuation allowance Deferred Tax Assets, Valuation Allowance Domestic Current Federal, State and Local, Tax Expense (Benefit) Deferred tax liability Deferred Income Tax Liabilities, Net Property and equipment, net Property, Plant and Equipment, Policy [Policy Text Block] Warrants issued (in shares) Class of Warrant or Right, Issued Class of Warrant or Right, Issued Secondary sale amount Temporary Equity Secondary Sale Amount Temporary Equity Secondary Sale Amount Income Statement [Abstract] Income Statement [Abstract] Granted (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Gross Entity Public Float Entity Public Float Impairments of long-lived assets Impairment, Long-Lived Asset, Held-for-Use Additional paid-in capital Additional Paid-in Capital [Member] Document Fiscal Period Focus Document Fiscal Period Focus Accretion of preferred stocks to redemption value Preferred Stocks, Accretion To Redemption Value, Adjustment Preferred Stocks, Accretion To Redemption Value, Adjustment Net loss per stock attributable to common stockholders Earnings Per Share, Basic [Abstract] Plus: Transaction costs allocated to Company Warrant Payments of Reverse Recapitalization Transaction Costs, Warrants Payments of Reverse Recapitalization Transaction Costs, Warrants Cash and cash equivalents Cash and Cash Equivalents, Unrestricted Cash and Cash Equivalents, Policy [Policy Text Block] Weighted-average number of stocks used in computing net loss per stock attributable to common stockholders, diluted (in shares) Weighted Average Number of Shares Outstanding, Diluted Accumulated depreciation Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment Warrants liability Derivative Liability Derivative liability fair value Derivative Liability, Subject to Master Netting Arrangement, before Offset Expected term (in years) Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Term ICFR Auditor Attestation Flag ICFR Auditor Attestation Flag Assets And Liabilities Lessee Assets And Liabilities Lessee [Table Text Block] Assets And Liabilities Lessee [Table Text Block] Founders’ note receivable Origination of Notes Receivable from Related Parties Common stock of $0.0001 par value - Authorized: 500,000,000 at December 31, 2022 and December 31, 2021; Issued and outstanding: 133,882,414 and 119,017,380 at December 31, 2022 and December 31, 2021, respectively Common Stock, Value, Issued Debt Instrument, Name [Domain] Debt Instrument, Name [Domain] Amended Credit Agreement Maturing December 2020 Amended Credit Agreement Maturing December 2020 [Member] Amended Credit Agreement Maturing December 2020 Business Acquisition, Acquiree [Domain] Business Acquisition, Acquiree [Domain] Decrease in operating lease right of use assets Decrease In Operating Lease Right Of Use Assets Decrease In Operating Lease Right Of Use Assets Warrants Warrants Liability [Policy Text Block] Warrants Liability Cash - ION trust account and cash, net of redemptions Cash Acquired Through Reverse Recapitalization Cash Acquired Through Reverse Recapitalization Schedule of Reverse Recapitalization Schedule Of Reverse Recapitalization [Table Text Block] Schedule Of Reverse Recapitalization Granted (in USD per share) Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value Aggregate number of shares of common stock outstanding Aggregate Number of Shares of Common Stock Outstanding Aggregate Number of Shares of Common Stock Outstanding APAC Asia Pacific [Member] Short-Term Debt [Line Items] Short-Term Debt [Line Items] Secondary Sale Secondary Sale [Member] Secondary Sale [Member] Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block] Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Table Text Block] Outstanding exercisable intrinsic value at the end of the period Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Intrinsic Value Short term lease cost Short-Term Lease, Cost Founders notes forgiven Founders Notes Forgiven Founders Notes Forgiven Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table] Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table] Private Placement Private Placement [Member] Cash, cash equivalents and restricted cash at the beginning of the year Cash, cash equivalents and restricted cash at the end of the year Total cash, cash equivalents, and restricted cash shown in the consolidated statements of cash flows Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents Foreign Income (Loss) from Continuing Operations before Income Taxes, Foreign Exercisable term from closing of business combination Warrants And Rights Outstanding Exercisable Term From Closing Of Business Combination Warrants And Rights Outstanding Exercisable Term From Closing Of Business Combination COMMITMENTS AND CONTINGENT LIABILITIES Commitments and Contingencies Disclosure [Text Block] Proceeds from exercise of options Proceeds from Stock Options Exercised Proceeds from loans Proceeds from Issuance of Long-Term Debt Net loss attributable to common stockholders, basic Net Income (Loss) Available to Common Stockholders, Basic Total tangible assets Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Tangible Assets Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Tangible Assets Common stock, shares issued (in shares) Common stock, shares issued (in shares) Common Stock, Shares, Issued Other Effective Income Tax Rate Reconciliation, Other Adjustments, Amount Concentration Risk [Line Items] Concentration Risk [Line Items] Accounting Standards Update 2016-02 Accounting Standards Update 2016-02 [Member] Retirement Plan Type [Domain] Retirement Plan Type [Domain] Income Statement Location [Domain] Income Statement Location [Domain] Acquisition related costs Business Combination, Acquisition Related Costs Amendment Flag Amendment Flag Estimated Useful Life Finite-Lived Intangible Asset, Useful Life Net cash used in investing activities Net Cash Provided by (Used in) Investing Activities Operating lease cost Operating Lease, Cost Temporary Equity, by Class of Stock [Table] Temporary Equity, by Class of Stock [Table] Business combination consideration paid in stock Noncash Or Part Noncash Acquisition Equity Instrument Consideration Equity Issued Noncash Or Part Noncash Acquisition Equity Instrument Consideration Equity Issued Revenues Business Acquisition, Pro Forma Revenue TRANSACTION Mergers, Acquisitions and Dispositions Disclosures [Text Block] Payment of SPAC merger transaction costs Payments of Merger Related Costs, Financing Activities Entity Current Reporting Status Entity Current Reporting Status Other current liabilities Other Liabilities, Current Goodwill and Intangible Assets Disclosure [Abstract] Exercisable term, from closing of public offering Warrants And Rights Outstanding, Exercisable Term, From Closing Of Public Offering Warrants And Rights Outstanding, Exercisable Term, From Closing Of Public Offering Less: Deferred tax liabilities Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Deferred Tax Liabilities Other non-current assets Other Assets, Noncurrent Holder Holder [Member] Holder Goodwill and acquired intangible assets Goodwill and Intangible Assets, Policy [Policy Text Block] Capital contribution Adjustments to Additional Paid in Capital, Increase in Carrying Amount of Redeemable Preferred Stock Increase in employees and payroll accruals Increase (Decrease) in Employee Related Liabilities Share-based Compensation Arrangement by Share-based Payment Award, Options, Additional Disclosures Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Additional Disclosures [Abstract] Exercisable options at the end of the period (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Number Depreciation, amortization and impairment Depreciation, Depletion and Amortization Commitment fee percentage Line of Credit Facility, Unused Capacity, Commitment Fee Percentage US statutory rate Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent Number of consecutive trading days Class Of Warrant Or Right, Redemption Of Warrants Or Rights, Threshold Consecutive Trading Days Class Of Warrant Or Right, Redemption Of Warrants Or Rights, Threshold Consecutive Trading Days Employee Severance Employee Severance [Member] Thereafter Finite-Lived Intangible Asset, Expected Amortization, after Year Five Shares issued under ESPP (in shares) Stock Issued During Period, Shares, Employee Stock Purchase Plans Counterparty Name [Axis] Counterparty Name [Axis] Schedule of Fair Values of the Assets Acquired and Liabilities Assumed Schedule of Recognized Identified Assets Acquired and Liabilities Assumed [Table Text Block] Outstanding at the beginning of the period (in shares) Outstanding at the end of the period (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number Proceeds from reverse recapitalization, net Net Proceeds From the Transaction Before Secondary Sale Amount Net Proceeds From the Transaction Before Secondary Sale Amount ACCRUED EXPENSES AND OTHER CURRENT LIABILITIES Accounts Payable, Accrued Liabilities, and Other Liabilities Disclosure, Current [Text Block] Intangible assets Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Finite-Lived Intangibles Domestic Deferred Federal, State and Local, Tax Expense (Benefit) IPO IPO [Member] Payment term Revenue From Contract With Customer, Payment Term Revenue From Contract With Customer, Payment Term Entity Incorporation, State or Country Code Entity Incorporation, State or Country Code Basis of Presentation Basis of Accounting, Policy [Policy Text Block] Property and equipment, net Depreciated cost Property, Plant and Equipment, Net Cash paid for amounts included in the measurement of lease liabilities Operating Lease, Payments Debt instrument, prime rate Debt Instrument, Prime Rate Percentage Debt Instrument, Prime Rate Percentage Loan repayment Repayments of Long-Term Debt Schedule of Finite-Lived Intangible Assets, Future Amortization Expense Schedule of Finite-Lived Intangible Assets, Future Amortization Expense [Table Text Block] Options outstanding Share-Based Payment Arrangement, Option [Member] Sales and marketing Selling and Marketing Expense [Member] Expected volatility Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Volatility Rate Trade receivables, allowance for doubtful receivables Accounts Receivable, Allowance for Credit Loss, Current Redemption Of Warrant Price Per Share Equals Or Exceeds 10.00 Redemption Of Warrant Price Per Share Equals Or Exceeds 10.00 [Member] Redemption Of Warrant Price Per Share Equals Or Exceeds 10.00 Stock options exercised Stock Issued During Period, Value, Stock Options Exercised Forfeited (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeited in Period Interest limitation carryforwards Deferred Tax Asset, Interest Carryforward Per unit price (in dollars per share) Sale of Stock, Price Per Share Common stock, shares authorized (in shares) Common Stock, Shares Authorized Short-term bank deposit Short Term Bank Deposit, Current Short Term Bank Deposit, Current Class of Warrant or Right [Axis] Class of Warrant or Right [Axis] Innovid Corp Innovid Corp [Member] Innovid Corp Maximum Maximum [Member] Schedule of Business Acquisitions, by Acquisition [Table] Schedule of Business Acquisitions, by Acquisition [Table] Restricted deposits and restricted cash Cash and Cash Equivalents, Restricted Cash and Cash Equivalents, Policy [Policy Text Block] Operating lease expense Operating Leases, Rent Expense Cash and cash equivalents Cash and Cash Equivalents, at Carrying Value Total current assets Assets, Current Tax payables Taxes Payable, Current Income taxes paid, net of tax refunds Income Taxes Paid, Net Lease of motor vehicles Lease Of Motor Vehicles [Member] Lease Of Motor Vehicles Business Acquisition [Line Items] Business Acquisition [Line Items] Entity Small Business Entity Small Business Shares outstanding (in shares) Shares, Outstanding Measurement Frequency [Domain] Measurement Frequency [Domain] Number of reporting units Number of Reporting Units STOCKHOLDERS’ EQUITY Stockholders' Equity Note Disclosure [Text Block] Weighted average interest rate of time deposits, three months through six months Weighted Average Interest Rate of Time Deposits, $100,000 or More, Three Months Through Six Months Net Carrying Amount Total Finite-Lived Intangible Assets, Net Line of Credit Facility [Table] Line of Credit Facility [Table] Long-term restricted deposits Restricted Cash Operating Loss Carryforwards [Table] Operating Loss Carryforwards [Table] SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Significant Accounting Policies [Text Block] Cost not yet recognized Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount 2025 Operating Leases, Future Minimum Payments, Due in Four Years Number of options Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding [Roll Forward] Deposits Deposits Assets, Current Ad serving services Revenue Recognition, Advertisement Serving Services, Percentage Revenue Recognition, Advertisement Serving Services, Percentage Schedules of Concentration of Risk, by Risk Factor Schedules of Concentration of Risk, by Risk Factor [Table Text Block] PROPERTY AND EQUIPMENT, NET Property, Plant and Equipment Disclosure [Text Block] Outstanding intrinsic value at the beginning of the period Outstanding intrinsic value at the end of the period Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Intrinsic Value Long-Lived Tangible Asset [Domain] Long-Lived Tangible Asset [Domain] Schedule of Other Noncurrent Liabilities Other Noncurrent Liabilities [Table Text Block] Increase in trade receivables, net Increase (Decrease) in Accounts Receivable Title of 12(b) Security Title of 12(b) Security DESCRIPTION OF BUSINESS Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block] Accretion of preferred stocks to redemption value Temporary Equity, Accretion to Redemption Value Consolidated Entities [Axis] Consolidated Entities [Axis] Schedule of Unrecognized Tax Benefits Roll Forward Schedule of Unrecognized Tax Benefits Roll Forward [Table Text Block] Payables and Accruals [Abstract] Repayment of line of credit Repayments of Lines of Credit Conversion of redeemable convertible preferred stock into common stock Conversion of Stock, Amount Converted Business Combination and Asset Acquisition [Abstract] Class of Warrant or Right [Table] Class of Warrant or Right [Table] Fair Value Measurement Inputs and Valuation Techniques [Line Items] Fair Value Measurement Inputs and Valuation Techniques [Line Items] Lease liabilities Total lease liabilities Total lease liabilities - operating Operating Lease, Liability SEGMENT REPORTING Segment Reporting Disclosure [Text Block] Useful lives (in years) Property, Plant and Equipment, Estimated Useful Lives Stock-based compensation Share-Based Payment Arrangement [Policy Text Block] Schedule of operating ROU assets and lease liabilities Assets And Liabilities Lessee Table Text Block [Table Text Block] Assets And Liabilities Lessee Table Text Block Redemption price of warrants (in dollars per share) Class Of Warrant Or Right Redemption Price Of Warrants Or Rights Class Of Warrant Or Right Redemption Price Of Warrants Or Rights Previously reported Previously Reported [Member] 2024 Finite-Lived Intangible Asset, Expected Amortization, Year Two Total deferred tax asset (liability) Deferred Tax Liabilities, Net LIABILITIES AND STOCKHOLDER’ EQUITY Liabilities and Equity [Abstract] Granted (in USD per share) Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Grants in Period, Weighted Average Exercise Price Deferred tax assets Deferred Tax Assets, Net of Valuation Allowance [Abstract] Accrued transaction cost, not yet paid Accrued Transaction Cost, Not Yet Paid Accrued Transaction Cost, Not Yet Paid Aggregate value Sale of Stock, Consideration Received on Transaction Office furniture and equipment Office Furniture And Equipment [Member] Office Furniture And Equipment Redemption of warrants, threshold trading days Class Of Warrant Or Right, Redemption Of Warrants Or Rights, Threshold Trading Days Class Of Warrant Or Right, Redemption Of Warrants Or Rights, Threshold Trading Days Trade payables Accounts Payable, Current Income Tax Authority [Axis] Income Tax Authority [Axis] Threshold period for not to transfer, assign or sell any shares or warrants after completion of initial business combination Threshold Period for Not to Transfer, Assign or Sell Any Shares or Warrants After Completion of Initial Business Combination Threshold Period for Not to Transfer, Assign or Sell Any Shares or Warrants After Completion of Initial Business Combination Accrued lease liability Other Accrued Liabilities, Noncurrent Auditor Location Auditor Location Conversion of Legacy Innovid warrants ( in shares) Stock Issued During Period, Share, Conversion of Warrants Stock Issued During Period, Share, Conversion of Warrants Entity Filer Category Entity Filer Category Warrant Warrants outstanding Warrant [Member] Weighted-average number of stocks used in computing net loss per stock attributable to common stockholders, basic (in shares) Weighted Average Number of Shares Outstanding, Basic Released (in shares) Share-based Compensation Arrangement By Share-based Payment Award, Equity Instruments Other Than Options, Released In Period Share-based Compensation Arrangement By Share-based Payment Award, Equity Instruments Other Than Options, Released In Period US UNITED STATES TV Squared TV Squared [Member] TV Squared Liabilities: Liabilities, Fair Value Disclosure [Abstract] Stock based compensation expenses Share-Based Payment Arrangement, Expense Non-cash transactions Noncash Investing and Financing Items [Abstract] COMMITMENTS AND CONTINGENT LIABILITIES (Note 13) Commitments and Contingencies Security Exchange Name Security Exchange Name Outstanding at the beginning of the period (in USD per share) Outstanding at the end of the period (in USD per share) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price Class of Warrant or Right [Domain] Class of Warrant or Right [Domain] Change in short-term bank deposits Payments To Acquire Short Term Bank Deposits Payments To Acquire Short Term Bank Deposits Acquired finite-lived intangible assets, weighted average useful life Acquired finite-lived intangible assets, weighted average (in years) Acquired Finite-Lived Intangible Assets, Weighted Average Useful Life Other Liabilities Disclosure [Abstract] Accretion of preferred stocks to redemption value Preferred Stock, Accretion of Redemption Discount Less: Other assumed liabilities Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Noncurrent Liabilities, Other Property, Plant and Equipment [Line Items] Property, Plant and Equipment [Line Items] General and administrative General and Administrative Expense [Member] Revenues Revenue from Contract with Customer, Excluding Assessed Tax Granted in acquisition (in shares) Share Based Compensation Arrangement By Share Based Payment Award, Options, Granted In Acquisition, Gross Share Based Compensation Arrangement By Share Based Payment Award, Options, Granted In Acquisition, Gross Conversion of redeemable convertible preferred stock into common stock (in shares) Stock Issued During Period, Shares, Conversion of Convertible Securities Entity Well-known Seasoned Issuer Entity Well-known Seasoned Issuer Schedule of Operating Leased Assets [Table] Schedule of Operating Leased Assets [Table] Options available for future option grants (in shares) Common Stock, Capital Shares Reserved for Future Issuance Cover [Abstract] Leases Lessee, Leases [Policy Text Block] Certificates of deposit Certificates of Deposit, at Carrying Value Level 3 Fair Value, Inputs, Level 3 [Member] Total non-current assets Assets, Noncurrent Entity Voluntary Filers Entity Voluntary Filers Geographic Distribution [Axis] Geographic Distribution [Axis] Goodwill impairment Goodwill, Impairment Loss Depreciation, amortization and impairment Depreciation, Depletion and Amortization, Nonproduction STOCK-BASED COMPENSATION Share-Based Payment Arrangement [Text Block] Accrued post-employment benefits Postemployment Benefit Plans, Policy [Policy Text Block] Other non-deductible items Effective Income Tax Rate Reconciliation, Nondeductible Expense, Amount Reverse recapitalization, net Reverse Recapitalization, Net of Transaction Costs Before Secondary Sale Amount Reverse Recapitalization, Net of Transaction Costs Before Secondary Sale Amount Undistributed foreign subsidiaries Undistributed Earnings of Foreign Subsidiaries Audit Information [Abstract] Audit Information Segment Reporting [Abstract] Forecast Forecast [Member] Rental of premises Rental Of Premises [Member] Rental Of Premises Risk-free interest rate Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Risk Free Interest Rate Documents Incorporated by Reference Documents Incorporated by Reference [Text Block] TOTAL LIABILITIES AND STOCKHOLDERS’ EQUITY Liabilities and Equity Schedule of Deferred Tax Assets and Liabilities Schedule of Deferred Tax Assets and Liabilities [Table Text Block] Tax credits Effective Income Tax Rate Reconciliation, Tax Credit, Amount Related Party [Axis] Related Party [Axis] Fixed assets Deferred Tax Assets, Goodwill and Intangible Assets Warrants Liability Warrants Liability [Member] Warrants Liability Organization, Consolidation and Presentation of Financial Statements [Abstract] Organization, Consolidation and Presentation of Financial Statements [Abstract] Total deferred tax assets, gross Deferred Tax Assets, Gross Schedule of Income (Loss) before Income Tax, Domestic and Foreign Schedule of Income before Income Tax, Domestic and Foreign [Table Text Block] Acquisitions of businesses, net of cash acquired Payments to Acquire Businesses, Net of Cash Acquired Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items] Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Line Items] Level 2 Fair Value, Inputs, Level 2 [Member] Current Fiscal Year End Date Current Fiscal Year End Date Shares of subsidiary pledged (in shares) Number Of Securities Pledged Number Of Securities Pledged Transaction costs Effective Income Tax Rate Reconciliation, Transaction Costs Effective Income Tax Rate Reconciliation, Transaction Costs GILTI Effective Income Tax Rate Reconciliation, Global Intangible Low Taxed Income, Amount Effective Income Tax Rate Reconciliation, Global Intangible Low Taxed Income, Amount Less: Interest Lessee, Operating Lease, Liability, Undiscounted Excess Amount Finite-Lived Intangible Assets [Line Items] Finite-Lived Intangible Assets [Line Items] Other current assets Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets, Other Net loss per stock attributable to common stockholders – diluted (in dollars per share) Earnings Per Share, Diluted Net loss attributable to common stockholders, diluted Net Income (Loss) Available to Common Stockholders, Diluted Intangible assets Intangible Assets, Net (Excluding Goodwill) Sale of Stock [Domain] Sale of Stock [Domain] Temporary Equity Disclosure [Abstract] Proceeds from sale of property and equipment Proceeds from Sale of Property, Plant, and Equipment Vesting period Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Period Loss on sale of property and equipment Gain (Loss) on Disposition of Property Plant Equipment Stock-based compensation APIC, Share-Based Payment Arrangement, Increase for Cost Recognition Schedule of Revenues from External Customers and Long-Lived Assets [Table] Schedule of Revenues from External Customers and Long-Lived Assets [Table] Change in fair value of warrants Fair Value Adjustment of Warrants Concentration Risk Type [Axis] Concentration Risk Type [Axis] Total current liabilities Liabilities, Current Risk free interest rate, minimum Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Minimum Private Placement Warrants Private Placement Warrants [Member] Private Placement Warrants 2024 Lessee, Operating Lease, Liability, to be Paid, Year Two Other current assets Other Assets, Current Uncertain tax position Accrued Income Taxes, Noncurrent Customer Concentration Risk Customer Concentration Risk [Member] Unrecognized tax benefits Gross unrecognized tax benefits, beginning balance Gross unrecognized tax benefits, ending balance Unrecognized Tax Benefits Total deferred tax assets, net Deferred Tax Assets, Net of Valuation Allowance Conversion of Legacy Innovid Warrants Stock Issued During Period, Value, Conversion of Warrants Stock Issued During Period, Value, Conversion of Warrants Capitalization cost Capitalized Computer Software, Additions Entity Ex Transition Period Entity Ex Transition Period Internal use software capitalization Payments to Develop Software Domestic Income (Loss) from Continuing Operations before Income Taxes, Domestic Expiration period Share-Based Compensation Arrangement by Share-Based Payment Award, Expiration Period Unrealized gain (loss) from changes in the fair value Equity Securities, FV-NI, Unrealized Gain (Loss) Risk free interest rate, maximum Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Maximum Less: Accrued transaction costs not yet paid Accrued Direct Transaction Cost Accrued Direct Transaction Cost Schedule of Operating Lease, Liability, Maturity Lessee, Operating Lease, Liability, Maturity [Table Text Block] Entity Address, Address Line Two Entity Address, Address Line Two Denominator: Earnings Per Share, Basic and Diluted EPS [Abstract] Earnings Per Share, Basic and Diluted EPS Entity Address, Address Line One Entity Address, Address Line One Income Tax Authority [Domain] Income Tax Authority [Domain] Cost of revenues Cost of Revenue Capitalized stock-based compensation expense Share-Based Payment Arrangement, Amount Capitalized Product and Service [Axis] Product and Service [Axis] Minimum threshold written notice period for redemption of warrants Class Of Warrant Or Right, Minimum Threshold Written Notice Period For Redemption Of Warrants Class Of Warrant Or Right, Minimum Threshold Written Notice Period For Redemption Of Warrants Deferred tax liabilities Deferred Tax Liabilities, Net [Abstract] Measurement serving services Revenue Recognition, Measurement Serving, Percentage Revenue Recognition, Measurement Serving, Percentage Class of Stock [Domain] Class of Stock [Domain] Summary of Significant Accounting Policies [Table] Summary of Significant Accounting Policies [Table] Summary of Significant Accounting Policies [Table] Derivative Instruments and Hedging Activities Disclosure [Abstract] Derivative Instruments and Hedging Activities Disclosure [Abstract] Trade name Trade Names [Member] Paycheck Protection Program Paycheck Protection Program [Member] Paycheck Protection Program Position expiration Unrecognized Tax Benefits, Position Expiration Tax Positions Unrecognized Tax Benefits, Position Expiration Tax Positions Credit Facility [Axis] Credit Facility [Axis] Transaction costs allocated to warrants Transaction Costs Allocated to Warrants Transaction Costs Allocated to Warrants Retirement Plan Type [Axis] Retirement Plan Type [Axis] Schedule of Accrued Liabilities Schedule of Accrued Liabilities [Table Text Block] Reconciliation of cash, cash equivalents, and restricted cash reported within the statement of financial position Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents [Abstract] Shares outstanding on the final day of the immediately preceding Shares Outstanding on the Final Day of the Immediately Preceding Shares Outstanding on the Final Day of the Immediately Preceding Right-of-use asset Deferred Tax Liabilities, Leasing Arrangements Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Abstract] Entity Tax Identification Number Entity Tax Identification Number Transfer between employee and consultant (in USD per share) Share-based Compensation Arrangements by Share-based Payment Award, Options, Transfer Between Employee And Consultant, Weighted Average Exercise Price Share-based Compensation Arrangements by Share-based Payment Award, Options, Transfer Between Employee And Consultant, Weighted Average Exercise Price Private Warrants Private Warrants [Member] Private Warrants Schedule of Short-Term Debt [Table] Schedule of Short-Term Debt [Table] Conversion of redeemable convertible preferred stock into common stock (in shares) Temporary Equity Conversion of Redeemable Convertible Preferred Stock Into Common Stock, Shares Temporary Equity Conversion of Redeemable Convertible Preferred Stock Into Common Stock, Shares Total deferred tax liability, net Deferred Tax Liabilities, Gross Consolidated Entities [Domain] Consolidated Entities [Domain] Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward] Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward] Schedule of Effective Income Tax Rate Reconciliation Schedule of Effective Income Tax Rate Reconciliation [Table Text Block] (Decrease) increase in cash, cash equivalents and restricted cash Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect Commitment fee amount Line of Credit Facility, Commitment Fee Amount State and local income taxes, net Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Amount 2027 Finite-Lived Intangible Asset, Expected Amortization, Year Five Other intangible assets Other Intangible Assets, Net Entity Central Index Key Entity Central Index Key Antidilutive Securities, Name [Domain] Antidilutive Securities, Name [Domain] Measurement Frequency [Axis] Measurement Frequency [Axis] Impairment Long Lived Asset Held For Use Statement Of Income Or Comprehensive Income Extensible Enumeration Not Disclosed Flag Impairment Long Lived Asset Held For Use Statement Of Income Or Comprehensive Income Extensible Enumeration Not Disclosed Flag Impairment Long Lived Asset Held For Use Statement Of Income Or Comprehensive Income Extensible Enumeration Not Disclosed Flag Research and development Research and Development Expense, Policy [Policy Text Block] Reverse recapitalization, net (in shares) Reverse Recapitalization, Net, Share Reverse Recapitalization, Net, Share LATAM Latin America [Member] Weighted average grant date fair value Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract] Warrant exercised (in shares) Stock Issued During Period, Shares, Warrant Exercised Stock Issued During Period, Shares, Warrant Exercised Finite-Lived Intangible Assets by Major Class [Axis] Finite-Lived Intangible Assets by Major Class [Axis] Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table] Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table] Concentration of credit risks Concentration Risk, Credit Risk, Policy [Policy Text Block] Accrued expenses Other Accrued Liabilities, Current Number of employee deposit, percent Restructuring and Related Cost, Number of Employee Entitled Monthly Deposit, Period Percent Restructuring and Related Cost, Number of Employee Entitled Monthly Deposit, Period Percent Entity [Domain] Entity [Domain] Accounting Standards Update [Domain] Accounting Standards Update [Domain] City Area Code City Area Code General and administrative General and Administrative Expense ASSETS Assets [Abstract] Granted in acquisition (in USD per share) Share Based Compensation Arrangements By Share Based Payment Award, Options, Granted In Acquisition, Weighted Average Exercise Price Share Based Compensation Arrangements By Share Based Payment Award, Options, Granted In Acquisition, Weighted Average Exercise Price Effect of change Revision of Prior Period, Adjustment [Member] General and administrative Selling, General and Administrative Expenses, Policy [Policy Text Block] Statement of Stockholders' Equity [Abstract] Statement of Stockholders' Equity [Abstract] Sale of Stock [Axis] Sale of Stock [Axis] Income taxed computed at U. S. federal statutory rate Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount Operating Leases Assets And Liabilities [Line Items] Operating Leases Assets And Liabilities [Line Items] Operating Leases Assets And Liabilities Cash flows from financing activities: Net Cash Provided by (Used in) Financing Activities [Abstract] Gross proceeds Proceeds from Issuance Initial Public Offering Schedule of Prepaid and Other Current Assets Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Table Text Block] Net loss per common stock Earnings Per Share, Policy [Policy Text Block] Stock-based compensation Share-Based Payment Arrangement, Noncash Expense Variable Rate [Axis] Variable Rate [Axis] Outstanding warrants (in shares) Class of Warrant or Right, Outstanding Other non-current liabilities Other non-current liabilities Other Liabilities, Noncurrent Asset impairment charges Asset Impairment Charges Purchase of property and equipment Payments to Acquire Property, Plant, and Equipment Research and development Research and Development Expense [Member] Incentive Plan Incentive Plan [Member] Incentive Plan 2023 Finite-Lived Intangible Asset, Expected Amortization, Year One Less: Transaction costs paid Payments of Reverse Recapitalization Transaction Costs Payments of Reverse Recapitalization Transaction Costs Schedule of Basic and Diluted Net Loss Per Share Schedule of Earnings Per Share, Basic and Diluted [Table Text Block] Preferred stocks Preferred Stocks [Member] Preferred Stocks [Member] Right of use assets obtained in exchange for operating lease liabilities upon lease modification Right Of Use Assets Obtained In Exchange For Operating Lease Liabilitie Upon Lease Modification Right Of Use Assets Obtained In Exchange For Operating Lease Liabilitie Upon Lease Modification Cost of goods sold Cost of Sales [Member] Repayment of acquisition liability Repayment of Acquisition Liability Repayment of Acquisition Liability Customer [Domain] Customer [Domain] 2024 Operating Leases, Future Minimum Payments, Due in Three Years EX-101.PRE 16 ctv-20221231_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT GRAPHIC 17 ctv-20221231_g1.jpg begin 644 ctv-20221231_g1.jpg M_]C_X 02D9)1@ ! 0$ > !X #_X0!:17AI9@ 34T *@ @ !0,! 4 M ! 2@,# $ ! %$0 $ ! 0 %$1 0 ! 7$5$2 M 0 ! 7$0 8:@ "QC__; $, @$! @$! @(" @(" @(#!0,# M P,#!@0$ P4'!@<'!P8'!P@)"PD(" H(!P<*#0H*"PP,# P'"0X/#0P."PP, M#/_; $,! @(" P,#!@,#!@P(!P@,# P,# P,# P,# P,# P,# P,# P,# P, M# P,# P,# P,# P,# P,# P,# P,# P,#/_ !$( (D ? ,!(@ "$0$#$0'_ MQ ? !!0$! 0$! 0 0(#! 4&!P@)"@O_Q "U$ " 0,# @0# M!04$! 7T! @, !!$%$B$Q008346$'(G$4,H&1H0@C0K'!%5+1\"0S8G*" M"0H6%Q@9&B4F)R@I*C0U-C+CY.7FY^CIZO'R\_3U]O?X^?K_Q ? 0 # 0$! M 0$! 0$! 0(#! 4&!P@)"@O_Q "U$0 " 0($! ,$!P4$! ! G< M 0(#$00%(3$&$D%1!V%Q$R(R@0@40I&AL<$)(S-2\!5B7J" M@X2%AH>(B8J2DY25EI>8F9JBHZ2EIJ>HJ:JRL[2UMK>XN;K"P\3%QL?(RKR\_3U]O?X^?K_V@ , P$ A$#$0 _ /W\HHHH M **** "C'-%%)JX!39/NTZHYFPI^E+1 1K\W44]1@>E01NV/F*J?7L:;)]0\23^9?7DUP2<[7;Y1]%Z"J).[_#TK^>.)/I,8JJW#+HJ, M>C>Y]!AN%X1=J\KO\#T+Q=^T7K6LG;9K#I\+9PZKO8_0UQMQK6H:C*9IKQII M&ZN\N":SU8HWRLR_0U(JKC_5QGZJ*_GW../H MY'2).JJ*SJ8FG35YR27F%I-V5BTT^U#8& W9].U9N72;)O02S?_$U\!GWBAD.61?MJZ;71'?1RVM5^ M%/U/;'U:.('>RKCOGBN6\5?&[P_X9#+-?1R3#CRXCO5CU MKQ9^U+>7H9=)LTC4<>;.=V?H!7GNO^-=6\3'_3K^XE7KM#E5_(50M]-NKYO+ MCM[F8L> L9Q6[I_P?\2:EM,>F7"JW0N,+7XMFG$/&'$4[2E4=^D5*Q[5+#8# M#:IHYO9D="?HO2A';[H.0/;)KT/3OV9O$5VZ^?RH'+$8;CT6OH MK3?V:O#NEL#*MS=$=I9,K^5=)I?PPT'21_H^FVD;#OLK] R_Z,^:5]<74C%] MCSI\545I!-GRY8:%?:HVVWL[J=NXCC+8^M:T?PN\1,@/]CWG_?-?4]KH]O:C M]W'&OT0"IO*Q_"37W&"^B_@>3_::SOY(XZO%566D8H%3:ORG)O'6C M^%8F;4-0M[?;R5W?-^76I]5\/G7%8->W443<&./"@_CUK+T_X2^']-N-WV"* M2;.2\Q,A)_X%FOZ:QW]I236%C%ONWI]Q\O%4WK(XKQ#^THLX:/0=,N]0YXE* M-Y?X8YKE=2U+XA?$%66..Z@B;^!%$/'UKWNST>TLFVPP0QT MK]D]G'^EZEM/4B%,_P Z]V\E1VI=@K'!^!N14Y<]9.H^\M3:6>XE_#IZ'EVD M_LR:#:1(+B.>X=?XF?;G\!71Z?\ "+0=-55CTJS8KSF2,,<_C77XHQ7V> \/ M,CPG\*A'YJYP5<=7J/WYLS+;1[>SC58K>.-?]A0HJU'!M';\JLXHQ7T^'RG" M4?X5-1]$DGZU( P]*DZT8KM5*/_#$K0KR!L]5IK;P>BU9VCT'Y M4AC!JU%!*[\O09$&8?-BE/%/"[:7%.[Z"42K"FP*JJRJ!G.*>BY.[#?0BOS& M^+/[5/Q$T/XG^(+.S\6:I#:V]Z\<48DX5>*P!^U_\3 K9\9:QUX'F]:F5%VO MU%&2/U98; S*O/TJ,W;J.%^;.,$8 K\J1^U_\3-_'C+62<\_O#Q7TY^Q1^T? MJG[0'P^U_P "ZUKEQ:^*EA:;3M027;-,G7.?56P/IFM/9V16G0^Q,_YQ4,ER MT4N#@*>F:_+CQQ^T=\7/A]XOU#0]0\6:U#J&G3M!(AE(#$=Q['M76_LQ?MQ^ M*?#_ ,8]-7Q5KU]JFBZ@PM+A9FSY&X\.,_[6!]*.1VN!^C0N=R[L\8SQ2K,S MMQ_#U(&0:@B598/,C>-58!U<!1T> M3R=0M#F-RFY:Z#,^V'_X))>#=O/B;Q.QX&XF+(]_NUL^ ?\ @FCX>^&?CC3] M>TKQ5XFAO]-E$D>/*P?8\?=(R,>]?,O_ \:^*C*O_$TM"K=?]' KT;]DG]M M?X@?%'X_Z'H.M:A!/IMZS+(BPX;A2>OX5G)2+1TO_!3K]F[^V='3X@:7;[KJ MQ"PZI&@Y>/HLGU7I^-?$0'F#EAQD9'4'L:_9+7M)M?$.E75A>K'-9W<312HP MR&4C!K\KOVH_@5<_L]?%R_T5HV;3Y"9M.F/W9(FY"Y[D=#3C+2PI;'O.@_MZ MFT_8MDTV2Z_XK"%?[(B)/S&,KQ)] O&?6OD1W8LS,S,TC98M]YF]?J:39N^^ M,C';TKO/V<_@E>_M!?%JQ\/V^Y;5F$U].!Q'".O/J>E.UM23Z8_X)B?LX?9K M:;X@ZK;AI)08-*5UQL'\4H'YBOM*$YB7Z5D^'- L_"&@6.FZ?&D%C8PK!$%_ M@4# _$]ZUH1B,5G*5S0=1114@%%%% !1110!^/\ \;O^2P>)O^O]OZ5I_LU_ M"^R^,_QGT;P[J%Q-;6M\Y#O%]_H>E9GQOVCXQ>)-QVJVH. 3^%4?AU\0M6^% MGBVUUS19EM=2LR?+D9 P'X&N@S/MX?\ !*#P7Y?_ "'M8(4Y' S^/-=1\'O^ M">GASX+_ !'L?$FG:MJ5Q=Z>Y98I5&Q@1C^M?)Y_X*+_ !<)_P"1@M1_VX1< M_I2C_@HS\6U7_D/6AQ_TXQ?X5G*Y1^E[(H7[N[G.!_,5\R_\%1/!>GZS\#;7 M5IH?^)AI5T/L\RC#!3P4/MT_*HO^">?[2/C#X^W_ (@C\4W\5\MB$:W:.W2+ M;GK]T5N_\%,U!_9DNERV/M29XZUGU&]C\XP<@]F7J1V-???_ 2J\&V&G_![ M4-:2%3J>H77ES2$?,J+T4'T[_6O@13^[_P!A1AA7Z(?\$N4S^SF?FW9O6.0* MTGL2MSZ4$*KC"CY>1[4X# HHK,L**** "BBB@ HHHH ^-_&W_!*^3QCXRU+5 M/^$Q2'^T)C,8OL98(3[[JS3_ ,$CG(S_ ,)LIS_TY'_XJOHB3]K'X+--2\CF\B4>7)M$G]S=MQ^M>C03^=$K0L)(Y$WH5.Y6!]#56>H7R6V:Z'PY\1='\7ZPUAIMYY]TEO'? ")@OER#*."1@Y':NFMP1$,Y)[DBI&?% M9_X)$S87_BM%+ 8W&R_^RKZ&_9<_9[E_9O\ AW_8+:@FK9N&F:81^7@?3->I M$X%(_P!P_2JI7D-A;R2I"K/_ M !NQ 55^IXK>BXC7K^-2,&<(1_M<"@3J>_?&?>LWQ;XJT_P9I!O]4O([&S5U MC,LAPH9B% _$G%1MXNTR'Q+:Z1]MC_M*]A-Q%!GYVC'5OI0!L449HS0 449H MH _/C4KS?\*?B);_ /"9:!I\)UBX)T2:V1[V[.Y/N,?G7=V*]*]1_P"%TMX( MUOQ%#J6J3>&K>3P5:7&EV-U<%5AF\L[@F>KYQGO7LNG>)OA7K&HZ5>1P^&YK MO6YI(K*5K2,R32)RX!(SD51^(/QA^%,UEI^K:_<:#=Q2R/;VTD]NLTBE3AL M@G:.Y[5=R>4^??$'C?4O$G@:\2^U*XN(;CX:# =2M$2T58E=9[$?B-KVHIXBT;1(GTK5CHFCI+ M;+)-<@=,*1GMTZ"ES!RGC7BKQ[J^C>%O%B6&KW5DUIX3T&KSQ4-0TG^S;5 M/L%Q<,@W(#_RR(QDY["CF!(\C_9CUW?^T':Z=IOC34O%6DW'AM+RX^T7?G)% M<%QG R0/3!Y%<_\ M8_&/4+?QYXJFTG5+C1[KPG]G39)J;0-<,V&S'!G$BXZ MDBO4OV8_!?@V]^(?B#Q5X?UJWU:Z9?L9AAMUMXM/C8[UCVJ!ECZFNKU#Q=\- M?%&L6-Y?+X?N[ZZNVTN*6Y@1Y3,O6/)&:.8H\]_;%U'^VOV9_#-Y>77V=KJ\ MT^XGN4.WR=VPLZGMCK7FOB3XP>)/!'ASQUI7AKQ-?>(/#UE>V<<>M/)YSVOF ME?,02#C&"?FS\M?0OC?X[_#JR\-HNKZEI;:;]I:UCAEA$BEXS@A4P?E7')]J M@U7XM?"_X:>$K>WENM!L](UR$W,45M K17B$X)VJ/F_+BCF)Y3YM^(]AK&O_ M +/FN3:AXBN+S0=&UNS:U:/4!>20[V4/YLF3D+]X9Z&NIF\/:/I/[4W@.]C\ M7ZE-9W>B"XL;N2\W)?2+G;"'SA@Q_AKU+P3\8/!MG:>-K"^TWP]HOA/P]%_CIXIU?3]/T'2)-%\'3HFDW*P+CD9+( M,?)@GM1S%(\3^!_Q)\:>+_B;%JG]O :E-?72:AI]U?A56%#T\8ZEXFUS5KB^EN(Q:W-P6@C42, #W%>U0_#S0;?7Y-5CT7 M2TU*88>Z%LGFM]6QFKVFZ'9Z-8K:VEK#;6ZDD11(%49Y/ H; EMGW;AW'4_T MJ6FK&J$[1C=UIU2!\:^._P!C/Q==^+_%VH:.5MX=,OWO_"Z*V!')-Q+@=ABN MBU#]GSQ+\(-2T74]#\-VGBK/AP:)VVL-Y!]STJ/Q[^SOXF_M M7Q9JFEZ;:>3!XFM=;M[)V"1WL,<6'4CH.>:^HF[?[IK'^)7_ "3'7_\ L&7/ M_HMJ0'BO[%.N3>+/'/Q*UJ73H],6]U*+]S"0T*%8\8# ,?4BN)^*G[&'B?6 MOB3XRO-(_=C(\HR"/O,1]*M_!G]F M+7O!'Q \#WVK6=K)([*29F98TSV&X#V-?2EK_Q[1U6O_OS?[RT M ?-7Q%_9U\5ZAXG\5:UIVFV]UY/B:VU:SL96 CU&-%4%3V'2NV_9>\&>(])^ M(?CC7-=T'^P5\17,4]M:[PZQA5 (R/IGI7LB?ZL?[H_G1I__ !^W'UH N444 (4 %%%% '_]D! end XML 18 R1.htm IDEA: XBRL DOCUMENT v3.22.4
Cover Page - USD ($)
$ in Millions
 12 Months Ended
Dec. 31, 2022
Mar. 01, 2023
Jun. 30, 2022
Document Information [Line Items]      
Document Type 10-K    
Document Annual Report true    
Document Period End Date Dec. 31, 2022    
Current Fiscal Year End Date --12-31    
Document Transition Report false    
Entity File Number 001-40048    
Entity Registrant Name Innovid Corp.    
Entity Incorporation, State or Country Code DE    
Entity Tax Identification Number 87-3769599    
Entity Address, Address Line One 30 Irving Place,    
Entity Address, Address Line Two 12th Floor    
Entity Address, City or Town New York    
Entity Address, State or Province NY    
Entity Address, Postal Zip Code 10003    
City Area Code 212    
Local Phone Number 966-7555    
Entity Well-known Seasoned Issuer No    
Entity Voluntary Filers No    
Entity Current Reporting Status Yes    
Entity Interactive Data Current Yes    
Entity Filer Category Accelerated Filer    
Entity Small Business true    
Entity Emerging Growth Company true    
Entity Ex Transition Period false    
ICFR Auditor Attestation Flag false    
Entity Shell Company false    
Entity Public Float     $ 220
Entity Common Stock, Shares Outstanding   136,281,196  
Documents Incorporated by Reference Portions of the registrant’s definitive Proxy Statement for its 2023 Annual Meeting of Stockholders are incorporated by reference into Part III of this Annual Report on Form 10-K.    
Entity Central Index Key 0001835378    
Document Fiscal Year Focus 2022    
Document Fiscal Period Focus FY    
Amendment Flag false    
Common stock, par value $0.0001 per share      
Document Information [Line Items]      
Title of 12(b) Security Common stock, par value $0.0001 per share    
Trading Symbol CTV    
Security Exchange Name NYSE    
Warrant      
Document Information [Line Items]      
Title of 12(b) Security Warrants to purchase one share of common stock, each at an exercise price of $11.50 per share    
Trading Symbol CTVWS    
Security Exchange Name NYSE    
XML 19 R2.htm IDEA: XBRL DOCUMENT v3.22.4
Audit Information
 12 Months Ended
Dec. 31, 2022
Audit Information [Abstract]  
Auditor Firm ID 1281
Auditor Location Tel-Aviv, Israel
Auditor Name KOST FORER GABBAY & KASIERER
XML 20 R3.htm IDEA: XBRL DOCUMENT v3.22.4
CONSOLIDATED BALANCE SHEETS - USD ($)
$ in Thousands
Dec. 31, 2022
Dec. 31, 2021
ASSETS    
Cash and cash equivalents $ 37,541 $ 156,696
Short-term bank deposit 10,000 0
Trade receivables, net of reserves of $65 at December 31, 2022 and $81 at December 31, 2021 43,653 35,422
Prepaid expenses and other current assets 2,640 3,131
Total current assets 93,834 195,249
Long-term deposit 277 310
Long-term restricted deposits 430 462
Property and equipment, net 14,322 4,840
Goodwill 116,976 4,555
Operating lease right of use asset 2,910 0
Intangible assets 29,918 0
Other non-current assets 938 116
Total non-current assets 165,771 10,283
TOTAL ASSETS 259,605 205,532
LIABILITIES AND STOCKHOLDER’ EQUITY    
Trade payables 3,361 5,026
Employee and payroll accruals 10,165 7,742
Current portion of long-term debt 0 6,000
Lease liabilities - current portion 2,186 0
Accrued expenses and other current liabilities 5,474 3,082
Total current liabilities 21,186 21,850
Long-term debt 20,000 0
Lease liabilities - non-current portion 1,636 0
Other non-current liabilities 6,554 3,455
Warrants liability 4,301 18,972
Total non-current liabilities 32,491 22,427
TOTAL LIABILITIES 53,677 44,277
COMMITMENTS AND CONTINGENT LIABILITIES (Note 13)
STOCKHOLDERS’ EQUITY:    
Common stock of $0.0001 par value - Authorized: 500,000,000 at December 31, 2022 and December 31, 2021; Issued and outstanding: 133,882,414 and 119,017,380 at December 31, 2022 and December 31, 2021, respectively 13 12
Additional paid-in capital 356,801 293,719
Accumulated deficit (150,886) (132,476)
TOTAL STOCKHOLDERS’ EQUITY 205,928 161,255
TOTAL LIABILITIES AND STOCKHOLDERS’ EQUITY $ 259,605 $ 205,532
XML 21 R4.htm IDEA: XBRL DOCUMENT v3.22.4
CONDENSED BALANCE SHEETS (Parenthetical) - USD ($)
$ in Thousands
Dec. 31, 2022
Dec. 31, 2021
Statement of Financial Position [Abstract]    
Trade receivables, allowance for doubtful receivables $ 65 $ 81
Common stock, par value (in dollars per share) $ 0.0001 $ 0.0001
Common stock, shares authorized (in shares) 500,000,000 500,000,000
Common stock, shares issued (in shares) 133,882,414 119,017,380
Common stock, shares outstanding (in shares) 133,882,414 119,017,380
XML 22 R5.htm IDEA: XBRL DOCUMENT v3.22.4
CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Dec. 31, 2020
Income Statement [Abstract]      
Revenues $ 127,117 $ 90,291 $ 68,801
Cost of revenues [1] 30,187 17,698 12,311
Research and development [1] 31,118 24,299 18,014
Sales and marketing [1] 50,266 32,841 28,521
General and administrative [1] 39,144 20,641 8,103
Depreciation, amortization and impairment 6,143 661 730
Operating (loss) profit (29,741) (5,849) 1,122
Finance expenses (income), net (13,348) 4,386 734
(Loss) profit before taxes (16,393) (10,235) 388
Taxes on income 2,017 1,237 1,200
Net loss (18,410) (11,472) (812)
Accretion of preferred stock to redemption value 0 (77,063) (7,297)
Net loss attributable to common stockholders, basic (18,410) (88,535) (8,109)
Net loss attributable to common stockholders, diluted $ (18,410) $ (88,535) $ (8,109)
Net loss per stock attributable to common stockholders      
Net loss per stock attributable to common stockholders – basic (in dollars per share) [2] $ (0.14) $ (3.31) $ (0.51)
Net loss per stock attributable to common stockholders – diluted (in dollars per share) [2] $ (0.14) $ (3.31) $ (0.51)
Weighted Average Number of Shares Outstanding, Basic [Abstract]      
Weighted-average number of stocks used in computing net loss per stock attributable to common stockholders, basic (in shares) [2] 130,756,484 26,745,020 16,028,560
Weighted-average number of stocks used in computing net loss per stock attributable to common stockholders, diluted (in shares) [2] 130,756,484 26,745,020 16,028,560
[1] (1) Exclusive of depreciation, amortization and impairment presented separately.
[2] (2) Prior period results have been adjusted to reflect the exchange of Innovid Inc’s common stock for Innovid Corp’s common stock at an exchange ratio of approximately 1.337 because of the Transaction. See Note 3, Transaction for further details.
XML 23 R6.htm IDEA: XBRL DOCUMENT v3.22.4
CONSOLIDATED STATEMENTS OF OPERATIONS (Parenthetical)
Dec. 31, 2022
Nov. 30, 2021
Income Statement [Abstract]    
Exchange ratio 1.337 1.337
XML 24 R7.htm IDEA: XBRL DOCUMENT v3.22.4
STATEMENTS OF CHANGES IN TEMPORARY EQUITY AND STOCKHOLDERS’ EQUITY (DEFICIT) - USD ($)
$ in Thousands
Total
Common stocks
Treasury stocks
Additional paid-in capital
Accumulated deficit
Beginning balance (in shares) at Dec. 31, 2019 73,690,340        
Beginning balance at Dec. 31, 2019 $ 79,700        
Increase (Decrease) in Temporary Equity [Roll Forward]          
Accretion of preferred stocks to redemption value $ 7,297        
Ending balance (in shares) at Dec. 31, 2020 73,690,340        
Ending balance at Dec. 31, 2020 $ 86,997        
Beginning balance (in shares) at Dec. 31, 2019   15,969,260      
Balance at Dec. 31, 2019 (42,787) $ 2 $ (1,629) $ 3,058 $ (44,218)
Beginning balance (in shares) at Dec. 31, 2019     1,914,328    
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Accretion of preferred stocks to redemption value (7,297)     (4,214) (3,083)
Capital contribution 504     504  
Stock-based compensation 584     584  
Stock options exercised (in shares)   306,349      
Stock options exercised 78     78  
Net loss (812)       (812)
Ending balance (in shares) at Dec. 31, 2020   16,275,609      
Balance at Dec. 31, 2020 (49,730) $ 2 $ (1,629) 10 (48,113)
Ending balance (in shares) at Dec. 31, 2020     1,914,328    
Increase (Decrease) in Temporary Equity [Roll Forward]          
Accretion of preferred stocks to redemption value $ 77,063        
Conversion of redeemable convertible preferred stock into common stock (in shares) (73,690,340)        
Conversion of redeemable convertible preferred stock into common stock $ (164,060)        
Ending balance (in shares) at Dec. 31, 2021 0        
Ending balance at Dec. 31, 2021 $ 0        
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Accretion of preferred stocks to redemption value (77,063)     (4,172) (72,891)
Conversion of redeemable convertible preferred stock into common stock (in shares)   73,690,340      
Conversion of redeemable convertible preferred stock into common stock 164,060 $ 7   164,053  
Reverse recapitalization, net (in shares)   25,154,340 (1,914,328)    
Reverse recapitalization, net 126,026 $ 3 $ 1,629 124,394  
Conversion of Legacy Innovid warrants ( in shares)   507,994      
Conversion of Legacy Innovid Warrants 5,080     5,080  
Warrant exercised (in shares) [1]   132,392      
Stock-based compensation 3,273     3,273  
Stock options exercised (in shares)   3,256,705      
Stock options exercised 1,081     1,081  
Net loss $ (11,472)       (11,472)
Ending balance (in shares) at Dec. 31, 2021 119,017,380 119,017,380      
Balance at Dec. 31, 2021 $ 161,255 $ 12 $ 0 293,719 (132,476)
Ending balance (in shares) at Dec. 31, 2021     0    
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Common stock, shares issued (in shares) 119,017,380        
Ending balance (in shares) at Dec. 31, 2022 0        
Ending balance at Dec. 31, 2022 $ 0        
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Stock Issued During Period, Shares, Acquisitions (in shares)   11,549,465      
Common stock and equity awards issued for acquisition of TVS 47,152 $ 1   47,151  
Stock-based compensation 14,945     14,945  
Stock options exercised and RSUs vested (in shares)   3,315,569      
Stock options exercised and RSUs vested 986     986  
Net loss $ (18,410)       (18,410)
Ending balance (in shares) at Dec. 31, 2022 133,882,414        
Balance at Dec. 31, 2022 $ 205,928 $ 13 $ 0 $ 356,801 $ (150,886)
Ending balance (in shares) at Dec. 31, 2022     0    
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Common stock, shares issued (in shares) 133,882,414        
[1] The warrant was exercised in November 2021 and was net share settled.
XML 25 R8.htm IDEA: XBRL DOCUMENT v3.22.4
CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Dec. 31, 2020
Cash flows from operating activities:      
Net loss $ (18,410) $ (11,472) $ (812)
Adjustments to reconcile net loss to net cash used in operating activities:      
Depreciation, amortization and impairment 6,143 661 730
Stock-based compensation 13,781 3,273 584
Loss on sale of property and equipment 0 0 127
Change in fair value of warrants (14,671) 762 86
Founders notes forgiven 0 459 0
Transaction costs allocated to warrants 0 2,750 0
Non-cash interest expense 0 0 22
Changes in operating assets and liabilities      
Increase in trade receivables, net (4,045) (618) (8,372)
(Increase)/ decrease in prepaid expenses and other assets 755 (1,823) 78
Decrease in operating lease right of use assets 1,831 0 0
Increase/ (decrease) in trade payables (622) 1,500 (545)
Increase in employees and payroll accruals 1,710 1,236 1,914
Decrease in operating lease liabilities (2,335) 0 0
Increase in accrued expenses and other liabilities 4,302 851 2,029
Net cash used in operating activities (11,561) (2,421) (4,159)
Cash flows from investing activities:      
Acquisitions of businesses, net of cash acquired (99,097) 0 0
Internal use software capitalization (9,961) (2,594) 0
Purchase of property and equipment (488) (549) (1,030)
Founders’ note receivable 0 (459) 0
Proceeds from sale of property and equipment 0 0 6
Change in short-term bank deposits (10,000) 0 0
Other deposits 120 (85) 76
Net cash used in investing activities (119,426) (3,687) (948)
Cash flows from financing activities:      
Proceeds from reverse recapitalization, net [1] 0 149,252 0
Capital contributions 0 0 504
Proceeds from loans 14,000 0 15,516
Loan repayment 0 (3,033) (6,504)
Repayment of acquisition liability 0 (126) (592)
Payment of SPAC merger transaction costs (3,185) 0 0
Proceeds from exercise of options 985 1,081 78
Net cash provided by financing activities 11,800 147,174 9,002
(Decrease) increase in cash, cash equivalents and restricted cash (119,187) 141,066 3,895
Cash, cash equivalents and restricted cash at the beginning of the year 157,158 16,092 12,197
Cash, cash equivalents and restricted cash at the end of the year 37,971 157,158 16,092
Supplemental disclosure of cash flows activities:      
Income taxes paid, net of tax refunds 785 535 421
Interest 675 259 272
Non-cash transactions      
Conversion of redeemable convertible preferred stock into common stock 0 164,060 0
Conversion of Legacy Innovid Warrants 0 5,080 0
Accrued acquisition liability 0 0 126
Accretion of preferred stocks to redemption value 0 77,063 7,297
Accrued transaction cost, not yet paid 0 3,185 0
Business combination consideration paid in stock 47,152 0 0
Reconciliation of cash, cash equivalents, and restricted cash reported within the statement of financial position      
Cash and cash equivalents 37,541 156,696 15,645
Long-term restricted deposits 430 462 447
Total cash, cash equivalents, and restricted cash shown in the consolidated statements of cash flows $ 37,971 $ 157,158 $ 16,092
[1] * Refer to Note 3, Transaction for details
XML 26 R9.htm IDEA: XBRL DOCUMENT v3.22.4
DESCRIPTION OF BUSINESS
 12 Months Ended
Dec. 31, 2022
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
DESCRIPTION OF BUSINESS DESCRIPTION OF BUSINESS
Innovid Corp. together with its consolidated subsidiaries, the “Company” or “Innovid”, is a leading independent software platform that provides ad serving and creative services for the creation, delivery, and measurement of TV ads across connected TV (“CTV”), mobile TV and desktop TV environments to advertisers, publishers and media agencies.
Innovid Corp. was originally incorporated as ION Acquisition Corp. 2 Ltd. (“ION”), a special purpose acquisition company, on November 23, 2020.
On November 30, 2021, ION and Innovid Inc. closed the mergers as described below (the “Transaction”). Through several merges and name changes Innovid Corp. was established and continues the operations of Innovid Inc.
On November 30, 2021, ION consummated a series of merger transactions, whereby it acquired the business of Innovid Inc. Immediately following these mergers, ION changed its name to “Innovid Corp.” In addition, ION entered into certain subscription agreements (“PIPE Investment”). Further, in connection with the closing of the Transaction, PIPE investors purchased equity securities of Innovid Inc. stockholders (the “Secondary Sale Transaction”) for an aggregate purchase price of $68,855 (the “Secondary Sale Amount”). See Note 3, Transaction for further details.
On February 28, 2022, the Company completed the acquisition of all outstanding shares of TVSquared (“TVS”), an independent global measurement and attribution platform for converged TV and a private company limited by shares incorporated under the laws of the Scotland. The Company acquired all of the equity of TVSquared for an aggregate amount of $100,000 in cash, 11,549,465 shares of the Company common stock at fair value of $3.80 per share, and the issuance of 949,893 fully vested stock options of the Company at a weighted average fair value of $3.49, subject to certain adjustments as defined in the Stock Purchase Agreement. See Note 4, Acquisition for further details.
Innovid Corp.’s common stock and warrants commenced trading on the NYSE under the symbols “CTV” and “CTV.WS,” respectively, on December 1, 2021.
XML 27 R10.htm IDEA: XBRL DOCUMENT v3.22.4
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
 12 Months Ended
Dec. 31, 2022
Accounting Policies [Abstract]  
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
Basis of Presentation
The accompanying Consolidated Financial Statements and Notes to the Consolidated Financial Statements included in this Annual Report on Form 10-K are prepared in accordance with generally accepted accounting principles in the United States ("GAAP") for annual financial information and the instructions to Form 10-K and Article 10 of Regulation S-X. The accompanying Consolidated Financial Statements include our accounts and those of our wholly-owned subsidiaries; all intercompany activity and balances have been eliminated. The Consolidated Financial Statements reflect all adjustments, which are, in the opinion of management, necessary for a fair presentation of the consolidated balance sheets of the Company as of December 31, 2022 and 2021 and the consolidated results of operations and cash flows for the years ended December 31, 2022, 2021 and 2020.
Prior Period Reclassification
During the second quarter of 2022, we presented depreciation, amortization and impairment expenses as a separate line item on our consolidated statements of operations and all prior periods have been adjusted.
Depreciation, amortization and impairment expenses were previously included in cost of sales and other operating expenses depending on the underlying asset’s function. Additionally, we no longer present gross profit as a subtotal on our consolidated statements of operations.
The reclassification is to better reflect the financial performance of transactions with customers as our business has evolved and reflects a better representation of our current operations, which include those of our most recent acquisition. The change provides more clarity about changes in cost of revenue and other operating expenses exclusive of depreciation, amortization and impairment.
In accordance with US GAAP, all periods presented below have been retrospectively adjusted to reflect the reclassification of cost of revenue and other operating expenses exclusive of depreciation and amortization. There was no net impact to loss from operations, net loss attributable to common stockholders or net loss per stock for any periods presented. The consolidated balance sheets, statements of changes in temporary equity and stockholders’ equity, and the consolidated statements of cash flows are not affected by this reclassification. The effect of the change is as follows:

Year ended December 31, 2022Year ended December 31, 2021Year ended December 31, 2020
Under previous classificationEffect of changeAs reportedPreviously reportedEffect of changeAs adjustedPreviously reportedEffect of changeAs adjusted
Cost of revenues$33,265 $(3,078)$30,187 $17,785 $(87)$17,698 $12,365 $(54)$12,311 
Operating expenses:
Research and development31,932 (814)31,118 24,619 (320)24,299 18,283 (269)18,014 
Sales and marketing52,226 (1,960)50,266 33,056 (215)32,841 28,810 (289)28,521 
General and administrative39,435 (291)39,144 20,680 (39)20,641 8,221 (118)8,103 
Depreciation, amortization and impairment$— $6,143 $6,143 $— $661 $661 $— $730 $730 
Use of Estimates
The preparation of the consolidated financial statements in conformity with US GAAP requires management to make estimates, judgments and assumptions. The Company’s management believes that the estimates, judgments and assumptions used are reasonable based upon information available at the time they are made. These estimates, judgments and assumptions can affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the dates of the financial statements, and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.
The Company has considered the impact of these factors on its estimates and assumptions and determined that there were no material adverse impacts on the consolidated financial statements for the periods ended December 31, 2022, 2021, and 2020. As events continue to evolve and additional information becomes available, the Company’s estimates and assumptions may change materially in future periods.
Accounting Policies
Functional currency
A majority of the Company’s revenues are generated in US dollars. In addition, a substantial portion of the Company’s costs are incurred in US dollars. The Company’s management believes that the US dollar is the currency of the primary economic environment in which the Company and each of its subsidiaries operate. Thus, the functional and reporting currency of the Company and its subsidiaries is the US dollar. Accordingly, accounts maintained in currencies other than the US dollar are re-measured into US dollars. All translation gains and losses resulting from the re-measurement of monetary assets and liabilities that are not denominated in the functional currency are recorded in Financial expenses, net on the consolidated statements of operations.
Cash and cash equivalents
Cash equivalents are short-term highly liquid investments that are readily convertible to cash with original maturities of three months or less, at the date acquired.
Short-term bank deposits
The Company utilizes short-term deposits in order to maximize the use of cash on hand. As of December 31, 2022 we had deposits of $10,000 with original maturities greater than 90 days at 4.1% interest. These deposits are expected to mature within no more than 180 days with an interest rate of 4.1%.
Restricted deposits and restricted cash
Restricted deposits presented in Prepaid expenses and other current assets and in Long-term restricted deposits are deposits used as security for the Company’s credit cards and for the rental of premises. As of December 31, 2022 and 2021, the Company’s restricted deposits are denominated in New Israeli Shekels (“NIS”) and bore interest at weighted average interest rates of 0.01% and 0.01%, respectively. Restricted deposits are presented at their cost, including accrued interest.
Property and equipment, net
Property and equipment are stated at cost, net of accumulated depreciation. Depreciation is calculated by the straight-line method over the estimated useful lives of the assets, at the following annual rates:

Years
Computers and peripheral equipment
3
Office furniture and equipment
5-7
Lease improvementsThe shorter of the lease term or the useful life of the asset
Internal-use software3
Software development costs
Software development costs, which are included in property and equipment, net, consists of capitalized costs related to purchase and develop internal-use software. The Company uses such software to provide services to its customers. The costs to purchase and develop internal-use software are capitalized from the time that the preliminary project stage is completed, and it is considered probable that the software will be used to perform the function intended. These costs include personnel and personnel-related employee benefits for employees directly associated with the software development and external costs of the materials or services consumed in developing or obtaining the software.
Any costs incurred for upgrades and functionality enhancements of the software are also capitalized. Once this software is ready for use in providing the Company's services, these costs are amortized on a straight-line basis over the three-year estimated useful life. The amortization is presented within depreciation and amortization in the consolidated statements of operations. During the years ended December 31, 2022 and 2021, the Company capitalized internal-use software cost of $11,143 and $2,594, respectively. In the third quarter of 2022, the Company recorded impairment charges included in depreciation, amortization and impairment in the consolidated statement of operations of $547 related to the abandonment of certain projects. There were no impairment of capitalized software costs for the year ended December 31, 2021 and 2020.
Impairment of long-lived assets
Long-lived assets, including property and equipment and finite-lived intangible assets, are reviewed for impairment whenever facts or circumstances either internally or externally may indicate that the carrying value of an asset may not be recoverable. If there are indications of an impairment, the Company tests for recoverability by comparing the estimated undiscounted future cash flows expected to result from the use of the asset to the carrying amount of the asset or asset group. If the asset or asset group is determined to be impaired, any excess of the carrying value of the asset or asset group over its estimated fair value is recognized as an impairment loss.
For the year ended December 31, 2022, we recognized impairment expense of $547. For the years ended December 31, 2021, and 2020 no impairments of long-lived assets were recorded.
Business combinations
The Company accounts for business combinations by applying the provisions of ASC 805, “Business Combination” (“ASC 805”) and allocates the fair value of purchase consideration to the tangible assets acquired, liabilities assumed, and intangible assets acquired based on their estimated fair values. The excess of the fair value of purchase consideration over the fair values of these identifiable assets and liabilities is recorded as goodwill. When determining the fair values of assets acquired and liabilities assumed, management makes significant estimates and assumptions, especially with respect to intangible assets.
Acquisition-related expenses are expensed as incurred.
Goodwill and acquired intangible assets
Goodwill and acquired intangible assets have been recorded in the Company's financial statements resulting from     various business combinations. Goodwill represents the excess of the purchase price in a business combination over the fair value of identifiable tangible and intangible assets acquired and liabilities assumed. Goodwill is subject to an annual impairment test.
The Company allocates goodwill to reporting units based on the expected benefit from the business combination. Reporting units are evaluated when changes in the Company’s operating structure occur, and if necessary, goodwill is reassigned using a relative fair value allocation approach. The Company currently has one reporting unit.
ASC 350, Intangibles—Goodwill and other (“ASC 350”) requires goodwill to be tested for impairment at least annually and, in certain circumstances, between annual tests. The accounting guidance gives the option to perform a qualitative assessment to determine whether further impairment testing is necessary. The qualitative assessment considers events and circumstances that might indicate that a reporting unit's fair value is less than its carrying amount. If it is determined, as a result of the qualitative assessment, that it is more likely than not that the fair value of a reporting unit is less than its carrying amount, a quantitative test is performed. The Company operates as one reporting unit. The Company elects to perform an annual impairment test of goodwill as of October 1 of each year, or more frequently if impairment indicators are present. For the years ended December 31, 2022, 2021 and 2020 no impairments of goodwill were recorded.
Separately acquired intangible assets are measured on initial recognition at cost including directly attributable costs. Intangible assets acquired in a business combination are measured at fair value at the acquisition date.
Customer relationships, acquired technology and trade name are being amortized over the estimated useful life of approximately 11 years, 6 years, and 4 years, respectively, using straight-line amortization method.
The amortization of customer relationships, acquired technology and trade name is presented within depreciation, amortization and impairment in the consolidated statement of operations.
Leases
Innovid's lease portfolio primarily consists of real estate properties and cars. Short-term leases with a term of 12 months or less are not recorded on the balance sheet. Innovid does not separate lease components from non-lease components.
The Company is a lessee in all its lease agreements. The Company records lease liabilities based on the present value of lease payments over the lease term. Innovid generally uses an incremental borrowing rate to discount its lease liabilities, as the rate implicit in the lease is typically not readily determinable. Certain lease agreements include renewal options that are under the Company's control. Innovid includes optional renewal periods in the lease term only when it is reasonably certain that Innovid will exercise its option.
Variable lease payments are primarily related to payments to lessors for taxes, maintenance, insurance, and other operating costs. The Company's lease agreements do not contain any significant residual value guarantees or restrictive covenants.
Fair value of financial instruments
The Company applies a fair value framework to measure and disclose its financial assets and liabilities. Fair value is defined as the exchange price that would be received for an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. The fair value hierarchy requires an entity to maximize the use of observable inputs, where available, and minimize the use of unobservable inputs when measuring fair value. There are three levels of inputs that may be used to measure fair value:
Level 1 - Observable inputs that reflect quoted prices (unadjusted) for identical assets or liabilities in active markets.
Level 2 - Includes other inputs that are directly or indirectly observable in the marketplace.
Level 3 - Unobservable inputs which are supported by little or no market activity.
The Company’s financial instruments consist of cash and cash equivalents, short term deposits, restricted deposits, trade receivables, net, trade payables, employees and payroll accruals, accrued expenses and other current liabilities and current portion of long term debts. Their historical carrying amounts are approximate fair values due to the short-term maturities of these instruments.
The Company measures its investments in money market funds classified as cash equivalents and warrants liability at fair value.
The following table presents information about the Company’s financial instruments that are measured at fair value on a recurring basis:

December 31, 2022

Level 1
Level 2
Level 3
Assets:
Money market funds$18,948 $— $— 
Certificates of deposit— 20,000 — 
Liabilities:
Warrants liability$1,265 $— $3,036 

December 31, 2021

Level 1
Level 2
Level 3
Assets:
Money market funds$4,515 $— $— 
Liabilities:
Warrants liability$3,510 $— $15,462 
The change in the fair value of the Level 3 warrant liability is summarized below:

December 31,

2022

2021
Beginning of the year
$15,462 $499 
Additions*— 18,427 
Change in fair value(12,426)1,616 
Conversion of Legacy Innovid Warrants on the Closing of the Transaction— (5,080)
End of the year$3,036 $15,462 
* Additions during the year ended December 31, 2021 represent Company Warrant liability assumed in the Transaction. See Note 11, Warrants for further detail.

Certificates of deposit represent our deposits with certain financial institutions with maturities ranging from 90 to 180 days. These amounts are included in Cash equivalents and Short-term deposits on our consolidated balance sheet and are carried at cost, which approximates fair value.
As of December 31, 2022, the Company’s warrant liability includes the Warrants, refer to Note 11, Warrants, that were originally issued in connection with ION’s initial public offering, the “ION IPO”, which were transferred to the Company as part of the Transaction. The Company’s Warrants are recorded on the balance sheet at fair value with changes in fair value recognized through earnings. This valuation is subject to re-measurement at each balance sheet date. With each re-measurement the valuation will be adjusted to fair value, with the change in fair value recognized in the Company’s statement of operations. ASC 820, Fair Value Measurements, indicates that the fair value should be determined “from the perspective of a market participant that holds the identical item” and “use the quoted price in an active market held by another party, if that price is available.”
The Company has determined that the fair value of the Public Warrants, refer to Note 11, Warrants, at a specific date is determined by the closing price of the Company’s warrants, and are within Level 1 of the fair value hierarchy. The closing price of the warrants was $0.40 and $1.11 as of December 31, 2022 and 2021, respectively. The fair value of the warrants was $1,265 and $3,510 as of December 31, 2022 and 2021, respectively. Gains and losses from the remeasurement of the Public Warrants’ liability is recognized in finance expenses, net in the consolidated statements of operations.
The Private Warrants are classified as Level 3 as of December 31, 2022 and continue to be valued based on a Black-Scholes option pricing model. Gains and losses from the remeasurement of the Private Warrants’ refer to Note 11, Warrants liability is recognized in finance expenses, net in the consolidated statements of operations.
The key inputs into the Black-Scholes model for the Private Warrants were as follows:

December 31,December 31,

20222021

Risk-free interest rate
4.07 %1.24 %
Expected dividends— %— %
Expected term (years)
3.94.9
Expected volatility85 %55 %
Fair value estimates are made at a specific point in time, based on relevant market information and information about the financial instruments.
Trade receivable, net
The Company records trade receivable for amounts invoiced and yet unbilled invoices. The Company maintains an allowance for doubtful accounts to reserve for potentially uncollectible receivables. The expectation of collectability is based on a review of credit profiles of customers, contractual terms and conditions, current economic trends, and historical payment experience. The Company regularly reviews the adequacy of the allowance for doubtful accounts by considering the age of each outstanding invoice and the collection history of each customer to determine the appropriate amount of allowance for doubtful accounts. Trade receivables deemed uncollectible are charged against the allowance for doubtful accounts when identified.
Accrued post-employment benefits
401(k) profit sharing plans:
The Company has a 401(k) retirement savings plan with a safe harbor employer match with a maximum of 4% employer contribution for its eligible employees in the US. During the years ended December 31, 2022, 2021 and 2020 the Company recorded expenses for matching contributions in the amount of $1,182, $961 and $705, respectively.
Severance pay:
The Israeli Severance Pay Law, 1963 (“Severance Pay Law”), specifies that employees are entitled to severance payment, following the termination of their employment. Under the Severance Pay Law, the severance payment is calculated as one-month salary for each year of employment, or a portion thereof.
The Israeli Subsidiary’s liability for all of its Israeli employees is covered by the provisions of Section 14 of the Severance Pay Law (“Section 14”). Under Section 14 employees are entitled to monthly deposits, at a rate of 8.33% of their monthly salary, continued on their behalf to their insurance funds. Payments in accordance with Section 14 release the Company from any future severance payments in respect of those employees. As a result, the Company does not recognize any liability for severance pay due to these employees and the deposits under Section 14 are not recorded as an asset in the Company’s balance sheets.
Severance pay expenses for the years ended December 31, 2022, 2021 and 2020, amounted to approximately $946, $755 and $600, respectively.
Income taxes and tax contingencies
Income taxes are computed using a balance sheet approach reflecting both current and deferred taxes. Current and deferred taxes reflect the tax impact of all of the events included in the financial statements. The basic principles employed in the balance sheet approach are to reflect a current tax liability or asset that is recognized for the estimated taxes payable or refundable on tax returns for the current and prior years, a deferred tax liability or asset that is recognized for the estimated future tax effects attributable to temporary differences and carryforwards, the measurement of current and deferred tax liabilities and assets is based on provisions of the enacted tax law of which the effects of future changes in tax laws or rates are not anticipated, and the measurement of deferred tax assets is reduced, if necessary, by the amount of any tax benefits that, based on available evidence, are not expected to be realized. There are certain situations in which deferred taxes are not provided. Some basis differences are not temporary differences because their reversals are not expected to result in taxable or deductible amounts.
The Company regularly evaluates deferred tax assets for future realization and establishes a valuation allowance to the extent that a portion is not more likely than not to be realized. The Company considers whether it is more likely than not that the deferred tax assets will be realized, including existing cumulative losses in recent years, expectations of future taxable income, carryforward periods, and other relevant quantitative and qualitative factors. The recoverability of the deferred tax assets is evaluated by assessing the adequacy of future expected taxable income from all sources, including reversal of taxable temporary differences, forecasted operating earnings and available tax planning strategies. These sources of income rely on estimates.
ASC 740, Income Taxes (“ASC 740”) contains a two-step approach to recognizing and measuring a liability for uncertain tax positions. The first step is to evaluate the tax position taken or expected to be taken in a tax return by determining if the weight of available evidence indicates that it is more likely than not that, on an evaluation of the technical merits, the tax position will be sustained on audit, including resolution of any related appeals or litigation processes. The second step is to measure the tax benefit as the largest amount that is more than 50% (cumulative basis) likely to be realized upon ultimate settlement. The Company classifies interest related to unrecognized tax benefits in taxes on income.
On December 20, 2017, Congress passed the “US Tax Act”. The US Tax Act requires complex computations to be performed that were not previously required by US tax law, significant judgments to be made in interpretation of the provisions of the US Tax Act, significant estimates in calculations, and the preparation and analysis of information not previously relevant or regularly produced the Act provides that a person who is a US shareholder of any CFC is required to include its GILTI in gross income for the tax year in a manner generally similar to that for Subpart F inclusions. The term “global intangible low-taxed income” is defined as the excess (if any) of the US shareholder’s net CFC tested income for that tax year, over the US shareholder’s net deemed tangible income return for that tax year. The Company’s policy is to treat GILTI as a period expense in the provision for income taxes.
Concentrations of credit risks
Financial instruments that potentially subject the Company to concentrations of credit risk consist principally of cash and cash equivalents, deposits and trade receivables, net.
The majority of the Company’s cash and cash equivalents are invested in deposits with major banks in US, Israel and UK. Generally, these investments may be redeemed upon demand and, therefore, bear minimal risk.
The Company’s trade receivables, net are mainly derived from sales to customers located in the US, APAC, EMEA, and LATAM. The Company mitigates its credit risks by performing an ongoing credit evaluations of its customers’ financial conditions.
The Company has no off-balance-sheet concentration of credit risk such as foreign exchange contracts, option contracts or other foreign hedging arrangements.
During the years ended December 31, 2022, 2021 and 2020, two of the Company’s customers accounted for more than 10% of the Company’s total revenues as presented below:

Year ended December 31,

202220212020
Customer A
11 %**
Customer B
10 %*10 %
* less than 10%
Stock-based compensation
The Company estimates the fair value of stock-based awards on the date of grant. The fair value of stock options with only service conditions is determined using the Black-Scholes option pricing model. The grant date fair value of the stock-based awards with graded vesting is recognized on a straight-line basis over the requisite service period. The determination of the fair value of the Company’s stock option awards is based on a variety of factors including Company’s common stock price, risk-free interest rate, expected volatility, expected life of awards and dividend yield. The Company has limited option exercise history and has elected to estimate the expected life of the stock option awards using the “simplified method” with the continued use of this method extended until such time that the Company has sufficient exercise history. The expected volatility of the price of such stocks is based on volatility of similar companies whose stock prices are publicly available over a historical period equivalent to the option’s expected term. The dividend yield is based on the Company’s historical and future expectation of dividends payouts. Historically, the Company has not paid cash dividends. Risk-free interest rates are based on the yield from US Treasury zero-coupon bonds with a term equivalent to the expected term of the options.
The Company accounts for forfeitures as they occur.
Warrants
The Company accounts for warrants as either equity-classified or liability-classified instruments based on an assessment of the warrant’s specific terms and applicable authoritative guidance. The assessment considers whether the warrants are freestanding financial instruments, meet the definition of a liability under ASC 480, and meet all of the requirements for equity classification, including whether the warrants are indexed to the Company’s own common stock and whether the warrant holders could potentially require “net cash settlement” in a circumstance outside of the Company’s control, among other conditions for equity classification. This assessment, which requires the use of professional judgment, is conducted at the time of warrant issuance and as of each subsequent reporting period end date while the warrants are outstanding.
Warrants that meet all the criteria for equity classification, are required to be recorded as a component of additional paid-in capital. Warrants that do not meet all the criteria for equity classification, are required to be recorded as liabilities at their initial fair value on the date of issuance and remeasured to fair value at each balance sheet date thereafter. The liability-classified warrants are recorded under non-current liabilities. Changes in the estimated fair value of the warrants are recognized in “Financial expenses, net” in the consolidated statements of operations.
Revenue recognition
The majority of Company’s revenues is derived from providing Ad serving services to advertisers, publishers, and media agencies. The services focus on standard, interactive and data driven digital video advertising. Ad serving services relate to utilizing Innovid’s platform to serve advertising impressions to various digital publishers across CTV, mobile TV, desktop TV, display, and other channels.
The Company also provides measurement services to brand and agencies, enterprise clients (networks) and publishers. The measurement service provide analysis on and track performance of advertisement campaigns. The measurement service provides insights into the effectiveness of TV and digital advertising.
Creative services relate to the design and development of interactive data-driven and dynamic ad formats by adding data, interactivity and dynamic features to standard ad units.
The Company recognizes revenue when its customer obtains control of promised services in an amount that reflects the consideration that the Company expects to receive in exchange for those services. The Company recognizes revenue in accordance with ASC Topic 606, Revenue from contracts with customers (“ASC 606”) and determines revenue recognition through the following steps: (1) identify the contract with a customer, (2) identify the performance obligations in the contract, (3) determine the transaction price, (4) allocate the transaction price to the performance obligations in the contract, and (5) recognize revenue when a performance obligation is satisfied.
For arrangements with multiple performance obligations, which represent promises within an arrangement that are capable of being distinct and are separately identifiable, the Company allocates the contract consideration to all distinct performance obligations based on their relative standalone selling price (“SSP”). SSP is typically estimated based on observable transactions when these services are sold on a standalone basis.
Revenues related to ad serving services are recognized when impressions are delivered. The Company recognizes revenue from the display of impression-based ads in the contracted period in which the impressions are delivered. Impressions are considered delivered when an ad is displayed to users.
Revenues related to the measurement services platform are recognized over time, since the customer simultaneously receives and consumes the benefits provided by the Company’s performance. Revenues for these measurement services are recognized over the service period.
Revenues related to creative projects are recognized at a point in time when the Company delivers an ad unit. Creative services projects are usually delivered within a week.
The Company’s accounts receivable, consist primarily of receivables related to providing ad serving, measurement and creative services, for which the Company’s contracted performance obligations have been satisfied, the amount has been billed and the Company has an unconditional right to payment. The Company typically bills customers monthly based on actual delivery. The payment terms vary, mainly with terms of 60 days or less.
The typical contract term is 12 months or less for ASC 606 purposes. Most of the Company’s contracts can be cancelled without a cause. The Company has the unconditional right to payment for the services provided as of the date of the termination of the contracts.
The Company applies the practical expedient in ASC 606 and does not adjust the promised amount of consideration for the effects of a significant financing component if the Company expects, at contract inception, that the period between when the Company transfers a promised good or service to a customer and when the customer pays for that good or service will be one year or less.
Deferred revenues represent mostly unrecognized fees billed or collected for measurement platform services. Deferred revenues are recognized as (or when) we perform under the contract.
Ad serving services were 76.7%, 93.6%, and 96.5% of the Company’s revenues for the years ended December 31, 2022, 2021 and 2020, respectively. Measurement services were 19.7%, 1.6% and 0.7% of the Company’s revenues for the years ended December 31, 2022, 2021 and 2020, respectively. Creative services were 3.6%, 4.8% and 2.8% of the Company’s revenues for the years ended December 31, 2022, 2021 and 2020, respectively.
Costs to obtain a contract
Contract costs include commission programs to compensate sales employees for generating sales orders with new customers or for new services with existing customers. Most commissions are commensurate. The Company elected to apply the practical expedient and recognize incremental costs of obtaining a contract as an expense when incurred if the amortization period of the asset that the Company otherwise would have recognized is one year or less. If commissions are not commensurate, the Company capitalizes these commissions. The term of amortization of capitalized commissions is three years. The amount of commissions capitalized as of December 31, 2022 is immaterial.
Cost of revenues
Cost of revenues consists primarily of costs to run the ad serving, creative and measurement services. These costs include hosting fees, cost to access data and personnel costs including stock-based compensation, professional services costs and facility related costs. The Company allocates overhead including rent and other facility related costs, communication costs based on headcount.
Research and development
Research and development expenses consist primarily of personnel costs, including stock-based compensation, professional services costs, hosting and facility related costs. We allocate overhead including rent and other facility related costs and communication costs based on headcount. We expect research and development expenses to increase in future periods to support our growth, including continuing to invest in optimization, accuracy and reliability of our platform and other technology improvements to support and drive efficiency in our operations. These expenses may vary from period to period as a percentage of revenue, depending primarily upon when we choose to make more significant investments.
Research and development costs are charged to the consolidated statements of operations as incurred. ASC 350-40, Internal-Use Software (“ASC 350-40”), requires the capitalization of certain costs incurred only during the application development stage.
Sales and marketing
Sales and marketing expenses consist primarily of personnel costs, including stock-based compensation, professional services costs and facility related costs as well as costs related to advertising, product management, promotional materials, public relations, other sales and marketing programs. The Company allocates overhead including rent and other facility related costs, communication costs based on headcount.
General and administrative
General and administrative expenses consist primarily of personnel costs, including stock-based compensation, for executive management, finance, accounting, human capital, legal and other administrative functions as well as professional services costs and facility related costs. The Company allocates overhead including rent and other facility related costs, communication costs based on headcount.
Net loss per common stock
Prior to the Company’s SPAC merger, the Company computed net loss per stock using the two-class method required for participating securities. The two-class method requires income available to common stockholders for the period to be allocated between common stocks and participating securities based upon their respective rights to receive dividends as if all income for the period had been distributed. The Company considered its preferred stocks to be participating securities as the holders of the preferred stocks would be entitled to dividends that would be distributed to the holders of common stocks, on a pro-rata basis assuming conversion of all preferred stocks into common stocks.
These participating securities do not contractually require the holders of such stocks to participate in the Company’s losses. As such, net loss for the periods presented was not allocated to the Company’s participating securities.
Following the SPAC merger, basic net loss per stock share is computed by dividing net income (loss) for each reporting period by the weighted-average number of ordinary shares outstanding during that period. Diluted net loss per stock is computed by dividing net income (loss) for each reporting period by the weighted average number of ordinary shares outstanding during the period, plus dilutive potential ordinary shares considered outstanding during the period. Diluted net loss per stock is the same as basic net loss per stock in periods when the effects of potentially dilutive stock of common stock are anti-dilutive.
All outstanding warrants, options and RSUs for the years ended December 31, 2022, 2021 and 2020 have been excluded from the calculation of the diluted net loss per share, because all such securities are anti-dilutive for all periods presented. Preferred stocks were converted and treasury stocks were cancelled as of December 31, 2021. For further information see Note 19 Basic and Diluted Net Loss Per Share.
Recently Adopted Accounting Pronouncements
In February 2016, the FASB issued the ASU No. 2016-02, Leases (Topic 842). The standard outlines a comprehensive lease accounting model that supersedes the previous lease guidance and requires lessees to recognize lease liabilities and corresponding right-of-use (“ROU”) assets for all leases with lease terms greater than 12 months. The guidance also changes the definition of a lease and expands the disclosure requirements of lease arrangements. Innovid adopted the standard in the first quarter of 2022 using the modified retrospective method. Results for reporting periods beginning after December 31, 2021, have been presented in accordance with the standard, while results for prior periods have not been adjusted and continue to be reported in accordance with the Company's historical accounting. The cumulative effect of initially applying the new leases standard was recognized as an adjustment to the opening consolidated balance sheet as of January 1, 2022.
The Company elected a package of practical expedients for leases that commenced prior to January 1, 2022, and did not reassess historical conclusions on: (i) whether any expired or existing contracts are or contain leases; (ii) lease classification for any expired or existing leases; and (iii) initial direct costs capitalization for any existing leases.
This standard has a significant impact on our consolidated balance sheet but did not have a significant impact on the Company’s consolidated statements of operations. The most significant effects relate to the recognition ROU assets and lease liabilities on interim consolidated balance sheet for real estate and cars operating leases.
Upon adoption, the Company recognized lease liabilities and corresponding ROU assets, adjusted for the accrued rent and remaining lease incentives received on the adoption date, as follows:
January 1, 2022
ROU assetsLease liabilities
Real Estate$3,928 $5,482 
Cars50 50 
Total operating leases$3,978 $5,532 
See Note 8, Leases for further details.
In December 2019, the FASB issued ASU 2019-12, Income Taxes (Topic 740): Simplifying the Accounting for Income Taxes (“ASU 2019-12”). The new guidance eliminates certain exceptions related to the approach for intraperiod tax allocation, the methodology for calculating income taxes in an interim period and the recognition of deferred tax liabilities for outside basis differences. It also clarifies and simplifies other aspects of the accounting for income taxes. Innovid adopted the standard in the first quarter of 2022. The adoption of the guidance did not have a material impact on the Company’s consolidated financial statements.
In October 2021, the FASB issued ASU 2021-08, Business Combinations (Topic 805), Accounting for Contract Assets and Contract Liabilities from Contracts with Customers, which requires contract assets and contract liabilities (i.e., deferred revenue) acquired in a business combination to be recognized and measured by the acquirer on the acquisition date in accordance with ASC 606, Revenue from Contracts with Customers. This new guidance will result in the acquirer recognizing contract assets and contract liabilities at the same amounts recorded by the acquiree. Historically, such amounts were recognized by the acquirer at fair value in acquisition accounting. The Company adopted the standard effective in the first quarter of 2022. The adoption of the guidance did not have a material impact on the Company’s consolidated financial statements.
Recently issued accounting pronouncements not yet adopted by the Company
As an “emerging growth company,” the JOBS Act allows the Company to delay adoption of new or revised accounting pronouncements applicable to public companies until such pronouncements are made applicable to private companies. The Company has elected to use this extended transition period under the JOBS Act. The adoption dates discussed below reflect this election.
In August 2020, the FASB issued ASU 2020-06, Debt — Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging — Contracts in Entity’s Own Equity (Subtopic 815-40): Accounting for Convertible Instruments and Contracts in an Entity’s Own Equity (“ASU 2020-06”). The final guidance issued by the FASB for convertible instruments eliminates two of the three models in ASC 470-20 that require separate accounting for embedded conversion features. Separate accounting is still required in certain cases. Additionally, among other changes, the guidance eliminates some of the conditions for equity classification in ASC 815-40-25 for contracts in an entity’s own equity. The guidance also requires entities to use the if-converted method for all convertible instruments in the diluted earnings per share calculation and include the effect of share settlement for instruments that may be settled in cash or shares, except for certain liability-classified share-based payment awards. ASU 2020-06 is effective for fiscal years beginning after December 15, 2023, and interim periods within those fiscal years. The Company evaluated the potential impact of this guidance on its consolidated financial statements and determined that it will not have an impact on the consolidated financial statements.
In June 2016, the FASB issued ASU 2016-13, Financial Instruments – Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments (“ASU 2016-13”). ASU 2016-13 requires the measurement of all expected credit losses for financial assets held at the reporting date based on historical experience, current conditions, and reasonable and supportable forecasts. ASU 2016-13 requires enhanced qualitative and quantitative disclosures to help investors and other financial statement users better understand significant estimates and judgments used in estimating credit losses, as well as the credit quality and underwriting standards of an organization’s portfolio. ASU 2016-13 is effective for fiscal years beginning after December 15, 2022, and interim periods within those fiscal years. The Company has evaluated the impact of this accounting standard update and has determined that its adoption will impact how the Company assesses its estimates for credit losses, but will not have an impact on the consolidated financial statements.

Other guidance that has been issued since the end of our previous reporting period is not expected to have an impact on the Company’s consolidated financial statements.
XML 28 R11.htm IDEA: XBRL DOCUMENT v3.22.4
TRANSACTION
 12 Months Ended
Dec. 31, 2022
Business Combination and Asset Acquisition [Abstract]  
TRANSACTION TRANSACTION
On November 30, 2021, the Transaction was closed. The Transaction was accounted for as a reverse recapitalization. Under this method of accounting, ION who was the legal acquirer, was treated as the acquired company for accounting purposes and the Transaction was treated as the equivalent of Innovid Corp. issuing stock for the net assets of ION. The net assets of ION are stated at historical cost, with no goodwill or other intangible assets recorded.
Upon the consummation of the Transaction all outstanding shares of Innovid Inc. common stock, Innovid Inc. redeemable convertible preferred stock, Innovid Inc. warrants, and Secondary Sale Transaction of 6,885,486 shares to PIPE investors, were exchanged for 93,787,278 shares of common stock in Innovid Corp.

Number of shares
Legacy Innovid common stock of January 1, 202116,275,609 
Warrant exercised132,392 
Stock option exercised3,180,943 
Conversion of redeemable convertible preferred stock into common stock73,690,340 
Conversion of Legacy Innovid Warrants507,994 
Exchanged into Innovid Corp. common stock on November 30, 202193,787,278 
Holders of 19,585,174 shares of ION’s Class A common stock sold in its initial public offering (the “Initial Shares”) exercised their right to have such shares redeemed for a full pro rata portion of the trust account holding the proceeds from ION IPO, which was approximately $10.00 per share, or $195,888 in the aggregate. The remaining shares of ION Class A common stock, including total shares of ION Class B common stock converted to ION Class A common stock immediately prior to the Domestication, were automatically converted to 12,039,826 shares of common stock in Innovid Corp.
After giving effect to the Transaction, the redemption of Initial Shares as described above and the consummation of the PIPE Investment, there were 118,941,618 shares of common stock issued and outstanding after the close of the Transaction.
Innovid Corp. received approximately $149,252 in cash proceeds, net of transaction costs paid. The Company paid an accrued liability of $3,185 directly related to the Transaction as of December 31, 2021.
The following table reconciles the elements of the Transaction to the Consolidated statement of cash flows and the Consolidated Statement of Changes in Temporary Equity and Stockholders’ Equity for the year ended December 31, 2021.

Total value
Cash - ION trust account and cash, net of redemptions
$55,466 
Cash - PIPE Investment, net of Secondary Sale Amount of $68,855
131,145 
Less: Transaction costs paid
(31,160)
Less: Deferred underwriting fee paid(6,199)
Proceeds from reverse recapitalization, net
149,252 
Less: Accrued transaction costs not yet paid*
(3,185)
Less: Company Warrant assumed as part of the Transaction
(22,791)
Plus: Transaction costs allocated to Company Warrant2,750 
Reverse recapitalization, net
$126,026 
* These amounts were paid in 2022.
As a result of the Transaction, each share of Innovid Inc. redeemable convertible preferred stock and common stock was converted into the right to receive approximately 1.337 shares of the common stock of the Company.
The consolidated assets, liabilities and results of operations prior to the Transaction are those of Innovid Inc.. The stocks and corresponding capital amounts and losses per stock, prior to the Transaction, have been retroactively restated based on stocks reflecting the exchange ratio established in the Transactions.
The equity structure has been recast in all comparative periods up to the Closing Date to reflect the number of shares of the Company’s common stock, $0.0001 par value per share, issued to Innovid Inc.’s stockholders in connection with the Transaction. As such, the shares and corresponding capital amounts and earnings per share related to Innovid Inc. redeemable convertible preferred stock and Innovid Inc.'s common stock prior to the Transaction have been retroactively recast as shares reflecting the exchange ratio of 1.337 established in the Transaction.
Public Warrants and Private Placement Warrants
As a result of the Transaction, the Company assumed the outstanding Public Warrants to purchase 3,162,500 shares of the Company’s common stock and the outstanding Private Warrants to purchase 7,060,000 shares of the Company’s common stock. Each whole Warrant entitles the registered holder to purchase one share of the Company’s common stock at a price of $11.50 per share, at any time commencing 30 days after the closing of the Transaction. The warrants expire five years after the completion of the Transaction. Refer to Note 11, Warrants for further discussion.
XML 29 R12.htm IDEA: XBRL DOCUMENT v3.22.4
ACQUISITION
 12 Months Ended
Dec. 31, 2022
Business Combination and Asset Acquisition [Abstract]  
ACQUISITION ACQUISITION
On February 28, 2022, the Company completed the acquisition of TVS. TVS is an independent global measurement and attribution platform for converged TV and a private company limited by shares incorporated under the laws of Scotland. The Company acquired all the equity of TVS for an aggregate amount of approximately $100,000 in cash, 11,549,465 shares of the Company common stock at fair value of $3.80 per share, and the issuance of 949,893 fully vested stock option of the Company at weighted average fair value of $3.49, subject to certain adjustments as defined in the Stock Purchase Agreement.
The Company, through this acquisition, added a real-time, cross-platform service to its offerings, including measurement outcomes such as frequency and unique unduplicated reach and performance metrics. The combination of ad serving, and cross-platform measurement enables the buy- and sell-sides to solve fragmentation by unlocking a complete picture of advertising across the linear TV, CTV and digital video marketplaces.
The acquisition of TVS has been accounted for as a business combination using the acquisition method of accounting. The acquisition method requires that assets acquired and liabilities assumed in a business combination be recognized at their fair values as of the acquisition date. The valuation of assets acquired and liabilities assumed have been finalized as of December 31, 2022. The Company finalized the purchase accounting for the TVS acquisition during the fourth quarter of fiscal 2022.
The following table summarizes the fair value of assets acquired and liabilities assumed as of the acquisition date:

Total value
Cash and cash equivalents
$5,318 
Accounts receivables
4,186
Other current assets1,173
Property and equipment154
Total tangible assets
10,831 
Technology15,075
Customer relationships
16,700
Trade name
2,000
Goodwill
112,421
Total assets acquired
157,027 
Less: Deferred tax liabilities(1,677)
Less: Other assumed liabilities
(3,782)
Net assets acquired
$151,568 
Intangible assets related to technology, customer relationship and trade name are being amortized over the estimated useful life of approximately 6 years, 11 years, and 4 years, respectively. The estimated fair values of identifiable intangible assets were determined using the "income approach", which is a valuation technique that provides an estimate of the fair value of an asset based on market participant expectations of the cash flows an asset would generate over its remaining useful life. Some of the more significant assumptions inherent in the development of these asset valuations include the estimated net cash flows for each year for the appropriate discount rate necessary to measure the risk inherent in each future cash flow stream, the life cycle of each asset, competitive trends impacting the asset and each cash flow stream, as well as other factors.
Goodwill was calculated as the excess of the consideration transferred over the net assets recognized and represents the future economic benefits arising from the other assets acquired that could not be individually identified and separately recognized. Specifically, the goodwill recognized from the acquisition of TVS represents the value of additional growth potential of the revenue base from the creation of a single combined global organization and synergies related to combined IT efforts for enhancement of the existing and acquired technologies. The goodwill is not deductible for tax purposes.
In addition to the purchase consideration, the Company entered cash compensation arrangements with certain employees, which amounted to $9,700 in aggregate and are subject to certain performance and employment conditions following the acquisition date.
The Company incurred approximately $5.0 million in total transaction costs for the acquisition. Acquisition related transaction costs include legal, accounting fees and other professional costs directly related to the acquisition and are recognized in “general and administrative” in the consolidated statements of operations.
Unaudited Pro Forma Financial Information
The following table presents the unaudited pro forma combined results of Innovid and TVS for the year ended December 31, 2022, and 2021 as if the acquisition of TVS had occurred on January 1, 2021:
Twelve months ended December 31,
2022

2021
(Unaudited)(Unaudited)
Revenues$131,433 $112,147 
Net loss(14,634)(37,195)
The unaudited pro forma combined financial information was prepared using the acquisition method of accounting and was based on the historical financial information of Innovid and TVS. In order to reflect the occurrence of the acquisition on January 1, 2021, the unaudited pro forma financial information includes adjustments to reflect incremental amortization expense to be incurred based on the current preliminary fair values of the identifiable intangible assets acquired and the reclassification of acquisition-related costs incurred during the three months and twelve months ended December 31, 2022 to the three months and twelve months ended December 31, 2021. The unaudited pro forma financial information is not necessarily indicative of what the consolidated results of operations would have been had the acquisition been completed on January 1, 2021. In addition, the unaudited pro forma financial information is not a projection of future results of operations of the combined company.
XML 30 R13.htm IDEA: XBRL DOCUMENT v3.22.4
INTANGIBLE ASSETS, NET
 12 Months Ended
Dec. 31, 2022
Goodwill and Intangible Assets Disclosure [Abstract]  
INTANGIBLE ASSETS, NET INTANGIBLE ASSETS, NET
The Company amortizes intangible assets on a straight line basis over their estimated useful lives. The estimated useful life, gross carrying amounts and accumulated amortization totals related to our identifiable intangible assets are as follows:
December 31, 2022
Estimated Useful LifeGross Carrying AmountAccumulated AmortizationNet Carrying Amount
Customer relationships11 years$16,898 $(1,469)$15,429 
Acquired technology6 years15,275 (2,367)12,907 
Trade name4 years2,000 (418)1,582 
Total$34,173 $(4,254)$29,918 
The weighted average useful life of our intangible assets at December 31, 2022 was 7.64 years. As described in Note 4, Acquisition, we acquired several intangible assets as part of the TVS acquisition. The Company assesses intangible assets for indicators of impairment on an annual basis, including an evaluation of our useful lives to determine if events and circumstances warrant a revision to the remaining period of amortization. If indicators of impairment are present, amortizable intangible assets are tested for impairment by comparing the carrying value to undiscounted cash flows and, if impaired, written down to fair value based on discounted cash flows. The company have not identified an impairment, nor a material change to the estimated remaining useful lives of its intangible assets during fiscal years 2022 and 2021. The intangible assets have no assigned residual values.
Amortization expense recorded for intangible assets was $3,850, $33, and $199 during fiscal years 2022, 2021, and 2020, respectively.
As of December 31, 2022, estimated intangible asset amortization expense for each of the next five years and thereafter are as follows:
Fiscal YearAmortization Expense
2023$4,518 
20244,518 
20254,518 
20264,081 
20274,018 
Thereafter8,265 
Total$29,918 
XML 31 R14.htm IDEA: XBRL DOCUMENT v3.22.4
PREPAID AND OTHER CURRENT ASSETS
 12 Months Ended
Dec. 31, 2022
Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Abstract]  
PREPAID AND OTHER CURRENT ASSETS PREPAID AND OTHER CURRENT ASSETS
Prepaid and other current assets consist of the following:

December 31,

2022

2021
Prepaid expenses$1,721 $2,333 
Deposits99 142 
Government authorities204 153 
Other current assets616 503 
Total
$2,640 $3,131 
XML 32 R15.htm IDEA: XBRL DOCUMENT v3.22.4
PROPERTY AND EQUIPMENT, NET
 12 Months Ended
Dec. 31, 2022
Property, Plant and Equipment [Abstract]  
PROPERTY AND EQUIPMENT, NET PROPERTY AND EQUIPMENT, NET
Property and equipment consist of the following:

December 31,

2022

2021
Cost:


Software development costs$13,190 $2,594 
Computers and peripheral equipment2,283 1,779 
Office furniture and equipment665 661 
Leasehold improvements2,167 2,164 

18,305 7,198 
Accumulated depreciation(3,983)(2,358)
Depreciated cost$14,322 $4,840 
The depreciation expense for the years ended December 31, 2022, 2021 and 2020 was $1,626, $630 and $531, respectively.
XML 33 R16.htm IDEA: XBRL DOCUMENT v3.22.4
LEASES
 12 Months Ended
Dec. 31, 2022
Leases [Abstract]  
LEASES LEASES
The Company has the following operating ROU assets and lease liabilities:
December 31, 2022
ROU assetsLease liabilities
Real Estate$2,886 $3,801 
Cars24 21 
Total operating leases$2,910 $3,822 
December 31, 2022
Lease liabilities
Current lease liabilities$2,186 
Non-current lease liabilities1,636 
Total lease liabilities$3,822 
The following table summarizes the lease costs recognized in the consolidated statement of operations:
Year ended
December 31, 2022
Operating lease cost$1,889 
Short term lease cost973 
Variable lease cost48 
Total lease cost$2,910 
As of December 31, 2022, the weighted-average remaining lease term and weighted-average discount rate for operating leases are 2.2 years and 3.6%, respectively.
The following table presents supplementary cash flow information regarding the company's operating leases:
Year ended
December 31, 2022
Cash paid for amounts included in the measurement of lease liabilities$2,162 
Right of use assets obtained in exchange for operating lease liabilities upon lease modification$610 

The following table summarizes the future payments of Innovid for its operating lease liabilities:
December 31, 2022
2023$2,219 
20241,018 
2025669 
Total undiscounted lease payments$3,906 
Less: Interest(84)
Total lease liabilities - operating$3,822 
Lease Disclosures Related to Periods Prior to the Adoption of ASU 2016-02 are as follows:
Operating lease expenses for the years ended December 31, 2021 and 2020 were $2,072 and, $2,215, respectively.
Future minimum lease commitments under non-cancelable operating leases as of December 31, 2021, are as follows:
Year ended December 31, 2021
Rental of premisesLease of motor vehicles
2022$2,486 $8 
20231,844 — 
2024826 — 
2025770 — 
Total
$5,926 $8 
XML 34 R17.htm IDEA: XBRL DOCUMENT v3.22.4
ACCRUED EXPENSES AND OTHER CURRENT LIABILITIES
 12 Months Ended
Dec. 31, 2022
Payables and Accruals [Abstract]  
ACCRUED EXPENSES AND OTHER CURRENT LIABILITIES ACCRUED EXPENSES AND OTHER CURRENT LIABILITIES
Accrued expenses and other current liability consist of the following:
December 31,
2022

2021
Accrued expenses$3,544 $2,485 
Tax payables1,325 39 
Deferred revenue426 — 
Accrued lease liability, current portion— 420 
Other current liabilities179 138 
Total
$5,474 $3,082 
XML 35 R18.htm IDEA: XBRL DOCUMENT v3.22.4
OTHER NON-CURRENT LIABILITIES
 12 Months Ended
Dec. 31, 2022
Other Liabilities Disclosure [Abstract]  
OTHER NON-CURRENT LIABILITIES OTHER NON-CURRENT LIABILITIES
Other non-current liabilities consist of the following:

December 31,
2022

2021
Accrued lease liability$— $996 
Uncertain tax position3,865 2,459 
Deferred tax liability489 — 
Other non-current liabilities2,200 — 
Total
$6,554 $3,455 
XML 36 R19.htm IDEA: XBRL DOCUMENT v3.22.4
WARRANTS
 12 Months Ended
Dec. 31, 2022
Derivative Instruments and Hedging Activities Disclosure [Abstract]  
WARRANTS WARRANTS
As of December 31, 2022, the Company had 3,162,500 Public Warrants and 7,060,000 Private Warrants outstanding.
Public Warrants
Warrants may only be exercised for a whole number of shares. No fractional shares will be issued upon exercise of the Public Warrants. The Public Warrants will become exercisable on the later of (a) 30 days after the completion of the Transaction and (b) one year from the closing of the Initial Public Offering. The Public Warrants will expire five years from the completion of the Transaction or earlier upon redemption or liquidation.
Redemption of warrants when the price per share of Innovid Corp. common stock equals or exceeds $18.00.
Once the warrants become exercisable, the Company may redeem the outstanding warrants (except as described with respect to the Private Placement Warrants):
•in whole and not in part.
•at a price of $0.01 per warrant.
•upon a minimum of 30 days’ prior written notice of redemption to each warrant holder; and
•if, and only if, the closing price of the Innovid Corp. common stock equals or exceeds $18.00 per share (as adjusted) for any 20 trading days within a 30-trading day period ending three business days before the Company sends the notice of redemption to the warrant holders.
When the warrants become redeemable by the Company, the Company may exercise its redemption right even if it is unable to register or qualify the underlying securities for sale under all applicable state securities laws.
The Company has established the last of the redemption criterion discussed above to prevent a redemption call unless there is at the time of the call a significant premium to the warrant exercise price. If the foregoing conditions are satisfied and the Company issues a notice of redemption of the warrants, each warrant holder will be entitled to exercise the warrant prior to the scheduled redemption date. However, the price of the Company’s common shares may fall below the $18.00 redemption trigger price (as adjusted for share sub-divisions, share capitalization, reorganization, recapitalization and the like) as well as the $11.50 warrant exercise price after the redemption notice is issued.
Redemption of warrants when the price per share of Innovid Corp. common stock equals or exceeds $10.00.
Once the warrants become exercisable, the Company may redeem the outstanding warrants:
•in whole and not in part.
•at a price of $0.10 per warrant.
•upon a minimum of 30 days’ prior written notice of redemption; if holders will be able to exercise their warrants on a cashless basis prior to redemption and receive that number of shares determined based on the redemption date and the fair market value of the Innovid Corp. common stock; and
•if, and only if, the closing price of the Innovid Corp. ordinary shares equals or exceeds $10.00 per share (as adjusted) for any 20 trading days within a 30-trading day period ending three business days before the Company sends the notice of redemption to the warrant holders.
If the Company calls these Public Warrants for redemption, as described above, its management will have the option to require any holder that wishes to exercise the Public Warrants to do so on a “cashless basis,” as described in the warrant agreement. The exercise price and number of ordinary shares issuable upon exercise of the Public Warrants may be adjusted in certain circumstances including in the event of a share dividend, extraordinary dividend or recapitalization, reorganization, merger, or consolidation. However, except as described below, the Public Warrants will not be adjusted for issuances of ordinary shares at a price below their exercise price. Additionally, in no event will the Company be required to net cash settle the Public Warrants.
Private Placement Warrants
The Private Placement Warrants are identical to the Public Warrants, except that the Private Placement Warrants and the Innovid Corp. ordinary shares issuable upon the exercise of the Private Placement Warrants will not be transferable, assignable or salable until 30 days after the completion of the Transaction subject to certain limited exceptions. Additionally, the Private Placement Warrants will be exercisable on a cashless basis and be non-redeemable, except as described above, so long as they are held by the initial purchaser or its permitted transferees.
The Company evaluated the Company Warrants (Public Warrants and Private Placement Warrants) in accordance with ASC 480, “Distinguishing Liabilities from Equity” and ASC 815-40, “Derivatives and Hedging — Contracts in Entity’s Own Equity” and concluded that the warrants do not meet all the conditions to be classified as equity pursuant to ASC 815-40. As the warrants do not meet all the requirements for equity classification, the Company Warrants are recorded as liabilities on the Balance Sheets and measured at fair value with changes in fair value recognized in the Statements of Operations in the period of change. The Company Warrants’ fair value as of December 31, 2022 and 2021 was $4,301 and $18,972, respectively.
XML 37 R20.htm IDEA: XBRL DOCUMENT v3.22.4
LONG-TERM DEBT
 12 Months Ended
Dec. 31, 2022
Debt Disclosure [Abstract]  
LONG-TERM DEBT LONG-TERM DEBT
2022 A&R Agreement
On August 4, 2022, two wholly owned subsidiaries of the Company, Innovid LLC and TV Squared Inc, entered an amended and restated loan and security agreement with Silicon Valley Bank (the “2022 A&R Agreement”), to increase the revolving line of credit from $15,000 to $50,000 (the “New Revolving Credit Facility”). The interest for the New Revolving Credit Facility is payable monthly in arrears. The New Revolving Credit Facility bears interest at an annual rate which is the greater of (a) WSJ Prime Rate plus 0.75% or (b) 4.25%, on the aggregate outstanding balance. Additional fees include fees in an amount of 0.20% per annum of the average unused portion of the New Revolving Credit Facility to be paid quarterly in arrears. The Company will also pay non-refundable commitment fees of $40 and $75 at inception and first anniversary date, respectively. The maturity date of the 2022 A&R Agreement is June 30, 2024. The New Revolving Credit Facility is subject to certain customary conditions precedent to the credit extension as stated in the 2022 A&R Agreement.
The New Revolving Credit Facility requires the Company to comply with all covenants, primarily maintaining an adjusted quick ratio of at least 1.30 to 1.00. As defined in the 2022 A&R Agreement “adjusted quick ratio” is the ratio of (a) quick assets to (b) current liabilities minus the current portion of deferred revenue. “Quick assets” are determined as the Company’s unrestricted cash plus accounts receivable, net, and is determined according to US GAAP. The Company is also required to maintain the minimum quarterly adjusted EBITDA as defined in the 2022 A&R Agreement if the Company does not maintain the quarterly adjusted quick ratio of at least 1.50 to 1.00.
As of December 31, 2022, the Company utilized $20,000 of the $50,000 credit line, $6,000 of which was drawn during 2020, $5,000 was drawn during the fourth quarter 2022 and $9,000 was drawn during the second quarter of 2022. In January 2023, the Company repaid $5,000 under the credit line.
As of December 31, 2022, the Company is in compliance with all the covenants.
Prior to the 2022 A&R Agreement, the credit installments bore US dollar denominated interest at an annual rate equal to 0.75%-1% plus a prime rate on the outstanding principal of each credit installment.
FINANCE EXPENSES (INCOME), NETThe Company recognizes the gains and losses from the remeasurement of the warrants liability related to Public Warrants and Private Placement Warrants in “Finance expenses (income), net” in the consolidated statements of operations. The unrealized gain from changes in the fair value of the Company Warrants for the years ended December 31, 2022 and 2021 was $14,671 and $3,819, respectively.The Company also recognized interest expenses in “Finance expenses (income), net” in the consolidated statements of operations. Interest expenses for the years ended December 31, 2022, 2021 and 2020 were $675, $259 and $328, respectively.
XML 38 R21.htm IDEA: XBRL DOCUMENT v3.22.4
COMMITMENTS AND CONTINGENT LIABILITIES
 12 Months Ended
Dec. 31, 2022
Commitments and Contingencies Disclosure [Abstract]  
COMMITMENTS AND CONTINGENT LIABILITIES COMMITMENTS AND CONTINGENT LIABILITIES
Pledges and bank guarantees:
1.In conjunction with the 2022 A&R Agreement (see Note 12, Long-term Debt), Innovid LLC. pledged 65,000 common stocks of its Israeli Subsidiary, NIS 0.01 par value each.
2.The Israeli Subsidiary pledged bank deposits in an aggregate amount of $629 in connection with an office rent agreement and credit cards.
3.Innovid Inc. obtained bank guarantees in an aggregate amount of $231 in connection with its office lease agreements.
Legal contingencies:
On March 4, 2022, a lawsuit was filed in the United States District Court for the Western District of Texas on March 4, 2022, by Nielsen, LLC against TVS alleging infringement of US Patent No. 10,063,378. On January 18, 2023 the Texas Court granted TVS’s motion to transfer venue to the Southern District of New York. It is expected that the Southern District of New York will issue a scheduling order detailing the next steps in the case in March 2023. The plaintiff has not specified the amount sought in the litigation.
XML 39 R22.htm IDEA: XBRL DOCUMENT v3.22.4
STOCKHOLDERS’ EQUITY
 12 Months Ended
Dec. 31, 2022
Temporary Equity Disclosure [Abstract]  
STOCKHOLDERS’ EQUITY STOCKHOLDERS’ EQUITY
Stockholders’ equity:
AuthorizedIssuedOutstanding
December 31,December 31,December 31,
2022

20212022

2021

20222021
Stocks of $0.0001, par value each:
Common stocks500,000,000 500,000,000 133,882,414 119,017,380 133,882,414 119,017,380 
The shares of the Company’s common stock, prior to the Transaction (as discussed in Note 3, Transaction) have been retrospectively adjusted to reflect the exchange ratio of 1.337 established in the Transaction.
i.Common stocks:
The rights and privileges of the common stocks are as follows:
Voting Rights - The holders of the common stocks are entitled to one vote for each share of common stocks.
Dividend Rights - Subject to preferences that may be applicable to dividends of any outstanding preferred stocks, dividends may be paid on the common stocks as and when declared by the Board of Directors. Such dividends will be distributed among the holders of common stocks pro rata in proportion of the number of common stocks held by each.
Liquidation Rights - In the event of any voluntary or involuntary liquidation, dissolution or winding up of the Company’s affairs, the holders of the Company common stock are entitled to share ratably in all assets remaining after payment of the Company’s debts and other liabilities, subject to prior distribution rights of the Company preferred stock or any class or series of stock having a preference over the Company common stock, then outstanding, if any.
Redemption Rights - The common stocks are not redeemable.
Options outstanding and options available for future option grants have been retroactively adjusted to give effect to the exchange ratio.
ii.Treasury stocks: As of December 31, 2022 there are no treasury stock issued or outstanding
iii.Equity classified warrants:
The Company issued 133,725 warrants to American Friends of Tmura, Inc. (the “Holder”) on February 25, 2010 to purchase an aggregate of 133,725 shares of the Company’s common stock, $0.001 par value each, with an exercise price of $0.07 which is subject to an adjustment on the occurrence of certain events. The warrants are exercisable until March 1, 2029. The warrants were recorded within equity based on their fair value on the date of issuance. These warrants are not remeasured. All equity classified warrants were exercised in November 2021 on a non-cash basis.
XML 40 R23.htm IDEA: XBRL DOCUMENT v3.22.4
STOCK-BASED COMPENSATION
 12 Months Ended
Dec. 31, 2022
Share-Based Payment Arrangement [Abstract]  
STOCK-BASED COMPENSATION STOCK-BASED COMPENSATION
The Innovid Corp. Incentive Plan (“2021 Incentive Plan”)
A total number of Company common stock equal to 10% of the fully-diluted shares outstanding following the closing of the Transaction will initially be authorized and reserved for issuance under the 2021 Incentive Plan, which is 15,617,049 shares of Company common stock. The number of shares authorized and reserved for issuance will be subject to an annual increase for 10 years on the first day of each calendar year beginning January 1, 2022, equal to the lesser of (A) 5% of the aggregate number of shares of Company common stock outstanding on the final day of the immediately preceding calendar year and (B) such smaller number of shares as is determined by the board of directors of Innovid Corp. The maximum number of shares of Company common stock that may be issued pursuant to the exercise of incentive stock options granted under the 2021 Incentive Plan will be equal to 30% of the total number of issued and outstanding shares of Company common stock on a fully diluted basis as of the closing of the Transaction, see Note 3, Transaction.
If shares covered by an award are not purchased or are forfeited or expire, or otherwise terminate without delivery of any shares subject thereto, then such shares will, to the extent of any such forfeiture, termination, cash-settlement or expiration, be available for future grant under the 2021 Incentive Plan. The payment of dividend equivalent rights in cash in conjunction with any outstanding awards will not be counted against the shares available for issuance under the 2021 Incentive Plan, and shares tendered by a participant, repurchased by the Company using proceeds from the exercise of stock options or withheld by the Company in payment of the exercise price of a stock option or to satisfy any tax withholding obligation for an award will not again be available for future awards.
Innovid Stock Plan (“Innovid Stock Plan")
Under the Innovid Stock Plan, options may be granted to officers, directors, employees and non-employee consultants of the Company. Each option granted under the Plan expires no later than 10 years from the date of grant. The options vest usually over four years from commencement of employment or services. Any options, which are forfeited or not exercised before expiration, become available for future grants. From and after the effectiveness of the 2021 Incentive Plan, no additional awards will be granted under the Innovid Stock Plan. Upon the effectiveness of the Transaction, all outstanding stock options under the Innovid Stock Plan, whether vested or unvested, were converted into options to purchase a number of shares of common stock of the Company. Awards previously granted under the Innovid Stock Plan will continue to be subject to the provisions thereof.
Stock-based compensation expense
Stock-based compensation expense is related to awards issued to employees pursuant to the Innovid Stock Plan and the 2021 Incentive Plan, summarized as follows:

Year ended December 31,

202220212020
Cost of goods sold
$1,171 $43 $11 
Research and development
3,489 501 121 
Sales and marketing
4,685 470 196 
General and administrative
3,342 1,997 92 
Total
$12,687 $3,011 $420 
In connection with the options granted to service providers and non-employee consultants, during the twelve months ended December 31, 2022, 2021 and 2020, the Company recorded stock compensation expenses in the amount of $1,190, $262 and $162, respectively. The majority of these expenses were recorded in general and administrative.
During the twelve months ended December 31, 2022 the Company capitalized stock-based compensation expense of $1,165 in internal-use software cost. The Company stock-based compensation expense related to internal-use software cost for the same period in 2021 were immaterial.
Stock Options
Stock options may be granted to officers, directors, employees, and non-employee consultants of the Company. Each option granted under the Plan expires no later than 10 years from the date of grant. The options vest usually over four years from commencement of employment or services. Any options, which are forfeited or not exercised before expiration, become available for future grants.
In connection with the TVS acquisition, Innovid issued 949,893 stock options to holders of TVS options for replacement options. These options were fully vested upon issuance due to acceleration upon acquisition and therefore do not require future service for vesting. The Company attributed a total amount of $152 to post acquisition service and recorded it as stock compensation expenses immediately after the acquisition closed. See Note 4, Acquisition for further details.
A summary of the employees’ stock option activity under the Innovid Stock Plan and the 2021 Incentive Plan for the years ended December 31, 2022 is as follows:

Year ended
December 31, 2022

Amount
of
options
Weighted
average
exercise
price
Weighted
average
remaining contractual term
(in years)
Aggregate intrinsic value (in thousands)
Outstanding at beginning of year
11,122,648 $0.82 6.87$64,818 
Transfer between employee and consultant40,118 0.64 
Granted2,105,258 2.10 
Granted in acquisition949,893 0.31 
Forfeited(355,998)1.60 
Expired(26,089)1.37 
Exercised(3,149,387)0.30 
Outstanding at end of year
10,686,443 $1.15 6.85$5,923 
Exercisable options at end of year
6,687,488 $0.75 5.77$6,409 

A summary of the consultants’ stock option activity under the Innovid Stock Plan for the year ended December 31, 2022 is as follows:

Year ended
December 31, 2022

Amount
of
options
Weighted
average
exercise
price
Weighted
average
remaining contractual term
(in years)
Aggregate intrinsic value (in thousands)
Outstanding at beginning of year
179,627 $0.31 2.34$1,139 
Consultant has become employee(40,118)0.64 
Granted— — 
Forfeited(460)2.81 
Expired(209)2.81 
Exercised(69,298)0.30 
Outstanding at end of year
69,542 $0.47 4.21$86 
Exercisable options at end of year
64,524 $0.46 3.93$81 
As of December 31, 2022, the Company had approximately $4,536 of total unrecognized compensation cost related to non-vested stock-based compensation. That cost is expected to be recognized over a weighted-average period of 1.8 years years.
The Company estimated the fair value of each option on the date of grant using the Black-Scholes option pricing model applying the weighted-average assumptions in the following table:

Year ended December 31,

2022

20212020
Expected volatility
69%-71%
65 %79 %
Expected dividends
— %— %— %
Expected term (in years)
4.316.026.11
Risk free interest
2.84%-3.81%
1.06%-1.11%
0.62%-0.82%
Restricted Stock Units
In connection with the Company’s transition to its next life-cycle stage post Transaction, Restricted Stock Units (“RSUs”) may be granted to officers, directors, employees, and non-employee consultants of the Company, and generally vest over a three- or four-year period.
A summary of the employees’ RSU activity under the 2021 Incentive Plan for the year ended December 31, 2022 is as follows:

Number of share units
Weighted
average
grant date
fair value
Outstanding at beginning of year
— — 
Granted9,329,639 5.65 
Released(96,884)5.90 
Forfeited(1,246,382)5.97 
Outstanding at end of year
7,986,373 $5.60 
A summary of the consultants’ RSU activity under the 2021 Incentive Plan for the year ended December 31, 2022 is as follows:

Number of share units
Weighted
average
grant date
fair value
Outstanding at beginning of year
— — 
Granted176,151 6.52 
Forfeited(45,883)6.28 
Outstanding at end of year
130,268 $6.60 
The weighted-average grant-date fair value of RSUs generally is determined based on the number of units granted and the quoted price of Innovid’s common stock on the date of grant.
As of December 31, 2022, $33,165 of unrecognized compensation cost related to RSUs is expected to be recognized as expense over the weighted average period of 2.0 years.
The Innovid Corp. Employee Stock Purchase Plan
On November 30, 2021, the ESPP became effective. A total of 2,868,438 shares of Company common stock were initially reserved for issuance under the ESPP. The compensation committee of our board of directors is the plan administrator of the ESPP and has the authority to interpret the terms of the ESPP and determine eligibility of participants. On the first day of each calendar year beginning on January 1, 2022 and ending on (and including) January 1, 2031, the number of shares available for issuance under the ESPP will be increased by a number of shares equal to the lesser of (i) 1% of the shares outstanding on the final day of the immediately preceding calendar year, and (ii) such smaller number of shares as determined by the board of directors. If any right granted under the ESPP terminates for any reason without having been exercised, the shares subject thereto that are not purchased under such right will again be available for issuance under the ESPP. Notwithstanding the foregoing, no more than 17,383,002 shares of Company Common Stock may be issued under the Section 423 Component of the ESPP.
As of December 31, 2022, the Company had not granted any options under the Innovid Corp. Employee Stock Purchase Plan.
XML 41 R24.htm IDEA: XBRL DOCUMENT v3.22.4
FINANCE EXPENSES (INCOME), NET
 12 Months Ended
Dec. 31, 2022
Other Income and Expenses [Abstract]  
FINANCE EXPENSES (INCOME), NET LONG-TERM DEBT
2022 A&R Agreement
On August 4, 2022, two wholly owned subsidiaries of the Company, Innovid LLC and TV Squared Inc, entered an amended and restated loan and security agreement with Silicon Valley Bank (the “2022 A&R Agreement”), to increase the revolving line of credit from $15,000 to $50,000 (the “New Revolving Credit Facility”). The interest for the New Revolving Credit Facility is payable monthly in arrears. The New Revolving Credit Facility bears interest at an annual rate which is the greater of (a) WSJ Prime Rate plus 0.75% or (b) 4.25%, on the aggregate outstanding balance. Additional fees include fees in an amount of 0.20% per annum of the average unused portion of the New Revolving Credit Facility to be paid quarterly in arrears. The Company will also pay non-refundable commitment fees of $40 and $75 at inception and first anniversary date, respectively. The maturity date of the 2022 A&R Agreement is June 30, 2024. The New Revolving Credit Facility is subject to certain customary conditions precedent to the credit extension as stated in the 2022 A&R Agreement.
The New Revolving Credit Facility requires the Company to comply with all covenants, primarily maintaining an adjusted quick ratio of at least 1.30 to 1.00. As defined in the 2022 A&R Agreement “adjusted quick ratio” is the ratio of (a) quick assets to (b) current liabilities minus the current portion of deferred revenue. “Quick assets” are determined as the Company’s unrestricted cash plus accounts receivable, net, and is determined according to US GAAP. The Company is also required to maintain the minimum quarterly adjusted EBITDA as defined in the 2022 A&R Agreement if the Company does not maintain the quarterly adjusted quick ratio of at least 1.50 to 1.00.
As of December 31, 2022, the Company utilized $20,000 of the $50,000 credit line, $6,000 of which was drawn during 2020, $5,000 was drawn during the fourth quarter 2022 and $9,000 was drawn during the second quarter of 2022. In January 2023, the Company repaid $5,000 under the credit line.
As of December 31, 2022, the Company is in compliance with all the covenants.
Prior to the 2022 A&R Agreement, the credit installments bore US dollar denominated interest at an annual rate equal to 0.75%-1% plus a prime rate on the outstanding principal of each credit installment.
FINANCE EXPENSES (INCOME), NETThe Company recognizes the gains and losses from the remeasurement of the warrants liability related to Public Warrants and Private Placement Warrants in “Finance expenses (income), net” in the consolidated statements of operations. The unrealized gain from changes in the fair value of the Company Warrants for the years ended December 31, 2022 and 2021 was $14,671 and $3,819, respectively.The Company also recognized interest expenses in “Finance expenses (income), net” in the consolidated statements of operations. Interest expenses for the years ended December 31, 2022, 2021 and 2020 were $675, $259 and $328, respectively.
XML 42 R25.htm IDEA: XBRL DOCUMENT v3.22.4
INCOME TAXES
 12 Months Ended
Dec. 31, 2022
Income Tax Disclosure [Abstract]  
INCOME TAXES INCOME TAXES
Income (loss) before taxes on income is comprised as follows:
Year ended December 31,
2022

20212020
Domestic$(7,910)$(11,098)$1,241 
Foreign(8,483)863 (853)
Total income (loss) before income taxes
$(16,393)$(10,235)$388 
Income taxes are comprised as follows:
Year ended December 31,
2022

20212020
Current income tax provision (benefit):  
Domestic$1,048 $(8)$96 
Foreign2,129 1,245 1,104 
Total current income tax (benefit) provision
$3,177 $1,237 $1,200 
Year ended December 31,
2022

20212020
Deferred income tax provision (benefit):  
Domestic$— $— $— 
Foreign(1,160)— — 
Total deferred income tax (benefit) provision
$(1,160)$— $— 
Total income tax (benefit) provision$2,017 $1,237 $1,200 
A reconciliation of the U. S. statutory income tax rate to the Company’s effective income tax rate for continuing operations is as follows:
Year ended December 31,
 202220212020
Total income (loss) before income taxes
$(16,393)$(10,235)$388 
US statutory rate21 %21 %21 %
Income taxed computed at U. S. federal statutory rate$(3,443)$(2,149)$81 
Foreign rate differential101 (14)(155)
State and local income taxes, net(239)(359)207 
Other non-deductible items546 (37)140 
GILTI2,892 308 — 
Change in valuation allowance2,305 1,493 159 
Tax credits(474)(338)(469)
Changes in uncertain tax positions1,202 881 956 
Transaction costs1,427 578 — 
Warrants - MTM(3,081)160 (5)
Other781 714 286 
Total income tax provision
$2,017 $1,237 $1,200 
Effective income tax rate
(12.3)%(12.1)%309.0 %
The Company’s effective tax rate is subject to significant variations due to several factors, including variability in pre-tax and taxable income (loss) and the mix of jurisdictions to which they relate, intercompany transactions, mergers and acquisitions, the applicability of special tax regimes, changes in the Company’s currently established valuation allowance, foreign currency gains (losses), and other laws and accounting rules in various jurisdictions.
Significant factors that impacted the Company’s effective tax rate between 2022 and 2021 were related to the acquisition of TVS, GILTI, uncertain tax positions, and increase in valuation allowance.
The Company’s effective tax rate between 2021 and 2020 was primarily reflects a pre-tax loss in 2021 compared to pre-tax income in 2020, offset by increases in non-deductible expenses, GILTI, uncertain tax positions and increase in valuation allowance.
Deferred income taxes are provided for the effects of temporary differences between assets and liabilities recognized for financial reporting purposes and the amounts recognized for income tax purposes. Significant components of deferred tax assets and deferred tax liabilities consisted of the following:
 December 31,
 20222021
Deferred tax assets  
Loss carryforwards$11,093 $10,201 
Tax credits1,271 1,128 
Interest limitation carryforwards— 25 
R&D capitalization costs7,497 — 
Accrued expenses1,157 597 
Share-based compensation4,398 127 
Fixed assets147 180 
Lease liabilities700 — 
Other28 187 
Total deferred tax assets, gross
26,291 12,445 
Valuation allowance(18,697)(12,445)
Total deferred tax assets, net
$7,594 $— 
Deferred tax liabilities
Intangibles$(7,239)$— 
Right-of-use asset(654)— 
Other(190)— 
Total deferred tax liability, net
$(8,083)$— 
Total deferred tax asset (liability)$(489)$— 
A valuation allowance is provided when it is more likely than not that the deferred tax assets will not be realized. The Company has established a valuation allowance to offset its deferred tax assets, excluding the newly acquired TVS UK which is in a net deferred tax liability position due primarily to acquisition accounting, at December 31, 2022 and 2021 due to the uncertainty of realizing future tax benefits from its net operating loss carryforwards and other deferred tax assets.
The Israeli corporate tax rate was 23% in 2022, 2021 and 2020. The Company’s production facilities in Israel have been granted the status of a “preferred enterprise” under the Law for the Encouragement of Capital Investments Law, 1959. According to the provisions of the Encouragement of Capital Investments Law, 1959, the Company has been granted a reduced tax rate for certain research and development activities the Company performs in Israel. A preferred enterprise located in development area A will be subject to a tax rate of 7.5% instead of 9%. The tax rate applicable to preferred enterprises located in other areas remains at 16%.
Foreign withholding taxes and Internal Revenue Code Section 986(c) gains and losses have not been recorded on permanently reinvested earnings of certain subsidiaries aggregating $12,888 and $8,720 as of December 31, 2022 and 2021, respectively. The amount of deferred international withholding taxes and Internal Revenue Code Section 986(c) gains and losses relating to these subsidiaries is approximately $1,237 and $1,224 as of December 31, 2022 and 2021, respectively.
The Company’s gross NOLs for tax return purposes are as follows:
 
Year ended December 31,
 20222021
Domestic NOLs (federal)$11,881 $36,817 
Domestic NOLs (state and local)10,992 36,245 
Foreign NOLs30,804 1,136 
Total
$53,677 $74,198 
Domestic (federal and state) NOLs expire in various year starting from 2030 through an indefinite period. Foreign NOLs expire starting from 2026 (Argentina) through an indefinite period (Germany, UK). A portion of domestic (federal and state) NOLs are subject to Internal Revenue Code Section 382 or similar provisions, but the net operating loss carryforwards are expected to be fully realized. The table above reflects gross NOLs for tax return purposes which are different than financial statement NOLs, as the Company’s intention is to settle additional income taxes from tax contingencies with NOLs. The other tax credit carryforwards expire in various years beginning in 2033. The Company’s intention is to settle the tax contingencies associated with the research and development credits with the attribute.
The Company’s unrecognized tax benefits are reconciled as follows:
December 31,
202220212020
Gross unrecognized tax benefits as of January 1
$3,162 $2,373 $1,438 
Increases - prior year tax positions60 508 — 
Decreases - prior year tax positions(231)(410)— 
Increases - current year tax positions2,562 691 935 
Position expiration(97)— — 
Gross unrecognized tax benefits as of December 31
$5,456 $3,162 $2,373 
The balances of unrecognized tax benefits of $5,456 and $3,162 as of December 31, 2022 and 2021, respectively, represent amounts that, if recognized, would impact the effective income tax rate in future periods, of which $1,495 relates to the Company’s acquisition of TVS.
The Company recognized interest and penalties related to unrecognized tax benefits in its income tax provision. The Company accrued $471 and $136 for interest and penalties as of December 31, 2022 and 2021, respectively.
The Company is subject to income taxes in the US and several foreign jurisdictions including Australia, Argentina, Germany, the UK and Israel. Significant judgment is required in evaluating the Company’s tax positions and determining the Company’s provision for income taxes. During the ordinary course of business there are many transactions and calculations for which the ultimate tax determination is uncertain. The Company establishes reserves for tax related uncertainties based on estimates of whether, and the extent to which, additional taxes will be due. These reserves are established when we believe that certain positions might be challenged despite the belief that the Company’s tax return positions are fully supportable. The Company adjusts these reserves in light of changing facts and circumstances, such as the outcome of tax audits. The provision for income taxes includes the impact of reserve provisions and changes to reserves that are considered appropriate.
The Company’s Israeli Subsidiary is currently under examination by the taxing authorities for 2017 to 2019 tax periods. The last tax assessment that was received by the Company related to tax years through 2014 in Israel.
XML 43 R26.htm IDEA: XBRL DOCUMENT v3.22.4
SEGMENT REPORTING
 12 Months Ended
Dec. 31, 2022
Segment Reporting [Abstract]  
SEGMENT REPORTING SEGMENT REPORTINGThe Company operates as one operating segment, which primarily focuses on ad serving, measurement and creative services. Our CEO is the chief operating decision-maker, manages and allocates resources to the operations of the Company on an entity-wide basis.
Revenue by geographical location are as follows:

December 31,

202220212020
US$114,528 $81,882 $62,760 
Canada1,266 1,039 518 
APAC4,249 3,151 2,636 
EMEA6,030 2,515 1,463 
LATAM1,044 1,704 1,424 
Total revenues
$127,117 $90,291 $68,801 
The Company’s property and equipment, net and ROU assets commencing January 1, 2022 by geographical location are as follows:
Year ended December 31,
20222021
Israel$2,707 $1,495 
US14,065 3,051 
Rest of the World 460 294 
Total
$17,232 $4,840 
XML 44 R27.htm IDEA: XBRL DOCUMENT v3.22.4
BASIC AND DILUTED NET LOSS PER SHARE
 12 Months Ended
Dec. 31, 2022
Earnings Per Share [Abstract]  
BASIC AND DILUTED NET LOSS PER SHARE BASIC AND DILUTED NET LOSS PER SHARE
Basic and diluted net loss per share attributable to common stockholders was calculated as follows:
Year ended December 31,
202220212020
Numerator:
Net loss$(18,410)$(11,472)$(812)
Accretion of preferred stocks to redemption value— (77,063)(7,297)
Net loss attributable to common stockholders - basic and diluted
$(18,410)$(88,535)$(8,109)
Denominator:
Weighted-average number of stocks used in computing net loss per stock attributable to common stockholders
130,756,484 26,745,020 16,028,560 
Net loss per stock attributable to common stockholders – basic and diluted
$(0.14)$(3.31)$(0.51)
Net loss per share calculations and potentially dilutive security amounts for all periods prior to the Transaction have been retrospectively adjusted to the equivalent number of shares outstanding immediately after the Transaction to effect the reverse recapitalization. Historically reported weighted average shares outstanding have been multiplied by the exchange ratio of 1.337.
The Company’s potentially dilutive securities have been excluded from the computation of diluted net loss per share as the effect would be to reduce the net loss per share attributable to common stockholders. Therefore, the weighted average number of common shares outstanding used to calculate both basic and diluted net loss per share attributable to common stockholders is the same.
The Company excluded the following potential common shares, presented based on amounts outstanding at each period end, from the computation of diluted net loss per share attributable to common stockholders for the periods indicated because including them would have had an anti-dilutive effect:
Year ended December 31,
202220212020
Preferred stocks— — 73,690,340 
Options outstanding10,755,985 11,302,275 13,204,528 
RSUs outstanding8,116,641 — — 
Warrants outstanding10,222,500 10,222,500 680,271 
Preferred stocks, options outstanding and warrant outstanding have been retroactively adjusted to give effect to the exchange ratio.
XML 45 R28.htm IDEA: XBRL DOCUMENT v3.22.4
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)
 12 Months Ended
Dec. 31, 2022
Accounting Policies [Abstract]  
Basis of Presentation
Basis of Presentation
The accompanying Consolidated Financial Statements and Notes to the Consolidated Financial Statements included in this Annual Report on Form 10-K are prepared in accordance with generally accepted accounting principles in the United States ("GAAP") for annual financial information and the instructions to Form 10-K and Article 10 of Regulation S-X. The accompanying Consolidated Financial Statements include our accounts and those of our wholly-owned subsidiaries; all intercompany activity and balances have been eliminated. The Consolidated Financial Statements reflect all adjustments, which are, in the opinion of management, necessary for a fair presentation of the consolidated balance sheets of the Company as of December 31, 2022 and 2021 and the consolidated results of operations and cash flows for the years ended December 31, 2022, 2021 and 2020.
Prior Period Reclassification
During the second quarter of 2022, we presented depreciation, amortization and impairment expenses as a separate line item on our consolidated statements of operations and all prior periods have been adjusted.
Depreciation, amortization and impairment expenses were previously included in cost of sales and other operating expenses depending on the underlying asset’s function. Additionally, we no longer present gross profit as a subtotal on our consolidated statements of operations.
The reclassification is to better reflect the financial performance of transactions with customers as our business has evolved and reflects a better representation of our current operations, which include those of our most recent acquisition. The change provides more clarity about changes in cost of revenue and other operating expenses exclusive of depreciation, amortization and impairment.
In accordance with US GAAP, all periods presented below have been retrospectively adjusted to reflect the reclassification of cost of revenue and other operating expenses exclusive of depreciation and amortization. There was no net impact to loss from operations, net loss attributable to common stockholders or net loss per stock for any periods presented. The consolidated balance sheets, statements of changes in temporary equity and stockholders’ equity, and the consolidated statements of cash flows are not affected by this reclassification.
Use of Estimates
Use of Estimates
The preparation of the consolidated financial statements in conformity with US GAAP requires management to make estimates, judgments and assumptions. The Company’s management believes that the estimates, judgments and assumptions used are reasonable based upon information available at the time they are made. These estimates, judgments and assumptions can affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the dates of the financial statements, and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.
The Company has considered the impact of these factors on its estimates and assumptions and determined that there were no material adverse impacts on the consolidated financial statements for the periods ended December 31, 2022, 2021, and 2020. As events continue to evolve and additional information becomes available, the Company’s estimates and assumptions may change materially in future periods.
Functional currency Functional currencyA majority of the Company’s revenues are generated in US dollars. In addition, a substantial portion of the Company’s costs are incurred in US dollars. The Company’s management believes that the US dollar is the currency of the primary economic environment in which the Company and each of its subsidiaries operate. Thus, the functional and reporting currency of the Company and its subsidiaries is the US dollar. Accordingly, accounts maintained in currencies other than the US dollar are re-measured into US dollars. All translation gains and losses resulting from the re-measurement of monetary assets and liabilities that are not denominated in the functional currency are recorded in Financial expenses, net on the consolidated statements of operations.
Cash and cash equivalents
Cash and cash equivalents
Cash equivalents are short-term highly liquid investments that are readily convertible to cash with original maturities of three months or less, at the date acquired.
Short-term bank deposits Short-term bank deposits The Company utilizes short-term deposits in order to maximize the use of cash on hand.
Restricted deposits and restricted cash Restricted deposits and restricted cashRestricted deposits presented in Prepaid expenses and other current assets and in Long-term restricted deposits are deposits used as security for the Company’s credit cards and for the rental of premises.
Property and equipment, net Property and equipment, netProperty and equipment are stated at cost, net of accumulated depreciation.
Software development costs
Software development costs
Software development costs, which are included in property and equipment, net, consists of capitalized costs related to purchase and develop internal-use software. The Company uses such software to provide services to its customers. The costs to purchase and develop internal-use software are capitalized from the time that the preliminary project stage is completed, and it is considered probable that the software will be used to perform the function intended. These costs include personnel and personnel-related employee benefits for employees directly associated with the software development and external costs of the materials or services consumed in developing or obtaining the software.
Any costs incurred for upgrades and functionality enhancements of the software are also capitalized. Once this software is ready for use in providing the Company's services, these costs are amortized on a straight-line basis over the three-year estimated useful life. The amortization is presented within depreciation and amortization in the consolidated statements of operations.
Impairment of long-lived assets
Impairment of long-lived assets
Long-lived assets, including property and equipment and finite-lived intangible assets, are reviewed for impairment whenever facts or circumstances either internally or externally may indicate that the carrying value of an asset may not be recoverable. If there are indications of an impairment, the Company tests for recoverability by comparing the estimated undiscounted future cash flows expected to result from the use of the asset to the carrying amount of the asset or asset group. If the asset or asset group is determined to be impaired, any excess of the carrying value of the asset or asset group over its estimated fair value is recognized as an impairment loss.
Business combinations
Business combinations
The Company accounts for business combinations by applying the provisions of ASC 805, “Business Combination” (“ASC 805”) and allocates the fair value of purchase consideration to the tangible assets acquired, liabilities assumed, and intangible assets acquired based on their estimated fair values. The excess of the fair value of purchase consideration over the fair values of these identifiable assets and liabilities is recorded as goodwill. When determining the fair values of assets acquired and liabilities assumed, management makes significant estimates and assumptions, especially with respect to intangible assets.
Acquisition-related expenses are expensed as incurred.
Goodwill and acquired intangible assets
Goodwill and acquired intangible assets
Goodwill and acquired intangible assets have been recorded in the Company's financial statements resulting from     various business combinations. Goodwill represents the excess of the purchase price in a business combination over the fair value of identifiable tangible and intangible assets acquired and liabilities assumed. Goodwill is subject to an annual impairment test.
The Company allocates goodwill to reporting units based on the expected benefit from the business combination. Reporting units are evaluated when changes in the Company’s operating structure occur, and if necessary, goodwill is reassigned using a relative fair value allocation approach. The Company currently has one reporting unit.
ASC 350, Intangibles—Goodwill and other (“ASC 350”) requires goodwill to be tested for impairment at least annually and, in certain circumstances, between annual tests. The accounting guidance gives the option to perform a qualitative assessment to determine whether further impairment testing is necessary. The qualitative assessment considers events and circumstances that might indicate that a reporting unit's fair value is less than its carrying amount. If it is determined, as a result of the qualitative assessment, that it is more likely than not that the fair value of a reporting unit is less than its carrying amount, a quantitative test is performed. The Company operates as one reporting unit. The Company elects to perform an annual impairment test of goodwill as of October 1 of each year, or more frequently if impairment indicators are present. For the years ended December 31, 2022, 2021 and 2020 no impairments of goodwill were recorded.
Separately acquired intangible assets are measured on initial recognition at cost including directly attributable costs. Intangible assets acquired in a business combination are measured at fair value at the acquisition date.
Customer relationships, acquired technology and trade name are being amortized over the estimated useful life of approximately 11 years, 6 years, and 4 years, respectively, using straight-line amortization method.
The amortization of customer relationships, acquired technology and trade name is presented within depreciation, amortization and impairment in the consolidated statement of operations.
Leases
Leases
Innovid's lease portfolio primarily consists of real estate properties and cars. Short-term leases with a term of 12 months or less are not recorded on the balance sheet. Innovid does not separate lease components from non-lease components.
The Company is a lessee in all its lease agreements. The Company records lease liabilities based on the present value of lease payments over the lease term. Innovid generally uses an incremental borrowing rate to discount its lease liabilities, as the rate implicit in the lease is typically not readily determinable. Certain lease agreements include renewal options that are under the Company's control. Innovid includes optional renewal periods in the lease term only when it is reasonably certain that Innovid will exercise its option.
Variable lease payments are primarily related to payments to lessors for taxes, maintenance, insurance, and other operating costs. The Company's lease agreements do not contain any significant residual value guarantees or restrictive covenants.
Fair value of financial instruments
Fair value of financial instruments
The Company applies a fair value framework to measure and disclose its financial assets and liabilities. Fair value is defined as the exchange price that would be received for an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. The fair value hierarchy requires an entity to maximize the use of observable inputs, where available, and minimize the use of unobservable inputs when measuring fair value. There are three levels of inputs that may be used to measure fair value:
Level 1 - Observable inputs that reflect quoted prices (unadjusted) for identical assets or liabilities in active markets.
Level 2 - Includes other inputs that are directly or indirectly observable in the marketplace.
Level 3 - Unobservable inputs which are supported by little or no market activity.
The Company’s financial instruments consist of cash and cash equivalents, short term deposits, restricted deposits, trade receivables, net, trade payables, employees and payroll accruals, accrued expenses and other current liabilities and current portion of long term debts. Their historical carrying amounts are approximate fair values due to the short-term maturities of these instruments.
The Company measures its investments in money market funds classified as cash equivalents and warrants liability at fair value.
Trade receivable, net Trade receivable, netThe Company records trade receivable for amounts invoiced and yet unbilled invoices. The Company maintains an allowance for doubtful accounts to reserve for potentially uncollectible receivables. The expectation of collectability is based on a review of credit profiles of customers, contractual terms and conditions, current economic trends, and historical payment experience. The Company regularly reviews the adequacy of the allowance for doubtful accounts by considering the age of each outstanding invoice and the collection history of each customer to determine the appropriate amount of allowance for doubtful accounts. Trade receivables deemed uncollectible are charged against the allowance for doubtful accounts when identified.
Accrued post-employment benefits
Accrued post-employment benefits
401(k) profit sharing plans:
The Company has a 401(k) retirement savings plan with a safe harbor employer match with a maximum of 4% employer contribution for its eligible employees in the US. During the years ended December 31, 2022, 2021 and 2020 the Company recorded expenses for matching contributions in the amount of $1,182, $961 and $705, respectively.
Severance pay:
The Israeli Severance Pay Law, 1963 (“Severance Pay Law”), specifies that employees are entitled to severance payment, following the termination of their employment. Under the Severance Pay Law, the severance payment is calculated as one-month salary for each year of employment, or a portion thereof.
The Israeli Subsidiary’s liability for all of its Israeli employees is covered by the provisions of Section 14 of the Severance Pay Law (“Section 14”). Under Section 14 employees are entitled to monthly deposits, at a rate of 8.33% of their monthly salary, continued on their behalf to their insurance funds. Payments in accordance with Section 14 release the Company from any future severance payments in respect of those employees. As a result, the Company does not recognize any liability for severance pay due to these employees and the deposits under Section 14 are not recorded as an asset in the Company’s balance sheets.
Income taxes and tax contingencies
Income taxes and tax contingencies
Income taxes are computed using a balance sheet approach reflecting both current and deferred taxes. Current and deferred taxes reflect the tax impact of all of the events included in the financial statements. The basic principles employed in the balance sheet approach are to reflect a current tax liability or asset that is recognized for the estimated taxes payable or refundable on tax returns for the current and prior years, a deferred tax liability or asset that is recognized for the estimated future tax effects attributable to temporary differences and carryforwards, the measurement of current and deferred tax liabilities and assets is based on provisions of the enacted tax law of which the effects of future changes in tax laws or rates are not anticipated, and the measurement of deferred tax assets is reduced, if necessary, by the amount of any tax benefits that, based on available evidence, are not expected to be realized. There are certain situations in which deferred taxes are not provided. Some basis differences are not temporary differences because their reversals are not expected to result in taxable or deductible amounts.
The Company regularly evaluates deferred tax assets for future realization and establishes a valuation allowance to the extent that a portion is not more likely than not to be realized. The Company considers whether it is more likely than not that the deferred tax assets will be realized, including existing cumulative losses in recent years, expectations of future taxable income, carryforward periods, and other relevant quantitative and qualitative factors. The recoverability of the deferred tax assets is evaluated by assessing the adequacy of future expected taxable income from all sources, including reversal of taxable temporary differences, forecasted operating earnings and available tax planning strategies. These sources of income rely on estimates.
ASC 740, Income Taxes (“ASC 740”) contains a two-step approach to recognizing and measuring a liability for uncertain tax positions. The first step is to evaluate the tax position taken or expected to be taken in a tax return by determining if the weight of available evidence indicates that it is more likely than not that, on an evaluation of the technical merits, the tax position will be sustained on audit, including resolution of any related appeals or litigation processes. The second step is to measure the tax benefit as the largest amount that is more than 50% (cumulative basis) likely to be realized upon ultimate settlement. The Company classifies interest related to unrecognized tax benefits in taxes on income.
On December 20, 2017, Congress passed the “US Tax Act”. The US Tax Act requires complex computations to be performed that were not previously required by US tax law, significant judgments to be made in interpretation of the provisions of the US Tax Act, significant estimates in calculations, and the preparation and analysis of information not previously relevant or regularly produced the Act provides that a person who is a US shareholder of any CFC is required to include its GILTI in gross income for the tax year in a manner generally similar to that for Subpart F inclusions. The term “global intangible low-taxed income” is defined as the excess (if any) of the US shareholder’s net CFC tested income for that tax year, over the US shareholder’s net deemed tangible income return for that tax year. The Company’s policy is to treat GILTI as a period expense in the provision for income taxes.
Concentration of credit risks
Concentrations of credit risks
Financial instruments that potentially subject the Company to concentrations of credit risk consist principally of cash and cash equivalents, deposits and trade receivables, net.
The majority of the Company’s cash and cash equivalents are invested in deposits with major banks in US, Israel and UK. Generally, these investments may be redeemed upon demand and, therefore, bear minimal risk.
The Company’s trade receivables, net are mainly derived from sales to customers located in the US, APAC, EMEA, and LATAM. The Company mitigates its credit risks by performing an ongoing credit evaluations of its customers’ financial conditions.
The Company has no off-balance-sheet concentration of credit risk such as foreign exchange contracts, option contracts or other foreign hedging arrangements.
Stock-based compensation
Stock-based compensation
The Company estimates the fair value of stock-based awards on the date of grant. The fair value of stock options with only service conditions is determined using the Black-Scholes option pricing model. The grant date fair value of the stock-based awards with graded vesting is recognized on a straight-line basis over the requisite service period. The determination of the fair value of the Company’s stock option awards is based on a variety of factors including Company’s common stock price, risk-free interest rate, expected volatility, expected life of awards and dividend yield. The Company has limited option exercise history and has elected to estimate the expected life of the stock option awards using the “simplified method” with the continued use of this method extended until such time that the Company has sufficient exercise history. The expected volatility of the price of such stocks is based on volatility of similar companies whose stock prices are publicly available over a historical period equivalent to the option’s expected term. The dividend yield is based on the Company’s historical and future expectation of dividends payouts. Historically, the Company has not paid cash dividends. Risk-free interest rates are based on the yield from US Treasury zero-coupon bonds with a term equivalent to the expected term of the options.
The Company accounts for forfeitures as they occur.
Warrants
Warrants
The Company accounts for warrants as either equity-classified or liability-classified instruments based on an assessment of the warrant’s specific terms and applicable authoritative guidance. The assessment considers whether the warrants are freestanding financial instruments, meet the definition of a liability under ASC 480, and meet all of the requirements for equity classification, including whether the warrants are indexed to the Company’s own common stock and whether the warrant holders could potentially require “net cash settlement” in a circumstance outside of the Company’s control, among other conditions for equity classification. This assessment, which requires the use of professional judgment, is conducted at the time of warrant issuance and as of each subsequent reporting period end date while the warrants are outstanding.
Warrants that meet all the criteria for equity classification, are required to be recorded as a component of additional paid-in capital. Warrants that do not meet all the criteria for equity classification, are required to be recorded as liabilities at their initial fair value on the date of issuance and remeasured to fair value at each balance sheet date thereafter. The liability-classified warrants are recorded under non-current liabilities. Changes in the estimated fair value of the warrants are recognized in “Financial expenses, net” in the consolidated statements of operations.
Revenue recognition and Cost of revenues
Revenue recognition
The majority of Company’s revenues is derived from providing Ad serving services to advertisers, publishers, and media agencies. The services focus on standard, interactive and data driven digital video advertising. Ad serving services relate to utilizing Innovid’s platform to serve advertising impressions to various digital publishers across CTV, mobile TV, desktop TV, display, and other channels.
The Company also provides measurement services to brand and agencies, enterprise clients (networks) and publishers. The measurement service provide analysis on and track performance of advertisement campaigns. The measurement service provides insights into the effectiveness of TV and digital advertising.
Creative services relate to the design and development of interactive data-driven and dynamic ad formats by adding data, interactivity and dynamic features to standard ad units.
The Company recognizes revenue when its customer obtains control of promised services in an amount that reflects the consideration that the Company expects to receive in exchange for those services. The Company recognizes revenue in accordance with ASC Topic 606, Revenue from contracts with customers (“ASC 606”) and determines revenue recognition through the following steps: (1) identify the contract with a customer, (2) identify the performance obligations in the contract, (3) determine the transaction price, (4) allocate the transaction price to the performance obligations in the contract, and (5) recognize revenue when a performance obligation is satisfied.
For arrangements with multiple performance obligations, which represent promises within an arrangement that are capable of being distinct and are separately identifiable, the Company allocates the contract consideration to all distinct performance obligations based on their relative standalone selling price (“SSP”). SSP is typically estimated based on observable transactions when these services are sold on a standalone basis.
Revenues related to ad serving services are recognized when impressions are delivered. The Company recognizes revenue from the display of impression-based ads in the contracted period in which the impressions are delivered. Impressions are considered delivered when an ad is displayed to users.
Revenues related to the measurement services platform are recognized over time, since the customer simultaneously receives and consumes the benefits provided by the Company’s performance. Revenues for these measurement services are recognized over the service period.
Revenues related to creative projects are recognized at a point in time when the Company delivers an ad unit. Creative services projects are usually delivered within a week.
The Company’s accounts receivable, consist primarily of receivables related to providing ad serving, measurement and creative services, for which the Company’s contracted performance obligations have been satisfied, the amount has been billed and the Company has an unconditional right to payment. The Company typically bills customers monthly based on actual delivery. The payment terms vary, mainly with terms of 60 days or less.
The typical contract term is 12 months or less for ASC 606 purposes. Most of the Company’s contracts can be cancelled without a cause. The Company has the unconditional right to payment for the services provided as of the date of the termination of the contracts.
The Company applies the practical expedient in ASC 606 and does not adjust the promised amount of consideration for the effects of a significant financing component if the Company expects, at contract inception, that the period between when the Company transfers a promised good or service to a customer and when the customer pays for that good or service will be one year or less.
Deferred revenues represent mostly unrecognized fees billed or collected for measurement platform services. Deferred revenues are recognized as (or when) we perform under the contract.
Costs to obtain a contract
Contract costs include commission programs to compensate sales employees for generating sales orders with new customers or for new services with existing customers. Most commissions are commensurate. The Company elected to apply the practical expedient and recognize incremental costs of obtaining a contract as an expense when incurred if the amortization period of the asset that the Company otherwise would have recognized is one year or less. If commissions are not commensurate, the Company capitalizes these commissions. The term of amortization of capitalized commissions is three years. The amount of commissions capitalized as of December 31, 2022 is immaterial.
Cost of revenues
Cost of revenues consists primarily of costs to run the ad serving, creative and measurement services. These costs include hosting fees, cost to access data and personnel costs including stock-based compensation, professional services costs and facility related costs. The Company allocates overhead including rent and other facility related costs, communication costs based on headcount.
Research and development
Research and development
Research and development expenses consist primarily of personnel costs, including stock-based compensation, professional services costs, hosting and facility related costs. We allocate overhead including rent and other facility related costs and communication costs based on headcount. We expect research and development expenses to increase in future periods to support our growth, including continuing to invest in optimization, accuracy and reliability of our platform and other technology improvements to support and drive efficiency in our operations. These expenses may vary from period to period as a percentage of revenue, depending primarily upon when we choose to make more significant investments.
Research and development costs are charged to the consolidated statements of operations as incurred. ASC 350-40, Internal-Use Software (“ASC 350-40”), requires the capitalization of certain costs incurred only during the application development stage.
Sales and marketing Sales and marketingSales and marketing expenses consist primarily of personnel costs, including stock-based compensation, professional services costs and facility related costs as well as costs related to advertising, product management, promotional materials, public relations, other sales and marketing programs. The Company allocates overhead including rent and other facility related costs, communication costs based on headcount.
General and administrative General and administrativeGeneral and administrative expenses consist primarily of personnel costs, including stock-based compensation, for executive management, finance, accounting, human capital, legal and other administrative functions as well as professional services costs and facility related costs. The Company allocates overhead including rent and other facility related costs, communication costs based on headcount.
Net loss per common stock
Net loss per common stock
Prior to the Company’s SPAC merger, the Company computed net loss per stock using the two-class method required for participating securities. The two-class method requires income available to common stockholders for the period to be allocated between common stocks and participating securities based upon their respective rights to receive dividends as if all income for the period had been distributed. The Company considered its preferred stocks to be participating securities as the holders of the preferred stocks would be entitled to dividends that would be distributed to the holders of common stocks, on a pro-rata basis assuming conversion of all preferred stocks into common stocks.
These participating securities do not contractually require the holders of such stocks to participate in the Company’s losses. As such, net loss for the periods presented was not allocated to the Company’s participating securities.
Following the SPAC merger, basic net loss per stock share is computed by dividing net income (loss) for each reporting period by the weighted-average number of ordinary shares outstanding during that period. Diluted net loss per stock is computed by dividing net income (loss) for each reporting period by the weighted average number of ordinary shares outstanding during the period, plus dilutive potential ordinary shares considered outstanding during the period. Diluted net loss per stock is the same as basic net loss per stock in periods when the effects of potentially dilutive stock of common stock are anti-dilutive.
All outstanding warrants, options and RSUs for the years ended December 31, 2022, 2021 and 2020 have been excluded from the calculation of the diluted net loss per share, because all such securities are anti-dilutive for all periods presented. Preferred stocks were converted and treasury stocks were cancelled as of December 31, 2021. For further information see Note 19 Basic and Diluted Net Loss Per Share.
Recently Adopted Accounting Pronouncements and Recently issued accounting pronouncements not yet adopted by the Company
Recently Adopted Accounting Pronouncements
In February 2016, the FASB issued the ASU No. 2016-02, Leases (Topic 842). The standard outlines a comprehensive lease accounting model that supersedes the previous lease guidance and requires lessees to recognize lease liabilities and corresponding right-of-use (“ROU”) assets for all leases with lease terms greater than 12 months. The guidance also changes the definition of a lease and expands the disclosure requirements of lease arrangements. Innovid adopted the standard in the first quarter of 2022 using the modified retrospective method. Results for reporting periods beginning after December 31, 2021, have been presented in accordance with the standard, while results for prior periods have not been adjusted and continue to be reported in accordance with the Company's historical accounting. The cumulative effect of initially applying the new leases standard was recognized as an adjustment to the opening consolidated balance sheet as of January 1, 2022.
The Company elected a package of practical expedients for leases that commenced prior to January 1, 2022, and did not reassess historical conclusions on: (i) whether any expired or existing contracts are or contain leases; (ii) lease classification for any expired or existing leases; and (iii) initial direct costs capitalization for any existing leases.
This standard has a significant impact on our consolidated balance sheet but did not have a significant impact on the Company’s consolidated statements of operations. The most significant effects relate to the recognition ROU assets and lease liabilities on interim consolidated balance sheet for real estate and cars operating leases.
In December 2019, the FASB issued ASU 2019-12, Income Taxes (Topic 740): Simplifying the Accounting for Income Taxes (“ASU 2019-12”). The new guidance eliminates certain exceptions related to the approach for intraperiod tax allocation, the methodology for calculating income taxes in an interim period and the recognition of deferred tax liabilities for outside basis differences. It also clarifies and simplifies other aspects of the accounting for income taxes. Innovid adopted the standard in the first quarter of 2022. The adoption of the guidance did not have a material impact on the Company’s consolidated financial statements.
In October 2021, the FASB issued ASU 2021-08, Business Combinations (Topic 805), Accounting for Contract Assets and Contract Liabilities from Contracts with Customers, which requires contract assets and contract liabilities (i.e., deferred revenue) acquired in a business combination to be recognized and measured by the acquirer on the acquisition date in accordance with ASC 606, Revenue from Contracts with Customers. This new guidance will result in the acquirer recognizing contract assets and contract liabilities at the same amounts recorded by the acquiree. Historically, such amounts were recognized by the acquirer at fair value in acquisition accounting. The Company adopted the standard effective in the first quarter of 2022. The adoption of the guidance did not have a material impact on the Company’s consolidated financial statements.
Recently issued accounting pronouncements not yet adopted by the Company
As an “emerging growth company,” the JOBS Act allows the Company to delay adoption of new or revised accounting pronouncements applicable to public companies until such pronouncements are made applicable to private companies. The Company has elected to use this extended transition period under the JOBS Act. The adoption dates discussed below reflect this election.
In August 2020, the FASB issued ASU 2020-06, Debt — Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging — Contracts in Entity’s Own Equity (Subtopic 815-40): Accounting for Convertible Instruments and Contracts in an Entity’s Own Equity (“ASU 2020-06”). The final guidance issued by the FASB for convertible instruments eliminates two of the three models in ASC 470-20 that require separate accounting for embedded conversion features. Separate accounting is still required in certain cases. Additionally, among other changes, the guidance eliminates some of the conditions for equity classification in ASC 815-40-25 for contracts in an entity’s own equity. The guidance also requires entities to use the if-converted method for all convertible instruments in the diluted earnings per share calculation and include the effect of share settlement for instruments that may be settled in cash or shares, except for certain liability-classified share-based payment awards. ASU 2020-06 is effective for fiscal years beginning after December 15, 2023, and interim periods within those fiscal years. The Company evaluated the potential impact of this guidance on its consolidated financial statements and determined that it will not have an impact on the consolidated financial statements.
In June 2016, the FASB issued ASU 2016-13, Financial Instruments – Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments (“ASU 2016-13”). ASU 2016-13 requires the measurement of all expected credit losses for financial assets held at the reporting date based on historical experience, current conditions, and reasonable and supportable forecasts. ASU 2016-13 requires enhanced qualitative and quantitative disclosures to help investors and other financial statement users better understand significant estimates and judgments used in estimating credit losses, as well as the credit quality and underwriting standards of an organization’s portfolio. ASU 2016-13 is effective for fiscal years beginning after December 15, 2022, and interim periods within those fiscal years. The Company has evaluated the impact of this accounting standard update and has determined that its adoption will impact how the Company assesses its estimates for credit losses, but will not have an impact on the consolidated financial statements.

Other guidance that has been issued since the end of our previous reporting period is not expected to have an impact on the Company’s consolidated financial statements.
XML 46 R29.htm IDEA: XBRL DOCUMENT v3.22.4
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)
 12 Months Ended
Dec. 31, 2022
Accounting Policies [Abstract]  
Condensed Income Statement The effect of the change is as follows:

Year ended December 31, 2022Year ended December 31, 2021Year ended December 31, 2020
Under previous classificationEffect of changeAs reportedPreviously reportedEffect of changeAs adjustedPreviously reportedEffect of changeAs adjusted
Cost of revenues$33,265 $(3,078)$30,187 $17,785 $(87)$17,698 $12,365 $(54)$12,311 
Operating expenses:
Research and development31,932 (814)31,118 24,619 (320)24,299 18,283 (269)18,014 
Sales and marketing52,226 (1,960)50,266 33,056 (215)32,841 28,810 (289)28,521 
General and administrative39,435 (291)39,144 20,680 (39)20,641 8,221 (118)8,103 
Depreciation, amortization and impairment$— $6,143 $6,143 $— $661 $661 $— $730 $730 
Schedule of Property, Plant and Equipment Depreciation is calculated by the straight-line method over the estimated useful lives of the assets, at the following annual rates:

Years
Computers and peripheral equipment
3
Office furniture and equipment
5-7
Lease improvementsThe shorter of the lease term or the useful life of the asset
Internal-use software3
Property and equipment consist of the following:

December 31,

2022

2021
Cost:


Software development costs$13,190 $2,594 
Computers and peripheral equipment2,283 1,779 
Office furniture and equipment665 661 
Leasehold improvements2,167 2,164 

18,305 7,198 
Accumulated depreciation(3,983)(2,358)
Depreciated cost$14,322 $4,840 
Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis
The following table presents information about the Company’s financial instruments that are measured at fair value on a recurring basis:

December 31, 2022

Level 1
Level 2
Level 3
Assets:
Money market funds$18,948 $— $— 
Certificates of deposit— 20,000 — 
Liabilities:
Warrants liability$1,265 $— $3,036 

December 31, 2021

Level 1
Level 2
Level 3
Assets:
Money market funds$4,515 $— $— 
Liabilities:
Warrants liability$3,510 $— $15,462 
Schedule of Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation
The change in the fair value of the Level 3 warrant liability is summarized below:

December 31,

2022

2021
Beginning of the year
$15,462 $499 
Additions*— 18,427 
Change in fair value(12,426)1,616 
Conversion of Legacy Innovid Warrants on the Closing of the Transaction— (5,080)
End of the year$3,036 $15,462 
* Additions during the year ended December 31, 2021 represent Company Warrant liability assumed in the Transaction. See Note 11, Warrants for further detail.
Schedule of Key Inputs for Valuation of Private Placement Warrants
The key inputs into the Black-Scholes model for the Private Warrants were as follows:

December 31,December 31,

20222021

Risk-free interest rate
4.07 %1.24 %
Expected dividends— %— %
Expected term (years)
3.94.9
Expected volatility85 %55 %
Schedules of Concentration of Risk, by Risk Factor
During the years ended December 31, 2022, 2021 and 2020, two of the Company’s customers accounted for more than 10% of the Company’s total revenues as presented below:

Year ended December 31,

202220212020
Customer A
11 %**
Customer B
10 %*10 %
* less than 10%
Assets And Liabilities Lessee
Upon adoption, the Company recognized lease liabilities and corresponding ROU assets, adjusted for the accrued rent and remaining lease incentives received on the adoption date, as follows:
January 1, 2022
ROU assetsLease liabilities
Real Estate$3,928 $5,482 
Cars50 50 
Total operating leases$3,978 $5,532 
XML 47 R30.htm IDEA: XBRL DOCUMENT v3.22.4
TRANSACTION (Tables)
 12 Months Ended
Dec. 31, 2022
Business Combination and Asset Acquisition [Abstract]  
Schedule of Reverse Recapitalization
Upon the consummation of the Transaction all outstanding shares of Innovid Inc. common stock, Innovid Inc. redeemable convertible preferred stock, Innovid Inc. warrants, and Secondary Sale Transaction of 6,885,486 shares to PIPE investors, were exchanged for 93,787,278 shares of common stock in Innovid Corp.

Number of shares
Legacy Innovid common stock of January 1, 202116,275,609 
Warrant exercised132,392 
Stock option exercised3,180,943 
Conversion of redeemable convertible preferred stock into common stock73,690,340 
Conversion of Legacy Innovid Warrants507,994 
Exchanged into Innovid Corp. common stock on November 30, 202193,787,278 
The following table reconciles the elements of the Transaction to the Consolidated statement of cash flows and the Consolidated Statement of Changes in Temporary Equity and Stockholders’ Equity for the year ended December 31, 2021.

Total value
Cash - ION trust account and cash, net of redemptions
$55,466 
Cash - PIPE Investment, net of Secondary Sale Amount of $68,855
131,145 
Less: Transaction costs paid
(31,160)
Less: Deferred underwriting fee paid(6,199)
Proceeds from reverse recapitalization, net
149,252 
Less: Accrued transaction costs not yet paid*
(3,185)
Less: Company Warrant assumed as part of the Transaction
(22,791)
Plus: Transaction costs allocated to Company Warrant2,750 
Reverse recapitalization, net
$126,026 
* These amounts were paid in 2022.
XML 48 R31.htm IDEA: XBRL DOCUMENT v3.22.4
ACQUISITION (Tables)
 12 Months Ended
Dec. 31, 2022
Business Combination and Asset Acquisition [Abstract]  
Schedule of Fair Values of the Assets Acquired and Liabilities Assumed
The following table summarizes the fair value of assets acquired and liabilities assumed as of the acquisition date:

Total value
Cash and cash equivalents
$5,318 
Accounts receivables
4,186
Other current assets1,173
Property and equipment154
Total tangible assets
10,831 
Technology15,075
Customer relationships
16,700
Trade name
2,000
Goodwill
112,421
Total assets acquired
157,027 
Less: Deferred tax liabilities(1,677)
Less: Other assumed liabilities
(3,782)
Net assets acquired
$151,568 
Business Acquisition, Unaudited Pro Forma Information The following table presents the unaudited pro forma combined results of Innovid and TVS for the year ended December 31, 2022, and 2021 as if the acquisition of TVS had occurred on January 1, 2021:
Twelve months ended December 31,
2022

2021
(Unaudited)(Unaudited)
Revenues$131,433 $112,147 
Net loss(14,634)(37,195)
XML 49 R32.htm IDEA: XBRL DOCUMENT v3.22.4
INTANGIBLE ASSETS, NET (Tables)
 12 Months Ended
Dec. 31, 2022
Goodwill and Intangible Assets Disclosure [Abstract]  
Schedule of Finite-Lived Intangible Assets The estimated useful life, gross carrying amounts and accumulated amortization totals related to our identifiable intangible assets are as follows:
December 31, 2022
Estimated Useful LifeGross Carrying AmountAccumulated AmortizationNet Carrying Amount
Customer relationships11 years$16,898 $(1,469)$15,429 
Acquired technology6 years15,275 (2,367)12,907 
Trade name4 years2,000 (418)1,582 
Total$34,173 $(4,254)$29,918 
Schedule of Finite-Lived Intangible Assets, Future Amortization Expense
As of December 31, 2022, estimated intangible asset amortization expense for each of the next five years and thereafter are as follows:
Fiscal YearAmortization Expense
2023$4,518 
20244,518 
20254,518 
20264,081 
20274,018 
Thereafter8,265 
Total$29,918 
XML 50 R33.htm IDEA: XBRL DOCUMENT v3.22.4
PREPAID AND OTHER CURRENT ASSETS (Tables)
 12 Months Ended
Dec. 31, 2022
Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Abstract]  
Schedule of Prepaid and Other Current Assets
Prepaid and other current assets consist of the following:

December 31,

2022

2021
Prepaid expenses$1,721 $2,333 
Deposits99 142 
Government authorities204 153 
Other current assets616 503 
Total
$2,640 $3,131 
XML 51 R34.htm IDEA: XBRL DOCUMENT v3.22.4
PROPERTY AND EQUIPMENT, NET (Tables)
 12 Months Ended
Dec. 31, 2022
Property, Plant and Equipment [Abstract]  
Schedule of Property, Plant and Equipment Depreciation is calculated by the straight-line method over the estimated useful lives of the assets, at the following annual rates:

Years
Computers and peripheral equipment
3
Office furniture and equipment
5-7
Lease improvementsThe shorter of the lease term or the useful life of the asset
Internal-use software3
Property and equipment consist of the following:

December 31,

2022

2021
Cost:


Software development costs$13,190 $2,594 
Computers and peripheral equipment2,283 1,779 
Office furniture and equipment665 661 
Leasehold improvements2,167 2,164 

18,305 7,198 
Accumulated depreciation(3,983)(2,358)
Depreciated cost$14,322 $4,840 
XML 52 R35.htm IDEA: XBRL DOCUMENT v3.22.4
LEASES (Tables)
 12 Months Ended
Dec. 31, 2022
Leases [Abstract]  
Schedule of operating ROU assets and lease liabilities
The Company has the following operating ROU assets and lease liabilities:
December 31, 2022
ROU assetsLease liabilities
Real Estate$2,886 $3,801 
Cars24 21 
Total operating leases$2,910 $3,822 
December 31, 2022
Lease liabilities
Current lease liabilities$2,186 
Non-current lease liabilities1,636 
Total lease liabilities$3,822 
Summary of Lease Cost
The following table summarizes the lease costs recognized in the consolidated statement of operations:
Year ended
December 31, 2022
Operating lease cost$1,889 
Short term lease cost973 
Variable lease cost48 
Total lease cost$2,910 
The following table presents supplementary cash flow information regarding the company's operating leases:
Year ended
December 31, 2022
Cash paid for amounts included in the measurement of lease liabilities$2,162 
Right of use assets obtained in exchange for operating lease liabilities upon lease modification$610 
Schedule of Operating Lease, Liability, Maturity
The following table summarizes the future payments of Innovid for its operating lease liabilities:
December 31, 2022
2023$2,219 
20241,018 
2025669 
Total undiscounted lease payments$3,906 
Less: Interest(84)
Total lease liabilities - operating$3,822 
Schedule of Future Minimum Lease Commitments
Future minimum lease commitments under non-cancelable operating leases as of December 31, 2021, are as follows:
Year ended December 31, 2021
Rental of premisesLease of motor vehicles
2022$2,486 $8 
20231,844 — 
2024826 — 
2025770 — 
Total
$5,926 $8 
XML 53 R36.htm IDEA: XBRL DOCUMENT v3.22.4
ACCRUED EXPENSES AND OTHER CURRENT LIABILITIES (Tables)
 12 Months Ended
Dec. 31, 2022
Payables and Accruals [Abstract]  
Schedule of Accrued Liabilities
Accrued expenses and other current liability consist of the following:
December 31,
2022

2021
Accrued expenses$3,544 $2,485 
Tax payables1,325 39 
Deferred revenue426 — 
Accrued lease liability, current portion— 420 
Other current liabilities179 138 
Total
$5,474 $3,082 
XML 54 R37.htm IDEA: XBRL DOCUMENT v3.22.4
OTHER NON-CURRENT LIABILITIES (Tables)
 12 Months Ended
Dec. 31, 2022
Other Liabilities Disclosure [Abstract]  
Schedule of Other Noncurrent Liabilities
Other non-current liabilities consist of the following:

December 31,
2022

2021
Accrued lease liability$— $996 
Uncertain tax position3,865 2,459 
Deferred tax liability489 — 
Other non-current liabilities2,200 — 
Total
$6,554 $3,455 
XML 55 R38.htm IDEA: XBRL DOCUMENT v3.22.4
STOCKHOLDERS’ EQUITY (Tables)
 12 Months Ended
Dec. 31, 2022
Temporary Equity Disclosure [Abstract]  
Schedule of Stockholders Equity
Stockholders’ equity:
AuthorizedIssuedOutstanding
December 31,December 31,December 31,
2022

20212022

2021

20222021
Stocks of $0.0001, par value each:
Common stocks500,000,000 500,000,000 133,882,414 119,017,380 133,882,414 119,017,380 
XML 56 R39.htm IDEA: XBRL DOCUMENT v3.22.4
STOCK-BASED COMPENSATION (Tables)
 12 Months Ended
Dec. 31, 2022
Share-Based Payment Arrangement [Abstract]  
Schedule Share Based Compensation Expenses
Stock-based compensation expense is related to awards issued to employees pursuant to the Innovid Stock Plan and the 2021 Incentive Plan, summarized as follows:

Year ended December 31,

202220212020
Cost of goods sold
$1,171 $43 $11 
Research and development
3,489 501 121 
Sales and marketing
4,685 470 196 
General and administrative
3,342 1,997 92 
Total
$12,687 $3,011 $420 
Schedule of Share Based Payment Arrangement, Option, Activity
A summary of the employees’ stock option activity under the Innovid Stock Plan and the 2021 Incentive Plan for the years ended December 31, 2022 is as follows:

Year ended
December 31, 2022

Amount
of
options
Weighted
average
exercise
price
Weighted
average
remaining contractual term
(in years)
Aggregate intrinsic value (in thousands)
Outstanding at beginning of year
11,122,648 $0.82 6.87$64,818 
Transfer between employee and consultant40,118 0.64 
Granted2,105,258 2.10 
Granted in acquisition949,893 0.31 
Forfeited(355,998)1.60 
Expired(26,089)1.37 
Exercised(3,149,387)0.30 
Outstanding at end of year
10,686,443 $1.15 6.85$5,923 
Exercisable options at end of year
6,687,488 $0.75 5.77$6,409 

A summary of the consultants’ stock option activity under the Innovid Stock Plan for the year ended December 31, 2022 is as follows:

Year ended
December 31, 2022

Amount
of
options
Weighted
average
exercise
price
Weighted
average
remaining contractual term
(in years)
Aggregate intrinsic value (in thousands)
Outstanding at beginning of year
179,627 $0.31 2.34$1,139 
Consultant has become employee(40,118)0.64 
Granted— — 
Forfeited(460)2.81 
Expired(209)2.81 
Exercised(69,298)0.30 
Outstanding at end of year
69,542 $0.47 4.21$86 
Exercisable options at end of year
64,524 $0.46 3.93$81 
Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions
The Company estimated the fair value of each option on the date of grant using the Black-Scholes option pricing model applying the weighted-average assumptions in the following table:

Year ended December 31,

2022

20212020
Expected volatility
69%-71%
65 %79 %
Expected dividends
— %— %— %
Expected term (in years)
4.316.026.11
Risk free interest
2.84%-3.81%
1.06%-1.11%
0.62%-0.82%
A summary of the employees’ RSU activity under the 2021 Incentive Plan for the year ended December 31, 2022 is as follows:

Number of share units
Weighted
average
grant date
fair value
Outstanding at beginning of year
— — 
Granted9,329,639 5.65 
Released(96,884)5.90 
Forfeited(1,246,382)5.97 
Outstanding at end of year
7,986,373 $5.60 
A summary of the consultants’ RSU activity under the 2021 Incentive Plan for the year ended December 31, 2022 is as follows:

Number of share units
Weighted
average
grant date
fair value
Outstanding at beginning of year
— — 
Granted176,151 6.52 
Forfeited(45,883)6.28 
Outstanding at end of year
130,268 $6.60 
XML 57 R40.htm IDEA: XBRL DOCUMENT v3.22.4
INCOME TAXES (Tables)
 12 Months Ended
Dec. 31, 2022
Income Tax Disclosure [Abstract]  
Schedule of Income (Loss) before Income Tax, Domestic and Foreign
Income (loss) before taxes on income is comprised as follows:
Year ended December 31,
2022

20212020
Domestic$(7,910)$(11,098)$1,241 
Foreign(8,483)863 (853)
Total income (loss) before income taxes
$(16,393)$(10,235)$388 
Schedule of Components of Income Tax Expense (Benefit)
Income taxes are comprised as follows:
Year ended December 31,
2022

20212020
Current income tax provision (benefit):  
Domestic$1,048 $(8)$96 
Foreign2,129 1,245 1,104 
Total current income tax (benefit) provision
$3,177 $1,237 $1,200 
Year ended December 31,
2022

20212020
Deferred income tax provision (benefit):  
Domestic$— $— $— 
Foreign(1,160)— — 
Total deferred income tax (benefit) provision
$(1,160)$— $— 
Total income tax (benefit) provision$2,017 $1,237 $1,200 
Schedule of Effective Income Tax Rate Reconciliation
A reconciliation of the U. S. statutory income tax rate to the Company’s effective income tax rate for continuing operations is as follows:
Year ended December 31,
 202220212020
Total income (loss) before income taxes
$(16,393)$(10,235)$388 
US statutory rate21 %21 %21 %
Income taxed computed at U. S. federal statutory rate$(3,443)$(2,149)$81 
Foreign rate differential101 (14)(155)
State and local income taxes, net(239)(359)207 
Other non-deductible items546 (37)140 
GILTI2,892 308 — 
Change in valuation allowance2,305 1,493 159 
Tax credits(474)(338)(469)
Changes in uncertain tax positions1,202 881 956 
Transaction costs1,427 578 — 
Warrants - MTM(3,081)160 (5)
Other781 714 286 
Total income tax provision
$2,017 $1,237 $1,200 
Effective income tax rate
(12.3)%(12.1)%309.0 %
Schedule of Deferred Tax Assets and Liabilities Significant components of deferred tax assets and deferred tax liabilities consisted of the following:
 December 31,
 20222021
Deferred tax assets  
Loss carryforwards$11,093 $10,201 
Tax credits1,271 1,128 
Interest limitation carryforwards— 25 
R&D capitalization costs7,497 — 
Accrued expenses1,157 597 
Share-based compensation4,398 127 
Fixed assets147 180 
Lease liabilities700 — 
Other28 187 
Total deferred tax assets, gross
26,291 12,445 
Valuation allowance(18,697)(12,445)
Total deferred tax assets, net
$7,594 $— 
Deferred tax liabilities
Intangibles$(7,239)$— 
Right-of-use asset(654)— 
Other(190)— 
Total deferred tax liability, net
$(8,083)$— 
Total deferred tax asset (liability)$(489)$— 
Summary of Operating Loss Carryforwards
The Company’s gross NOLs for tax return purposes are as follows:
 
Year ended December 31,
 20222021
Domestic NOLs (federal)$11,881 $36,817 
Domestic NOLs (state and local)10,992 36,245 
Foreign NOLs30,804 1,136 
Total
$53,677 $74,198 
Schedule of Unrecognized Tax Benefits Roll Forward
The Company’s unrecognized tax benefits are reconciled as follows:
December 31,
202220212020
Gross unrecognized tax benefits as of January 1
$3,162 $2,373 $1,438 
Increases - prior year tax positions60 508 — 
Decreases - prior year tax positions(231)(410)— 
Increases - current year tax positions2,562 691 935 
Position expiration(97)— — 
Gross unrecognized tax benefits as of December 31
$5,456 $3,162 $2,373 
XML 58 R41.htm IDEA: XBRL DOCUMENT v3.22.4
SEGMENT REPORTING (Tables)
 12 Months Ended
Dec. 31, 2022
Segment Reporting [Abstract]  
Schedule of Revenue and Property and Equipment, by Geographical Areas
Revenue by geographical location are as follows:

December 31,

202220212020
US$114,528 $81,882 $62,760 
Canada1,266 1,039 518 
APAC4,249 3,151 2,636 
EMEA6,030 2,515 1,463 
LATAM1,044 1,704 1,424 
Total revenues
$127,117 $90,291 $68,801 
The Company’s property and equipment, net and ROU assets commencing January 1, 2022 by geographical location are as follows:
Year ended December 31,
20222021
Israel$2,707 $1,495 
US14,065 3,051 
Rest of the World 460 294 
Total
$17,232 $4,840 
XML 59 R42.htm IDEA: XBRL DOCUMENT v3.22.4
BASIC AND DILUTED NET LOSS PER SHARE (Tables)
 12 Months Ended
Dec. 31, 2022
Earnings Per Share [Abstract]  
Schedule of Basic and Diluted Net Loss Per Share
Basic and diluted net loss per share attributable to common stockholders was calculated as follows:
Year ended December 31,
202220212020
Numerator:
Net loss$(18,410)$(11,472)$(812)
Accretion of preferred stocks to redemption value— (77,063)(7,297)
Net loss attributable to common stockholders - basic and diluted
$(18,410)$(88,535)$(8,109)
Denominator:
Weighted-average number of stocks used in computing net loss per stock attributable to common stockholders
130,756,484 26,745,020 16,028,560 
Net loss per stock attributable to common stockholders – basic and diluted
$(0.14)$(3.31)$(0.51)
Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share
The Company excluded the following potential common shares, presented based on amounts outstanding at each period end, from the computation of diluted net loss per share attributable to common stockholders for the periods indicated because including them would have had an anti-dilutive effect:
Year ended December 31,
202220212020
Preferred stocks— — 73,690,340 
Options outstanding10,755,985 11,302,275 13,204,528 
RSUs outstanding8,116,641 — — 
Warrants outstanding10,222,500 10,222,500 680,271 
XML 60 R43.htm IDEA: XBRL DOCUMENT v3.22.4
DESCRIPTION OF BUSINESS (Details) - USD ($)
$ / shares in Units, $ in Thousands
 11 Months Ended 12 Months Ended
Feb. 28, 2022
Nov. 30, 2021
Dec. 31, 2022
Dec. 31, 2021
Business Acquisition [Line Items]        
Secondary sale amount   $ 68,855   $ 68,855
TV Squared        
Business Acquisition [Line Items]        
Payments to acquire business $ 100,000      
Shares issued as consideration (in shares) 11,549,465      
Share price (in dollars per share) $ 3.80      
Issued, fully vested stock option (in shares) 949,893   949,893  
Weighted average fair value (in dollars per share) $ 3.49      
XML 61 R44.htm IDEA: XBRL DOCUMENT v3.22.4
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Schedule of Reclassification (Details) - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Dec. 31, 2020
New Accounting Pronouncements or Change in Accounting Principle [Line Items]      
Cost of revenues [1] $ 30,187 $ 17,698 $ 12,311
Operating expenses:      
Research and development [1] 31,118 24,299 18,014
Sales and marketing [1] 50,266 32,841 28,521
General and administrative [1] 39,144 20,641 8,103
Depreciation, amortization and impairment 6,143 661 730
Previously reported      
New Accounting Pronouncements or Change in Accounting Principle [Line Items]      
Cost of revenues 33,265 17,785 12,365
Operating expenses:      
Research and development 31,932 24,619 18,283
Sales and marketing 52,226 33,056 28,810
General and administrative 39,435 20,680 8,221
Depreciation, amortization and impairment 0 0 0
Effect of change      
New Accounting Pronouncements or Change in Accounting Principle [Line Items]      
Cost of revenues (3,078) (87) (54)
Operating expenses:      
Research and development (814) (320) (269)
Sales and marketing (1,960) (215) (289)
General and administrative (291) (39) (118)
Depreciation, amortization and impairment $ 6,143 $ 661 $ 730
[1] (1) Exclusive of depreciation, amortization and impairment presented separately.
XML 62 R45.htm IDEA: XBRL DOCUMENT v3.22.4
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Narrative) (Details)
 3 Months Ended 12 Months Ended
Sep. 30, 2022
USD ($)
Dec. 31, 2022
USD ($)
reportingUnit
$ / shares
Dec. 31, 2021
USD ($)
$ / shares
Dec. 31, 2020
USD ($)
Summary of Significant Accounting Policies [Line Items]        
Short-term bank deposit   $ 10,000,000 $ 0  
Weighted average interest rate of time deposits, three months or less   4.10%    
Weighted average interest rate of time deposits, three months through six months   4.10%    
Impairment Long Lived Asset Held For Use Statement Of Income Or Comprehensive Income Extensible Enumeration Not Disclosed Flag   recognized impairment expense    
Impairments of long-lived assets   $ 547,000 0 $ 0
Number of reporting units | reportingUnit   1    
Goodwill impairment   $ 0 0  
Acquired finite-lived intangible assets, weighted average useful life   7 years 7 months 20 days    
Severance costs   $ 946,000 $ 755,000 $ 600,000
Payment term   60 days    
Ad serving services   76.70% 93.60% 96.50%
Measurement serving services   19.70% 1.60% 0.70%
Creative serving services   3.60% 4.80% 2.80%
Employee Severance        
Summary of Significant Accounting Policies [Line Items]        
Number of employee deposit, percent   8.33%    
Postemployment Retirement Benefits        
Summary of Significant Accounting Policies [Line Items]        
Maximum annual contributions per employee, percent   4.00% 4.00%  
Defined contribution plan, cost   $ 1,182,000 $ 961,000 $ 705,000
Public | Level 1        
Summary of Significant Accounting Policies [Line Items]        
Exercise price per share (in dollars per share) | $ / shares   $ 0.40 $ 1.11  
Fair value of warrant   $ 1,265,000 $ 3,510,000  
Customer relationships        
Summary of Significant Accounting Policies [Line Items]        
Acquired finite-lived intangible assets, weighted average useful life   11 years    
Technology        
Summary of Significant Accounting Policies [Line Items]        
Acquired finite-lived intangible assets, weighted average useful life   6 years    
Trade name        
Summary of Significant Accounting Policies [Line Items]        
Acquired finite-lived intangible assets, weighted average useful life   4 years    
Software development costs        
Summary of Significant Accounting Policies [Line Items]        
Useful lives (in years)   three-year    
Capitalization cost   $ 11,143,000 2,594,000  
Asset impairment charges $ 547,000   $ 0 $ 0
Geographic Distribution, Foreign        
Summary of Significant Accounting Policies [Line Items]        
Weighted average interest rate   0.01% 0.01%  
XML 63 R46.htm IDEA: XBRL DOCUMENT v3.22.4
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Schedule of Property, Plant and Equipment) (Details)
 12 Months Ended
Dec. 31, 2022
Computers and peripheral equipment  
Property, Plant and Equipment [Line Items]  
Years 3 years
Office furniture and equipment | Minimum  
Property, Plant and Equipment [Line Items]  
Years 5 years
Office furniture and equipment | Maximum  
Property, Plant and Equipment [Line Items]  
Years 7 years
XML 64 R47.htm IDEA: XBRL DOCUMENT v3.22.4
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis) (Details) - USD ($)
$ in Thousands
Dec. 31, 2022
Dec. 31, 2021
Liabilities:    
Derivative Liability, Statement of Financial Position [Extensible Enumeration] Warrants liability Warrants liability
Fair Value, Recurring | Level 1    
Assets:    
Money market funds $ 18,948 $ 4,515
Certificates of deposit 0  
Liabilities:    
Warrants liability 1,265 3,510
Fair Value, Recurring | Level 2    
Assets:    
Money market funds 0 0
Certificates of deposit 20,000  
Liabilities:    
Warrants liability 0 0
Fair Value, Recurring | Level 3    
Assets:    
Money market funds 0 0
Certificates of deposit 0  
Liabilities:    
Warrants liability $ 3,036 $ 15,462
XML 65 R48.htm IDEA: XBRL DOCUMENT v3.22.4
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Schedule of Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation) (Details) - Fair Value, Recurring - Warrants Liability - Level 3 - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]    
Beginning of the year $ 15,462 $ 499
Additions 0 18,427
Change in fair value (12,426) 1,616
Conversion of Legacy Innovid Warrants on the Closing of the Transaction 0 (5,080)
End of the year $ 3,036 $ 15,462
XML 66 R49.htm IDEA: XBRL DOCUMENT v3.22.4
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Schedule of Warrants Follows at Initial Measurement) (Details)
 12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Dec. 31, 2020
Fair Value Measurement Inputs and Valuation Techniques [Line Items]      
Expected dividends 0.00% 0.00% 0.00%
Expected term (in years) 4 years 3 months 21 days 6 years 7 days 6 years 1 month 9 days
Expected volatility   65.00% 79.00%
Private Placement      
Fair Value Measurement Inputs and Valuation Techniques [Line Items]      
Risk-free interest rate 4.07% 1.24%  
Expected dividends 0.00% 0.00%  
Expected term (in years) 3 years 10 months 24 days 4 years 10 months 24 days  
Expected volatility 85.00% 55.00%  
XML 67 R50.htm IDEA: XBRL DOCUMENT v3.22.4
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Schedule of Concentration Risk) (Details) - Revenue Benchmark - Customer Concentration Risk
 12 Months Ended
Dec. 31, 2022
Dec. 31, 2020
Customer A    
Concentration Risk [Line Items]    
Concentration risk, percentage 11.00%  
Customer B    
Concentration Risk [Line Items]    
Concentration risk, percentage 10.00% 10.00%
XML 68 R51.htm IDEA: XBRL DOCUMENT v3.22.4
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Schedule of Operating Lease Liabilities and ROU Assets (Details) - USD ($)
$ in Thousands
Dec. 31, 2022
Jan. 01, 2022
Dec. 31, 2021
Summary of Significant Accounting Policies [Line Items]      
ROU assets $ 2,910   $ 0
Lease liabilities 3,822    
Accounting Standards Update 2016-02      
Summary of Significant Accounting Policies [Line Items]      
ROU assets   $ 3,978  
Lease liabilities   5,532  
Real Estate      
Summary of Significant Accounting Policies [Line Items]      
ROU assets 2,886    
Lease liabilities 3,801    
Real Estate | Accounting Standards Update 2016-02      
Summary of Significant Accounting Policies [Line Items]      
ROU assets   3,928  
Lease liabilities   5,482  
Cars      
Summary of Significant Accounting Policies [Line Items]      
ROU assets 24    
Lease liabilities $ 21    
Cars | Accounting Standards Update 2016-02      
Summary of Significant Accounting Policies [Line Items]      
ROU assets   50  
Lease liabilities   $ 50  
XML 69 R52.htm IDEA: XBRL DOCUMENT v3.22.4
TRANSACTION - Narrative (Details)
 12 Months Ended
Nov. 30, 2021
USD ($)
$ / shares
shares
Dec. 31, 2022
USD ($)
$ / shares
shares
Dec. 31, 2021
USD ($)
$ / shares
shares
Dec. 31, 2020
USD ($)
shares
Dec. 01, 2021
shares
Jan. 01, 2021
shares
Dec. 31, 2019
shares
Related Party Transaction [Line Items]              
Goodwill | $   $ 116,976,000 $ 4,555,000        
Common stock, shares issued (in shares)   133,882,414 119,017,380        
Common stock, shares outstanding (in shares)   133,882,414 119,017,380        
Accrued transaction cost, not yet paid | $   $ 0 $ 3,185,000 $ 0      
Exchange ratio 1.337 1.337          
Ordinary shares, par value (in dollars per share) | $ / shares   $ 0.0001 $ 0.0001        
Number of securities callable by warrants (in shares) 1            
Exercisable term from closing of business combination 30 days            
Expiration term of warrant (in years) 5 years            
Common stocks              
Related Party Transaction [Line Items]              
Per unit price (in dollars per share) | $ / shares $ 11.50            
Common stock, shares outstanding (in shares)     119,017,380 16,275,609     15,969,260
Ordinary shares, par value (in dollars per share) | $ / shares $ 0.0001            
Public Warrants | Common stocks              
Related Party Transaction [Line Items]              
Shares issued in transaction (in shares) 3,162,500            
Private Placement Warrants | Common stocks              
Related Party Transaction [Line Items]              
Shares issued in transaction (in shares) 7,060,000            
PIPE Investors              
Related Party Transaction [Line Items]              
Common stock, shares issued (in shares)         118,941,618    
Common stock, shares outstanding (in shares)         118,941,618    
PIPE Investors | Secondary Sale              
Related Party Transaction [Line Items]              
Shares issued in transaction (in shares) 6,885,486            
ION              
Related Party Transaction [Line Items]              
Goodwill | $ $ 0            
Other intangible assets | $ 0            
Aggregate value | $ $ 149,252,000            
ION | IPO              
Related Party Transaction [Line Items]              
Shares issued in transaction (in shares) 19,585,174            
Per unit price (in dollars per share) | $ / shares $ 10.00            
Gross proceeds | $ $ 195,888,000            
Conversion of stock (in shares) 12,039,826            
Innovid Corp              
Related Party Transaction [Line Items]              
Exchanged into Innovid Corp. common stock on November 30, 2021 (in shares) 93,787,278            
Common stock, shares outstanding (in shares)           16,275,609  
Exercisable term from closing of business combination   30 days          
Expiration term of warrant (in years)   5 years          
XML 70 R53.htm IDEA: XBRL DOCUMENT v3.22.4
TRANSACTION - Common Stock in Innovid Corp (Details) - shares
Nov. 30, 2021
Dec. 31, 2022
Dec. 31, 2021
Jan. 01, 2021
Business Acquisition [Line Items]        
Common stock, shares outstanding (in shares)   133,882,414 119,017,380  
Innovid Corp        
Business Acquisition [Line Items]        
Common stock, shares outstanding (in shares)       16,275,609
Warrant exercised (in shares) 132,392      
Stock options exercised (in shares) 3,180,943      
Conversion of redeemable convertible preferred stock into common stock (in shares) 73,690,340      
Conversion of Legacy Innovid warrants ( in shares) 507,994      
Exchanged into Innovid Corp. common stock on November 30, 2021 (in shares) 93,787,278      
XML 71 R54.htm IDEA: XBRL DOCUMENT v3.22.4
TRANSACTION - Transaction to Cash Flow and Changes in Temporary Equity and Stockholders’ Equity (Details) - USD ($)
$ in Thousands
 11 Months Ended 12 Months Ended
Nov. 30, 2021
Dec. 31, 2021
Business Acquisition [Line Items]    
Less: Transaction costs paid   $ (31,160)
Less: Deferred underwriting fee paid   (6,199)
Proceeds from reverse recapitalization, net   149,252
Less: Accrued transaction costs not yet paid   (3,185)
Less: Company Warrant assumed as part of the Transaction   (22,791)
Plus: Transaction costs allocated to Company Warrant   2,750
Reverse recapitalization, net   126,026
Secondary sale amount $ 68,855 68,855
PIPE Investors    
Business Acquisition [Line Items]    
Cash - PIPE Investment, net of Secondary Sale Amount of $68,855   131,145
ION    
Business Acquisition [Line Items]    
Cash - ION trust account and cash, net of redemptions   $ 55,466
XML 72 R55.htm IDEA: XBRL DOCUMENT v3.22.4
ACQUISITION - Narrative (Details) - USD ($)
$ / shares in Units, $ in Thousands
 12 Months Ended
Feb. 28, 2022
Dec. 31, 2022
Business Acquisition [Line Items]    
Acquired finite-lived intangible assets, weighted average useful life   7 years 7 months 20 days
Technology    
Business Acquisition [Line Items]    
Acquired finite-lived intangible assets, weighted average useful life   6 years
Trade name    
Business Acquisition [Line Items]    
Acquired finite-lived intangible assets, weighted average useful life   4 years
Customer relationships    
Business Acquisition [Line Items]    
Acquired finite-lived intangible assets, weighted average useful life   11 years
TV Squared    
Business Acquisition [Line Items]    
Payments to acquire business $ 100,000  
Shares issued as consideration (in shares) 11,549,465  
Share price (in dollars per share) $ 3.80  
Issued, fully vested stock option (in shares) 949,893 949,893
Weighted average fair value (in dollars per share) $ 3.49  
Cash compensation arrangement for certain employees $ 9,700  
Acquisition related costs $ 5,000  
TV Squared | Technology    
Business Acquisition [Line Items]    
Acquired finite-lived intangible assets, weighted average useful life 6 years  
TV Squared | Trade name    
Business Acquisition [Line Items]    
Acquired finite-lived intangible assets, weighted average useful life 4 years  
TV Squared | Customer relationships    
Business Acquisition [Line Items]    
Acquired finite-lived intangible assets, weighted average useful life 11 years  
XML 73 R56.htm IDEA: XBRL DOCUMENT v3.22.4
ACQUISITION - Fair Values of the Assets Acquired and Liabilities Assumed (Details) - USD ($)
$ in Thousands
Dec. 31, 2022
Feb. 28, 2022
Dec. 31, 2021
Business Acquisition [Line Items]      
Goodwill $ 116,976   $ 4,555
TV Squared      
Business Acquisition [Line Items]      
Cash and cash equivalents   $ 5,318  
Accounts receivables   4,186  
Other current assets   1,173  
Property and equipment   154  
Total tangible assets   10,831  
Goodwill   112,421  
Total assets acquired   157,027  
Less: Deferred tax liabilities   (1,677)  
Less: Other assumed liabilities   (3,782)  
Net assets acquired   151,568  
TV Squared | Technology      
Business Acquisition [Line Items]      
Intangible assets   15,075  
TV Squared | Customer relationships      
Business Acquisition [Line Items]      
Intangible assets   16,700  
TV Squared | Trade name      
Business Acquisition [Line Items]      
Intangible assets   $ 2,000  
XML 74 R57.htm IDEA: XBRL DOCUMENT v3.22.4
ACQUISITION - Unaudited Pro Forma Financial Information (Details) - TV Squared - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Business Acquisition [Line Items]    
Revenues $ 131,433 $ 112,147
Net losses $ (14,634) $ (37,195)
XML 75 R58.htm IDEA: XBRL DOCUMENT v3.22.4
INTANGIBLE ASSETS, NET - Intangible Assets (Details)
$ in Thousands
 12 Months Ended
Dec. 31, 2022
USD ($)
Finite-Lived Intangible Assets [Line Items]  
Gross Carrying Amount $ 34,173
Accumulated Amortization (4,254)
Net Carrying Amount $ 29,918
Customer relationships  
Finite-Lived Intangible Assets [Line Items]  
Estimated Useful Life 11 years
Gross Carrying Amount $ 16,898
Accumulated Amortization (1,469)
Net Carrying Amount $ 15,429
Acquired technology  
Finite-Lived Intangible Assets [Line Items]  
Estimated Useful Life 6 years
Gross Carrying Amount $ 15,275
Accumulated Amortization (2,367)
Net Carrying Amount $ 12,907
Trade name  
Finite-Lived Intangible Assets [Line Items]  
Estimated Useful Life 4 years
Gross Carrying Amount $ 2,000
Accumulated Amortization (418)
Net Carrying Amount $ 1,582
XML 76 R59.htm IDEA: XBRL DOCUMENT v3.22.4
INTANGIBLE ASSETS, NET - Narrative (Details) - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Dec. 31, 2020
Goodwill and Intangible Assets Disclosure [Abstract]      
Acquired finite-lived intangible assets, weighted average (in years) 7 years 7 months 20 days    
Amortization of intangible assets $ 3,850 $ 33 $ 199
XML 77 R60.htm IDEA: XBRL DOCUMENT v3.22.4
INTANGIBLE ASSETS, NET - Intangible Assets Amortization Expense (Details)
$ in Thousands
Dec. 31, 2022
USD ($)
Goodwill and Intangible Assets Disclosure [Abstract]  
2023 $ 4,518
2024 4,518
2025 4,518
2026 4,081
2027 4,018
Thereafter 8,265
Total $ 29,918
XML 78 R61.htm IDEA: XBRL DOCUMENT v3.22.4
PREPAID AND OTHER CURRENT ASSETS (Details) - USD ($)
$ in Thousands
Dec. 31, 2022
Dec. 31, 2021
Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Abstract]    
Prepaid expenses $ 1,721 $ 2,333
Deposits 99 142
Government authorities 204 153
Other current assets 616 503
Total $ 2,640 $ 3,131
XML 79 R62.htm IDEA: XBRL DOCUMENT v3.22.4
PROPERTY AND EQUIPMENT, NET (Details) - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Dec. 31, 2020
Property, Plant and Equipment [Line Items]      
Total cost $ 18,305 $ 7,198  
Accumulated depreciation (3,983) (2,358)  
Depreciated cost 14,322 4,840  
Depreciation 1,626 630 $ 531
Software development costs      
Property, Plant and Equipment [Line Items]      
Total cost 13,190 2,594  
Computers and peripheral equipment      
Property, Plant and Equipment [Line Items]      
Total cost 2,283 1,779  
Office furniture and equipment      
Property, Plant and Equipment [Line Items]      
Total cost 665 661  
Leasehold improvements      
Property, Plant and Equipment [Line Items]      
Total cost $ 2,167 $ 2,164  
XML 80 R63.htm IDEA: XBRL DOCUMENT v3.22.4
LEASES (Schedule of operating ROU assets and lease liabilities) (Details) - USD ($)
$ in Thousands
Dec. 31, 2022
Dec. 31, 2021
Operating Leases Assets And Liabilities [Line Items]    
Operating lease right of use asset $ 2,910 $ 0
Lease liabilities 3,822  
Real Estate    
Operating Leases Assets And Liabilities [Line Items]    
Operating lease right of use asset 2,886  
Lease liabilities 3,801  
Cars    
Operating Leases Assets And Liabilities [Line Items]    
Operating lease right of use asset 24  
Lease liabilities $ 21  
XML 81 R64.htm IDEA: XBRL DOCUMENT v3.22.4
LEASES (Schedule of lease liability) (Details) - USD ($)
$ in Thousands
Dec. 31, 2022
Dec. 31, 2021
Leases [Abstract]    
Current lease liabilities $ 2,186 $ 0
Non-current lease liabilities 1,636 $ 0
Total lease liabilities $ 3,822  
XML 82 R65.htm IDEA: XBRL DOCUMENT v3.22.4
LEASES (Schedule Of Lease Costs Recognized In The Consolidated Statement Of Earnings) (Details)
$ in Thousands
 12 Months Ended
Dec. 31, 2022
USD ($)
Leases [Abstract]  
Operating lease cost $ 1,889
Short term lease cost 973
Variable lease cost 48
Total lease cost $ 2,910
XML 83 R66.htm IDEA: XBRL DOCUMENT v3.22.4
LEASES (Narrative) (Details) - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2021
Dec. 31, 2020
Dec. 31, 2022
Leases [Abstract]      
Operating lease, weighted average remaining lease term     2 years 2 months 12 days
Operating lease, weighted average discount rate, percent     3.60%
Operating lease expense $ 2,072 $ 2,215  
XML 84 R67.htm IDEA: XBRL DOCUMENT v3.22.4
LEASE (Supplementary Cash Flow Information) (Details)
$ in Thousands
 12 Months Ended
Dec. 31, 2022
USD ($)
Leases [Abstract]  
Cash paid for amounts included in the measurement of lease liabilities $ 2,162
Right of use assets obtained in exchange for operating lease liabilities upon lease modification $ 610
XML 85 R68.htm IDEA: XBRL DOCUMENT v3.22.4
LEASES (Schedule of Operating Lease Liability Maturities) (Details)
$ in Thousands
Dec. 31, 2022
USD ($)
Leases [Abstract]  
2023 $ 2,219
2024 1,018
2025 669
Total undiscounted lease payments 3,906
Less: Interest (84)
Total lease liabilities - operating $ 3,822
XML 86 R69.htm IDEA: XBRL DOCUMENT v3.22.4
LEASES (Schedule Of Commitments Under Non-Cancelable Operating Leases) (Details)
$ in Thousands
Dec. 31, 2021
USD ($)
Rental of premises  
Operating Leased Assets [Line Items]  
2022 $ 2,486
2023 1,844
2024 826
2025 770
Total 5,926
Lease of motor vehicles  
Operating Leased Assets [Line Items]  
2022 8
2023 0
2024 0
2025 0
Total $ 8
XML 87 R70.htm IDEA: XBRL DOCUMENT v3.22.4
ACCRUED EXPENSES AND OTHER CURRENT LIABILITIES (Details) - USD ($)
$ in Thousands
Dec. 31, 2022
Dec. 31, 2021
Payables and Accruals [Abstract]    
Accrued expenses $ 3,544 $ 2,485
Tax payables 1,325 39
Deferred revenue 426 0
Accrued lease liability, current portion 0 420
Other current liabilities 179 138
Total $ 5,474 $ 3,082
XML 88 R71.htm IDEA: XBRL DOCUMENT v3.22.4
OTHER NON-CURRENT LIABILITIES (Details) - USD ($)
$ in Thousands
Dec. 31, 2022
Dec. 31, 2021
Other Liabilities Disclosure [Abstract]    
Accrued lease liability $ 0 $ 996
Uncertain tax position 3,865 2,459
Deferred tax liability 489 0
Other non-current liabilities 2,200 0
Other non-current liabilities $ 6,554 $ 3,455
Operating Lease, Liability, Noncurrent, Statement of Financial Position [Extensible Enumeration] Other non-current liabilities Other non-current liabilities
XML 89 R72.htm IDEA: XBRL DOCUMENT v3.22.4
WARRANTS (Details) - USD ($)
$ / shares in Units, $ in Thousands
 12 Months Ended
Dec. 30, 2021
Nov. 30, 2021
Dec. 31, 2022
Dec. 31, 2021
Class of Warrant or Right [Line Items]        
Fractional shares issued upon exercise (in shares)     0  
Exercisable term from closing of business combination   30 days    
Expiration term of warrant (in years)   5 years    
Threshold period for not to transfer, assign or sell any shares or warrants after completion of initial business combination     30 days  
Innovid Corp        
Class of Warrant or Right [Line Items]        
Exercisable term from closing of business combination     30 days  
Exercisable term, from closing of public offering     1 year  
Expiration term of warrant (in years)     5 years  
Exercise price per share (in dollars per share) $ 11.50      
Public Warrants        
Class of Warrant or Right [Line Items]        
Outstanding warrants (in shares)     3,162,500  
Private Warrants        
Class of Warrant or Right [Line Items]        
Outstanding warrants (in shares)     7,060,000  
Redemption Of Warrant Price Per Share Equals Or Exceeds 18.00 | Innovid Corp        
Class of Warrant or Right [Line Items]        
Redemption of warrants, reference price (in dollars per share) 18.00      
Redemption price of warrants (in dollars per share) $ 0.01      
Number of consecutive trading days 30 days      
Initial public offering per share (in dollars per share) $ 18.00      
Redemption of warrants, threshold trading days 20 days      
Minimum threshold written notice period for redemption of warrants 30 days      
Redemption Of Warrant Price Per Share Equals Or Exceeds 10.00 | Innovid Corp        
Class of Warrant or Right [Line Items]        
Redemption of warrants, reference price (in dollars per share) $ 10.00      
Redemption price of warrants (in dollars per share) $ 0.10      
Number of consecutive trading days 30 days      
Initial public offering per share (in dollars per share) $ 10.00      
Redemption of warrants, threshold trading days 20 days      
Minimum threshold written notice period for redemption of warrants 30 days      
Private Placement Warrants        
Class of Warrant or Right [Line Items]        
Derivative liability fair value     $ 4,301 $ 18,972
XML 90 R73.htm IDEA: XBRL DOCUMENT v3.22.4
LONG-TERM DEBT (Details) - USD ($)
$ in Thousands
 1 Months Ended 3 Months Ended 12 Months Ended
Aug. 04, 2023
Aug. 04, 2022
Dec. 29, 2020
Jan. 31, 2023
Dec. 31, 2022
Jun. 30, 2022
Dec. 31, 2020
Aug. 03, 2022
Subsequent Event                
Line of Credit Facility [Line Items]                
Repayment of line of credit       $ 5,000        
Revolving Credit Facility                
Line of Credit Facility [Line Items]                
Line of credit outstanding   $ 50,000     $ 50,000     $ 15,000
Debt instrument, prime rate   0.75%            
Commitment fee percentage   0.20%            
Commitment fee amount   $ 40            
Line of credit quick ratio   1.30            
Quarterly adjusted quick ratio   1.50            
Revolving Credit Facility | Forecast                
Line of Credit Facility [Line Items]                
Commitment fee amount $ 75              
Revolving Credit Facility | Maximum                
Line of Credit Facility [Line Items]                
Interest rate during period   4.25%            
Line of Credit                
Line of Credit Facility [Line Items]                
Proceeds from line of credit         5,000   $ 6,000  
Line of Credit | Amended Credit Agreement Maturing December 2020                
Line of Credit Facility [Line Items]                
Line of credit outstanding         $ 20,000      
Proceeds from line of credit           $ 9,000    
Line of Credit | Maximum | Amended Credit Agreement Maturing October 2018 | Prime Rate                
Line of Credit Facility [Line Items]                
Debt instrument, variable rate     1.00%          
Line of Credit | Minimum | Amended Credit Agreement Maturing October 2018 | Prime Rate                
Line of Credit Facility [Line Items]                
Debt instrument, variable rate     0.75%          
XML 91 R74.htm IDEA: XBRL DOCUMENT v3.22.4
COMMITMENTS AND CONTINGENT LIABILITIES (Details) - USD ($)
$ / shares in Units, shares in Thousands, $ in Thousands
Dec. 31, 2022
Dec. 31, 2021
Commitments and Contingencies [Line Items]    
Ordinary shares, par value (in dollars per share) $ 0.0001 $ 0.0001
Bank guarantees $ 231  
Israeli Subsidiary    
Commitments and Contingencies [Line Items]    
Bank deposits pledged $ 629  
Subsidiaries    
Commitments and Contingencies [Line Items]    
Shares of subsidiary pledged (in shares) 65  
Ordinary shares, par value (in dollars per share) $ 0.01  
XML 92 R75.htm IDEA: XBRL DOCUMENT v3.22.4
STOCKHOLDERS’ EQUITY (Common Shares Activity) (Details) - $ / shares
Dec. 31, 2022
Dec. 31, 2021
Temporary Equity Disclosure [Abstract]    
Common stock, par value (in dollars per share) $ 0.0001 $ 0.0001
Common stock, shares authorized (in shares) 500,000,000 500,000,000
Common stock, shares issued (in shares) 133,882,414 119,017,380
Common stock, shares outstanding (in shares) 133,882,414 119,017,380
XML 93 R76.htm IDEA: XBRL DOCUMENT v3.22.4
STOCKHOLDERS’ EQUITY (Narrative) (Details)
Dec. 31, 2022
vote
$ / shares
shares
Dec. 31, 2021
$ / shares
Nov. 30, 2021
$ / shares
shares
Feb. 25, 2010
$ / shares
shares
Temporary Equity [Line Items]        
Exchange ratio 1.337   1.337  
Number of securities callable by warrants (in shares)     1  
Ordinary shares, par value (in dollars per share) | $ / shares $ 0.0001 $ 0.0001    
Holder        
Temporary Equity [Line Items]        
Warrants issued (in shares) 133,725      
Number of securities callable by warrants (in shares)       133,725
Ordinary shares, par value (in dollars per share) | $ / shares       $ 0.001
Exercise price per share (in dollars per share) | $ / shares       $ 0.07
Common stocks        
Temporary Equity [Line Items]        
Number of votes for each share | vote 1      
Ordinary shares, par value (in dollars per share) | $ / shares     $ 0.0001  
Treasury stocks        
Temporary Equity [Line Items]        
Shares issued (in shares) 0      
Shares outstanding (in shares) 0      
XML 94 R77.htm IDEA: XBRL DOCUMENT v3.22.4
STOCK-BASED COMPENSATION (Narrative) (Details) - USD ($)
$ in Thousands
 12 Months Ended
Feb. 28, 2022
Nov. 30, 2021
Dec. 31, 2022
Dec. 31, 2021
Dec. 31, 2020
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]          
Stock based compensation expenses     $ 152    
Capitalized stock-based compensation expense     1,165    
Cost not yet recognized     $ 4,536    
Period for cost yet to be recognized     1 year 9 months 18 days    
Restricted Stock Units (RSUs)          
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]          
Cost not yet recognized     $ 33,165    
Period for cost yet to be recognized     2 years    
TV Squared          
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]          
Issued, fully vested stock option (in shares) 949,893   949,893    
Consultants          
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]          
Granted (in shares)     0    
Stock based compensation expenses     $ 1,190 $ 262 $ 162
Minimum          
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]          
Expiration period     10 years    
Minimum | Restricted Stock Units (RSUs)          
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]          
Vesting period     3 years    
Maximum          
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]          
Vesting period     4 years    
Maximum | Restricted Stock Units (RSUs)          
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]          
Vesting period     4 years    
Incentive Plan          
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]          
Number of common stock equal to the fully-diluted shares outstanding   10.00%      
Options available for future option grants (in shares)   15,617,049      
Annual increase period   10 years      
Aggregate number of shares of common stock outstanding   5.00%      
Number of issued and outstanding shares of common stock fully diluted basis   30.00%      
Legacy Plan          
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]          
Vesting period     4 years    
Granted (in shares)     0    
Legacy Plan | Minimum          
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]          
Expiration period     10 years    
Employee Stock Purchase Plan          
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]          
Options available for future option grants (in shares)   2,868,438      
Shares outstanding on the final day of the immediately preceding   1.00%      
Shares issued under ESPP (in shares)     0    
Employee Stock Purchase Plan | Maximum          
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]          
Options available for future option grants (in shares)   17,383,002      
XML 95 R78.htm IDEA: XBRL DOCUMENT v3.22.4
STOCK-BASED COMPENSATION ( Stock Option Activity Under Plan) (Details) - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Dec. 31, 2020
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]      
Stock based compensation expenses $ 152    
Stock Option Plan | Employees      
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]      
Stock based compensation expenses 12,687 $ 3,011 $ 420
Cost of goods sold | Stock Option Plan | Employees      
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]      
Stock based compensation expenses 1,171 43 11
Research and development | Stock Option Plan | Employees      
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]      
Stock based compensation expenses 3,489 501 121
Sales and marketing | Stock Option Plan | Employees      
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]      
Stock based compensation expenses 4,685 470 196
General and administrative | Stock Option Plan | Employees      
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]      
Stock based compensation expenses $ 3,342 $ 1,997 $ 92
XML 96 R79.htm IDEA: XBRL DOCUMENT v3.22.4
STOCK-BASED COMPENSATION ( Stock Option Activity) (Details) - USD ($)
$ / shares in Units, $ in Thousands
 12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Employees    
Number of options    
Outstanding at the beginning of the period (in shares) 11,122,648  
Transfer between employee and consultant (in shares) 40,118  
Granted (in shares) 2,105,258  
Granted in acquisition (in shares) 949,893  
Forfeited (in shares) (355,998)  
Expired (in shares) (26,089)  
Exercised (in shares) (3,149,387)  
Outstanding at the end of the period (in shares) 10,686,443 11,122,648
Exercisable options at the end of the period (in shares) 6,687,488  
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Abstract]    
Outstanding at the beginning of the period (in USD per share) $ 0.82  
Transfer between employee and consultant (in USD per share) 0.64  
Granted (in USD per share) 2.10  
Granted in acquisition (in USD per share) 0.31  
Forfeited (in USD per share) 1.60  
Expired (in USD per share) 1.37  
Exercised (in USD per share) 0.30  
Outstanding at the end of the period (in USD per share) 1.15 $ 0.82
Exercisable exercise price at the end of the period (in USD per share) $ 0.75  
Share-based Compensation Arrangement by Share-based Payment Award, Options, Additional Disclosures    
Outstanding option, weighted average remaining contractual term (in years) 6 years 10 months 6 days 6 years 10 months 13 days
Outstanding exercisable, weighted average remaining contractual term (in years) 5 years 9 months 7 days  
Outstanding intrinsic value at the beginning of the period $ 64,818  
Outstanding intrinsic value at the end of the period 5,923 $ 64,818
Outstanding exercisable intrinsic value at the end of the period $ 6,409  
Consultants    
Number of options    
Outstanding at the beginning of the period (in shares) 179,627  
Transfer between employee and consultant (in shares) 40,118  
Granted (in shares) 0  
Forfeited (in shares) (460)  
Expired (in shares) (209)  
Exercised (in shares) (69,298)  
Outstanding at the end of the period (in shares) 69,542 179,627
Exercisable options at the end of the period (in shares) 64,524  
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Abstract]    
Outstanding at the beginning of the period (in USD per share) $ 0.31  
Transfer between employee and consultant (in USD per share) 0.64  
Granted (in USD per share) 0  
Forfeited (in USD per share) 2.81  
Expired (in USD per share) 2.81  
Exercised (in USD per share) 0.30  
Outstanding at the end of the period (in USD per share) 0.47 $ 0.31
Exercisable exercise price at the end of the period (in USD per share) $ 0.46  
Share-based Compensation Arrangement by Share-based Payment Award, Options, Additional Disclosures    
Outstanding option, weighted average remaining contractual term (in years) 4 years 2 months 15 days 2 years 4 months 2 days
Outstanding exercisable, weighted average remaining contractual term (in years) 3 years 11 months 4 days  
Outstanding intrinsic value at the beginning of the period $ 1,139  
Outstanding intrinsic value at the end of the period 86 $ 1,139
Outstanding exercisable intrinsic value at the end of the period $ 81  
XML 97 R80.htm IDEA: XBRL DOCUMENT v3.22.4
STOCK-BASED COMPENSATION ( Fair Value of Each Option on The Date of Grant) (Details)
 12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Dec. 31, 2020
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Expected volatility   65.00% 79.00%
Expected dividends 0.00% 0.00% 0.00%
Expected term (in years) 4 years 3 months 21 days 6 years 7 days 6 years 1 month 9 days
Risk free interest rate, minimum 2.84% 1.06% 0.62%
Risk free interest rate, maximum 3.81% 1.11% 0.82%
Minimum      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Expected volatility 69.00%    
Maximum      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Expected volatility 71.00%    
XML 98 R81.htm IDEA: XBRL DOCUMENT v3.22.4
STOCK-BASED COMPENSATION - Restricted Stock Unit Activity (Details) - RSUs outstanding
 12 Months Ended
Dec. 31, 2022
$ / shares
shares
Employees  
Number of share units  
Outstanding at the beginning of the year (in shares) | shares 0
Granted (in shares) | shares 9,329,639
Released (in shares) | shares (96,884)
Forfeited (in shares) | shares (1,246,382)
Outstanding at the ending of the year (in shares) | shares 7,986,373
Weighted average grant date fair value  
Outstanding at the beginning of the year (in USD per share) | $ / shares $ 0
Granted (in USD per share) | $ / shares 5.65
Released (in USD per share) | $ / shares 5.90
Forfeited (in USD per share) | $ / shares 5.97
Outstanding at the ending of the year (in USD per share) | $ / shares $ 5.60
Consultants  
Number of share units  
Outstanding at the beginning of the year (in shares) | shares 0
Granted (in shares) | shares 176,151
Forfeited (in shares) | shares (45,883)
Outstanding at the ending of the year (in shares) | shares 130,268
Weighted average grant date fair value  
Outstanding at the beginning of the year (in USD per share) | $ / shares $ 0
Granted (in USD per share) | $ / shares 6.52
Forfeited (in USD per share) | $ / shares 6.28
Outstanding at the ending of the year (in USD per share) | $ / shares $ 6.60
XML 99 R82.htm IDEA: XBRL DOCUMENT v3.22.4
FINANCE EXPENSES (INCOME), NET (Details) - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Dec. 31, 2020
Paycheck Protection Program      
Short-Term Debt [Line Items]      
Debt related interest expense $ 675 $ 259 $ 328
Warrant      
Short-Term Debt [Line Items]      
Unrealized gain (loss) from changes in the fair value $ 14,671 $ 3,819  
XML 100 R83.htm IDEA: XBRL DOCUMENT v3.22.4
INCOME TAXES - Income before Income Tax, Domestic and Foreign (Details) - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Dec. 31, 2020
Income Tax Disclosure [Abstract]      
Domestic $ (7,910) $ (11,098) $ 1,241
Foreign (8,483) 863 (853)
(Loss) profit before taxes $ (16,393) $ (10,235) $ 388
XML 101 R84.htm IDEA: XBRL DOCUMENT v3.22.4
INCOME TAXES - Income Tax Expense (Benefit) (Details) - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Dec. 31, 2020
Current income tax provision (benefit):      
Domestic $ 1,048 $ (8) $ 96
Foreign 2,129 1,245 1,104
Total current income tax (benefit) provision 3,177 1,237 1,200
Deferred income tax provision (benefit):      
Domestic 0 0 0
Foreign (1,160) 0 0
Total deferred income tax (benefit) provision (1,160) 0 0
Total income tax (benefit) provision $ 2,017 $ 1,237 $ 1,200
XML 102 R85.htm IDEA: XBRL DOCUMENT v3.22.4
INCOME TAXES - Effective Income Tax Rate Reconciliation (Details) - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Dec. 31, 2020
Income Tax Disclosure [Abstract]      
Total income (loss) before income taxes $ (16,393) $ (10,235) $ 388
US statutory rate 21.00% 21.00% 21.00%
Income taxed computed at U. S. federal statutory rate $ (3,443) $ (2,149) $ 81
Foreign rate differential 101 (14) (155)
State and local income taxes, net (239) (359) 207
Other non-deductible items 546 (37) 140
GILTI 2,892 308 0
Change in valuation allowance 2,305 1,493 159
Tax credits (474) (338) (469)
Changes in uncertain tax positions 1,202 881 956
Transaction costs 1,427 578 0
Warrants - MTM (3,081) 160 (5)
Other 781 714 286
Total income tax (benefit) provision $ 2,017 $ 1,237 $ 1,200
Effective income tax rate (12.30%) (12.10%) 309.00%
XML 103 R86.htm IDEA: XBRL DOCUMENT v3.22.4
INCOME TAXES - Deferred Tax Assets and Liabilities (Details) - USD ($)
$ in Thousands
Dec. 31, 2022
Dec. 31, 2021
Deferred tax assets    
Loss carryforwards $ 11,093 $ 10,201
Tax credits 1,271 1,128
Interest limitation carryforwards 0 25
R&D capitalization costs 7,497 0
Accrued expenses 1,157 597
Share-based compensation 4,398 127
Fixed assets 147 180
Lease liabilities 700 0
Other 28 187
Total deferred tax assets, gross 26,291 12,445
Valuation allowance (18,697) (12,445)
Total deferred tax assets, net 7,594 0
Deferred tax liabilities    
Intangibles (7,239) 0
Right-of-use asset (654) 0
Other (190) 0
Total deferred tax liability, net (8,083) 0
Total deferred tax asset (liability) $ (489)  
Total deferred tax asset (liability)   $ 0
XML 104 R87.htm IDEA: XBRL DOCUMENT v3.22.4
INCOME TAXES - Narrative (Details) - USD ($)
$ in Thousands
Dec. 31, 2022
Dec. 31, 2021
Dec. 31, 2020
Dec. 31, 2019
Operating Loss Carryforwards [Line Items]        
Undistributed foreign subsidiaries $ 12,888 $ 8,720    
Amount of unrecognized deferred tax liability, undistributed earnings of foreign subsidiaries 1,237 1,224    
Unrecognized tax benefits 5,456 3,162 $ 2,373 $ 1,438
Interest on income taxes accrued 471 $ 136    
TV Squared        
Operating Loss Carryforwards [Line Items]        
Unrecognized tax benefits $ 1,495      
XML 105 R88.htm IDEA: XBRL DOCUMENT v3.22.4
INCOME TAXES - Operating Loss Carryforwards (Details) - USD ($)
$ in Thousands
Dec. 31, 2022
Dec. 31, 2021
Operating Loss Carryforwards [Line Items]    
Operating loss carryforwards $ 53,677 $ 74,198
Domestic NOLs (federal)    
Operating Loss Carryforwards [Line Items]    
Operating loss carryforwards 11,881 36,817
Domestic NOLs (state and local)    
Operating Loss Carryforwards [Line Items]    
Operating loss carryforwards 10,992 36,245
Foreign NOLs    
Operating Loss Carryforwards [Line Items]    
Operating loss carryforwards $ 30,804 $ 1,136
XML 106 R89.htm IDEA: XBRL DOCUMENT v3.22.4
INCOME TAXES - Income Tax Contingencies (Details) - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Dec. 31, 2020
Reconciliation of Unrecognized Tax Benefits, Excluding Amounts Pertaining to Examined Tax Returns [Roll Forward]      
Gross unrecognized tax benefits, beginning balance $ 3,162 $ 2,373 $ 1,438
Increases - prior year tax positions 60 508 0
Decreases - prior year tax positions (231) (410) 0
Increases - current year tax positions 2,562 691 935
Position expiration (97) 0 0
Gross unrecognized tax benefits, ending balance $ 5,456 $ 3,162 $ 2,373
XML 107 R90.htm IDEA: XBRL DOCUMENT v3.22.4
SEGMENT REPORTING - Narrative (Details)
 12 Months Ended
Dec. 31, 2022
segment
Segment Reporting [Abstract]  
Number of operating segments 1
XML 108 R91.htm IDEA: XBRL DOCUMENT v3.22.4
SEGMENT REPORTING (Revenue and Property and Equipment, by Geographical Areas) (Details) - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Dec. 31, 2020
Revenues from External Customers and Long-Lived Assets [Line Items]      
Revenues $ 127,117 $ 90,291 $ 68,801
Long-lived tangible assets 17,232 4,840  
US      
Revenues from External Customers and Long-Lived Assets [Line Items]      
Revenues 114,528 81,882 62,760
Long-lived tangible assets 14,065 3,051  
Canada      
Revenues from External Customers and Long-Lived Assets [Line Items]      
Revenues 1,266 1,039 518
APAC      
Revenues from External Customers and Long-Lived Assets [Line Items]      
Revenues 4,249 3,151 2,636
EMEA      
Revenues from External Customers and Long-Lived Assets [Line Items]      
Revenues 6,030 2,515 1,463
LATAM      
Revenues from External Customers and Long-Lived Assets [Line Items]      
Revenues 1,044 1,704 $ 1,424
Israel      
Revenues from External Customers and Long-Lived Assets [Line Items]      
Long-lived tangible assets 2,707 1,495  
Rest of the World      
Revenues from External Customers and Long-Lived Assets [Line Items]      
Long-lived tangible assets $ 460 $ 294  
XML 109 R92.htm IDEA: XBRL DOCUMENT v3.22.4
BASIC AND DILUTED NET LOSS PER SHARE (Basic and Diluted Net loss Per Share) (Details) - USD ($)
$ / shares in Units, $ in Thousands
 12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Dec. 31, 2020
Numerator:      
Net loss $ (18,410) $ (11,472) $ (812)
Accretion of preferred stocks to redemption value 0 (77,063) (7,297)
Net loss attributable to common stockholders, basic (18,410) (88,535) (8,109)
Net loss attributable to common stockholders, diluted $ (18,410) $ (88,535) $ (8,109)
Denominator:      
Weighted-average number of stocks used in computing net loss per stock attributable to common stockholders, basic (in shares) [1] 130,756,484 26,745,020 16,028,560
Weighted-average number of stocks used in computing net loss per stock attributable to common stockholders, diluted (in shares) [1] 130,756,484 26,745,020 16,028,560
Net loss per stock attributable to common stockholders – basic (in dollars per share) [1] $ (0.14) $ (3.31) $ (0.51)
Net loss per stock attributable to common stockholders – diluted (in dollars per share) [1] $ (0.14) $ (3.31) $ (0.51)
[1] (2) Prior period results have been adjusted to reflect the exchange of Innovid Inc’s common stock for Innovid Corp’s common stock at an exchange ratio of approximately 1.337 because of the Transaction. See Note 3, Transaction for further details.
XML 110 R93.htm IDEA: XBRL DOCUMENT v3.22.4
BASIC AND DILUTED NET LOSS PER SHARE (Narrative) (Details)
Dec. 31, 2022
Nov. 30, 2021
Earnings Per Share [Abstract]    
Exchange ratio 1.337 1.337
XML 111 R94.htm IDEA: XBRL DOCUMENT v3.22.4
BASIC AND DILUTED NET LOSS PER SHARE (Securities Excluded from Computation of Earnings Per Share) (Details) - shares
 12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Dec. 31, 2020
Preferred stocks      
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]      
Securities excluded from computation of earnings per share (in shares) 0 0 73,690,340
Options outstanding      
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]      
Securities excluded from computation of earnings per share (in shares) 10,755,985 11,302,275 13,204,528
RSUs outstanding      
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]      
Securities excluded from computation of earnings per share (in shares) 8,116,641 0 0
Warrants outstanding      
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]      
Securities excluded from computation of earnings per share (in shares) 10,222,500 10,222,500 680,271
XML 112 ctv-20221231_htm.xml IDEA: XBRL DOCUMENT 0001835378 2022-01-01 2022-12-31 0001835378 us-gaap:CommonStockMember 2022-01-01 2022-12-31 0001835378 us-gaap:WarrantMember 2022-01-01 2022-12-31 0001835378 2022-06-30 0001835378 2023-03-01 0001835378 2022-12-31 0001835378 2021-12-31 0001835378 2021-01-01 2021-12-31 0001835378 2020-01-01 2020-12-31 0001835378 2019-12-31 0001835378 us-gaap:CommonStockMember 2019-12-31 0001835378 us-gaap:TreasuryStockCommonMember 2019-12-31 0001835378 us-gaap:AdditionalPaidInCapitalMember 2019-12-31 0001835378 us-gaap:RetainedEarningsMember 2019-12-31 0001835378 us-gaap:AdditionalPaidInCapitalMember 2020-01-01 2020-12-31 0001835378 us-gaap:RetainedEarningsMember 2020-01-01 2020-12-31 0001835378 us-gaap:CommonStockMember 2020-01-01 2020-12-31 0001835378 2020-12-31 0001835378 us-gaap:CommonStockMember 2020-12-31 0001835378 us-gaap:TreasuryStockCommonMember 2020-12-31 0001835378 us-gaap:AdditionalPaidInCapitalMember 2020-12-31 0001835378 us-gaap:RetainedEarningsMember 2020-12-31 0001835378 us-gaap:AdditionalPaidInCapitalMember 2021-01-01 2021-12-31 0001835378 us-gaap:RetainedEarningsMember 2021-01-01 2021-12-31 0001835378 us-gaap:CommonStockMember 2021-01-01 2021-12-31 0001835378 us-gaap:TreasuryStockCommonMember 2021-01-01 2021-12-31 0001835378 us-gaap:CommonStockMember 2021-12-31 0001835378 us-gaap:TreasuryStockCommonMember 2021-12-31 0001835378 us-gaap:AdditionalPaidInCapitalMember 2021-12-31 0001835378 us-gaap:RetainedEarningsMember 2021-12-31 0001835378 us-gaap:CommonStockMember 2022-01-01 2022-12-31 0001835378 us-gaap:AdditionalPaidInCapitalMember 2022-01-01 2022-12-31 0001835378 us-gaap:RetainedEarningsMember 2022-01-01 2022-12-31 0001835378 us-gaap:CommonStockMember 2022-12-31 0001835378 us-gaap:TreasuryStockCommonMember 2022-12-31 0001835378 us-gaap:AdditionalPaidInCapitalMember 2022-12-31 0001835378 us-gaap:RetainedEarningsMember 2022-12-31 0001835378 2021-01-01 2021-11-30 0001835378 ctv:TVSquaredMember 2022-02-28 2022-02-28 0001835378 ctv:TVSquaredMember 2022-02-28 0001835378 srt:ScenarioPreviouslyReportedMember 2022-01-01 2022-12-31 0001835378 srt:RestatementAdjustmentMember 2022-01-01 2022-12-31 0001835378 srt:ScenarioPreviouslyReportedMember 2021-01-01 2021-12-31 0001835378 srt:RestatementAdjustmentMember 2021-01-01 2021-12-31 0001835378 srt:ScenarioPreviouslyReportedMember 2020-01-01 2020-12-31 0001835378 srt:RestatementAdjustmentMember 2020-01-01 2020-12-31 0001835378 us-gaap:GeographicDistributionForeignMember 2022-12-31 0001835378 us-gaap:GeographicDistributionForeignMember 2021-12-31 0001835378 us-gaap:ComputerEquipmentMember 2022-01-01 2022-12-31 0001835378 srt:MinimumMember ctv:OfficeFurnitureAndEquipmentMember 2022-01-01 2022-12-31 0001835378 srt:MaximumMember ctv:OfficeFurnitureAndEquipmentMember 2022-01-01 2022-12-31 0001835378 us-gaap:SoftwareAndSoftwareDevelopmentCostsMember 2022-01-01 2022-12-31 0001835378 us-gaap:SoftwareAndSoftwareDevelopmentCostsMember 2021-01-01 2021-12-31 0001835378 us-gaap:SoftwareAndSoftwareDevelopmentCostsMember 2022-07-01 2022-09-30 0001835378 us-gaap:SoftwareAndSoftwareDevelopmentCostsMember 2020-01-01 2020-12-31 0001835378 us-gaap:CustomerRelationshipsMember 2022-01-01 2022-12-31 0001835378 us-gaap:TechnologyBasedIntangibleAssetsMember 2022-01-01 2022-12-31 0001835378 us-gaap:TradeNamesMember 2022-01-01 2022-12-31 0001835378 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2022-12-31 0001835378 us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2022-12-31 0001835378 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2022-12-31 0001835378 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2021-12-31 0001835378 us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2021-12-31 0001835378 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2021-12-31 0001835378 us-gaap:FairValueInputsLevel3Member ctv:WarrantsLiabilityMember us-gaap:FairValueMeasurementsRecurringMember 2021-12-31 0001835378 us-gaap:FairValueInputsLevel3Member ctv:WarrantsLiabilityMember us-gaap:FairValueMeasurementsRecurringMember 2020-12-31 0001835378 us-gaap:FairValueInputsLevel3Member ctv:WarrantsLiabilityMember us-gaap:FairValueMeasurementsRecurringMember 2022-01-01 2022-12-31 0001835378 us-gaap:FairValueInputsLevel3Member ctv:WarrantsLiabilityMember us-gaap:FairValueMeasurementsRecurringMember 2021-01-01 2021-12-31 0001835378 us-gaap:FairValueInputsLevel3Member ctv:WarrantsLiabilityMember us-gaap:FairValueMeasurementsRecurringMember 2022-12-31 0001835378 us-gaap:FairValueInputsLevel1Member ctv:PublicMember 2022-12-31 0001835378 us-gaap:FairValueInputsLevel1Member ctv:PublicMember 2021-12-31 0001835378 us-gaap:PrivatePlacementMember 2022-01-01 2022-12-31 0001835378 us-gaap:PrivatePlacementMember 2021-01-01 2021-12-31 0001835378 us-gaap:PostemploymentRetirementBenefitsMember 2022-01-01 2022-12-31 0001835378 us-gaap:PostemploymentRetirementBenefitsMember 2021-01-01 2021-12-31 0001835378 us-gaap:PostemploymentRetirementBenefitsMember 2020-01-01 2020-12-31 0001835378 us-gaap:EmployeeSeveranceMember 2022-01-01 2022-12-31 0001835378 ctv:CustomerAMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2022-01-01 2022-12-31 0001835378 ctv:CustomerBMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2022-01-01 2022-12-31 0001835378 ctv:CustomerBMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2020-01-01 2020-12-31 0001835378 us-gaap:RealEstateMember us-gaap:AccountingStandardsUpdate201602Member 2022-01-01 0001835378 ctv:CarsMemberMember us-gaap:AccountingStandardsUpdate201602Member 2022-01-01 0001835378 us-gaap:AccountingStandardsUpdate201602Member 2022-01-01 0001835378 ctv:IONMember 2021-11-30 0001835378 ctv:PIPEInvestorsMember ctv:SecondarySaleMember 2021-11-30 2021-11-30 0001835378 ctv:InnovidCorpMember 2021-11-30 2021-11-30 0001835378 ctv:InnovidCorpMember 2021-01-01 0001835378 us-gaap:IPOMember ctv:IONMember 2021-11-30 2021-11-30 0001835378 us-gaap:IPOMember ctv:IONMember 2021-11-30 0001835378 ctv:PIPEInvestorsMember 2021-12-01 0001835378 ctv:IONMember 2021-11-30 2021-11-30 0001835378 ctv:IONMember 2021-01-01 2021-12-31 0001835378 ctv:PIPEInvestorsMember 2021-01-01 2021-12-31 0001835378 2021-11-30 0001835378 us-gaap:CommonStockMember 2021-11-30 0001835378 us-gaap:CommonStockMember ctv:PublicWarrantsMember 2021-11-30 2021-11-30 0001835378 us-gaap:CommonStockMember ctv:PrivatePlacementWarrantsMember 2021-11-30 2021-11-30 0001835378 2021-11-30 2021-11-30 0001835378 ctv:TVSquaredMember us-gaap:TechnologyBasedIntangibleAssetsMember 2022-02-28 0001835378 ctv:TVSquaredMember us-gaap:CustomerRelationshipsMember 2022-02-28 0001835378 ctv:TVSquaredMember us-gaap:TradeNamesMember 2022-02-28 0001835378 ctv:TVSquaredMember us-gaap:TechnologyBasedIntangibleAssetsMember 2022-02-28 2022-02-28 0001835378 ctv:TVSquaredMember us-gaap:CustomerRelationshipsMember 2022-02-28 2022-02-28 0001835378 ctv:TVSquaredMember us-gaap:TradeNamesMember 2022-02-28 2022-02-28 0001835378 ctv:TVSquaredMember 2022-01-01 2022-12-31 0001835378 ctv:TVSquaredMember 2021-01-01 2021-12-31 0001835378 us-gaap:CustomerRelationshipsMember 2022-12-31 0001835378 us-gaap:TechnologyBasedIntangibleAssetsMember 2022-12-31 0001835378 us-gaap:TradeNamesMember 2022-12-31 0001835378 us-gaap:SoftwareAndSoftwareDevelopmentCostsMember 2022-12-31 0001835378 us-gaap:SoftwareAndSoftwareDevelopmentCostsMember 2021-12-31 0001835378 us-gaap:ComputerEquipmentMember 2022-12-31 0001835378 us-gaap:ComputerEquipmentMember 2021-12-31 0001835378 ctv:OfficeFurnitureAndEquipmentMember 2022-12-31 0001835378 ctv:OfficeFurnitureAndEquipmentMember 2021-12-31 0001835378 us-gaap:LeaseholdImprovementsMember 2022-12-31 0001835378 us-gaap:LeaseholdImprovementsMember 2021-12-31 0001835378 us-gaap:RealEstateMember 2022-12-31 0001835378 ctv:CarsMemberMember 2022-12-31 0001835378 ctv:RentalOfPremisesMember 2021-12-31 0001835378 ctv:LeaseOfMotorVehiclesMember 2021-12-31 0001835378 ctv:PublicWarrantsMember 2022-12-31 0001835378 ctv:PrivateWarrantsMember 2022-12-31 0001835378 ctv:InnovidCorpMember 2022-01-01 2022-12-31 0001835378 ctv:InnovidCorpMember 2022-12-31 0001835378 ctv:RedemptionOfWarrantPricePerShareEqualsOrExceeds1800Member ctv:InnovidCorpMember 2021-12-30 0001835378 ctv:RedemptionOfWarrantPricePerShareEqualsOrExceeds1800Member ctv:InnovidCorpMember 2021-12-30 2021-12-30 0001835378 ctv:InnovidCorpMember 2021-12-30 0001835378 ctv:RedemptionOfWarrantPricePerShareEqualsOrExceeds1000Member ctv:InnovidCorpMember 2021-12-30 0001835378 ctv:RedemptionOfWarrantPricePerShareEqualsOrExceeds1000Member ctv:InnovidCorpMember 2021-12-30 2021-12-30 0001835378 ctv:PrivatePlacementWarrantsMember 2022-12-31 0001835378 ctv:PrivatePlacementWarrantsMember 2021-12-31 0001835378 us-gaap:RevolvingCreditFacilityMember 2022-08-03 0001835378 us-gaap:RevolvingCreditFacilityMember 2022-08-04 0001835378 srt:MaximumMember us-gaap:RevolvingCreditFacilityMember 2022-08-04 2022-08-04 0001835378 us-gaap:RevolvingCreditFacilityMember 2022-08-04 2022-08-04 0001835378 srt:ScenarioForecastMember us-gaap:RevolvingCreditFacilityMember 2023-08-04 2023-08-04 0001835378 us-gaap:LineOfCreditMember ctv:AmendedCreditAgreementMaturingDecember2020Member 2022-12-31 0001835378 us-gaap:RevolvingCreditFacilityMember 2022-12-31 0001835378 us-gaap:LineOfCreditMember 2020-01-01 2020-12-31 0001835378 us-gaap:LineOfCreditMember 2022-10-01 2022-12-31 0001835378 us-gaap:LineOfCreditMember ctv:AmendedCreditAgreementMaturingDecember2020Member 2022-04-01 2022-06-30 0001835378 us-gaap:SubsequentEventMember 2023-01-01 2023-01-31 0001835378 srt:MinimumMember us-gaap:LineOfCreditMember ctv:AmendedCreditAgreementMaturingOctober2018Member us-gaap:PrimeRateMember 2020-12-29 2020-12-29 0001835378 srt:MaximumMember us-gaap:LineOfCreditMember ctv:AmendedCreditAgreementMaturingOctober2018Member us-gaap:PrimeRateMember 2020-12-29 2020-12-29 0001835378 srt:SubsidiariesMember 2022-12-31 0001835378 ctv:IsraeliSubsidiaryMember 2022-12-31 0001835378 ctv:HolderMember 2022-12-31 0001835378 ctv:HolderMember 2010-02-25 0001835378 ctv:IncentivePlanMember 2021-11-30 0001835378 ctv:IncentivePlanMember 2021-11-30 2021-11-30 0001835378 srt:MinimumMember ctv:LegacyPlanMember 2022-01-01 2022-12-31 0001835378 ctv:LegacyPlanMember 2022-01-01 2022-12-31 0001835378 us-gaap:ShareBasedPaymentArrangementEmployeeMember us-gaap:CostOfSalesMember ctv:LegacyPlanAnd2021PlanMemberMember 2022-01-01 2022-12-31 0001835378 us-gaap:ShareBasedPaymentArrangementEmployeeMember us-gaap:CostOfSalesMember ctv:LegacyPlanAnd2021PlanMemberMember 2021-01-01 2021-12-31 0001835378 us-gaap:ShareBasedPaymentArrangementEmployeeMember us-gaap:CostOfSalesMember ctv:LegacyPlanAnd2021PlanMemberMember 2020-01-01 2020-12-31 0001835378 us-gaap:ShareBasedPaymentArrangementEmployeeMember us-gaap:ResearchAndDevelopmentExpenseMember ctv:LegacyPlanAnd2021PlanMemberMember 2022-01-01 2022-12-31 0001835378 us-gaap:ShareBasedPaymentArrangementEmployeeMember us-gaap:ResearchAndDevelopmentExpenseMember ctv:LegacyPlanAnd2021PlanMemberMember 2021-01-01 2021-12-31 0001835378 us-gaap:ShareBasedPaymentArrangementEmployeeMember us-gaap:ResearchAndDevelopmentExpenseMember ctv:LegacyPlanAnd2021PlanMemberMember 2020-01-01 2020-12-31 0001835378 us-gaap:ShareBasedPaymentArrangementEmployeeMember us-gaap:SellingAndMarketingExpenseMember ctv:LegacyPlanAnd2021PlanMemberMember 2022-01-01 2022-12-31 0001835378 us-gaap:ShareBasedPaymentArrangementEmployeeMember us-gaap:SellingAndMarketingExpenseMember ctv:LegacyPlanAnd2021PlanMemberMember 2021-01-01 2021-12-31 0001835378 us-gaap:ShareBasedPaymentArrangementEmployeeMember us-gaap:SellingAndMarketingExpenseMember ctv:LegacyPlanAnd2021PlanMemberMember 2020-01-01 2020-12-31 0001835378 us-gaap:ShareBasedPaymentArrangementEmployeeMember us-gaap:GeneralAndAdministrativeExpenseMember ctv:LegacyPlanAnd2021PlanMemberMember 2022-01-01 2022-12-31 0001835378 us-gaap:ShareBasedPaymentArrangementEmployeeMember us-gaap:GeneralAndAdministrativeExpenseMember ctv:LegacyPlanAnd2021PlanMemberMember 2021-01-01 2021-12-31 0001835378 us-gaap:ShareBasedPaymentArrangementEmployeeMember us-gaap:GeneralAndAdministrativeExpenseMember ctv:LegacyPlanAnd2021PlanMemberMember 2020-01-01 2020-12-31 0001835378 us-gaap:ShareBasedPaymentArrangementEmployeeMember ctv:LegacyPlanAnd2021PlanMemberMember 2022-01-01 2022-12-31 0001835378 us-gaap:ShareBasedPaymentArrangementEmployeeMember ctv:LegacyPlanAnd2021PlanMemberMember 2021-01-01 2021-12-31 0001835378 us-gaap:ShareBasedPaymentArrangementEmployeeMember ctv:LegacyPlanAnd2021PlanMemberMember 2020-01-01 2020-12-31 0001835378 us-gaap:ShareBasedPaymentArrangementNonemployeeMember 2022-01-01 2022-12-31 0001835378 us-gaap:ShareBasedPaymentArrangementNonemployeeMember 2021-01-01 2021-12-31 0001835378 us-gaap:ShareBasedPaymentArrangementNonemployeeMember 2020-01-01 2020-12-31 0001835378 srt:MinimumMember 2022-01-01 2022-12-31 0001835378 srt:MaximumMember 2022-01-01 2022-12-31 0001835378 us-gaap:ShareBasedPaymentArrangementEmployeeMember 2021-12-31 0001835378 us-gaap:ShareBasedPaymentArrangementEmployeeMember 2021-01-01 2021-12-31 0001835378 us-gaap:ShareBasedPaymentArrangementEmployeeMember 2022-01-01 2022-12-31 0001835378 us-gaap:ShareBasedPaymentArrangementEmployeeMember 2022-12-31 0001835378 us-gaap:ShareBasedPaymentArrangementNonemployeeMember 2021-12-31 0001835378 us-gaap:ShareBasedPaymentArrangementNonemployeeMember 2022-12-31 0001835378 srt:MinimumMember us-gaap:RestrictedStockUnitsRSUMember 2022-01-01 2022-12-31 0001835378 srt:MaximumMember us-gaap:RestrictedStockUnitsRSUMember 2022-01-01 2022-12-31 0001835378 us-gaap:RestrictedStockUnitsRSUMember us-gaap:ShareBasedPaymentArrangementEmployeeMember 2021-12-31 0001835378 us-gaap:RestrictedStockUnitsRSUMember us-gaap:ShareBasedPaymentArrangementEmployeeMember 2022-01-01 2022-12-31 0001835378 us-gaap:RestrictedStockUnitsRSUMember us-gaap:ShareBasedPaymentArrangementEmployeeMember 2022-12-31 0001835378 us-gaap:RestrictedStockUnitsRSUMember us-gaap:ShareBasedPaymentArrangementNonemployeeMember 2021-12-31 0001835378 us-gaap:RestrictedStockUnitsRSUMember us-gaap:ShareBasedPaymentArrangementNonemployeeMember 2022-01-01 2022-12-31 0001835378 us-gaap:RestrictedStockUnitsRSUMember us-gaap:ShareBasedPaymentArrangementNonemployeeMember 2022-12-31 0001835378 us-gaap:RestrictedStockUnitsRSUMember 2022-12-31 0001835378 us-gaap:RestrictedStockUnitsRSUMember 2022-01-01 2022-12-31 0001835378 ctv:EmployeeStockPurchasePlanMember 2021-11-30 0001835378 ctv:EmployeeStockPurchasePlanMember 2021-11-30 2021-11-30 0001835378 srt:MaximumMember ctv:EmployeeStockPurchasePlanMember 2021-11-30 0001835378 ctv:EmployeeStockPurchasePlanMember 2022-01-01 2022-12-31 0001835378 us-gaap:WarrantMember 2022-01-01 2022-12-31 0001835378 us-gaap:WarrantMember 2021-01-01 2021-12-31 0001835378 ctv:PaycheckProtectionProgramMember 2022-01-01 2022-12-31 0001835378 ctv:PaycheckProtectionProgramMember 2021-01-01 2021-12-31 0001835378 ctv:PaycheckProtectionProgramMember 2020-01-01 2020-12-31 0001835378 us-gaap:DomesticCountryMember 2022-12-31 0001835378 us-gaap:DomesticCountryMember 2021-12-31 0001835378 us-gaap:StateAndLocalJurisdictionMember 2022-12-31 0001835378 us-gaap:StateAndLocalJurisdictionMember 2021-12-31 0001835378 us-gaap:ForeignCountryMember 2022-12-31 0001835378 us-gaap:ForeignCountryMember 2021-12-31 0001835378 ctv:TVSquaredMember 2022-12-31 0001835378 country:US 2022-01-01 2022-12-31 0001835378 country:US 2021-01-01 2021-12-31 0001835378 country:US 2020-01-01 2020-12-31 0001835378 country:CA 2022-01-01 2022-12-31 0001835378 country:CA 2021-01-01 2021-12-31 0001835378 country:CA 2020-01-01 2020-12-31 0001835378 srt:AsiaPacificMember 2022-01-01 2022-12-31 0001835378 srt:AsiaPacificMember 2021-01-01 2021-12-31 0001835378 srt:AsiaPacificMember 2020-01-01 2020-12-31 0001835378 us-gaap:EMEAMember 2022-01-01 2022-12-31 0001835378 us-gaap:EMEAMember 2021-01-01 2021-12-31 0001835378 us-gaap:EMEAMember 2020-01-01 2020-12-31 0001835378 srt:LatinAmericaMember 2022-01-01 2022-12-31 0001835378 srt:LatinAmericaMember 2021-01-01 2021-12-31 0001835378 srt:LatinAmericaMember 2020-01-01 2020-12-31 0001835378 country:IL 2022-12-31 0001835378 country:IL 2021-12-31 0001835378 country:US 2022-12-31 0001835378 country:US 2021-12-31 0001835378 ctv:RestOfTheWorldMember 2022-12-31 0001835378 ctv:RestOfTheWorldMember 2021-12-31 0001835378 ctv:PreferredStocksMember 2022-01-01 2022-12-31 0001835378 ctv:PreferredStocksMember 2021-01-01 2021-12-31 0001835378 ctv:PreferredStocksMember 2020-01-01 2020-12-31 0001835378 us-gaap:EmployeeStockOptionMember 2022-01-01 2022-12-31 0001835378 us-gaap:EmployeeStockOptionMember 2021-01-01 2021-12-31 0001835378 us-gaap:EmployeeStockOptionMember 2020-01-01 2020-12-31 0001835378 us-gaap:RestrictedStockUnitsRSUMember 2022-01-01 2022-12-31 0001835378 us-gaap:RestrictedStockUnitsRSUMember 2021-01-01 2021-12-31 0001835378 us-gaap:RestrictedStockUnitsRSUMember 2020-01-01 2020-12-31 0001835378 us-gaap:WarrantMember 2022-01-01 2022-12-31 0001835378 us-gaap:WarrantMember 2021-01-01 2021-12-31 0001835378 us-gaap:WarrantMember 2020-01-01 2020-12-31 iso4217:USD shares iso4217:USD shares pure ctv:reportingUnit ctv:vote ctv:segment 0001835378 2022 FY false http://innovid.com/20221231#WarrantLiabilityNoncurrent http://innovid.com/20221231#WarrantLiabilityNoncurrent http://fasb.org/us-gaap/2022#OtherLiabilitiesNoncurrent http://fasb.org/us-gaap/2022#OtherLiabilitiesNoncurrent P3Y 10-K true 2022-12-31 --12-31 false 001-40048 Innovid Corp. DE 87-3769599 30 Irving Place, 12th Floor New York NY 10003 212 966-7555 Common stock, par value $0.0001 per share CTV NYSE Warrants to purchase one share of common stock, each at an exercise price of $11.50 per share CTVWS NYSE No No Yes Yes Accelerated Filer true true false false false 220000000 136281196 Portions of the registrant’s definitive Proxy Statement for its 2023 Annual Meeting of Stockholders are incorporated by reference into Part III of this Annual Report on Form 10-K. 1281 Tel-Aviv, Israel KOST FORER GABBAY & KASIERER 37541000 156696000 10000000 0 65000 81000 43653000 35422000 2640000 3131000 93834000 195249000 277000 310000 430000 462000 14322000 4840000 116976000 4555000 2910000 0 29918000 0 938000 116000 165771000 10283000 259605000 205532000 3361000 5026000 10165000 7742000 0 6000000 2186000 0 5474000 3082000 21186000 21850000 20000000 0 1636000 0 6554000 3455000 4301000 18972000 32491000 22427000 53677000 44277000 0.0001 0.0001 500000000 500000000 133882414 133882414 119017380 119017380 13000 12000 356801000 293719000 -150886000 -132476000 205928000 161255000 259605000 205532000 127117000 90291000 68801000 30187000 17698000 12311000 31118000 24299000 18014000 50266000 32841000 28521000 39144000 20641000 8103000 6143000 661000 730000 -29741000 -5849000 1122000 -13348000 4386000 734000 -16393000 -10235000 388000 2017000 1237000 1200000 -18410000 -11472000 -812000 0 77063000 7297000 -18410000 -18410000 -88535000 -88535000 -8109000 -8109000 -0.14 -0.14 -3.31 -3.31 -0.51 -0.51 130756484 130756484 26745020 26745020 16028560 16028560 1.337 73690340 79700000 15969260 2000 1914328 -1629000 3058000 -44218000 -42787000 7297000 4214000 3083000 7297000 -504000 -504000 584000 584000 306349 78000 78000 -812000 -812000 73690340 86997000 16275609 2000 1914328 -1629000 10000 -48113000 -49730000 77063000 4172000 72891000 77063000 73690340 -164060000 73690340 7000 164053000 164060000 25154340 3000 -1914328 1629000 124394000 126026000 507994 5080000 5080000 132392 3273000 3273000 3256705 1081000 1081000 -11472000 -11472000 0 0 119017380 12000 0 0 293719000 -132476000 161255000 11549465 1000 47151000 47152000 14945000 14945000 3315569 986000 986000 -18410000 -18410000 0 0 133882414 13000 0 0 356801000 -150886000 205928000 -18410000 -11472000 -812000 6143000 661000 730000 13781000 3273000 584000 0 0 -127000 -14671000 762000 86000 0 459000 0 0 2750000 0 0 0 22000 4045000 618000 8372000 -755000 1823000 -78000 1831000 0 0 -622000 1500000 -545000 1710000 1236000 1914000 -2335000 0 0 4302000 851000 2029000 -11561000 -2421000 -4159000 99097000 0 0 9961000 2594000 0 488000 549000 1030000 0 459000 0 0 0 6000 10000000 0 0 120000 -85000 76000 -119426000 -3687000 -948000 0 149252000 0 0 0 504000 14000000 0 15516000 0 3033000 6504000 0 126000 592000 3185000 0 0 985000 1081000 78000 11800000 147174000 9002000 -119187000 141066000 3895000 157158000 16092000 12197000 37971000 157158000 16092000 785000 535000 421000 675000 259000 272000 0 164060000 0 0 5080000 0 0 0 126000 0 77063000 7297000 0 3185000 0 47152000 0 0 37541000 156696000 15645000 430000 462000 447000 37971000 157158000 16092000 DESCRIPTION OF BUSINESS<div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Innovid Corp. together with its consolidated subsidiaries, the “Company” or “Innovid”, is a leading independent software platform that provides ad serving and creative services for the creation, delivery, and measurement of TV ads across connected TV (“CTV”), mobile TV and desktop TV environments to advertisers, publishers and media agencies.</span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Innovid Corp. was originally incorporated as ION Acquisition Corp. 2 Ltd. (“ION”), a special purpose acquisition company, on November 23, 2020. </span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On November 30, 2021, ION and Innovid Inc. closed the mergers as described below (the “Transaction”). Through several merges and name changes Innovid Corp. was established and continues the operations of Innovid Inc.</span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On November 30, 2021, ION consummated a series of merger transactions, whereby it acquired the business of Innovid Inc. Immediately following these mergers, ION changed its name to “Innovid Corp.” In addition, ION entered into certain subscription agreements (“PIPE Investment”). Further, in connection with the closing of the Transaction, PIPE investors purchased equity securities of Innovid Inc. stockholders (the “Secondary Sale Transaction”) for an aggregate purchase price of $68,855 (the “Secondary Sale Amount”). See Note 3, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Transaction</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> for further details. </span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On February 28, 2022, the Company completed the acquisition </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">of all outstanding shares </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">of TVSquared (“TVS”), an independent global measurement and attribution platform for converged TV and a private company limited by shares incorporated under the laws of the Scotland. The Company acquired all of the equity of TVSquared for an aggregate amount of $100,000 in cash, 11,549,465 shares of the Company common stock at fair value of $3.80 per share, and the issuance of 949,893 fully vested stock options of the Company at a weighted average fair value of $3.49, subject to certain adjustments as defined in the Stock Purchase Agreement. See Note 4, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Acquisition</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> for further details. </span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Innovid Corp.’s common stock and warrants commenced trading on the NYSE under the symbols “CTV” and “CTV.WS,” respectively, on December 1, 2021.</span></div> 68855000 100000000 11549465 3.80 949893 3.49 SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES<div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Basis of Presentation</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying Consolidated Financial Statements and Notes to the Consolidated Financial Statements included in this Annual Report on Form 10-K are prepared in accordance with generally accepted accounting principles in the United States ("GAAP") for annual financial information and the instructions to Form 10-K and Article 10 of Regulation S-X. The accompanying Consolidated Financial Statements include our accounts and those of our wholly-owned subsidiaries; all intercompany activity and balances have been eliminated. The Consolidated Financial Statements reflect all adjustments, which are, in the opinion of management, necessary for a fair presentation of the consolidated balance sheets of the Company as of December 31, 2022 and 2021 and the consolidated results of operations and cash flows for the years ended December 31, 2022, 2021 and 2020.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Prior Period Reclassification</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the second quarter of 2022, we presented depreciation, amortization and impairment expenses as a separate line item on our consolidated statements of operations and all prior periods have been adjusted. </span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Depreciation, amortization and impairment expenses were previously included in cost of sales and other operating expenses depending on the underlying asset’s function. Additionally, we no longer present gross profit as a subtotal on our consolidated statements of operations. </span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The reclassification is to better reflect the financial performance of transactions with customers as our business has evolved and reflects a better representation of our current operations, which include those of our most recent acquisition. The change provides more clarity about changes in cost of revenue and other operating expenses exclusive of depreciation, amortization and impairment. </span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In accordance with US GAAP, all periods presented below have been retrospectively adjusted to reflect the reclassification of cost of revenue and other operating expenses exclusive of depreciation and amortization. There was no net impact to loss from operations, net loss attributable to common stockholders or net loss per stock for any periods presented. The consolidated balance sheets, statements of changes in temporary equity and stockholders’ equity, and the consolidated statements of cash flows are not affected by this reclassification. The effect of the change is as follows:</span></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:16.475%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.596%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.233%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.233%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.233%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.627%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.778%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.445%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.536%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.996%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"><div style="padding-left:2.85pt;text-align:justify"><span><br/></span></div></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year ended December 31, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year ended December 31, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year ended December 31, 2020</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Under previous classification</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Effect of change</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As reported</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Previously reported</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Effect of change</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As adjusted</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Previously reported</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Effect of change</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As adjusted</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of revenues</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33,265 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,078)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30,187 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,785 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(87)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,698 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,365 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(54)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,311 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating expenses:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31,932 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(814)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31,118 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24,619 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(320)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24,299 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,283 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(269)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,014 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Sales and marketing</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52,226 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,960)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50,266 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33,056 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(215)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32,841 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28,810 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(289)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28,521 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">General and administrative</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39,435 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(291)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39,144 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,680 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(39)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,641 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,221 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(118)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,103 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation, amortization and impairment</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,143 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,143 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">661 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">661 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">730 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">730 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Use of Estimates</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of the consolidated financial statements in conformity with US GAAP requires management to make estimates, judgments and assumptions. The Company’s management believes that the estimates, judgments and assumptions used are reasonable based upon information available at the time they are made. These estimates, judgments and assumptions can affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the dates of the financial statements, and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates. </span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The Company has considered the impact of these factors on its estimates and assumptions and determined that there were no material adverse impacts on the consolidated financial statements for the periods ended December 31, 2022, 2021, and 2020. As events continue to evolve and additional information becomes available, the Company’s estimates and assumptions may change materially in future periods. </span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Accounting Policies</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Functional currency</span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A majority of the Company’s revenues are generated in US dollars. In addition, a substantial portion of the Company’s costs are incurred in US dollars. The Company’s management believes that the US dollar is the currency of the primary economic environment in which the Company and each of its subsidiaries operate. Thus, the functional and reporting currency of the Company and its subsidiaries is the US dollar. Accordingly, accounts maintained in currencies other than the US dollar are re-measured into US dollars. All translation gains and losses resulting from the re-measurement of monetary assets and liabilities that are not denominated in the functional currency are recorded in Financial expenses, net on the consolidated statements of operations. </span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Cash and cash equivalents</span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cash equivalents are short-term highly liquid investments that are readily convertible to cash with original maturities of three months or less, at the date acquired.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Short-term bank deposits </span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company utilizes short-term deposits in order to maximize the use of cash on hand. As of December 31, 2022 we had deposits of $10,000 with original maturities greater than 90 days at 4.1% interest. These deposits are expected to mature within no more than 180 days with an interest rate of 4.1%.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Restricted deposits and restricted cash</span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Restricted deposits presented in Prepaid expenses and other current assets and in Long-term restricted deposits are deposits used as security for the Company’s credit cards and for the rental of premises. As of December 31, 2022 and 2021, the Company’s restricted deposits are denominated in New Israeli Shekels (“NIS”) and bore interest at weighted average interest rates of</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> 0.01%</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and 0.01%, respectively. Restricted deposits are presented at their cost, including accrued interest.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Property and equipment, net</span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Property and equipment are stated at cost, net of accumulated depreciation. Depreciation is calculated by the straight-line method over the estimated useful lives of the assets, at the following annual rates:</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:96.515%"><tr><td style="width:1.0%"/><td style="width:67.502%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:30.298%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"><div style="padding-left:11.35pt;text-align:justify;text-indent:-8.5pt"><span><br/></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Years</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Computers and peripheral equipment</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Office furniture and equipment</span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5-7</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Lease improvements</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The shorter of the lease term or the useful life of the asset</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Internal-use software</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3</span></td></tr></table></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Software development costs</span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Software development costs, which are included in property and equipment, net, consists of capitalized costs related to purchase and develop internal-use software. The Company uses such software to provide services to its customers. The costs to purchase and develop internal-use software are capitalized from the time that the preliminary project stage is completed, and it is considered probable that the software will be used to perform the function intended. These costs include personnel and personnel-related employee benefits for employees directly associated with the software development and external costs of the materials or services consumed in developing or obtaining the software. </span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Any costs incurred for upgrades and functionality enhancements of the software are also capitalized. Once this software is ready for use in providing the Company's services, these costs are amortized on a straight-line basis over the three-year estimated useful life. The amortization is presented within depreciation and amortization in the consolidated statements of operations. During the years ended December 31, 2022 and 2021, the Company capitalized internal-use software cost of </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$11,143 an</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">d $2,594, respectively. In the third quarter of 2022, the Company recorded impairment charges included in depreciation, amortization and impairment in the consolidated statement of operations of $547 related to the abandonment of certain projects. There were no impairment of capitalized software costs for the year ended December 31, 2021 and 2020.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Impairment of long-lived assets</span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Long-lived assets, including property and equipment and finite-lived intangible assets, are reviewed for impairment whenever facts or circumstances either internally or externally may indicate that the carrying value of an asset may not be recoverable. If there are indications of an impairment, the Company tests for recoverability by comparing the estimated undiscounted future cash flows expected to result from the use of the asset to the carrying amount of the asset or asset group. If the asset or asset group is determined to be impaired, any excess of the carrying value of the asset or asset group over its estimated fair value is recognized as an impairment loss.</span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the year ended December 31, 2022, we recognized impairment expense of $547. For the years ended December 31, 2021, and 2020 no impairments of long-lived assets were recorded.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Business combinations</span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company accounts for business combinations by applying the provisions of ASC 805, “Business Combination” (“ASC 805”) and allocates the fair value of purchase consideration to the tangible assets acquired, liabilities assumed, and intangible assets acquired based on their estimated fair values. The excess of the fair value of purchase consideration over the fair values of these identifiable assets and liabilities is recorded as goodwill. When determining the fair values of assets acquired and liabilities assumed, management makes significant estimates and assumptions, especially with respect to intangible assets. </span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Acquisition-related expenses are expensed as incurred. </span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Goodwill and acquired intangible assets</span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Goodwill and acquired intangible assets have been recorded in the Company's financial statements resulting from     various business combinations. Goodwill represents the excess of the purchase price in a business combination over the fair value of identifiable tangible and intangible assets acquired and liabilities assumed. Goodwill is subject to an annual impairment test. </span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company allocates goodwill to reporting units based on the expected benefit from the business combination. Reporting units are evaluated when changes in the Company’s operating structure occur, and if necessary, goodwill is reassigned using a relative fair value allocation approach. The Company currently has one reporting unit. </span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ASC 350, Intangibles—Goodwill and other (“ASC 350”) requires goodwill to be tested for impairment at least annually and, in certain circumstances, between annual tests. The accounting guidance gives the option to perform a qualitative assessment to determine whether further impairment testing is necessary. The qualitative assessment considers events and circumstances that might indicate that a reporting unit's fair value is less than its carrying amount. If it is determined, as a result of the qualitative assessment, that it is more likely than not that the fair value of a reporting unit is less than its carrying amount, a quantitative test is performed. The Company operates as one reporting unit. The Company elects to perform an annual impairment test of goodwill as of October 1 of each year, or more frequently if impairment indicators are present. For the years ended December 31, 2022, 2021 and 2020 no impairments of goodwill were recorded.</span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Separately acquired intangible assets are measured on initial recognition at cost including directly attributable costs. Intangible assets acquired in a business combination are measured at fair value at the acquisition date. </span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Customer relationships, acquired technology and trade name are being amortized over the estimated useful life of approximately 11 years, 6 years, and 4 years, respectively, using straight-line amortization method. </span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The amortization of customer relationships, acquired technology and trade name is presented within depreciation, amortization and impairment in the consolidated statement of operations.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Leases</span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Innovid's lease portfolio primarily consists of real estate properties and cars. Short-term leases with a term of 12 months or less are not recorded on the balance sheet. Innovid does not separate lease components from non-lease components.</span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is a lessee in all its lease agreements. The Company records lease liabilities based on the present value of lease payments over the lease term. Innovid generally uses an incremental borrowing rate to discount its lease liabilities, as the rate implicit in the lease is typically not readily determinable. Certain lease agreements include renewal options that are under the Company's control. Innovid includes optional renewal periods in the lease term only when it is reasonably certain that Innovid will exercise its option.</span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Variable lease payments are primarily related to payments to lessors for taxes, maintenance, insurance, and other operating costs. The Company's lease agreements do not contain any significant residual value guarantees or restrictive covenants.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Fair value of financial instruments</span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company applies a fair value framework to measure and disclose its financial assets and liabilities. Fair value is defined as the exchange price that would be received for an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. The fair value hierarchy requires an entity to maximize the use of observable inputs, where available, and minimize the use of unobservable inputs when measuring fair value. There are three levels of inputs that may be used to measure fair value:</span></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Level 1 - Observable inputs that reflect quoted prices (unadjusted) for identical assets or liabilities in active markets.</span></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Level 2 - Includes other inputs that are directly or indirectly observable in the marketplace.</span></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Level 3 - Unobservable inputs which are supported by little or no market activity.</span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company’s financial instruments consist of cash and cash equivalents, short term deposits, restricted deposits, trade receivables, net, trade payables, employees and payroll accruals, accrued expenses and other current liabilities and current portion of long term debts. Their historical carrying amounts are approximate fair values due to the short-term maturities of these instruments. </span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company measures its investments in money market funds classified as cash equivalents and warrants liability at fair value.</span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents information about the Company’s financial instruments that are measured at fair value on a recurring basis:</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:58.142%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.084%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"><div style="padding-left:11.35pt;text-align:justify;text-indent:-8.5pt"><span><br/></span></div></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr><td colspan="3" style="padding:0 1pt"><div style="padding-left:11.35pt;text-align:justify;text-indent:-8.5pt"><span><br/></span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 2</span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 3</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Assets:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Money market funds</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,948 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Certificates of deposit</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,000 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Liabilities:</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmEyNzExY2UwODA5NTQ1MmM4MmY5NTk5ZDYwZjZiNWEyL3NlYzphMjcxMWNlMDgwOTU0NTJjODJmOTU5OWQ2MGY2YjVhMl8xMTIvZnJhZzozNDQwZjc5ZTQ2MTc0YjdlOTU4OTlhOTFhYmI0NGE3ZC90YWJsZTpiM2M2MjVlOTNlMzQ0YjNiODYwNGNjY2EyOTBlYWY2ZS90YWJsZXJhbmdlOmIzYzYyNWU5M2UzNDRiM2I4NjA0Y2NjYTI5MGVhZjZlXzUtMC0xLTEtMTg4MjA2_64d1049f-3986-4432-9386-6dce1d10a859">Warrants liability</span></span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,265 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,036 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:58.142%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.084%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"><div style="padding-left:11.35pt;text-align:justify;text-indent:-8.5pt"><span><br/></span></div></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"><div style="padding-left:11.35pt;text-align:justify;text-indent:-8.5pt"><span><br/></span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 2</span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 3</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Assets:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Money market funds</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,515 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Liabilities:</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmEyNzExY2UwODA5NTQ1MmM4MmY5NTk5ZDYwZjZiNWEyL3NlYzphMjcxMWNlMDgwOTU0NTJjODJmOTU5OWQ2MGY2YjVhMl8xMTIvZnJhZzozNDQwZjc5ZTQ2MTc0YjdlOTU4OTlhOTFhYmI0NGE3ZC90YWJsZTpmZTgyYTIwMWU5ZTc0MjFlYjM4Y2JlNjkzNjFiNGJjNC90YWJsZXJhbmdlOmZlODJhMjAxZTllNzQyMWViMzhjYmU2OTM2MWI0YmM0XzUtMC0xLTEtMjAwNTYx_8c27e416-da30-41da-88af-f5bd9725d672">Warrants liability</span></span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,510 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,462 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The change in the fair value of the Level 3 warrant liability is summarized below: </span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:71.930%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.083%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"><div style="padding-left:11.35pt;text-align:justify;text-indent:-8.5pt"><span><br/></span></div></td><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,</span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"><div style="padding-left:11.35pt;text-align:justify;text-indent:-8.5pt"><span><br/></span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"><div style="text-align:center"><span><br/></span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Beginning of the year</span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,462 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">499 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Additions*</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,427 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in fair value</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12,426)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,616 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Conversion of Legacy Innovid Warrants on the Closing of the Transaction</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5,080)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">End of the year</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,036 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,462 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">* Additions during the year ended December 31, 2021 represent Company Warrant liability assumed in the Transaction. See Note 11, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%">Warrants</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"> for further detail. </span></div><div style="padding-left:18pt;text-indent:-18pt"><span><br/></span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certificates of deposit represent our deposits with certain financial institutions with maturities ranging from 90 to 180 days. These amounts are included in Cash equivalents and Short-term deposits on our consolidated balance sheet and are carried at cost, which approximates fair value. </span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December 31, 2022, the Company’s warrant liability includes the Warrants, refer to Note 11, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Warrants</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, that were originally issued in connection with ION’s initial public offering, the “ION IPO”, which were transferred to the Company as part of the Transaction. The Company’s Warrants are recorded on the balance sheet at fair value with changes in fair value recognized through earnings. This valuation is subject to re-measurement at each balance sheet date. With each re-measurement the valuation will be adjusted to fair value, with the change in fair value recognized in the Company’s statement of operations. ASC 820, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Fair Value Measurements, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">indicates that the fair value should be determined “from the perspective of a market participant that holds the identical item” and “use the quoted price in an active market held by another party, if that price is available.”</span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has determined that the fair value of the Public Warrants, refer to Note 11, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Warrants</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, at a specific date is determined by the closing price of the Company’s warrants, and are within Level 1 of the fair value hierarchy. The closing price of the warrants was $0.40 and $1.11 as of December 31, 2022 and 2021, respectively. The fair value of the warrants was $1,265 and $3,510 as of December 31, 2022 and 2021, respectively. Gains and losses from the remeasurement of the Public Warrants’ liability is recognized in finance expenses, net in the consolidated statements of operations.</span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Private Warrants are classified as Level 3 as of December 31, 2022 and continue to be valued based on a Black-Scholes option pricing model. Gains and losses from the remeasurement of the Private Warrants’ refer to Note 11, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Warrants</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> liability is recognized in finance expenses, net in the consolidated statements of operations.</span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The key inputs into the Black-Scholes model for the Private Warrants were as follows: </span></div><div style="margin-bottom:9pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:96.363%"><tr><td style="width:1.0%"/><td style="width:68.711%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.365%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.428%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.365%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.431%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"><div style="padding-left:11.35pt;text-align:justify;text-indent:-8.5pt"><span><br/></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:0 1pt"><div style="padding-left:11.35pt;text-align:justify;text-indent:-8.5pt"><span><br/></span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"><div style="padding-left:1.42pt;padding-right:1.42pt;text-align:center"><span><br/></span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Risk-free interest rate</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.07 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.24 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected dividends</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected term (years)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.9</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.9</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected volatility</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">85 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr></table></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Fair value estimates are made at a specific point in time, based on relevant market information and information about the financial instruments. </span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Trade receivable, net</span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company records trade receivable for amounts invoiced and yet unbilled invoices. The Company maintains an allowance for doubtful accounts to reserve for potentially uncollectible receivables. The expectation of collectability is based on a review of credit profiles of customers, contractual terms and conditions, current economic trends, and historical payment experience. The Company regularly reviews the adequacy of the allowance for doubtful accounts by considering the age of each outstanding invoice and the collection history of each customer to determine the appropriate amount of allowance for doubtful accounts. Trade receivables deemed uncollectible are charged against the allowance for doubtful accounts when identified. </span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Accrued post-employment benefits</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">401(k) profit sharing plans:</span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has a 401(k) retirement savings plan with a safe harbor employer match with a maximum of 4% employer contribution for its eligible employees in the US. During the years ended December 31, 2022, 2021 and 2020 the Company recorded expenses for matching contributions in the amount of $1,182, $961 and $705, respectively.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Severance pay:</span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Israeli Severance Pay Law, 1963 (“Severance Pay Law”), specifies that employees are entitled to severance payment, following the termination of their employment. Under the Severance Pay Law, the severance payment is calculated as one-month salary for each year of employment, or a portion thereof.</span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Israeli Subsidiary’s liability for all of its Israeli employees is covered by the provisions of Section 14 of the Severance Pay Law (“Section 14”). Under Section 14 employees are entitled to monthly deposits, at a rate of 8.33% of their monthly salary, continued on their behalf to their insurance funds. Payments in accordance with Section 14 release the Company from any future severance payments in respect of those employees. As a result, the Company does not recognize any liability for severance pay due to these employees and the deposits under Section 14 are not recorded as an asset in the Company’s balance sheets.</span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Severance pay expenses for the years ended December 31, 2022, 2021 and 2020, amounted to approximately $946, $755 and $600, respectively.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Income taxes and tax contingencies</span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Income taxes are computed using a balance sheet approach reflecting both current and deferred taxes. Current and deferred taxes reflect the tax impact of all of the events included in the financial statements. The basic principles employed in the balance sheet approach are to reflect a current tax liability or asset that is recognized for the estimated taxes payable or refundable on tax returns for the current and prior years, a deferred tax liability or asset that is recognized for the estimated future tax effects attributable to temporary differences and carryforwards, the measurement of current and deferred tax liabilities and assets is based on provisions of the enacted tax law of which the effects of future changes in tax laws or rates are not anticipated, and the measurement of deferred tax assets is reduced, if necessary, by the amount of any tax benefits that, based on available evidence, are not expected to be realized. There are certain situations in which deferred taxes are not provided. Some basis differences are not temporary differences because their reversals are not expected to result in taxable or deductible amounts. </span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company regularly evaluates deferred tax assets for future realization and establishes a valuation allowance to the extent that a portion is not more likely than not to be realized. The Company considers whether it is more likely than not that the deferred tax assets will be realized, including existing cumulative losses in recent years, expectations of future taxable income, carryforward periods, and other relevant quantitative and qualitative factors. The recoverability of the deferred tax assets is evaluated by assessing the adequacy of future expected taxable income from all sources, including reversal of taxable temporary differences, forecasted operating earnings and available tax planning strategies. These sources of income rely on estimates.</span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ASC 740, Income Taxes (“ASC 740”) contains a two-step approach to recognizing and measuring a liability for uncertain tax positions. The first step is to evaluate the tax position taken or expected to be taken in a tax return by determining if the weight of available evidence indicates that it is more likely than not that, on an evaluation of the technical merits, the tax position will be sustained on audit, including resolution of any related appeals or litigation processes. The second step is to measure the tax benefit as the largest amount that is more than 50% (cumulative basis) likely to be realized upon ultimate settlement. The Company classifies interest related to unrecognized tax benefits in taxes on income. </span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On December 20, 2017, Congress passed the “US Tax Act”. The US Tax Act requires complex computations to be performed that were not previously required by US tax law, significant judgments to be made in interpretation of the provisions of the US Tax Act, significant estimates in calculations, and the preparation and analysis of information not previously relevant or regularly produced the Act provides that a person who is a US shareholder of any CFC is required to include its GILTI in gross income for the tax year in a manner generally similar to that for Subpart F inclusions. The term “global intangible low-taxed income” is defined as the excess (if any) of the US shareholder’s net CFC tested income for that tax year, over the US shareholder’s net deemed tangible income return for that tax year. The Company’s policy is to treat GILTI as a period expense in the provision for income taxes.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Concentrations of credit risks</span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Financial instruments that potentially subject the Company to concentrations of credit risk consist principally of cash and cash equivalents, deposits and trade receivables, net.</span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The majority of the Company’s cash and cash equivalents are invested in deposits with major banks in US, Israel and UK. Generally, these investments may be redeemed upon demand and, therefore, bear minimal risk.</span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company’s trade receivables, net are mainly derived from sales to customers located in the US, APAC, EMEA, and LATAM. The Company mitigates its credit risks by performing an ongoing credit evaluations of its customers’ financial conditions.</span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has no off-balance-sheet concentration of credit risk such as foreign exchange contracts, option contracts or other foreign hedging arrangements. </span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the years ended December 31, 2022, 2021 and 2020, two of the Company’s customers accounted for more than 10% of the Company’s total revenues as presented below:</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:58.142%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.084%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"><div style="padding-left:11.35pt;text-align:justify;text-indent:-8.5pt"><span><br/></span></div></td><td colspan="15" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year ended December 31,</span></div></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"><div style="padding-left:11.35pt;text-align:justify;text-indent:-8.5pt"><span><br/></span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Customer A</span></div></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">11 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">*</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">*</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Customer B</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">*</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10 %</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">* less than 10%</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Stock-based compensation</span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company estimates the fair value of stock-based awards on the date of grant. The fair value of stock options with only service conditions is determined using the Black-Scholes option pricing model. The grant date fair value of the stock-based awards with graded vesting is recognized on a straight-line basis over the requisite service period. The determination of the fair value of the Company’s stock option awards is based on a variety of factors including Company’s common stock price, risk-free interest rate, expected volatility, expected life of awards and dividend yield. The Company has limited option exercise history and has elected to estimate the expected life of the stock option awards using the “simplified method” with the continued use of this method extended until such time that the Company has sufficient exercise history. The expected volatility of the price of such stocks is based on volatility of similar companies whose stock prices are publicly available over a historical period equivalent to the option’s expected term. The dividend yield is based on the Company’s historical and future expectation of dividends payouts. Historically, the Company has not paid cash dividends. Risk-free interest rates are based on the yield from US Treasury zero-coupon bonds with a term equivalent to the expected term of the options.</span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company accounts for forfeitures as they occur. </span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Warrants</span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company accounts for warrants as either equity-classified or liability-classified instruments based on an assessment of the warrant’s specific terms and applicable authoritative guidance. The assessment considers whether the warrants are freestanding financial instruments, meet the definition of a liability under ASC 480, and meet all of the requirements for equity classification, including whether the warrants are indexed to the Company’s own common stock and whether the warrant holders could potentially require “net cash settlement” in a circumstance outside of the Company’s control, among other conditions for equity classification. This assessment, which requires the use of professional judgment, is conducted at the time of warrant issuance and as of each subsequent reporting period end date while the warrants are outstanding.</span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Warrants that meet all the criteria for equity classification, are required to be recorded as a component of additional paid-in capital. Warrants that do not meet all the criteria for equity classification, are required to be recorded as liabilities at their initial fair value on the date of issuance and remeasured to fair value at each balance sheet date thereafter. The liability-classified warrants are recorded under non-current liabilities. Changes in the estimated fair value of the warrants are recognized in “Financial expenses, net” in the consolidated statements of operations. </span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Revenue recognition</span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The majority of Company’s revenues is derived from providing Ad serving services to advertisers, publishers, and media agencies. The services focus on standard, interactive and data driven digital video advertising. Ad serving services relate to utilizing Innovid’s platform to serve advertising impressions to various digital publishers across CTV, mobile TV, desktop TV, display, and other channels. </span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company also provides measurement services to brand and agencies, enterprise clients (networks) and publishers. The measurement service provide analysis on and track performance of advertisement campaigns. The measurement service provides insights into the effectiveness of TV and digital advertising.</span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Creative services relate to the design and development of interactive data-driven and dynamic ad formats by adding data, interactivity and dynamic features to standard ad units. </span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company recognizes revenue when its customer obtains control of promised services in an amount that reflects the consideration that the Company expects to receive in exchange for those services. The Company recognizes revenue in accordance with ASC Topic 606, Revenue from contracts with customers (“ASC 606”) and determines revenue recognition through the following steps: (1) identify the contract with a customer, (2) identify the performance obligations in the contract, (3) determine the transaction price, (4) allocate the transaction price to the performance obligations in the contract, and (5) recognize revenue when a performance obligation is satisfied.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">For arrangements with multiple performance obligations, which represent promises within an arrangement that are capable of being distinct and are separately identifiable, the Company allocates the contract consideration to all distinct performance obligations based on their relative standalone selling price (“SSP”). SSP is typically estimated based on observable transactions when these services are sold on a standalone basis.</span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenues related to ad serving services are recognized when impressions are delivered. The Company recognizes revenue from the display of impression-based ads in the contracted period in which the impressions are delivered. Impressions are considered delivered when an ad is displayed to users.</span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenues related to the measurement services platform are recognized over time, since the customer simultaneously receives and consumes the benefits provided by the Company’s performance. Revenues for these measurement services are recognized over the service period.</span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenues related to creative projects are recognized at a point in time when the Company delivers an ad unit. Creative services projects are usually delivered within a week.</span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company’s accounts receivable, consist primarily of receivables related to providing ad serving, measurement and creative services, for which the Company’s contracted performance obligations have been satisfied, the amount has been billed and the Company has an unconditional right to payment. The Company typically bills customers monthly based on actual delivery. The payment terms vary, mainly with terms of 60 days or less. </span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The typical contract term is 12 months or less for ASC 606 purposes. Most of the Company’s contracts can be cancelled without a cause. The Company has the unconditional right to payment for the services provided as of the date of the termination of the contracts. </span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company applies the practical expedient in ASC 606 and does not adjust the promised amount of consideration for the effects of a significant financing component if the Company expects, at contract inception, that the period between when the Company transfers a promised good or service to a customer and when the customer pays for that good or service will be one year or less.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Deferred revenues represent mostly unrecognized fees billed or collected for measurement platform services. Deferred revenues are recognized as (or when) we perform under the contract. </span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Ad serving services were 76.7%, 93.6%, and 96.5% of the Company’s revenues for the years ended December 31, 2022, 2021 and 2020, respectively. </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Measurement services were 19.7%, 1.6%</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and 0.7% of the Company’s revenues for the years ended December 31, 2022, 2021 and 2020, respectively. Creative services were</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> 3.6%, 4.8% and 2.8% of the Company’s revenues for the years ended December 31, 2022, 2021 and 2020, respectively. </span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Costs to obtain a contract</span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Contract costs include commission programs to compensate sales employees for generating sales orders with new customers or for new services with existing customers. Most commissions are commensurate. The Company elected to apply the practical expedient and recognize incremental costs of obtaining a contract as an expense when incurred if the amortization period of the asset that the Company otherwise would have recognized is one year or less. If commissions are not commensurate, the Company capitalizes these commissions. The term of amortization of capitalized commissions is three years. The amount of commissions capitalized as of December 31, 2022 is immaterial. </span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Cost of revenues</span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cost of revenues consists primarily of costs to run the ad serving, creative and measurement services. These costs include hosting fees, cost to access data and personnel costs including stock-based compensation, professional services costs and facility related costs. The Company allocates overhead including rent and other facility related costs, communication costs based on headcount.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Research and development</span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Research and development expenses consist primarily of personnel costs, including stock-based compensation, professional services costs, hosting and facility related costs. We allocate overhead including rent and other facility related costs and communication costs based on headcount. We expect research and development expenses to increase in future periods to support our growth, including continuing to invest in optimization, accuracy and reliability of our platform and other technology improvements to support and drive efficiency in our operations. These expenses may vary from period to period as a percentage of revenue, depending primarily upon when we choose to make more significant investments.</span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Research and development costs are charged to the consolidated statements of operations as incurred. ASC 350-40, Internal-Use Software (“ASC 350-40”), requires the capitalization of certain costs incurred only during the application development stage.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Sales and marketing</span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Sales and marketing expenses consist primarily of personnel costs, including stock-based compensation, professional services costs and facility related costs as well as costs related to advertising, product management, promotional materials, public relations, other sales and marketing programs. The Company allocates overhead including rent and other facility related costs, communication costs based on headcount. </span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">General and administrative</span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">General and administrative expenses consist primarily of personnel costs, including stock-based compensation, for executive management, finance, accounting, human capital, legal and other administrative functions as well as professional services costs and facility related costs. The Company allocates overhead including rent and other facility related costs, communication costs based on headcount. </span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Net loss per common stock</span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Prior to the Company’s SPAC merger, the Company computed net loss per stock using the two-class method required for participating securities. The two-class method requires income available to common stockholders for the period to be allocated between common stocks and participating securities based upon their respective rights to receive dividends as if all income for the period had been distributed. The Company considered its preferred stocks to be participating securities as the holders of the preferred stocks would be entitled to dividends that would be distributed to the holders of common stocks, on a pro-rata basis assuming conversion of all preferred stocks into common stocks. </span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">These participating securities do not contractually require the holders of such stocks to participate in the Company’s losses. As such, net loss for the periods presented was not allocated to the Company’s participating securities.</span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Following the SPAC merger, basic net loss per stock share is computed by dividing net income (loss) for each reporting period by the weighted-average number of ordinary shares outstanding during that period. Diluted net loss per stock is computed by dividing net income (loss) for each reporting period by the weighted average number of ordinary shares outstanding during the period, plus dilutive potential ordinary shares considered outstanding during the period. Diluted net loss per stock is the same as basic net loss per stock in periods when the effects of potentially dilutive stock of common stock are anti-dilutive.</span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">All outstanding warrants, options and RSUs for the years ended December 31, 2022, 2021 and 2020 have been excluded from the calculation of the diluted net loss per share, because all such securities are anti-dilutive for all periods presented. Preferred stocks were converted and treasury stocks were cancelled as of December 31, 2021. For further information see Note 19 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Basic and Diluted Net Loss Per Share</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Recently Adopted Accounting Pronouncements</span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In February 2016, the FASB issued the ASU No. 2016-02, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Leases (Topic 842)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The standard outlines a comprehensive lease accounting model that supersedes the previous lease guidance and requires lessees to recognize lease liabilities and corresponding right-of-use (“ROU”) assets for all leases with lease terms greater than 12 months. The guidance also changes the definition of a lease and expands the disclosure requirements of lease arrangements. Innovid adopted the standard in the first quarter of 2022 using the modified retrospective method. Results for reporting periods beginning after December 31, 2021, have been presented in accordance with the standard, while results for prior periods have not been adjusted and continue to be reported in accordance with the Company's historical accounting. The cumulative effect of initially applying the new leases standard was recognized as an adjustment to the opening consolidated balance sheet as of January 1, 2022.</span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company elected a package of practical expedients for leases that commenced prior to January 1, 2022, and did not reassess historical conclusions on: (i) whether any expired or existing contracts are or contain leases; (ii) lease classification for any expired or existing leases; and (iii) initial direct costs capitalization for any existing leases.</span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">This standard has a significant impact on our consolidated balance sheet but did not have a significant impact on the Company’s consolidated statements of operations. The most significant effects relate to the recognition ROU assets and lease liabilities on interim consolidated balance sheet for real estate and cars operating leases.</span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Upon adoption, the Company recognized lease liabilities and corresponding ROU assets, adjusted for the accrued rent and remaining lease incentives received on the adoption date, as follows:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.696%"><tr><td style="width:1.0%"/><td style="width:59.690%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.200%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.407%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.203%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">January 1, 2022</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">ROU assets</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Lease liabilities</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Real Estate</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,928 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,482 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cars</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total operating leases</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3,978</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">5,532</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See Note 8, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Leases </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">for further details.</span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In December 2019, the FASB issued ASU 2019-12, Income Taxes (Topic 740): Simplifying the Accounting for Income Taxes (“ASU 2019-12”). The new guidance eliminates certain exceptions related to the approach for intraperiod tax allocation, the methodology for calculating income taxes in an interim period and the recognition of deferred tax liabilities for outside basis differences. It also clarifies and simplifies other aspects of the accounting for income taxes. Innovid adopted the standard in the first quarter of 2022. The adoption of the guidance did not have a material impact on the Company’s consolidated financial statements.</span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In October 2021, the FASB issued ASU 2021-08, Business Combinations (Topic 805), Accounting for Contract Assets and Contract Liabilities from Contracts with Customers, which requires contract assets and contract liabilities (i.e., deferred revenue) acquired in a business combination to be recognized and measured by the acquirer on the acquisition date in accordance with ASC 606, Revenue from Contracts with Customers. This new guidance will result in the acquirer recognizing contract assets and contract liabilities at the same amounts recorded by the acquiree. Historically, such amounts were recognized by the acquirer at fair value in acquisition accounting. The Company adopted the standard effective in the first quarter of 2022. The adoption of the guidance did not have a material impact on the Company’s consolidated financial statements.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Recently issued accounting pronouncements not yet adopted by the Company</span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As an “emerging growth company,” the JOBS Act allows the Company to delay adoption of new or revised accounting pronouncements applicable to public companies until such pronouncements are made applicable to private companies. The Company has elected to use this extended transition period under the JOBS Act. The adoption dates discussed below reflect this election.</span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In August 2020, the FASB issued ASU 2020-06, Debt — Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging — Contracts in Entity’s Own Equity (Subtopic 815-40): Accounting for Convertible Instruments and Contracts in an Entity’s Own Equity (“ASU 2020-06”). The final guidance issued by the FASB for convertible instruments eliminates two of the three models in ASC 470-20 that require separate accounting for embedded conversion features. Separate accounting is still required in certain cases. Additionally, among other changes, the guidance eliminates some of the conditions for equity classification in ASC 815-40-25 for contracts in an entity’s own equity. The guidance also requires entities to use the if-converted method for all convertible instruments in the diluted earnings per share calculation and include the effect of share settlement for instruments that may be settled in cash or shares, except for certain liability-classified share-based payment awards. ASU 2020-06 is effective for fiscal years beginning after December 15, 2023, and interim periods within those fiscal years. The Company evaluated the potential impact of this guidance on its consolidated financial statements and determined that it will not have an impact on the consolidated financial statements. </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">In June 2016, the FASB issued ASU 2016-13, Financial Instruments – Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments (“ASU 2016-13”). ASU 2016-13 requires the measurement of all expected credit losses for financial assets held at the reporting date based on historical experience, current conditions, and reasonable and supportable forecasts. ASU 2016-13 requires enhanced qualitative and quantitative disclosures to help investors and other financial statement users better understand significant estimates and judgments used in estimating credit losses, as well as the credit quality and underwriting standards of an organization’s portfolio. ASU 2016-13 is effective for fiscal years beginning after December 15, 2022, and interim periods within those fiscal years. The Company has evaluated the impact of this accounting standard update and has determined that its adoption will impact how the Company assesses its estimates for credit losses, but will not have an impact on the consolidated financial statements. </span></div><div style="text-align:justify"><span><br/></span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other guidance that has been issued since the end of our previous reporting period is not expected to have an impact on the Company’s consolidated financial statements.</span></div> <div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Basis of Presentation</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying Consolidated Financial Statements and Notes to the Consolidated Financial Statements included in this Annual Report on Form 10-K are prepared in accordance with generally accepted accounting principles in the United States ("GAAP") for annual financial information and the instructions to Form 10-K and Article 10 of Regulation S-X. The accompanying Consolidated Financial Statements include our accounts and those of our wholly-owned subsidiaries; all intercompany activity and balances have been eliminated. The Consolidated Financial Statements reflect all adjustments, which are, in the opinion of management, necessary for a fair presentation of the consolidated balance sheets of the Company as of December 31, 2022 and 2021 and the consolidated results of operations and cash flows for the years ended December 31, 2022, 2021 and 2020.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Prior Period Reclassification</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the second quarter of 2022, we presented depreciation, amortization and impairment expenses as a separate line item on our consolidated statements of operations and all prior periods have been adjusted. </span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Depreciation, amortization and impairment expenses were previously included in cost of sales and other operating expenses depending on the underlying asset’s function. Additionally, we no longer present gross profit as a subtotal on our consolidated statements of operations. </span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The reclassification is to better reflect the financial performance of transactions with customers as our business has evolved and reflects a better representation of our current operations, which include those of our most recent acquisition. The change provides more clarity about changes in cost of revenue and other operating expenses exclusive of depreciation, amortization and impairment. </span></div>In accordance with US GAAP, all periods presented below have been retrospectively adjusted to reflect the reclassification of cost of revenue and other operating expenses exclusive of depreciation and amortization. There was no net impact to loss from operations, net loss attributable to common stockholders or net loss per stock for any periods presented. The consolidated balance sheets, statements of changes in temporary equity and stockholders’ equity, and the consolidated statements of cash flows are not affected by this reclassification. The effect of the change is as follows:<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:16.475%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.596%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.233%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.233%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.233%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.627%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.778%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.445%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.536%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.996%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"><div style="padding-left:2.85pt;text-align:justify"><span><br/></span></div></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year ended December 31, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year ended December 31, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year ended December 31, 2020</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Under previous classification</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Effect of change</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As reported</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Previously reported</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Effect of change</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As adjusted</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Previously reported</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Effect of change</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As adjusted</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of revenues</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33,265 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,078)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30,187 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,785 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(87)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,698 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,365 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(54)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,311 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating expenses:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31,932 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(814)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31,118 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24,619 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(320)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24,299 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,283 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(269)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,014 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Sales and marketing</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52,226 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,960)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50,266 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33,056 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(215)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32,841 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28,810 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(289)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28,521 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">General and administrative</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39,435 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(291)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39,144 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,680 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(39)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,641 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,221 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(118)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,103 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation, amortization and impairment</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,143 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,143 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">661 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">661 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">730 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">730 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table> 33265000 -3078000 30187000 17785000 -87000 17698000 12365000 -54000 12311000 31932000 -814000 31118000 24619000 -320000 24299000 18283000 -269000 18014000 52226000 -1960000 50266000 33056000 -215000 32841000 28810000 -289000 28521000 39435000 -291000 39144000 20680000 -39000 20641000 8221000 -118000 8103000 0 6143000 6143000 0 661000 661000 0 730000 730000 <div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Use of Estimates</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of the consolidated financial statements in conformity with US GAAP requires management to make estimates, judgments and assumptions. The Company’s management believes that the estimates, judgments and assumptions used are reasonable based upon information available at the time they are made. These estimates, judgments and assumptions can affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the dates of the financial statements, and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates. </span></div>The Company has considered the impact of these factors on its estimates and assumptions and determined that there were no material adverse impacts on the consolidated financial statements for the periods ended December 31, 2022, 2021, and 2020. As events continue to evolve and additional information becomes available, the Company’s estimates and assumptions may change materially in future periods. Functional currencyA majority of the Company’s revenues are generated in US dollars. In addition, a substantial portion of the Company’s costs are incurred in US dollars. The Company’s management believes that the US dollar is the currency of the primary economic environment in which the Company and each of its subsidiaries operate. Thus, the functional and reporting currency of the Company and its subsidiaries is the US dollar. Accordingly, accounts maintained in currencies other than the US dollar are re-measured into US dollars. All translation gains and losses resulting from the re-measurement of monetary assets and liabilities that are not denominated in the functional currency are recorded in Financial expenses, net on the consolidated statements of operations. <div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Cash and cash equivalents</span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cash equivalents are short-term highly liquid investments that are readily convertible to cash with original maturities of three months or less, at the date acquired.</span></div> Short-term bank deposits The Company utilizes short-term deposits in order to maximize the use of cash on hand. 10000000 0.041 0.041 Restricted deposits and restricted cashRestricted deposits presented in Prepaid expenses and other current assets and in Long-term restricted deposits are deposits used as security for the Company’s credit cards and for the rental of premises. 0.0001 0.0001 Property and equipment, netProperty and equipment are stated at cost, net of accumulated depreciation. Depreciation is calculated by the straight-line method over the estimated useful lives of the assets, at the following annual rates:<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:96.515%"><tr><td style="width:1.0%"/><td style="width:67.502%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:30.298%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"><div style="padding-left:11.35pt;text-align:justify;text-indent:-8.5pt"><span><br/></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Years</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Computers and peripheral equipment</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Office furniture and equipment</span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5-7</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Lease improvements</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The shorter of the lease term or the useful life of the asset</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Internal-use software</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3</span></td></tr></table><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Property and equipment consist of the following:</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:71.930%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.083%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"><div style="padding-left:11.35pt;text-align:justify;text-indent:-8.5pt"><span><br/></span></div></td><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,</span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"><div style="padding-left:11.35pt;text-align:justify;text-indent:-8.5pt"><span><br/></span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"><div style="text-align:center"><span><br/></span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"><div style="padding-left:2.85pt;text-align:justify"><span><br/></span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"><div style="padding-left:2.85pt;text-align:justify"><span><br/></span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Software development costs</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,190 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,594 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Computers and peripheral equipment</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,283 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,779 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Office furniture and equipment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">665 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">661 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Leasehold improvements</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,167 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,164 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"><div style="padding-left:11.35pt;text-align:justify;text-indent:-8.5pt"><span><br/></span></div></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,305 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,198 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated depreciation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,983)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,358)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Depreciated cost</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,322 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,840 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div> P3Y P5Y P7Y P3Y <div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Software development costs</span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Software development costs, which are included in property and equipment, net, consists of capitalized costs related to purchase and develop internal-use software. The Company uses such software to provide services to its customers. The costs to purchase and develop internal-use software are capitalized from the time that the preliminary project stage is completed, and it is considered probable that the software will be used to perform the function intended. These costs include personnel and personnel-related employee benefits for employees directly associated with the software development and external costs of the materials or services consumed in developing or obtaining the software. </span></div>Any costs incurred for upgrades and functionality enhancements of the software are also capitalized. Once this software is ready for use in providing the Company's services, these costs are amortized on a straight-line basis over the three-year estimated useful life. The amortization is presented within depreciation and amortization in the consolidated statements of operations. three-year 11143000 2594000 547000 0 0 <div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Impairment of long-lived assets</span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Long-lived assets, including property and equipment and finite-lived intangible assets, are reviewed for impairment whenever facts or circumstances either internally or externally may indicate that the carrying value of an asset may not be recoverable. If there are indications of an impairment, the Company tests for recoverability by comparing the estimated undiscounted future cash flows expected to result from the use of the asset to the carrying amount of the asset or asset group. If the asset or asset group is determined to be impaired, any excess of the carrying value of the asset or asset group over its estimated fair value is recognized as an impairment loss.</span></div> recognized impairment expense 547000 0 0 <div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Business combinations</span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company accounts for business combinations by applying the provisions of ASC 805, “Business Combination” (“ASC 805”) and allocates the fair value of purchase consideration to the tangible assets acquired, liabilities assumed, and intangible assets acquired based on their estimated fair values. The excess of the fair value of purchase consideration over the fair values of these identifiable assets and liabilities is recorded as goodwill. When determining the fair values of assets acquired and liabilities assumed, management makes significant estimates and assumptions, especially with respect to intangible assets. </span></div>Acquisition-related expenses are expensed as incurred. <div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Goodwill and acquired intangible assets</span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Goodwill and acquired intangible assets have been recorded in the Company's financial statements resulting from     various business combinations. Goodwill represents the excess of the purchase price in a business combination over the fair value of identifiable tangible and intangible assets acquired and liabilities assumed. Goodwill is subject to an annual impairment test. </span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company allocates goodwill to reporting units based on the expected benefit from the business combination. Reporting units are evaluated when changes in the Company’s operating structure occur, and if necessary, goodwill is reassigned using a relative fair value allocation approach. The Company currently has one reporting unit. </span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ASC 350, Intangibles—Goodwill and other (“ASC 350”) requires goodwill to be tested for impairment at least annually and, in certain circumstances, between annual tests. The accounting guidance gives the option to perform a qualitative assessment to determine whether further impairment testing is necessary. The qualitative assessment considers events and circumstances that might indicate that a reporting unit's fair value is less than its carrying amount. If it is determined, as a result of the qualitative assessment, that it is more likely than not that the fair value of a reporting unit is less than its carrying amount, a quantitative test is performed. The Company operates as one reporting unit. The Company elects to perform an annual impairment test of goodwill as of October 1 of each year, or more frequently if impairment indicators are present. For the years ended December 31, 2022, 2021 and 2020 no impairments of goodwill were recorded.</span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Separately acquired intangible assets are measured on initial recognition at cost including directly attributable costs. Intangible assets acquired in a business combination are measured at fair value at the acquisition date. </span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Customer relationships, acquired technology and trade name are being amortized over the estimated useful life of approximately 11 years, 6 years, and 4 years, respectively, using straight-line amortization method. </span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The amortization of customer relationships, acquired technology and trade name is presented within depreciation, amortization and impairment in the consolidated statement of operations.</span></div> 1 1 0 0 P11Y P6Y P4Y <div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Leases</span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Innovid's lease portfolio primarily consists of real estate properties and cars. Short-term leases with a term of 12 months or less are not recorded on the balance sheet. Innovid does not separate lease components from non-lease components.</span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is a lessee in all its lease agreements. The Company records lease liabilities based on the present value of lease payments over the lease term. Innovid generally uses an incremental borrowing rate to discount its lease liabilities, as the rate implicit in the lease is typically not readily determinable. Certain lease agreements include renewal options that are under the Company's control. Innovid includes optional renewal periods in the lease term only when it is reasonably certain that Innovid will exercise its option.</span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Variable lease payments are primarily related to payments to lessors for taxes, maintenance, insurance, and other operating costs. The Company's lease agreements do not contain any significant residual value guarantees or restrictive covenants.</span></div> <div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Fair value of financial instruments</span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company applies a fair value framework to measure and disclose its financial assets and liabilities. Fair value is defined as the exchange price that would be received for an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. The fair value hierarchy requires an entity to maximize the use of observable inputs, where available, and minimize the use of unobservable inputs when measuring fair value. There are three levels of inputs that may be used to measure fair value:</span></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Level 1 - Observable inputs that reflect quoted prices (unadjusted) for identical assets or liabilities in active markets.</span></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Level 2 - Includes other inputs that are directly or indirectly observable in the marketplace.</span></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Level 3 - Unobservable inputs which are supported by little or no market activity.</span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company’s financial instruments consist of cash and cash equivalents, short term deposits, restricted deposits, trade receivables, net, trade payables, employees and payroll accruals, accrued expenses and other current liabilities and current portion of long term debts. Their historical carrying amounts are approximate fair values due to the short-term maturities of these instruments. </span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company measures its investments in money market funds classified as cash equivalents and warrants liability at fair value.</span></div> <div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents information about the Company’s financial instruments that are measured at fair value on a recurring basis:</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:58.142%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.084%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"><div style="padding-left:11.35pt;text-align:justify;text-indent:-8.5pt"><span><br/></span></div></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr><td colspan="3" style="padding:0 1pt"><div style="padding-left:11.35pt;text-align:justify;text-indent:-8.5pt"><span><br/></span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 2</span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 3</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Assets:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Money market funds</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,948 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Certificates of deposit</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,000 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Liabilities:</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmEyNzExY2UwODA5NTQ1MmM4MmY5NTk5ZDYwZjZiNWEyL3NlYzphMjcxMWNlMDgwOTU0NTJjODJmOTU5OWQ2MGY2YjVhMl8xMTIvZnJhZzozNDQwZjc5ZTQ2MTc0YjdlOTU4OTlhOTFhYmI0NGE3ZC90YWJsZTpiM2M2MjVlOTNlMzQ0YjNiODYwNGNjY2EyOTBlYWY2ZS90YWJsZXJhbmdlOmIzYzYyNWU5M2UzNDRiM2I4NjA0Y2NjYTI5MGVhZjZlXzUtMC0xLTEtMTg4MjA2_64d1049f-3986-4432-9386-6dce1d10a859">Warrants liability</span></span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,265 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,036 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:58.142%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.084%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"><div style="padding-left:11.35pt;text-align:justify;text-indent:-8.5pt"><span><br/></span></div></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"><div style="padding-left:11.35pt;text-align:justify;text-indent:-8.5pt"><span><br/></span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 2</span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 3</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Assets:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Money market funds</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,515 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Liabilities:</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmEyNzExY2UwODA5NTQ1MmM4MmY5NTk5ZDYwZjZiNWEyL3NlYzphMjcxMWNlMDgwOTU0NTJjODJmOTU5OWQ2MGY2YjVhMl8xMTIvZnJhZzozNDQwZjc5ZTQ2MTc0YjdlOTU4OTlhOTFhYmI0NGE3ZC90YWJsZTpmZTgyYTIwMWU5ZTc0MjFlYjM4Y2JlNjkzNjFiNGJjNC90YWJsZXJhbmdlOmZlODJhMjAxZTllNzQyMWViMzhjYmU2OTM2MWI0YmM0XzUtMC0xLTEtMjAwNTYx_8c27e416-da30-41da-88af-f5bd9725d672">Warrants liability</span></span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,510 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,462 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div> 18948000 0 0 0 20000000 0 1265000 0 3036000 4515000 0 0 3510000 0 15462000 <div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The change in the fair value of the Level 3 warrant liability is summarized below: </span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:71.930%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.083%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"><div style="padding-left:11.35pt;text-align:justify;text-indent:-8.5pt"><span><br/></span></div></td><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,</span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"><div style="padding-left:11.35pt;text-align:justify;text-indent:-8.5pt"><span><br/></span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"><div style="text-align:center"><span><br/></span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Beginning of the year</span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,462 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">499 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Additions*</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,427 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in fair value</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12,426)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,616 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Conversion of Legacy Innovid Warrants on the Closing of the Transaction</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5,080)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">End of the year</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,036 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,462 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">* Additions during the year ended December 31, 2021 represent Company Warrant liability assumed in the Transaction. See Note 11, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%">Warrants</span> for further detail. 15462000 499000 0 18427000 -12426000 1616000 0 5080000 3036000 15462000 0.40 1.11 1265000 3510000 <div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The key inputs into the Black-Scholes model for the Private Warrants were as follows: </span></div><div style="margin-bottom:9pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:96.363%"><tr><td style="width:1.0%"/><td style="width:68.711%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.365%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.428%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.365%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.431%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"><div style="padding-left:11.35pt;text-align:justify;text-indent:-8.5pt"><span><br/></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:0 1pt"><div style="padding-left:11.35pt;text-align:justify;text-indent:-8.5pt"><span><br/></span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"><div style="padding-left:1.42pt;padding-right:1.42pt;text-align:center"><span><br/></span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Risk-free interest rate</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.07 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.24 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected dividends</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected term (years)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.9</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.9</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected volatility</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">85 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr></table></div> 0.0407 0.0124 0 0 P3Y10M24D P4Y10M24D 0.85 0.55 Trade receivable, netThe Company records trade receivable for amounts invoiced and yet unbilled invoices. The Company maintains an allowance for doubtful accounts to reserve for potentially uncollectible receivables. The expectation of collectability is based on a review of credit profiles of customers, contractual terms and conditions, current economic trends, and historical payment experience. The Company regularly reviews the adequacy of the allowance for doubtful accounts by considering the age of each outstanding invoice and the collection history of each customer to determine the appropriate amount of allowance for doubtful accounts. Trade receivables deemed uncollectible are charged against the allowance for doubtful accounts when identified. <div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Accrued post-employment benefits</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">401(k) profit sharing plans:</span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has a 401(k) retirement savings plan with a safe harbor employer match with a maximum of 4% employer contribution for its eligible employees in the US. During the years ended December 31, 2022, 2021 and 2020 the Company recorded expenses for matching contributions in the amount of $1,182, $961 and $705, respectively.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Severance pay:</span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Israeli Severance Pay Law, 1963 (“Severance Pay Law”), specifies that employees are entitled to severance payment, following the termination of their employment. Under the Severance Pay Law, the severance payment is calculated as one-month salary for each year of employment, or a portion thereof.</span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Israeli Subsidiary’s liability for all of its Israeli employees is covered by the provisions of Section 14 of the Severance Pay Law (“Section 14”). Under Section 14 employees are entitled to monthly deposits, at a rate of 8.33% of their monthly salary, continued on their behalf to their insurance funds. Payments in accordance with Section 14 release the Company from any future severance payments in respect of those employees. As a result, the Company does not recognize any liability for severance pay due to these employees and the deposits under Section 14 are not recorded as an asset in the Company’s balance sheets.</span></div> 0.04 0.04 1182000 961000 705000 0.0833 946000 755000 600000 <div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Income taxes and tax contingencies</span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Income taxes are computed using a balance sheet approach reflecting both current and deferred taxes. Current and deferred taxes reflect the tax impact of all of the events included in the financial statements. The basic principles employed in the balance sheet approach are to reflect a current tax liability or asset that is recognized for the estimated taxes payable or refundable on tax returns for the current and prior years, a deferred tax liability or asset that is recognized for the estimated future tax effects attributable to temporary differences and carryforwards, the measurement of current and deferred tax liabilities and assets is based on provisions of the enacted tax law of which the effects of future changes in tax laws or rates are not anticipated, and the measurement of deferred tax assets is reduced, if necessary, by the amount of any tax benefits that, based on available evidence, are not expected to be realized. There are certain situations in which deferred taxes are not provided. Some basis differences are not temporary differences because their reversals are not expected to result in taxable or deductible amounts. </span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company regularly evaluates deferred tax assets for future realization and establishes a valuation allowance to the extent that a portion is not more likely than not to be realized. The Company considers whether it is more likely than not that the deferred tax assets will be realized, including existing cumulative losses in recent years, expectations of future taxable income, carryforward periods, and other relevant quantitative and qualitative factors. The recoverability of the deferred tax assets is evaluated by assessing the adequacy of future expected taxable income from all sources, including reversal of taxable temporary differences, forecasted operating earnings and available tax planning strategies. These sources of income rely on estimates.</span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ASC 740, Income Taxes (“ASC 740”) contains a two-step approach to recognizing and measuring a liability for uncertain tax positions. The first step is to evaluate the tax position taken or expected to be taken in a tax return by determining if the weight of available evidence indicates that it is more likely than not that, on an evaluation of the technical merits, the tax position will be sustained on audit, including resolution of any related appeals or litigation processes. The second step is to measure the tax benefit as the largest amount that is more than 50% (cumulative basis) likely to be realized upon ultimate settlement. The Company classifies interest related to unrecognized tax benefits in taxes on income. </span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On December 20, 2017, Congress passed the “US Tax Act”. The US Tax Act requires complex computations to be performed that were not previously required by US tax law, significant judgments to be made in interpretation of the provisions of the US Tax Act, significant estimates in calculations, and the preparation and analysis of information not previously relevant or regularly produced the Act provides that a person who is a US shareholder of any CFC is required to include its GILTI in gross income for the tax year in a manner generally similar to that for Subpart F inclusions. The term “global intangible low-taxed income” is defined as the excess (if any) of the US shareholder’s net CFC tested income for that tax year, over the US shareholder’s net deemed tangible income return for that tax year. The Company’s policy is to treat GILTI as a period expense in the provision for income taxes.</span></div> <div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Concentrations of credit risks</span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Financial instruments that potentially subject the Company to concentrations of credit risk consist principally of cash and cash equivalents, deposits and trade receivables, net.</span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The majority of the Company’s cash and cash equivalents are invested in deposits with major banks in US, Israel and UK. Generally, these investments may be redeemed upon demand and, therefore, bear minimal risk.</span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company’s trade receivables, net are mainly derived from sales to customers located in the US, APAC, EMEA, and LATAM. The Company mitigates its credit risks by performing an ongoing credit evaluations of its customers’ financial conditions.</span></div>The Company has no off-balance-sheet concentration of credit risk such as foreign exchange contracts, option contracts or other foreign hedging arrangements. <div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the years ended December 31, 2022, 2021 and 2020, two of the Company’s customers accounted for more than 10% of the Company’s total revenues as presented below:</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:58.142%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.084%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"><div style="padding-left:11.35pt;text-align:justify;text-indent:-8.5pt"><span><br/></span></div></td><td colspan="15" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year ended December 31,</span></div></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"><div style="padding-left:11.35pt;text-align:justify;text-indent:-8.5pt"><span><br/></span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Customer A</span></div></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">11 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">*</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">*</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Customer B</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">*</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10 %</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">* less than 10%</span></div> 0.11 0.10 0.10 <div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Stock-based compensation</span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company estimates the fair value of stock-based awards on the date of grant. The fair value of stock options with only service conditions is determined using the Black-Scholes option pricing model. The grant date fair value of the stock-based awards with graded vesting is recognized on a straight-line basis over the requisite service period. The determination of the fair value of the Company’s stock option awards is based on a variety of factors including Company’s common stock price, risk-free interest rate, expected volatility, expected life of awards and dividend yield. The Company has limited option exercise history and has elected to estimate the expected life of the stock option awards using the “simplified method” with the continued use of this method extended until such time that the Company has sufficient exercise history. The expected volatility of the price of such stocks is based on volatility of similar companies whose stock prices are publicly available over a historical period equivalent to the option’s expected term. The dividend yield is based on the Company’s historical and future expectation of dividends payouts. Historically, the Company has not paid cash dividends. Risk-free interest rates are based on the yield from US Treasury zero-coupon bonds with a term equivalent to the expected term of the options.</span></div>The Company accounts for forfeitures as they occur. <div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Warrants</span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company accounts for warrants as either equity-classified or liability-classified instruments based on an assessment of the warrant’s specific terms and applicable authoritative guidance. The assessment considers whether the warrants are freestanding financial instruments, meet the definition of a liability under ASC 480, and meet all of the requirements for equity classification, including whether the warrants are indexed to the Company’s own common stock and whether the warrant holders could potentially require “net cash settlement” in a circumstance outside of the Company’s control, among other conditions for equity classification. This assessment, which requires the use of professional judgment, is conducted at the time of warrant issuance and as of each subsequent reporting period end date while the warrants are outstanding.</span></div>Warrants that meet all the criteria for equity classification, are required to be recorded as a component of additional paid-in capital. Warrants that do not meet all the criteria for equity classification, are required to be recorded as liabilities at their initial fair value on the date of issuance and remeasured to fair value at each balance sheet date thereafter. The liability-classified warrants are recorded under non-current liabilities. Changes in the estimated fair value of the warrants are recognized in “Financial expenses, net” in the consolidated statements of operations. <div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Revenue recognition</span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The majority of Company’s revenues is derived from providing Ad serving services to advertisers, publishers, and media agencies. The services focus on standard, interactive and data driven digital video advertising. Ad serving services relate to utilizing Innovid’s platform to serve advertising impressions to various digital publishers across CTV, mobile TV, desktop TV, display, and other channels. </span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company also provides measurement services to brand and agencies, enterprise clients (networks) and publishers. The measurement service provide analysis on and track performance of advertisement campaigns. The measurement service provides insights into the effectiveness of TV and digital advertising.</span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Creative services relate to the design and development of interactive data-driven and dynamic ad formats by adding data, interactivity and dynamic features to standard ad units. </span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company recognizes revenue when its customer obtains control of promised services in an amount that reflects the consideration that the Company expects to receive in exchange for those services. The Company recognizes revenue in accordance with ASC Topic 606, Revenue from contracts with customers (“ASC 606”) and determines revenue recognition through the following steps: (1) identify the contract with a customer, (2) identify the performance obligations in the contract, (3) determine the transaction price, (4) allocate the transaction price to the performance obligations in the contract, and (5) recognize revenue when a performance obligation is satisfied.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">For arrangements with multiple performance obligations, which represent promises within an arrangement that are capable of being distinct and are separately identifiable, the Company allocates the contract consideration to all distinct performance obligations based on their relative standalone selling price (“SSP”). SSP is typically estimated based on observable transactions when these services are sold on a standalone basis.</span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenues related to ad serving services are recognized when impressions are delivered. The Company recognizes revenue from the display of impression-based ads in the contracted period in which the impressions are delivered. Impressions are considered delivered when an ad is displayed to users.</span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenues related to the measurement services platform are recognized over time, since the customer simultaneously receives and consumes the benefits provided by the Company’s performance. Revenues for these measurement services are recognized over the service period.</span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenues related to creative projects are recognized at a point in time when the Company delivers an ad unit. Creative services projects are usually delivered within a week.</span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company’s accounts receivable, consist primarily of receivables related to providing ad serving, measurement and creative services, for which the Company’s contracted performance obligations have been satisfied, the amount has been billed and the Company has an unconditional right to payment. The Company typically bills customers monthly based on actual delivery. The payment terms vary, mainly with terms of 60 days or less. </span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The typical contract term is 12 months or less for ASC 606 purposes. Most of the Company’s contracts can be cancelled without a cause. The Company has the unconditional right to payment for the services provided as of the date of the termination of the contracts. </span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company applies the practical expedient in ASC 606 and does not adjust the promised amount of consideration for the effects of a significant financing component if the Company expects, at contract inception, that the period between when the Company transfers a promised good or service to a customer and when the customer pays for that good or service will be one year or less.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Deferred revenues represent mostly unrecognized fees billed or collected for measurement platform services. Deferred revenues are recognized as (or when) we perform under the contract. </span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Costs to obtain a contract</span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Contract costs include commission programs to compensate sales employees for generating sales orders with new customers or for new services with existing customers. Most commissions are commensurate. The Company elected to apply the practical expedient and recognize incremental costs of obtaining a contract as an expense when incurred if the amortization period of the asset that the Company otherwise would have recognized is one year or less. If commissions are not commensurate, the Company capitalizes these commissions. The term of amortization of capitalized commissions is three years. The amount of commissions capitalized as of December 31, 2022 is immaterial. </span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Cost of revenues</span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cost of revenues consists primarily of costs to run the ad serving, creative and measurement services. These costs include hosting fees, cost to access data and personnel costs including stock-based compensation, professional services costs and facility related costs. The Company allocates overhead including rent and other facility related costs, communication costs based on headcount.</span></div> P60D 0.767 0.936 0.965 0.197 0.016 0.007 0.036 0.048 0.028 <div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Research and development</span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Research and development expenses consist primarily of personnel costs, including stock-based compensation, professional services costs, hosting and facility related costs. We allocate overhead including rent and other facility related costs and communication costs based on headcount. We expect research and development expenses to increase in future periods to support our growth, including continuing to invest in optimization, accuracy and reliability of our platform and other technology improvements to support and drive efficiency in our operations. These expenses may vary from period to period as a percentage of revenue, depending primarily upon when we choose to make more significant investments.</span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Research and development costs are charged to the consolidated statements of operations as incurred. ASC 350-40, Internal-Use Software (“ASC 350-40”), requires the capitalization of certain costs incurred only during the application development stage.</span></div> Sales and marketingSales and marketing expenses consist primarily of personnel costs, including stock-based compensation, professional services costs and facility related costs as well as costs related to advertising, product management, promotional materials, public relations, other sales and marketing programs. The Company allocates overhead including rent and other facility related costs, communication costs based on headcount. General and administrativeGeneral and administrative expenses consist primarily of personnel costs, including stock-based compensation, for executive management, finance, accounting, human capital, legal and other administrative functions as well as professional services costs and facility related costs. The Company allocates overhead including rent and other facility related costs, communication costs based on headcount. <div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Net loss per common stock</span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Prior to the Company’s SPAC merger, the Company computed net loss per stock using the two-class method required for participating securities. The two-class method requires income available to common stockholders for the period to be allocated between common stocks and participating securities based upon their respective rights to receive dividends as if all income for the period had been distributed. The Company considered its preferred stocks to be participating securities as the holders of the preferred stocks would be entitled to dividends that would be distributed to the holders of common stocks, on a pro-rata basis assuming conversion of all preferred stocks into common stocks. </span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">These participating securities do not contractually require the holders of such stocks to participate in the Company’s losses. As such, net loss for the periods presented was not allocated to the Company’s participating securities.</span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Following the SPAC merger, basic net loss per stock share is computed by dividing net income (loss) for each reporting period by the weighted-average number of ordinary shares outstanding during that period. Diluted net loss per stock is computed by dividing net income (loss) for each reporting period by the weighted average number of ordinary shares outstanding during the period, plus dilutive potential ordinary shares considered outstanding during the period. Diluted net loss per stock is the same as basic net loss per stock in periods when the effects of potentially dilutive stock of common stock are anti-dilutive.</span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">All outstanding warrants, options and RSUs for the years ended December 31, 2022, 2021 and 2020 have been excluded from the calculation of the diluted net loss per share, because all such securities are anti-dilutive for all periods presented. Preferred stocks were converted and treasury stocks were cancelled as of December 31, 2021. For further information see Note 19 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Basic and Diluted Net Loss Per Share</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span></div> <div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Recently Adopted Accounting Pronouncements</span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In February 2016, the FASB issued the ASU No. 2016-02, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Leases (Topic 842)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The standard outlines a comprehensive lease accounting model that supersedes the previous lease guidance and requires lessees to recognize lease liabilities and corresponding right-of-use (“ROU”) assets for all leases with lease terms greater than 12 months. The guidance also changes the definition of a lease and expands the disclosure requirements of lease arrangements. Innovid adopted the standard in the first quarter of 2022 using the modified retrospective method. Results for reporting periods beginning after December 31, 2021, have been presented in accordance with the standard, while results for prior periods have not been adjusted and continue to be reported in accordance with the Company's historical accounting. The cumulative effect of initially applying the new leases standard was recognized as an adjustment to the opening consolidated balance sheet as of January 1, 2022.</span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company elected a package of practical expedients for leases that commenced prior to January 1, 2022, and did not reassess historical conclusions on: (i) whether any expired or existing contracts are or contain leases; (ii) lease classification for any expired or existing leases; and (iii) initial direct costs capitalization for any existing leases.</span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">This standard has a significant impact on our consolidated balance sheet but did not have a significant impact on the Company’s consolidated statements of operations. The most significant effects relate to the recognition ROU assets and lease liabilities on interim consolidated balance sheet for real estate and cars operating leases.</span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In December 2019, the FASB issued ASU 2019-12, Income Taxes (Topic 740): Simplifying the Accounting for Income Taxes (“ASU 2019-12”). The new guidance eliminates certain exceptions related to the approach for intraperiod tax allocation, the methodology for calculating income taxes in an interim period and the recognition of deferred tax liabilities for outside basis differences. It also clarifies and simplifies other aspects of the accounting for income taxes. Innovid adopted the standard in the first quarter of 2022. The adoption of the guidance did not have a material impact on the Company’s consolidated financial statements.</span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In October 2021, the FASB issued ASU 2021-08, Business Combinations (Topic 805), Accounting for Contract Assets and Contract Liabilities from Contracts with Customers, which requires contract assets and contract liabilities (i.e., deferred revenue) acquired in a business combination to be recognized and measured by the acquirer on the acquisition date in accordance with ASC 606, Revenue from Contracts with Customers. This new guidance will result in the acquirer recognizing contract assets and contract liabilities at the same amounts recorded by the acquiree. Historically, such amounts were recognized by the acquirer at fair value in acquisition accounting. The Company adopted the standard effective in the first quarter of 2022. The adoption of the guidance did not have a material impact on the Company’s consolidated financial statements.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Recently issued accounting pronouncements not yet adopted by the Company</span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As an “emerging growth company,” the JOBS Act allows the Company to delay adoption of new or revised accounting pronouncements applicable to public companies until such pronouncements are made applicable to private companies. The Company has elected to use this extended transition period under the JOBS Act. The adoption dates discussed below reflect this election.</span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In August 2020, the FASB issued ASU 2020-06, Debt — Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging — Contracts in Entity’s Own Equity (Subtopic 815-40): Accounting for Convertible Instruments and Contracts in an Entity’s Own Equity (“ASU 2020-06”). The final guidance issued by the FASB for convertible instruments eliminates two of the three models in ASC 470-20 that require separate accounting for embedded conversion features. Separate accounting is still required in certain cases. Additionally, among other changes, the guidance eliminates some of the conditions for equity classification in ASC 815-40-25 for contracts in an entity’s own equity. The guidance also requires entities to use the if-converted method for all convertible instruments in the diluted earnings per share calculation and include the effect of share settlement for instruments that may be settled in cash or shares, except for certain liability-classified share-based payment awards. ASU 2020-06 is effective for fiscal years beginning after December 15, 2023, and interim periods within those fiscal years. The Company evaluated the potential impact of this guidance on its consolidated financial statements and determined that it will not have an impact on the consolidated financial statements. </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">In June 2016, the FASB issued ASU 2016-13, Financial Instruments – Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments (“ASU 2016-13”). ASU 2016-13 requires the measurement of all expected credit losses for financial assets held at the reporting date based on historical experience, current conditions, and reasonable and supportable forecasts. ASU 2016-13 requires enhanced qualitative and quantitative disclosures to help investors and other financial statement users better understand significant estimates and judgments used in estimating credit losses, as well as the credit quality and underwriting standards of an organization’s portfolio. ASU 2016-13 is effective for fiscal years beginning after December 15, 2022, and interim periods within those fiscal years. The Company has evaluated the impact of this accounting standard update and has determined that its adoption will impact how the Company assesses its estimates for credit losses, but will not have an impact on the consolidated financial statements. </span></div><div style="text-align:justify"><span><br/></span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other guidance that has been issued since the end of our previous reporting period is not expected to have an impact on the Company’s consolidated financial statements.</span></div> <div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Upon adoption, the Company recognized lease liabilities and corresponding ROU assets, adjusted for the accrued rent and remaining lease incentives received on the adoption date, as follows:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.696%"><tr><td style="width:1.0%"/><td style="width:59.690%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.200%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.407%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.203%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">January 1, 2022</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">ROU assets</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Lease liabilities</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Real Estate</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,928 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,482 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cars</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total operating leases</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3,978</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">5,532</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div> 3928000 5482000 50000 50000 3978000 5532000 TRANSACTION<div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On November 30, 2021, the Transaction was closed. The Transaction was accounted for as a reverse recapitalization. Under this method of accounting, ION who was the legal acquirer, was treated as the acquired company for accounting purposes and the Transaction was treated as the equivalent of Innovid Corp. issuing stock for the net assets of ION. The net assets of ION are stated at historical cost, with no goodwill or other intangible assets recorded. </span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Upon the consummation of the Transaction all outstanding shares of Innovid Inc. common stock, Innovid Inc. redeemable convertible preferred stock, Innovid Inc. warrants, and Secondary Sale Transaction of 6,885,486 shares to PIPE investors, were exchanged for 93,787,278 shares of common stock in Innovid Corp.</span></div><div style="margin-bottom:9pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:79.657%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.143%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"><div style="padding-left:56.7pt;text-align:justify"><span><br/></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Number of shares</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Legacy Innovid common stock of January 1, 2021</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,275,609 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Warrant exercised</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">132,392 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock option exercised</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,180,943 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Conversion of redeemable convertible preferred stock into common stock</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">73,690,340 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Conversion of Legacy Innovid Warrants</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">507,994 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Exchanged into Innovid Corp. common stock on November 30, 2021</span></td><td colspan="2" style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">93,787,278</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Holders of 19,585,174 shares of ION’s Class A common stock sold in its initial public offering (the “Initial Shares”) exercised their right to have such shares redeemed for a full pro rata portion of the trust account holding the proceeds from ION IPO, which was approximately $10.00 per share, or $195,888 in the aggregate. The remaining shares of ION Class A common stock, including total shares of ION Class B common stock converted to ION Class A common stock immediately prior to the Domestication, were automatically converted to 12,039,826 shares of common stock in Innovid Corp.</span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">After giving effect to the Transaction, the redemption of Initial Shares as described above and the consummation of the PIPE Investment, there were 118,941,618 shares of common stock issued and outstanding after the close of the Transaction.</span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Innovid Corp. received approximately $149,252 in cash proceeds, net of transaction costs paid. The Company paid an accrued liability of $3,185 directly related to the Transaction as of December 31, 2021. </span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table reconciles the elements of the Transaction to the Consolidated statement of cash flows and the Consolidated Statement of Changes in Temporary Equity and Stockholders’ Equity for the year ended December 31, 2021.</span></div><div style="margin-bottom:9pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:96.515%"><tr><td style="width:1.0%"/><td style="width:85.242%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.558%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"><div style="padding-left:56.7pt;text-align:justify"><span><br/></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total value</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash - ION trust account and cash, net of redemptions</span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55,466 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash - PIPE Investment, net of Secondary Sale Amount of $68,855</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">131,145 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: Transaction costs paid</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(31,160)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: Deferred underwriting fee paid</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6,199)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Proceeds from reverse recapitalization, net </span></div></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">149,252</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: Accrued transaction costs not yet paid*</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,185)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: Company Warrant assumed as part of the Transaction</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(22,791)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Plus: Transaction costs allocated to Company Warrant</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,750 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Reverse recapitalization, net</span></div></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">126,026</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">* These amounts were paid in 2022.</span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As a result of the Transaction, each share of Innovid Inc. redeemable convertible preferred stock and common stock was converted into the right to receive approximately 1.337 shares of the common stock of the Company.</span></div><div style="margin-bottom:9pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The consolidated assets, liabilities and results of operations prior to the Transaction are those of Innovid Inc.. The stocks and corresponding capital amounts and losses per stock, prior to the Transaction, have been retroactively restated based on stocks reflecting the exchange ratio established in the Transactions.</span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The equity structure has been recast in all comparative periods up to the Closing Date to reflect the number of shares of the Company’s common stock, $0.0001 par value per share, issued to Innovid Inc.’s stockholders in connection with the Transaction. As such, the shares and corresponding capital amounts and earnings per share related to Innovid Inc. redeemable convertible preferred stock and Innovid Inc.'s common stock prior to the Transaction have been retroactively recast as shares reflecting the exchange ratio of 1.337 established in the Transaction.</span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Public Warrants and Private Placement Warrants</span></div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As a result of the Transaction, the Company assumed the outstanding Public Warrants to purchase 3,162,500 shares of the Company’s common stock and the outstanding Private Warrants to purchase 7,060,000 shares of the Company’s common stock. Each whole Warrant entitles the registered holder to purchase one share of the Company’s common stock at a price of $11.50 per share, at any time commencing 30 days after the closing of the Transaction. The warrants expire five years after the completion of the Transaction. Refer to Note 11, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Warrants </span>for further discussion. 0 0 <div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Upon the consummation of the Transaction all outstanding shares of Innovid Inc. common stock, Innovid Inc. redeemable convertible preferred stock, Innovid Inc. warrants, and Secondary Sale Transaction of 6,885,486 shares to PIPE investors, were exchanged for 93,787,278 shares of common stock in Innovid Corp.</span></div><div style="margin-bottom:9pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:79.657%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.143%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"><div style="padding-left:56.7pt;text-align:justify"><span><br/></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Number of shares</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Legacy Innovid common stock of January 1, 2021</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,275,609 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Warrant exercised</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">132,392 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock option exercised</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,180,943 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Conversion of redeemable convertible preferred stock into common stock</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">73,690,340 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Conversion of Legacy Innovid Warrants</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">507,994 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Exchanged into Innovid Corp. common stock on November 30, 2021</span></td><td colspan="2" style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">93,787,278</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table reconciles the elements of the Transaction to the Consolidated statement of cash flows and the Consolidated Statement of Changes in Temporary Equity and Stockholders’ Equity for the year ended December 31, 2021.</span></div><div style="margin-bottom:9pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:96.515%"><tr><td style="width:1.0%"/><td style="width:85.242%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.558%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"><div style="padding-left:56.7pt;text-align:justify"><span><br/></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total value</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash - ION trust account and cash, net of redemptions</span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55,466 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash - PIPE Investment, net of Secondary Sale Amount of $68,855</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">131,145 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: Transaction costs paid</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(31,160)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: Deferred underwriting fee paid</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6,199)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Proceeds from reverse recapitalization, net </span></div></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">149,252</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: Accrued transaction costs not yet paid*</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,185)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: Company Warrant assumed as part of the Transaction</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(22,791)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Plus: Transaction costs allocated to Company Warrant</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,750 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Reverse recapitalization, net</span></div></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">126,026</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">* These amounts were paid in 2022.</span></div> 6885486 93787278 16275609 132392 3180943 73690340 507994 93787278 19585174 10.00 195888000 12039826 118941618 118941618 149252000 3185000 55466000 68855000 131145000 31160000 6199000 149252000 3185000 22791000 2750000 126026000 1.337 0.0001 1.337 3162500 7060000 1 11.50 P30D P5Y ACQUISITION<div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On February 28, 2022, the Company completed the acquisition of TVS. TVS is an independent global measurement and attribution platform for converged TV and a private company limited by shares incorporated under the laws of Scotland. The Company acquired all the equity of TVS for an aggregate amount of approximately $100,000 in cash, 11,549,465 shares of the Company common stock at fair value of $3.80 per share, and the issuance of 949,893 fully vested stock option of the Company at weighted average fair value of $3.49, subject to certain adjustments as defined in the Stock Purchase Agreement.</span></div><div style="margin-bottom:9pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company, through this acquisition, added a real-time, cross-platform service to its offerings, including measurement outcomes such as frequency and unique unduplicated reach and performance metrics. The combination of ad serving, and cross-platform measurement enables the buy- and sell-sides to solve fragmentation by unlocking a complete picture of advertising across the linear TV, CTV and digital video marketplaces. </span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The acquisition of TVS has been accounted for as a business combination using the acquisition method of accounting. The acquisition method requires that assets acquired and liabilities assumed in a business combination be recognized at their fair values as of the acquisition date. The valuation of assets acquired and liabilities assumed have been finalized as of December 31, 2022. The Company finalized the purchase accounting for the TVS acquisition during the fourth quarter of fiscal 2022.</span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the fair value of assets acquired and liabilities assumed as of the acquisition date:</span></div><div style="margin-bottom:9pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:85.112%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.082%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"><div style="padding-left:56.7pt;text-align:justify"><span><br/></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total value</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,318 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts receivables</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,186</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other current assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,173</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property and equipment</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">154</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total tangible assets</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,831 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Technology</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,075</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Customer relationships</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,700</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trade name</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,000</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">112,421</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total assets acquired</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">157,027 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: Deferred tax liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,677)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: Other assumed liabilities</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,782)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net assets acquired</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">151,568</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Intangible assets related to technology, customer relationship and trade name are being amortized over the estimated useful life of approximately 6 years, 11 years, and 4 years, respectively. The estimated fair values of identifiable intangible assets were determined using the "income approach", which is a valuation technique that provides an estimate of the fair value of an asset based on market participant expectations of the cash flows an asset would generate over its remaining useful life. Some of the more significant assumptions inherent in the development of these asset valuations include the estimated net cash flows for each year for the appropriate discount rate necessary to measure the risk inherent in each future cash flow stream, the life cycle of each asset, competitive trends impacting the asset and each cash flow stream, as well as other factors.</span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Goodwill was calculated as the excess of the consideration transferred over the net assets recognized and represents the future economic benefits arising from the other assets acquired that could not be individually identified and separately recognized. Specifically, the goodwill recognized from the acquisition of TVS represents the value of additional growth potential of the revenue base from the creation of a single combined global organization and synergies related to combined IT efforts for enhancement of the existing and acquired technologies. The goodwill is not deductible for tax purposes.</span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition to the purchase consideration, the Company entered cash compensation arrangements with certain employees, which amounted to $9,700 in aggregate and are subject to certain performance and employment conditions following the acquisition date.</span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company incurred approximately $5.0 million in total transaction costs for the acquisition. Acquisition related transaction costs include legal, accounting fees and other professional costs directly related to the acquisition and are recognized in “general and administrative” in the consolidated statements of operations.</span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Unaudited Pro Forma Financial Informa</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ti</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">on </span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the unaudited pro forma combined results of Innovid and TVS for the year ended December 31, 2022, and 2021 as if the acquisition of TVS had occurred on January 1, 2021:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:68.293%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.506%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.689%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Twelve months ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"><div style="padding-left:1.42pt;padding-right:1.42pt;text-align:center"><span><br/></span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Unaudited)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Unaudited)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenues</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">131,433 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">112,147 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(14,634)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(37,195)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The unaudited pro forma combined financial information was prepared using the acquisition method of accounting and was based on the historical financial information of Innovid and TVS. In order to reflect the occurrence of the acquisition on January 1, 2021, the unaudited pro forma financial information includes adjustments to reflect incremental amortization expense to be incurred based on the current preliminary fair values of the identifiable intangible assets acquired and the reclassification of acquisition-related costs incurred during the three months and twelve months ended December 31, 2022</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> to the three months and twelve months ended December 31, 2021. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The unaudited pro forma financial information is not necessarily indicative of what the consolidated results of operations would have been had the acquisition been completed on January 1, 2021. In addition, the unaudited pro forma financial information is not a projection of future results of operations of the combined company.</span></div> 100000000 11549465 3.80 949893 3.49 <div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the fair value of assets acquired and liabilities assumed as of the acquisition date:</span></div><div style="margin-bottom:9pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:85.112%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.082%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"><div style="padding-left:56.7pt;text-align:justify"><span><br/></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total value</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,318 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts receivables</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,186</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other current assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,173</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property and equipment</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">154</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total tangible assets</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,831 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Technology</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,075</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Customer relationships</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,700</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trade name</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,000</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">112,421</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total assets acquired</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">157,027 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: Deferred tax liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,677)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: Other assumed liabilities</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,782)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net assets acquired</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">151,568</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div> 5318000 4186000 1173000 154000 10831000 15075000 16700000 2000000 112421000 157027000 1677000 3782000 151568000 P6Y P11Y P4Y 9700000 5000000 <span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the unaudited pro forma combined results of Innovid and TVS for the year ended December 31, 2022, and 2021 as if the acquisition of TVS had occurred on January 1, 2021:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:68.293%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.506%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.689%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Twelve months ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"><div style="padding-left:1.42pt;padding-right:1.42pt;text-align:center"><span><br/></span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Unaudited)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Unaudited)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenues</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">131,433 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">112,147 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(14,634)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(37,195)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table> 131433000 112147000 -14634000 -37195000 INTANGIBLE ASSETS, NET<div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company amortizes intangible assets on a straight line basis over their estimated useful lives. The estimated useful life, gross carrying amounts and accumulated amortization totals related to our identifiable intangible assets are as follows:</span></div><div style="margin-bottom:9pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:44.809%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.445%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:12.084%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Estimated Useful Life</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross Carrying Amount</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated Amortization</span></td><td colspan="3" style="display:none"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net Carrying Amount</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Customer relationships</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11 years</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,898 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,469)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,429 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquired technology</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6 years</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,275 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,367)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,907 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trade name</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4 years</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,000 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(418)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,582 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">34,173</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(4,254)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">29,918</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The weighted average useful life of our intangible assets at December 31, 2022 was 7.64 years. As described in Note 4, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Acquisition</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, we acquired several intangible assets as part of the TVS acquisition. The Company assesses intangible assets for indicators of impairment on an annual basis, including an evaluation of our useful lives to determine if events and circumstances warrant a revision to the remaining period of amortization. If indicators of impairment are present, amortizable intangible assets are tested for impairment by comparing the carrying value to undiscounted cash flows and, if impaired, written down to fair value based on discounted cash flows. The company have not identified an impairment, nor a material change to the estimated remaining useful lives of its intangible assets during fiscal years 2022 and 2021. The intangible assets have no assigned residual values.</span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Amortization expense recorded for intangible assets was $3,850, $33, and $199 during fiscal years 2022, 2021, and 2020, respectively.</span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December 31, 2022, estimated intangible asset amortization expense for each of the next five years and thereafter are as follows:</span></div><div style="margin-bottom:9pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:78.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fiscal Year</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amortization Expense</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,518 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,518 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,518 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,081 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2027</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,018 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,265 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">29,918</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div> The estimated useful life, gross carrying amounts and accumulated amortization totals related to our identifiable intangible assets are as follows:<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:44.809%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.445%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:12.084%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Estimated Useful Life</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross Carrying Amount</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated Amortization</span></td><td colspan="3" style="display:none"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net Carrying Amount</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Customer relationships</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11 years</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,898 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,469)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,429 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquired technology</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6 years</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,275 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,367)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,907 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trade name</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4 years</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,000 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(418)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,582 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">34,173</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(4,254)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">29,918</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table> P11Y 16898000 1469000 15429000 P6Y 15275000 2367000 12907000 P4Y 2000000 418000 1582000 34173000 4254000 29918000 P7Y7M20D 3850000 33000 199000 <div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December 31, 2022, estimated intangible asset amortization expense for each of the next five years and thereafter are as follows:</span></div><div style="margin-bottom:9pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:78.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fiscal Year</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amortization Expense</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,518 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,518 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,518 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,081 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2027</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,018 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,265 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">29,918</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div> 4518000 4518000 4518000 4081000 4018000 8265000 29918000 PREPAID AND OTHER CURRENT ASSETS<div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Prepaid and other current assets consist of the following: </span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:71.930%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.083%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"><div style="padding-left:11.35pt;text-align:justify;text-indent:-8.5pt"><span><br/></span></div></td><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,</span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"><div style="padding-left:11.35pt;text-align:justify;text-indent:-8.5pt"><span><br/></span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"><div style="padding-left:1.42pt;padding-right:1.42pt;text-align:center"><span><br/></span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid expenses</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,721 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,333 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deposits</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">99 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">142 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Government authorities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">204 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">153 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other current assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">616 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">503 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2,640</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3,131</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"/></tr></table></div> <div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Prepaid and other current assets consist of the following: </span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:71.930%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.083%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"><div style="padding-left:11.35pt;text-align:justify;text-indent:-8.5pt"><span><br/></span></div></td><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,</span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"><div style="padding-left:11.35pt;text-align:justify;text-indent:-8.5pt"><span><br/></span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"><div style="padding-left:1.42pt;padding-right:1.42pt;text-align:center"><span><br/></span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid expenses</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,721 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,333 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deposits</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">99 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">142 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Government authorities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">204 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">153 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other current assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">616 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">503 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2,640</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3,131</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"/></tr></table></div> 1721000 2333000 99000 142000 204000 153000 616000 503000 2640000 3131000 PROPERTY AND EQUIPMENT, NET<div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Property and equipment consist of the following:</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:71.930%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.083%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"><div style="padding-left:11.35pt;text-align:justify;text-indent:-8.5pt"><span><br/></span></div></td><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,</span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"><div style="padding-left:11.35pt;text-align:justify;text-indent:-8.5pt"><span><br/></span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"><div style="text-align:center"><span><br/></span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"><div style="padding-left:2.85pt;text-align:justify"><span><br/></span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"><div style="padding-left:2.85pt;text-align:justify"><span><br/></span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Software development costs</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,190 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,594 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Computers and peripheral equipment</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,283 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,779 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Office furniture and equipment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">665 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">661 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Leasehold improvements</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,167 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,164 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"><div style="padding-left:11.35pt;text-align:justify;text-indent:-8.5pt"><span><br/></span></div></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,305 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,198 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated depreciation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,983)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,358)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Depreciated cost</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,322 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,840 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The depreciation expense for the years ended December 31, 2022, 2021 and 2020 was $1,626, $630 and $531, respectively.</span></div> 13190000 2594000 2283000 1779000 665000 661000 2167000 2164000 18305000 7198000 3983000 2358000 14322000 4840000 1626000 630000 531000 LEASES<div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has the following operating ROU assets and lease liabilities:</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:66.475%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.809%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.810%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">ROU assets</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Lease liabilities</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Real Estate</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,886 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,801 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cars</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total operating leases</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2,910</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3,822</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.848%"><tr><td style="width:1.0%"/><td style="width:81.297%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.469%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.834%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Lease liabilities</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current lease liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,186 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-current lease liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,636 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total lease liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3,822</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the lease costs recognized in the consolidated statement of operations:</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:82.384%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.810%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year ended <br/>December 31, 2022</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease cost</span></td><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,889 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Short term lease cost</span></td><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">973 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Variable lease cost</span></td><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total lease cost</span></td><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2,910</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December 31, 2022, the weighted-average remaining lease term and weighted-average discount rate for operating leases are 2.2 years and 3.6%, respectively.</span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents supplementary cash flow information regarding the company's operating leases:</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:81.930%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.860%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.810%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year ended <br/>December 31, 2022</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash paid for amounts included in the measurement of lease liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,162 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Right of use assets obtained in exchange for operating lease liabilities upon lease modification</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">610 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:9pt;text-align:justify"><span><br/></span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the future payments of Innovid for its operating lease liabilities:</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:82.990%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.810%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,219 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,018 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">669 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total undiscounted lease payments</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3,906</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: Interest</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(84)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total lease liabilities - operating</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3,822</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:6pt;padding-left:13.5pt;text-align:justify;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Lease Disclosures Related to Periods Prior to the Adoption of ASU 2016-02 are as follows:</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operating lease expenses for the years ended December 31, 2021 and 2020 were $2,072 and, $2,215, respectively. </span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Future minimum lease commitments under non-cancelable operating leases as of December 31, 2021, are as follows:</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:96.515%"><tr><td style="width:1.0%"/><td style="width:70.956%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.557%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.427%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.560%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year ended December 31, 2021</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Rental of premises</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Lease of motor vehicles</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,486 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,844 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">826 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">770 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></div></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">5,926</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">8</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div> <div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has the following operating ROU assets and lease liabilities:</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:66.475%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.809%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.810%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">ROU assets</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Lease liabilities</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Real Estate</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,886 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,801 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cars</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total operating leases</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2,910</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3,822</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.848%"><tr><td style="width:1.0%"/><td style="width:81.297%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.469%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.834%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Lease liabilities</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current lease liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,186 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-current lease liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,636 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total lease liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3,822</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div> 2886000 3801000 24000 21000 2910000 3822000 2186000 1636000 3822000 <div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the lease costs recognized in the consolidated statement of operations:</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:82.384%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.810%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year ended <br/>December 31, 2022</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease cost</span></td><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,889 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Short term lease cost</span></td><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">973 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Variable lease cost</span></td><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total lease cost</span></td><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2,910</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents supplementary cash flow information regarding the company's operating leases:</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:81.930%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.860%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.810%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year ended <br/>December 31, 2022</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash paid for amounts included in the measurement of lease liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,162 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Right of use assets obtained in exchange for operating lease liabilities upon lease modification</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">610 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div> 1889000 973000 48000 2910000 P2Y2M12D 0.036 2162000 610000 <div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the future payments of Innovid for its operating lease liabilities:</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:82.990%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.810%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,219 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,018 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">669 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total undiscounted lease payments</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3,906</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: Interest</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(84)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total lease liabilities - operating</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3,822</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div> 2219000 1018000 669000 3906000 84000 3822000 2072000 2215000 <div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Future minimum lease commitments under non-cancelable operating leases as of December 31, 2021, are as follows:</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:96.515%"><tr><td style="width:1.0%"/><td style="width:70.956%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.557%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.427%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.560%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year ended December 31, 2021</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Rental of premises</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Lease of motor vehicles</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,486 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,844 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">826 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">770 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></div></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">5,926</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">8</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div> 2486000 8000 1844000 0 826000 0 770000 0 5926000 8000 ACCRUED EXPENSES AND OTHER CURRENT LIABILITIES<div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accrued expenses and other current liability consist of the following: </span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:96.515%"><tr><td style="width:1.0%"/><td style="width:70.956%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.557%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.427%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.560%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,</span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"><div style="padding-left:1.42pt;padding-right:1.42pt;text-align:center"><span><br/></span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued expenses</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,544 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,485 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tax payables</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,325 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred revenue</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">426 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued lease liability, current portion</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">420 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other current liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">179 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">138 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></div></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">5,474</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3,082</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div> <div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accrued expenses and other current liability consist of the following: </span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:96.515%"><tr><td style="width:1.0%"/><td style="width:70.956%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.557%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.427%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.560%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,</span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"><div style="padding-left:1.42pt;padding-right:1.42pt;text-align:center"><span><br/></span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued expenses</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,544 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,485 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tax payables</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,325 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred revenue</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">426 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued lease liability, current portion</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">420 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other current liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">179 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">138 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></div></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">5,474</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3,082</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div> 3544000 2485000 1325000 39000 426000 0 0 420000 179000 138000 5474000 3082000 OTHER NON-CURRENT LIABILITIES<div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other non-current liabilities consist of the following: </span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:96.515%"><tr><td style="width:1.0%"/><td style="width:70.956%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.557%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.427%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.560%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"><div style="padding-left:11.35pt;text-align:justify;text-indent:-8.5pt"><span><br/></span></div></td><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,</span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"><div style="padding-left:1.42pt;padding-right:1.42pt;text-align:center"><span><br/></span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmEyNzExY2UwODA5NTQ1MmM4MmY5NTk5ZDYwZjZiNWEyL3NlYzphMjcxMWNlMDgwOTU0NTJjODJmOTU5OWQ2MGY2YjVhMl8xMjcvZnJhZzpmNDBmNmNjNTRhMWE0N2Y5YmJhMDFkMjlkNmYyYmQ3Mi90YWJsZTpmOGE5NDI4MTU4ZTM0MzdjOGQ3ZGYyMjgwMTFiZTAzNS90YWJsZXJhbmdlOmY4YTk0MjgxNThlMzQzN2M4ZDdkZjIyODAxMWJlMDM1XzItMC0xLTEtMTg4MjA2_087379ee-dd88-42d0-b13e-48c7464e6107"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmEyNzExY2UwODA5NTQ1MmM4MmY5NTk5ZDYwZjZiNWEyL3NlYzphMjcxMWNlMDgwOTU0NTJjODJmOTU5OWQ2MGY2YjVhMl8xMjcvZnJhZzpmNDBmNmNjNTRhMWE0N2Y5YmJhMDFkMjlkNmYyYmQ3Mi90YWJsZTpmOGE5NDI4MTU4ZTM0MzdjOGQ3ZGYyMjgwMTFiZTAzNS90YWJsZXJhbmdlOmY4YTk0MjgxNThlMzQzN2M4ZDdkZjIyODAxMWJlMDM1XzItMC0xLTEtMTg4MjA2_1591b5cd-b526-4f43-9a4a-2c31e94ab4f3">Accrued lease liability</span></span></span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">996 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Uncertain tax position</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,865 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,459 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred tax liability</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">489 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">—</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other non-current liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,200 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></div></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">6,554</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3,455</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div> <div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other non-current liabilities consist of the following: </span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:96.515%"><tr><td style="width:1.0%"/><td style="width:70.956%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.557%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.427%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.560%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"><div style="padding-left:11.35pt;text-align:justify;text-indent:-8.5pt"><span><br/></span></div></td><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,</span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"><div style="padding-left:1.42pt;padding-right:1.42pt;text-align:center"><span><br/></span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmEyNzExY2UwODA5NTQ1MmM4MmY5NTk5ZDYwZjZiNWEyL3NlYzphMjcxMWNlMDgwOTU0NTJjODJmOTU5OWQ2MGY2YjVhMl8xMjcvZnJhZzpmNDBmNmNjNTRhMWE0N2Y5YmJhMDFkMjlkNmYyYmQ3Mi90YWJsZTpmOGE5NDI4MTU4ZTM0MzdjOGQ3ZGYyMjgwMTFiZTAzNS90YWJsZXJhbmdlOmY4YTk0MjgxNThlMzQzN2M4ZDdkZjIyODAxMWJlMDM1XzItMC0xLTEtMTg4MjA2_087379ee-dd88-42d0-b13e-48c7464e6107"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmEyNzExY2UwODA5NTQ1MmM4MmY5NTk5ZDYwZjZiNWEyL3NlYzphMjcxMWNlMDgwOTU0NTJjODJmOTU5OWQ2MGY2YjVhMl8xMjcvZnJhZzpmNDBmNmNjNTRhMWE0N2Y5YmJhMDFkMjlkNmYyYmQ3Mi90YWJsZTpmOGE5NDI4MTU4ZTM0MzdjOGQ3ZGYyMjgwMTFiZTAzNS90YWJsZXJhbmdlOmY4YTk0MjgxNThlMzQzN2M4ZDdkZjIyODAxMWJlMDM1XzItMC0xLTEtMTg4MjA2_1591b5cd-b526-4f43-9a4a-2c31e94ab4f3">Accrued lease liability</span></span></span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">996 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Uncertain tax position</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,865 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,459 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred tax liability</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">489 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">—</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other non-current liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,200 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></div></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">6,554</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3,455</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div> 0 996000 3865000 2459000 489000 0 2200000 0 6554000 3455000 WARRANTS<div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December 31, 2022, the Company had 3,162,500 Public Warrants and 7,060,000 Private Warrants outstanding.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Public Warrants</span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Warrants may only be exercised for a whole number of shares. No fractional shares will be issued upon exercise of the Public Warrants. The Public Warrants will become exercisable on the later of (a) 30 days after the completion of the Transaction and (b) one year from the closing of the Initial Public Offering. The Public Warrants will expire five years from the completion of the Transaction or earlier upon redemption or liquidation. </span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Redemption of warrants when the price per share of Innovid Corp. common stock equals or exceeds $18.00. </span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Once the warrants become exercisable, the Company may redeem the outstanding warrants (except as described with respect to the Private Placement Warrants): </span></div><div style="margin-bottom:9pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">•</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">in whole and not in part. </span></div><div style="margin-bottom:9pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">•</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">at a price of $0.01 per warrant. </span></div><div style="margin-bottom:9pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">•</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">upon a minimum of 30 days’ prior written notice of redemption to each warrant holder; and </span></div><div style="margin-bottom:9pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">•</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">if, and only if, the closing price of the Innovid Corp. common stock equals or exceeds $18.00 per share (as adjusted) for any 20 trading days within a 30-trading day period ending three business days before the Company sends the notice of redemption to the warrant holders. </span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">When the warrants become redeemable by the Company, the Company may exercise its redemption right even if it is unable to register or qualify the underlying securities for sale under all applicable state securities laws. </span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has established the last of the redemption criterion discussed above to prevent a redemption call unless there is at the time of the call a significant premium to the warrant exercise price. If the foregoing conditions are satisfied and the Company issues a notice of redemption of the warrants, each warrant holder will be entitled to exercise the warrant prior to the scheduled redemption date. However, the price of the Company’s common shares may fall below the $18.00 redemption trigger price (as adjusted for share sub-divisions, share capitalization, reorganization, recapitalization and the like) as well as the $11.50 warrant exercise price after the redemption notice is issued.</span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Redemption of warrants when the price per share of Innovid Corp. common stock equals or exceeds $10.00</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. </span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Once the warrants become exercisable, the Company may redeem the outstanding warrants: </span></div><div style="margin-bottom:9pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">•</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">in whole and not in part. </span></div><div style="margin-bottom:9pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">•</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">at a price of $0.10 per warrant. </span></div><div style="margin-bottom:9pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">•</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">upon a minimum of 30 days’ prior written notice of redemption; if holders will be able to exercise their warrants on a cashless basis prior to redemption and receive that number of shares determined based on the redemption date and the fair market value of the Innovid Corp. common stock; and </span></div><div style="margin-bottom:9pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">•</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">if, and only if, the closing price of the Innovid Corp. ordinary shares equals or exceeds $10.00 per share (as adjusted) for any 20 trading days within a 30-trading day period ending three business days before the Company sends the notice of redemption to the warrant holders. </span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If the Company calls these Public Warrants for redemption, as described above, its management will have the option to require any holder that wishes to exercise the Public Warrants to do so on a “cashless basis,” as described in the warrant agreement. The exercise price and number of ordinary shares issuable upon exercise of the Public Warrants may be adjusted in certain circumstances including in the event of a share dividend, extraordinary dividend or recapitalization, reorganization, merger, or consolidation. However, except as described below, the Public Warrants will not be adjusted for issuances of ordinary shares at a price below their exercise price. Additionally, in no event will the Company be required to net cash settle the Public Warrants.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Private Placement Warrants</span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Private Placement Warrants are identical to the Public Warrants, except that the Private Placement Warrants and the Innovid Corp. ordinary shares issuable upon the exercise of the Private Placement Warrants will not be transferable, assignable or salable until 30 days after the completion of the Transaction subject to certain limited exceptions. Additionally, the Private Placement Warrants will be exercisable on a cashless basis and be non-redeemable, except as described above, so long as they are held by the initial purchaser or its permitted transferees.</span></div>The Company evaluated the Company Warrants (Public Warrants and Private Placement Warrants) in accordance with ASC 480, “Distinguishing Liabilities from Equity” and ASC 815-40, “Derivatives and Hedging — Contracts in Entity’s Own Equity” and concluded that the warrants do not meet all the conditions to be classified as equity pursuant to ASC 815-40. As the warrants do not meet all the requirements for equity classification, the Company Warrants are recorded as liabilities on the Balance Sheets and measured at fair value with changes in fair value recognized in the Statements of Operations in the period of change. The Company Warrants’ fair value as of December 31, 2022 and 2021 was $4,301 and $18,972, respectively. 3162500 7060000 0 P30D P1Y P5Y 18.00 0.01 P30D 18.00 P20D P30D 18.00 11.50 10.00 0.10 P30D 10.00 P20D P30D P30D 4301000 18972000 LONG-TERM DEBT<div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2022 A&amp;R Agreement</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On August 4, 2022, two wholly owned subsidiaries of the Company, Innovid LLC and TV Squared Inc, entered an amended and restated loan and security agreement with Silicon Valley Bank (the “2022 A&amp;R Agreement”), to increase the revolving line of credit from $15,000 to $50,000 (the “New Revolving Credit Facility”). The interest for the New Revolving Credit Facility is payable monthly in arrears. The New Revolving Credit Facility bears interest at an annual rate which is the greater of (a) WSJ Prime Rate plus 0.75% or (b) 4.25%, on the aggregate outstanding balance. Additional fees include fees in an amount of 0.20% per annum of the average unused portion of the New Revolving Credit Facility to be paid quarterly in arrears. The Company will also pay non-refundable commitment fees of $40 and $75 at inception and first anniversary date, respectively. The maturity date of the 2022 A&amp;R Agreement is June 30, 2024. The New Revolving Credit Facility is subject to certain customary conditions precedent to the credit extension as stated in the 2022 A&amp;R Agreement.</span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The New Revolving Credit Facility requires the Company to comply with all covenants, primarily maintaining an adjusted quick ratio of at least 1.30 to 1.00. As defined in the 2022 A&amp;R Agreement “adjusted quick ratio” is the ratio of (a) quick assets to (b) current liabilities minus the current portion of deferred revenue. “Quick assets” are determined as the Company’s unrestricted cash plus accounts receivable, net, and is determined according to US GAAP. The Company is also required to maintain the minimum quarterly adjusted EBITDA as defined in the 2022 A&amp;R Agreement if the Company does not maintain the quarterly adjusted quick ratio of at least 1.50 to 1.00. </span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December 31, 2022, the Company utilized $20,000 of the $50,000 credit line, $6,000 of which was drawn during 2020, $5,000 was drawn during the fourth quarter 2022 and $9,000 was drawn during the second quarter of 2022. In January 2023, the Company repaid $5,000 under the credit line. </span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December 31, 2022, the Company is in compliance with all the covenants.</span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Prior to the 2022 A&amp;R Agreement, the credit installments bore US dollar denominated interest at an annual rate equal to 0.75%-1% plus a prime rate on the outstanding principal of each credit installment. </span></div>FINANCE EXPENSES (INCOME), NETThe Company recognizes the gains and losses from the remeasurement of the warrants liability related to Public Warrants and Private Placement Warrants in “Finance expenses (income), net” in the consolidated statements of operations. The unrealized gain from changes in the fair value of the Company Warrants for the years ended December 31, 2022 and 2021 was $14,671 and $3,819, respectively.The Company also recognized interest expenses in “Finance expenses (income), net” in the consolidated statements of operations. Interest expenses for the years ended December 31, 2022, 2021 and 2020 were $675, $259 and $328, respectively. 15000000 50000000 0.0075 0.0425 0.0020 40000 75000 1.30 1.50 20000000 50000000 6000000 5000000 9000000 5000000 0.0075 0.01 COMMITMENTS AND CONTINGENT LIABILITIES<div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Pledges and bank guarantees:</span></div><div style="margin-bottom:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">In conjunction with the 2022 A&amp;R Agreement (see Note 12, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Long-term Debt</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">), Innovid LLC. pledged 65,000 common stocks of its Israeli Subsidiary, NIS 0.01 par value each.</span></div><div style="margin-bottom:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">The Israeli Subsidiary pledged bank deposits in an aggregate amount of $629 in connection with an office rent agreement and credit cards.</span></div><div style="margin-bottom:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">Innovid Inc. obtained bank guarantees in an aggregate amount of $231 in connection with its office lease agreements.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Legal contingencies:</span></div>On March 4, 2022, a lawsuit was filed in the United States District Court for the Western District of Texas on March 4, 2022, by Nielsen, LLC against TVS alleging infringement of US Patent No. 10,063,378. On January 18, 2023 the Texas Court granted TVS’s motion to transfer venue to the Southern District of New York. It is expected that the Southern District of New York will issue a scheduling order detailing the next steps in the case in March 2023. The plaintiff has not specified the amount sought in the litigation. 65000 0.01 629000 231000 STOCKHOLDERS’ EQUITY<div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Stockholders’ equity:</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:29.506%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.960%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.960%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.960%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.960%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.960%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.964%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Authorized</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Issued</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Outstanding </span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"><div style="padding-left:1.42pt;padding-right:1.42pt;text-align:center"><span><br/></span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"><div style="text-align:center"><span><br/></span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"><div style="padding-left:1.42pt;padding-right:1.42pt;text-align:center"><span><br/></span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stocks of $0.0001, par value each:</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:0.25pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:0.25pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Common stocks</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">500,000,000 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">500,000,000 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">133,882,414 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">119,017,380 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">133,882,414 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">119,017,380 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The shares of the Company’s common stock, prior to the Transaction (as discussed in Note 3, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Transaction</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">) have been retrospectively adjusted to reflect the exchange ratio of 1.337 established in the Transaction.</span></div><div style="margin-bottom:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">i.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:12.73pt">Common stocks:</span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The rights and privileges of the common stocks are as follows:</span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Voting Rights - </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The holders of the common stocks are entitled to one vote for each share of common stocks.</span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Dividend Rights - </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Subject to preferences that may be applicable to dividends of any outstanding preferred stocks, dividends may be paid on the common stocks as and when declared by the Board of Directors. Such dividends will be distributed among the holders of common stocks pro rata in proportion of the number of common stocks held by each.</span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Liquidation Rights - </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the event of any voluntary or involuntary liquidation, dissolution or winding up of the Company’s affairs, the holders of the Company common stock are entitled to share ratably in all assets remaining after payment of the Company’s debts and other liabilities, subject to prior distribution rights of the Company preferred stock or any class or series of stock having a preference over the Company common stock, then outstanding, if any. </span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Redemption Rights - </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The common stocks are not redeemable.</span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Options outstanding and options available for future option grants have been retroactively adjusted to give effect to the exchange ratio.</span></div><div style="margin-bottom:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ii.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:9.96pt">Treasury stocks: As of December 31, 2022 there are no treasury stock issued or outstanding</span></div><div style="margin-bottom:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">iii.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:7.19pt">Equity classified warrants:</span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company issued 133,725 warrants to American Friends of Tmura, Inc. (the “Holder”) on February 25, 2010 to purchase an aggregate of 133,725 shares of the Company’s common stock, $0.001 par value each, with an exercise price of $0.07 which is subject to an adjustment on the occurrence of certain events. The warrants are exercisable until March 1, 2029. The warrants were recorded within equity based on their fair value on the date of issuance. These warrants are not remeasured. All equity classified warrants were exercised in November 2021 on a non-cash basis.</span></div> <div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Stockholders’ equity:</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:29.506%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.960%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.960%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.960%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.960%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.960%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.964%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Authorized</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Issued</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Outstanding </span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"><div style="padding-left:1.42pt;padding-right:1.42pt;text-align:center"><span><br/></span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"><div style="text-align:center"><span><br/></span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"><div style="padding-left:1.42pt;padding-right:1.42pt;text-align:center"><span><br/></span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stocks of $0.0001, par value each:</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:0.25pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:0.25pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Common stocks</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">500,000,000 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">500,000,000 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">133,882,414 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">119,017,380 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">133,882,414 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">119,017,380 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div> 0.0001 0.0001 500000000 500000000 133882414 119017380 133882414 119017380 1.337 1 0 0 133725 133725 0.001 0.07 STOCK-BASED COMPENSATION<div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">The Innovid Corp. Incentive Plan (“2021 Incentive Plan”)</span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A total number of Company common stock equal to 10% of the fully-diluted shares outstanding following the closing of the Transaction will initially be authorized and reserved for issuance under the 2021 Incentive Plan, which is 15,617,049 shares of Company common stock. The number of shares authorized and reserved for issuance will be subject to an annual increase for 10 years on the first day of each calendar year beginning January 1, 2022, equal to the lesser of (A) 5% of the aggregate number of shares of Company common stock outstanding on the final day of the immediately preceding calendar year and (B) such smaller number of shares as is determined by the board of directors of Innovid Corp. The maximum number of shares of Company common stock that may be issued pursuant to the exercise of incentive stock options granted under the 2021 Incentive Plan will be equal to 30% of the total number of issued and outstanding shares of Company common stock on a fully diluted basis as of the closing of the Transaction, see Note 3, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Transaction</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If shares covered by an award are not purchased or are forfeited or expire, or otherwise terminate without delivery of any shares subject thereto, then such shares will, to the extent of any such forfeiture, termination, cash-settlement or expiration, be available for future grant under the 2021 Incentive Plan. The payment of dividend equivalent rights in cash in conjunction with any outstanding awards will not be counted against the shares available for issuance under the 2021 Incentive Plan, and shares tendered by a participant, repurchased by the Company using proceeds from the exercise of stock options or withheld by the Company in payment of the exercise price of a stock option or to satisfy any tax withholding obligation for an award will not again be available for future awards. </span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Innovid Stock Plan (“Innovid Stock Plan")</span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under the Innovid Stock Plan, options may be granted to officers, directors, employees and non-employee consultants of the Company. Each option granted under the Plan expires no later than 10 years from the date of grant. The options vest usually over four years from commencement of employment or services. Any options, which are forfeited or not exercised before expiration, become available for future grants. From and after the effectiveness of the 2021 Incentive Plan, no additional awards will be granted under the Innovid Stock Plan. Upon the effectiveness of the Transaction, all outstanding stock options under the Innovid Stock Plan, whether vested or unvested, were converted into options to purchase a number of shares of common stock of the Company. Awards previously granted under the Innovid Stock Plan will continue to be subject to the provisions thereof.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Stock-based compensation expense</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Stock-based compensation expense is related to awards issued to employees pursuant to the Innovid Stock Plan and the 2021 Incentive Plan, summarized as follows:</span></div><div style="margin-bottom:9pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:57.990%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.557%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.085%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"><div style="padding-left:2.85pt;padding-right:2.85pt;text-align:justify"><span><br/></span></div></td><td colspan="15" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year ended December 31,</span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"><div style="padding-left:2.85pt;padding-right:2.85pt;text-align:justify"><span><br/></span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of goods sold</span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,171 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,489 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">501 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">121 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Sales and marketing</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,685 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">470 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">196 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">General and administrative</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,342 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,997 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">92 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></div></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">12,687</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3,011</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">420</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with the options granted to service providers and non-employee consultants, during the twelve months ended December 31, 2022, 2021 and 2020, the Company recorded stock compensation expenses in the amount of $1,190, $262 and $162, respectively. The majority of these expenses were recorded in general and administrative. </span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the twelve months ended December 31, 2022 the Company capitalized stock-based compensation expense of $1,165 in internal-use software cost. The Company stock-based compensation expense related to internal-use software cost for the same period in 2021 were immaterial.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Stock Options</span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Stock options may be granted to officers, directors, employees, and non-employee consultants of the Company. Each option granted under the Plan expires no later than 10 years from the date of grant. The options vest usually over four years from commencement of employment or services. Any options, which are forfeited or not exercised before expiration, become available for future grants.</span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with the TVS acquisition, Innovid issued 949,893 stock options to holders of TVS options for replacement options. These options were fully vested upon issuance due to acceleration upon acquisition and therefore do not require future service for vesting. The Company attributed a total amount of $152 to post acquisition service and recorded it as stock compensation expenses immediately after the acquisition closed. See Note 4, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Acquisition</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> for further details.</span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A summary of the employees’ stock option activity under the Innovid Stock Plan and the 2021 Incentive Plan for the years ended December 31, 2022 is as follows:</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:44.354%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.085%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"><div style="padding-left:11.35pt;text-align:justify;text-indent:-8.5pt"><span><br/></span></div></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year ended <br/>December 31, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:0 1pt"><div style="padding-left:11.35pt;text-align:justify;text-indent:-8.5pt"><span><br/></span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">of</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">options </span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">average</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">exercise</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">price </span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">average</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">remaining contractual term</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in years)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Aggregate intrinsic value (in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Outstanding at beginning of year</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></div></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">11,122,648</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">0.82</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">6.87</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">64,818</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Transfer between employee and consultant</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40,118 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.64 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,105,258 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.10 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted in acquisition</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">949,893 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.31 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(355,998)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.60 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expired</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(26,089)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.37 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercised</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,149,387)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.30 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Outstanding at end of year</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></div></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">10,686,443</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1.15</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">6.85</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">5,923</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Exercisable options at end of year</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></div></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">6,687,488</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">0.75</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">5.77</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">6,409</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:9pt;text-align:justify"><span><br/></span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A summary of the consultants’ stock option activity under the Innovid Stock Plan for the year ended December 31, 2022 is as follows:</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:44.354%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.085%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"><div style="padding-left:11.35pt;text-align:justify;text-indent:-8.5pt"><span><br/></span></div></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year ended <br/>December 31, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:0 1pt"><div style="padding-left:11.35pt;text-align:justify;text-indent:-8.5pt"><span><br/></span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">of</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">options </span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">average</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">exercise</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">price </span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">average</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">remaining contractual term</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in years)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Aggregate intrinsic value (in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Outstanding at beginning of year</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></div></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">179,627</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">0.31</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2.34</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,139</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Consultant has become employee</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(40,118)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.64 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(460)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.81 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expired</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(209)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.81 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercised</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(69,298)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.30 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Outstanding at end of year</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></div></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">69,542</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">0.47</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">4.21</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">86</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Exercisable options at end of year</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></div></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">64,524</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">0.46</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3.93</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">81</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December 31, 2022, the Company had approximately $4,536 of total unrecognized compensation cost related to non-vested stock-based compensation. That cost is expected to be recognized over a weighted-average period of 1.8 years years. </span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company estimated the fair value of each option on the date of grant using the Black-Scholes option pricing model applying the weighted-average assumptions in the following table: </span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:58.142%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.084%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"><div style="padding-left:2.85pt;padding-right:2.85pt;text-align:justify"><span><br/></span></div></td><td colspan="15" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year ended December 31,</span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"><div style="padding-left:2.85pt;padding-right:2.85pt;text-align:justify"><span><br/></span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"><div style="padding-left:1.42pt;padding-right:1.42pt;text-align:center"><span><br/></span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected volatility</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">69%-71%</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">65 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">79 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected dividends</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected term (in years)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.31</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.02</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.11</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Risk free interest</span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.84%-3.81%</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.06%-1.11%</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.62%-0.82%</span></div></td></tr></table></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Restricted Stock Units</span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with the Company’s transition to its next life-cycle stage post Transaction, Restricted Stock Units (“RSUs”) may be granted to officers, directors, employees, and non-employee consultants of the Company, and generally vest over a <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmEyNzExY2UwODA5NTQ1MmM4MmY5NTk5ZDYwZjZiNWEyL3NlYzphMjcxMWNlMDgwOTU0NTJjODJmOTU5OWQ2MGY2YjVhMl8xNDUvZnJhZzo2MWI4ZGQyNjI1Y2I0ZTM1YmYxNzQ5NjI1ODcwZmI1OC90ZXh0cmVnaW9uOjYxYjhkZDI2MjVjYjRlMzViZjE3NDk2MjU4NzBmYjU4XzEwOTk1MTE2NDYxMzk_10607c94-8cad-4ed5-9d9b-5661e479151b">three</span>- or four-year period.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A summary of the employees’ RSU activity under the 2021 Incentive Plan for the year ended December 31, 2022 is as follows:</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:71.930%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.083%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"><div style="padding-left:11.35pt;text-align:justify;text-indent:-8.5pt"><span><br/></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Number of share units</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">average</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">grant date</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">fair value</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Outstanding at beginning of year</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">—</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">—</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,329,639 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.65 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Released</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(96,884)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.90 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,246,382)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.97 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Outstanding at end of year</span></div></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">7,986,373</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">5.60</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A summary of the consultants’ RSU activity under the 2021 Incentive Plan for the year ended December 31, 2022 is as follows:</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:71.930%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.083%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"><div style="padding-left:11.35pt;text-align:justify;text-indent:-8.5pt"><span><br/></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Number of share units</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">average</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">grant date</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">fair value</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Outstanding at beginning of year</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">—</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">—</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">176,151 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.52 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(45,883)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.28 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Outstanding at end of year</span></div></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">130,268</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">6.60</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The weighted-average grant-date fair value of RSUs generally is determined based on the number of units granted and the quoted price of Innovid’s common stock on the date of grant.</span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December 31, 2022, $33,165 of unrecognized compensation cost related to RSUs is expected to be recognized as expense over the weighted average period of 2.0 years.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">The Innovid Corp. Employee Stock Purchase Plan </span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On November 30, 2021, the ESPP became effective. A total of 2,868,438 shares of Company common stock were initially reserved for issuance under the ESPP. The compensation committee of our board of directors is the plan administrator of the ESPP and has the authority to interpret the terms of the ESPP and determine eligibility of participants. On the first day of each calendar year beginning on January 1, 2022 and ending on (and including) January 1, 2031, the number of shares available for issuance under the ESPP will be increased by a number of shares equal to the lesser of (i) 1% of the shares outstanding on the final day of the immediately preceding calendar year, and (ii) such smaller number of shares as determined by the board of directors. If any right granted under the ESPP terminates for any reason without having been exercised, the shares subject thereto that are not purchased under such right will again be available for issuance under the ESPP. Notwithstanding the foregoing, no more than 17,383,002 shares of Company Common Stock may be issued under the Section 423 Component of the ESPP. </span></div><div style="margin-bottom:9pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December 31, 2022, the Company had not granted any options under the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Innovid Corp. Employee Stock Purchase Plan</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span></div> 0.10 15617049 P10Y 0.05 0.30 P10Y P4Y 0 <div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Stock-based compensation expense is related to awards issued to employees pursuant to the Innovid Stock Plan and the 2021 Incentive Plan, summarized as follows:</span></div><div style="margin-bottom:9pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:57.990%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.557%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.085%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"><div style="padding-left:2.85pt;padding-right:2.85pt;text-align:justify"><span><br/></span></div></td><td colspan="15" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year ended December 31,</span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"><div style="padding-left:2.85pt;padding-right:2.85pt;text-align:justify"><span><br/></span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of goods sold</span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,171 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,489 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">501 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">121 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Sales and marketing</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,685 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">470 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">196 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">General and administrative</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,342 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,997 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">92 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></div></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">12,687</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3,011</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">420</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div> 1171000 43000 11000 3489000 501000 121000 4685000 470000 196000 3342000 1997000 92000 12687000 3011000 420000 1190000 262000 162000 1165000 P10Y P4Y 949893 152000 <div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A summary of the employees’ stock option activity under the Innovid Stock Plan and the 2021 Incentive Plan for the years ended December 31, 2022 is as follows:</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:44.354%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.085%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"><div style="padding-left:11.35pt;text-align:justify;text-indent:-8.5pt"><span><br/></span></div></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year ended <br/>December 31, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:0 1pt"><div style="padding-left:11.35pt;text-align:justify;text-indent:-8.5pt"><span><br/></span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">of</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">options </span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">average</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">exercise</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">price </span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">average</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">remaining contractual term</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in years)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Aggregate intrinsic value (in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Outstanding at beginning of year</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></div></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">11,122,648</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">0.82</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">6.87</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">64,818</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Transfer between employee and consultant</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40,118 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.64 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,105,258 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.10 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted in acquisition</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">949,893 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.31 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(355,998)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.60 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expired</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(26,089)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.37 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercised</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,149,387)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.30 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Outstanding at end of year</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></div></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">10,686,443</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1.15</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">6.85</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">5,923</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Exercisable options at end of year</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></div></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">6,687,488</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">0.75</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">5.77</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">6,409</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:9pt;text-align:justify"><span><br/></span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A summary of the consultants’ stock option activity under the Innovid Stock Plan for the year ended December 31, 2022 is as follows:</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:44.354%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.085%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"><div style="padding-left:11.35pt;text-align:justify;text-indent:-8.5pt"><span><br/></span></div></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year ended <br/>December 31, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:0 1pt"><div style="padding-left:11.35pt;text-align:justify;text-indent:-8.5pt"><span><br/></span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">of</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">options </span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">average</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">exercise</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">price </span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">average</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">remaining contractual term</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in years)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Aggregate intrinsic value (in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Outstanding at beginning of year</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></div></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">179,627</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">0.31</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2.34</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,139</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Consultant has become employee</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(40,118)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.64 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(460)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.81 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expired</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(209)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.81 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercised</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(69,298)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.30 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Outstanding at end of year</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></div></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">69,542</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">0.47</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">4.21</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">86</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Exercisable options at end of year</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></div></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">64,524</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">0.46</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3.93</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">81</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div> 11122648 0.82 P6Y10M13D 64818000 40118 0.64 2105258 2.10 949893 0.31 355998 1.60 26089 1.37 3149387 0.30 10686443 1.15 P6Y10M6D 5923000 6687488 0.75 P5Y9M7D 6409000 179627 0.31 P2Y4M2D 1139000 40118 0.64 0 0 460 2.81 209 2.81 69298 0.30 69542 0.47 P4Y2M15D 86000 64524 0.46 P3Y11M4D 81000 4536000 P1Y9M18D <div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company estimated the fair value of each option on the date of grant using the Black-Scholes option pricing model applying the weighted-average assumptions in the following table: </span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:58.142%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.084%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"><div style="padding-left:2.85pt;padding-right:2.85pt;text-align:justify"><span><br/></span></div></td><td colspan="15" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year ended December 31,</span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"><div style="padding-left:2.85pt;padding-right:2.85pt;text-align:justify"><span><br/></span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"><div style="padding-left:1.42pt;padding-right:1.42pt;text-align:center"><span><br/></span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected volatility</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">69%-71%</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">65 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">79 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected dividends</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected term (in years)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.31</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.02</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.11</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Risk free interest</span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.84%-3.81%</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.06%-1.11%</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.62%-0.82%</span></div></td></tr></table></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A summary of the employees’ RSU activity under the 2021 Incentive Plan for the year ended December 31, 2022 is as follows:</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:71.930%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.083%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"><div style="padding-left:11.35pt;text-align:justify;text-indent:-8.5pt"><span><br/></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Number of share units</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">average</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">grant date</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">fair value</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Outstanding at beginning of year</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">—</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">—</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,329,639 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.65 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Released</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(96,884)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.90 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,246,382)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.97 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Outstanding at end of year</span></div></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">7,986,373</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">5.60</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A summary of the consultants’ RSU activity under the 2021 Incentive Plan for the year ended December 31, 2022 is as follows:</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:71.930%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.083%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"><div style="padding-left:11.35pt;text-align:justify;text-indent:-8.5pt"><span><br/></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Number of share units</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">average</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">grant date</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">fair value</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Outstanding at beginning of year</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">—</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">—</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">176,151 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.52 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(45,883)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.28 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Outstanding at end of year</span></div></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">130,268</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">6.60</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div> 0.69 0.71 0.65 0.79 0 0 0 P4Y3M21D P6Y7D P6Y1M9D 0.0284 0.0381 0.0106 0.0111 0.0062 0.0082 P4Y 0 0 9329639 5.65 96884 5.90 1246382 5.97 7986373 5.60 0 0 176151 6.52 45883 6.28 130268 6.60 33165000 P2Y 2868438 0.01 17383002 0 14671000 3819000 675000 259000 328000 INCOME TAXES <div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Income (loss) before taxes on income is comprised as follows: </span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:58.142%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.084%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year ended December 31,</span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"><div style="padding-left:1.42pt;padding-right:1.42pt;text-align:center"><span><br/></span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Domestic</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7,910)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11,098)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,241 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8,483)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">863 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(853)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total income (loss) before income taxes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></div></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(16,393)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(10,235)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">388</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Income taxes are comprised as follows:</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:58.142%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.084%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year ended December 31,</span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"><div style="text-align:center"><span><br/></span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current income tax provision (benefit):</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Domestic</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,048 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">96 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,129 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,245 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,104 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total current income tax (benefit) provision</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></div></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3,177</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,237</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,200</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:58.142%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.084%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year ended December 31,</span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"><div style="text-align:center"><span><br/></span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred income tax provision (benefit):</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Domestic</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,160)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total deferred income tax (benefit) provision</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></div></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(1,160)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">—</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">—</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total income tax (benefit) provision</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2,017</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,237</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,200</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A reconciliation of the U. S. statutory income tax rate to the Company’s effective income tax rate for continuing operations is as follows:</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:57.990%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.557%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.085%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year ended December 31,</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total income (loss) before income taxes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(16,393)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(10,235)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">388</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">US statutory rate</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income taxed computed at U. S. federal statutory rate</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,443)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,149)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">81 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign rate differential</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(14)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(155)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">State and local income taxes, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(239)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(359)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">207 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other non-deductible items</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">546 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(37)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">140 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">GILTI</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,892 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">308 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in valuation allowance</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,305 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,493 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">159 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tax credits</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(474)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(338)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(469)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Changes in uncertain tax positions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,202 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">881 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">956 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Transaction costs</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,427 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">578 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Warrants - MTM</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,081)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">160 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">781 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">714 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">286 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total income tax provision</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></div></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2,017</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,237</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,200</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Effective income tax rate</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></div></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(12.3)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(12.1)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">309.0</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</span></td></tr></table></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company’s effective tax rate is subject to significant variations due to several factors, including variability in pre-tax and taxable income (loss) and the mix of jurisdictions to which they relate, intercompany transactions, mergers and acquisitions, the applicability of special tax regimes, changes in the Company’s currently established valuation allowance, foreign currency gains (losses), and other laws and accounting rules in various jurisdictions.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Significant factors that impacted the Company’s effective tax rate between 2022 and 2021 were related to the acquisition of TVS, GILTI, uncertain tax positions, and increase in valuation allowance.</span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company’s effective tax rate between 2021 and 2020 was primarily reflects a pre-tax loss in 2021 compared to pre-tax income in 2020, offset by increases in non-deductible expenses, GILTI, uncertain tax positions and increase in valuation allowance. </span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Deferred income taxes are provided for the effects of temporary differences between assets and liabilities recognized for financial reporting purposes and the amounts recognized for income tax purposes. Significant components of deferred tax assets and deferred tax liabilities consisted of the following:</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:96.515%"><tr><td style="width:1.0%"/><td style="width:70.956%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.557%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.427%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.560%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Deferred tax assets</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss carryforwards</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,093 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,201 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tax credits</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,271 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,128 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest limitation carryforwards</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">R&amp;D capitalization costs</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,497 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued expenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,157 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">597 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Share-based compensation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,398 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">127 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fixed assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">147 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">180 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Lease liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">700 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">187 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total deferred tax assets, gross</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">26,291</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">12,445</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Valuation allowance</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(18,697)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12,445)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total deferred tax assets, net</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">7,594</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">—</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Deferred tax liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intangibles</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7,239)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Right-of-use asset</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(654)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(190)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total deferred tax liability, net </span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(8,083)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">—</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total deferred tax asset (liability)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(489)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">—</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A valuation allowance is provided when it is more likely than not that the deferred tax assets will not be realized. The Company has established a valuation allowance to offset its deferred tax assets, excluding the newly acquired TVS UK which is in a net deferred tax liability position due primarily to acquisition accounting, at December 31, 2022 and 2021 due to the uncertainty of realizing future tax benefits from its net operating loss carryforwards and other deferred tax assets. </span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Israeli corporate tax rate was 23% in 2022, 2021 and 2020. The Company’s production facilities in Israel have been granted the status of a “preferred enterprise” under the Law for the Encouragement of Capital Investments Law, 1959. According to the provisions of the Encouragement of Capital Investments Law, 1959, the Company has been granted a reduced tax rate for certain research and development activities the Company performs in Israel. A preferred enterprise located in development area A will be subject to a tax rate of 7.5% instead of 9%. The tax rate applicable to preferred enterprises located in other areas remains at 16%. </span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Foreign withholding taxes and Internal Revenue Code Section 986(c) gains and losses have not been recorded on permanently reinvested earnings of certain subsidiaries aggregating $12,888 and $8,720 as of December 31, 2022 and 2021, respectively. The amount of deferred international withholding taxes and Internal Revenue Code Section 986(c) gains and losses relating to these subsidiaries is approximately $1,237 and $1,224 as of December 31, 2022 and 2021, respectively. </span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company’s gross NOLs for tax return purposes are as follows: </span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:71.930%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.083%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year ended December 31,</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Domestic NOLs (federal)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,881 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36,817 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Domestic NOLs (state and local)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,992 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36,245 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign NOLs</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30,804 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,136 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></div></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">53,677</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">74,198</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Domestic (federal and state) NOLs expire in various year starting from 2030 through an indefinite period. Foreign NOLs expire starting from 2026 (Argentina) through an indefinite period (Germany, UK). A portion of domestic (federal and state) NOLs are subject to Internal Revenue Code Section 382 or similar provisions, but the net operating loss carryforwards are expected to be fully realized. The table above reflects gross NOLs for tax return purposes which are different than financial statement NOLs, as the Company’s intention is to settle additional income taxes from tax contingencies with NOLs. The other tax credit carryforwards expire in various years beginning in 2033. The Company’s intention is to settle the tax contingencies associated with the research and development credits with the attribute. </span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company’s unrecognized tax benefits are reconciled as follows: </span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:58.142%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.084%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,</span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Gross unrecognized tax benefits as of January 1</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3,162</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2,373</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,438</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Increases - prior year tax positions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">508 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Decreases - prior year tax positions</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(231)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(410)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Increases - current year tax positions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,562 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">691 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">935 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Position expiration</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(97)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">—</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">—</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Gross unrecognized tax benefits as of December 31</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></div></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">5,456</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3,162</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2,373</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The balances of unrecognized tax benefits of $5,456 and $3,162 as of December 31, 2022 and 2021, respectively, represent amounts that, if recognized, would impact the effective income tax rate in future periods, of which $1,495 relates to the Company’s acquisition of TVS. </span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company recognized interest and penalties related to unrecognized tax benefits in its income tax provision. The Company accrued $471 and $136 for interest and penalties as of December 31, 2022 and 2021, respectively. </span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is subject to income taxes in the US and several foreign jurisdictions including Australia, Argentina, Germany, the UK and Israel. Significant judgment is required in evaluating the Company’s tax positions and determining the Company’s provision for income taxes. During the ordinary course of business there are many transactions and calculations for which the ultimate tax determination is uncertain. The Company establishes reserves for tax related uncertainties based on estimates of whether, and the extent to which, additional taxes will be due. These reserves are established when we believe that certain positions might be challenged despite the belief that the Company’s tax return positions are fully supportable. The Company adjusts these reserves in light of changing facts and circumstances, such as the outcome of tax audits. The provision for income taxes includes the impact of reserve provisions and changes to reserves that are considered appropriate. </span></div>The Company’s Israeli Subsidiary is currently under examination by the taxing authorities for 2017 to 2019 tax periods. The last tax assessment that was received by the Company related to tax years through 2014 in Israel. <div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Income (loss) before taxes on income is comprised as follows: </span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:58.142%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.084%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year ended December 31,</span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"><div style="padding-left:1.42pt;padding-right:1.42pt;text-align:center"><span><br/></span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Domestic</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7,910)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11,098)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,241 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8,483)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">863 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(853)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total income (loss) before income taxes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></div></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(16,393)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(10,235)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">388</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div> -7910000 -11098000 1241000 -8483000 863000 -853000 -16393000 -10235000 388000 <div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Income taxes are comprised as follows:</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:58.142%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.084%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year ended December 31,</span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"><div style="text-align:center"><span><br/></span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current income tax provision (benefit):</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Domestic</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,048 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">96 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,129 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,245 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,104 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total current income tax (benefit) provision</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></div></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3,177</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,237</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,200</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:58.142%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.084%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year ended December 31,</span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"><div style="text-align:center"><span><br/></span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred income tax provision (benefit):</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Domestic</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,160)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total deferred income tax (benefit) provision</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></div></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(1,160)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">—</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">—</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total income tax (benefit) provision</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2,017</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,237</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,200</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div> 1048000 -8000 96000 2129000 1245000 1104000 3177000 1237000 1200000 0 0 0 -1160000 0 0 -1160000 0 0 2017000 1237000 1200000 <div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A reconciliation of the U. S. statutory income tax rate to the Company’s effective income tax rate for continuing operations is as follows:</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:57.990%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.557%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.085%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year ended December 31,</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total income (loss) before income taxes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(16,393)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(10,235)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">388</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">US statutory rate</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income taxed computed at U. S. federal statutory rate</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,443)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,149)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">81 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign rate differential</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(14)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(155)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">State and local income taxes, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(239)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(359)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">207 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other non-deductible items</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">546 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(37)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">140 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">GILTI</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,892 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">308 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in valuation allowance</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,305 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,493 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">159 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tax credits</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(474)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(338)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(469)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Changes in uncertain tax positions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,202 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">881 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">956 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Transaction costs</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,427 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">578 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Warrants - MTM</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,081)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">160 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">781 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">714 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">286 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total income tax provision</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></div></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2,017</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,237</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,200</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Effective income tax rate</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></div></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(12.3)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(12.1)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">309.0</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</span></td></tr></table></div> -16393000 -10235000 388000 0.21 0.21 0.21 -3443000 -2149000 81000 101000 -14000 -155000 -239000 -359000 207000 546000 -37000 140000 2892000 308000 0 2305000 1493000 159000 474000 338000 469000 1202000 881000 956000 1427000 578000 0 -3081000 160000 -5000 781000 714000 286000 2017000 1237000 1200000 -0.123 -0.121 3.090 Significant components of deferred tax assets and deferred tax liabilities consisted of the following:<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:96.515%"><tr><td style="width:1.0%"/><td style="width:70.956%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.557%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.427%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.560%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Deferred tax assets</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss carryforwards</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,093 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,201 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tax credits</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,271 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,128 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest limitation carryforwards</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">R&amp;D capitalization costs</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,497 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued expenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,157 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">597 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Share-based compensation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,398 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">127 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fixed assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">147 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">180 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Lease liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">700 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">187 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total deferred tax assets, gross</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">26,291</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">12,445</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Valuation allowance</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(18,697)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12,445)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total deferred tax assets, net</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">7,594</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">—</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Deferred tax liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intangibles</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7,239)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Right-of-use asset</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(654)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(190)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total deferred tax liability, net </span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(8,083)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">—</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total deferred tax asset (liability)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(489)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">—</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table> 11093000 10201000 1271000 1128000 0 25000 7497000 0 1157000 597000 4398000 127000 147000 180000 700000 0 28000 187000 26291000 12445000 18697000 12445000 7594000 0 7239000 0 654000 0 190000 0 8083000 0 489000 0 12888000 8720000 1237000 1224000 <div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company’s gross NOLs for tax return purposes are as follows: </span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:71.930%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.083%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year ended December 31,</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Domestic NOLs (federal)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,881 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36,817 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Domestic NOLs (state and local)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,992 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36,245 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign NOLs</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30,804 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,136 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></div></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">53,677</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">74,198</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div> 11881000 36817000 10992000 36245000 30804000 1136000 53677000 74198000 <div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company’s unrecognized tax benefits are reconciled as follows: </span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:58.142%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.084%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,</span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Gross unrecognized tax benefits as of January 1</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3,162</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2,373</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,438</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Increases - prior year tax positions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">508 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Decreases - prior year tax positions</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(231)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(410)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Increases - current year tax positions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,562 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">691 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">935 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Position expiration</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(97)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">—</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">—</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Gross unrecognized tax benefits as of December 31</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></div></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">5,456</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3,162</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2,373</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div> 3162000 2373000 1438000 60000 508000 0 231000 410000 0 2562000 691000 935000 -97000 0 0 5456000 3162000 2373000 5456000 3162000 1495000 471000 136000 SEGMENT REPORTINGThe Company operates as one operating segment, which primarily focuses on ad serving, measurement and creative services. Our CEO is the chief operating decision-maker, manages and allocates resources to the operations of the Company on an entity-wide basis. <div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenue by geographical location are as follows:</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:58.142%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.084%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"><div style="padding-left:11.35pt;text-align:justify;text-indent:-8.5pt"><span><br/></span></div></td><td colspan="15" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,</span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"><div style="padding-left:11.35pt;text-align:justify;text-indent:-8.5pt"><span><br/></span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">US</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">114,528 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">81,882 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">62,760 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Canada</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,266 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,039 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">518 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">APAC</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,249 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,151 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,636 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">EMEA</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,030 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,515 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,463 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">LATAM</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,044 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,704 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,424 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total revenues</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></div></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">127,117</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">90,291</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">68,801</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company’s property and equipment, net and ROU assets commencing January 1, 2022 by geographical location are as follows:</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:71.930%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.083%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Israel</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,707 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,495 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">US</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,065 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,051 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Rest of the World </span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">460 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">294 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></div></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">17,232</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">4,840</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div> 1 <div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenue by geographical location are as follows:</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:58.142%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.084%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"><div style="padding-left:11.35pt;text-align:justify;text-indent:-8.5pt"><span><br/></span></div></td><td colspan="15" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,</span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"><div style="padding-left:11.35pt;text-align:justify;text-indent:-8.5pt"><span><br/></span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">US</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">114,528 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">81,882 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">62,760 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Canada</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,266 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,039 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">518 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">APAC</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,249 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,151 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,636 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">EMEA</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,030 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,515 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,463 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">LATAM</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,044 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,704 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,424 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total revenues</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></div></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">127,117</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">90,291</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">68,801</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company’s property and equipment, net and ROU assets commencing January 1, 2022 by geographical location are as follows:</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:71.930%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.083%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Israel</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,707 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,495 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">US</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,065 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,051 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Rest of the World </span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">460 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">294 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></div></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">17,232</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">4,840</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div> 114528000 81882000 62760000 1266000 1039000 518000 4249000 3151000 2636000 6030000 2515000 1463000 1044000 1704000 1424000 127117000 90291000 68801000 2707000 1495000 14065000 3051000 460000 294000 17232000 4840000 BASIC AND DILUTED NET LOSS PER SHARE<div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Basic and diluted net loss per share attributable to common stockholders was calculated as follows:</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:57.081%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.466%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.085%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Numerator:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(18,410)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11,472)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(812)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accretion of preferred stocks to redemption value</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(77,063)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7,297)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net loss attributable to common stockholders - basic and diluted</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></div></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(18,410)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(88,535)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(8,109)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Denominator:</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted-average number of stocks used in computing net loss per stock attributable to common stockholders</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">130,756,484</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">26,745,020</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">16,028,560</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net loss per stock attributable to common stockholders – basic and diluted</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></div></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(0.14)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(3.31)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(0.51)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net loss per share calculations and potentially dilutive security amounts for all periods prior to the Transaction have been retrospectively adjusted to the equivalent number of shares outstanding immediately after the Transaction to effect the reverse recapitalization. Historically reported weighted average shares outstanding have been multiplied by the exchange ratio of 1.337.</span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company’s potentially dilutive securities have been excluded from the computation of diluted net loss per share as the effect would be to reduce the net loss per share attributable to common stockholders. Therefore, the weighted average number of common shares outstanding used to calculate both basic and diluted net loss per share attributable to common stockholders is the same.</span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company excluded the following potential common shares, presented based on amounts outstanding at each period end, from the computation of diluted net loss per share attributable to common stockholders for the periods indicated because including them would have had an anti-dilutive effect:</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:58.142%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.084%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Preferred stocks</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">73,690,340 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Options outstanding</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,755,985 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,302,275 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,204,528 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">RSUs outstanding</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,116,641 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Warrants outstanding</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,222,500 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,222,500 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">680,271 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Preferred stocks, options outstanding and warrant outstanding have been retroactively adjusted to give effect to the exchange ratio.</span></div> <div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Basic and diluted net loss per share attributable to common stockholders was calculated as follows:</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:57.081%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.466%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.085%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Numerator:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(18,410)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11,472)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(812)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accretion of preferred stocks to redemption value</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(77,063)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7,297)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net loss attributable to common stockholders - basic and diluted</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></div></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(18,410)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(88,535)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(8,109)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Denominator:</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted-average number of stocks used in computing net loss per stock attributable to common stockholders</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">130,756,484</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">26,745,020</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">16,028,560</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net loss per stock attributable to common stockholders – basic and diluted</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></div></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(0.14)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(3.31)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(0.51)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div> -18410000 -11472000 -812000 0 77063000 7297000 -18410000 -18410000 -88535000 -88535000 -8109000 -8109000 130756484 130756484 26745020 26745020 16028560 16028560 -0.14 -0.14 -3.31 -3.31 -0.51 -0.51 1.337 <div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company excluded the following potential common shares, presented based on amounts outstanding at each period end, from the computation of diluted net loss per share attributable to common stockholders for the periods indicated because including them would have had an anti-dilutive effect:</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:58.142%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.084%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Preferred stocks</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">73,690,340 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Options outstanding</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,755,985 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,302,275 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,204,528 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">RSUs outstanding</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,116,641 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Warrants outstanding</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,222,500 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,222,500 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">680,271 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div> 0 0 73690340 10755985 11302275 13204528 8116641 0 0 10222500 10222500 680271 (2) Prior period results have been adjusted to reflect the exchange of Innovid Inc’s common stock for Innovid Corp’s common stock at an exchange ratio of approximately 1.337 because of the Transaction. See Note 3, Transaction for further details. (1) Exclusive of depreciation, amortization and impairment presented separately. The warrant was exercised in November 2021 and was net share settled. * Refer to Note 3, Transaction for details EXCEL 113 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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

&PO=V]R:W-H965T&UL4$L! A0#% @ $8)C M5C.%QP!J! "Q( !D ("!<8 ! 'AL+W=OTX% ^( &0 M @($2A0$ >&PO=V]R:W-H965T 9 " @9>* 0!X;"]W;W)K M&UL4$L! A0#% @ $8)C5EA610F< @ :P8 M !D ("!LX\! 'AL+W=O&PO=V]R:W-H965T&UL4$L! A0#% @ $8)C5FKW44F/ @ W08 !D M ("!JYD! 'AL+W=O&PO=V]R:W-H965T M&UL4$L! A0# M% @ $8)C5L>VT:(- P 0 T !D ("! J0! 'AL+W=O M&PO=V]R:W-H965TNFP( $H& 9 " @=RI M 0!X;"]W;W)K&UL4$L! A0#% @ $8)C5L=B MX,O8 @ / D !D ("!KJP! 'AL+W=O&PO=V]R:W-H965T&UL4$L! A0#% @ $8)C5J':8P/S @ $0H !D M ("!4[4! 'AL+W=O$?G.@" O" &0 @(%]N $ >&PO M=V]R:W-H965T&UL4$L! A0#% @ $8)C5O N!F-?!P [3T !D ("! MWKX! 'AL+W=O&PO=V]R:W-H965T&UL4$L! A0#% M @ $8)C5B@]OUNS @ ? < !D ("!V-$! 'AL+W=O&PO=V]R:W-H965T&UL4$L! A0#% @ $8)C5I]%T QJ M! H1D !D ("!..,! 'AL+W=O&PO=V]R:W-H965T&UL4$L! A0#% @ $8)C5D/67C$@! B1( !D M ("!Y?,! 'AL+W=O&PO=V]R M:W-H965T&UL M4$L! A0#% @ $8)C5BV1,S)2 P H P !D ("!IOX! M 'AL+W=O&PO=V]R:W-H965T&UL4$L! A0#% @ M$8)C5E6O($I^ P = \ !D ("!P@L" 'AL+W=O&PO=V]R:W-H965T @!X;"]W;W)K&UL4$L! A0#% @ $8)C5MO$\KHQ @ _@0 !D M ("!*2," 'AL+W=O&PO=V]R:W-H M965T7!E&UL4$L%!@ !F &8 1P ) XML 114 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 115 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 116 FilingSummary.xml IDEA: XBRL DOCUMENT 3.22.4 html 238 479 1 true 86 0 false 7 false false R1.htm 0000001 - Document - Cover Page Sheet http://innovid.com/role/CoverPage Cover Page Cover 1 false false R2.htm 0000002 - Document - Audit Information Sheet http://innovid.com/role/AuditInformation Audit Information Cover 2 false false R3.htm 0000003 - Statement - CONSOLIDATED BALANCE SHEETS Sheet http://innovid.com/role/CONSOLIDATEDBALANCESHEETS CONSOLIDATED BALANCE SHEETS Statements 3 false false R4.htm 0000004 - Statement - CONDENSED BALANCE SHEETS (Parenthetical) Sheet http://innovid.com/role/CONDENSEDBALANCESHEETSParenthetical CONDENSED BALANCE SHEETS (Parenthetical) Statements 4 false false R5.htm 0000005 - Statement - CONSOLIDATED STATEMENTS OF OPERATIONS Sheet http://innovid.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS CONSOLIDATED STATEMENTS OF OPERATIONS Statements 5 false false R6.htm 0000006 - Statement - CONSOLIDATED STATEMENTS OF OPERATIONS (Parenthetical) Sheet http://innovid.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONSParenthetical CONSOLIDATED STATEMENTS OF OPERATIONS (Parenthetical) Statements 6 false false R7.htm 0000007 - Statement - STATEMENTS OF CHANGES IN TEMPORARY EQUITY AND STOCKHOLDERS??? EQUITY (DEFICIT) Sheet http://innovid.com/role/STATEMENTSOFCHANGESINTEMPORARYEQUITYANDSTOCKHOLDERSEQUITYDEFICIT STATEMENTS OF CHANGES IN TEMPORARY EQUITY AND STOCKHOLDERS??? EQUITY (DEFICIT) Statements 7 false false R8.htm 0000008 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS Sheet http://innovid.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS CONSOLIDATED STATEMENTS OF CASH FLOWS Statements 8 false false R9.htm 0000009 - Disclosure - DESCRIPTION OF BUSINESS Sheet http://innovid.com/role/DESCRIPTIONOFBUSINESS DESCRIPTION OF BUSINESS Notes 9 false false R10.htm 0000010 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Sheet http://innovid.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIES SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Notes 10 false false R11.htm 0000011 - Disclosure - TRANSACTION Sheet http://innovid.com/role/TRANSACTION TRANSACTION Notes 11 false false R12.htm 0000012 - Disclosure - ACQUISITION Sheet http://innovid.com/role/ACQUISITION ACQUISITION Notes 12 false false R13.htm 0000013 - Disclosure - INTANGIBLE ASSETS, NET Sheet http://innovid.com/role/INTANGIBLEASSETSNET INTANGIBLE ASSETS, NET Notes 13 false false R14.htm 0000014 - Disclosure - PREPAID AND OTHER CURRENT ASSETS Sheet http://innovid.com/role/PREPAIDANDOTHERCURRENTASSETS PREPAID AND OTHER CURRENT ASSETS Notes 14 false false R15.htm 0000015 - Disclosure - PROPERTY AND EQUIPMENT, NET Sheet http://innovid.com/role/PROPERTYANDEQUIPMENTNET PROPERTY AND EQUIPMENT, NET Notes 15 false false R16.htm 0000016 - Disclosure - LEASES Sheet http://innovid.com/role/LEASES LEASES Notes 16 false false R17.htm 0000017 - Disclosure - ACCRUED EXPENSES AND OTHER CURRENT LIABILITIES Sheet http://innovid.com/role/ACCRUEDEXPENSESANDOTHERCURRENTLIABILITIES ACCRUED EXPENSES AND OTHER CURRENT LIABILITIES Notes 17 false false R18.htm 0000018 - Disclosure - OTHER NON-CURRENT LIABILITIES Sheet http://innovid.com/role/OTHERNONCURRENTLIABILITIES OTHER NON-CURRENT LIABILITIES Notes 18 false false R19.htm 0000019 - Disclosure - WARRANTS Sheet http://innovid.com/role/WARRANTS WARRANTS Notes 19 false false R20.htm 0000020 - Disclosure - LONG-TERM DEBT Sheet http://innovid.com/role/LONGTERMDEBT LONG-TERM DEBT Notes 20 false false R21.htm 0000021 - Disclosure - COMMITMENTS AND CONTINGENT LIABILITIES Sheet http://innovid.com/role/COMMITMENTSANDCONTINGENTLIABILITIES COMMITMENTS AND CONTINGENT LIABILITIES Notes 21 false false R22.htm 0000022 - Disclosure - STOCKHOLDERS??? EQUITY Sheet http://innovid.com/role/STOCKHOLDERSEQUITY STOCKHOLDERS??? EQUITY Notes 22 false false R23.htm 0000023 - Disclosure - STOCK-BASED COMPENSATION Sheet http://innovid.com/role/STOCKBASEDCOMPENSATION STOCK-BASED COMPENSATION Notes 23 false false R24.htm 0000024 - Disclosure - FINANCE EXPENSES (INCOME), NET Sheet http://innovid.com/role/FINANCEEXPENSESINCOMENET FINANCE EXPENSES (INCOME), NET Notes 24 false false R25.htm 0000025 - Disclosure - INCOME TAXES Sheet http://innovid.com/role/INCOMETAXES INCOME TAXES Notes 25 false false R26.htm 0000026 - Disclosure - SEGMENT REPORTING Sheet http://innovid.com/role/SEGMENTREPORTING SEGMENT REPORTING Notes 26 false false R27.htm 0000027 - Disclosure - BASIC AND DILUTED NET LOSS PER SHARE Sheet http://innovid.com/role/BASICANDDILUTEDNETLOSSPERSHARE BASIC AND DILUTED NET LOSS PER SHARE Notes 27 false false R28.htm 0000028 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies) Sheet http://innovid.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies) Policies 28 false false R29.htm 0000029 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables) Sheet http://innovid.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESTables SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables) Tables http://innovid.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIES 29 false false R30.htm 0000030 - Disclosure - TRANSACTION (Tables) Sheet http://innovid.com/role/TRANSACTIONTables TRANSACTION (Tables) Tables http://innovid.com/role/TRANSACTION 30 false false R31.htm 0000031 - Disclosure - ACQUISITION (Tables) Sheet http://innovid.com/role/ACQUISITIONTables ACQUISITION (Tables) Tables http://innovid.com/role/ACQUISITION 31 false false R32.htm 0000032 - Disclosure - INTANGIBLE ASSETS, NET (Tables) Sheet http://innovid.com/role/INTANGIBLEASSETSNETTables INTANGIBLE ASSETS, NET (Tables) Tables http://innovid.com/role/INTANGIBLEASSETSNET 32 false false R33.htm 0000033 - Disclosure - PREPAID AND OTHER CURRENT ASSETS (Tables) Sheet http://innovid.com/role/PREPAIDANDOTHERCURRENTASSETSTables PREPAID AND OTHER CURRENT ASSETS (Tables) Tables http://innovid.com/role/PREPAIDANDOTHERCURRENTASSETS 33 false false R34.htm 0000034 - Disclosure - PROPERTY AND EQUIPMENT, NET (Tables) Sheet http://innovid.com/role/PROPERTYANDEQUIPMENTNETTables PROPERTY AND EQUIPMENT, NET (Tables) Tables http://innovid.com/role/PROPERTYANDEQUIPMENTNET 34 false false R35.htm 0000035 - Disclosure - LEASES (Tables) Sheet http://innovid.com/role/LEASESTables LEASES (Tables) Tables http://innovid.com/role/LEASES 35 false false R36.htm 0000036 - Disclosure - ACCRUED EXPENSES AND OTHER CURRENT LIABILITIES (Tables) Sheet http://innovid.com/role/ACCRUEDEXPENSESANDOTHERCURRENTLIABILITIESTables ACCRUED EXPENSES AND OTHER CURRENT LIABILITIES (Tables) Tables http://innovid.com/role/ACCRUEDEXPENSESANDOTHERCURRENTLIABILITIES 36 false false R37.htm 0000037 - Disclosure - OTHER NON-CURRENT LIABILITIES (Tables) Sheet http://innovid.com/role/OTHERNONCURRENTLIABILITIESTables OTHER NON-CURRENT LIABILITIES (Tables) Tables http://innovid.com/role/OTHERNONCURRENTLIABILITIES 37 false false R38.htm 0000038 - Disclosure - STOCKHOLDERS??? EQUITY (Tables) Sheet http://innovid.com/role/STOCKHOLDERSEQUITYTables STOCKHOLDERS??? EQUITY (Tables) Tables http://innovid.com/role/STOCKHOLDERSEQUITY 38 false false R39.htm 0000039 - Disclosure - STOCK-BASED COMPENSATION (Tables) Sheet http://innovid.com/role/STOCKBASEDCOMPENSATIONTables STOCK-BASED COMPENSATION (Tables) Tables http://innovid.com/role/STOCKBASEDCOMPENSATION 39 false false R40.htm 0000040 - Disclosure - INCOME TAXES (Tables) Sheet http://innovid.com/role/INCOMETAXESTables INCOME TAXES (Tables) Tables http://innovid.com/role/INCOMETAXES 40 false false R41.htm 0000041 - Disclosure - SEGMENT REPORTING (Tables) Sheet http://innovid.com/role/SEGMENTREPORTINGTables SEGMENT REPORTING (Tables) Tables http://innovid.com/role/SEGMENTREPORTING 41 false false R42.htm 0000042 - Disclosure - BASIC AND DILUTED NET LOSS PER SHARE (Tables) Sheet http://innovid.com/role/BASICANDDILUTEDNETLOSSPERSHARETables BASIC AND DILUTED NET LOSS PER SHARE (Tables) Tables http://innovid.com/role/BASICANDDILUTEDNETLOSSPERSHARE 42 false false R43.htm 0000043 - Disclosure - DESCRIPTION OF BUSINESS (Details) Sheet http://innovid.com/role/DESCRIPTIONOFBUSINESSDetails DESCRIPTION OF BUSINESS (Details) Details http://innovid.com/role/DESCRIPTIONOFBUSINESS 43 false false R44.htm 0000044 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Schedule of Reclassification (Details) Sheet http://innovid.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESScheduleofReclassificationDetails SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Schedule of Reclassification (Details) Details 44 false false R45.htm 0000045 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Narrative) (Details) Sheet http://innovid.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Narrative) (Details) Details http://innovid.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESTables 45 false false R46.htm 0000046 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Schedule of Property, Plant and Equipment) (Details) Sheet http://innovid.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESScheduleofPropertyPlantandEquipmentDetails SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Schedule of Property, Plant and Equipment) (Details) Details http://innovid.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESTables 46 false false R47.htm 0000047 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis) (Details) Sheet http://innovid.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESScheduleofFairValueAssetsandLiabilitiesMeasuredonRecurringBasisDetails SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis) (Details) Details http://innovid.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESTables 47 false false R48.htm 0000048 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Schedule of Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation) (Details) Sheet http://innovid.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESScheduleofFairValueLiabilitiesMeasuredonRecurringBasisUnobservableInputReconciliationDetails SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Schedule of Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation) (Details) Details http://innovid.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESTables 48 false false R49.htm 0000049 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Schedule of Warrants Follows at Initial Measurement) (Details) Sheet http://innovid.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESScheduleofWarrantsFollowsatInitialMeasurementDetails SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Schedule of Warrants Follows at Initial Measurement) (Details) Details http://innovid.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESTables 49 false false R50.htm 0000050 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Schedule of Concentration Risk) (Details) Sheet http://innovid.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESScheduleofConcentrationRiskDetails SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Schedule of Concentration Risk) (Details) Details http://innovid.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESTables 50 false false R51.htm 0000051 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Schedule of Operating Lease Liabilities and ROU Assets (Details) Sheet http://innovid.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESScheduleofOperatingLeaseLiabilitiesandROUAssetsDetails SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Schedule of Operating Lease Liabilities and ROU Assets (Details) Details 51 false false R52.htm 0000052 - Disclosure - TRANSACTION - Narrative (Details) Sheet http://innovid.com/role/TRANSACTIONNarrativeDetails TRANSACTION - Narrative (Details) Details 52 false false R53.htm 0000053 - Disclosure - TRANSACTION - Common Stock in Innovid Corp (Details) Sheet http://innovid.com/role/TRANSACTIONCommonStockinInnovidCorpDetails TRANSACTION - Common Stock in Innovid Corp (Details) Details 53 false false R54.htm 0000054 - Disclosure - TRANSACTION - Transaction to Cash Flow and Changes in Temporary Equity and Stockholders??? Equity (Details) Sheet http://innovid.com/role/TRANSACTIONTransactiontoCashFlowandChangesinTemporaryEquityandStockholdersEquityDetails TRANSACTION - Transaction to Cash Flow and Changes in Temporary Equity and Stockholders??? Equity (Details) Details 54 false false R55.htm 0000055 - Disclosure - ACQUISITION - Narrative (Details) Sheet http://innovid.com/role/ACQUISITIONNarrativeDetails ACQUISITION - Narrative (Details) Details 55 false false R56.htm 0000056 - Disclosure - ACQUISITION - Fair Values of the Assets Acquired and Liabilities Assumed (Details) Sheet http://innovid.com/role/ACQUISITIONFairValuesoftheAssetsAcquiredandLiabilitiesAssumedDetails ACQUISITION - Fair Values of the Assets Acquired and Liabilities Assumed (Details) Details 56 false false R57.htm 0000057 - Disclosure - ACQUISITION - Unaudited Pro Forma Financial Information (Details) Sheet http://innovid.com/role/ACQUISITIONUnauditedProFormaFinancialInformationDetails ACQUISITION - Unaudited Pro Forma Financial Information (Details) Details 57 false false R58.htm 0000058 - Disclosure - INTANGIBLE ASSETS, NET - Intangible Assets (Details) Sheet http://innovid.com/role/INTANGIBLEASSETSNETIntangibleAssetsDetails INTANGIBLE ASSETS, NET - Intangible Assets (Details) Details 58 false false R59.htm 0000059 - Disclosure - INTANGIBLE ASSETS, NET - Narrative (Details) Sheet http://innovid.com/role/INTANGIBLEASSETSNETNarrativeDetails INTANGIBLE ASSETS, NET - Narrative (Details) Details 59 false false R60.htm 0000060 - Disclosure - INTANGIBLE ASSETS, NET - Intangible Assets Amortization Expense (Details) Sheet http://innovid.com/role/INTANGIBLEASSETSNETIntangibleAssetsAmortizationExpenseDetails INTANGIBLE ASSETS, NET - Intangible Assets Amortization Expense (Details) Details 60 false false R61.htm 0000061 - Disclosure - PREPAID AND OTHER CURRENT ASSETS (Details) Sheet http://innovid.com/role/PREPAIDANDOTHERCURRENTASSETSDetails PREPAID AND OTHER CURRENT ASSETS (Details) Details http://innovid.com/role/PREPAIDANDOTHERCURRENTASSETSTables 61 false false R62.htm 0000062 - Disclosure - PROPERTY AND EQUIPMENT, NET (Details) Sheet http://innovid.com/role/PROPERTYANDEQUIPMENTNETDetails PROPERTY AND EQUIPMENT, NET (Details) Details http://innovid.com/role/PROPERTYANDEQUIPMENTNETTables 62 false false R63.htm 0000063 - Disclosure - LEASES (Schedule of operating ROU assets and lease liabilities) (Details) Sheet http://innovid.com/role/LEASESScheduleofoperatingROUassetsandleaseliabilitiesDetails LEASES (Schedule of operating ROU assets and lease liabilities) (Details) Details http://innovid.com/role/LEASESTables 63 false false R64.htm 0000064 - Disclosure - LEASES (Schedule of lease liability) (Details) Sheet http://innovid.com/role/LEASESScheduleofleaseliabilityDetails LEASES (Schedule of lease liability) (Details) Details http://innovid.com/role/LEASESTables 64 false false R65.htm 0000065 - Disclosure - LEASES (Schedule Of Lease Costs Recognized In The Consolidated Statement Of Earnings) (Details) Sheet http://innovid.com/role/LEASESScheduleOfLeaseCostsRecognizedInTheConsolidatedStatementOfEarningsDetails LEASES (Schedule Of Lease Costs Recognized In The Consolidated Statement Of Earnings) (Details) Details http://innovid.com/role/LEASESTables 65 false false R66.htm 0000066 - Disclosure - LEASES (Narrative) (Details) Sheet http://innovid.com/role/LEASESNarrativeDetails LEASES (Narrative) (Details) Details http://innovid.com/role/LEASESTables 66 false false R67.htm 0000067 - Disclosure - LEASE (Supplementary Cash Flow Information) (Details) Sheet http://innovid.com/role/LEASESupplementaryCashFlowInformationDetails LEASE (Supplementary Cash Flow Information) (Details) Details http://innovid.com/role/LEASESTables 67 false false R68.htm 0000068 - Disclosure - LEASES (Schedule of Operating Lease Liability Maturities) (Details) Sheet http://innovid.com/role/LEASESScheduleofOperatingLeaseLiabilityMaturitiesDetails LEASES (Schedule of Operating Lease Liability Maturities) (Details) Details http://innovid.com/role/LEASESTables 68 false false R69.htm 0000069 - Disclosure - LEASES (Schedule Of Commitments Under Non-Cancelable Operating Leases) (Details) Sheet http://innovid.com/role/LEASESScheduleOfCommitmentsUnderNonCancelableOperatingLeasesDetails LEASES (Schedule Of Commitments Under Non-Cancelable Operating Leases) (Details) Details http://innovid.com/role/LEASESTables 69 false false R70.htm 0000070 - Disclosure - ACCRUED EXPENSES AND OTHER CURRENT LIABILITIES (Details) Sheet http://innovid.com/role/ACCRUEDEXPENSESANDOTHERCURRENTLIABILITIESDetails ACCRUED EXPENSES AND OTHER CURRENT LIABILITIES (Details) Details http://innovid.com/role/ACCRUEDEXPENSESANDOTHERCURRENTLIABILITIESTables 70 false false R71.htm 0000071 - Disclosure - OTHER NON-CURRENT LIABILITIES (Details) Sheet http://innovid.com/role/OTHERNONCURRENTLIABILITIESDetails OTHER NON-CURRENT LIABILITIES (Details) Details http://innovid.com/role/OTHERNONCURRENTLIABILITIESTables 71 false false R72.htm 0000072 - Disclosure - WARRANTS (Details) Sheet http://innovid.com/role/WARRANTSDetails WARRANTS (Details) Details http://innovid.com/role/WARRANTS 72 false false R73.htm 0000073 - Disclosure - LONG-TERM DEBT (Details) Sheet http://innovid.com/role/LONGTERMDEBTDetails LONG-TERM DEBT (Details) Details http://innovid.com/role/LONGTERMDEBT 73 false false R74.htm 0000074 - Disclosure - COMMITMENTS AND CONTINGENT LIABILITIES (Details) Sheet http://innovid.com/role/COMMITMENTSANDCONTINGENTLIABILITIESDetails COMMITMENTS AND CONTINGENT LIABILITIES (Details) Details http://innovid.com/role/COMMITMENTSANDCONTINGENTLIABILITIES 74 false false R75.htm 0000075 - Disclosure - STOCKHOLDERS??? EQUITY (Common Shares Activity) (Details) Sheet http://innovid.com/role/STOCKHOLDERSEQUITYCommonSharesActivityDetails STOCKHOLDERS??? EQUITY (Common Shares Activity) (Details) Details http://innovid.com/role/STOCKHOLDERSEQUITYTables 75 false false R76.htm 0000076 - Disclosure - STOCKHOLDERS??? EQUITY (Narrative) (Details) Sheet http://innovid.com/role/STOCKHOLDERSEQUITYNarrativeDetails STOCKHOLDERS??? EQUITY (Narrative) (Details) Details http://innovid.com/role/STOCKHOLDERSEQUITYTables 76 false false R77.htm 0000077 - Disclosure - STOCK-BASED COMPENSATION (Narrative) (Details) Sheet http://innovid.com/role/STOCKBASEDCOMPENSATIONNarrativeDetails STOCK-BASED COMPENSATION (Narrative) (Details) Details http://innovid.com/role/STOCKBASEDCOMPENSATIONTables 77 false false R78.htm 0000078 - Disclosure - STOCK-BASED COMPENSATION ( Stock Option Activity Under Plan) (Details) Sheet http://innovid.com/role/STOCKBASEDCOMPENSATIONStockOptionActivityUnderPlanDetails STOCK-BASED COMPENSATION ( Stock Option Activity Under Plan) (Details) Details http://innovid.com/role/STOCKBASEDCOMPENSATIONTables 78 false false R79.htm 0000079 - Disclosure - STOCK-BASED COMPENSATION ( Stock Option Activity) (Details) Sheet http://innovid.com/role/STOCKBASEDCOMPENSATIONStockOptionActivityDetails STOCK-BASED COMPENSATION ( Stock Option Activity) (Details) Details http://innovid.com/role/STOCKBASEDCOMPENSATIONTables 79 false false R80.htm 0000080 - Disclosure - STOCK-BASED COMPENSATION ( Fair Value of Each Option on The Date of Grant) (Details) Sheet http://innovid.com/role/STOCKBASEDCOMPENSATIONFairValueofEachOptiononTheDateofGrantDetails STOCK-BASED COMPENSATION ( Fair Value of Each Option on The Date of Grant) (Details) Details http://innovid.com/role/STOCKBASEDCOMPENSATIONTables 80 false false R81.htm 0000081 - Disclosure - STOCK-BASED COMPENSATION - Restricted Stock Unit Activity (Details) Sheet http://innovid.com/role/STOCKBASEDCOMPENSATIONRestrictedStockUnitActivityDetails STOCK-BASED COMPENSATION - Restricted Stock Unit Activity (Details) Details 81 false false R82.htm 0000082 - Disclosure - FINANCE EXPENSES (INCOME), NET (Details) Sheet http://innovid.com/role/FINANCEEXPENSESINCOMENETDetails FINANCE EXPENSES (INCOME), NET (Details) Details http://innovid.com/role/FINANCEEXPENSESINCOMENET 82 false false R83.htm 0000083 - Disclosure - INCOME TAXES - Income before Income Tax, Domestic and Foreign (Details) Sheet http://innovid.com/role/INCOMETAXESIncomebeforeIncomeTaxDomesticandForeignDetails INCOME TAXES - Income before Income Tax, Domestic and Foreign (Details) Details 83 false false R84.htm 0000084 - Disclosure - INCOME TAXES - Income Tax Expense (Benefit) (Details) Sheet http://innovid.com/role/INCOMETAXESIncomeTaxExpenseBenefitDetails INCOME TAXES - Income Tax Expense (Benefit) (Details) Details 84 false false R85.htm 0000085 - Disclosure - INCOME TAXES - Effective Income Tax Rate Reconciliation (Details) Sheet http://innovid.com/role/INCOMETAXESEffectiveIncomeTaxRateReconciliationDetails INCOME TAXES - Effective Income Tax Rate Reconciliation (Details) Details 85 false false R86.htm 0000086 - Disclosure - INCOME TAXES - Deferred Tax Assets and Liabilities (Details) Sheet http://innovid.com/role/INCOMETAXESDeferredTaxAssetsandLiabilitiesDetails INCOME TAXES - Deferred Tax Assets and Liabilities (Details) Details 86 false false R87.htm 0000087 - Disclosure - INCOME TAXES - Narrative (Details) Sheet http://innovid.com/role/INCOMETAXESNarrativeDetails INCOME TAXES - Narrative (Details) Details 87 false false R88.htm 0000088 - Disclosure - INCOME TAXES - Operating Loss Carryforwards (Details) Sheet http://innovid.com/role/INCOMETAXESOperatingLossCarryforwardsDetails INCOME TAXES - Operating Loss Carryforwards (Details) Details 88 false false R89.htm 0000089 - Disclosure - INCOME TAXES - Income Tax Contingencies (Details) Sheet http://innovid.com/role/INCOMETAXESIncomeTaxContingenciesDetails INCOME TAXES - Income Tax Contingencies (Details) Details 89 false false R90.htm 0000090 - Disclosure - SEGMENT REPORTING - Narrative (Details) Sheet http://innovid.com/role/SEGMENTREPORTINGNarrativeDetails SEGMENT REPORTING - Narrative (Details) Details 90 false false R91.htm 0000091 - Disclosure - SEGMENT REPORTING (Revenue and Property and Equipment, by Geographical Areas) (Details) Sheet http://innovid.com/role/SEGMENTREPORTINGRevenueandPropertyandEquipmentbyGeographicalAreasDetails SEGMENT REPORTING (Revenue and Property and Equipment, by Geographical Areas) (Details) Details http://innovid.com/role/SEGMENTREPORTINGTables 91 false false R92.htm 0000092 - Disclosure - BASIC AND DILUTED NET LOSS PER SHARE (Basic and Diluted Net loss Per Share) (Details) Sheet http://innovid.com/role/BASICANDDILUTEDNETLOSSPERSHAREBasicandDilutedNetlossPerShareDetails BASIC AND DILUTED NET LOSS PER SHARE (Basic and Diluted Net loss Per Share) (Details) Details http://innovid.com/role/BASICANDDILUTEDNETLOSSPERSHARETables 92 false false R93.htm 0000093 - Disclosure - BASIC AND DILUTED NET LOSS PER SHARE (Narrative) (Details) Sheet http://innovid.com/role/BASICANDDILUTEDNETLOSSPERSHARENarrativeDetails BASIC AND DILUTED NET LOSS PER SHARE (Narrative) (Details) Details http://innovid.com/role/BASICANDDILUTEDNETLOSSPERSHARETables 93 false false R94.htm 0000094 - Disclosure - BASIC AND DILUTED NET LOSS PER SHARE (Securities Excluded from Computation of Earnings Per Share) (Details) Sheet http://innovid.com/role/BASICANDDILUTEDNETLOSSPERSHARESecuritiesExcludedfromComputationofEarningsPerShareDetails BASIC AND DILUTED NET LOSS PER SHARE (Securities Excluded from Computation of Earnings Per Share) (Details) Details http://innovid.com/role/BASICANDDILUTEDNETLOSSPERSHARETables 94 false false All Reports Book All Reports [ix-0514-Hidden-Fact-Eligible-For-Transform] WARN: 1 fact(s) appearing in ix:hidden were eligible for transformation: us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1 - ctv-20221231.htm 4 ctv-20221231.htm a1017innovidcorpformofstoc.htm a1018innovidcorpformofrest.htm a1019executiveseveranceplan.htm a1020executivechangeinctrl.htm a211listofsubsidiariesofth.htm a231consentofernstyoungglo.htm a311certificationofceosect.htm a312certificationofcfosect.htm a321certificationofceo18us.htm a322certificationofcfo18us.htm ctv-20221231.xsd ctv-20221231_cal.xml ctv-20221231_def.xml ctv-20221231_lab.xml ctv-20221231_pre.xml ctv-20221231_g1.jpg http://fasb.org/srt/2022 http://fasb.org/us-gaap/2022 http://xbrl.sec.gov/dei/2022 true true JSON 119 MetaLinks.json IDEA: XBRL DOCUMENT { "instance": { "ctv-20221231.htm": { "axisCustom": 0, "axisStandard": 37, "baseTaxonomies": { "http://fasb.org/srt/2022": 1, "http://fasb.org/us-gaap/2022": 975, "http://xbrl.sec.gov/dei/2022": 42 }, "contextCount": 238, "dts": { "calculationLink": { "local": [ "ctv-20221231_cal.xml" ] }, "definitionLink": { "local": [ "ctv-20221231_def.xml" ] }, "inline": { "local": [ "ctv-20221231.htm" ] }, "labelLink": { "local": [ "ctv-20221231_lab.xml" ] }, "presentationLink": { "local": [ "ctv-20221231_pre.xml" ] }, "schema": { "local": [ "ctv-20221231.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd", "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd", "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd", "https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd", "https://xbrl.fasb.org/srt/2022/elts/srt-roles-2022.xsd", "https://xbrl.fasb.org/srt/2022/elts/srt-types-2022.xsd", "https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd", "https://xbrl.fasb.org/us-gaap/2022/elts/us-roles-2022.xsd", "https://xbrl.fasb.org/us-gaap/2022/elts/us-types-2022.xsd", "https://xbrl.sec.gov/country/2022/country-2022.xsd", "https://xbrl.sec.gov/dei/2022/dei-2022.xsd" ] } }, "elementCount": 733, "entityCount": 1, "hidden": { "http://fasb.org/us-gaap/2022": 5, "http://xbrl.sec.gov/dei/2022": 4, "total": 9 }, "keyCustom": 91, "keyStandard": 388, "memberCustom": 29, "memberStandard": 51, "nsprefix": "ctv", "nsuri": "http://innovid.com/20221231", "report": { "R1": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "ctv-20221231.htm", "contextRef": "i6c9150567ae44c3cb706b8fe5d71914b_D20220101-20221231", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "document", "isDefault": "true", "longName": "0000001 - Document - Cover Page", "menuCat": "Cover", "order": "1", "role": "http://innovid.com/role/CoverPage", "shortName": "Cover Page", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "ctv-20221231.htm", "contextRef": "i6c9150567ae44c3cb706b8fe5d71914b_D20220101-20221231", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R10": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "ctv-20221231.htm", "contextRef": "i6c9150567ae44c3cb706b8fe5d71914b_D20220101-20221231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SignificantAccountingPoliciesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000010 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES", "menuCat": "Notes", "order": "10", "role": "http://innovid.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIES", "shortName": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "ctv-20221231.htm", "contextRef": "i6c9150567ae44c3cb706b8fe5d71914b_D20220101-20221231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SignificantAccountingPoliciesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R11": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "ctv-20221231.htm", "contextRef": "i6c9150567ae44c3cb706b8fe5d71914b_D20220101-20221231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:MergersAcquisitionsAndDispositionsDisclosuresTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000011 - Disclosure - TRANSACTION", "menuCat": "Notes", "order": "11", "role": "http://innovid.com/role/TRANSACTION", "shortName": "TRANSACTION", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "ctv-20221231.htm", "contextRef": "i6c9150567ae44c3cb706b8fe5d71914b_D20220101-20221231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:MergersAcquisitionsAndDispositionsDisclosuresTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R12": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "ctv-20221231.htm", "contextRef": "i6c9150567ae44c3cb706b8fe5d71914b_D20220101-20221231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:BusinessCombinationDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000012 - Disclosure - ACQUISITION", "menuCat": "Notes", "order": "12", "role": "http://innovid.com/role/ACQUISITION", "shortName": "ACQUISITION", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "ctv-20221231.htm", "contextRef": "i6c9150567ae44c3cb706b8fe5d71914b_D20220101-20221231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:BusinessCombinationDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R13": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "ctv-20221231.htm", "contextRef": "i6c9150567ae44c3cb706b8fe5d71914b_D20220101-20221231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:IntangibleAssetsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000013 - Disclosure - INTANGIBLE ASSETS, NET", "menuCat": "Notes", "order": "13", "role": "http://innovid.com/role/INTANGIBLEASSETSNET", "shortName": "INTANGIBLE ASSETS, NET", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "ctv-20221231.htm", "contextRef": "i6c9150567ae44c3cb706b8fe5d71914b_D20220101-20221231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:IntangibleAssetsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R14": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "ctv-20221231.htm", "contextRef": "i6c9150567ae44c3cb706b8fe5d71914b_D20220101-20221231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:OtherAssetsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000014 - Disclosure - PREPAID AND OTHER CURRENT ASSETS", "menuCat": "Notes", "order": "14", "role": "http://innovid.com/role/PREPAIDANDOTHERCURRENTASSETS", "shortName": "PREPAID AND OTHER CURRENT ASSETS", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "ctv-20221231.htm", "contextRef": "i6c9150567ae44c3cb706b8fe5d71914b_D20220101-20221231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:OtherAssetsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R15": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "ctv-20221231.htm", "contextRef": "i6c9150567ae44c3cb706b8fe5d71914b_D20220101-20221231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000015 - Disclosure - PROPERTY AND EQUIPMENT, NET", "menuCat": "Notes", "order": "15", "role": "http://innovid.com/role/PROPERTYANDEQUIPMENTNET", "shortName": "PROPERTY AND EQUIPMENT, NET", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "ctv-20221231.htm", "contextRef": "i6c9150567ae44c3cb706b8fe5d71914b_D20220101-20221231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R16": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "ctv-20221231.htm", "contextRef": "i6c9150567ae44c3cb706b8fe5d71914b_D20220101-20221231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:LesseeOperatingLeasesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000016 - Disclosure - LEASES", "menuCat": "Notes", "order": "16", "role": "http://innovid.com/role/LEASES", "shortName": "LEASES", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "ctv-20221231.htm", "contextRef": "i6c9150567ae44c3cb706b8fe5d71914b_D20220101-20221231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:LesseeOperatingLeasesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R17": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "ctv-20221231.htm", "contextRef": "i6c9150567ae44c3cb706b8fe5d71914b_D20220101-20221231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000017 - Disclosure - ACCRUED EXPENSES AND OTHER CURRENT LIABILITIES", "menuCat": "Notes", "order": "17", "role": "http://innovid.com/role/ACCRUEDEXPENSESANDOTHERCURRENTLIABILITIES", "shortName": "ACCRUED EXPENSES AND OTHER CURRENT LIABILITIES", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "ctv-20221231.htm", "contextRef": "i6c9150567ae44c3cb706b8fe5d71914b_D20220101-20221231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R18": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "ctv-20221231.htm", "contextRef": "i6c9150567ae44c3cb706b8fe5d71914b_D20220101-20221231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:OtherLiabilitiesDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000018 - Disclosure - OTHER NON-CURRENT LIABILITIES", "menuCat": "Notes", "order": "18", "role": "http://innovid.com/role/OTHERNONCURRENTLIABILITIES", "shortName": "OTHER NON-CURRENT LIABILITIES", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "ctv-20221231.htm", "contextRef": "i6c9150567ae44c3cb706b8fe5d71914b_D20220101-20221231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:OtherLiabilitiesDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R19": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "ctv-20221231.htm", "contextRef": "i6c9150567ae44c3cb706b8fe5d71914b_D20220101-20221231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000019 - Disclosure - WARRANTS", "menuCat": "Notes", "order": "19", "role": "http://innovid.com/role/WARRANTS", "shortName": "WARRANTS", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "ctv-20221231.htm", "contextRef": "i6c9150567ae44c3cb706b8fe5d71914b_D20220101-20221231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R2": { "firstAnchor": { "ancestors": [ "span", "div", "td", "tr", "table", "div", "body", "html" ], "baseRef": "ctv-20221231.htm", "contextRef": "i6c9150567ae44c3cb706b8fe5d71914b_D20220101-20221231", "decimals": null, "first": true, "lang": "en-US", "name": "dei:AuditorFirmId", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "document", "isDefault": "false", "longName": "0000002 - Document - Audit Information", "menuCat": "Cover", "order": "2", "role": "http://innovid.com/role/AuditInformation", "shortName": "Audit Information", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "td", "tr", "table", "div", "body", "html" ], "baseRef": "ctv-20221231.htm", "contextRef": "i6c9150567ae44c3cb706b8fe5d71914b_D20220101-20221231", "decimals": null, "first": true, "lang": "en-US", "name": "dei:AuditorFirmId", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R20": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "ctv-20221231.htm", "contextRef": "i6c9150567ae44c3cb706b8fe5d71914b_D20220101-20221231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DebtDisclosureTextBlock", "reportCount": 1, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000020 - Disclosure - LONG-TERM DEBT", "menuCat": "Notes", "order": "20", "role": "http://innovid.com/role/LONGTERMDEBT", "shortName": "LONG-TERM DEBT", "subGroupType": "", "uniqueAnchor": null }, "R21": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "ctv-20221231.htm", "contextRef": "i6c9150567ae44c3cb706b8fe5d71914b_D20220101-20221231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000021 - Disclosure - COMMITMENTS AND CONTINGENT LIABILITIES", "menuCat": "Notes", "order": "21", "role": "http://innovid.com/role/COMMITMENTSANDCONTINGENTLIABILITIES", "shortName": "COMMITMENTS AND CONTINGENT LIABILITIES", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "ctv-20221231.htm", "contextRef": "i6c9150567ae44c3cb706b8fe5d71914b_D20220101-20221231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R22": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "ctv-20221231.htm", "contextRef": "i6c9150567ae44c3cb706b8fe5d71914b_D20220101-20221231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000022 - Disclosure - STOCKHOLDERS\u2019 EQUITY", "menuCat": "Notes", "order": "22", "role": "http://innovid.com/role/STOCKHOLDERSEQUITY", "shortName": "STOCKHOLDERS\u2019 EQUITY", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "ctv-20221231.htm", "contextRef": "i6c9150567ae44c3cb706b8fe5d71914b_D20220101-20221231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R23": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "ctv-20221231.htm", "contextRef": "i6c9150567ae44c3cb706b8fe5d71914b_D20220101-20221231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000023 - Disclosure - STOCK-BASED COMPENSATION", "menuCat": "Notes", "order": "23", "role": "http://innovid.com/role/STOCKBASEDCOMPENSATION", "shortName": "STOCK-BASED COMPENSATION", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "ctv-20221231.htm", "contextRef": "i6c9150567ae44c3cb706b8fe5d71914b_D20220101-20221231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R24": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "ctv-20221231.htm", "contextRef": "i6c9150567ae44c3cb706b8fe5d71914b_D20220101-20221231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DebtDisclosureTextBlock", "reportCount": 1, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000024 - Disclosure - FINANCE EXPENSES (INCOME), NET", "menuCat": "Notes", "order": "24", "role": "http://innovid.com/role/FINANCEEXPENSESINCOMENET", "shortName": "FINANCE EXPENSES (INCOME), NET", "subGroupType": "", "uniqueAnchor": null }, "R25": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "ctv-20221231.htm", "contextRef": "i6c9150567ae44c3cb706b8fe5d71914b_D20220101-20221231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:IncomeTaxDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000025 - Disclosure - INCOME TAXES", "menuCat": "Notes", "order": "25", "role": "http://innovid.com/role/INCOMETAXES", "shortName": "INCOME TAXES", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "ctv-20221231.htm", "contextRef": "i6c9150567ae44c3cb706b8fe5d71914b_D20220101-20221231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:IncomeTaxDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R26": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "ctv-20221231.htm", "contextRef": "i6c9150567ae44c3cb706b8fe5d71914b_D20220101-20221231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SegmentReportingDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000026 - Disclosure - SEGMENT REPORTING", "menuCat": "Notes", "order": "26", "role": "http://innovid.com/role/SEGMENTREPORTING", "shortName": "SEGMENT REPORTING", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "ctv-20221231.htm", "contextRef": "i6c9150567ae44c3cb706b8fe5d71914b_D20220101-20221231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SegmentReportingDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R27": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "ctv-20221231.htm", "contextRef": "i6c9150567ae44c3cb706b8fe5d71914b_D20220101-20221231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:EarningsPerShareTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000027 - Disclosure - BASIC AND DILUTED NET LOSS PER SHARE", "menuCat": "Notes", "order": "27", "role": "http://innovid.com/role/BASICANDDILUTEDNETLOSSPERSHARE", "shortName": "BASIC AND DILUTED NET LOSS PER SHARE", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "ctv-20221231.htm", "contextRef": "i6c9150567ae44c3cb706b8fe5d71914b_D20220101-20221231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:EarningsPerShareTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R28": { "firstAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "ctv-20221231.htm", "contextRef": "i6c9150567ae44c3cb706b8fe5d71914b_D20220101-20221231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000028 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)", "menuCat": "Policies", "order": "28", "role": "http://innovid.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies", "shortName": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)", "subGroupType": "policies", "uniqueAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "ctv-20221231.htm", "contextRef": "i6c9150567ae44c3cb706b8fe5d71914b_D20220101-20221231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R29": { "firstAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "ctv-20221231.htm", "contextRef": "i6c9150567ae44c3cb706b8fe5d71914b_D20220101-20221231", "decimals": null, "first": true, "lang": "en-US", "name": "srt:ScheduleOfCondensedIncomeStatementTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000029 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)", "menuCat": "Tables", "order": "29", "role": "http://innovid.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESTables", "shortName": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "ctv-20221231.htm", "contextRef": "i6c9150567ae44c3cb706b8fe5d71914b_D20220101-20221231", "decimals": null, "first": true, "lang": "en-US", "name": "srt:ScheduleOfCondensedIncomeStatementTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R3": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "ctv-20221231.htm", "contextRef": "i9bcf2d0b1c9541269938d4b1df1554c7_I20221231", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "0000003 - Statement - CONSOLIDATED BALANCE SHEETS", "menuCat": "Statements", "order": "3", "role": "http://innovid.com/role/CONSOLIDATEDBALANCESHEETS", "shortName": "CONSOLIDATED BALANCE SHEETS", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "ctv-20221231.htm", "contextRef": "i9bcf2d0b1c9541269938d4b1df1554c7_I20221231", "decimals": "-3", "lang": "en-US", "name": "us-gaap:AccountsReceivableNetCurrent", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R30": { "firstAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "ctv-20221231.htm", "contextRef": "i6c9150567ae44c3cb706b8fe5d71914b_D20220101-20221231", "decimals": null, "first": true, "lang": "en-US", "name": "ctv:ScheduleOfReverseRecapitalizationTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000030 - Disclosure - TRANSACTION (Tables)", "menuCat": "Tables", "order": "30", "role": "http://innovid.com/role/TRANSACTIONTables", "shortName": "TRANSACTION (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "ctv-20221231.htm", "contextRef": "i6c9150567ae44c3cb706b8fe5d71914b_D20220101-20221231", "decimals": null, "first": true, "lang": "en-US", "name": "ctv:ScheduleOfReverseRecapitalizationTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R31": { "firstAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "ctv-20221231.htm", "contextRef": "i6c9150567ae44c3cb706b8fe5d71914b_D20220101-20221231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000031 - Disclosure - ACQUISITION (Tables)", "menuCat": "Tables", "order": "31", "role": "http://innovid.com/role/ACQUISITIONTables", "shortName": "ACQUISITION (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "ctv-20221231.htm", "contextRef": "i6c9150567ae44c3cb706b8fe5d71914b_D20220101-20221231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R32": { "firstAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "ctv-20221231.htm", "contextRef": "i6c9150567ae44c3cb706b8fe5d71914b_D20220101-20221231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000032 - Disclosure - INTANGIBLE ASSETS, NET (Tables)", "menuCat": "Tables", "order": "32", "role": "http://innovid.com/role/INTANGIBLEASSETSNETTables", "shortName": "INTANGIBLE ASSETS, NET (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "ctv-20221231.htm", "contextRef": "i6c9150567ae44c3cb706b8fe5d71914b_D20220101-20221231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R33": { "firstAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "ctv-20221231.htm", "contextRef": "i6c9150567ae44c3cb706b8fe5d71914b_D20220101-20221231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000033 - Disclosure - PREPAID AND OTHER CURRENT ASSETS (Tables)", "menuCat": "Tables", "order": "33", "role": "http://innovid.com/role/PREPAIDANDOTHERCURRENTASSETSTables", "shortName": "PREPAID AND OTHER CURRENT ASSETS (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "ctv-20221231.htm", "contextRef": "i6c9150567ae44c3cb706b8fe5d71914b_D20220101-20221231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R34": { "firstAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "ctv-20221231.htm", "contextRef": "i6c9150567ae44c3cb706b8fe5d71914b_D20220101-20221231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:PropertyPlantAndEquipmentTextBlock", "reportCount": 1, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000034 - Disclosure - PROPERTY AND EQUIPMENT, NET (Tables)", "menuCat": "Tables", "order": "34", "role": "http://innovid.com/role/PROPERTYANDEQUIPMENTNETTables", "shortName": "PROPERTY AND EQUIPMENT, NET (Tables)", "subGroupType": "tables", "uniqueAnchor": null }, "R35": { "firstAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "ctv-20221231.htm", "contextRef": "i6c9150567ae44c3cb706b8fe5d71914b_D20220101-20221231", "decimals": null, "first": true, "lang": "en-US", "name": "ctv:AssetsAndLiabilitiesLesseeTableTextBlockTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000035 - Disclosure - LEASES (Tables)", "menuCat": "Tables", "order": "35", "role": "http://innovid.com/role/LEASESTables", "shortName": "LEASES (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "ctv-20221231.htm", "contextRef": "i6c9150567ae44c3cb706b8fe5d71914b_D20220101-20221231", "decimals": null, "first": true, "lang": "en-US", "name": "ctv:AssetsAndLiabilitiesLesseeTableTextBlockTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R36": { "firstAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "ctv-20221231.htm", "contextRef": "i6c9150567ae44c3cb706b8fe5d71914b_D20220101-20221231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000036 - Disclosure - ACCRUED EXPENSES AND OTHER CURRENT LIABILITIES (Tables)", "menuCat": "Tables", "order": "36", "role": "http://innovid.com/role/ACCRUEDEXPENSESANDOTHERCURRENTLIABILITIESTables", "shortName": "ACCRUED EXPENSES AND OTHER CURRENT LIABILITIES (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "ctv-20221231.htm", "contextRef": "i6c9150567ae44c3cb706b8fe5d71914b_D20220101-20221231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R37": { "firstAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "ctv-20221231.htm", "contextRef": "i6c9150567ae44c3cb706b8fe5d71914b_D20220101-20221231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:OtherNoncurrentLiabilitiesTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000037 - Disclosure - OTHER NON-CURRENT LIABILITIES (Tables)", "menuCat": "Tables", "order": "37", "role": "http://innovid.com/role/OTHERNONCURRENTLIABILITIESTables", "shortName": "OTHER NON-CURRENT LIABILITIES (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "ctv-20221231.htm", "contextRef": "i6c9150567ae44c3cb706b8fe5d71914b_D20220101-20221231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:OtherNoncurrentLiabilitiesTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R38": { "firstAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "ctv-20221231.htm", "contextRef": "i6c9150567ae44c3cb706b8fe5d71914b_D20220101-20221231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfStockholdersEquityTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000038 - Disclosure - STOCKHOLDERS\u2019 EQUITY (Tables)", "menuCat": "Tables", "order": "38", "role": "http://innovid.com/role/STOCKHOLDERSEQUITYTables", "shortName": "STOCKHOLDERS\u2019 EQUITY (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "ctv-20221231.htm", "contextRef": "i6c9150567ae44c3cb706b8fe5d71914b_D20220101-20221231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfStockholdersEquityTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R39": { "firstAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "ctv-20221231.htm", "contextRef": "i6c9150567ae44c3cb706b8fe5d71914b_D20220101-20221231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000039 - Disclosure - STOCK-BASED COMPENSATION (Tables)", "menuCat": "Tables", "order": "39", "role": "http://innovid.com/role/STOCKBASEDCOMPENSATIONTables", "shortName": "STOCK-BASED COMPENSATION (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "ctv-20221231.htm", "contextRef": "i6c9150567ae44c3cb706b8fe5d71914b_D20220101-20221231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R4": { "firstAnchor": { "ancestors": [ "span", "div", "td", "tr", "table", "div", "body", "html" ], "baseRef": "ctv-20221231.htm", "contextRef": "i9bcf2d0b1c9541269938d4b1df1554c7_I20221231", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "0000004 - Statement - CONDENSED BALANCE SHEETS (Parenthetical)", "menuCat": "Statements", "order": "4", "role": "http://innovid.com/role/CONDENSEDBALANCESHEETSParenthetical", "shortName": "CONDENSED BALANCE SHEETS (Parenthetical)", "subGroupType": "parenthetical", "uniqueAnchor": { "ancestors": [ "span", "div", "td", "tr", "table", "div", "body", "html" ], "baseRef": "ctv-20221231.htm", "contextRef": "i9bcf2d0b1c9541269938d4b1df1554c7_I20221231", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R40": { "firstAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "ctv-20221231.htm", "contextRef": "i6c9150567ae44c3cb706b8fe5d71914b_D20220101-20221231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000040 - Disclosure - INCOME TAXES (Tables)", "menuCat": "Tables", "order": "40", "role": "http://innovid.com/role/INCOMETAXESTables", "shortName": "INCOME TAXES (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "ctv-20221231.htm", "contextRef": "i6c9150567ae44c3cb706b8fe5d71914b_D20220101-20221231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R41": { "firstAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "ctv-20221231.htm", "contextRef": "i6c9150567ae44c3cb706b8fe5d71914b_D20220101-20221231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000041 - Disclosure - SEGMENT REPORTING (Tables)", "menuCat": "Tables", "order": "41", "role": "http://innovid.com/role/SEGMENTREPORTINGTables", "shortName": "SEGMENT REPORTING (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "ctv-20221231.htm", "contextRef": "i6c9150567ae44c3cb706b8fe5d71914b_D20220101-20221231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R42": { "firstAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "ctv-20221231.htm", "contextRef": "i6c9150567ae44c3cb706b8fe5d71914b_D20220101-20221231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000042 - Disclosure - BASIC AND DILUTED NET LOSS PER SHARE (Tables)", "menuCat": "Tables", "order": "42", "role": "http://innovid.com/role/BASICANDDILUTEDNETLOSSPERSHARETables", "shortName": "BASIC AND DILUTED NET LOSS PER SHARE (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "ctv-20221231.htm", "contextRef": "i6c9150567ae44c3cb706b8fe5d71914b_D20220101-20221231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R43": { "firstAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "ctv-20221231.htm", "contextRef": "if420e379b5e3409382acc3ccec7a85b7_D20210101-20211130", "decimals": "-3", "first": true, "lang": "en-US", "name": "ctv:TemporaryEquitySecondarySaleAmount", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000043 - Disclosure - DESCRIPTION OF BUSINESS (Details)", "menuCat": "Details", "order": "43", "role": "http://innovid.com/role/DESCRIPTIONOFBUSINESSDetails", "shortName": "DESCRIPTION OF BUSINESS (Details)", "subGroupType": "details", "uniqueAnchor": null }, "R44": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "ctv-20221231.htm", "contextRef": "i6c9150567ae44c3cb706b8fe5d71914b_D20220101-20221231", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:CostOfRevenue", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000044 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Schedule of Reclassification (Details)", "menuCat": "Details", "order": "44", "role": "http://innovid.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESScheduleofReclassificationDetails", "shortName": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Schedule of Reclassification (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "ix:continuation", "div", "ix:continuation", "body", "html" ], "baseRef": "ctv-20221231.htm", "contextRef": "i6c9150567ae44c3cb706b8fe5d71914b_D20220101-20221231", "decimals": "-3", "lang": "en-US", "name": "us-gaap:DepreciationAndAmortization", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R45": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "ctv-20221231.htm", "contextRef": "i9bcf2d0b1c9541269938d4b1df1554c7_I20221231", "decimals": "-3", "first": true, "lang": "en-US", "name": "ctv:ShortTermBankDepositCurrent", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000045 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Narrative) (Details)", "menuCat": "Details", "order": "45", "role": "http://innovid.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails", "shortName": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Narrative) (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "ctv-20221231.htm", "contextRef": "i9bcf2d0b1c9541269938d4b1df1554c7_I20221231", "decimals": "INF", "lang": "en-US", "name": "us-gaap:WeightedAverageInterestRateOfTimeDeposits100000OrMoreThreeMonthsOrLess", "reportCount": 1, "unique": true, "unitRef": "number", "xsiNil": "false" } }, "R46": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "ix:continuation", "div", "ix:continuation", "body", "html" ], "baseRef": "ctv-20221231.htm", "contextRef": "i82ec502dd3614c6f94354d269bd72719_D20220101-20221231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:PropertyPlantAndEquipmentUsefulLife", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000046 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Schedule of Property, Plant and Equipment) (Details)", "menuCat": "Details", "order": "46", "role": "http://innovid.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESScheduleofPropertyPlantandEquipmentDetails", "shortName": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Schedule of Property, Plant and Equipment) (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "ix:continuation", "div", "ix:continuation", "body", "html" ], "baseRef": "ctv-20221231.htm", "contextRef": "i82ec502dd3614c6f94354d269bd72719_D20220101-20221231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:PropertyPlantAndEquipmentUsefulLife", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R47": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "ctv-20221231.htm", "contextRef": "ia5ac017f317d482ea26aa22388aa2079_I20221231", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:CashAndCashEquivalentsFairValueDisclosure", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000047 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis) (Details)", "menuCat": "Details", "order": "47", "role": "http://innovid.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESScheduleofFairValueAssetsandLiabilitiesMeasuredonRecurringBasisDetails", "shortName": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis) (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "ctv-20221231.htm", "contextRef": "ia5ac017f317d482ea26aa22388aa2079_I20221231", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:CashAndCashEquivalentsFairValueDisclosure", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R48": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock", "ix:continuation", "body", "html" ], "baseRef": "ctv-20221231.htm", "contextRef": "i927b64486a644a5fa49e0c0ee9b8f701_I20211231", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000048 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Schedule of Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation) (Details)", "menuCat": "Details", "order": "48", "role": "http://innovid.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESScheduleofFairValueLiabilitiesMeasuredonRecurringBasisUnobservableInputReconciliationDetails", "shortName": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Schedule of Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation) (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock", "ix:continuation", "body", "html" ], "baseRef": "ctv-20221231.htm", "contextRef": "ide5cb79f1de743b1a861acf61bc0a1dc_I20201231", "decimals": "-3", "lang": "en-US", "name": "us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R49": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "ctv-20221231.htm", "contextRef": "i6c9150567ae44c3cb706b8fe5d71914b_D20220101-20221231", "decimals": "0", "first": true, "lang": "en-US", "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate", "reportCount": 1, "unitRef": "number", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000049 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Schedule of Warrants Follows at Initial Measurement) (Details)", "menuCat": "Details", "order": "49", "role": "http://innovid.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESScheduleofWarrantsFollowsatInitialMeasurementDetails", "shortName": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Schedule of Warrants Follows at Initial Measurement) (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "ctv-20221231.htm", "contextRef": "i34a150325e5c4fe6891e90e6081bb3d4_D20220101-20221231", "decimals": "INF", "lang": "en-US", "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate", "reportCount": 1, "unique": true, "unitRef": "number", "xsiNil": "false" } }, "R5": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "ctv-20221231.htm", "contextRef": "i6c9150567ae44c3cb706b8fe5d71914b_D20220101-20221231", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "0000005 - Statement - CONSOLIDATED STATEMENTS OF OPERATIONS", "menuCat": "Statements", "order": "5", "role": "http://innovid.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS", "shortName": "CONSOLIDATED STATEMENTS OF OPERATIONS", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "ctv-20221231.htm", "contextRef": "i6c9150567ae44c3cb706b8fe5d71914b_D20220101-20221231", "decimals": "-3", "lang": "en-US", "name": "us-gaap:OperatingIncomeLoss", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R50": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:SchedulesOfConcentrationOfRiskByRiskFactorTextBlock", "ix:continuation", "body", "html" ], "baseRef": "ctv-20221231.htm", "contextRef": "ie4e9acc1afbf4efba330ca913eee3596_D20220101-20221231", "decimals": "2", "first": true, "lang": "en-US", "name": "us-gaap:ConcentrationRiskPercentage1", "reportCount": 1, "unique": true, "unitRef": "number", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000050 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Schedule of Concentration Risk) (Details)", "menuCat": "Details", "order": "50", "role": "http://innovid.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESScheduleofConcentrationRiskDetails", "shortName": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Schedule of Concentration Risk) (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:SchedulesOfConcentrationOfRiskByRiskFactorTextBlock", "ix:continuation", "body", "html" ], "baseRef": "ctv-20221231.htm", "contextRef": "ie4e9acc1afbf4efba330ca913eee3596_D20220101-20221231", "decimals": "2", "first": true, "lang": "en-US", "name": "us-gaap:ConcentrationRiskPercentage1", "reportCount": 1, "unique": true, "unitRef": "number", "xsiNil": "false" } }, "R51": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "ctv-20221231.htm", "contextRef": "i9bcf2d0b1c9541269938d4b1df1554c7_I20221231", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:OperatingLeaseRightOfUseAsset", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000051 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Schedule of Operating Lease Liabilities and ROU Assets (Details)", "menuCat": "Details", "order": "51", "role": "http://innovid.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESScheduleofOperatingLeaseLiabilitiesandROUAssetsDetails", "shortName": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Schedule of Operating Lease Liabilities and ROU Assets (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "ctv:AssetsAndLiabilitiesLesseeTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "ctv-20221231.htm", "contextRef": "ie86ac71661b745d5a754aec6b121cec8_I20220101", "decimals": "-3", "lang": "en-US", "name": "us-gaap:OperatingLeaseRightOfUseAsset", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R52": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "ctv-20221231.htm", "contextRef": "i9bcf2d0b1c9541269938d4b1df1554c7_I20221231", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:Goodwill", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000052 - Disclosure - TRANSACTION - Narrative (Details)", "menuCat": "Details", "order": "52", "role": "http://innovid.com/role/TRANSACTIONNarrativeDetails", "shortName": "TRANSACTION - Narrative (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "ix:continuation", "div", "body", "html" ], "baseRef": "ctv-20221231.htm", "contextRef": "i2e77c37184854259a8bd5117e0476e8b_I20211130", "decimals": "INF", "lang": "en-US", "name": "us-gaap:SaleOfStockPricePerShare", "reportCount": 1, "unique": true, "unitRef": "usdPerShare", "xsiNil": "false" } }, "R53": { "firstAnchor": { "ancestors": [ "us-gaap:CommonStockSharesIssued", "span", "div", "td", "tr", "table", "div", "body", "html" ], "baseRef": "ctv-20221231.htm", "contextRef": "i9bcf2d0b1c9541269938d4b1df1554c7_I20221231", "decimals": "INF", "first": true, "lang": "en-US", "name": "us-gaap:CommonStockSharesOutstanding", "reportCount": 1, "unitRef": "shares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000053 - Disclosure - TRANSACTION - Common Stock in Innovid Corp (Details)", "menuCat": "Details", "order": "53", "role": "http://innovid.com/role/TRANSACTIONCommonStockinInnovidCorpDetails", "shortName": "TRANSACTION - Common Stock in Innovid Corp (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "ctv:ScheduleOfReverseRecapitalizationTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "ctv-20221231.htm", "contextRef": "i3f306cbac56441d2a8c2a980048d7171_D20211130-20211130", "decimals": "INF", "lang": "en-US", "name": "ctv:StockIssuedDuringPeriodSharesWarrantExercised", "reportCount": 1, "unique": true, "unitRef": "shares", "xsiNil": "false" } }, "R54": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "ix:continuation", "ix:continuation", "body", "html" ], "baseRef": "ctv-20221231.htm", "contextRef": "i51e9f0e2d4e548ad828fb6d7cdaa6c27_D20210101-20211231", "decimals": "-3", "first": true, "lang": "en-US", "name": "ctv:PaymentsOfReverseRecapitalizationTransactionCosts", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000054 - Disclosure - TRANSACTION - Transaction to Cash Flow and Changes in Temporary Equity and Stockholders\u2019 Equity (Details)", "menuCat": "Details", "order": "54", "role": "http://innovid.com/role/TRANSACTIONTransactiontoCashFlowandChangesinTemporaryEquityandStockholdersEquityDetails", "shortName": "TRANSACTION - Transaction to Cash Flow and Changes in Temporary Equity and Stockholders\u2019 Equity (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "ix:continuation", "ix:continuation", "body", "html" ], "baseRef": "ctv-20221231.htm", "contextRef": "i51e9f0e2d4e548ad828fb6d7cdaa6c27_D20210101-20211231", "decimals": "-3", "first": true, "lang": "en-US", "name": "ctv:PaymentsOfReverseRecapitalizationTransactionCosts", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R55": { "firstAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "ctv-20221231.htm", "contextRef": "i6c9150567ae44c3cb706b8fe5d71914b_D20220101-20221231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife", "reportCount": 1, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000055 - Disclosure - ACQUISITION - Narrative (Details)", "menuCat": "Details", "order": "55", "role": "http://innovid.com/role/ACQUISITIONNarrativeDetails", "shortName": "ACQUISITION - Narrative (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "ctv-20221231.htm", "contextRef": "ia8bcc51b63854c198f885a496f058207_D20220228-20220228", "decimals": "-3", "lang": "en-US", "name": "ctv:BusinessCombinationPostClosingCompensationExpense", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R56": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "ctv-20221231.htm", "contextRef": "i9bcf2d0b1c9541269938d4b1df1554c7_I20221231", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:Goodwill", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000056 - Disclosure - ACQUISITION - Fair Values of the Assets Acquired and Liabilities Assumed (Details)", "menuCat": "Details", "order": "56", "role": "http://innovid.com/role/ACQUISITIONFairValuesoftheAssetsAcquiredandLiabilitiesAssumedDetails", "shortName": "ACQUISITION - Fair Values of the Assets Acquired and Liabilities Assumed (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "ctv-20221231.htm", "contextRef": "i7a17187b41714494ab79aae9772f41cc_I20220228", "decimals": "-3", "lang": "en-US", "name": "us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R57": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "us-gaap:BusinessAcquisitionProFormaInformationTextBlock", "div", "ix:continuation", "body", "html" ], "baseRef": "ctv-20221231.htm", "contextRef": "i7d3f71482776403d8a41cca88e5c8a44_D20220101-20221231", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:BusinessAcquisitionsProFormaRevenue", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000057 - Disclosure - ACQUISITION - Unaudited Pro Forma Financial Information (Details)", "menuCat": "Details", "order": "57", "role": "http://innovid.com/role/ACQUISITIONUnauditedProFormaFinancialInformationDetails", "shortName": "ACQUISITION - Unaudited Pro Forma Financial Information (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "us-gaap:BusinessAcquisitionProFormaInformationTextBlock", "div", "ix:continuation", "body", "html" ], "baseRef": "ctv-20221231.htm", "contextRef": "i7d3f71482776403d8a41cca88e5c8a44_D20220101-20221231", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:BusinessAcquisitionsProFormaRevenue", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R58": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "ix:continuation", "div", "ix:continuation", "body", "html" ], "baseRef": "ctv-20221231.htm", "contextRef": "i9bcf2d0b1c9541269938d4b1df1554c7_I20221231", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:FiniteLivedIntangibleAssetsGross", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000058 - Disclosure - INTANGIBLE ASSETS, NET - Intangible Assets (Details)", "menuCat": "Details", "order": "58", "role": "http://innovid.com/role/INTANGIBLEASSETSNETIntangibleAssetsDetails", "shortName": "INTANGIBLE ASSETS, NET - Intangible Assets (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "ix:continuation", "div", "ix:continuation", "body", "html" ], "baseRef": "ctv-20221231.htm", "contextRef": "i9bcf2d0b1c9541269938d4b1df1554c7_I20221231", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:FiniteLivedIntangibleAssetsGross", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R59": { "firstAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "ctv-20221231.htm", "contextRef": "i6c9150567ae44c3cb706b8fe5d71914b_D20220101-20221231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife", "reportCount": 1, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000059 - Disclosure - INTANGIBLE ASSETS, NET - Narrative (Details)", "menuCat": "Details", "order": "59", "role": "http://innovid.com/role/INTANGIBLEASSETSNETNarrativeDetails", "shortName": "INTANGIBLE ASSETS, NET - Narrative (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "ctv-20221231.htm", "contextRef": "i6c9150567ae44c3cb706b8fe5d71914b_D20220101-20221231", "decimals": "-3", "lang": "en-US", "name": "us-gaap:AmortizationOfIntangibleAssets", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R6": { "firstAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "ctv-20221231.htm", "contextRef": "i9bcf2d0b1c9541269938d4b1df1554c7_I20221231", "decimals": "3", "first": true, "lang": "en-US", "name": "us-gaap:PreferredStockConvertibleConversionRatio", "reportCount": 1, "unitRef": "number", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "0000006 - Statement - CONSOLIDATED STATEMENTS OF OPERATIONS (Parenthetical)", "menuCat": "Statements", "order": "6", "role": "http://innovid.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONSParenthetical", "shortName": "CONSOLIDATED STATEMENTS OF OPERATIONS (Parenthetical)", "subGroupType": "parenthetical", "uniqueAnchor": null }, "R60": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "ctv-20221231.htm", "contextRef": "i9bcf2d0b1c9541269938d4b1df1554c7_I20221231", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000060 - Disclosure - INTANGIBLE ASSETS, NET - Intangible Assets Amortization Expense (Details)", "menuCat": "Details", "order": "60", "role": "http://innovid.com/role/INTANGIBLEASSETSNETIntangibleAssetsAmortizationExpenseDetails", "shortName": "INTANGIBLE ASSETS, NET - Intangible Assets Amortization Expense (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "ctv-20221231.htm", "contextRef": "i9bcf2d0b1c9541269938d4b1df1554c7_I20221231", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R61": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock", "ix:continuation", "body", "html" ], "baseRef": "ctv-20221231.htm", "contextRef": "i9bcf2d0b1c9541269938d4b1df1554c7_I20221231", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:PrepaidExpenseCurrent", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000061 - Disclosure - PREPAID AND OTHER CURRENT ASSETS (Details)", "menuCat": "Details", "order": "61", "role": "http://innovid.com/role/PREPAIDANDOTHERCURRENTASSETSDetails", "shortName": "PREPAID AND OTHER CURRENT ASSETS (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock", "ix:continuation", "body", "html" ], "baseRef": "ctv-20221231.htm", "contextRef": "i9bcf2d0b1c9541269938d4b1df1554c7_I20221231", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:PrepaidExpenseCurrent", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R62": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "ix:continuation", "ix:continuation", "body", "html" ], "baseRef": "ctv-20221231.htm", "contextRef": "i9bcf2d0b1c9541269938d4b1df1554c7_I20221231", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:PropertyPlantAndEquipmentGross", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000062 - Disclosure - PROPERTY AND EQUIPMENT, NET (Details)", "menuCat": "Details", "order": "62", "role": "http://innovid.com/role/PROPERTYANDEQUIPMENTNETDetails", "shortName": "PROPERTY AND EQUIPMENT, NET (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "ix:continuation", "ix:continuation", "body", "html" ], "baseRef": "ctv-20221231.htm", "contextRef": "i9bcf2d0b1c9541269938d4b1df1554c7_I20221231", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:PropertyPlantAndEquipmentGross", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R63": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "ctv-20221231.htm", "contextRef": "i9bcf2d0b1c9541269938d4b1df1554c7_I20221231", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:OperatingLeaseRightOfUseAsset", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000063 - Disclosure - LEASES (Schedule of operating ROU assets and lease liabilities) (Details)", "menuCat": "Details", "order": "63", "role": "http://innovid.com/role/LEASESScheduleofoperatingROUassetsandleaseliabilitiesDetails", "shortName": "LEASES (Schedule of operating ROU assets and lease liabilities) (Details)", "subGroupType": "details", "uniqueAnchor": null }, "R64": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "ctv-20221231.htm", "contextRef": "i9bcf2d0b1c9541269938d4b1df1554c7_I20221231", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:OperatingLeaseLiabilityCurrent", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000064 - Disclosure - LEASES (Schedule of lease liability) (Details)", "menuCat": "Details", "order": "64", "role": "http://innovid.com/role/LEASESScheduleofleaseliabilityDetails", "shortName": "LEASES (Schedule of lease liability) (Details)", "subGroupType": "details", "uniqueAnchor": null }, "R65": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:LeaseCostTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "ctv-20221231.htm", "contextRef": "i6c9150567ae44c3cb706b8fe5d71914b_D20220101-20221231", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:OperatingLeaseCost", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000065 - Disclosure - LEASES (Schedule Of Lease Costs Recognized In The Consolidated Statement Of Earnings) (Details)", "menuCat": "Details", "order": "65", "role": "http://innovid.com/role/LEASESScheduleOfLeaseCostsRecognizedInTheConsolidatedStatementOfEarningsDetails", "shortName": "LEASES (Schedule Of Lease Costs Recognized In The Consolidated Statement Of Earnings) (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:LeaseCostTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "ctv-20221231.htm", "contextRef": "i6c9150567ae44c3cb706b8fe5d71914b_D20220101-20221231", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:OperatingLeaseCost", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R66": { "firstAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "ctv-20221231.htm", "contextRef": "i9bcf2d0b1c9541269938d4b1df1554c7_I20221231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000066 - Disclosure - LEASES (Narrative) (Details)", "menuCat": "Details", "order": "66", "role": "http://innovid.com/role/LEASESNarrativeDetails", "shortName": "LEASES (Narrative) (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "ctv-20221231.htm", "contextRef": "i9bcf2d0b1c9541269938d4b1df1554c7_I20221231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R67": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "ix:continuation", "ix:continuation", "body", "html" ], "baseRef": "ctv-20221231.htm", "contextRef": "i6c9150567ae44c3cb706b8fe5d71914b_D20220101-20221231", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:OperatingLeasePayments", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000067 - Disclosure - LEASE (Supplementary Cash Flow Information) (Details)", "menuCat": "Details", "order": "67", "role": "http://innovid.com/role/LEASESupplementaryCashFlowInformationDetails", "shortName": "LEASE (Supplementary Cash Flow Information) (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "ix:continuation", "ix:continuation", "body", "html" ], "baseRef": "ctv-20221231.htm", "contextRef": "i6c9150567ae44c3cb706b8fe5d71914b_D20220101-20221231", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:OperatingLeasePayments", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R68": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "ctv-20221231.htm", "contextRef": "i9bcf2d0b1c9541269938d4b1df1554c7_I20221231", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000068 - Disclosure - LEASES (Schedule of Operating Lease Liability Maturities) (Details)", "menuCat": "Details", "order": "68", "role": "http://innovid.com/role/LEASESScheduleofOperatingLeaseLiabilityMaturitiesDetails", "shortName": "LEASES (Schedule of Operating Lease Liability Maturities) (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "ctv-20221231.htm", "contextRef": "i9bcf2d0b1c9541269938d4b1df1554c7_I20221231", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R69": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "ctv-20221231.htm", "contextRef": "i5fd7460441cc4652b31f9cc511cdeaff_I20211231", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:OperatingLeasesFutureMinimumPaymentsDueCurrent", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000069 - Disclosure - LEASES (Schedule Of Commitments Under Non-Cancelable Operating Leases) (Details)", "menuCat": "Details", "order": "69", "role": "http://innovid.com/role/LEASESScheduleOfCommitmentsUnderNonCancelableOperatingLeasesDetails", "shortName": "LEASES (Schedule Of Commitments Under Non-Cancelable Operating Leases) (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "ctv-20221231.htm", "contextRef": "i5fd7460441cc4652b31f9cc511cdeaff_I20211231", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:OperatingLeasesFutureMinimumPaymentsDueCurrent", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R7": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "ctv-20221231.htm", "contextRef": "i431633e7e13447ca8f020cbcd6d5a2ef_I20191231", "decimals": "INF", "first": true, "lang": "en-US", "name": "us-gaap:TemporaryEquitySharesOutstanding", "reportCount": 1, "unique": true, "unitRef": "shares", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "0000007 - Statement - STATEMENTS OF CHANGES IN TEMPORARY EQUITY AND STOCKHOLDERS\u2019 EQUITY (DEFICIT)", "menuCat": "Statements", "order": "7", "role": "http://innovid.com/role/STATEMENTSOFCHANGESINTEMPORARYEQUITYANDSTOCKHOLDERSEQUITYDEFICIT", "shortName": "STATEMENTS OF CHANGES IN TEMPORARY EQUITY AND STOCKHOLDERS\u2019 EQUITY (DEFICIT)", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "ctv-20221231.htm", "contextRef": "i431633e7e13447ca8f020cbcd6d5a2ef_I20191231", "decimals": "INF", "first": true, "lang": "en-US", "name": "us-gaap:TemporaryEquitySharesOutstanding", "reportCount": 1, "unique": true, "unitRef": "shares", "xsiNil": "false" } }, "R70": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "ctv-20221231.htm", "contextRef": "i9bcf2d0b1c9541269938d4b1df1554c7_I20221231", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:OtherAccruedLiabilitiesCurrent", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000070 - Disclosure - ACCRUED EXPENSES AND OTHER CURRENT LIABILITIES (Details)", "menuCat": "Details", "order": "70", "role": "http://innovid.com/role/ACCRUEDEXPENSESANDOTHERCURRENTLIABILITIESDetails", "shortName": "ACCRUED EXPENSES AND OTHER CURRENT LIABILITIES (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "ctv-20221231.htm", "contextRef": "i9bcf2d0b1c9541269938d4b1df1554c7_I20221231", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:OtherAccruedLiabilitiesCurrent", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R71": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:OtherNoncurrentLiabilitiesTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "ctv-20221231.htm", "contextRef": "i9bcf2d0b1c9541269938d4b1df1554c7_I20221231", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:OtherAccruedLiabilitiesNoncurrent", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000071 - Disclosure - OTHER NON-CURRENT LIABILITIES (Details)", "menuCat": "Details", "order": "71", "role": "http://innovid.com/role/OTHERNONCURRENTLIABILITIESDetails", "shortName": "OTHER NON-CURRENT LIABILITIES (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:OtherNoncurrentLiabilitiesTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "ctv-20221231.htm", "contextRef": "i9bcf2d0b1c9541269938d4b1df1554c7_I20221231", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:OtherAccruedLiabilitiesNoncurrent", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R72": { "firstAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "ctv-20221231.htm", "contextRef": "i6c9150567ae44c3cb706b8fe5d71914b_D20220101-20221231", "decimals": "INF", "first": true, "lang": "en-US", "name": "ctv:FractionalSharesIssuedUponExercise", "reportCount": 1, "unique": true, "unitRef": "shares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000072 - Disclosure - WARRANTS (Details)", "menuCat": "Details", "order": "72", "role": "http://innovid.com/role/WARRANTSDetails", "shortName": "WARRANTS (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "ctv-20221231.htm", "contextRef": "i6c9150567ae44c3cb706b8fe5d71914b_D20220101-20221231", "decimals": "INF", "first": true, "lang": "en-US", "name": "ctv:FractionalSharesIssuedUponExercise", "reportCount": 1, "unique": true, "unitRef": "shares", "xsiNil": "false" } }, "R73": { "firstAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "ctv-20221231.htm", "contextRef": "ib98ee1149af94d0dbfec0421f6f44c59_D20230101-20230131", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:RepaymentsOfLinesOfCredit", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000073 - Disclosure - LONG-TERM DEBT (Details)", "menuCat": "Details", "order": "73", "role": "http://innovid.com/role/LONGTERMDEBTDetails", "shortName": "LONG-TERM DEBT (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "ctv-20221231.htm", "contextRef": "ib98ee1149af94d0dbfec0421f6f44c59_D20230101-20230131", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:RepaymentsOfLinesOfCredit", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R74": { "firstAnchor": { "ancestors": [ "span", "div", "td", "tr", "table", "div", "us-gaap:ScheduleOfStockholdersEquityTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "ctv-20221231.htm", "contextRef": "i9bcf2d0b1c9541269938d4b1df1554c7_I20221231", "decimals": "INF", "first": true, "lang": "en-US", "name": "us-gaap:CommonStockParOrStatedValuePerShare", "reportCount": 1, "unitRef": "usdPerShare", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000074 - Disclosure - COMMITMENTS AND CONTINGENT LIABILITIES (Details)", "menuCat": "Details", "order": "74", "role": "http://innovid.com/role/COMMITMENTSANDCONTINGENTLIABILITIESDetails", "shortName": "COMMITMENTS AND CONTINGENT LIABILITIES (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "ctv-20221231.htm", "contextRef": "i9bcf2d0b1c9541269938d4b1df1554c7_I20221231", "decimals": "-3", "lang": "en-US", "name": "ctv:BankGuaranteesInConnectionWithOfficeLeaseAgreement", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R75": { "firstAnchor": { "ancestors": [ "span", "div", "td", "tr", "table", "div", "us-gaap:ScheduleOfStockholdersEquityTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "ctv-20221231.htm", "contextRef": "i9bcf2d0b1c9541269938d4b1df1554c7_I20221231", "decimals": "INF", "first": true, "lang": "en-US", "name": "us-gaap:CommonStockParOrStatedValuePerShare", "reportCount": 1, "unitRef": "usdPerShare", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000075 - Disclosure - STOCKHOLDERS\u2019 EQUITY (Common Shares Activity) (Details)", "menuCat": "Details", "order": "75", "role": "http://innovid.com/role/STOCKHOLDERSEQUITYCommonSharesActivityDetails", "shortName": "STOCKHOLDERS\u2019 EQUITY (Common Shares Activity) (Details)", "subGroupType": "details", "uniqueAnchor": null }, "R76": { "firstAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "ctv-20221231.htm", "contextRef": "i9bcf2d0b1c9541269938d4b1df1554c7_I20221231", "decimals": "3", "first": true, "lang": "en-US", "name": "us-gaap:PreferredStockConvertibleConversionRatio", "reportCount": 1, "unitRef": "number", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000076 - Disclosure - STOCKHOLDERS\u2019 EQUITY (Narrative) (Details)", "menuCat": "Details", "order": "76", "role": "http://innovid.com/role/STOCKHOLDERSEQUITYNarrativeDetails", "shortName": "STOCKHOLDERS\u2019 EQUITY (Narrative) (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "ctv-20221231.htm", "contextRef": "ibe38574dd01947f683d67ea4024496a5_I20221231", "decimals": "0", "lang": "en-US", "name": "ctv:ClassOfWarrantOrRightIssued", "reportCount": 1, "unique": true, "unitRef": "shares", "xsiNil": "false" } }, "R77": { "firstAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "ctv-20221231.htm", "contextRef": "i6c9150567ae44c3cb706b8fe5d71914b_D20220101-20221231", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:AllocatedShareBasedCompensationExpense", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000077 - Disclosure - STOCK-BASED COMPENSATION (Narrative) (Details)", "menuCat": "Details", "order": "77", "role": "http://innovid.com/role/STOCKBASEDCOMPENSATIONNarrativeDetails", "shortName": "STOCK-BASED COMPENSATION (Narrative) (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "ctv-20221231.htm", "contextRef": "i6c9150567ae44c3cb706b8fe5d71914b_D20220101-20221231", "decimals": "-3", "lang": "en-US", "name": "us-gaap:EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R78": { "firstAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "ctv-20221231.htm", "contextRef": "i6c9150567ae44c3cb706b8fe5d71914b_D20220101-20221231", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:AllocatedShareBasedCompensationExpense", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000078 - Disclosure - STOCK-BASED COMPENSATION ( Stock Option Activity Under Plan) (Details)", "menuCat": "Details", "order": "78", "role": "http://innovid.com/role/STOCKBASEDCOMPENSATIONStockOptionActivityUnderPlanDetails", "shortName": "STOCK-BASED COMPENSATION ( Stock Option Activity Under Plan) (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock", "ix:continuation", "body", "html" ], "baseRef": "ctv-20221231.htm", "contextRef": "i465a0465a56344b38b9c44531439bf85_D20220101-20221231", "decimals": "-3", "lang": "en-US", "name": "us-gaap:AllocatedShareBasedCompensationExpense", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R79": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "ctv-20221231.htm", "contextRef": "i3f11f35a4c324004abcefb71f14fb891_I20211231", "decimals": "INF", "first": true, "lang": "en-US", "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber", "reportCount": 1, "unitRef": "shares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000079 - Disclosure - STOCK-BASED COMPENSATION ( Stock Option Activity) (Details)", "menuCat": "Details", "order": "79", "role": "http://innovid.com/role/STOCKBASEDCOMPENSATIONStockOptionActivityDetails", "shortName": "STOCK-BASED COMPENSATION ( Stock Option Activity) (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "ctv-20221231.htm", "contextRef": "i8a28edc5875c41cea65024339390bf64_D20220101-20221231", "decimals": "INF", "lang": "en-US", "name": "ctv:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsTransferBetweenEmployeeAndConsultant", "reportCount": 1, "unique": true, "unitRef": "shares", "xsiNil": "false" } }, "R8": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "ctv-20221231.htm", "contextRef": "i6c9150567ae44c3cb706b8fe5d71914b_D20220101-20221231", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:NetIncomeLoss", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "0000008 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS", "menuCat": "Statements", "order": "8", "role": "http://innovid.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS", "shortName": "CONSOLIDATED STATEMENTS OF CASH FLOWS", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "ctv-20221231.htm", "contextRef": "i6c9150567ae44c3cb706b8fe5d71914b_D20220101-20221231", "decimals": "-3", "lang": "en-US", "name": "us-gaap:ShareBasedCompensation", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R80": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "ctv-20221231.htm", "contextRef": "i51e9f0e2d4e548ad828fb6d7cdaa6c27_D20210101-20211231", "decimals": "2", "first": true, "lang": "en-US", "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate", "reportCount": 1, "unitRef": "number", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000080 - Disclosure - STOCK-BASED COMPENSATION ( Fair Value of Each Option on The Date of Grant) (Details)", "menuCat": "Details", "order": "80", "role": "http://innovid.com/role/STOCKBASEDCOMPENSATIONFairValueofEachOptiononTheDateofGrantDetails", "shortName": "STOCK-BASED COMPENSATION ( Fair Value of Each Option on The Date of Grant) (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "div", "td", "tr", "table", "div", "us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "ctv-20221231.htm", "contextRef": "i6c9150567ae44c3cb706b8fe5d71914b_D20220101-20221231", "decimals": "4", "lang": "en-US", "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum", "reportCount": 1, "unique": true, "unitRef": "number", "xsiNil": "false" } }, "R81": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "ix:continuation", "ix:continuation", "body", "html" ], "baseRef": "ctv-20221231.htm", "contextRef": "i02d836def7ff4ae8a95a5c925e185504_I20211231", "decimals": "INF", "first": true, "lang": "en-US", "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber", "reportCount": 1, "unique": true, "unitRef": "shares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000081 - Disclosure - STOCK-BASED COMPENSATION - Restricted Stock Unit Activity (Details)", "menuCat": "Details", "order": "81", "role": "http://innovid.com/role/STOCKBASEDCOMPENSATIONRestrictedStockUnitActivityDetails", "shortName": "STOCK-BASED COMPENSATION - Restricted Stock Unit Activity (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "ix:continuation", "ix:continuation", "body", "html" ], "baseRef": "ctv-20221231.htm", "contextRef": "i02d836def7ff4ae8a95a5c925e185504_I20211231", "decimals": "INF", "first": true, "lang": "en-US", "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber", "reportCount": 1, "unique": true, "unitRef": "shares", "xsiNil": "false" } }, "R82": { "firstAnchor": { "ancestors": [ "ix:continuation", "span", "div", "body", "html" ], "baseRef": "ctv-20221231.htm", "contextRef": "i3b679fb260264376a5454beec4dcc768_D20220101-20221231", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:InterestExpenseDebt", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000082 - Disclosure - FINANCE EXPENSES (INCOME), NET (Details)", "menuCat": "Details", "order": "82", "role": "http://innovid.com/role/FINANCEEXPENSESINCOMENETDetails", "shortName": "FINANCE EXPENSES (INCOME), NET (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "ix:continuation", "span", "div", "body", "html" ], "baseRef": "ctv-20221231.htm", "contextRef": "i3b679fb260264376a5454beec4dcc768_D20220101-20221231", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:InterestExpenseDebt", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R83": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "ctv-20221231.htm", "contextRef": "i6c9150567ae44c3cb706b8fe5d71914b_D20220101-20221231", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000083 - Disclosure - INCOME TAXES - Income before Income Tax, Domestic and Foreign (Details)", "menuCat": "Details", "order": "83", "role": "http://innovid.com/role/INCOMETAXESIncomebeforeIncomeTaxDomesticandForeignDetails", "shortName": "INCOME TAXES - Income before Income Tax, Domestic and Foreign (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "ctv-20221231.htm", "contextRef": "i6c9150567ae44c3cb706b8fe5d71914b_D20220101-20221231", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R84": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "ctv-20221231.htm", "contextRef": "i6c9150567ae44c3cb706b8fe5d71914b_D20220101-20221231", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:CurrentFederalStateAndLocalTaxExpenseBenefit", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000084 - Disclosure - INCOME TAXES - Income Tax Expense (Benefit) (Details)", "menuCat": "Details", "order": "84", "role": "http://innovid.com/role/INCOMETAXESIncomeTaxExpenseBenefitDetails", "shortName": "INCOME TAXES - Income Tax Expense (Benefit) (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "ctv-20221231.htm", "contextRef": "i6c9150567ae44c3cb706b8fe5d71914b_D20220101-20221231", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:CurrentFederalStateAndLocalTaxExpenseBenefit", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R85": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "ctv-20221231.htm", "contextRef": "i6c9150567ae44c3cb706b8fe5d71914b_D20220101-20221231", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000085 - Disclosure - INCOME TAXES - Effective Income Tax Rate Reconciliation (Details)", "menuCat": "Details", "order": "85", "role": "http://innovid.com/role/INCOMETAXESEffectiveIncomeTaxRateReconciliationDetails", "shortName": "INCOME TAXES - Effective Income Tax Rate Reconciliation (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "ctv-20221231.htm", "contextRef": "i6c9150567ae44c3cb706b8fe5d71914b_D20220101-20221231", "decimals": "INF", "lang": "en-US", "name": "us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate", "reportCount": 1, "unique": true, "unitRef": "number", "xsiNil": "false" } }, "R86": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "ix:continuation", "div", "ix:continuation", "body", "html" ], "baseRef": "ctv-20221231.htm", "contextRef": "i9bcf2d0b1c9541269938d4b1df1554c7_I20221231", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:DeferredTaxAssetsOperatingLossCarryforwards", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000086 - Disclosure - INCOME TAXES - Deferred Tax Assets and Liabilities (Details)", "menuCat": "Details", "order": "86", "role": "http://innovid.com/role/INCOMETAXESDeferredTaxAssetsandLiabilitiesDetails", "shortName": "INCOME TAXES - Deferred Tax Assets and Liabilities (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "ix:continuation", "div", "ix:continuation", "body", "html" ], "baseRef": "ctv-20221231.htm", "contextRef": "i9bcf2d0b1c9541269938d4b1df1554c7_I20221231", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:DeferredTaxAssetsOperatingLossCarryforwards", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R87": { "firstAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "ctv-20221231.htm", "contextRef": "i9bcf2d0b1c9541269938d4b1df1554c7_I20221231", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:UndistributedEarningsOfForeignSubsidiaries", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000087 - Disclosure - INCOME TAXES - Narrative (Details)", "menuCat": "Details", "order": "87", "role": "http://innovid.com/role/INCOMETAXESNarrativeDetails", "shortName": "INCOME TAXES - Narrative (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "ctv-20221231.htm", "contextRef": "i9bcf2d0b1c9541269938d4b1df1554c7_I20221231", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:UndistributedEarningsOfForeignSubsidiaries", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R88": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:SummaryOfOperatingLossCarryforwardsTextBlock", "ix:continuation", "body", "html" ], "baseRef": "ctv-20221231.htm", "contextRef": "i9bcf2d0b1c9541269938d4b1df1554c7_I20221231", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:OperatingLossCarryforwards", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000088 - Disclosure - INCOME TAXES - Operating Loss Carryforwards (Details)", "menuCat": "Details", "order": "88", "role": "http://innovid.com/role/INCOMETAXESOperatingLossCarryforwardsDetails", "shortName": "INCOME TAXES - Operating Loss Carryforwards (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:SummaryOfOperatingLossCarryforwardsTextBlock", "ix:continuation", "body", "html" ], "baseRef": "ctv-20221231.htm", "contextRef": "i9bcf2d0b1c9541269938d4b1df1554c7_I20221231", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:OperatingLossCarryforwards", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R89": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "ctv-20221231.htm", "contextRef": "ied41ff7bfba84bba86e6b8f333f5e690_I20211231", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:UnrecognizedTaxBenefits", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000089 - Disclosure - INCOME TAXES - Income Tax Contingencies (Details)", "menuCat": "Details", "order": "89", "role": "http://innovid.com/role/INCOMETAXESIncomeTaxContingenciesDetails", "shortName": "INCOME TAXES - Income Tax Contingencies (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "ctv-20221231.htm", "contextRef": "i6c9150567ae44c3cb706b8fe5d71914b_D20220101-20221231", "decimals": "-3", "lang": "en-US", "name": "us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R9": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "ctv-20221231.htm", "contextRef": "i6c9150567ae44c3cb706b8fe5d71914b_D20220101-20221231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000009 - Disclosure - DESCRIPTION OF BUSINESS", "menuCat": "Notes", "order": "9", "role": "http://innovid.com/role/DESCRIPTIONOFBUSINESS", "shortName": "DESCRIPTION OF BUSINESS", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "ctv-20221231.htm", "contextRef": "i6c9150567ae44c3cb706b8fe5d71914b_D20220101-20221231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R90": { "firstAnchor": { "ancestors": [ "ix:continuation", "span", "div", "body", "html" ], "baseRef": "ctv-20221231.htm", "contextRef": "i6c9150567ae44c3cb706b8fe5d71914b_D20220101-20221231", "decimals": "INF", "first": true, "lang": "en-US", "name": "us-gaap:NumberOfOperatingSegments", "reportCount": 1, "unique": true, "unitRef": "segment", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000090 - Disclosure - SEGMENT REPORTING - Narrative (Details)", "menuCat": "Details", "order": "90", "role": "http://innovid.com/role/SEGMENTREPORTINGNarrativeDetails", "shortName": "SEGMENT REPORTING - Narrative (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "ix:continuation", "span", "div", "body", "html" ], "baseRef": "ctv-20221231.htm", "contextRef": "i6c9150567ae44c3cb706b8fe5d71914b_D20220101-20221231", "decimals": "INF", "first": true, "lang": "en-US", "name": "us-gaap:NumberOfOperatingSegments", "reportCount": 1, "unique": true, "unitRef": "segment", "xsiNil": "false" } }, "R91": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "ctv-20221231.htm", "contextRef": "i6c9150567ae44c3cb706b8fe5d71914b_D20220101-20221231", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000091 - Disclosure - SEGMENT REPORTING (Revenue and Property and Equipment, by Geographical Areas) (Details)", "menuCat": "Details", "order": "91", "role": "http://innovid.com/role/SEGMENTREPORTINGRevenueandPropertyandEquipmentbyGeographicalAreasDetails", "shortName": "SEGMENT REPORTING (Revenue and Property and Equipment, by Geographical Areas) (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "ctv-20221231.htm", "contextRef": "i9bcf2d0b1c9541269938d4b1df1554c7_I20221231", "decimals": "-3", "lang": "en-US", "name": "us-gaap:NoncurrentAssets", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R92": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "ctv-20221231.htm", "contextRef": "i6c9150567ae44c3cb706b8fe5d71914b_D20220101-20221231", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:NetIncomeLoss", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000092 - Disclosure - BASIC AND DILUTED NET LOSS PER SHARE (Basic and Diluted Net loss Per Share) (Details)", "menuCat": "Details", "order": "92", "role": "http://innovid.com/role/BASICANDDILUTEDNETLOSSPERSHAREBasicandDilutedNetlossPerShareDetails", "shortName": "BASIC AND DILUTED NET LOSS PER SHARE (Basic and Diluted Net loss Per Share) (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "ctv-20221231.htm", "contextRef": "i6c9150567ae44c3cb706b8fe5d71914b_D20220101-20221231", "decimals": "-3", "lang": "en-US", "name": "ctv:PreferredStocksAccretionToRedemptionValueAdjustment", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R93": { "firstAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "ctv-20221231.htm", "contextRef": "i9bcf2d0b1c9541269938d4b1df1554c7_I20221231", "decimals": "3", "first": true, "lang": "en-US", "name": "us-gaap:PreferredStockConvertibleConversionRatio", "reportCount": 1, "unitRef": "number", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000093 - Disclosure - BASIC AND DILUTED NET LOSS PER SHARE (Narrative) (Details)", "menuCat": "Details", "order": "93", "role": "http://innovid.com/role/BASICANDDILUTEDNETLOSSPERSHARENarrativeDetails", "shortName": "BASIC AND DILUTED NET LOSS PER SHARE (Narrative) (Details)", "subGroupType": "details", "uniqueAnchor": null }, "R94": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock", "ix:continuation", "body", "html" ], "baseRef": "ctv-20221231.htm", "contextRef": "ia94dabc5d8984acc89293ff5aa02830c_D20220101-20221231", "decimals": "0", "first": true, "lang": "en-US", "name": "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount", "reportCount": 1, "unique": true, "unitRef": "shares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000094 - Disclosure - BASIC AND DILUTED NET LOSS PER SHARE (Securities Excluded from Computation of Earnings Per Share) (Details)", "menuCat": "Details", "order": "94", "role": "http://innovid.com/role/BASICANDDILUTEDNETLOSSPERSHARESecuritiesExcludedfromComputationofEarningsPerShareDetails", "shortName": "BASIC AND DILUTED NET LOSS PER SHARE (Securities Excluded from Computation of Earnings Per Share) (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock", "ix:continuation", "body", "html" ], "baseRef": "ctv-20221231.htm", "contextRef": "ia94dabc5d8984acc89293ff5aa02830c_D20220101-20221231", "decimals": "0", "first": true, "lang": "en-US", "name": "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount", "reportCount": 1, "unique": true, "unitRef": "shares", "xsiNil": "false" } } }, "segmentCount": 86, "tag": { "country_CA": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "CANADA", "terseLabel": "Canada" } } }, "localname": "CA", "nsuri": "http://xbrl.sec.gov/country/2022", "presentation": [ "http://innovid.com/role/SEGMENTREPORTINGRevenueandPropertyandEquipmentbyGeographicalAreasDetails" ], "xbrltype": "domainItemType" }, "country_IL": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "ISRAEL", "terseLabel": "Israel" } } }, "localname": "IL", "nsuri": "http://xbrl.sec.gov/country/2022", "presentation": [ "http://innovid.com/role/SEGMENTREPORTINGRevenueandPropertyandEquipmentbyGeographicalAreasDetails" ], "xbrltype": "domainItemType" }, "country_US": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "UNITED STATES", "terseLabel": "US" } } }, "localname": "US", "nsuri": "http://xbrl.sec.gov/country/2022", "presentation": [ "http://innovid.com/role/SEGMENTREPORTINGRevenueandPropertyandEquipmentbyGeographicalAreasDetails" ], "xbrltype": "domainItemType" }, "ctv_AccruedDirectTransactionCost": { "auth_ref": [], "calculation": { "http://innovid.com/role/TRANSACTIONTransactiontoCashFlowandChangesinTemporaryEquityandStockholdersEquityDetails": { "order": 4.0, "parentTag": "ctv_ReverseRecapitalizationNetOfTransactionCostsBeforeSecondarySaleAmount", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Accrued Direct Transaction Cost", "label": "Accrued Direct Transaction Cost", "negatedTerseLabel": "Less: Accrued transaction costs not yet paid" } } }, "localname": "AccruedDirectTransactionCost", "nsuri": "http://innovid.com/20221231", "presentation": [ "http://innovid.com/role/TRANSACTIONTransactiontoCashFlowandChangesinTemporaryEquityandStockholdersEquityDetails" ], "xbrltype": "monetaryItemType" }, "ctv_AccruedTransactionCostNotYetPaid": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Accrued Transaction Cost, Not Yet Paid", "label": "Accrued Transaction Cost, Not Yet Paid", "terseLabel": "Accrued transaction cost, not yet paid" } } }, "localname": "AccruedTransactionCostNotYetPaid", "nsuri": "http://innovid.com/20221231", "presentation": [ "http://innovid.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS", "http://innovid.com/role/TRANSACTIONNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "ctv_AggregateNumberOfSharesOfCommonStockOutstanding": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Aggregate Number of Shares of Common Stock Outstanding", "label": "Aggregate Number of Shares of Common Stock Outstanding", "terseLabel": "Aggregate number of shares of common stock outstanding" } } }, "localname": "AggregateNumberOfSharesOfCommonStockOutstanding", "nsuri": "http://innovid.com/20221231", "presentation": [ "http://innovid.com/role/STOCKBASEDCOMPENSATIONNarrativeDetails" ], "xbrltype": "percentItemType" }, "ctv_AmendedCreditAgreementMaturingDecember2020Member": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Amended Credit Agreement Maturing December 2020", "label": "Amended Credit Agreement Maturing December 2020 [Member]", "terseLabel": "Amended Credit Agreement Maturing December 2020" } } }, "localname": "AmendedCreditAgreementMaturingDecember2020Member", "nsuri": "http://innovid.com/20221231", "presentation": [ "http://innovid.com/role/LONGTERMDEBTDetails" ], "xbrltype": "domainItemType" }, "ctv_AmendedCreditAgreementMaturingOctober2018Member": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Amended Credit Agreement Maturing October 2018", "label": "Amended Credit Agreement Maturing October 2018 [Member]", "terseLabel": "Amended Credit Agreement Maturing October 2018" } } }, "localname": "AmendedCreditAgreementMaturingOctober2018Member", "nsuri": "http://innovid.com/20221231", "presentation": [ "http://innovid.com/role/LONGTERMDEBTDetails" ], "xbrltype": "domainItemType" }, "ctv_AssetsAndLiabilitiesLesseeTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Assets And Liabilities Lessee [Table Text Block]", "label": "Assets And Liabilities Lessee [Table Text Block]", "terseLabel": "Assets And Liabilities Lessee" } } }, "localname": "AssetsAndLiabilitiesLesseeTableTextBlock", "nsuri": "http://innovid.com/20221231", "presentation": [ "http://innovid.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESTables" ], "xbrltype": "textBlockItemType" }, "ctv_AssetsAndLiabilitiesLesseeTableTextBlockTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Assets And Liabilities Lessee Table Text Block", "label": "Assets And Liabilities Lessee Table Text Block [Table Text Block]", "terseLabel": "Schedule of operating ROU assets and lease liabilities" } } }, "localname": "AssetsAndLiabilitiesLesseeTableTextBlockTableTextBlock", "nsuri": "http://innovid.com/20221231", "presentation": [ "http://innovid.com/role/LEASESTables" ], "xbrltype": "textBlockItemType" }, "ctv_AuditInformationAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Audit Information", "label": "Audit Information [Abstract]" } } }, "localname": "AuditInformationAbstract", "nsuri": "http://innovid.com/20221231", "xbrltype": "stringItemType" }, "ctv_BankDepositsPledged": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Bank Deposits, Pledged", "label": "Bank Deposits, Pledged", "terseLabel": "Bank deposits pledged" } } }, "localname": "BankDepositsPledged", "nsuri": "http://innovid.com/20221231", "presentation": [ "http://innovid.com/role/COMMITMENTSANDCONTINGENTLIABILITIESDetails" ], "xbrltype": "monetaryItemType" }, "ctv_BankGuaranteesInConnectionWithOfficeLeaseAgreement": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Bank Guarantees In connection With Office Lease Agreement", "label": "Bank Guarantees In connection With Office Lease Agreement", "terseLabel": "Bank guarantees" } } }, "localname": "BankGuaranteesInConnectionWithOfficeLeaseAgreement", "nsuri": "http://innovid.com/20221231", "presentation": [ "http://innovid.com/role/COMMITMENTSANDCONTINGENTLIABILITIESDetails" ], "xbrltype": "monetaryItemType" }, "ctv_BusinessAcquisitionEquityInterestIssuedOrIssuableFullyVestedStockOption": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Business Acquisition, Equity Interest Issued or Issuable, Fully Vested Stock Option", "label": "Business Acquisition, Equity Interest Issued or Issuable, Fully Vested Stock Option", "terseLabel": "Issued, fully vested stock option (in shares)", "verboseLabel": "Issued, fully vested stock option (in shares)" } } }, "localname": "BusinessAcquisitionEquityInterestIssuedOrIssuableFullyVestedStockOption", "nsuri": "http://innovid.com/20221231", "presentation": [ "http://innovid.com/role/ACQUISITIONNarrativeDetails", "http://innovid.com/role/DESCRIPTIONOFBUSINESSDetails", "http://innovid.com/role/STOCKBASEDCOMPENSATIONNarrativeDetails" ], "xbrltype": "sharesItemType" }, "ctv_BusinessAcquisitionFullyVestedStockOptionWeightedAverageFairValue": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Business Acquisition, Fully Vested Stock Option, Weighted Average Fair Value", "label": "Business Acquisition, Fully Vested Stock Option, Weighted Average Fair Value", "terseLabel": "Weighted average fair value (in dollars per share)" } } }, "localname": "BusinessAcquisitionFullyVestedStockOptionWeightedAverageFairValue", "nsuri": "http://innovid.com/20221231", "presentation": [ "http://innovid.com/role/ACQUISITIONNarrativeDetails", "http://innovid.com/role/DESCRIPTIONOFBUSINESSDetails" ], "xbrltype": "perShareItemType" }, "ctv_BusinessCombinationPostClosingCompensationExpense": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Business Combination, Post Closing Compensation Expense", "label": "Business Combination, Post Closing Compensation Expense", "terseLabel": "Cash compensation arrangement for certain employees" } } }, "localname": "BusinessCombinationPostClosingCompensationExpense", "nsuri": "http://innovid.com/20221231", "presentation": [ "http://innovid.com/role/ACQUISITIONNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "ctv_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAcquiredIncludingGoodwill": { "auth_ref": [], "calculation": { "http://innovid.com/role/ACQUISITIONFairValuesoftheAssetsAcquiredandLiabilitiesAssumedDetails": { "order": 1.0, "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Assets Acquired Including Goodwill", "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Assets Acquired Including Goodwill", "totalLabel": "Total assets acquired" } } }, "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAcquiredIncludingGoodwill", "nsuri": "http://innovid.com/20221231", "presentation": [ "http://innovid.com/role/ACQUISITIONFairValuesoftheAssetsAcquiredandLiabilitiesAssumedDetails" ], "xbrltype": "monetaryItemType" }, "ctv_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedTangibleAssets": { "auth_ref": [], "calculation": { "http://innovid.com/role/ACQUISITIONFairValuesoftheAssetsAcquiredandLiabilitiesAssumedDetails": { "order": 1.0, "parentTag": "ctv_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAcquiredIncludingGoodwill", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Tangible Assets", "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Tangible Assets", "totalLabel": "Total tangible assets" } } }, "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedTangibleAssets", "nsuri": "http://innovid.com/20221231", "presentation": [ "http://innovid.com/role/ACQUISITIONFairValuesoftheAssetsAcquiredandLiabilitiesAssumedDetails" ], "xbrltype": "monetaryItemType" }, "ctv_CarsMemberMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Cars Member", "label": "Cars Member [Member]", "terseLabel": "Cars" } } }, "localname": "CarsMemberMember", "nsuri": "http://innovid.com/20221231", "presentation": [ "http://innovid.com/role/LEASESScheduleofoperatingROUassetsandleaseliabilitiesDetails", "http://innovid.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESScheduleofOperatingLeaseLiabilitiesandROUAssetsDetails" ], "xbrltype": "domainItemType" }, "ctv_CashAcquiredThroughReverseRecapitalization": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Cash Acquired Through Reverse Recapitalization", "label": "Cash Acquired Through Reverse Recapitalization", "terseLabel": "Cash - ION trust account and cash, net of redemptions" } } }, "localname": "CashAcquiredThroughReverseRecapitalization", "nsuri": "http://innovid.com/20221231", "presentation": [ "http://innovid.com/role/TRANSACTIONTransactiontoCashFlowandChangesinTemporaryEquityandStockholdersEquityDetails" ], "xbrltype": "monetaryItemType" }, "ctv_ClassOfWarrantOrRightIssued": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Class of Warrant or Right, Issued", "label": "Class of Warrant or Right, Issued", "terseLabel": "Warrants issued (in shares)" } } }, "localname": "ClassOfWarrantOrRightIssued", "nsuri": "http://innovid.com/20221231", "presentation": [ "http://innovid.com/role/STOCKHOLDERSEQUITYNarrativeDetails" ], "xbrltype": "sharesItemType" }, "ctv_ClassOfWarrantOrRightMinimumThresholdWrittenNoticePeriodForRedemptionOfWarrants": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Class Of Warrant Or Right, Minimum Threshold Written Notice Period For Redemption Of Warrants", "label": "Class Of Warrant Or Right, Minimum Threshold Written Notice Period For Redemption Of Warrants", "terseLabel": "Minimum threshold written notice period for redemption of warrants" } } }, "localname": "ClassOfWarrantOrRightMinimumThresholdWrittenNoticePeriodForRedemptionOfWarrants", "nsuri": "http://innovid.com/20221231", "presentation": [ "http://innovid.com/role/WARRANTSDetails" ], "xbrltype": "durationItemType" }, "ctv_ClassOfWarrantOrRightRedemptionOfWarrantsOrRightsReferencePrice": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Class Of Warrant Or Right, Redemption Of Warrants Or Rights, Reference Price", "label": "Class Of Warrant Or Right, Redemption Of Warrants Or Rights, Reference Price", "terseLabel": "Redemption of warrants, reference price (in dollars per share)" } } }, "localname": "ClassOfWarrantOrRightRedemptionOfWarrantsOrRightsReferencePrice", "nsuri": "http://innovid.com/20221231", "presentation": [ "http://innovid.com/role/WARRANTSDetails" ], "xbrltype": "perShareItemType" }, "ctv_ClassOfWarrantOrRightRedemptionOfWarrantsOrRightsThresholdConsecutiveTradingDays": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Class Of Warrant Or Right, Redemption Of Warrants Or Rights, Threshold Consecutive Trading Days", "label": "Class Of Warrant Or Right, Redemption Of Warrants Or Rights, Threshold Consecutive Trading Days", "terseLabel": "Number of consecutive trading days" } } }, "localname": "ClassOfWarrantOrRightRedemptionOfWarrantsOrRightsThresholdConsecutiveTradingDays", "nsuri": "http://innovid.com/20221231", "presentation": [ "http://innovid.com/role/WARRANTSDetails" ], "xbrltype": "durationItemType" }, "ctv_ClassOfWarrantOrRightRedemptionOfWarrantsOrRightsThresholdTradingDays": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Class Of Warrant Or Right, Redemption Of Warrants Or Rights, Threshold Trading Days", "label": "Class Of Warrant Or Right, Redemption Of Warrants Or Rights, Threshold Trading Days", "terseLabel": "Redemption of warrants, threshold trading days" } } }, "localname": "ClassOfWarrantOrRightRedemptionOfWarrantsOrRightsThresholdTradingDays", "nsuri": "http://innovid.com/20221231", "presentation": [ "http://innovid.com/role/WARRANTSDetails" ], "xbrltype": "durationItemType" }, "ctv_ClassOfWarrantOrRightRedemptionPriceOfWarrantsOrRights": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Class Of Warrant Or Right Redemption Price Of Warrants Or Rights", "label": "Class Of Warrant Or Right Redemption Price Of Warrants Or Rights", "terseLabel": "Redemption price of warrants (in dollars per share)" } } }, "localname": "ClassOfWarrantOrRightRedemptionPriceOfWarrantsOrRights", "nsuri": "http://innovid.com/20221231", "presentation": [ "http://innovid.com/role/WARRANTSDetails" ], "xbrltype": "perShareItemType" }, "ctv_CommitmentsAndContingenciesLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Commitments and Contingencies", "label": "Commitments and Contingencies [Line Items]", "terseLabel": "Commitments and Contingencies [Line Items]" } } }, "localname": "CommitmentsAndContingenciesLineItems", "nsuri": "http://innovid.com/20221231", "presentation": [ "http://innovid.com/role/COMMITMENTSANDCONTINGENTLIABILITIESDetails" ], "xbrltype": "stringItemType" }, "ctv_CommitmentsAndContingenciesTable": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Commitments and Contingencies", "label": "Commitments and Contingencies [Table]", "terseLabel": "Commitments and Contingencies [Table]" } } }, "localname": "CommitmentsAndContingenciesTable", "nsuri": "http://innovid.com/20221231", "presentation": [ "http://innovid.com/role/COMMITMENTSANDCONTINGENTLIABILITIESDetails" ], "xbrltype": "stringItemType" }, "ctv_CommonSharesAuthorizedAndReservedForIssuanceAnnualIncreasePeriod": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Common Shares Authorized and Reserved For Issuance Annual Increase Period", "label": "Common Shares Authorized and Reserved For Issuance Annual Increase Period", "terseLabel": "Annual increase period" } } }, "localname": "CommonSharesAuthorizedAndReservedForIssuanceAnnualIncreasePeriod", "nsuri": "http://innovid.com/20221231", "presentation": [ "http://innovid.com/role/STOCKBASEDCOMPENSATIONNarrativeDetails" ], "xbrltype": "durationItemType" }, "ctv_ConversionOfLegacyInnovidWarrants": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Conversion of Legacy Innovid Warrants", "label": "Conversion of Legacy Innovid Warrants", "terseLabel": "Conversion of Legacy Innovid Warrants" } } }, "localname": "ConversionOfLegacyInnovidWarrants", "nsuri": "http://innovid.com/20221231", "presentation": [ "http://innovid.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "monetaryItemType" }, "ctv_CustomerAMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Customer A", "label": "Customer A [Member]", "terseLabel": "Customer A" } } }, "localname": "CustomerAMember", "nsuri": "http://innovid.com/20221231", "presentation": [ "http://innovid.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESScheduleofConcentrationRiskDetails" ], "xbrltype": "domainItemType" }, "ctv_CustomerBMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Customer B", "label": "Customer B [Member]", "terseLabel": "Customer B" } } }, "localname": "CustomerBMember", "nsuri": "http://innovid.com/20221231", "presentation": [ "http://innovid.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESScheduleofConcentrationRiskDetails" ], "xbrltype": "domainItemType" }, "ctv_DebtInstrumentPrimeRatePercentage": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Debt Instrument, Prime Rate Percentage", "label": "Debt Instrument, Prime Rate Percentage", "terseLabel": "Debt instrument, prime rate" } } }, "localname": "DebtInstrumentPrimeRatePercentage", "nsuri": "http://innovid.com/20221231", "presentation": [ "http://innovid.com/role/LONGTERMDEBTDetails" ], "xbrltype": "percentItemType" }, "ctv_DecreaseInOperatingLeaseRightOfUseAssets": { "auth_ref": [], "calculation": { "http://innovid.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "order": 13.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Decrease In Operating Lease Right Of Use Assets", "label": "Decrease In Operating Lease Right Of Use Assets", "terseLabel": "Decrease in operating lease right of use assets" } } }, "localname": "DecreaseInOperatingLeaseRightOfUseAssets", "nsuri": "http://innovid.com/20221231", "presentation": [ "http://innovid.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "monetaryItemType" }, "ctv_DeferredTaxAssetsLeaseLiabilities": { "auth_ref": [], "calculation": { "http://innovid.com/role/INCOMETAXESDeferredTaxAssetsandLiabilitiesDetails": { "order": 9.0, "parentTag": "us-gaap_DeferredTaxAssetsGross", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Deferred Tax Assets, Lease Liabilities", "label": "Deferred Tax Assets, Lease Liabilities", "netLabel": "Lease liabilities" } } }, "localname": "DeferredTaxAssetsLeaseLiabilities", "nsuri": "http://innovid.com/20221231", "presentation": [ "http://innovid.com/role/INCOMETAXESDeferredTaxAssetsandLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "ctv_EarningsPerShareBasicAndDilutedEPSAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Earnings Per Share, Basic and Diluted EPS", "label": "Earnings Per Share, Basic and Diluted EPS [Abstract]", "terseLabel": "Denominator:" } } }, "localname": "EarningsPerShareBasicAndDilutedEPSAbstract", "nsuri": "http://innovid.com/20221231", "presentation": [ "http://innovid.com/role/BASICANDDILUTEDNETLOSSPERSHAREBasicandDilutedNetlossPerShareDetails" ], "xbrltype": "stringItemType" }, "ctv_EffectiveIncomeTaxRateReconciliationChangeInUncertainTaxPositionsAmount": { "auth_ref": [], "calculation": { "http://innovid.com/role/INCOMETAXESEffectiveIncomeTaxRateReconciliationDetails": { "order": 1.0, "parentTag": "us-gaap_IncomeTaxExpenseBenefit", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Effective Income Tax Rate Reconciliation, Change in Uncertain Tax Positions, Amount", "label": "Effective Income Tax Rate Reconciliation, Change in Uncertain Tax Positions, Amount", "terseLabel": "Changes in uncertain tax positions" } } }, "localname": "EffectiveIncomeTaxRateReconciliationChangeInUncertainTaxPositionsAmount", "nsuri": "http://innovid.com/20221231", "presentation": [ "http://innovid.com/role/INCOMETAXESEffectiveIncomeTaxRateReconciliationDetails" ], "xbrltype": "monetaryItemType" }, "ctv_EffectiveIncomeTaxRateReconciliationGlobalIntangibleLowTaxedIncomeAmount": { "auth_ref": [], "calculation": { "http://innovid.com/role/INCOMETAXESEffectiveIncomeTaxRateReconciliationDetails": { "order": 4.0, "parentTag": "us-gaap_IncomeTaxExpenseBenefit", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Effective Income Tax Rate Reconciliation, Global Intangible Low Taxed Income, Amount", "label": "Effective Income Tax Rate Reconciliation, Global Intangible Low Taxed Income, Amount", "terseLabel": "GILTI" } } }, "localname": "EffectiveIncomeTaxRateReconciliationGlobalIntangibleLowTaxedIncomeAmount", "nsuri": "http://innovid.com/20221231", "presentation": [ "http://innovid.com/role/INCOMETAXESEffectiveIncomeTaxRateReconciliationDetails" ], "xbrltype": "monetaryItemType" }, "ctv_EffectiveIncomeTaxRateReconciliationTransactionCosts": { "auth_ref": [], "calculation": { "http://innovid.com/role/INCOMETAXESEffectiveIncomeTaxRateReconciliationDetails": { "order": 7.0, "parentTag": "us-gaap_IncomeTaxExpenseBenefit", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Effective Income Tax Rate Reconciliation, Transaction Costs", "label": "Effective Income Tax Rate Reconciliation, Transaction Costs", "terseLabel": "Transaction costs" } } }, "localname": "EffectiveIncomeTaxRateReconciliationTransactionCosts", "nsuri": "http://innovid.com/20221231", "presentation": [ "http://innovid.com/role/INCOMETAXESEffectiveIncomeTaxRateReconciliationDetails" ], "xbrltype": "monetaryItemType" }, "ctv_EffectiveIncomeTaxRateReconciliationWarrants": { "auth_ref": [], "calculation": { "http://innovid.com/role/INCOMETAXESEffectiveIncomeTaxRateReconciliationDetails": { "order": 8.0, "parentTag": "us-gaap_IncomeTaxExpenseBenefit", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Effective Income Tax Rate Reconciliation, Warrants", "label": "Effective Income Tax Rate Reconciliation, Warrants", "terseLabel": "Warrants - MTM" } } }, "localname": "EffectiveIncomeTaxRateReconciliationWarrants", "nsuri": "http://innovid.com/20221231", "presentation": [ "http://innovid.com/role/INCOMETAXESEffectiveIncomeTaxRateReconciliationDetails" ], "xbrltype": "monetaryItemType" }, "ctv_EmployeeStockPurchasePlanMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Employee Stock Purchase Plan", "label": "Employee Stock Purchase Plan [Member]", "terseLabel": "Employee Stock Purchase Plan" } } }, "localname": "EmployeeStockPurchasePlanMember", "nsuri": "http://innovid.com/20221231", "presentation": [ "http://innovid.com/role/STOCKBASEDCOMPENSATIONNarrativeDetails" ], "xbrltype": "domainItemType" }, "ctv_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAdditions": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Additions", "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Additions", "terseLabel": "Additions" } } }, "localname": "FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAdditions", "nsuri": "http://innovid.com/20221231", "presentation": [ "http://innovid.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESScheduleofFairValueLiabilitiesMeasuredonRecurringBasisUnobservableInputReconciliationDetails" ], "xbrltype": "monetaryItemType" }, "ctv_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisConversionOfWarrants": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Conversion of Warrants", "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Conversion of Warrants", "negatedTerseLabel": "Conversion of Legacy Innovid Warrants on the Closing of the Transaction" } } }, "localname": "FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisConversionOfWarrants", "nsuri": "http://innovid.com/20221231", "presentation": [ "http://innovid.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESScheduleofFairValueLiabilitiesMeasuredonRecurringBasisUnobservableInputReconciliationDetails" ], "xbrltype": "monetaryItemType" }, "ctv_FinanceExpensesIncomeNet": { "auth_ref": [], "calculation": { "http://innovid.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": { "order": 2.0, "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Finance Expenses (Income), Net", "label": "Finance Expenses (Income), Net", "terseLabel": "Finance expenses (income), net" } } }, "localname": "FinanceExpensesIncomeNet", "nsuri": "http://innovid.com/20221231", "presentation": [ "http://innovid.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS" ], "xbrltype": "monetaryItemType" }, "ctv_FoundersNotesForgiven": { "auth_ref": [], "calculation": { "http://innovid.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "order": 8.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Founders Notes Forgiven", "label": "Founders Notes Forgiven", "terseLabel": "Founders notes forgiven" } } }, "localname": "FoundersNotesForgiven", "nsuri": "http://innovid.com/20221231", "presentation": [ "http://innovid.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "monetaryItemType" }, "ctv_FractionalSharesIssuedUponExercise": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Fractional Shares Issued Upon Exercise", "label": "Fractional Shares Issued Upon Exercise", "terseLabel": "Fractional shares issued upon exercise (in shares)" } } }, "localname": "FractionalSharesIssuedUponExercise", "nsuri": "http://innovid.com/20221231", "presentation": [ "http://innovid.com/role/WARRANTSDetails" ], "xbrltype": "sharesItemType" }, "ctv_GovernmentContractReceivableCurrent": { "auth_ref": [], "calculation": { "http://innovid.com/role/PREPAIDANDOTHERCURRENTASSETSDetails": { "order": 1.0, "parentTag": "us-gaap_PrepaidExpenseAndOtherAssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Government Contract Receivable, Current", "label": "Government Contract Receivable, Current", "terseLabel": "Government authorities" } } }, "localname": "GovernmentContractReceivableCurrent", "nsuri": "http://innovid.com/20221231", "presentation": [ "http://innovid.com/role/PREPAIDANDOTHERCURRENTASSETSDetails" ], "xbrltype": "monetaryItemType" }, "ctv_HolderMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Holder", "label": "Holder [Member]", "terseLabel": "Holder" } } }, "localname": "HolderMember", "nsuri": "http://innovid.com/20221231", "presentation": [ "http://innovid.com/role/STOCKHOLDERSEQUITYNarrativeDetails" ], "xbrltype": "domainItemType" }, "ctv_IONMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "ION", "label": "ION [Member]", "terseLabel": "ION" } } }, "localname": "IONMember", "nsuri": "http://innovid.com/20221231", "presentation": [ "http://innovid.com/role/TRANSACTIONNarrativeDetails", "http://innovid.com/role/TRANSACTIONTransactiontoCashFlowandChangesinTemporaryEquityandStockholdersEquityDetails" ], "xbrltype": "domainItemType" }, "ctv_ImpairmentLongLivedAssetHeldForUseStatementOfIncomeOrComprehensiveIncomeExtensibleEnumerationNotDisclosedFlag": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Impairment Long Lived Asset Held For Use Statement Of Income Or Comprehensive Income Extensible Enumeration Not Disclosed Flag", "label": "Impairment Long Lived Asset Held For Use Statement Of Income Or Comprehensive Income Extensible Enumeration Not Disclosed Flag", "terseLabel": "Impairment Long Lived Asset Held For Use Statement Of Income Or Comprehensive Income Extensible Enumeration Not Disclosed Flag" } } }, "localname": "ImpairmentLongLivedAssetHeldForUseStatementOfIncomeOrComprehensiveIncomeExtensibleEnumerationNotDisclosedFlag", "nsuri": "http://innovid.com/20221231", "presentation": [ "http://innovid.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails" ], "xbrltype": "stringItemType" }, "ctv_IncentivePlanMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Incentive Plan", "label": "Incentive Plan [Member]", "terseLabel": "Incentive Plan" } } }, "localname": "IncentivePlanMember", "nsuri": "http://innovid.com/20221231", "presentation": [ "http://innovid.com/role/STOCKBASEDCOMPENSATIONNarrativeDetails" ], "xbrltype": "domainItemType" }, "ctv_InnovidCorpMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Innovid Corp", "label": "Innovid Corp [Member]", "terseLabel": "Innovid Corp" } } }, "localname": "InnovidCorpMember", "nsuri": "http://innovid.com/20221231", "presentation": [ "http://innovid.com/role/TRANSACTIONCommonStockinInnovidCorpDetails", "http://innovid.com/role/TRANSACTIONNarrativeDetails", "http://innovid.com/role/WARRANTSDetails" ], "xbrltype": "domainItemType" }, "ctv_IsraeliSubsidiaryMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Israeli Subsidiary [Member]", "label": "Israeli Subsidiary [Member]", "terseLabel": "Israeli Subsidiary" } } }, "localname": "IsraeliSubsidiaryMember", "nsuri": "http://innovid.com/20221231", "presentation": [ "http://innovid.com/role/COMMITMENTSANDCONTINGENTLIABILITIESDetails" ], "xbrltype": "domainItemType" }, "ctv_LeaseOfMotorVehiclesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Lease Of Motor Vehicles", "label": "Lease Of Motor Vehicles [Member]", "terseLabel": "Lease of motor vehicles" } } }, "localname": "LeaseOfMotorVehiclesMember", "nsuri": "http://innovid.com/20221231", "presentation": [ "http://innovid.com/role/LEASESScheduleOfCommitmentsUnderNonCancelableOperatingLeasesDetails" ], "xbrltype": "domainItemType" }, "ctv_LegacyPlanAnd2021PlanMemberMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Legacy Plan And2021 Plan Member", "label": "Legacy Plan And2021 Plan Member [Member]", "terseLabel": "Stock Option Plan" } } }, "localname": "LegacyPlanAnd2021PlanMemberMember", "nsuri": "http://innovid.com/20221231", "presentation": [ "http://innovid.com/role/STOCKBASEDCOMPENSATIONStockOptionActivityUnderPlanDetails" ], "xbrltype": "domainItemType" }, "ctv_LegacyPlanMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Legacy Plan", "label": "Legacy Plan [Member]", "terseLabel": "Legacy Plan" } } }, "localname": "LegacyPlanMember", "nsuri": "http://innovid.com/20221231", "presentation": [ "http://innovid.com/role/STOCKBASEDCOMPENSATIONNarrativeDetails" ], "xbrltype": "domainItemType" }, "ctv_LineOfCreditQuickRatio": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line Of Credit Quick Ratio", "label": "Line Of Credit Quick Ratio", "terseLabel": "Line of credit quick ratio" } } }, "localname": "LineOfCreditQuickRatio", "nsuri": "http://innovid.com/20221231", "presentation": [ "http://innovid.com/role/LONGTERMDEBTDetails" ], "xbrltype": "decimalItemType" }, "ctv_LongTermLeaseDeposit": { "auth_ref": [], "calculation": { "http://innovid.com/role/CONSOLIDATEDBALANCESHEETS": { "order": 2.0, "parentTag": "us-gaap_AssetsNoncurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Long Term Lease Deposit", "label": "Long Term Lease Deposit", "terseLabel": "Long-term deposit" } } }, "localname": "LongTermLeaseDeposit", "nsuri": "http://innovid.com/20221231", "presentation": [ "http://innovid.com/role/CONSOLIDATEDBALANCESHEETS" ], "xbrltype": "monetaryItemType" }, "ctv_LongTermRestrictedDeposit": { "auth_ref": [], "calculation": { "http://innovid.com/role/CONSOLIDATEDBALANCESHEETS": { "order": 6.0, "parentTag": "us-gaap_AssetsNoncurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Long Term Restricted Deposit", "label": "Long Term Restricted Deposit", "terseLabel": "Long-term restricted deposits" } } }, "localname": "LongTermRestrictedDeposit", "nsuri": "http://innovid.com/20221231", "presentation": [ "http://innovid.com/role/CONSOLIDATEDBALANCESHEETS" ], "xbrltype": "monetaryItemType" }, "ctv_NetProceedsFromTheTransactionBeforeSecondarySaleAmount": { "auth_ref": [], "calculation": { "http://innovid.com/role/TRANSACTIONTransactiontoCashFlowandChangesinTemporaryEquityandStockholdersEquityDetails": { "order": 1.0, "parentTag": "ctv_ReverseRecapitalizationNetOfTransactionCostsBeforeSecondarySaleAmount", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Net Proceeds From the Transaction Before Secondary Sale Amount", "label": "Net Proceeds From the Transaction Before Secondary Sale Amount", "terseLabel": "Proceeds from reverse recapitalization, net" } } }, "localname": "NetProceedsFromTheTransactionBeforeSecondarySaleAmount", "nsuri": "http://innovid.com/20221231", "presentation": [ "http://innovid.com/role/TRANSACTIONTransactiontoCashFlowandChangesinTemporaryEquityandStockholdersEquityDetails" ], "xbrltype": "monetaryItemType" }, "ctv_NoncashInterestExpense": { "auth_ref": [], "calculation": { "http://innovid.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "order": 2.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Noncash Interest Expense", "label": "Noncash Interest Expense", "terseLabel": "Non-cash interest expense" } } }, "localname": "NoncashInterestExpense", "nsuri": "http://innovid.com/20221231", "presentation": [ "http://innovid.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "monetaryItemType" }, "ctv_NoncashOrPartNoncashAcquisitionEquityInstrumentConsiderationEquityIssued": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Noncash Or Part Noncash Acquisition Equity Instrument Consideration Equity Issued", "label": "Noncash Or Part Noncash Acquisition Equity Instrument Consideration Equity Issued", "terseLabel": "Business combination consideration paid in stock" } } }, "localname": "NoncashOrPartNoncashAcquisitionEquityInstrumentConsiderationEquityIssued", "nsuri": "http://innovid.com/20221231", "presentation": [ "http://innovid.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "monetaryItemType" }, "ctv_NoncashPreferredStockAccretionOfRedemptionValue": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Noncash Preferred Stock, Accretion Of Redemption Value", "label": "Noncash Preferred Stock, Accretion Of Redemption Value", "terseLabel": "Accretion of preferred stocks to redemption value" } } }, "localname": "NoncashPreferredStockAccretionOfRedemptionValue", "nsuri": "http://innovid.com/20221231", "presentation": [ "http://innovid.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "monetaryItemType" }, "ctv_NumberOfCommonStockEqualToTheFullyDilutedSharesOutstanding": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of Common Stock Equal to the Fully-Diluted Shares Outstanding", "label": "Number of Common Stock Equal to the Fully-Diluted Shares Outstanding", "terseLabel": "Number of common stock equal to the fully-diluted shares outstanding" } } }, "localname": "NumberOfCommonStockEqualToTheFullyDilutedSharesOutstanding", "nsuri": "http://innovid.com/20221231", "presentation": [ "http://innovid.com/role/STOCKBASEDCOMPENSATIONNarrativeDetails" ], "xbrltype": "percentItemType" }, "ctv_NumberOfIssuedAndOutstandingSharesOfCommonStockFullyDilutedBasis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of Issued and Outstanding Shares of Common Stock Fully Diluted Basis", "label": "Number of Issued and Outstanding Shares of Common Stock Fully Diluted Basis", "terseLabel": "Number of issued and outstanding shares of common stock fully diluted basis" } } }, "localname": "NumberOfIssuedAndOutstandingSharesOfCommonStockFullyDilutedBasis", "nsuri": "http://innovid.com/20221231", "presentation": [ "http://innovid.com/role/STOCKBASEDCOMPENSATIONNarrativeDetails" ], "xbrltype": "percentItemType" }, "ctv_NumberOfSecuritiesPledged": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number Of Securities Pledged", "label": "Number Of Securities Pledged", "terseLabel": "Shares of subsidiary pledged (in shares)" } } }, "localname": "NumberOfSecuritiesPledged", "nsuri": "http://innovid.com/20221231", "presentation": [ "http://innovid.com/role/COMMITMENTSANDCONTINGENTLIABILITIESDetails" ], "xbrltype": "sharesItemType" }, "ctv_NumberOfVotesForEachShare": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of Votes for Each Share", "label": "Number of Votes for Each Share", "terseLabel": "Number of votes for each share" } } }, "localname": "NumberOfVotesForEachShare", "nsuri": "http://innovid.com/20221231", "presentation": [ "http://innovid.com/role/STOCKHOLDERSEQUITYNarrativeDetails" ], "xbrltype": "integerItemType" }, "ctv_OfficeFurnitureAndEquipmentMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Office Furniture And Equipment", "label": "Office Furniture And Equipment [Member]", "terseLabel": "Office furniture and equipment" } } }, "localname": "OfficeFurnitureAndEquipmentMember", "nsuri": "http://innovid.com/20221231", "presentation": [ "http://innovid.com/role/PROPERTYANDEQUIPMENTNETDetails", "http://innovid.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESScheduleofPropertyPlantandEquipmentDetails" ], "xbrltype": "domainItemType" }, "ctv_OperatingLeasesAssetsAndLiabilitiesLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Operating Leases Assets And Liabilities", "label": "Operating Leases Assets And Liabilities [Line Items]", "terseLabel": "Operating Leases Assets And Liabilities [Line Items]" } } }, "localname": "OperatingLeasesAssetsAndLiabilitiesLineItems", "nsuri": "http://innovid.com/20221231", "presentation": [ "http://innovid.com/role/LEASESScheduleofoperatingROUassetsandleaseliabilitiesDetails" ], "xbrltype": "stringItemType" }, "ctv_PIPEInvestorsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "PIPE Investors", "label": "PIPE Investors [Member]", "terseLabel": "PIPE Investors" } } }, "localname": "PIPEInvestorsMember", "nsuri": "http://innovid.com/20221231", "presentation": [ "http://innovid.com/role/TRANSACTIONNarrativeDetails", "http://innovid.com/role/TRANSACTIONTransactiontoCashFlowandChangesinTemporaryEquityandStockholdersEquityDetails" ], "xbrltype": "domainItemType" }, "ctv_PaycheckProtectionProgramMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Paycheck Protection Program", "label": "Paycheck Protection Program [Member]", "terseLabel": "Paycheck Protection Program" } } }, "localname": "PaycheckProtectionProgramMember", "nsuri": "http://innovid.com/20221231", "presentation": [ "http://innovid.com/role/FINANCEEXPENSESINCOMENETDetails" ], "xbrltype": "domainItemType" }, "ctv_PaymentsOfReverseRecapitalizationTransactionCosts": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Payments of Reverse Recapitalization Transaction Costs", "label": "Payments of Reverse Recapitalization Transaction Costs", "negatedTerseLabel": "Less: Transaction costs paid" } } }, "localname": "PaymentsOfReverseRecapitalizationTransactionCosts", "nsuri": "http://innovid.com/20221231", "presentation": [ "http://innovid.com/role/TRANSACTIONTransactiontoCashFlowandChangesinTemporaryEquityandStockholdersEquityDetails" ], "xbrltype": "monetaryItemType" }, "ctv_PaymentsOfReverseRecapitalizationTransactionCostsWarrants": { "auth_ref": [], "calculation": { "http://innovid.com/role/TRANSACTIONTransactiontoCashFlowandChangesinTemporaryEquityandStockholdersEquityDetails": { "order": 2.0, "parentTag": "ctv_ReverseRecapitalizationNetOfTransactionCostsBeforeSecondarySaleAmount", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Payments of Reverse Recapitalization Transaction Costs, Warrants", "label": "Payments of Reverse Recapitalization Transaction Costs, Warrants", "terseLabel": "Plus: Transaction costs allocated to Company Warrant" } } }, "localname": "PaymentsOfReverseRecapitalizationTransactionCostsWarrants", "nsuri": "http://innovid.com/20221231", "presentation": [ "http://innovid.com/role/TRANSACTIONTransactiontoCashFlowandChangesinTemporaryEquityandStockholdersEquityDetails" ], "xbrltype": "monetaryItemType" }, "ctv_PaymentsToAcquireShortTermBankDeposits": { "auth_ref": [], "calculation": { "http://innovid.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "order": 4.0, "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Payments To Acquire Short Term Bank Deposits", "label": "Payments To Acquire Short Term Bank Deposits", "negatedTerseLabel": "Change in short-term bank deposits" } } }, "localname": "PaymentsToAcquireShortTermBankDeposits", "nsuri": "http://innovid.com/20221231", "presentation": [ "http://innovid.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "monetaryItemType" }, "ctv_PreferredStocksAccretionToRedemptionValueAdjustment": { "auth_ref": [], "calculation": { "http://innovid.com/role/BASICANDDILUTEDNETLOSSPERSHAREBasicandDilutedNetlossPerShareDetails": { "order": 2.0, "parentTag": "us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Preferred Stocks, Accretion To Redemption Value, Adjustment", "label": "Preferred Stocks, Accretion To Redemption Value, Adjustment", "negatedLabel": "Accretion of preferred stocks to redemption value" } } }, "localname": "PreferredStocksAccretionToRedemptionValueAdjustment", "nsuri": "http://innovid.com/20221231", "presentation": [ "http://innovid.com/role/BASICANDDILUTEDNETLOSSPERSHAREBasicandDilutedNetlossPerShareDetails" ], "xbrltype": "monetaryItemType" }, "ctv_PreferredStocksMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Preferred Stocks [Member]", "label": "Preferred Stocks [Member]", "terseLabel": "Preferred stocks" } } }, "localname": "PreferredStocksMember", "nsuri": "http://innovid.com/20221231", "presentation": [ "http://innovid.com/role/BASICANDDILUTEDNETLOSSPERSHARESecuritiesExcludedfromComputationofEarningsPerShareDetails" ], "xbrltype": "domainItemType" }, "ctv_PrivatePlacementWarrantsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Private Placement Warrants", "label": "Private Placement Warrants [Member]", "terseLabel": "Private Placement Warrants" } } }, "localname": "PrivatePlacementWarrantsMember", "nsuri": "http://innovid.com/20221231", "presentation": [ "http://innovid.com/role/TRANSACTIONNarrativeDetails", "http://innovid.com/role/WARRANTSDetails" ], "xbrltype": "domainItemType" }, "ctv_PrivateWarrantsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Private Warrants", "label": "Private Warrants [Member]", "terseLabel": "Private Warrants" } } }, "localname": "PrivateWarrantsMember", "nsuri": "http://innovid.com/20221231", "presentation": [ "http://innovid.com/role/WARRANTSDetails" ], "xbrltype": "domainItemType" }, "ctv_ProceedsFromPaymentsForOtherDepositsInvestingActivities": { "auth_ref": [], "calculation": { "http://innovid.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "order": 2.0, "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Proceeds From (Payments For) Other Deposits, Investing Activities", "label": "Proceeds From (Payments For) Other Deposits, Investing Activities", "terseLabel": "Other deposits" } } }, "localname": "ProceedsFromPaymentsForOtherDepositsInvestingActivities", "nsuri": "http://innovid.com/20221231", "presentation": [ "http://innovid.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "monetaryItemType" }, "ctv_ProceedsFromReverseRecapitalizationNet": { "auth_ref": [], "calculation": { "http://innovid.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "order": 5.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Proceeds From Reverse Recapitalization, Net", "label": "Proceeds From Reverse Recapitalization, Net", "verboseLabel": "Proceeds from reverse recapitalization, net" } } }, "localname": "ProceedsFromReverseRecapitalizationNet", "nsuri": "http://innovid.com/20221231", "presentation": [ "http://innovid.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "monetaryItemType" }, "ctv_PublicMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Public [Member]", "label": "Public [Member]", "terseLabel": "Public" } } }, "localname": "PublicMember", "nsuri": "http://innovid.com/20221231", "presentation": [ "http://innovid.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails" ], "xbrltype": "domainItemType" }, "ctv_PublicWarrantsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Public Warrants [Member]", "label": "Public Warrants [Member]", "terseLabel": "Public Warrants" } } }, "localname": "PublicWarrantsMember", "nsuri": "http://innovid.com/20221231", "presentation": [ "http://innovid.com/role/TRANSACTIONNarrativeDetails", "http://innovid.com/role/WARRANTSDetails" ], "xbrltype": "domainItemType" }, "ctv_QuarterlyAdjustedQuickRatio": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Quarterly Adjusted Quick Ratio", "label": "Quarterly Adjusted Quick Ratio", "terseLabel": "Quarterly adjusted quick ratio" } } }, "localname": "QuarterlyAdjustedQuickRatio", "nsuri": "http://innovid.com/20221231", "presentation": [ "http://innovid.com/role/LONGTERMDEBTDetails" ], "xbrltype": "decimalItemType" }, "ctv_RedemptionOfWarrantPricePerShareEqualsOrExceeds1000Member": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Redemption Of Warrant Price Per Share Equals Or Exceeds 10.00", "label": "Redemption Of Warrant Price Per Share Equals Or Exceeds 10.00 [Member]", "terseLabel": "Redemption Of Warrant Price Per Share Equals Or Exceeds 10.00" } } }, "localname": "RedemptionOfWarrantPricePerShareEqualsOrExceeds1000Member", "nsuri": "http://innovid.com/20221231", "presentation": [ "http://innovid.com/role/WARRANTSDetails" ], "xbrltype": "domainItemType" }, "ctv_RedemptionOfWarrantPricePerShareEqualsOrExceeds1800Member": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Redemption Of Warrant Price Per Share Equals Or Exceeds 18.00", "label": "Redemption Of Warrant Price Per Share Equals Or Exceeds 18.00 [Member]", "terseLabel": "Redemption Of Warrant Price Per Share Equals Or Exceeds 18.00" } } }, "localname": "RedemptionOfWarrantPricePerShareEqualsOrExceeds1800Member", "nsuri": "http://innovid.com/20221231", "presentation": [ "http://innovid.com/role/WARRANTSDetails" ], "xbrltype": "domainItemType" }, "ctv_RentalOfPremisesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Rental Of Premises", "label": "Rental Of Premises [Member]", "terseLabel": "Rental of premises" } } }, "localname": "RentalOfPremisesMember", "nsuri": "http://innovid.com/20221231", "presentation": [ "http://innovid.com/role/LEASESScheduleOfCommitmentsUnderNonCancelableOperatingLeasesDetails" ], "xbrltype": "domainItemType" }, "ctv_RepaymentOfAcquisitionLiability": { "auth_ref": [], "calculation": { "http://innovid.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "order": 3.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Repayment of Acquisition Liability", "label": "Repayment of Acquisition Liability", "negatedLabel": "Repayment of acquisition liability" } } }, "localname": "RepaymentOfAcquisitionLiability", "nsuri": "http://innovid.com/20221231", "presentation": [ "http://innovid.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "monetaryItemType" }, "ctv_RestOfTheWorldMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Rest of the World [Member]", "label": "Rest Of The World [Member]", "terseLabel": "Rest of the World" } } }, "localname": "RestOfTheWorldMember", "nsuri": "http://innovid.com/20221231", "presentation": [ "http://innovid.com/role/SEGMENTREPORTINGRevenueandPropertyandEquipmentbyGeographicalAreasDetails" ], "xbrltype": "domainItemType" }, "ctv_RestructuringAndRelatedCostNumberOfEmployeeEntitledMonthlyDepositPeriodPercent": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Restructuring and Related Cost, Number of Employee Entitled Monthly Deposit, Period Percent", "label": "Restructuring and Related Cost, Number of Employee Entitled Monthly Deposit, Period Percent", "terseLabel": "Number of employee deposit, percent" } } }, "localname": "RestructuringAndRelatedCostNumberOfEmployeeEntitledMonthlyDepositPeriodPercent", "nsuri": "http://innovid.com/20221231", "presentation": [ "http://innovid.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails" ], "xbrltype": "percentItemType" }, "ctv_RevenueFromContractWithCustomerPaymentTerm": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Revenue From Contract With Customer, Payment Term", "label": "Revenue From Contract With Customer, Payment Term", "terseLabel": "Payment term" } } }, "localname": "RevenueFromContractWithCustomerPaymentTerm", "nsuri": "http://innovid.com/20221231", "presentation": [ "http://innovid.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails" ], "xbrltype": "durationItemType" }, "ctv_RevenueRecognitionAdvertisementServingServicesPercentage": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Revenue Recognition, Advertisement Serving Services, Percentage", "label": "Revenue Recognition, Advertisement Serving Services, Percentage", "terseLabel": "Ad serving services" } } }, "localname": "RevenueRecognitionAdvertisementServingServicesPercentage", "nsuri": "http://innovid.com/20221231", "presentation": [ "http://innovid.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails" ], "xbrltype": "percentItemType" }, "ctv_RevenueRecognitionCreativeServingPercentage": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Revenue Recognition, Creative Serving, Percentage", "label": "Revenue Recognition, Creative Serving, Percentage", "terseLabel": "Creative serving services" } } }, "localname": "RevenueRecognitionCreativeServingPercentage", "nsuri": "http://innovid.com/20221231", "presentation": [ "http://innovid.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails" ], "xbrltype": "percentItemType" }, "ctv_RevenueRecognitionMeasurementServingPercentage": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Revenue Recognition, Measurement Serving, Percentage", "label": "Revenue Recognition, Measurement Serving, Percentage", "terseLabel": "Measurement serving services" } } }, "localname": "RevenueRecognitionMeasurementServingPercentage", "nsuri": "http://innovid.com/20221231", "presentation": [ "http://innovid.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails" ], "xbrltype": "percentItemType" }, "ctv_ReverseRecapitalizationNetOfTransactionCostsBeforeSecondarySaleAmount": { "auth_ref": [], "calculation": { "http://innovid.com/role/TRANSACTIONTransactiontoCashFlowandChangesinTemporaryEquityandStockholdersEquityDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Reverse Recapitalization, Net of Transaction Costs Before Secondary Sale Amount", "label": "Reverse Recapitalization, Net of Transaction Costs Before Secondary Sale Amount", "totalLabel": "Reverse recapitalization, net" } } }, "localname": "ReverseRecapitalizationNetOfTransactionCostsBeforeSecondarySaleAmount", "nsuri": "http://innovid.com/20221231", "presentation": [ "http://innovid.com/role/TRANSACTIONTransactiontoCashFlowandChangesinTemporaryEquityandStockholdersEquityDetails" ], "xbrltype": "monetaryItemType" }, "ctv_ReverseRecapitalizationNetShare": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Reverse Recapitalization, Net, Share", "label": "Reverse Recapitalization, Net, Share", "terseLabel": "Reverse recapitalization, net (in shares)" } } }, "localname": "ReverseRecapitalizationNetShare", "nsuri": "http://innovid.com/20221231", "presentation": [ "http://innovid.com/role/STATEMENTSOFCHANGESINTEMPORARYEQUITYANDSTOCKHOLDERSEQUITYDEFICIT" ], "xbrltype": "sharesItemType" }, "ctv_ReverseRecapitalizationValueNet": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Reverse Recapitalization, Value, Net", "label": "Reverse Recapitalization, Value, Net", "terseLabel": "Reverse recapitalization, net" } } }, "localname": "ReverseRecapitalizationValueNet", "nsuri": "http://innovid.com/20221231", "presentation": [ "http://innovid.com/role/STATEMENTSOFCHANGESINTEMPORARYEQUITYANDSTOCKHOLDERSEQUITYDEFICIT" ], "xbrltype": "monetaryItemType" }, "ctv_RightOfUseAssetsObtainedInExchangeForOperatingLeaseLiabilitieUponLeaseModification": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Right Of Use Assets Obtained In Exchange For Operating Lease Liabilitie Upon Lease Modification", "label": "Right Of Use Assets Obtained In Exchange For Operating Lease Liabilitie Upon Lease Modification", "terseLabel": "Right of use assets obtained in exchange for operating lease liabilities upon lease modification" } } }, "localname": "RightOfUseAssetsObtainedInExchangeForOperatingLeaseLiabilitieUponLeaseModification", "nsuri": "http://innovid.com/20221231", "presentation": [ "http://innovid.com/role/LEASESupplementaryCashFlowInformationDetails" ], "xbrltype": "monetaryItemType" }, "ctv_SalesAndMarketingPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Sales and Marketing", "label": "Sales and Marketing [Policy Text Block]", "terseLabel": "Sales and marketing" } } }, "localname": "SalesAndMarketingPolicyTextBlock", "nsuri": "http://innovid.com/20221231", "presentation": [ "http://innovid.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies" ], "xbrltype": "textBlockItemType" }, "ctv_ScheduleOfReverseRecapitalizationTable": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Schedule Of Reverse Recapitalization", "label": "Schedule Of Reverse Recapitalization [Table]", "terseLabel": "Schedule of Related Party Transactions, by Related Party [Table]" } } }, "localname": "ScheduleOfReverseRecapitalizationTable", "nsuri": "http://innovid.com/20221231", "presentation": [ "http://innovid.com/role/TRANSACTIONNarrativeDetails", "http://innovid.com/role/TRANSACTIONTransactiontoCashFlowandChangesinTemporaryEquityandStockholdersEquityDetails" ], "xbrltype": "stringItemType" }, "ctv_ScheduleOfReverseRecapitalizationTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Schedule Of Reverse Recapitalization", "label": "Schedule Of Reverse Recapitalization [Table Text Block]", "terseLabel": "Schedule of Reverse Recapitalization" } } }, "localname": "ScheduleOfReverseRecapitalizationTableTextBlock", "nsuri": "http://innovid.com/20221231", "presentation": [ "http://innovid.com/role/TRANSACTIONTables" ], "xbrltype": "textBlockItemType" }, "ctv_SecondarySaleMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Secondary Sale [Member]", "label": "Secondary Sale [Member]", "terseLabel": "Secondary Sale" } } }, "localname": "SecondarySaleMember", "nsuri": "http://innovid.com/20221231", "presentation": [ "http://innovid.com/role/TRANSACTIONNarrativeDetails" ], "xbrltype": "domainItemType" }, "ctv_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsReleasedInPeriod": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Share-based Compensation Arrangement By Share-based Payment Award, Equity Instruments Other Than Options, Released In Period", "label": "Share-based Compensation Arrangement By Share-based Payment Award, Equity Instruments Other Than Options, Released In Period", "negatedLabel": "Released (in shares)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsReleasedInPeriod", "nsuri": "http://innovid.com/20221231", "presentation": [ "http://innovid.com/role/STOCKBASEDCOMPENSATIONRestrictedStockUnitActivityDetails" ], "xbrltype": "sharesItemType" }, "ctv_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsReleasedInPeriodWeightedAverageGrantDateFairValue": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Released In Period Weighted Average Grant Date Fair Value", "label": "Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Released In Period Weighted Average Grant Date Fair Value", "terseLabel": "Released (in USD per share)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsReleasedInPeriodWeightedAverageGrantDateFairValue", "nsuri": "http://innovid.com/20221231", "presentation": [ "http://innovid.com/role/STOCKBASEDCOMPENSATIONRestrictedStockUnitActivityDetails" ], "xbrltype": "perShareItemType" }, "ctv_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantedInAcquisitionGross": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Share Based Compensation Arrangement By Share Based Payment Award, Options, Granted In Acquisition, Gross", "label": "Share Based Compensation Arrangement By Share Based Payment Award, Options, Granted In Acquisition, Gross", "terseLabel": "Granted in acquisition (in shares)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantedInAcquisitionGross", "nsuri": "http://innovid.com/20221231", "presentation": [ "http://innovid.com/role/STOCKBASEDCOMPENSATIONStockOptionActivityDetails" ], "xbrltype": "sharesItemType" }, "ctv_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsTransferBetweenEmployeeAndConsultant": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Transfer Between Employee And Consultant", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Transfer Between Employee And Consultant", "terseLabel": "Transfer between employee and consultant (in shares)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsTransferBetweenEmployeeAndConsultant", "nsuri": "http://innovid.com/20221231", "presentation": [ "http://innovid.com/role/STOCKBASEDCOMPENSATIONStockOptionActivityDetails" ], "xbrltype": "sharesItemType" }, "ctv_ShareBasedCompensationArrangementByShareBasedPaymentAwardStockOptionsExercisedAndRestrictedStockUnitsVestedInPeriodShares": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Share Based Compensation Arrangement By Share Based Payment Award, Stock Options Exercised And Restricted Stock Units Vested In Period, Shares", "label": "Share Based Compensation Arrangement By Share Based Payment Award, Stock Options Exercised And Restricted Stock Units Vested In Period, Shares", "terseLabel": "Stock options exercised and RSUs vested (in shares)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardStockOptionsExercisedAndRestrictedStockUnitsVestedInPeriodShares", "nsuri": "http://innovid.com/20221231", "presentation": [ "http://innovid.com/role/STATEMENTSOFCHANGESINTEMPORARYEQUITYANDSTOCKHOLDERSEQUITYDEFICIT" ], "xbrltype": "sharesItemType" }, "ctv_ShareBasedCompensationArrangementByShareBasedPaymentAwardStockOptionsExercisedAndRestrictedStockUnitsVestedInPeriodValue": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Share Based Compensation Arrangement By Share Based Payment Award, Stock Options Exercised And Restricted Stock Units Vested In Period, Value", "label": "Share Based Compensation Arrangement By Share Based Payment Award, Stock Options Exercised And Restricted Stock Units Vested In Period, Value", "terseLabel": "Stock options exercised and RSUs vested" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardStockOptionsExercisedAndRestrictedStockUnitsVestedInPeriodValue", "nsuri": "http://innovid.com/20221231", "presentation": [ "http://innovid.com/role/STATEMENTSOFCHANGESINTEMPORARYEQUITYANDSTOCKHOLDERSEQUITYDEFICIT" ], "xbrltype": "monetaryItemType" }, "ctv_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantedInAcquisitionWeightedAverageExercisePrice": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Share Based Compensation Arrangements By Share Based Payment Award, Options, Granted In Acquisition, Weighted Average Exercise Price", "label": "Share Based Compensation Arrangements By Share Based Payment Award, Options, Granted In Acquisition, Weighted Average Exercise Price", "terseLabel": "Granted in acquisition (in USD per share)" } } }, "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantedInAcquisitionWeightedAverageExercisePrice", "nsuri": "http://innovid.com/20221231", "presentation": [ "http://innovid.com/role/STOCKBASEDCOMPENSATIONStockOptionActivityDetails" ], "xbrltype": "perShareItemType" }, "ctv_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsTransferBetweenEmployeeAndConsultantWeightedAverageExercisePrice": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Share-based Compensation Arrangements by Share-based Payment Award, Options, Transfer Between Employee And Consultant, Weighted Average Exercise Price", "label": "Share-based Compensation Arrangements by Share-based Payment Award, Options, Transfer Between Employee And Consultant, Weighted Average Exercise Price", "terseLabel": "Transfer between employee and consultant (in USD per share)" } } }, "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsTransferBetweenEmployeeAndConsultantWeightedAverageExercisePrice", "nsuri": "http://innovid.com/20221231", "presentation": [ "http://innovid.com/role/STOCKBASEDCOMPENSATIONStockOptionActivityDetails" ], "xbrltype": "perShareItemType" }, "ctv_SharesOutstandingOnTheFinalDayOfTheImmediatelyPreceding": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Shares Outstanding on the Final Day of the Immediately Preceding", "label": "Shares Outstanding on the Final Day of the Immediately Preceding", "terseLabel": "Shares outstanding on the final day of the immediately preceding" } } }, "localname": "SharesOutstandingOnTheFinalDayOfTheImmediatelyPreceding", "nsuri": "http://innovid.com/20221231", "presentation": [ "http://innovid.com/role/STOCKBASEDCOMPENSATIONNarrativeDetails" ], "xbrltype": "percentItemType" }, "ctv_ShortTermBankDepositCurrent": { "auth_ref": [], "calculation": { "http://innovid.com/role/CONSOLIDATEDBALANCESHEETS": { "order": 4.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Short Term Bank Deposit, Current", "label": "Short Term Bank Deposit, Current", "terseLabel": "Short-term bank deposit" } } }, "localname": "ShortTermBankDepositCurrent", "nsuri": "http://innovid.com/20221231", "presentation": [ "http://innovid.com/role/CONSOLIDATEDBALANCESHEETS", "http://innovid.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "ctv_ShortTermBankDepositsPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Short-Term Bank Deposits", "label": "Short-Term Bank Deposits [Policy Text Block]", "terseLabel": "Short-term bank deposits" } } }, "localname": "ShortTermBankDepositsPolicyTextBlock", "nsuri": "http://innovid.com/20221231", "presentation": [ "http://innovid.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies" ], "xbrltype": "textBlockItemType" }, "ctv_StockIssuedDuringPeriodShareConversionOfWarrants": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Stock Issued During Period, Share, Conversion of Warrants", "label": "Stock Issued During Period, Share, Conversion of Warrants", "terseLabel": "Conversion of Legacy Innovid warrants ( in shares)" } } }, "localname": "StockIssuedDuringPeriodShareConversionOfWarrants", "nsuri": "http://innovid.com/20221231", "presentation": [ "http://innovid.com/role/STATEMENTSOFCHANGESINTEMPORARYEQUITYANDSTOCKHOLDERSEQUITYDEFICIT", "http://innovid.com/role/TRANSACTIONCommonStockinInnovidCorpDetails" ], "xbrltype": "sharesItemType" }, "ctv_StockIssuedDuringPeriodSharesReverseRecapitalization": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Stock Issued During Period, Shares, Reverse Recapitalization", "label": "Stock Issued During Period, Shares, Reverse Recapitalization", "terseLabel": "Exchanged into Innovid Corp. common stock on November 30, 2021 (in shares)" } } }, "localname": "StockIssuedDuringPeriodSharesReverseRecapitalization", "nsuri": "http://innovid.com/20221231", "presentation": [ "http://innovid.com/role/TRANSACTIONCommonStockinInnovidCorpDetails", "http://innovid.com/role/TRANSACTIONNarrativeDetails" ], "xbrltype": "sharesItemType" }, "ctv_StockIssuedDuringPeriodSharesWarrantExercised": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Stock Issued During Period, Shares, Warrant Exercised", "label": "Stock Issued During Period, Shares, Warrant Exercised", "terseLabel": "Warrant exercised (in shares)" } } }, "localname": "StockIssuedDuringPeriodSharesWarrantExercised", "nsuri": "http://innovid.com/20221231", "presentation": [ "http://innovid.com/role/STATEMENTSOFCHANGESINTEMPORARYEQUITYANDSTOCKHOLDERSEQUITYDEFICIT", "http://innovid.com/role/TRANSACTIONCommonStockinInnovidCorpDetails" ], "xbrltype": "sharesItemType" }, "ctv_StockIssuedDuringPeriodValueConversionOfWarrants": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Stock Issued During Period, Value, Conversion of Warrants", "label": "Stock Issued During Period, Value, Conversion of Warrants", "terseLabel": "Conversion of Legacy Innovid Warrants" } } }, "localname": "StockIssuedDuringPeriodValueConversionOfWarrants", "nsuri": "http://innovid.com/20221231", "presentation": [ "http://innovid.com/role/STATEMENTSOFCHANGESINTEMPORARYEQUITYANDSTOCKHOLDERSEQUITYDEFICIT" ], "xbrltype": "monetaryItemType" }, "ctv_SummaryOfSignificantAccountingPoliciesLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Summary of Significant Accounting Policies [Line Items]", "label": "Summary of Significant Accounting Policies [Line Items]", "terseLabel": "Summary of Significant Accounting Policies [Line Items]" } } }, "localname": "SummaryOfSignificantAccountingPoliciesLineItems", "nsuri": "http://innovid.com/20221231", "presentation": [ "http://innovid.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails", "http://innovid.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESScheduleofOperatingLeaseLiabilitiesandROUAssetsDetails" ], "xbrltype": "stringItemType" }, "ctv_SummaryOfSignificantAccountingPoliciesTable": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Summary of Significant Accounting Policies [Table]", "label": "Summary of Significant Accounting Policies [Table]", "terseLabel": "Summary of Significant Accounting Policies [Table]" } } }, "localname": "SummaryOfSignificantAccountingPoliciesTable", "nsuri": "http://innovid.com/20221231", "presentation": [ "http://innovid.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails", "http://innovid.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESScheduleofOperatingLeaseLiabilitiesandROUAssetsDetails" ], "xbrltype": "stringItemType" }, "ctv_TVSquaredMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "TV Squared", "label": "TV Squared [Member]", "terseLabel": "TV Squared" } } }, "localname": "TVSquaredMember", "nsuri": "http://innovid.com/20221231", "presentation": [ "http://innovid.com/role/ACQUISITIONFairValuesoftheAssetsAcquiredandLiabilitiesAssumedDetails", "http://innovid.com/role/ACQUISITIONNarrativeDetails", "http://innovid.com/role/ACQUISITIONUnauditedProFormaFinancialInformationDetails", "http://innovid.com/role/DESCRIPTIONOFBUSINESSDetails", "http://innovid.com/role/INCOMETAXESNarrativeDetails", "http://innovid.com/role/STOCKBASEDCOMPENSATIONNarrativeDetails" ], "xbrltype": "domainItemType" }, "ctv_TemporaryEquityConversionOfRedeemableConvertiblePreferredStockIntoCommonStock": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Temporary Equity Conversion of Redeemable Convertible Preferred Stock Into Common Stock", "label": "Temporary Equity Conversion of Redeemable Convertible Preferred Stock Into Common Stock", "terseLabel": "Conversion of redeemable convertible preferred stock into common stock" } } }, "localname": "TemporaryEquityConversionOfRedeemableConvertiblePreferredStockIntoCommonStock", "nsuri": "http://innovid.com/20221231", "presentation": [ "http://innovid.com/role/STATEMENTSOFCHANGESINTEMPORARYEQUITYANDSTOCKHOLDERSEQUITYDEFICIT" ], "xbrltype": "monetaryItemType" }, "ctv_TemporaryEquityConversionOfRedeemableConvertiblePreferredStockIntoCommonStockShares": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Temporary Equity Conversion of Redeemable Convertible Preferred Stock Into Common Stock, Shares", "label": "Temporary Equity Conversion of Redeemable Convertible Preferred Stock Into Common Stock, Shares", "negatedTerseLabel": "Conversion of redeemable convertible preferred stock into common stock (in shares)" } } }, "localname": "TemporaryEquityConversionOfRedeemableConvertiblePreferredStockIntoCommonStockShares", "nsuri": "http://innovid.com/20221231", "presentation": [ "http://innovid.com/role/STATEMENTSOFCHANGESINTEMPORARYEQUITYANDSTOCKHOLDERSEQUITYDEFICIT" ], "xbrltype": "sharesItemType" }, "ctv_TemporaryEquitySecondarySaleAmount": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Temporary Equity Secondary Sale Amount", "label": "Temporary Equity Secondary Sale Amount", "terseLabel": "Secondary sale amount" } } }, "localname": "TemporaryEquitySecondarySaleAmount", "nsuri": "http://innovid.com/20221231", "presentation": [ "http://innovid.com/role/DESCRIPTIONOFBUSINESSDetails", "http://innovid.com/role/TRANSACTIONTransactiontoCashFlowandChangesinTemporaryEquityandStockholdersEquityDetails" ], "xbrltype": "monetaryItemType" }, "ctv_ThresholdPeriodForNotToTransferAssignOrSellAnySharesOrWarrantsAfterCompletionOfInitialBusinessCombination": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Threshold Period for Not to Transfer, Assign or Sell Any Shares or Warrants After Completion of Initial Business Combination", "label": "Threshold Period for Not to Transfer, Assign or Sell Any Shares or Warrants After Completion of Initial Business Combination", "terseLabel": "Threshold period for not to transfer, assign or sell any shares or warrants after completion of initial business combination" } } }, "localname": "ThresholdPeriodForNotToTransferAssignOrSellAnySharesOrWarrantsAfterCompletionOfInitialBusinessCombination", "nsuri": "http://innovid.com/20221231", "presentation": [ "http://innovid.com/role/WARRANTSDetails" ], "xbrltype": "durationItemType" }, "ctv_TransactionCostsAllocatedToWarrants": { "auth_ref": [], "calculation": { "http://innovid.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "order": 5.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Transaction Costs Allocated to Warrants", "label": "Transaction Costs Allocated to Warrants", "terseLabel": "Transaction costs allocated to warrants" } } }, "localname": "TransactionCostsAllocatedToWarrants", "nsuri": "http://innovid.com/20221231", "presentation": [ "http://innovid.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "monetaryItemType" }, "ctv_UnrecognizedTaxBenefitsPositionExpirationTaxPositions": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Unrecognized Tax Benefits, Position Expiration Tax Positions", "label": "Unrecognized Tax Benefits, Position Expiration Tax Positions", "terseLabel": "Position expiration" } } }, "localname": "UnrecognizedTaxBenefitsPositionExpirationTaxPositions", "nsuri": "http://innovid.com/20221231", "presentation": [ "http://innovid.com/role/INCOMETAXESIncomeTaxContingenciesDetails" ], "xbrltype": "monetaryItemType" }, "ctv_WarrantAssumedAsPartOfTransaction": { "auth_ref": [], "calculation": { "http://innovid.com/role/TRANSACTIONTransactiontoCashFlowandChangesinTemporaryEquityandStockholdersEquityDetails": { "order": 3.0, "parentTag": "ctv_ReverseRecapitalizationNetOfTransactionCostsBeforeSecondarySaleAmount", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Warrant Assumed as Part of Transaction", "label": "Warrant Assumed as Part of Transaction", "negatedTerseLabel": "Less: Company Warrant assumed as part of the Transaction" } } }, "localname": "WarrantAssumedAsPartOfTransaction", "nsuri": "http://innovid.com/20221231", "presentation": [ "http://innovid.com/role/TRANSACTIONTransactiontoCashFlowandChangesinTemporaryEquityandStockholdersEquityDetails" ], "xbrltype": "monetaryItemType" }, "ctv_WarrantLiabilityNoncurrent": { "auth_ref": [], "calculation": { "http://innovid.com/role/CONSOLIDATEDBALANCESHEETS": { "order": 1.0, "parentTag": "us-gaap_LiabilitiesNoncurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Warrant Liability, Noncurrent", "label": "Warrant Liability, Noncurrent", "terseLabel": "Warrants liability" } } }, "localname": "WarrantLiabilityNoncurrent", "nsuri": "http://innovid.com/20221231", "presentation": [ "http://innovid.com/role/CONSOLIDATEDBALANCESHEETS" ], "xbrltype": "monetaryItemType" }, "ctv_WarrantsAndRightsOutstandingExercisableTermFromClosingOfBusinessCombination": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Warrants And Rights Outstanding Exercisable Term From Closing Of Business Combination", "label": "Warrants And Rights Outstanding Exercisable Term From Closing Of Business Combination", "terseLabel": "Exercisable term from closing of business combination" } } }, "localname": "WarrantsAndRightsOutstandingExercisableTermFromClosingOfBusinessCombination", "nsuri": "http://innovid.com/20221231", "presentation": [ "http://innovid.com/role/TRANSACTIONNarrativeDetails", "http://innovid.com/role/WARRANTSDetails" ], "xbrltype": "durationItemType" }, "ctv_WarrantsAndRightsOutstandingExercisableTermFromClosingOfPublicOffering": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Warrants And Rights Outstanding, Exercisable Term, From Closing Of Public Offering", "label": "Warrants And Rights Outstanding, Exercisable Term, From Closing Of Public Offering", "terseLabel": "Exercisable term, from closing of public offering" } } }, "localname": "WarrantsAndRightsOutstandingExercisableTermFromClosingOfPublicOffering", "nsuri": "http://innovid.com/20221231", "presentation": [ "http://innovid.com/role/WARRANTSDetails" ], "xbrltype": "durationItemType" }, "ctv_WarrantsLiabilityMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Warrants Liability", "label": "Warrants Liability [Member]", "terseLabel": "Warrants Liability" } } }, "localname": "WarrantsLiabilityMember", "nsuri": "http://innovid.com/20221231", "presentation": [ "http://innovid.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESScheduleofFairValueLiabilitiesMeasuredonRecurringBasisUnobservableInputReconciliationDetails" ], "xbrltype": "domainItemType" }, "ctv_WarrantsLiabilityPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Warrants Liability", "label": "Warrants Liability [Policy Text Block]", "terseLabel": "Warrants" } } }, "localname": "WarrantsLiabilityPolicyTextBlock", "nsuri": "http://innovid.com/20221231", "presentation": [ "http://innovid.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies" ], "xbrltype": "textBlockItemType" }, "dei_AmendmentFlag": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.", "label": "Amendment Flag", "terseLabel": "Amendment Flag" } } }, "localname": "AmendmentFlag", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://innovid.com/role/CoverPage" ], "xbrltype": "booleanItemType" }, "dei_AuditorFirmId": { "auth_ref": [ "r792", "r793", "r794" ], "lang": { "en-us": { "role": { "documentation": "PCAOB issued Audit Firm Identifier", "label": "Auditor Firm ID", "terseLabel": "Auditor Firm ID" } } }, "localname": "AuditorFirmId", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://innovid.com/role/AuditInformation" ], "xbrltype": "nonemptySequenceNumberItemType" }, "dei_AuditorLocation": { "auth_ref": [ "r792", "r793", "r794" ], "lang": { "en-us": { "role": { "label": "Auditor Location", "terseLabel": "Auditor Location" } } }, "localname": "AuditorLocation", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://innovid.com/role/AuditInformation" ], "xbrltype": "internationalNameItemType" }, "dei_AuditorName": { "auth_ref": [ "r792", "r793", "r794" ], "lang": { "en-us": { "role": { "label": "Auditor Name", "terseLabel": "Auditor Name" } } }, "localname": "AuditorName", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://innovid.com/role/AuditInformation" ], "xbrltype": "internationalNameItemType" }, "dei_CityAreaCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Area code of city", "label": "City Area Code", "terseLabel": "City Area Code" } } }, "localname": "CityAreaCode", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://innovid.com/role/CoverPage" ], "xbrltype": "normalizedStringItemType" }, "dei_CoverAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Cover page.", "label": "Cover [Abstract]" } } }, "localname": "CoverAbstract", "nsuri": "http://xbrl.sec.gov/dei/2022", "xbrltype": "stringItemType" }, "dei_CurrentFiscalYearEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "End date of current fiscal year in the format --MM-DD.", "label": "Current Fiscal Year End Date", "terseLabel": "Current Fiscal Year End Date" } } }, "localname": "CurrentFiscalYearEndDate", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://innovid.com/role/CoverPage" ], "xbrltype": "gMonthDayItemType" }, "dei_DocumentAnnualReport": { "auth_ref": [ "r792", "r793", "r794" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as an annual report.", "label": "Document Annual Report", "terseLabel": "Document Annual Report" } } }, "localname": "DocumentAnnualReport", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://innovid.com/role/CoverPage" ], "xbrltype": "booleanItemType" }, "dei_DocumentFiscalPeriodFocus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.", "label": "Document Fiscal Period Focus", "terseLabel": "Document Fiscal Period Focus" } } }, "localname": "DocumentFiscalPeriodFocus", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://innovid.com/role/CoverPage" ], "xbrltype": "fiscalPeriodItemType" }, "dei_DocumentFiscalYearFocus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.", "label": "Document Fiscal Year Focus", "terseLabel": "Document Fiscal Year Focus" } } }, "localname": "DocumentFiscalYearFocus", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://innovid.com/role/CoverPage" ], "xbrltype": "gYearItemType" }, "dei_DocumentInformationLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Document Information [Line Items]", "terseLabel": "Document Information [Line Items]" } } }, "localname": "DocumentInformationLineItems", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://innovid.com/role/CoverPage" ], "xbrltype": "stringItemType" }, "dei_DocumentInformationTable": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Container to support the formal attachment of each official or unofficial, public or private document as part of a submission package.", "label": "Document Information [Table]", "terseLabel": "Document Information [Table]" } } }, "localname": "DocumentInformationTable", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://innovid.com/role/CoverPage" ], "xbrltype": "stringItemType" }, "dei_DocumentPeriodEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.", "label": "Document Period End Date", "terseLabel": "Document Period End Date" } } }, "localname": "DocumentPeriodEndDate", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://innovid.com/role/CoverPage" ], "xbrltype": "dateItemType" }, "dei_DocumentTransitionReport": { "auth_ref": [ "r795" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as a transition report.", "label": "Document Transition Report", "terseLabel": "Document Transition Report" } } }, "localname": "DocumentTransitionReport", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://innovid.com/role/CoverPage" ], "xbrltype": "booleanItemType" }, "dei_DocumentType": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.", "label": "Document Type", "terseLabel": "Document Type" } } }, "localname": "DocumentType", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://innovid.com/role/CoverPage" ], "xbrltype": "submissionTypeItemType" }, "dei_DocumentsIncorporatedByReferenceTextBlock": { "auth_ref": [ "r790" ], "lang": { "en-us": { "role": { "documentation": "Documents incorporated by reference.", "label": "Documents Incorporated by Reference [Text Block]", "terseLabel": "Documents Incorporated by Reference" } } }, "localname": "DocumentsIncorporatedByReferenceTextBlock", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://innovid.com/role/CoverPage" ], "xbrltype": "textBlockItemType" }, "dei_EntityAddressAddressLine1": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 1 such as Attn, Building Name, Street Name", "label": "Entity Address, Address Line One", "terseLabel": "Entity Address, Address Line One" } } }, "localname": "EntityAddressAddressLine1", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://innovid.com/role/CoverPage" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressAddressLine2": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 2 such as Street or Suite number", "label": "Entity Address, Address Line Two", "terseLabel": "Entity Address, Address Line Two" } } }, "localname": "EntityAddressAddressLine2", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://innovid.com/role/CoverPage" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCityOrTown": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the City or Town", "label": "Entity Address, City or Town", "terseLabel": "Entity Address, City or Town" } } }, "localname": "EntityAddressCityOrTown", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://innovid.com/role/CoverPage" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressPostalZipCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Code for the postal or zip code", "label": "Entity Address, Postal Zip Code", "terseLabel": "Entity Address, Postal Zip Code" } } }, "localname": "EntityAddressPostalZipCode", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://innovid.com/role/CoverPage" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressStateOrProvince": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the state or province.", "label": "Entity Address, State or Province", "terseLabel": "Entity Address, State or Province" } } }, "localname": "EntityAddressStateOrProvince", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://innovid.com/role/CoverPage" ], "xbrltype": "stateOrProvinceItemType" }, "dei_EntityCentralIndexKey": { "auth_ref": [ "r789" ], "lang": { "en-us": { "role": { "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.", "label": "Entity Central Index Key", "terseLabel": "Entity Central Index Key" } } }, "localname": "EntityCentralIndexKey", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://innovid.com/role/CoverPage" ], "xbrltype": "centralIndexKeyItemType" }, "dei_EntityCommonStockSharesOutstanding": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.", "label": "Entity Common Stock, Shares Outstanding", "terseLabel": "Entity Common Stock, Shares Outstanding" } } }, "localname": "EntityCommonStockSharesOutstanding", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://innovid.com/role/CoverPage" ], "xbrltype": "sharesItemType" }, "dei_EntityCurrentReportingStatus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.", "label": "Entity Current Reporting Status", "terseLabel": "Entity Current Reporting Status" } } }, "localname": "EntityCurrentReportingStatus", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://innovid.com/role/CoverPage" ], "xbrltype": "yesNoItemType" }, "dei_EntityDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "All the names of the entities being reported upon in a document. Any legal structure used to conduct activities or to hold assets. Some examples of such structures are corporations, partnerships, limited liability companies, grantor trusts, and other trusts. This item does not include business and geographical segments which are included in the geographical or business segments domains.", "label": "Entity [Domain]", "terseLabel": "Entity [Domain]" } } }, "localname": "EntityDomain", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://innovid.com/role/COMMITMENTSANDCONTINGENTLIABILITIESDetails", "http://innovid.com/role/TRANSACTIONCommonStockinInnovidCorpDetails", "http://innovid.com/role/TRANSACTIONNarrativeDetails", "http://innovid.com/role/TRANSACTIONTransactiontoCashFlowandChangesinTemporaryEquityandStockholdersEquityDetails", "http://innovid.com/role/WARRANTSDetails" ], "xbrltype": "domainItemType" }, "dei_EntityEmergingGrowthCompany": { "auth_ref": [ "r789" ], "lang": { "en-us": { "role": { "documentation": "Indicate if registrant meets the emerging growth company criteria.", "label": "Entity Emerging Growth Company", "terseLabel": "Entity Emerging Growth Company" } } }, "localname": "EntityEmergingGrowthCompany", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://innovid.com/role/CoverPage" ], "xbrltype": "booleanItemType" }, "dei_EntityExTransitionPeriod": { "auth_ref": [ "r798" ], "lang": { "en-us": { "role": { "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.", "label": "Entity Ex Transition Period", "terseLabel": "Entity Ex Transition Period" } } }, "localname": "EntityExTransitionPeriod", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://innovid.com/role/CoverPage" ], "xbrltype": "booleanItemType" }, "dei_EntityFileNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.", "label": "Entity File Number", "terseLabel": "Entity File Number" } } }, "localname": "EntityFileNumber", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://innovid.com/role/CoverPage" ], "xbrltype": "fileNumberItemType" }, "dei_EntityFilerCategory": { "auth_ref": [ "r789" ], "lang": { "en-us": { "role": { "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.", "label": "Entity Filer Category", "terseLabel": "Entity Filer Category" } } }, "localname": "EntityFilerCategory", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://innovid.com/role/CoverPage" ], "xbrltype": "filerCategoryItemType" }, "dei_EntityIncorporationStateCountryCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Two-character EDGAR code representing the state or country of incorporation.", "label": "Entity Incorporation, State or Country Code", "terseLabel": "Entity Incorporation, State or Country Code" } } }, "localname": "EntityIncorporationStateCountryCode", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://innovid.com/role/CoverPage" ], "xbrltype": "edgarStateCountryItemType" }, "dei_EntityInteractiveDataCurrent": { "auth_ref": [ "r796" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).", "label": "Entity Interactive Data Current", "terseLabel": "Entity Interactive Data Current" } } }, "localname": "EntityInteractiveDataCurrent", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://innovid.com/role/CoverPage" ], "xbrltype": "yesNoItemType" }, "dei_EntityPublicFloat": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter.", "label": "Entity Public Float", "terseLabel": "Entity Public Float" } } }, "localname": "EntityPublicFloat", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://innovid.com/role/CoverPage" ], "xbrltype": "monetaryItemType" }, "dei_EntityRegistrantName": { "auth_ref": [ "r789" ], "lang": { "en-us": { "role": { "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.", "label": "Entity Registrant Name", "terseLabel": "Entity Registrant Name" } } }, "localname": "EntityRegistrantName", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://innovid.com/role/CoverPage" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityShellCompany": { "auth_ref": [ "r789" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.", "label": "Entity Shell Company", "terseLabel": "Entity Shell Company" } } }, "localname": "EntityShellCompany", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://innovid.com/role/CoverPage" ], "xbrltype": "booleanItemType" }, "dei_EntitySmallBusiness": { "auth_ref": [ "r789" ], "lang": { "en-us": { "role": { "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).", "label": "Entity Small Business", "terseLabel": "Entity Small Business" } } }, "localname": "EntitySmallBusiness", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://innovid.com/role/CoverPage" ], "xbrltype": "booleanItemType" }, "dei_EntityTaxIdentificationNumber": { "auth_ref": [ "r789" ], "lang": { "en-us": { "role": { "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.", "label": "Entity Tax Identification Number", "terseLabel": "Entity Tax Identification Number" } } }, "localname": "EntityTaxIdentificationNumber", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://innovid.com/role/CoverPage" ], "xbrltype": "employerIdItemType" }, "dei_EntityVoluntaryFilers": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.", "label": "Entity Voluntary Filers", "terseLabel": "Entity Voluntary Filers" } } }, "localname": "EntityVoluntaryFilers", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://innovid.com/role/CoverPage" ], "xbrltype": "yesNoItemType" }, "dei_EntityWellKnownSeasonedIssuer": { "auth_ref": [ "r797" ], "lang": { "en-us": { "role": { "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.", "label": "Entity Well-known Seasoned Issuer", "terseLabel": "Entity Well-known Seasoned Issuer" } } }, "localname": "EntityWellKnownSeasonedIssuer", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://innovid.com/role/CoverPage" ], "xbrltype": "yesNoItemType" }, "dei_IcfrAuditorAttestationFlag": { "auth_ref": [ "r792", "r793", "r794" ], "lang": { "en-us": { "role": { "label": "ICFR Auditor Attestation Flag", "terseLabel": "ICFR Auditor Attestation Flag" } } }, "localname": "IcfrAuditorAttestationFlag", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://innovid.com/role/CoverPage" ], "xbrltype": "booleanItemType" }, "dei_LegalEntityAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The set of legal entities associated with a report.", "label": "Legal Entity [Axis]", "terseLabel": "Legal Entity [Axis]" } } }, "localname": "LegalEntityAxis", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://innovid.com/role/COMMITMENTSANDCONTINGENTLIABILITIESDetails", "http://innovid.com/role/TRANSACTIONCommonStockinInnovidCorpDetails", "http://innovid.com/role/TRANSACTIONNarrativeDetails", "http://innovid.com/role/TRANSACTIONTransactiontoCashFlowandChangesinTemporaryEquityandStockholdersEquityDetails", "http://innovid.com/role/WARRANTSDetails" ], "xbrltype": "stringItemType" }, "dei_LocalPhoneNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Local phone number for entity.", "label": "Local Phone Number", "terseLabel": "Local Phone Number" } } }, "localname": "LocalPhoneNumber", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://innovid.com/role/CoverPage" ], "xbrltype": "normalizedStringItemType" }, "dei_Security12bTitle": { "auth_ref": [ "r788" ], "lang": { "en-us": { "role": { "documentation": "Title of a 12(b) registered security.", "label": "Title of 12(b) Security", "terseLabel": "Title of 12(b) Security" } } }, "localname": "Security12bTitle", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://innovid.com/role/CoverPage" ], "xbrltype": "securityTitleItemType" }, "dei_SecurityExchangeName": { "auth_ref": [ "r791" ], "lang": { "en-us": { "role": { "documentation": "Name of the Exchange on which a security is registered.", "label": "Security Exchange Name", "terseLabel": "Security Exchange Name" } } }, "localname": "SecurityExchangeName", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://innovid.com/role/CoverPage" ], "xbrltype": "edgarExchangeCodeItemType" }, "dei_TradingSymbol": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Trading symbol of an instrument as listed on an exchange.", "label": "Trading Symbol", "terseLabel": "Trading Symbol" } } }, "localname": "TradingSymbol", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://innovid.com/role/CoverPage" ], "xbrltype": "tradingSymbolItemType" }, "srt_AsiaPacificMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Region of Asia Pacific.", "label": "Asia Pacific [Member]", "terseLabel": "APAC" } } }, "localname": "AsiaPacificMember", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://innovid.com/role/SEGMENTREPORTINGRevenueandPropertyandEquipmentbyGeographicalAreasDetails" ], "xbrltype": "domainItemType" }, "srt_ConsolidatedEntitiesAxis": { "auth_ref": [ "r244", "r579", "r580", "r581", "r582", "r652", "r714", "r736", "r841", "r844", "r845", "r914", "r915", "r916" ], "lang": { "en-us": { "role": { "documentation": "Information by consolidated entity or group of entities.", "label": "Consolidated Entities [Axis]", "terseLabel": "Consolidated Entities [Axis]" } } }, "localname": "ConsolidatedEntitiesAxis", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://innovid.com/role/COMMITMENTSANDCONTINGENTLIABILITIESDetails" ], "xbrltype": "stringItemType" }, "srt_ConsolidatedEntitiesDomain": { "auth_ref": [ "r244", "r579", "r580", "r581", "r582", "r652", "r714", "r736", "r841", "r844", "r845", "r914", "r915", "r916" ], "lang": { "en-us": { "role": { "documentation": "Entity or group of entities consolidated into reporting entity.", "label": "Consolidated Entities [Domain]", "terseLabel": "Consolidated Entities [Domain]" } } }, "localname": "ConsolidatedEntitiesDomain", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://innovid.com/role/COMMITMENTSANDCONTINGENTLIABILITIESDetails" ], "xbrltype": "domainItemType" }, "srt_CounterpartyNameAxis": { "auth_ref": [ "r242", "r243", "r369", "r396", "r746", "r750", "r752" ], "lang": { "en-us": { "role": { "documentation": "Information by name of counterparty. A counterparty is the other party that participates in a financial transaction. Examples include, but not limited to, the name of the financial institution.", "label": "Counterparty Name [Axis]", "terseLabel": "Counterparty Name [Axis]" } } }, "localname": "CounterpartyNameAxis", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://innovid.com/role/STOCKHOLDERSEQUITYNarrativeDetails" ], "xbrltype": "stringItemType" }, "srt_LatinAmericaMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Region of Latin America.", "label": "Latin America [Member]", "terseLabel": "LATAM" } } }, "localname": "LatinAmericaMember", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://innovid.com/role/SEGMENTREPORTINGRevenueandPropertyandEquipmentbyGeographicalAreasDetails" ], "xbrltype": "domainItemType" }, "srt_MajorCustomersAxis": { "auth_ref": [ "r316", "r768", "r847", "r910" ], "lang": { "en-us": { "role": { "documentation": "Information by name or description of a single external customer or a group of external customers.", "label": "Customer [Axis]", "terseLabel": "Customer [Axis]" } } }, "localname": "MajorCustomersAxis", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://innovid.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESScheduleofConcentrationRiskDetails" ], "xbrltype": "stringItemType" }, "srt_MaximumMember": { "auth_ref": [ "r353", "r354", "r355", "r356", "r485", "r658", "r685", "r715", "r716", "r765", "r779", "r787", "r846", "r900", "r901", "r902", "r903", "r904", "r905" ], "lang": { "en-us": { "role": { "documentation": "Upper limit of the provided range.", "label": "Maximum [Member]", "terseLabel": "Maximum" } } }, "localname": "MaximumMember", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://innovid.com/role/LONGTERMDEBTDetails", "http://innovid.com/role/STOCKBASEDCOMPENSATIONFairValueofEachOptiononTheDateofGrantDetails", "http://innovid.com/role/STOCKBASEDCOMPENSATIONNarrativeDetails", "http://innovid.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESScheduleofPropertyPlantandEquipmentDetails" ], "xbrltype": "domainItemType" }, "srt_MinimumMember": { "auth_ref": [ "r353", "r354", "r355", "r356", "r485", "r658", "r685", "r715", "r716", "r765", "r779", "r787", "r846", "r900", "r901", "r902", "r903", "r904", "r905" ], "lang": { "en-us": { "role": { "documentation": "Lower limit of the provided range.", "label": "Minimum [Member]", "terseLabel": "Minimum" } } }, "localname": "MinimumMember", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://innovid.com/role/LONGTERMDEBTDetails", "http://innovid.com/role/STOCKBASEDCOMPENSATIONFairValueofEachOptiononTheDateofGrantDetails", "http://innovid.com/role/STOCKBASEDCOMPENSATIONNarrativeDetails", "http://innovid.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESScheduleofPropertyPlantandEquipmentDetails" ], "xbrltype": "domainItemType" }, "srt_NameOfMajorCustomerDomain": { "auth_ref": [ "r316", "r768", "r847", "r910" ], "lang": { "en-us": { "role": { "documentation": "Single external customer or group of external customers.", "label": "Customer [Domain]", "terseLabel": "Customer [Domain]" } } }, "localname": "NameOfMajorCustomerDomain", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://innovid.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESScheduleofConcentrationRiskDetails" ], "xbrltype": "domainItemType" }, "srt_ProductOrServiceAxis": { "auth_ref": [ "r312", "r659", "r766", "r785", "r838", "r839", "r847", "r909" ], "lang": { "en-us": { "role": { "documentation": "Information by product and service, or group of similar products and similar services.", "label": "Product and Service [Axis]", "terseLabel": "Product and Service [Axis]" } } }, "localname": "ProductOrServiceAxis", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://innovid.com/role/LEASESScheduleofoperatingROUassetsandleaseliabilitiesDetails", "http://innovid.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESScheduleofOperatingLeaseLiabilitiesandROUAssetsDetails" ], "xbrltype": "stringItemType" }, "srt_ProductsAndServicesDomain": { "auth_ref": [ "r312", "r659", "r766", "r785", "r838", "r839", "r847", "r909" ], "lang": { "en-us": { "role": { "documentation": "Product or service, or a group of similar products or similar services.", "label": "Product and Service [Domain]", "terseLabel": "Product and Service [Domain]" } } }, "localname": "ProductsAndServicesDomain", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://innovid.com/role/LEASESScheduleofoperatingROUassetsandleaseliabilitiesDetails", "http://innovid.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESScheduleofOperatingLeaseLiabilitiesandROUAssetsDetails" ], "xbrltype": "domainItemType" }, "srt_RangeAxis": { "auth_ref": [ "r353", "r354", "r355", "r356", "r445", "r485", "r517", "r518", "r519", "r657", "r658", "r685", "r715", "r716", "r765", "r779", "r787", "r837", "r846", "r901", "r902", "r903", "r904", "r905" ], "lang": { "en-us": { "role": { "documentation": "Information by statistical measurement. Includes, but is not limited to, minimum, maximum, weighted average, arithmetic average, and median.", "label": "Statistical Measurement [Axis]", "terseLabel": "Statistical Measurement [Axis]" } } }, "localname": "RangeAxis", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://innovid.com/role/LONGTERMDEBTDetails", "http://innovid.com/role/STOCKBASEDCOMPENSATIONFairValueofEachOptiononTheDateofGrantDetails", "http://innovid.com/role/STOCKBASEDCOMPENSATIONNarrativeDetails", "http://innovid.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESScheduleofPropertyPlantandEquipmentDetails" ], "xbrltype": "stringItemType" }, "srt_RangeMember": { "auth_ref": [ "r353", "r354", "r355", "r356", "r445", "r485", "r517", "r518", "r519", "r657", "r658", "r685", "r715", "r716", "r765", "r779", "r787", "r837", "r846", "r901", "r902", "r903", "r904", "r905" ], "lang": { "en-us": { "role": { "documentation": "Statistical measurement. Includes, but is not limited to, minimum, maximum, weighted average, arithmetic average, and median.", "label": "Statistical Measurement [Domain]", "terseLabel": "Statistical Measurement [Domain]" } } }, "localname": "RangeMember", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://innovid.com/role/LONGTERMDEBTDetails", "http://innovid.com/role/STOCKBASEDCOMPENSATIONFairValueofEachOptiononTheDateofGrantDetails", "http://innovid.com/role/STOCKBASEDCOMPENSATIONNarrativeDetails", "http://innovid.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESScheduleofPropertyPlantandEquipmentDetails" ], "xbrltype": "domainItemType" }, "srt_RepurchaseAgreementCounterpartyNameDomain": { "auth_ref": [ "r242", "r243", "r369", "r396", "r751", "r752" ], "lang": { "en-us": { "role": { "documentation": "Named other party that participates in a financial transaction. Examples include, but not limited to, the name of the financial institution.", "label": "Counterparty Name [Domain]", "terseLabel": "Counterparty Name [Domain]" } } }, "localname": "RepurchaseAgreementCounterpartyNameDomain", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://innovid.com/role/STOCKHOLDERSEQUITYNarrativeDetails" ], "xbrltype": "domainItemType" }, "srt_RestatementAdjustmentMember": { "auth_ref": [ "r245", "r246", "r247", "r258", "r259", "r281", "r594", "r595", "r816", "r817", "r818", "r819", "r821", "r825", "r826" ], "lang": { "en-us": { "role": { "documentation": "Cumulative increase (decrease) for adjustment to previously issued financial statements. Includes, but is not limited to, adjustment for retrospective application of amendment to accounting standards, other change in accounting principle, correction of error, and other revision.", "label": "Revision of Prior Period, Adjustment [Member]", "terseLabel": "Effect of change" } } }, "localname": "RestatementAdjustmentMember", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://innovid.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESScheduleofReclassificationDetails" ], "xbrltype": "domainItemType" }, "srt_RestatementAxis": { "auth_ref": [ "r201", "r245", "r246", "r247", "r249", "r250", "r253", "r254", "r255", "r256", "r258", "r259", "r260", "r261", "r262", "r263", "r281", "r331", "r332", "r557", "r590", "r594", "r595", "r596", "r629", "r648", "r649", "r688", "r689", "r690", "r691", "r692", "r693", "r694", "r695", "r696", "r697" ], "lang": { "en-us": { "role": { "documentation": "Information by adjustment to previously issued financial statements. Includes, but is not limited to, adjustment for retrospective application of amendment to accounting standards, other change in accounting principle, correction of error, and other revision.", "label": "Revision of Prior Period [Axis]", "terseLabel": "Revision of Prior Period [Axis]" } } }, "localname": "RestatementAxis", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://innovid.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESScheduleofReclassificationDetails" ], "xbrltype": "stringItemType" }, "srt_RestatementDomain": { "auth_ref": [ "r201", "r245", "r246", "r247", "r249", "r250", "r253", "r254", "r255", "r256", "r258", "r259", "r260", "r261", "r262", "r263", "r281", "r331", "r332", "r557", "r590", "r594", "r595", "r596", "r629", "r648", "r649", "r688", "r689", "r690", "r691", "r692", "r693", "r694", "r695", "r696", "r697" ], "lang": { "en-us": { "role": { "documentation": "Adjustment to previously issued financial statements. Includes, but is not limited to, adjustment for retrospective application of amendment to accounting standards, other change in accounting principle, correction of error, and other revision.", "label": "Revision of Prior Period [Domain]", "terseLabel": "Revision of Prior Period [Domain]" } } }, "localname": "RestatementDomain", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://innovid.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESScheduleofReclassificationDetails" ], "xbrltype": "domainItemType" }, "srt_ScenarioForecastMember": { "auth_ref": [ "r486", "r822", "r912" ], "lang": { "en-us": { "role": { "documentation": "Information reported for future period. Excludes information expected to be reported in future period for effect on historical fact.", "label": "Forecast [Member]", "terseLabel": "Forecast" } } }, "localname": "ScenarioForecastMember", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://innovid.com/role/LONGTERMDEBTDetails" ], "xbrltype": "domainItemType" }, "srt_ScenarioPreviouslyReportedMember": { "auth_ref": [ "r201", "r245", "r247", "r249", "r250", "r253", "r254", "r262", "r281", "r557", "r590", "r594", "r595", "r629", "r688", "r689", "r690", "r691", "r692", "r693", "r694", "r695", "r696", "r697", "r820", "r821", "r823", "r824", "r825", "r833", "r834", "r887", "r893", "r894" ], "lang": { "en-us": { "role": { "documentation": "Represents amount as previously reported before adjustment for retrospective application of amendment to accounting standards, other change in accounting principle, correction of error, and other revision.", "label": "Previously Reported [Member]", "terseLabel": "Previously reported" } } }, "localname": "ScenarioPreviouslyReportedMember", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://innovid.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESScheduleofReclassificationDetails" ], "xbrltype": "domainItemType" }, "srt_ScenarioUnspecifiedDomain": { "auth_ref": [ "r263", "r486", "r800", "r822" ], "lang": { "en-us": { "role": { "documentation": "Scenario reported, distinguishing information from actual fact. Includes, but is not limited to, pro forma and forecast. Excludes actual facts.", "label": "Scenario [Domain]", "terseLabel": "Scenario [Domain]" } } }, "localname": "ScenarioUnspecifiedDomain", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://innovid.com/role/LONGTERMDEBTDetails" ], "xbrltype": "domainItemType" }, "srt_ScheduleOfCondensedIncomeStatementTableTextBlock": { "auth_ref": [ "r812", "r913" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of condensed income statement, including, but not limited to, income statements of consolidated entities and consolidation eliminations.", "label": "Condensed Income Statement [Table Text Block]", "terseLabel": "Condensed Income Statement" } } }, "localname": "ScheduleOfCondensedIncomeStatementTableTextBlock", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://innovid.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESTables" ], "xbrltype": "textBlockItemType" }, "srt_SegmentGeographicalDomain": { "auth_ref": [ "r313", "r314", "r705", "r706", "r707", "r708", "r709", "r710", "r711", "r712", "r713", "r735", "r738", "r739", "r740", "r741", "r742", "r743", "r744", "r745", "r767", "r786", "r847" ], "lang": { "en-us": { "role": { "documentation": "Geographical area.", "label": "Geographical [Domain]", "terseLabel": "Geographical [Domain]" } } }, "localname": "SegmentGeographicalDomain", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://innovid.com/role/SEGMENTREPORTINGRevenueandPropertyandEquipmentbyGeographicalAreasDetails" ], "xbrltype": "domainItemType" }, "srt_StatementGeographicalAxis": { "auth_ref": [ "r313", "r314", "r699", "r705", "r706", "r707", "r708", "r709", "r710", "r711", "r712", "r713", "r735", "r737", "r767", "r786", "r847" ], "lang": { "en-us": { "role": { "documentation": "Information by geographical components.", "label": "Geographical [Axis]", "terseLabel": "Geographical [Axis]" } } }, "localname": "StatementGeographicalAxis", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://innovid.com/role/SEGMENTREPORTINGRevenueandPropertyandEquipmentbyGeographicalAreasDetails" ], "xbrltype": "stringItemType" }, "srt_StatementScenarioAxis": { "auth_ref": [ "r263", "r486", "r800", "r801", "r822" ], "lang": { "en-us": { "role": { "documentation": "Information by scenario reported, distinguishing information from actual fact. Includes, but is not limited to, pro forma and forecast. Excludes actual facts.", "label": "Scenario [Axis]", "terseLabel": "Scenario [Axis]" } } }, "localname": "StatementScenarioAxis", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://innovid.com/role/LONGTERMDEBTDetails" ], "xbrltype": "stringItemType" }, "srt_SubsidiariesMember": { "auth_ref": [ "r849", "r895", "r896", "r897" ], "lang": { "en-us": { "role": { "documentation": "Entity owned or controlled by another entity.", "label": "Subsidiaries [Member]", "terseLabel": "Subsidiaries" } } }, "localname": "SubsidiariesMember", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://innovid.com/role/COMMITMENTSANDCONTINGENTLIABILITIESDetails" ], "xbrltype": "domainItemType" }, "us-gaap_AccountingPoliciesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Accounting Policies [Abstract]", "terseLabel": "Accounting Policies [Abstract]" } } }, "localname": "AccountingPoliciesAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_AccountingStandardsUpdate201602Member": { "auth_ref": [ "r625" ], "lang": { "en-us": { "role": { "documentation": "Accounting Standards Update 2016-02 Leases (Topic 842).", "label": "Accounting Standards Update 2016-02 [Member]", "terseLabel": "Accounting Standards Update 2016-02" } } }, "localname": "AccountingStandardsUpdate201602Member", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovid.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESScheduleofOperatingLeaseLiabilitiesandROUAssetsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for accounts payable, accrued expenses, and other liabilities that are classified as current at the end of the reporting period.", "label": "Accounts Payable, Accrued Liabilities, and Other Liabilities Disclosure, Current [Text Block]", "terseLabel": "ACCRUED EXPENSES AND OTHER CURRENT LIABILITIES" } } }, "localname": "AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovid.com/role/ACCRUEDEXPENSESANDOTHERCURRENTLIABILITIES" ], "xbrltype": "textBlockItemType" }, "us-gaap_AccountsPayableCurrent": { "auth_ref": [ "r21", "r784" ], "calculation": { "http://innovid.com/role/CONSOLIDATEDBALANCESHEETS": { "order": 5.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).", "label": "Accounts Payable, Current", "terseLabel": "Trade payables" } } }, "localname": "AccountsPayableCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovid.com/role/CONSOLIDATEDBALANCESHEETS" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccountsReceivableNetCurrent": { "auth_ref": [ "r318", "r319" ], "calculation": { "http://innovid.com/role/CONSOLIDATEDBALANCESHEETS": { "order": 2.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.", "label": "Accounts Receivable, after Allowance for Credit Loss, Current", "terseLabel": "Trade receivables, net of reserves of $65 at December\u00a031, 2022 and $81 at December\u00a031, 2021" } } }, "localname": "AccountsReceivableNetCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovid.com/role/CONSOLIDATEDBALANCESHEETS" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccruedIncomeTaxesNoncurrent": { "auth_ref": [ "r10", "r168", "r181" ], "calculation": { "http://innovid.com/role/OTHERNONCURRENTLIABILITIESDetails": { "order": 4.0, "parentTag": "us-gaap_OtherLiabilitiesNoncurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying amount as of the balance sheet date of the unpaid sum of the known and estimated amounts payable to satisfy all domestic and foreign income tax obligations due beyond one year or the operating cycle, whichever is longer. Alternate captions include income taxes payable, noncurrent.", "label": "Accrued Income Taxes, Noncurrent", "terseLabel": "Uncertain tax position" } } }, "localname": "AccruedIncomeTaxesNoncurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovid.com/role/OTHERNONCURRENTLIABILITIESDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccruedLiabilitiesCurrent": { "auth_ref": [ "r26" ], "calculation": { "http://innovid.com/role/ACCRUEDEXPENSESANDOTHERCURRENTLIABILITIESDetails": { "order": null, "parentTag": null, "root": true, "weight": null }, "http://innovid.com/role/CONSOLIDATEDBALANCESHEETS": { "order": 2.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).", "label": "Accrued Liabilities, Current", "totalLabel": "Total", "verboseLabel": "Accrued expenses and other current liabilities" } } }, "localname": "AccruedLiabilitiesCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovid.com/role/ACCRUEDEXPENSESANDOTHERCURRENTLIABILITIESDetails", "http://innovid.com/role/CONSOLIDATEDBALANCESHEETS" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccruedRentCurrent": { "auth_ref": [ "r26", "r749" ], "calculation": { "http://innovid.com/role/ACCRUEDEXPENSESANDOTHERCURRENTLIABILITIESDetails": { "order": 3.0, "parentTag": "us-gaap_AccruedLiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying value as of the balance sheet date of obligations incurred through that date and payable for contractual rent under lease arrangements. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).", "label": "Accrued Rent, Current", "terseLabel": "Accrued lease liability, current portion" } } }, "localname": "AccruedRentCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovid.com/role/ACCRUEDEXPENSESANDOTHERCURRENTLIABILITIESDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment": { "auth_ref": [ "r97", "r208" ], "calculation": { "http://innovid.com/role/PROPERTYANDEQUIPMENTNETDetails": { "order": 1.0, "parentTag": "us-gaap_PropertyPlantAndEquipmentNet", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services.", "label": "Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment", "negatedTerseLabel": "Accumulated depreciation" } } }, "localname": "AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovid.com/role/PROPERTYANDEQUIPMENTNETDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife": { "auth_ref": [ "r83" ], "lang": { "en-us": { "role": { "documentation": "Weighted average amortization period of finite-lived intangible assets acquired either individually or as part of a group of assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.", "label": "Acquired Finite-Lived Intangible Assets, Weighted Average Useful Life", "terseLabel": "Acquired finite-lived intangible assets, weighted average useful life", "verboseLabel": "Acquired finite-lived intangible assets, weighted average (in years)" } } }, "localname": "AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovid.com/role/ACQUISITIONNarrativeDetails", "http://innovid.com/role/INTANGIBLEASSETSNETNarrativeDetails", "http://innovid.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails" ], "xbrltype": "durationItemType" }, "us-gaap_AdditionalPaidInCapital": { "auth_ref": [ "r16", "r784" ], "calculation": { "http://innovid.com/role/CONSOLIDATEDBALANCESHEETS": { "order": 2.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock.", "label": "Additional Paid in Capital", "terseLabel": "Additional paid-in capital" } } }, "localname": "AdditionalPaidInCapital", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovid.com/role/CONSOLIDATEDBALANCESHEETS" ], "xbrltype": "monetaryItemType" }, "us-gaap_AdditionalPaidInCapitalMember": { "auth_ref": [ "r527", "r528", "r529", "r813", "r814", "r815", "r886" ], "lang": { "en-us": { "role": { "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders.", "label": "Additional Paid-in Capital [Member]", "terseLabel": "Additional paid-in capital" } } }, "localname": "AdditionalPaidInCapitalMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovid.com/role/STATEMENTSOFCHANGESINTEMPORARYEQUITYANDSTOCKHOLDERSEQUITYDEFICIT" ], "xbrltype": "domainItemType" }, "us-gaap_AdjustmentsForNewAccountingPronouncementsAxis": { "auth_ref": [ "r198", "r199", "r200", "r201", "r202", "r249", "r250", "r251", "r252", "r263", "r324", "r325", "r327", "r328", "r329", "r330", "r331", "r332", "r527", "r528", "r529", "r554", "r555", "r556", "r557", "r575", "r576", "r577", "r586", "r587", "r588", "r589", "r590", "r591", "r592", "r593", "r594", "r595", "r596", "r597", "r606", "r607", "r608", "r609", "r610", "r611", "r612", "r613", "r622", "r623", "r626", "r627", "r628", "r629", "r644", "r645", "r646", "r647", "r648", "r649", "r661", "r662", "r663", "r686", "r687", "r688", "r689", "r690", "r691", "r692", "r693", "r694", "r695", "r696", "r697" ], "lang": { "en-us": { "role": { "documentation": "Information by amendment to accounting standards.", "label": "Accounting Standards Update [Axis]", "terseLabel": "Accounting Standards Update [Axis]" } } }, "localname": "AdjustmentsForNewAccountingPronouncementsAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovid.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESScheduleofOperatingLeaseLiabilitiesandROUAssetsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Adjustments, Noncash Items, to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]", "terseLabel": "Adjustments to reconcile net loss to net cash used in operating activities:" } } }, "localname": "AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovid.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "stringItemType" }, "us-gaap_AdjustmentsToAdditionalPaidInCapitalIncreaseInCarryingAmountOfRedeemablePreferredStock": { "auth_ref": [ "r106", "r107", "r109" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of decrease (increase) in additional paid in capital (APIC) for the increase in carrying amount of redeemable preferred stock.", "label": "Adjustments to Additional Paid in Capital, Increase in Carrying Amount of Redeemable Preferred Stock", "negatedTerseLabel": "Capital contribution" } } }, "localname": "AdjustmentsToAdditionalPaidInCapitalIncreaseInCarryingAmountOfRedeemablePreferredStock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovid.com/role/STATEMENTSOFCHANGESINTEMPORARYEQUITYANDSTOCKHOLDERSEQUITYDEFICIT" ], "xbrltype": "monetaryItemType" }, "us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue": { "auth_ref": [ "r125", "r126", "r489" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement.", "label": "APIC, Share-Based Payment Arrangement, Increase for Cost Recognition", "terseLabel": "Stock-based compensation" } } }, "localname": "AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovid.com/role/STATEMENTSOFCHANGESINTEMPORARYEQUITYANDSTOCKHOLDERSEQUITYDEFICIT" ], "xbrltype": "monetaryItemType" }, "us-gaap_AllocatedShareBasedCompensationExpense": { "auth_ref": [ "r521" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.", "label": "Share-Based Payment Arrangement, Expense", "terseLabel": "Stock based compensation expenses" } } }, "localname": "AllocatedShareBasedCompensationExpense", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovid.com/role/STOCKBASEDCOMPENSATIONNarrativeDetails", "http://innovid.com/role/STOCKBASEDCOMPENSATIONStockOptionActivityUnderPlanDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent": { "auth_ref": [ "r217", "r322", "r333" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of allowance for credit loss on accounts receivable, classified as current.", "label": "Accounts Receivable, Allowance for Credit Loss, Current", "terseLabel": "Trade receivables, allowance for doubtful receivables" } } }, "localname": "AllowanceForDoubtfulAccountsReceivableCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovid.com/role/CONDENSEDBALANCESHEETSParenthetical" ], "xbrltype": "monetaryItemType" }, "us-gaap_AmortizationOfIntangibleAssets": { "auth_ref": [ "r56", "r81", "r88" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.", "label": "Amortization of Intangible Assets", "terseLabel": "Amortization of intangible assets" } } }, "localname": "AmortizationOfIntangibleAssets", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovid.com/role/INTANGIBLEASSETSNETNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount": { "auth_ref": [ "r278" ], "lang": { "en-us": { "role": { "documentation": "Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.", "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount", "terseLabel": "Securities excluded from computation of earnings per share (in shares)" } } }, "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovid.com/role/BASICANDDILUTEDNETLOSSPERSHARESecuritiesExcludedfromComputationofEarningsPerShareDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis": { "auth_ref": [ "r67" ], "lang": { "en-us": { "role": { "documentation": "Information by type of antidilutive security.", "label": "Antidilutive Securities [Axis]", "terseLabel": "Antidilutive Securities [Axis]" } } }, "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovid.com/role/BASICANDDILUTEDNETLOSSPERSHARESecuritiesExcludedfromComputationofEarningsPerShareDetails" ], "xbrltype": "stringItemType" }, "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]", "terseLabel": "Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]" } } }, "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovid.com/role/BASICANDDILUTEDNETLOSSPERSHARESecuritiesExcludedfromComputationofEarningsPerShareDetails" ], "xbrltype": "stringItemType" }, "us-gaap_AntidilutiveSecuritiesNameDomain": { "auth_ref": [ "r67" ], "lang": { "en-us": { "role": { "documentation": "Incremental common shares attributable to securities that were not included in diluted earnings per share (EPS) because to do so would increase EPS amounts or decrease loss per share amounts for the period presented.", "label": "Antidilutive Securities, Name [Domain]", "terseLabel": "Antidilutive Securities, Name [Domain]" } } }, "localname": "AntidilutiveSecuritiesNameDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovid.com/role/BASICANDDILUTEDNETLOSSPERSHARESecuritiesExcludedfromComputationofEarningsPerShareDetails" ], "xbrltype": "domainItemType" }, "us-gaap_AssetImpairmentCharges": { "auth_ref": [ "r56", "r94" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of write-down of assets recognized in the income statement. Includes, but is not limited to, losses from tangible assets, intangible assets and goodwill.", "label": "Asset Impairment Charges", "terseLabel": "Asset impairment charges" } } }, "localname": "AssetImpairmentCharges", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovid.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_Assets": { "auth_ref": [ "r166", "r180", "r212", "r238", "r299", "r303", "r308", "r326", "r357", "r358", "r359", "r360", "r361", "r362", "r363", "r364", "r365", "r579", "r581", "r605", "r784", "r842", "r843", "r898" ], "calculation": { "http://innovid.com/role/CONSOLIDATEDBALANCESHEETS": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.", "label": "Assets", "totalLabel": "TOTAL ASSETS" } } }, "localname": "Assets", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovid.com/role/CONSOLIDATEDBALANCESHEETS" ], "xbrltype": "monetaryItemType" }, "us-gaap_AssetsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Assets [Abstract]", "terseLabel": "ASSETS" } } }, "localname": "AssetsAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovid.com/role/CONSOLIDATEDBALANCESHEETS" ], "xbrltype": "stringItemType" }, "us-gaap_AssetsCurrent": { "auth_ref": [ "r204", "r220", "r238", "r326", "r357", "r358", "r359", "r360", "r361", "r362", "r363", "r364", "r365", "r579", "r581", "r605", "r784", "r842", "r843", "r898" ], "calculation": { "http://innovid.com/role/CONSOLIDATEDBALANCESHEETS": { "order": 2.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.", "label": "Assets, Current", "totalLabel": "Total current assets" } } }, "localname": "AssetsCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovid.com/role/CONSOLIDATEDBALANCESHEETS" ], "xbrltype": "monetaryItemType" }, "us-gaap_AssetsFairValueDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Assets, Fair Value Disclosure [Abstract]", "terseLabel": "Assets:" } } }, "localname": "AssetsFairValueDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovid.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESScheduleofFairValueAssetsandLiabilitiesMeasuredonRecurringBasisDetails" ], "xbrltype": "stringItemType" }, "us-gaap_AssetsNoncurrent": { "auth_ref": [ "r238", "r326", "r357", "r358", "r359", "r360", "r361", "r362", "r363", "r364", "r365", "r579", "r581", "r605", "r842", "r843", "r898" ], "calculation": { "http://innovid.com/role/CONSOLIDATEDBALANCESHEETS": { "order": 1.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold or consumed after one year or beyond the normal operating cycle, if longer.", "label": "Assets, Noncurrent", "totalLabel": "Total non-current assets" } } }, "localname": "AssetsNoncurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovid.com/role/CONSOLIDATEDBALANCESHEETS" ], "xbrltype": "monetaryItemType" }, "us-gaap_AwardTypeAxis": { "auth_ref": [ "r492", "r493", "r494", "r496", "r497", "r498", "r499", "r500", "r501", "r502", "r503", "r504", "r505", "r506", "r507", "r508", "r509", "r510", "r511", "r512", "r513", "r516", "r517", "r518", "r519", "r520" ], "lang": { "en-us": { "role": { "documentation": "Information by type of award under share-based payment arrangement.", "label": "Award Type [Axis]", "terseLabel": "Award Type [Axis]" } } }, "localname": "AwardTypeAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovid.com/role/STOCKBASEDCOMPENSATIONNarrativeDetails", "http://innovid.com/role/STOCKBASEDCOMPENSATIONRestrictedStockUnitActivityDetails" ], "xbrltype": "stringItemType" }, "us-gaap_BasisOfAccountingPolicyPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).", "label": "Basis of Accounting, Policy [Policy Text Block]", "terseLabel": "Basis of Presentation" } } }, "localname": "BasisOfAccountingPolicyPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovid.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_BusinessAcquisitionAcquireeDomain": { "auth_ref": [ "r573", "r773", "r776" ], "lang": { "en-us": { "role": { "documentation": "Identification of the acquiree in a material business combination (or series of individually immaterial business combinations), which may include the name or other type of identification of the acquiree.", "label": "Business Acquisition, Acquiree [Domain]", "terseLabel": "Business Acquisition, Acquiree [Domain]" } } }, "localname": "BusinessAcquisitionAcquireeDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovid.com/role/ACQUISITIONFairValuesoftheAssetsAcquiredandLiabilitiesAssumedDetails", "http://innovid.com/role/ACQUISITIONNarrativeDetails", "http://innovid.com/role/ACQUISITIONUnauditedProFormaFinancialInformationDetails", "http://innovid.com/role/DESCRIPTIONOFBUSINESSDetails", "http://innovid.com/role/INCOMETAXESNarrativeDetails", "http://innovid.com/role/STOCKBASEDCOMPENSATIONNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_BusinessAcquisitionAxis": { "auth_ref": [ "r140", "r141", "r573", "r773", "r776" ], "lang": { "en-us": { "role": { "documentation": "Information by business combination or series of individually immaterial business combinations.", "label": "Business Acquisition [Axis]", "terseLabel": "Business Acquisition [Axis]" } } }, "localname": "BusinessAcquisitionAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovid.com/role/ACQUISITIONFairValuesoftheAssetsAcquiredandLiabilitiesAssumedDetails", "http://innovid.com/role/ACQUISITIONNarrativeDetails", "http://innovid.com/role/ACQUISITIONUnauditedProFormaFinancialInformationDetails", "http://innovid.com/role/DESCRIPTIONOFBUSINESSDetails", "http://innovid.com/role/INCOMETAXESNarrativeDetails", "http://innovid.com/role/STOCKBASEDCOMPENSATIONNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued": { "auth_ref": [ "r148" ], "lang": { "en-us": { "role": { "documentation": "Number of shares of equity interests issued or issuable to acquire entity.", "label": "Business Acquisition, Equity Interest Issued or Issuable, Number of Shares", "terseLabel": "Shares issued as consideration (in shares)" } } }, "localname": "BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovid.com/role/ACQUISITIONNarrativeDetails", "http://innovid.com/role/DESCRIPTIONOFBUSINESSDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_BusinessAcquisitionLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Business Acquisition [Line Items]", "terseLabel": "Business Acquisition [Line Items]" } } }, "localname": "BusinessAcquisitionLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovid.com/role/ACQUISITIONFairValuesoftheAssetsAcquiredandLiabilitiesAssumedDetails", "http://innovid.com/role/ACQUISITIONNarrativeDetails", "http://innovid.com/role/ACQUISITIONUnauditedProFormaFinancialInformationDetails", "http://innovid.com/role/DESCRIPTIONOFBUSINESSDetails", "http://innovid.com/role/TRANSACTIONCommonStockinInnovidCorpDetails", "http://innovid.com/role/TRANSACTIONTransactiontoCashFlowandChangesinTemporaryEquityandStockholdersEquityDetails" ], "xbrltype": "stringItemType" }, "us-gaap_BusinessAcquisitionProFormaInformationTextBlock": { "auth_ref": [ "r884", "r885" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of pro forma results of operations for a material business acquisition or series of individually immaterial business acquisitions that are material in the aggregate.", "label": "Business Acquisition, Pro Forma Information [Table Text Block]", "terseLabel": "Business Acquisition, Unaudited Pro Forma Information" } } }, "localname": "BusinessAcquisitionProFormaInformationTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovid.com/role/ACQUISITIONTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_BusinessAcquisitionSharePrice": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Price of a single share of a number of saleable stocks paid or offered to be paid in a business combination.", "label": "Business Acquisition, Share Price", "terseLabel": "Share price (in dollars per share)" } } }, "localname": "BusinessAcquisitionSharePrice", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovid.com/role/ACQUISITIONNarrativeDetails", "http://innovid.com/role/DESCRIPTIONOFBUSINESSDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss": { "auth_ref": [ "r571", "r572" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The pro forma net Income or Loss for the period as if the business combination or combinations had been completed at the beginning of a period.", "label": "Business Acquisition, Pro Forma Net Income (Loss)", "terseLabel": "Net losses" } } }, "localname": "BusinessAcquisitionsProFormaNetIncomeLoss", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovid.com/role/ACQUISITIONUnauditedProFormaFinancialInformationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessAcquisitionsProFormaRevenue": { "auth_ref": [ "r571", "r572" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The pro forma revenue for a period as if the business combination or combinations had been completed at the beginning of the period.", "label": "Business Acquisition, Pro Forma Revenue", "terseLabel": "Revenues" } } }, "localname": "BusinessAcquisitionsProFormaRevenue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovid.com/role/ACQUISITIONUnauditedProFormaFinancialInformationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationAcquisitionRelatedCosts": { "auth_ref": [ "r139" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "This element represents acquisition-related costs incurred to effect a business combination which costs have been expensed during the period. Such costs include finder's fees; advisory, legal, accounting, valuation, and other professional or consulting fees; general administrative costs, including the costs of maintaining an internal acquisitions department; and may include costs of registering and issuing debt and equity securities.", "label": "Business Combination, Acquisition Related Costs", "terseLabel": "Acquisition related costs" } } }, "localname": "BusinessCombinationAcquisitionRelatedCosts", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovid.com/role/ACQUISITIONNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationAndAssetAcquisitionAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Business Combination and Asset Acquisition [Abstract]" } } }, "localname": "BusinessCombinationAndAssetAcquisitionAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_BusinessCombinationDisclosureTextBlock": { "auth_ref": [ "r149", "r574" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for a business combination (or series of individually immaterial business combinations) completed during the period, including background, timing, and recognized assets and liabilities. The disclosure may include leverage buyout transactions (as applicable).", "label": "Business Combination Disclosure [Text Block]", "terseLabel": "ACQUISITION" } } }, "localname": "BusinessCombinationDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovid.com/role/ACQUISITION" ], "xbrltype": "textBlockItemType" }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents": { "auth_ref": [ "r143" ], "calculation": { "http://innovid.com/role/ACQUISITIONFairValuesoftheAssetsAcquiredandLiabilitiesAssumedDetails": { "order": 1.0, "parentTag": "ctv_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedTangibleAssets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions, acquired at the acquisition date. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.", "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Cash and Equivalents", "terseLabel": "Cash and cash equivalents" } } }, "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovid.com/role/ACQUISITIONFairValuesoftheAssetsAcquiredandLiabilitiesAssumedDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther": { "auth_ref": [ "r143" ], "calculation": { "http://innovid.com/role/ACQUISITIONFairValuesoftheAssetsAcquiredandLiabilitiesAssumedDetails": { "order": 3.0, "parentTag": "ctv_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedTangibleAssets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of other assets expected to be realized or consumed before one year or the normal operating cycle, if longer, acquired at the acquisition date.", "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets, Other", "terseLabel": "Other current assets" } } }, "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovid.com/role/ACQUISITIONFairValuesoftheAssetsAcquiredandLiabilitiesAssumedDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables": { "auth_ref": [ "r143" ], "calculation": { "http://innovid.com/role/ACQUISITIONFairValuesoftheAssetsAcquiredandLiabilitiesAssumedDetails": { "order": 2.0, "parentTag": "ctv_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedTangibleAssets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount due from customers or clients for goods or services, including trade receivables, that have been delivered or sold in the normal course of business, and amounts due from others, including related parties expected to be converted to cash, sold or exchanged within one year or the normal operating cycle, if longer, acquired at the acquisition date.", "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets, Receivables", "terseLabel": "Accounts receivables" } } }, "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovid.com/role/ACQUISITIONFairValuesoftheAssetsAcquiredandLiabilitiesAssumedDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities": { "auth_ref": [ "r143" ], "calculation": { "http://innovid.com/role/ACQUISITIONFairValuesoftheAssetsAcquiredandLiabilitiesAssumedDetails": { "order": 2.0, "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of deferred tax liability attributable to taxable temporary differences assumed at the acquisition date.", "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Deferred Tax Liabilities", "negatedTerseLabel": "Less: Deferred tax liabilities" } } }, "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovid.com/role/ACQUISITIONFairValuesoftheAssetsAcquiredandLiabilitiesAssumedDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles": { "auth_ref": [ "r142", "r143" ], "calculation": { "http://innovid.com/role/ACQUISITIONFairValuesoftheAssetsAcquiredandLiabilitiesAssumedDetails": { "order": 2.0, "parentTag": "ctv_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAcquiredIncludingGoodwill", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The amount of identifiable intangible assets recognized as of the acquisition date.", "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Finite-Lived Intangibles", "terseLabel": "Intangible assets" } } }, "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovid.com/role/ACQUISITIONFairValuesoftheAssetsAcquiredandLiabilitiesAssumedDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther": { "auth_ref": [ "r143" ], "calculation": { "http://innovid.com/role/ACQUISITIONFairValuesoftheAssetsAcquiredandLiabilitiesAssumedDetails": { "order": 3.0, "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of other liabilities due after one year or the normal operating cycle, if longer, assumed at the acquisition date.", "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Noncurrent Liabilities, Other", "negatedTerseLabel": "Less: Other assumed liabilities" } } }, "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovid.com/role/ACQUISITIONFairValuesoftheAssetsAcquiredandLiabilitiesAssumedDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment": { "auth_ref": [ "r142", "r143" ], "calculation": { "http://innovid.com/role/ACQUISITIONFairValuesoftheAssetsAcquiredandLiabilitiesAssumedDetails": { "order": 4.0, "parentTag": "ctv_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedTangibleAssets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The amount of property, plant, and equipment recognized as of the acquisition date.", "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Property, Plant, and Equipment", "verboseLabel": "Property and equipment" } } }, "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovid.com/role/ACQUISITIONFairValuesoftheAssetsAcquiredandLiabilitiesAssumedDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet": { "auth_ref": [ "r143" ], "calculation": { "http://innovid.com/role/ACQUISITIONFairValuesoftheAssetsAcquiredandLiabilitiesAssumedDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount recognized for assets, including goodwill, in excess of (less than) the aggregate liabilities assumed.", "label": "Business Combination, Recognized Identifiable Assets Acquired, Goodwill, and Liabilities Assumed, Net", "totalLabel": "Net assets acquired" } } }, "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovid.com/role/ACQUISITIONFairValuesoftheAssetsAcquiredandLiabilitiesAssumedDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationsPolicy": { "auth_ref": [ "r138" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for completed business combinations (purchase method, acquisition method or combination of entities under common control). This accounting policy may include a general discussion of the purchase method or acquisition method of accounting (including for example, the treatment accorded contingent consideration, the identification of assets and liabilities, the purchase price allocation process, how the fair values of acquired assets and liabilities are determined) and the entity's specific application thereof. An entity that acquires another entity in a leveraged buyout transaction generally discloses the accounting policy followed by the acquiring entity in determining the basis used to value its interest in the acquired entity, and the rationale for that accounting policy.", "label": "Business Combinations Policy [Policy Text Block]", "terseLabel": "Business combinations" } } }, "localname": "BusinessCombinationsPolicy", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovid.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_CapitalizedComputerSoftwareAdditions": { "auth_ref": [ "r82" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Additions made to capitalized computer software costs during the period.", "label": "Capitalized Computer Software, Additions", "terseLabel": "Capitalization cost" } } }, "localname": "CapitalizedComputerSoftwareAdditions", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovid.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashAndCashEquivalentsAtCarryingValue": { "auth_ref": [ "r58", "r206", "r747" ], "calculation": { "http://innovid.com/role/CONSOLIDATEDBALANCESHEETS": { "order": 3.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 }, "http://innovid.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "order": 1.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.", "label": "Cash and Cash Equivalents, at Carrying Value", "terseLabel": "Cash and cash equivalents" } } }, "localname": "CashAndCashEquivalentsAtCarryingValue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovid.com/role/CONSOLIDATEDBALANCESHEETS", "http://innovid.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashAndCashEquivalentsFairValueDisclosure": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Fair value portion of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.", "label": "Cash and Cash Equivalents, Fair Value Disclosure", "terseLabel": "Money market funds" } } }, "localname": "CashAndCashEquivalentsFairValueDisclosure", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovid.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESScheduleofFairValueAssetsandLiabilitiesMeasuredonRecurringBasisDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy": { "auth_ref": [ "r59", "r165" ], "lang": { "en-us": { "role": { "documentation": "Entity's cash and cash equivalents accounting policy with respect to restricted balances. Restrictions may include legally restricted deposits held as compensating balances against short-term borrowing arrangements, contracts entered into with others, or company statements of intention with regard to particular deposits; however, time deposits and short-term certificates of deposit are not generally included in legally restricted deposits.", "label": "Cash and Cash Equivalents, Restricted Cash and Cash Equivalents, Policy [Policy Text Block]", "terseLabel": "Restricted deposits and restricted cash" } } }, "localname": "CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovid.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_CashAndCashEquivalentsUnrestrictedCashAndCashEquivalentsPolicy": { "auth_ref": [ "r59" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for cash and cash equivalents with respect to unrestricted balances.", "label": "Cash and Cash Equivalents, Unrestricted Cash and Cash Equivalents, Policy [Policy Text Block]", "terseLabel": "Cash and cash equivalents" } } }, "localname": "CashAndCashEquivalentsUnrestrictedCashAndCashEquivalentsPolicy", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovid.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": { "auth_ref": [ "r52", "r58", "r64" ], "calculation": { "http://innovid.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.", "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents", "periodEndLabel": "Cash, cash equivalents and restricted cash at the end of the year", "periodStartLabel": "Cash, cash equivalents and restricted cash at the beginning of the year", "totalLabel": "Total cash, cash equivalents, and restricted cash shown in the consolidated statements of cash flows" } } }, "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovid.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents [Abstract]", "terseLabel": "Reconciliation of cash, cash equivalents, and restricted cash reported within the statement of financial position" } } }, "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovid.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "stringItemType" }, "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect": { "auth_ref": [ "r52", "r162" ], "calculation": { "http://innovid.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.", "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect", "totalLabel": "(Decrease) increase in cash, cash equivalents and restricted cash" } } }, "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovid.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "monetaryItemType" }, "us-gaap_CertificatesOfDepositAtCarryingValue": { "auth_ref": [ "r802" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "A savings certificate entitling the Entity (that is, bearer) to receive interest at an established maturity date, based upon a fixed interest rate. A certificate of deposit may be issued in any denomination. Certificates of deposit are generally issued by commercial banks and, therefore, insured by the FDIC (up to the prescribed limit). Certificates of deposit generally restrict holders from withdrawing funds on demand without the incurrence of penalties. Generally, only certificates of deposit with original maturities of three months or less qualify as cash equivalents. Original maturity means original maturity to the entity holding the investment. As a related example, both a three-month US Treasury bill and a three-year Treasury note purchased three months from maturity qualify as cash equivalents. However, a Treasury note purchased three-years ago does not become a cash equivalent when its remaining maturity is three months.", "label": "Certificates of Deposit, at Carrying Value", "terseLabel": "Certificates of deposit" } } }, "localname": "CertificatesOfDepositAtCarryingValue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovid.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESScheduleofFairValueAssetsandLiabilitiesMeasuredonRecurringBasisDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ClassOfStockDomain": { "auth_ref": [ "r214", "r215", "r216", "r238", "r267", "r268", "r275", "r277", "r285", "r286", "r326", "r357", "r359", "r360", "r361", "r364", "r365", "r393", "r394", "r398", "r402", "r408", "r605", "r717", "r799", "r808", "r827" ], "lang": { "en-us": { "role": { "documentation": "Share of stock differentiated by the voting rights the holder receives. Examples include, but are not limited to, common stock, redeemable preferred stock, nonredeemable preferred stock, and convertible stock.", "label": "Class of Stock [Domain]", "terseLabel": "Class of Stock [Domain]" } } }, "localname": "ClassOfStockDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovid.com/role/CoverPage" ], "xbrltype": "domainItemType" }, "us-gaap_ClassOfWarrantOrRightAxis": { "auth_ref": [ "r111", "r115" ], "lang": { "en-us": { "role": { "documentation": "Information by type of warrant or right issued.", "label": "Class of Warrant or Right [Axis]", "terseLabel": "Class of Warrant or Right [Axis]" } } }, "localname": "ClassOfWarrantOrRightAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovid.com/role/WARRANTSDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ClassOfWarrantOrRightDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the class or type of warrant or right outstanding. Warrants and rights represent derivative securities that give the holder the right to purchase securities (usually equity) from the issuer at a specific price within a certain time frame. Warrants are often included in a new debt issue to entice investors by a higher return potential. The main difference between warrants and call options is that warrants are issued and guaranteed by the company, whereas options are exchange instruments and are not issued by the company. Also, the lifetime of a warrant is often measured in years, while the lifetime of a typical option is measured in months.", "label": "Class of Warrant or Right [Domain]", "terseLabel": "Class of Warrant or Right [Domain]" } } }, "localname": "ClassOfWarrantOrRightDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovid.com/role/WARRANTSDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1": { "auth_ref": [ "r409" ], "lang": { "en-us": { "role": { "documentation": "Exercise price per share or per unit of warrants or rights outstanding.", "label": "Class of Warrant or Right, Exercise Price of Warrants or Rights", "terseLabel": "Exercise price per share (in dollars per share)" } } }, "localname": "ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovid.com/role/STOCKHOLDERSEQUITYNarrativeDetails", "http://innovid.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails", "http://innovid.com/role/WARRANTSDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_ClassOfWarrantOrRightLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Class of Warrant or Right [Line Items]", "terseLabel": "Class of Warrant or Right [Line Items]" } } }, "localname": "ClassOfWarrantOrRightLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovid.com/role/WARRANTSDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights": { "auth_ref": [ "r409" ], "lang": { "en-us": { "role": { "documentation": "Number of securities into which the class of warrant or right may be converted. For example, but not limited to, 500,000 warrants may be converted into 1,000,000 shares.", "label": "Class of Warrant or Right, Number of Securities Called by Warrants or Rights", "terseLabel": "Number of securities callable by warrants (in shares)" } } }, "localname": "ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovid.com/role/STOCKHOLDERSEQUITYNarrativeDetails", "http://innovid.com/role/TRANSACTIONNarrativeDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ClassOfWarrantOrRightOutstanding": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of warrants or rights outstanding.", "label": "Class of Warrant or Right, Outstanding", "terseLabel": "Outstanding warrants (in shares)" } } }, "localname": "ClassOfWarrantOrRightOutstanding", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovid.com/role/WARRANTSDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ClassOfWarrantOrRightTable": { "auth_ref": [ "r111", "r115" ], "lang": { "en-us": { "role": { "documentation": "Disclosure for warrants or rights issued, which includes the title of issue of securities called for by warrants and rights outstanding, the aggregate amount of securities called for by warrants and rights outstanding, the date from which the warrants or rights are exercisable, and the price at which the warrant or right is exercisable.", "label": "Class of Warrant or Right [Table]", "terseLabel": "Class of Warrant or Right [Table]" } } }, "localname": "ClassOfWarrantOrRightTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovid.com/role/WARRANTSDetails" ], "xbrltype": "stringItemType" }, "us-gaap_CommitmentsAndContingencies": { "auth_ref": [ "r31", "r173", "r186" ], "calculation": { "http://innovid.com/role/CONSOLIDATEDBALANCESHEETS": { "order": 2.0, "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.", "label": "Commitments and Contingencies", "terseLabel": "COMMITMENTS AND CONTINGENT LIABILITIES (Note 13)" } } }, "localname": "CommitmentsAndContingencies", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovid.com/role/CONSOLIDATEDBALANCESHEETS" ], "xbrltype": "monetaryItemType" }, "us-gaap_CommitmentsAndContingenciesDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Commitments and Contingencies Disclosure [Abstract]", "terseLabel": "Commitments and Contingencies Disclosure [Abstract]" } } }, "localname": "CommitmentsAndContingenciesDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_CommitmentsAndContingenciesDisclosureTextBlock": { "auth_ref": [ "r102", "r351", "r352", "r701", "r840" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for commitments and contingencies.", "label": "Commitments and Contingencies Disclosure [Text Block]", "terseLabel": "COMMITMENTS AND CONTINGENT LIABILITIES" } } }, "localname": "CommitmentsAndContingenciesDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovid.com/role/COMMITMENTSANDCONTINGENTLIABILITIES" ], "xbrltype": "textBlockItemType" }, "us-gaap_CommonStockCapitalSharesReservedForFutureIssuance": { "auth_ref": [ "r32" ], "lang": { "en-us": { "role": { "documentation": "Aggregate number of common shares reserved for future issuance.", "label": "Common Stock, Capital Shares Reserved for Future Issuance", "terseLabel": "Options available for future option grants (in shares)" } } }, "localname": "CommonStockCapitalSharesReservedForFutureIssuance", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovid.com/role/STOCKBASEDCOMPENSATIONNarrativeDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockMember": { "auth_ref": [ "r813", "r814", "r886" ], "lang": { "en-us": { "role": { "documentation": "Stock that is subordinate to all other stock of the issuer.", "label": "Common Stock [Member]", "terseLabel": "Common stocks", "verboseLabel": "Common stock, par value $0.0001 per share" } } }, "localname": "CommonStockMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovid.com/role/CoverPage", "http://innovid.com/role/STATEMENTSOFCHANGESINTEMPORARYEQUITYANDSTOCKHOLDERSEQUITYDEFICIT", "http://innovid.com/role/STOCKHOLDERSEQUITYNarrativeDetails", "http://innovid.com/role/TRANSACTIONNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_CommonStockParOrStatedValuePerShare": { "auth_ref": [ "r15" ], "lang": { "en-us": { "role": { "documentation": "Face amount or stated value per share of common stock.", "label": "Common Stock, Par or Stated Value Per Share", "terseLabel": "Ordinary shares, par value (in dollars per share)", "verboseLabel": "Common stock, par value (in dollars per share)" } } }, "localname": "CommonStockParOrStatedValuePerShare", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovid.com/role/COMMITMENTSANDCONTINGENTLIABILITIESDetails", "http://innovid.com/role/CONDENSEDBALANCESHEETSParenthetical", "http://innovid.com/role/STOCKHOLDERSEQUITYCommonSharesActivityDetails", "http://innovid.com/role/STOCKHOLDERSEQUITYNarrativeDetails", "http://innovid.com/role/TRANSACTIONNarrativeDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_CommonStockSharesAuthorized": { "auth_ref": [ "r15" ], "lang": { "en-us": { "role": { "documentation": "The maximum number of common shares permitted to be issued by an entity's charter and bylaws.", "label": "Common Stock, Shares Authorized", "verboseLabel": "Common stock, shares authorized (in shares)" } } }, "localname": "CommonStockSharesAuthorized", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovid.com/role/CONDENSEDBALANCESHEETSParenthetical", "http://innovid.com/role/STOCKHOLDERSEQUITYCommonSharesActivityDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockSharesIssued": { "auth_ref": [ "r15" ], "lang": { "en-us": { "role": { "documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.", "label": "Common Stock, Shares, Issued", "terseLabel": "Common stock, shares issued (in shares)", "verboseLabel": "Common stock, shares issued (in shares)" } } }, "localname": "CommonStockSharesIssued", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovid.com/role/CONDENSEDBALANCESHEETSParenthetical", "http://innovid.com/role/STATEMENTSOFCHANGESINTEMPORARYEQUITYANDSTOCKHOLDERSEQUITYDEFICIT", "http://innovid.com/role/STOCKHOLDERSEQUITYCommonSharesActivityDetails", "http://innovid.com/role/TRANSACTIONNarrativeDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockSharesOutstanding": { "auth_ref": [ "r15", "r107" ], "lang": { "en-us": { "role": { "documentation": "Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.", "label": "Common Stock, Shares, Outstanding", "periodEndLabel": "Ending balance (in shares)", "periodStartLabel": "Beginning balance (in shares)", "terseLabel": "Common stock, shares outstanding (in shares)", "verboseLabel": "Common stock, shares outstanding (in shares)" } } }, "localname": "CommonStockSharesOutstanding", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovid.com/role/CONDENSEDBALANCESHEETSParenthetical", "http://innovid.com/role/STATEMENTSOFCHANGESINTEMPORARYEQUITYANDSTOCKHOLDERSEQUITYDEFICIT", "http://innovid.com/role/STOCKHOLDERSEQUITYCommonSharesActivityDetails", "http://innovid.com/role/TRANSACTIONCommonStockinInnovidCorpDetails", "http://innovid.com/role/TRANSACTIONNarrativeDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockValue": { "auth_ref": [ "r15", "r784" ], "calculation": { "http://innovid.com/role/CONSOLIDATEDBALANCESHEETS": { "order": 1.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.", "label": "Common Stock, Value, Issued", "terseLabel": "Common stock of $0.0001 par value - Authorized: 500,000,000 at December\u00a031, 2022 and December\u00a031, 2021; Issued and outstanding: 133,882,414 and 119,017,380 at December\u00a031, 2022 and December\u00a031, 2021, respectively" } } }, "localname": "CommonStockValue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovid.com/role/CONSOLIDATEDBALANCESHEETS" ], "xbrltype": "monetaryItemType" }, "us-gaap_ComputerEquipmentMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Long lived, depreciable assets that are used in the creation, maintenance and utilization of information systems.", "label": "Computer Equipment [Member]", "terseLabel": "Computers and peripheral equipment" } } }, "localname": "ComputerEquipmentMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovid.com/role/PROPERTYANDEQUIPMENTNETDetails", "http://innovid.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESScheduleofPropertyPlantandEquipmentDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ConcentrationRiskBenchmarkDomain": { "auth_ref": [ "r71", "r72", "r159", "r160", "r316", "r700" ], "lang": { "en-us": { "role": { "documentation": "The denominator in a calculation of a disclosed concentration risk percentage.", "label": "Concentration Risk Benchmark [Domain]", "terseLabel": "Concentration Risk Benchmark [Domain]" } } }, "localname": "ConcentrationRiskBenchmarkDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovid.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESScheduleofConcentrationRiskDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ConcentrationRiskByBenchmarkAxis": { "auth_ref": [ "r71", "r72", "r159", "r160", "r316", "r698", "r700" ], "lang": { "en-us": { "role": { "documentation": "Information by benchmark of concentration risk.", "label": "Concentration Risk Benchmark [Axis]", "terseLabel": "Concentration Risk Benchmark [Axis]" } } }, "localname": "ConcentrationRiskByBenchmarkAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovid.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESScheduleofConcentrationRiskDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ConcentrationRiskByTypeAxis": { "auth_ref": [ "r71", "r72", "r159", "r160", "r316", "r700", "r911" ], "lang": { "en-us": { "role": { "documentation": "Information by type of concentration risk, for example, but not limited to, asset, liability, net assets, geographic, customer, employees, supplier, lender.", "label": "Concentration Risk Type [Axis]", "terseLabel": "Concentration Risk Type [Axis]" } } }, "localname": "ConcentrationRiskByTypeAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovid.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESScheduleofConcentrationRiskDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ConcentrationRiskCreditRisk": { "auth_ref": [ "r177", "r289" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for credit risk.", "label": "Concentration Risk, Credit Risk, Policy [Policy Text Block]", "terseLabel": "Concentration of credit risks" } } }, "localname": "ConcentrationRiskCreditRisk", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovid.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_ConcentrationRiskLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Concentration Risk [Line Items]", "terseLabel": "Concentration Risk [Line Items]" } } }, "localname": "ConcentrationRiskLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovid.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESScheduleofConcentrationRiskDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ConcentrationRiskPercentage1": { "auth_ref": [ "r71", "r72", "r159", "r160", "r316" ], "lang": { "en-us": { "role": { "documentation": "For an entity that discloses a concentration risk in relation to quantitative amount, which serves as the \"benchmark\" (or denominator) in the equation, this concept represents the concentration percentage derived from the division.", "label": "Concentration Risk, Percentage", "terseLabel": "Concentration risk, percentage" } } }, "localname": "ConcentrationRiskPercentage1", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovid.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESScheduleofConcentrationRiskDetails" ], "xbrltype": "percentItemType" }, "us-gaap_ConcentrationRiskTable": { "auth_ref": [ "r69", "r71", "r72", "r73", "r159", "r161", "r700" ], "lang": { "en-us": { "role": { "documentation": "Describes the nature of a concentration, a benchmark to which it is compared, and the percentage that the risk is to the benchmark.", "label": "Concentration Risk [Table]", "terseLabel": "Concentration Risk [Table]" } } }, "localname": "ConcentrationRiskTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovid.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESScheduleofConcentrationRiskDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ConcentrationRiskTypeDomain": { "auth_ref": [ "r71", "r72", "r159", "r160", "r316", "r700" ], "lang": { "en-us": { "role": { "documentation": "For an entity that discloses a concentration risk as a percentage of some financial balance or benchmark, identifies the type (for example, asset, liability, net assets, geographic, customer, employees, supplier, lender) of the concentration.", "label": "Concentration Risk Type [Domain]", "terseLabel": "Concentration Risk Type [Domain]" } } }, "localname": "ConcentrationRiskTypeDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovid.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESScheduleofConcentrationRiskDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ConversionOfStockAmountConverted1": { "auth_ref": [ "r61", "r62", "r63" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The value of the stock converted in a noncash (or part noncash) transaction. Noncash is defined as transactions during a period that do not result in cash receipts or cash payments in the period. \"Part noncash\" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.", "label": "Conversion of Stock, Amount Converted", "terseLabel": "Conversion of redeemable convertible preferred stock into common stock" } } }, "localname": "ConversionOfStockAmountConverted1", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovid.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "monetaryItemType" }, "us-gaap_ConversionOfStockSharesConverted1": { "auth_ref": [ "r61", "r62", "r63" ], "lang": { "en-us": { "role": { "documentation": "The number of shares converted in a noncash (or part noncash) transaction. Noncash is defined as transactions during a period that do not result in cash receipts or cash payments in the period. \"Part noncash\" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.", "label": "Conversion of Stock, Shares Converted", "terseLabel": "Conversion of stock (in shares)" } } }, "localname": "ConversionOfStockSharesConverted1", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovid.com/role/TRANSACTIONNarrativeDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_CostOfRevenue": { "auth_ref": [ "r41", "r238", "r326", "r357", "r358", "r359", "r360", "r361", "r362", "r363", "r364", "r365", "r605", "r842" ], "calculation": { "http://innovid.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": { "order": 2.0, "parentTag": "us-gaap_OperatingIncomeLoss", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The aggregate cost of goods produced and sold and services rendered during the reporting period.", "label": "Cost of Revenue", "terseLabel": "Cost of revenues" } } }, "localname": "CostOfRevenue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovid.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS", "http://innovid.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESScheduleofReclassificationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_CostOfSalesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Primary financial statement caption encompassing cost of sales.", "label": "Cost of Sales [Member]", "terseLabel": "Cost of goods sold" } } }, "localname": "CostOfSalesMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovid.com/role/STOCKBASEDCOMPENSATIONStockOptionActivityUnderPlanDetails" ], "xbrltype": "domainItemType" }, "us-gaap_CreditFacilityAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Information by type of credit facility. Credit facilities provide capital to borrowers without the need to structure a loan for each borrowing.", "label": "Credit Facility [Axis]", "terseLabel": "Credit Facility [Axis]" } } }, "localname": "CreditFacilityAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovid.com/role/LONGTERMDEBTDetails" ], "xbrltype": "stringItemType" }, "us-gaap_CreditFacilityDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Type of credit facility. Credit facilities provide capital to borrowers without the need to structure a loan for each borrowing.", "label": "Credit Facility [Domain]", "terseLabel": "Credit Facility [Domain]" } } }, "localname": "CreditFacilityDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovid.com/role/LONGTERMDEBTDetails" ], "xbrltype": "domainItemType" }, "us-gaap_CurrentFederalStateAndLocalTaxExpenseBenefit": { "auth_ref": [ "r882" ], "calculation": { "http://innovid.com/role/INCOMETAXESIncomeTaxExpenseBenefitDetails": { "order": 1.0, "parentTag": "us-gaap_CurrentIncomeTaxExpenseBenefit", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of current federal, state, and local tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, current national, regional, territorial, and provincial tax expense (benefit) for non-US (United States of America) jurisdiction.", "label": "Current Federal, State and Local, Tax Expense (Benefit)", "terseLabel": "Domestic" } } }, "localname": "CurrentFederalStateAndLocalTaxExpenseBenefit", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovid.com/role/INCOMETAXESIncomeTaxExpenseBenefitDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_CurrentForeignTaxExpenseBenefit": { "auth_ref": [ "r811", "r882" ], "calculation": { "http://innovid.com/role/INCOMETAXESIncomeTaxExpenseBenefitDetails": { "order": 2.0, "parentTag": "us-gaap_CurrentIncomeTaxExpenseBenefit", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of current foreign income tax expense (benefit) pertaining to income (loss) from continuing operations.", "label": "Current Foreign Tax Expense (Benefit)", "terseLabel": "Foreign" } } }, "localname": "CurrentForeignTaxExpenseBenefit", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovid.com/role/INCOMETAXESIncomeTaxExpenseBenefitDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_CurrentIncomeTaxExpenseBenefit": { "auth_ref": [ "r137", "r551", "r561", "r811" ], "calculation": { "http://innovid.com/role/INCOMETAXESIncomeTaxExpenseBenefitDetails": { "order": 1.0, "parentTag": "us-gaap_IncomeTaxExpenseBenefit", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of current income tax expense (benefit) pertaining to taxable income (loss) from continuing operations.", "label": "Current Income Tax Expense (Benefit)", "totalLabel": "Total current income tax (benefit) provision" } } }, "localname": "CurrentIncomeTaxExpenseBenefit", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovid.com/role/INCOMETAXESIncomeTaxExpenseBenefitDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Current Income Tax Expense (Benefit), Continuing Operations [Abstract]", "terseLabel": "Current income tax provision (benefit):" } } }, "localname": "CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovid.com/role/INCOMETAXESIncomeTaxExpenseBenefitDetails" ], "xbrltype": "stringItemType" }, "us-gaap_CustomerConcentrationRiskMember": { "auth_ref": [ "r70", "r316" ], "lang": { "en-us": { "role": { "documentation": "Reflects the percentage that revenues in the period from one or more significant customers is to net revenues, as defined by the entity, such as total net revenues, product line revenues, segment revenues. The risk is the materially adverse effects of loss of a significant customer.", "label": "Customer Concentration Risk [Member]", "terseLabel": "Customer Concentration Risk" } } }, "localname": "CustomerConcentrationRiskMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovid.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESScheduleofConcentrationRiskDetails" ], "xbrltype": "domainItemType" }, "us-gaap_CustomerRelationshipsMember": { "auth_ref": [ "r147" ], "lang": { "en-us": { "role": { "documentation": "Customer relationship that exists between an entity and its customer, for example, but not limited to, tenant relationships.", "label": "Customer Relationships [Member]", "terseLabel": "Customer relationships" } } }, "localname": "CustomerRelationshipsMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovid.com/role/ACQUISITIONFairValuesoftheAssetsAcquiredandLiabilitiesAssumedDetails", "http://innovid.com/role/ACQUISITIONNarrativeDetails", "http://innovid.com/role/INTANGIBLEASSETSNETIntangibleAssetsDetails", "http://innovid.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_DebtDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Debt Disclosure [Abstract]" } } }, "localname": "DebtDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_DebtDisclosureTextBlock": { "auth_ref": [ "r103", "r236", "r371", "r372", "r373", "r374", "r375", "r376", "r377", "r382", "r389", "r390", "r391" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants.", "label": "Debt Disclosure [Text Block]", "terseLabel": "LONG-TERM DEBT", "verboseLabel": "FINANCE EXPENSES (INCOME), NET" } } }, "localname": "DebtDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovid.com/role/FINANCEEXPENSESINCOMENET", "http://innovid.com/role/LONGTERMDEBT" ], "xbrltype": "textBlockItemType" }, "us-gaap_DebtInstrumentAxis": { "auth_ref": [ "r6", "r7", "r8", "r167", "r171", "r179", "r244", "r366", "r367", "r368", "r369", "r370", "r372", "r378", "r379", "r380", "r381", "r383", "r384", "r385", "r386", "r387", "r388", "r624", "r760", "r761", "r762", "r763", "r764", "r809" ], "lang": { "en-us": { "role": { "documentation": "Information by type of debt instrument, including, but not limited to, draws against credit facilities.", "label": "Debt Instrument [Axis]", "terseLabel": "Debt Instrument [Axis]" } } }, "localname": "DebtInstrumentAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovid.com/role/FINANCEEXPENSESINCOMENETDetails", "http://innovid.com/role/LONGTERMDEBTDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DebtInstrumentBasisSpreadOnVariableRate1": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Percentage points added to the reference rate to compute the variable rate on the debt instrument.", "label": "Debt Instrument, Basis Spread on Variable Rate", "terseLabel": "Debt instrument, variable rate" } } }, "localname": "DebtInstrumentBasisSpreadOnVariableRate1", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovid.com/role/LONGTERMDEBTDetails" ], "xbrltype": "percentItemType" }, "us-gaap_DebtInstrumentNameDomain": { "auth_ref": [ "r29", "r244", "r366", "r367", "r368", "r369", "r370", "r372", "r378", "r379", "r380", "r381", "r383", "r384", "r385", "r386", "r387", "r388", "r624", "r760", "r761", "r762", "r763", "r764", "r809" ], "lang": { "en-us": { "role": { "documentation": "The name for the particular debt instrument or borrowing that distinguishes it from other debt instruments or borrowings, including draws against credit facilities.", "label": "Debt Instrument, Name [Domain]", "terseLabel": "Debt Instrument, Name [Domain]" } } }, "localname": "DebtInstrumentNameDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovid.com/role/FINANCEEXPENSESINCOMENETDetails", "http://innovid.com/role/LONGTERMDEBTDetails" ], "xbrltype": "domainItemType" }, "us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Abstract]" } } }, "localname": "DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the amounts paid in advance for capitalized costs that will be expensed with the passage of time or the occurrence of a triggering event, and will be charged against earnings within one year or the normal operating cycle, if longer; the aggregate carrying amount of current assets, not separately presented elsewhere in the balance sheet; and other deferred costs.", "label": "Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Table Text Block]", "terseLabel": "Schedule of Prepaid and Other Current Assets" } } }, "localname": "DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovid.com/role/PREPAIDANDOTHERCURRENTASSETSTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_DeferredFederalStateAndLocalTaxExpenseBenefit": { "auth_ref": [ "r876" ], "calculation": { "http://innovid.com/role/INCOMETAXESIncomeTaxExpenseBenefitDetails": { "order": 2.0, "parentTag": "us-gaap_DeferredIncomeTaxExpenseBenefit", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of deferred federal, state, and local tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, deferred national, regional, territorial, and provincial tax expense (benefit) for non-US (United States of America) jurisdiction.", "label": "Deferred Federal, State and Local, Tax Expense (Benefit)", "terseLabel": "Domestic" } } }, "localname": "DeferredFederalStateAndLocalTaxExpenseBenefit", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovid.com/role/INCOMETAXESIncomeTaxExpenseBenefitDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredForeignIncomeTaxExpenseBenefit": { "auth_ref": [ "r137", "r811", "r883" ], "calculation": { "http://innovid.com/role/INCOMETAXESIncomeTaxExpenseBenefitDetails": { "order": 1.0, "parentTag": "us-gaap_DeferredIncomeTaxExpenseBenefit", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of deferred foreign income tax expense (benefit) pertaining to income (loss) from continuing operations.", "label": "Deferred Foreign Income Tax Expense (Benefit)", "terseLabel": "Foreign" } } }, "localname": "DeferredForeignIncomeTaxExpenseBenefit", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovid.com/role/INCOMETAXESIncomeTaxExpenseBenefitDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredIncomeTaxExpenseBenefit": { "auth_ref": [ "r56", "r137", "r552", "r560", "r561", "r811" ], "calculation": { "http://innovid.com/role/INCOMETAXESIncomeTaxExpenseBenefitDetails": { "order": 2.0, "parentTag": "us-gaap_IncomeTaxExpenseBenefit", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.", "label": "Deferred Income Tax Expense (Benefit)", "totalLabel": "Total deferred income tax (benefit) provision" } } }, "localname": "DeferredIncomeTaxExpenseBenefit", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovid.com/role/INCOMETAXESIncomeTaxExpenseBenefitDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Deferred Income Tax Expense (Benefit), Continuing Operations [Abstract]", "terseLabel": "Deferred income tax provision (benefit):" } } }, "localname": "DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovid.com/role/INCOMETAXESIncomeTaxExpenseBenefitDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DeferredIncomeTaxLiabilities": { "auth_ref": [ "r11", "r12", "r169", "r178", "r546" ], "calculation": { "http://innovid.com/role/INCOMETAXESDeferredTaxAssetsandLiabilitiesDetails": { "order": 2.0, "parentTag": "us-gaap_DeferredTaxLiabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of deferred tax liability attributable to taxable temporary differences.", "label": "Deferred Tax Liabilities, Gross", "negatedTotalLabel": "Total deferred tax liability, net" } } }, "localname": "DeferredIncomeTaxLiabilities", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovid.com/role/INCOMETAXESDeferredTaxAssetsandLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredIncomeTaxLiabilitiesNet": { "auth_ref": [ "r536", "r537" ], "calculation": { "http://innovid.com/role/OTHERNONCURRENTLIABILITIESDetails": { "order": 3.0, "parentTag": "us-gaap_OtherLiabilitiesNoncurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences with jurisdictional netting.", "label": "Deferred Income Tax Liabilities, Net", "terseLabel": "Deferred tax liability" } } }, "localname": "DeferredIncomeTaxLiabilitiesNet", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovid.com/role/OTHERNONCURRENTLIABILITIESDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredRevenueCurrent": { "auth_ref": [ "r803" ], "calculation": { "http://innovid.com/role/ACCRUEDEXPENSESANDOTHERCURRENTLIABILITIESDetails": { "order": 5.0, "parentTag": "us-gaap_AccruedLiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of deferred income and obligation to transfer product and service to customer for which consideration has been received or is receivable, classified as current.", "label": "Deferred Revenue, Current", "terseLabel": "Deferred revenue" } } }, "localname": "DeferredRevenueCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovid.com/role/ACCRUEDEXPENSESANDOTHERCURRENTLIABILITIESDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxAssetInterestCarryforward": { "auth_ref": [ "r881" ], "calculation": { "http://innovid.com/role/INCOMETAXESDeferredTaxAssetsandLiabilitiesDetails": { "order": 3.0, "parentTag": "us-gaap_DeferredTaxAssetsGross", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, before allocation of valuation allowance, of deferred tax asset attributable to deductible interest carryforward.", "label": "Deferred Tax Asset, Interest Carryforward", "terseLabel": "Interest limitation carryforwards" } } }, "localname": "DeferredTaxAssetInterestCarryforward", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovid.com/role/INCOMETAXESDeferredTaxAssetsandLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxAssetsGoodwillAndIntangibleAssets": { "auth_ref": [], "calculation": { "http://innovid.com/role/INCOMETAXESDeferredTaxAssetsandLiabilitiesDetails": { "order": 7.0, "parentTag": "us-gaap_DeferredTaxAssetsGross", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from intangible assets including goodwill.", "label": "Deferred Tax Assets, Goodwill and Intangible Assets", "terseLabel": "Fixed assets" } } }, "localname": "DeferredTaxAssetsGoodwillAndIntangibleAssets", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovid.com/role/INCOMETAXESDeferredTaxAssetsandLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxAssetsGross": { "auth_ref": [ "r547" ], "calculation": { "http://innovid.com/role/INCOMETAXESDeferredTaxAssetsandLiabilitiesDetails": { "order": 2.0, "parentTag": "us-gaap_DeferredTaxAssetsNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.", "label": "Deferred Tax Assets, Gross", "totalLabel": "Total deferred tax assets, gross" } } }, "localname": "DeferredTaxAssetsGross", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovid.com/role/INCOMETAXESDeferredTaxAssetsandLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxAssetsInProcessResearchAndDevelopment": { "auth_ref": [ "r135", "r881" ], "calculation": { "http://innovid.com/role/INCOMETAXESDeferredTaxAssetsandLiabilitiesDetails": { "order": 4.0, "parentTag": "us-gaap_DeferredTaxAssetsGross", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from in-process research and development costs expensed in connection with a business combination.", "label": "Deferred Tax Assets, in Process Research and Development", "terseLabel": "R&D capitalization costs" } } }, "localname": "DeferredTaxAssetsInProcessResearchAndDevelopment", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovid.com/role/INCOMETAXESDeferredTaxAssetsandLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxAssetsLiabilitiesNet": { "auth_ref": [ "r880" ], "calculation": { "http://innovid.com/role/INCOMETAXESDeferredTaxAssetsandLiabilitiesDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, without jurisdictional netting.", "label": "Deferred Tax Assets, Net", "totalLabel": "Total deferred tax asset (liability)" } } }, "localname": "DeferredTaxAssetsLiabilitiesNet", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovid.com/role/INCOMETAXESDeferredTaxAssetsandLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxAssetsNet": { "auth_ref": [ "r880" ], "calculation": { "http://innovid.com/role/INCOMETAXESDeferredTaxAssetsandLiabilitiesDetails": { "order": 2.0, "parentTag": "us-gaap_DeferredTaxAssetsLiabilitiesNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount after allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.", "label": "Deferred Tax Assets, Net of Valuation Allowance", "totalLabel": "Total deferred tax assets, net" } } }, "localname": "DeferredTaxAssetsNet", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovid.com/role/INCOMETAXESDeferredTaxAssetsandLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxAssetsNetOfValuationAllowanceAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Deferred Tax Assets, Net of Valuation Allowance [Abstract]", "terseLabel": "Deferred tax assets" } } }, "localname": "DeferredTaxAssetsNetOfValuationAllowanceAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovid.com/role/INCOMETAXESDeferredTaxAssetsandLiabilitiesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DeferredTaxAssetsOperatingLossCarryforwards": { "auth_ref": [ "r135", "r881" ], "calculation": { "http://innovid.com/role/INCOMETAXESDeferredTaxAssetsandLiabilitiesDetails": { "order": 6.0, "parentTag": "us-gaap_DeferredTaxAssetsGross", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating loss carryforwards.", "label": "Deferred Tax Assets, Operating Loss Carryforwards", "terseLabel": "Loss carryforwards" } } }, "localname": "DeferredTaxAssetsOperatingLossCarryforwards", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovid.com/role/INCOMETAXESDeferredTaxAssetsandLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxAssetsOther": { "auth_ref": [ "r135", "r881" ], "calculation": { "http://innovid.com/role/INCOMETAXESDeferredTaxAssetsandLiabilitiesDetails": { "order": 8.0, "parentTag": "us-gaap_DeferredTaxAssetsGross", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, before allocation of valuation allowance, of deferred tax asset attributable to deductible temporary differences, classified as other.", "label": "Deferred Tax Assets, Other", "terseLabel": "Other" } } }, "localname": "DeferredTaxAssetsOther", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovid.com/role/INCOMETAXESDeferredTaxAssetsandLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxAssetsTaxCreditCarryforwards": { "auth_ref": [ "r133", "r135", "r881" ], "calculation": { "http://innovid.com/role/INCOMETAXESDeferredTaxAssetsandLiabilitiesDetails": { "order": 5.0, "parentTag": "us-gaap_DeferredTaxAssetsGross", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, before allocation of a valuation allowances, of deferred tax assets attributable to deductible tax credit carryforwards including, but not limited to, research, foreign, general business, alternative minimum tax, and other deductible tax credit carryforwards.", "label": "Deferred Tax Assets, Tax Credit Carryforwards", "terseLabel": "Tax credits" } } }, "localname": "DeferredTaxAssetsTaxCreditCarryforwards", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovid.com/role/INCOMETAXESDeferredTaxAssetsandLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost": { "auth_ref": [ "r135", "r881" ], "calculation": { "http://innovid.com/role/INCOMETAXESDeferredTaxAssetsandLiabilitiesDetails": { "order": 2.0, "parentTag": "us-gaap_DeferredTaxAssetsGross", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from share-based compensation.", "label": "Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-Based Compensation Cost", "terseLabel": "Share-based compensation" } } }, "localname": "DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovid.com/role/INCOMETAXESDeferredTaxAssetsandLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities": { "auth_ref": [ "r135", "r881" ], "calculation": { "http://innovid.com/role/INCOMETAXESDeferredTaxAssetsandLiabilitiesDetails": { "order": 1.0, "parentTag": "us-gaap_DeferredTaxAssetsGross", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from accrued liabilities.", "label": "Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals, Accrued Liabilities", "terseLabel": "Accrued expenses" } } }, "localname": "DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovid.com/role/INCOMETAXESDeferredTaxAssetsandLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxAssetsValuationAllowance": { "auth_ref": [ "r548" ], "calculation": { "http://innovid.com/role/INCOMETAXESDeferredTaxAssetsandLiabilitiesDetails": { "order": 1.0, "parentTag": "us-gaap_DeferredTaxAssetsNet", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.", "label": "Deferred Tax Assets, Valuation Allowance", "negatedTerseLabel": "Valuation allowance" } } }, "localname": "DeferredTaxAssetsValuationAllowance", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovid.com/role/INCOMETAXESDeferredTaxAssetsandLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxLiabilities": { "auth_ref": [ "r129", "r880" ], "calculation": { "http://innovid.com/role/INCOMETAXESDeferredTaxAssetsandLiabilitiesDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences without jurisdictional netting.", "label": "Deferred Tax Liabilities, Net", "negatedTotalLabel": "Total deferred tax asset (liability)" } } }, "localname": "DeferredTaxLiabilities", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovid.com/role/INCOMETAXESDeferredTaxAssetsandLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssets": { "auth_ref": [ "r135", "r881" ], "calculation": { "http://innovid.com/role/INCOMETAXESDeferredTaxAssetsandLiabilitiesDetails": { "order": 2.0, "parentTag": "us-gaap_DeferredIncomeTaxLiabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of deferred tax liability attributable to taxable temporary differences from intangible assets including goodwill.", "label": "Deferred Tax Liabilities, Goodwill and Intangible Assets", "negatedTerseLabel": "Intangibles" } } }, "localname": "DeferredTaxLiabilitiesGoodwillAndIntangibleAssets", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovid.com/role/INCOMETAXESDeferredTaxAssetsandLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxLiabilitiesLeasingArrangements": { "auth_ref": [ "r135", "r881" ], "calculation": { "http://innovid.com/role/INCOMETAXESDeferredTaxAssetsandLiabilitiesDetails": { "order": 3.0, "parentTag": "us-gaap_DeferredIncomeTaxLiabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of deferred tax liability attributable to taxable temporary differences from leasing arrangements.", "label": "Deferred Tax Liabilities, Leasing Arrangements", "negatedTerseLabel": "Right-of-use asset" } } }, "localname": "DeferredTaxLiabilitiesLeasingArrangements", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovid.com/role/INCOMETAXESDeferredTaxAssetsandLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxLiabilitiesNetAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Deferred Tax Liabilities, Net [Abstract]", "terseLabel": "Deferred tax liabilities" } } }, "localname": "DeferredTaxLiabilitiesNetAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovid.com/role/INCOMETAXESDeferredTaxAssetsandLiabilitiesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DeferredTaxLiabilitiesOther": { "auth_ref": [ "r135", "r881" ], "calculation": { "http://innovid.com/role/INCOMETAXESDeferredTaxAssetsandLiabilitiesDetails": { "order": 1.0, "parentTag": "us-gaap_DeferredIncomeTaxLiabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of deferred tax liability attributable to taxable temporary differences classified as other.", "label": "Deferred Tax Liabilities, Other", "negatedTerseLabel": "Other" } } }, "localname": "DeferredTaxLiabilitiesOther", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovid.com/role/INCOMETAXESDeferredTaxAssetsandLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxLiabilityNotRecognizedAmountOfUnrecognizedDeferredTaxLiabilityUndistributedEarningsOfForeignSubsidiaries": { "auth_ref": [ "r569" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of deferred tax liability not recognized because of the exceptions to comprehensive recognition of deferred taxes related to undistributed earnings of foreign subsidiaries.", "label": "Deferred Tax Liability Not Recognized, Amount of Unrecognized Deferred Tax Liability, Undistributed Earnings of Foreign Subsidiaries", "terseLabel": "Amount of unrecognized deferred tax liability, undistributed earnings of foreign subsidiaries" } } }, "localname": "DeferredTaxLiabilityNotRecognizedAmountOfUnrecognizedDeferredTaxLiabilityUndistributedEarningsOfForeignSubsidiaries", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovid.com/role/INCOMETAXESNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DefinedContributionPlanCostRecognized": { "auth_ref": [ "r482" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cost for defined contribution plan.", "label": "Defined Contribution Plan, Cost", "terseLabel": "Defined contribution plan, cost" } } }, "localname": "DefinedContributionPlanCostRecognized", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovid.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Maximum percentage of employee gross pay the employee may contribute to a defined contribution plan.", "label": "Defined Contribution Plan, Maximum Annual Contributions Per Employee, Percent", "terseLabel": "Maximum annual contributions per employee, percent" } } }, "localname": "DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovid.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails" ], "xbrltype": "percentItemType" }, "us-gaap_DepositsAssetsCurrent": { "auth_ref": [ "r804" ], "calculation": { "http://innovid.com/role/PREPAIDANDOTHERCURRENTASSETSDetails": { "order": 2.0, "parentTag": "us-gaap_PrepaidExpenseAndOtherAssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Carrying value of amounts transferred to third parties for security purposes that are expected to be returned or applied towards payment within one year or during the operating cycle, if shorter.", "label": "Deposits Assets, Current", "terseLabel": "Deposits" } } }, "localname": "DepositsAssetsCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovid.com/role/PREPAIDANDOTHERCURRENTASSETSDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_Depreciation": { "auth_ref": [ "r56", "r95" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.", "label": "Depreciation", "terseLabel": "Depreciation" } } }, "localname": "Depreciation", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovid.com/role/PROPERTYANDEQUIPMENTNETDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DepreciationAndAmortization": { "auth_ref": [ "r56", "r95" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The current period expense charged against earnings on long-lived, physical assets not used in production, and which are not intended for resale, to allocate or recognize the cost of such assets over their useful lives; or to record the reduction in book value of an intangible asset over the benefit period of such asset; or to reflect consumption during the period of an asset that is not used in production.", "label": "Depreciation, Depletion and Amortization, Nonproduction", "terseLabel": "Depreciation, amortization and impairment" } } }, "localname": "DepreciationAndAmortization", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovid.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESScheduleofReclassificationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DepreciationDepletionAndAmortization": { "auth_ref": [ "r56", "r297" ], "calculation": { "http://innovid.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "order": 3.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 }, "http://innovid.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": { "order": 4.0, "parentTag": "us-gaap_OperatingIncomeLoss", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.", "label": "Depreciation, Depletion and Amortization", "terseLabel": "Depreciation, amortization and impairment" } } }, "localname": "DepreciationDepletionAndAmortization", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovid.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS", "http://innovid.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS" ], "xbrltype": "monetaryItemType" }, "us-gaap_DerivativeFairValueOfDerivativeLiability": { "auth_ref": [ "r35", "r151", "r163", "r221", "r752" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Fair value, before effects of master netting arrangements, of a financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes liabilities elected not to be offset. Excludes liabilities not subject to a master netting arrangement.", "label": "Derivative Liability, Subject to Master Netting Arrangement, before Offset", "terseLabel": "Derivative liability fair value" } } }, "localname": "DerivativeFairValueOfDerivativeLiability", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovid.com/role/WARRANTSDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Derivative Instruments and Hedging Activities Disclosure [Abstract]", "terseLabel": "Derivative Instruments and Hedging Activities Disclosure [Abstract]" } } }, "localname": "DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock": { "auth_ref": [ "r152", "r584" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for derivative instruments and hedging activities including, but not limited to, risk management strategies, non-hedging derivative instruments, assets, liabilities, revenue and expenses, and methodologies and assumptions used in determining the amounts.", "label": "Derivative Instruments and Hedging Activities Disclosure [Text Block]", "terseLabel": "WARRANTS" } } }, "localname": "DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovid.com/role/WARRANTS" ], "xbrltype": "textBlockItemType" }, "us-gaap_DerivativeLiabilities": { "auth_ref": [ "r222", "r223", "r604", "r752" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Fair value, after the effects of master netting arrangements, of a financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes liabilities not subject to a master netting arrangement and not elected to be offset.", "label": "Derivative Liability", "terseLabel": "Warrants liability" } } }, "localname": "DerivativeLiabilities", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovid.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESScheduleofFairValueAssetsandLiabilitiesMeasuredonRecurringBasisDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DerivativeLiabilityStatementOfFinancialPositionExtensibleEnumeration": { "auth_ref": [ "r583" ], "lang": { "en-us": { "role": { "documentation": "Indicates line item in statement of financial position that includes derivative liability.", "label": "Derivative Liability, Statement of Financial Position [Extensible Enumeration]", "terseLabel": "Derivative Liability, Statement of Financial Position [Extensible Enumeration]" } } }, "localname": "DerivativeLiabilityStatementOfFinancialPositionExtensibleEnumeration", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovid.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESScheduleofFairValueAssetsandLiabilitiesMeasuredonRecurringBasisDetails" ], "xbrltype": "enumerationSetItemType" }, "us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock": { "auth_ref": [ "r491", "r523", "r524", "r526", "r531", "r780" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for share-based payment arrangement.", "label": "Share-Based Payment Arrangement [Text Block]", "terseLabel": "STOCK-BASED COMPENSATION" } } }, "localname": "DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovid.com/role/STOCKBASEDCOMPENSATION" ], "xbrltype": "textBlockItemType" }, "us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Share-Based Payment Arrangement [Abstract]" } } }, "localname": "DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_DomesticCountryMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Designated tax department of the government that is entitled to levy and collect income taxes from the entity in its country of domicile.", "label": "Domestic Tax Authority [Member]", "terseLabel": "Domestic NOLs (federal)" } } }, "localname": "DomesticCountryMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovid.com/role/INCOMETAXESOperatingLossCarryforwardsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_EMEAMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Regions of Europe, Middle East and Africa.", "label": "EMEA [Member]", "terseLabel": "EMEA" } } }, "localname": "EMEAMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovid.com/role/SEGMENTREPORTINGRevenueandPropertyandEquipmentbyGeographicalAreasDetails" ], "xbrltype": "domainItemType" }, "us-gaap_EarningsPerShareAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Earnings Per Share [Abstract]" } } }, "localname": "EarningsPerShareAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_EarningsPerShareBasic": { "auth_ref": [ "r230", "r253", "r254", "r256", "r257", "r258", "r264", "r267", "r275", "r276", "r277", "r281", "r595", "r596", "r678", "r682", "r754" ], "lang": { "en-us": { "role": { "documentation": "The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.", "label": "Earnings Per Share, Basic", "verboseLabel": "Net loss per stock attributable to common stockholders \u2013 basic (in dollars per share)" } } }, "localname": "EarningsPerShareBasic", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovid.com/role/BASICANDDILUTEDNETLOSSPERSHAREBasicandDilutedNetlossPerShareDetails", "http://innovid.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS" ], "xbrltype": "perShareItemType" }, "us-gaap_EarningsPerShareBasicAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Earnings Per Share, Basic [Abstract]", "terseLabel": "Net loss per stock attributable to common stockholders" } } }, "localname": "EarningsPerShareBasicAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovid.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS" ], "xbrltype": "stringItemType" }, "us-gaap_EarningsPerShareDiluted": { "auth_ref": [ "r230", "r253", "r254", "r256", "r257", "r258", "r267", "r275", "r276", "r277", "r281", "r595", "r596", "r678", "r682", "r754" ], "lang": { "en-us": { "role": { "documentation": "The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.", "label": "Earnings Per Share, Diluted", "verboseLabel": "Net loss per stock attributable to common stockholders \u2013 diluted (in dollars per share)" } } }, "localname": "EarningsPerShareDiluted", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovid.com/role/BASICANDDILUTEDNETLOSSPERSHAREBasicandDilutedNetlossPerShareDetails", "http://innovid.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS" ], "xbrltype": "perShareItemType" }, "us-gaap_EarningsPerSharePolicyTextBlock": { "auth_ref": [ "r67", "r68" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security. Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements.", "label": "Earnings Per Share, Policy [Policy Text Block]", "terseLabel": "Net loss per common stock" } } }, "localname": "EarningsPerSharePolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovid.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_EarningsPerShareTextBlock": { "auth_ref": [ "r278", "r279", "r280", "r283" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for earnings per share.", "label": "Earnings Per Share [Text Block]", "terseLabel": "BASIC AND DILUTED NET LOSS PER SHARE" } } }, "localname": "EarningsPerShareTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovid.com/role/BASICANDDILUTEDNETLOSSPERSHARE" ], "xbrltype": "textBlockItemType" }, "us-gaap_EffectiveIncomeTaxRateContinuingOperations": { "auth_ref": [ "r539" ], "lang": { "en-us": { "role": { "documentation": "Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.", "label": "Effective Income Tax Rate Reconciliation, Percent", "terseLabel": "Effective income tax rate" } } }, "localname": "EffectiveIncomeTaxRateContinuingOperations", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovid.com/role/INCOMETAXESEffectiveIncomeTaxRateReconciliationDetails" ], "xbrltype": "percentItemType" }, "us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate": { "auth_ref": [ "r240", "r539", "r563" ], "lang": { "en-us": { "role": { "documentation": "Percentage of domestic federal statutory tax rate applicable to pretax income (loss).", "label": "Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent", "terseLabel": "US statutory rate" } } }, "localname": "EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovid.com/role/INCOMETAXESEffectiveIncomeTaxRateReconciliationDetails" ], "xbrltype": "percentItemType" }, "us-gaap_EmployeeRelatedLiabilitiesCurrent": { "auth_ref": [ "r26" ], "calculation": { "http://innovid.com/role/CONSOLIDATEDBALANCESHEETS": { "order": 4.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).", "label": "Employee-related Liabilities, Current", "terseLabel": "Employee and payroll accruals" } } }, "localname": "EmployeeRelatedLiabilitiesCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovid.com/role/CONSOLIDATEDBALANCESHEETS" ], "xbrltype": "monetaryItemType" }, "us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount": { "auth_ref": [ "r522" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cost capitalized for award under share-based payment arrangement.", "label": "Share-Based Payment Arrangement, Amount Capitalized", "terseLabel": "Capitalized stock-based compensation expense" } } }, "localname": "EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovid.com/role/STOCKBASEDCOMPENSATIONNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]", "terseLabel": "Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]" } } }, "localname": "EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovid.com/role/STOCKBASEDCOMPENSATIONStockOptionActivityUnderPlanDetails" ], "xbrltype": "stringItemType" }, "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized": { "auth_ref": [ "r525" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cost not yet recognized for nonvested award under share-based payment arrangement.", "label": "Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount", "terseLabel": "Cost not yet recognized" } } }, "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovid.com/role/STOCKBASEDCOMPENSATIONNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1": { "auth_ref": [ "r525" ], "lang": { "en-us": { "role": { "documentation": "Weighted-average period over which cost not yet recognized is expected to be recognized for award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.", "label": "Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition", "terseLabel": "Period for cost yet to be recognized" } } }, "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovid.com/role/STOCKBASEDCOMPENSATIONNarrativeDetails" ], "xbrltype": "durationItemType" }, "us-gaap_EmployeeSeveranceMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Termination of an employee associated with exit from or disposal of business activities or restructurings pursuant to a plan.", "label": "Employee Severance [Member]", "terseLabel": "Employee Severance" } } }, "localname": "EmployeeSeveranceMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovid.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_EmployeeStockOptionMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Share-based payment arrangement granting right, subject to vesting and other restrictions, to purchase or sell certain number of shares at predetermined price for specified period of time.", "label": "Share-Based Payment Arrangement, Option [Member]", "terseLabel": "Options outstanding" } } }, "localname": "EmployeeStockOptionMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovid.com/role/BASICANDDILUTEDNETLOSSPERSHARESecuritiesExcludedfromComputationofEarningsPerShareDetails" ], "xbrltype": "domainItemType" }, "us-gaap_EquityComponentDomain": { "auth_ref": [ "r107", "r200", "r227", "r228", "r229", "r245", "r246", "r247", "r250", "r259", "r262", "r284", "r330", "r410", "r527", "r528", "r529", "r556", "r557", "r594", "r614", "r615", "r616", "r617", "r618", "r619", "r649", "r688", "r689", "r690" ], "lang": { "en-us": { "role": { "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc.", "label": "Equity Component [Domain]", "terseLabel": "Equity Component [Domain]" } } }, "localname": "EquityComponentDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovid.com/role/FINANCEEXPENSESINCOMENETDetails", "http://innovid.com/role/STATEMENTSOFCHANGESINTEMPORARYEQUITYANDSTOCKHOLDERSEQUITYDEFICIT", "http://innovid.com/role/STOCKHOLDERSEQUITYNarrativeDetails", "http://innovid.com/role/TRANSACTIONNarrativeDetails", "http://innovid.com/role/WARRANTSDetails" ], "xbrltype": "domainItemType" }, "us-gaap_EquitySecuritiesFvNiUnrealizedGainLoss": { "auth_ref": [ "r683", "r831" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of unrealized gain (loss) on investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI).", "label": "Equity Securities, FV-NI, Unrealized Gain (Loss)", "terseLabel": "Unrealized gain (loss) from changes in the fair value" } } }, "localname": "EquitySecuritiesFvNiUnrealizedGainLoss", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovid.com/role/FINANCEEXPENSESINCOMENETDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FairValueAdjustmentOfWarrants": { "auth_ref": [ "r56", "r104" ], "calculation": { "http://innovid.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "order": 15.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of expense (income) related to adjustment to fair value of warrant liability.", "label": "Fair Value Adjustment of Warrants", "terseLabel": "Change in fair value of warrants" } } }, "localname": "FairValueAdjustmentOfWarrants", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovid.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "monetaryItemType" }, "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Fair Value Measurement Inputs and Valuation Techniques [Line Items]", "terseLabel": "Fair Value Measurement Inputs and Valuation Techniques [Line Items]" } } }, "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovid.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESScheduleofWarrantsFollowsatInitialMeasurementDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable": { "auth_ref": [ "r153" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about input and valuation technique used to measure fair value and change in valuation approach and technique for each separate class of asset and liability measured on recurring and nonrecurring basis.", "label": "Fair Value Measurement Inputs and Valuation Techniques [Table]", "terseLabel": "Fair Value Measurement Inputs and Valuation Techniques [Table]" } } }, "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovid.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESScheduleofWarrantsFollowsatInitialMeasurementDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock": { "auth_ref": [ "r153" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of input and valuation technique used to measure fair value and change in valuation approach and technique for each separate class of asset and liability measured on recurring and nonrecurring basis.", "label": "Fair Value Measurement Inputs and Valuation Techniques [Table Text Block]", "terseLabel": "Schedule of Key Inputs for Valuation of Private Placement Warrants" } } }, "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovid.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_FairValueByFairValueHierarchyLevelAxis": { "auth_ref": [ "r380", "r447", "r448", "r449", "r450", "r451", "r452", "r599", "r654", "r655", "r656", "r761", "r762", "r769", "r770", "r771" ], "lang": { "en-us": { "role": { "documentation": "Information by level within fair value hierarchy and fair value measured at net asset value per share as practical expedient.", "label": "Fair Value Hierarchy and NAV [Axis]", "terseLabel": "Fair Value Hierarchy and NAV [Axis]" } } }, "localname": "FairValueByFairValueHierarchyLevelAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovid.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails", "http://innovid.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESScheduleofFairValueAssetsandLiabilitiesMeasuredonRecurringBasisDetails", "http://innovid.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESScheduleofFairValueLiabilitiesMeasuredonRecurringBasisUnobservableInputReconciliationDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FairValueByLiabilityClassAxis": { "auth_ref": [ "r155", "r156" ], "lang": { "en-us": { "role": { "documentation": "Information by class of liability.", "label": "Liability Class [Axis]", "terseLabel": "Liability Class [Axis]" } } }, "localname": "FairValueByLiabilityClassAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovid.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails", "http://innovid.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESScheduleofFairValueLiabilitiesMeasuredonRecurringBasisUnobservableInputReconciliationDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FairValueByMeasurementFrequencyAxis": { "auth_ref": [ "r598", "r599", "r600", "r601", "r603" ], "lang": { "en-us": { "role": { "documentation": "Information by measurement frequency.", "label": "Measurement Frequency [Axis]", "terseLabel": "Measurement Frequency [Axis]" } } }, "localname": "FairValueByMeasurementFrequencyAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovid.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESScheduleofFairValueAssetsandLiabilitiesMeasuredonRecurringBasisDetails", "http://innovid.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESScheduleofFairValueLiabilitiesMeasuredonRecurringBasisUnobservableInputReconciliationDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FairValueInputsLevel1Member": { "auth_ref": [ "r380", "r447", "r452", "r599", "r654", "r769", "r770", "r771" ], "lang": { "en-us": { "role": { "documentation": "Quoted prices in active markets for identical assets or liabilities that the reporting entity can access at the measurement date.", "label": "Fair Value, Inputs, Level 1 [Member]", "terseLabel": "Level 1" } } }, "localname": "FairValueInputsLevel1Member", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovid.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails", "http://innovid.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESScheduleofFairValueAssetsandLiabilitiesMeasuredonRecurringBasisDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueInputsLevel2Member": { "auth_ref": [ "r380", "r447", "r452", "r599", "r655", "r761", "r762", "r769", "r770", "r771" ], "lang": { "en-us": { "role": { "documentation": "Inputs other than quoted prices included within level 1 that are observable for an asset or liability, either directly or indirectly, including, but not limited to, quoted prices for similar assets or liabilities in active markets, or quoted prices for identical or similar assets or liabilities in inactive markets.", "label": "Fair Value, Inputs, Level 2 [Member]", "terseLabel": "Level 2" } } }, "localname": "FairValueInputsLevel2Member", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovid.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESScheduleofFairValueAssetsandLiabilitiesMeasuredonRecurringBasisDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueInputsLevel3Member": { "auth_ref": [ "r380", "r447", "r448", "r449", "r450", "r451", "r452", "r599", "r656", "r761", "r762", "r769", "r770", "r771" ], "lang": { "en-us": { "role": { "documentation": "Unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.", "label": "Fair Value, Inputs, Level 3 [Member]", "terseLabel": "Level 3" } } }, "localname": "FairValueInputsLevel3Member", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovid.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails", "http://innovid.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESScheduleofFairValueAssetsandLiabilitiesMeasuredonRecurringBasisDetails", "http://innovid.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESScheduleofFairValueLiabilitiesMeasuredonRecurringBasisUnobservableInputReconciliationDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain": { "auth_ref": [ "r154" ], "lang": { "en-us": { "role": { "documentation": "Represents classes of liabilities measured and disclosed at fair value.", "label": "Fair Value by Liability Class [Domain]", "terseLabel": "Fair Value by Liability Class [Domain]" } } }, "localname": "FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovid.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails", "http://innovid.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESScheduleofFairValueLiabilitiesMeasuredonRecurringBasisUnobservableInputReconciliationDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.", "label": "Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]", "terseLabel": "Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]" } } }, "localname": "FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovid.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESScheduleofFairValueLiabilitiesMeasuredonRecurringBasisUnobservableInputReconciliationDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]", "terseLabel": "Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]" } } }, "localname": "FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovid.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESScheduleofFairValueAssetsandLiabilitiesMeasuredonRecurringBasisDetails", "http://innovid.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESScheduleofFairValueLiabilitiesMeasuredonRecurringBasisUnobservableInputReconciliationDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable": { "auth_ref": [ "r154", "r156" ], "lang": { "en-us": { "role": { "documentation": "Schedule of information required and determined to be provided for purposes of reconciling beginning and ending balances of fair value measurements of liabilities using significant unobservable inputs (level 3). Separately presenting changes during the period, attributable to: (1) total gains or losses for the period (realized and unrealized) and location reported in the statement of income (or activities); (2) purchases, sales, issuances, and settlements (net); (3) transfers in and/or out of Level 3.", "label": "Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table]", "terseLabel": "Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table]" } } }, "localname": "FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovid.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESScheduleofFairValueAssetsandLiabilitiesMeasuredonRecurringBasisDetails", "http://innovid.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESScheduleofFairValueLiabilitiesMeasuredonRecurringBasisUnobservableInputReconciliationDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock": { "auth_ref": [ "r154", "r156" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the fair value measurement of liabilities using significant unobservable inputs (Level 3), a reconciliation of the beginning and ending balances, separately presenting changes attributable to the following: (1) total gains or losses for the period (realized and unrealized), segregating those gains or losses included in earnings (or changes in net assets), and gains or losses recognized in other comprehensive income (loss) and a description of where those gains or losses included in earnings (or changes in net assets) are reported in the statement of income (or activities); (2) purchases, sales, issues, and settlements (each type disclosed separately); and (3) transfers in and transfers out of Level 3 (for example, transfers due to changes in the observability of significant inputs) by class of liability.", "label": "Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table Text Block]", "terseLabel": "Schedule of Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation" } } }, "localname": "FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovid.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_FairValueMeasurementFrequencyDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Measurement frequency.", "label": "Measurement Frequency [Domain]", "terseLabel": "Measurement Frequency [Domain]" } } }, "localname": "FairValueMeasurementFrequencyDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovid.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESScheduleofFairValueAssetsandLiabilitiesMeasuredonRecurringBasisDetails", "http://innovid.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESScheduleofFairValueLiabilitiesMeasuredonRecurringBasisUnobservableInputReconciliationDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease": { "auth_ref": [ "r154" ], "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.", "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Period Increase (Decrease)", "terseLabel": "Change in fair value" } } }, "localname": "FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovid.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESScheduleofFairValueLiabilitiesMeasuredonRecurringBasisUnobservableInputReconciliationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue": { "auth_ref": [ "r154" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Fair value of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.", "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value", "periodEndLabel": "End of the year", "periodStartLabel": "Beginning of the year", "terseLabel": "Fair value of warrant" } } }, "localname": "FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovid.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails", "http://innovid.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESScheduleofFairValueLiabilitiesMeasuredonRecurringBasisUnobservableInputReconciliationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FairValueMeasurementsFairValueHierarchyDomain": { "auth_ref": [ "r380", "r447", "r448", "r449", "r450", "r451", "r452", "r654", "r655", "r656", "r761", "r762", "r769", "r770", "r771" ], "lang": { "en-us": { "role": { "documentation": "Categories used to prioritize the inputs to valuation techniques to measure fair value.", "label": "Fair Value Hierarchy and NAV [Domain]", "terseLabel": "Fair Value Hierarchy and NAV [Domain]" } } }, "localname": "FairValueMeasurementsFairValueHierarchyDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovid.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails", "http://innovid.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESScheduleofFairValueAssetsandLiabilitiesMeasuredonRecurringBasisDetails", "http://innovid.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESScheduleofFairValueLiabilitiesMeasuredonRecurringBasisUnobservableInputReconciliationDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueMeasurementsRecurringMember": { "auth_ref": [ "r602", "r603" ], "lang": { "en-us": { "role": { "documentation": "Frequent fair value measurement. Includes, but is not limited to, fair value adjustment for impairment of asset, liability or equity, frequently measured at fair value.", "label": "Fair Value, Recurring [Member]", "terseLabel": "Fair Value, Recurring" } } }, "localname": "FairValueMeasurementsRecurringMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovid.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESScheduleofFairValueAssetsandLiabilitiesMeasuredonRecurringBasisDetails", "http://innovid.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESScheduleofFairValueLiabilitiesMeasuredonRecurringBasisUnobservableInputReconciliationDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueOfFinancialInstrumentsPolicy": { "auth_ref": [ "r157", "r158" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for determining the fair value of financial instruments.", "label": "Fair Value of Financial Instruments, Policy [Policy Text Block]", "terseLabel": "Fair value of financial instruments" } } }, "localname": "FairValueOfFinancialInstrumentsPolicy", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovid.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_FiniteLivedIntangibleAssetUsefulLife": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Useful life of finite-lived intangible assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.", "label": "Finite-Lived Intangible Asset, Useful Life", "terseLabel": "Estimated Useful Life" } } }, "localname": "FiniteLivedIntangibleAssetUsefulLife", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovid.com/role/INTANGIBLEASSETSNETIntangibleAssetsDetails" ], "xbrltype": "durationItemType" }, "us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization": { "auth_ref": [ "r210", "r342" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Accumulated amount of amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.", "label": "Finite-Lived Intangible Assets, Accumulated Amortization", "negatedTerseLabel": "Accumulated Amortization" } } }, "localname": "FiniteLivedIntangibleAssetsAccumulatedAmortization", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovid.com/role/INTANGIBLEASSETSNETIntangibleAssetsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive": { "auth_ref": [], "calculation": { "http://innovid.com/role/INTANGIBLEASSETSNETIntangibleAssetsAmortizationExpenseDetails": { "order": 6.0, "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of amortization for asset, excluding financial asset and goodwill, lacking physical substance with finite life expected to be recognized after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Finite-Lived Intangible Asset, Expected Amortization, after Year Five", "terseLabel": "Thereafter" } } }, "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovid.com/role/INTANGIBLEASSETSNETIntangibleAssetsAmortizationExpenseDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths": { "auth_ref": [ "r89" ], "calculation": { "http://innovid.com/role/INTANGIBLEASSETSNETIntangibleAssetsAmortizationExpenseDetails": { "order": 4.0, "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Finite-Lived Intangible Asset, Expected Amortization, Year One", "terseLabel": "2023" } } }, "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovid.com/role/INTANGIBLEASSETSNETIntangibleAssetsAmortizationExpenseDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive": { "auth_ref": [ "r89" ], "calculation": { "http://innovid.com/role/INTANGIBLEASSETSNETIntangibleAssetsAmortizationExpenseDetails": { "order": 5.0, "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Five", "terseLabel": "2027" } } }, "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearFive", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovid.com/role/INTANGIBLEASSETSNETIntangibleAssetsAmortizationExpenseDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour": { "auth_ref": [ "r89" ], "calculation": { "http://innovid.com/role/INTANGIBLEASSETSNETIntangibleAssetsAmortizationExpenseDetails": { "order": 2.0, "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Four", "terseLabel": "2026" } } }, "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearFour", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovid.com/role/INTANGIBLEASSETSNETIntangibleAssetsAmortizationExpenseDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree": { "auth_ref": [ "r89" ], "calculation": { "http://innovid.com/role/INTANGIBLEASSETSNETIntangibleAssetsAmortizationExpenseDetails": { "order": 1.0, "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Three", "terseLabel": "2025" } } }, "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearThree", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovid.com/role/INTANGIBLEASSETSNETIntangibleAssetsAmortizationExpenseDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo": { "auth_ref": [ "r89" ], "calculation": { "http://innovid.com/role/INTANGIBLEASSETSNETIntangibleAssetsAmortizationExpenseDetails": { "order": 3.0, "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Two", "terseLabel": "2024" } } }, "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovid.com/role/INTANGIBLEASSETSNETIntangibleAssetsAmortizationExpenseDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis": { "auth_ref": [ "r340", "r341", "r342", "r343", "r660", "r664" ], "lang": { "en-us": { "role": { "documentation": "Information by major type or class of finite-lived intangible assets.", "label": "Finite-Lived Intangible Assets by Major Class [Axis]", "terseLabel": "Finite-Lived Intangible Assets by Major Class [Axis]" } } }, "localname": "FiniteLivedIntangibleAssetsByMajorClassAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovid.com/role/ACQUISITIONFairValuesoftheAssetsAcquiredandLiabilitiesAssumedDetails", "http://innovid.com/role/ACQUISITIONNarrativeDetails", "http://innovid.com/role/INTANGIBLEASSETSNETIntangibleAssetsDetails", "http://innovid.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FiniteLivedIntangibleAssetsGross": { "auth_ref": [ "r87", "r664" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount before amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.", "label": "Finite-Lived Intangible Assets, Gross", "terseLabel": "Gross Carrying Amount" } } }, "localname": "FiniteLivedIntangibleAssetsGross", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovid.com/role/INTANGIBLEASSETSNETIntangibleAssetsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FiniteLivedIntangibleAssetsLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Finite-Lived Intangible Assets [Line Items]", "terseLabel": "Finite-Lived Intangible Assets [Line Items]" } } }, "localname": "FiniteLivedIntangibleAssetsLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovid.com/role/INTANGIBLEASSETSNETIntangibleAssetsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain": { "auth_ref": [ "r82", "r86" ], "lang": { "en-us": { "role": { "documentation": "The major class of finite-lived intangible asset (for example, patents, trademarks, copyrights, etc.) A major class is composed of intangible assets that can be grouped together because they are similar, either by their nature or by their use in the operations of a company.", "label": "Finite-Lived Intangible Assets, Major Class Name [Domain]", "terseLabel": "Finite-Lived Intangible Assets, Major Class Name [Domain]" } } }, "localname": "FiniteLivedIntangibleAssetsMajorClassNameDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovid.com/role/ACQUISITIONFairValuesoftheAssetsAcquiredandLiabilitiesAssumedDetails", "http://innovid.com/role/ACQUISITIONNarrativeDetails", "http://innovid.com/role/INTANGIBLEASSETSNETIntangibleAssetsDetails", "http://innovid.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FiniteLivedIntangibleAssetsNet": { "auth_ref": [ "r87", "r660" ], "calculation": { "http://innovid.com/role/INTANGIBLEASSETSNETIntangibleAssetsAmortizationExpenseDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount after amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.", "label": "Finite-Lived Intangible Assets, Net", "terseLabel": "Net Carrying Amount", "totalLabel": "Total" } } }, "localname": "FiniteLivedIntangibleAssetsNet", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovid.com/role/INTANGIBLEASSETSNETIntangibleAssetsAmortizationExpenseDetails", "http://innovid.com/role/INTANGIBLEASSETSNETIntangibleAssetsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ForeignCountryMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Designated tax departments of governments entitled to levy and collect income taxes from the entity outside the entity's country of domicile.", "label": "Foreign Tax Authority [Member]", "terseLabel": "Foreign NOLs" } } }, "localname": "ForeignCountryMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovid.com/role/INCOMETAXESOperatingLossCarryforwardsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock": { "auth_ref": [ "r621" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for (1) transactions denominated in a currency other than the reporting enterprise's functional currency, (2) translating foreign currency financial statements that are incorporated into the financial statements of the reporting enterprise by consolidation, combination, or the equity method of accounting, and (3) remeasurement of the financial statements of a foreign reporting enterprise in a hyperinflationary economy.", "label": "Foreign Currency Transactions and Translations Policy [Policy Text Block]", "terseLabel": "Functional currency" } } }, "localname": "ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovid.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_GainLossOnSaleOfPropertyPlantEquipment": { "auth_ref": [ "r56" ], "calculation": { "http://innovid.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "order": 4.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of gain (loss) on sale or disposal of property, plant and equipment assets, including oil and gas property and timber property.", "label": "Gain (Loss) on Disposition of Property Plant Equipment", "negatedTerseLabel": "Loss on sale of property and equipment" } } }, "localname": "GainLossOnSaleOfPropertyPlantEquipment", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovid.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "monetaryItemType" }, "us-gaap_GeneralAndAdministrativeExpense": { "auth_ref": [ "r42" ], "calculation": { "http://innovid.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": { "order": 3.0, "parentTag": "us-gaap_OperatingIncomeLoss", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line.", "label": "General and Administrative Expense", "terseLabel": "General and administrative" } } }, "localname": "GeneralAndAdministrativeExpense", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovid.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS", "http://innovid.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESScheduleofReclassificationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_GeneralAndAdministrativeExpenseMember": { "auth_ref": [ "r39" ], "lang": { "en-us": { "role": { "documentation": "Primary financial statement caption encompassing general and administrative expense.", "label": "General and Administrative Expense [Member]", "verboseLabel": "General and administrative" } } }, "localname": "GeneralAndAdministrativeExpenseMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovid.com/role/STOCKBASEDCOMPENSATIONStockOptionActivityUnderPlanDetails" ], "xbrltype": "domainItemType" }, "us-gaap_GeographicDistributionAxis": { "auth_ref": [ "r679", "r680", "r717", "r718", "r719", "r720", "r721", "r722", "r723", "r724", "r725", "r726", "r727", "r728", "r729", "r730", "r731", "r732", "r733", "r734", "r757" ], "lang": { "en-us": { "role": { "documentation": "Information by geographic distribution of business activity identified as either domestic or foreign. Excludes names of countries, states and provinces, and cities.", "label": "Geographic Distribution [Axis]", "terseLabel": "Geographic Distribution [Axis]" } } }, "localname": "GeographicDistributionAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovid.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_GeographicDistributionDomain": { "auth_ref": [ "r679", "r680", "r717", "r718", "r719", "r720", "r721", "r722", "r723", "r724", "r725", "r726", "r727", "r728", "r729", "r730", "r731", "r732", "r733", "r734" ], "lang": { "en-us": { "role": { "documentation": "Allocation of business activity identified as domestic or foreign. Excludes names of countries, states and provinces, and cities.", "label": "Geographic Distribution [Domain]", "terseLabel": "Geographic Distribution [Domain]" } } }, "localname": "GeographicDistributionDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovid.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_GeographicDistributionForeignMember": { "auth_ref": [ "r679", "r680", "r717", "r718", "r719", "r720", "r721", "r722", "r723", "r724", "r725", "r726", "r727", "r728", "r729", "r730", "r731", "r732", "r733", "r734", "r758" ], "lang": { "en-us": { "role": { "documentation": "Allocation of business activity identified as foreign.", "label": "Geographic Distribution, Foreign [Member]", "terseLabel": "Geographic Distribution, Foreign" } } }, "localname": "GeographicDistributionForeignMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovid.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_Goodwill": { "auth_ref": [ "r209", "r336", "r677", "r759", "r784", "r835", "r836" ], "calculation": { "http://innovid.com/role/ACQUISITIONFairValuesoftheAssetsAcquiredandLiabilitiesAssumedDetails": { "order": 3.0, "parentTag": "ctv_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAcquiredIncludingGoodwill", "weight": 1.0 }, "http://innovid.com/role/CONSOLIDATEDBALANCESHEETS": { "order": 7.0, "parentTag": "us-gaap_AssetsNoncurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.", "label": "Goodwill", "terseLabel": "Goodwill", "verboseLabel": "Goodwill" } } }, "localname": "Goodwill", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovid.com/role/ACQUISITIONFairValuesoftheAssetsAcquiredandLiabilitiesAssumedDetails", "http://innovid.com/role/CONSOLIDATEDBALANCESHEETS", "http://innovid.com/role/TRANSACTIONNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Goodwill and Intangible Assets Disclosure [Abstract]" } } }, "localname": "GoodwillAndIntangibleAssetsDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock": { "auth_ref": [ "r79", "r84" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for goodwill and intangible assets. This accounting policy also may address how an entity assesses and measures impairment of goodwill and intangible assets.", "label": "Goodwill and Intangible Assets, Policy [Policy Text Block]", "terseLabel": "Goodwill and acquired intangible assets" } } }, "localname": "GoodwillAndIntangibleAssetsPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovid.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_GoodwillImpairmentLoss": { "auth_ref": [ "r56", "r337", "r338", "r339", "r759" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of loss from the write-down of an asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.", "label": "Goodwill, Impairment Loss", "terseLabel": "Goodwill impairment" } } }, "localname": "GoodwillImpairmentLoss", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovid.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_GranteeStatusAxis": { "auth_ref": [ "r488", "r490", "r492", "r493", "r494", "r496", "r497", "r498", "r499", "r500", "r501", "r502", "r503", "r504", "r505", "r506", "r507", "r508", "r509", "r510", "r511", "r512", "r513", "r516", "r517", "r518", "r519", "r520" ], "lang": { "en-us": { "role": { "documentation": "Information by status of recipient to whom award is granted.", "label": "Grantee Status [Axis]", "terseLabel": "Grantee Status [Axis]" } } }, "localname": "GranteeStatusAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovid.com/role/STOCKBASEDCOMPENSATIONNarrativeDetails", "http://innovid.com/role/STOCKBASEDCOMPENSATIONRestrictedStockUnitActivityDetails", "http://innovid.com/role/STOCKBASEDCOMPENSATIONStockOptionActivityDetails", "http://innovid.com/role/STOCKBASEDCOMPENSATIONStockOptionActivityUnderPlanDetails" ], "xbrltype": "stringItemType" }, "us-gaap_GranteeStatusDomain": { "auth_ref": [ "r488", "r490", "r492", "r493", "r494", "r496", "r497", "r498", "r499", "r500", "r501", "r502", "r503", "r504", "r505", "r506", "r507", "r508", "r509", "r510", "r511", "r512", "r513", "r516", "r517", "r518", "r519", "r520" ], "lang": { "en-us": { "role": { "documentation": "Status of recipient to whom award is granted.", "label": "Grantee Status [Domain]", "terseLabel": "Grantee Status [Domain]" } } }, "localname": "GranteeStatusDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovid.com/role/STOCKBASEDCOMPENSATIONNarrativeDetails", "http://innovid.com/role/STOCKBASEDCOMPENSATIONRestrictedStockUnitActivityDetails", "http://innovid.com/role/STOCKBASEDCOMPENSATIONStockOptionActivityDetails", "http://innovid.com/role/STOCKBASEDCOMPENSATIONStockOptionActivityUnderPlanDetails" ], "xbrltype": "domainItemType" }, "us-gaap_IPOMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "First sale of stock by a private company to the public.", "label": "IPO [Member]", "terseLabel": "IPO" } } }, "localname": "IPOMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovid.com/role/TRANSACTIONNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ImpairmentOfLongLivedAssetsHeldForUse": { "auth_ref": [ "r56", "r94", "r99" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The aggregate amount of write-downs for impairments recognized during the period for long lived assets held for use (including those held for disposal by means other than sale).", "label": "Impairment, Long-Lived Asset, Held-for-Use", "terseLabel": "Impairments of long-lived assets" } } }, "localname": "ImpairmentOfLongLivedAssetsHeldForUse", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovid.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock": { "auth_ref": [ "r92", "r100" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for recognizing and measuring the impairment of long-lived assets. An entity also may disclose its accounting policy for long-lived assets to be sold. This policy excludes goodwill and intangible assets.", "label": "Impairment or Disposal of Long-Lived Assets, Policy [Policy Text Block]", "terseLabel": "Impairment of long-lived assets" } } }, "localname": "ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovid.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic": { "auth_ref": [ "r239", "r562" ], "calculation": { "http://innovid.com/role/INCOMETAXESIncomebeforeIncomeTaxDomesticandForeignDetails": { "order": 1.0, "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The portion of earnings or loss from continuing operations before income taxes that is attributable to domestic operations.", "label": "Income (Loss) from Continuing Operations before Income Taxes, Domestic", "terseLabel": "Domestic" } } }, "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovid.com/role/INCOMETAXESIncomebeforeIncomeTaxDomesticandForeignDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest": { "auth_ref": [ "r37", "r164", "r174", "r188", "r299", "r302", "r307", "r310", "r680", "r756" ], "calculation": { "http://innovid.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": { "order": 1.0, "parentTag": "us-gaap_NetIncomeLoss", "weight": 1.0 }, "http://innovid.com/role/INCOMETAXESIncomebeforeIncomeTaxDomesticandForeignDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.", "label": "Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest", "terseLabel": "Total income (loss) before income taxes", "totalLabel": "(Loss) profit before taxes" } } }, "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovid.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS", "http://innovid.com/role/INCOMETAXESEffectiveIncomeTaxRateReconciliationDetails", "http://innovid.com/role/INCOMETAXESIncomebeforeIncomeTaxDomesticandForeignDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign": { "auth_ref": [ "r239", "r562" ], "calculation": { "http://innovid.com/role/INCOMETAXESIncomebeforeIncomeTaxDomesticandForeignDetails": { "order": 2.0, "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The portion of earnings or loss from continuing operations before income taxes that is attributable to foreign operations, which is defined as Income or Loss generated from operations located outside the entity's country of domicile.", "label": "Income (Loss) from Continuing Operations before Income Taxes, Foreign", "terseLabel": "Foreign" } } }, "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovid.com/role/INCOMETAXESIncomebeforeIncomeTaxDomesticandForeignDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeStatementAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Income Statement [Abstract]", "terseLabel": "Income Statement [Abstract]" } } }, "localname": "IncomeStatementAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_IncomeStatementLocationAxis": { "auth_ref": [ "r345", "r348" ], "lang": { "en-us": { "role": { "documentation": "Information by location in the income statement.", "label": "Income Statement Location [Axis]", "terseLabel": "Income Statement Location [Axis]" } } }, "localname": "IncomeStatementLocationAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovid.com/role/STOCKBASEDCOMPENSATIONStockOptionActivityUnderPlanDetails" ], "xbrltype": "stringItemType" }, "us-gaap_IncomeStatementLocationDomain": { "auth_ref": [ "r348" ], "lang": { "en-us": { "role": { "documentation": "Location in the income statement.", "label": "Income Statement Location [Domain]", "terseLabel": "Income Statement Location [Domain]" } } }, "localname": "IncomeStatementLocationDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovid.com/role/STOCKBASEDCOMPENSATIONStockOptionActivityUnderPlanDetails" ], "xbrltype": "domainItemType" }, "us-gaap_IncomeTaxAuthorityAxis": { "auth_ref": [ "r131" ], "lang": { "en-us": { "role": { "documentation": "Information by tax jurisdiction.", "label": "Income Tax Authority [Axis]", "terseLabel": "Income Tax Authority [Axis]" } } }, "localname": "IncomeTaxAuthorityAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovid.com/role/INCOMETAXESOperatingLossCarryforwardsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_IncomeTaxAuthorityDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Agency, division or body classification that levies income taxes, examines tax returns for compliance, or grants exemptions from or makes other decisions pertaining to income taxes.", "label": "Income Tax Authority [Domain]", "terseLabel": "Income Tax Authority [Domain]" } } }, "localname": "IncomeTaxAuthorityDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovid.com/role/INCOMETAXESOperatingLossCarryforwardsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_IncomeTaxDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Income Tax Disclosure [Abstract]" } } }, "localname": "IncomeTaxDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_IncomeTaxDisclosureTextBlock": { "auth_ref": [ "r240", "r540", "r544", "r550", "r558", "r564", "r566", "r567", "r570" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.", "label": "Income Tax Disclosure [Text Block]", "terseLabel": "INCOME TAXES" } } }, "localname": "IncomeTaxDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovid.com/role/INCOMETAXES" ], "xbrltype": "textBlockItemType" }, "us-gaap_IncomeTaxExpenseBenefit": { "auth_ref": [ "r241", "r261", "r262", "r298", "r538", "r559", "r565", "r684" ], "calculation": { "http://innovid.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": { "order": 2.0, "parentTag": "us-gaap_NetIncomeLoss", "weight": -1.0 }, "http://innovid.com/role/INCOMETAXESEffectiveIncomeTaxRateReconciliationDetails": { "order": null, "parentTag": null, "root": true, "weight": null }, "http://innovid.com/role/INCOMETAXESIncomeTaxExpenseBenefitDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.", "label": "Income Tax Expense (Benefit)", "terseLabel": "Taxes on income", "totalLabel": "Total income tax (benefit) provision" } } }, "localname": "IncomeTaxExpenseBenefit", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovid.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS", "http://innovid.com/role/INCOMETAXESEffectiveIncomeTaxRateReconciliationDetails", "http://innovid.com/role/INCOMETAXESIncomeTaxExpenseBenefitDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeTaxPolicyTextBlock": { "auth_ref": [ "r226", "r534", "r535", "r544", "r545", "r549", "r553" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for income taxes, which may include its accounting policies for recognizing and measuring deferred tax assets and liabilities and related valuation allowances, recognizing investment tax credits, operating loss carryforwards, tax credit carryforwards, and other carryforwards, methodologies for determining its effective income tax rate and the characterization of interest and penalties in the financial statements.", "label": "Income Tax, Policy [Policy Text Block]", "terseLabel": "Income taxes and tax contingencies" } } }, "localname": "IncomeTaxPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovid.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance": { "auth_ref": [ "r877" ], "calculation": { "http://innovid.com/role/INCOMETAXESEffectiveIncomeTaxRateReconciliationDetails": { "order": 5.0, "parentTag": "us-gaap_IncomeTaxExpenseBenefit", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to increase (decrease) in the valuation allowance for deferred tax assets.", "label": "Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Amount", "terseLabel": "Change in valuation allowance" } } }, "localname": "IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovid.com/role/INCOMETAXESEffectiveIncomeTaxRateReconciliationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential": { "auth_ref": [ "r877" ], "calculation": { "http://innovid.com/role/INCOMETAXESEffectiveIncomeTaxRateReconciliationDetails": { "order": 11.0, "parentTag": "us-gaap_IncomeTaxExpenseBenefit", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to foreign income tax expense (benefit).", "label": "Effective Income Tax Rate Reconciliation, Foreign Income Tax Rate Differential, Amount", "terseLabel": "Foreign rate differential" } } }, "localname": "IncomeTaxReconciliationForeignIncomeTaxRateDifferential", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovid.com/role/INCOMETAXESEffectiveIncomeTaxRateReconciliationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate": { "auth_ref": [ "r539" ], "calculation": { "http://innovid.com/role/INCOMETAXESEffectiveIncomeTaxRateReconciliationDetails": { "order": 2.0, "parentTag": "us-gaap_IncomeTaxExpenseBenefit", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The amount of income tax expense or benefit for the period computed by applying the domestic federal statutory tax rates to pretax income from continuing operations.", "label": "Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount", "terseLabel": "Income taxed computed at U. S. federal statutory rate" } } }, "localname": "IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovid.com/role/INCOMETAXESEffectiveIncomeTaxRateReconciliationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeTaxReconciliationNondeductibleExpense": { "auth_ref": [ "r877" ], "calculation": { "http://innovid.com/role/INCOMETAXESEffectiveIncomeTaxRateReconciliationDetails": { "order": 3.0, "parentTag": "us-gaap_IncomeTaxExpenseBenefit", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to nondeductible expenses.", "label": "Effective Income Tax Rate Reconciliation, Nondeductible Expense, Amount", "terseLabel": "Other non-deductible items" } } }, "localname": "IncomeTaxReconciliationNondeductibleExpense", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovid.com/role/INCOMETAXESEffectiveIncomeTaxRateReconciliationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeTaxReconciliationOtherAdjustments": { "auth_ref": [ "r877" ], "calculation": { "http://innovid.com/role/INCOMETAXESEffectiveIncomeTaxRateReconciliationDetails": { "order": 9.0, "parentTag": "us-gaap_IncomeTaxExpenseBenefit", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to other adjustments.", "label": "Effective Income Tax Rate Reconciliation, Other Adjustments, Amount", "terseLabel": "Other" } } }, "localname": "IncomeTaxReconciliationOtherAdjustments", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovid.com/role/INCOMETAXESEffectiveIncomeTaxRateReconciliationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes": { "auth_ref": [ "r877" ], "calculation": { "http://innovid.com/role/INCOMETAXESEffectiveIncomeTaxRateReconciliationDetails": { "order": 6.0, "parentTag": "us-gaap_IncomeTaxExpenseBenefit", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to state and local income tax expense (benefit).", "label": "Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Amount", "terseLabel": "State and local income taxes, net" } } }, "localname": "IncomeTaxReconciliationStateAndLocalIncomeTaxes", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovid.com/role/INCOMETAXESEffectiveIncomeTaxRateReconciliationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeTaxReconciliationTaxCredits": { "auth_ref": [ "r877" ], "calculation": { "http://innovid.com/role/INCOMETAXESEffectiveIncomeTaxRateReconciliationDetails": { "order": 10.0, "parentTag": "us-gaap_IncomeTaxExpenseBenefit", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to tax credits. Including, but not limited to, research credit, foreign tax credit, investment tax credit, and other tax credits.", "label": "Effective Income Tax Rate Reconciliation, Tax Credit, Amount", "negatedTerseLabel": "Tax credits" } } }, "localname": "IncomeTaxReconciliationTaxCredits", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovid.com/role/INCOMETAXESEffectiveIncomeTaxRateReconciliationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeTaxesPaidNet": { "auth_ref": [ "r60" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The amount of cash paid during the current period to foreign, federal, state, and local authorities as taxes on income, net of any cash received during the current period as refunds for the overpayment of taxes.", "label": "Income Taxes Paid, Net", "terseLabel": "Income taxes paid, net of tax refunds" } } }, "localname": "IncomeTaxesPaidNet", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovid.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInAccountsPayable": { "auth_ref": [ "r55" ], "calculation": { "http://innovid.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "order": 12.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The increase (decrease) during the reporting period in the aggregate amount of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business.", "label": "Increase (Decrease) in Accounts Payable", "terseLabel": "Increase/ (decrease) in trade payables" } } }, "localname": "IncreaseDecreaseInAccountsPayable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovid.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInAccountsReceivable": { "auth_ref": [ "r55" ], "calculation": { "http://innovid.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "order": 7.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.", "label": "Increase (Decrease) in Accounts Receivable", "negatedTerseLabel": "Increase in trade receivables, net" } } }, "localname": "IncreaseDecreaseInAccountsReceivable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovid.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities": { "auth_ref": [ "r806" ], "calculation": { "http://innovid.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "order": 11.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) in accrued expenses, and obligations classified as other.", "label": "Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities", "terseLabel": "Increase in accrued expenses and other liabilities" } } }, "localname": "IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovid.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities": { "auth_ref": [ "r55" ], "calculation": { "http://innovid.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "order": 1.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The increase (decrease) during the reporting period in the aggregate amount of obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits.", "label": "Increase (Decrease) in Employee Related Liabilities", "terseLabel": "Increase in employees and payroll accruals" } } }, "localname": "IncreaseDecreaseInEmployeeRelatedLiabilities", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovid.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInOperatingCapitalAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Increase (Decrease) in Operating Capital [Abstract]", "terseLabel": "Changes in operating assets and liabilities" } } }, "localname": "IncreaseDecreaseInOperatingCapitalAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovid.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "stringItemType" }, "us-gaap_IncreaseDecreaseInOperatingLeaseLiability": { "auth_ref": [ "r806", "r890" ], "calculation": { "http://innovid.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "order": 14.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) in obligation for operating lease.", "label": "Increase (Decrease) in Operating Lease Liability", "terseLabel": "Decrease in operating lease liabilities" } } }, "localname": "IncreaseDecreaseInOperatingLeaseLiability", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovid.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets": { "auth_ref": [ "r55" ], "calculation": { "http://innovid.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "order": 10.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) in prepaid expenses, and assets classified as other.", "label": "Increase (Decrease) in Prepaid Expense and Other Assets", "negatedTerseLabel": "(Increase)/ decrease in prepaid expenses and other assets" } } }, "localname": "IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovid.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInStockholdersEquityRollForward": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.", "label": "Increase (Decrease) in Stockholders' Equity [Roll Forward]", "terseLabel": "Increase (Decrease) in Stockholders' Equity [Roll Forward]" } } }, "localname": "IncreaseDecreaseInStockholdersEquityRollForward", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovid.com/role/STATEMENTSOFCHANGESINTEMPORARYEQUITYANDSTOCKHOLDERSEQUITYDEFICIT" ], "xbrltype": "stringItemType" }, "us-gaap_IncreaseDecreaseInTemporaryEquityRollForward": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.", "label": "Increase (Decrease) in Temporary Equity [Roll Forward]", "terseLabel": "Increase (Decrease) in Temporary Equity [Roll Forward]" } } }, "localname": "IncreaseDecreaseInTemporaryEquityRollForward", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovid.com/role/STATEMENTSOFCHANGESINTEMPORARYEQUITYANDSTOCKHOLDERSEQUITYDEFICIT" ], "xbrltype": "stringItemType" }, "us-gaap_IntangibleAssetsDisclosureTextBlock": { "auth_ref": [ "r344" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for all or part of the information related to intangible assets.", "label": "Intangible Assets Disclosure [Text Block]", "terseLabel": "INTANGIBLE ASSETS, NET" } } }, "localname": "IntangibleAssetsDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovid.com/role/INTANGIBLEASSETSNET" ], "xbrltype": "textBlockItemType" }, "us-gaap_IntangibleAssetsNetExcludingGoodwill": { "auth_ref": [ "r80", "r85" ], "calculation": { "http://innovid.com/role/CONSOLIDATEDBALANCESHEETS": { "order": 3.0, "parentTag": "us-gaap_AssetsNoncurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.", "label": "Intangible Assets, Net (Excluding Goodwill)", "terseLabel": "Intangible assets" } } }, "localname": "IntangibleAssetsNetExcludingGoodwill", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovid.com/role/CONSOLIDATEDBALANCESHEETS" ], "xbrltype": "monetaryItemType" }, "us-gaap_InterestExpenseDebt": { "auth_ref": [ "r43", "r386", "r392", "r763", "r764" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of the cost of borrowed funds accounted for as interest expense for debt.", "label": "Interest Expense, Debt", "terseLabel": "Debt related interest expense" } } }, "localname": "InterestExpenseDebt", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovid.com/role/FINANCEEXPENSESINCOMENETDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_InterestPaidNet": { "auth_ref": [ "r231", "r233", "r234" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount.", "label": "Interest Paid, Excluding Capitalized Interest, Operating Activities", "terseLabel": "Interest" } } }, "localname": "InterestPaidNet", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovid.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "monetaryItemType" }, "us-gaap_LeaseAndRentalExpense": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of rent expense incurred for leased assets, including but not limited to, furniture and equipment, that is not directly or indirectly associated with the manufacture, sale or creation of a product or product line.", "label": "Operating Leases, Rent Expense", "terseLabel": "Operating lease expense" } } }, "localname": "LeaseAndRentalExpense", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovid.com/role/LEASESNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LeaseCost": { "auth_ref": [ "r641", "r783" ], "calculation": { "http://innovid.com/role/LEASESScheduleOfLeaseCostsRecognizedInTheConsolidatedStatementOfEarningsDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of lease cost recognized by lessee for lease contract.", "label": "Lease, Cost", "totalLabel": "Total lease cost" } } }, "localname": "LeaseCost", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovid.com/role/LEASESScheduleOfLeaseCostsRecognizedInTheConsolidatedStatementOfEarningsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LeaseCostTableTextBlock": { "auth_ref": [ "r891" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of lessee's lease cost. Includes, but is not limited to, interest expense for finance lease, amortization of right-of-use asset for finance lease, operating lease cost, short-term lease cost, variable lease cost and sublease income.", "label": "Lease, Cost [Table Text Block]", "terseLabel": "Summary of Lease Cost" } } }, "localname": "LeaseCostTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovid.com/role/LEASESTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_LeaseholdImprovementsMember": { "auth_ref": [ "r96" ], "lang": { "en-us": { "role": { "documentation": "Additions or improvements to assets held under a lease arrangement.", "label": "Leasehold Improvements [Member]", "terseLabel": "Leasehold improvements" } } }, "localname": "LeaseholdImprovementsMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovid.com/role/PROPERTYANDEQUIPMENTNETDetails" ], "xbrltype": "domainItemType" }, "us-gaap_LeasesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Leases [Abstract]" } } }, "localname": "LeasesAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_LesseeLeasesPolicyTextBlock": { "auth_ref": [ "r634" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for leasing arrangement entered into by lessee.", "label": "Lessee, Leases [Policy Text Block]", "terseLabel": "Leases" } } }, "localname": "LesseeLeasesPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovid.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock": { "auth_ref": [ "r892" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of undiscounted cash flows of lessee's operating lease liability. Includes, but is not limited to, reconciliation of undiscounted cash flows to operating lease liability recognized in statement of financial position.", "label": "Lessee, Operating Lease, Liability, Maturity [Table Text Block]", "terseLabel": "Schedule of Operating Lease, Liability, Maturity" } } }, "localname": "LesseeOperatingLeaseLiabilityMaturityTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovid.com/role/LEASESTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue": { "auth_ref": [ "r642" ], "calculation": { "http://innovid.com/role/LEASESScheduleofOperatingLeaseLiabilityMaturitiesDetails": { "order": null, "parentTag": null, "root": true, "weight": null }, "http://innovid.com/role/LEASESScheduleofOperatingLeaseLiabilityMaturitiesDetails_1": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease.", "label": "Lessee, Operating Lease, Liability, to be Paid", "totalLabel": "Total undiscounted lease payments" } } }, "localname": "LesseeOperatingLeaseLiabilityPaymentsDue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovid.com/role/LEASESScheduleofOperatingLeaseLiabilityMaturitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths": { "auth_ref": [ "r642" ], "calculation": { "http://innovid.com/role/LEASESScheduleofOperatingLeaseLiabilityMaturitiesDetails_1": { "order": 2.0, "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Lessee, Operating Lease, Liability, to be Paid, Year One", "terseLabel": "2023" } } }, "localname": "LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovid.com/role/LEASESScheduleofOperatingLeaseLiabilityMaturitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree": { "auth_ref": [ "r642" ], "calculation": { "http://innovid.com/role/LEASESScheduleofOperatingLeaseLiabilityMaturitiesDetails_1": { "order": 1.0, "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Lessee, Operating Lease, Liability, to be Paid, Year Three", "verboseLabel": "2025" } } }, "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearThree", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovid.com/role/LEASESScheduleofOperatingLeaseLiabilityMaturitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo": { "auth_ref": [ "r642" ], "calculation": { "http://innovid.com/role/LEASESScheduleofOperatingLeaseLiabilityMaturitiesDetails_1": { "order": 3.0, "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Lessee, Operating Lease, Liability, to be Paid, Year Two", "terseLabel": "2024" } } }, "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearTwo", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovid.com/role/LEASESScheduleofOperatingLeaseLiabilityMaturitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount": { "auth_ref": [ "r642" ], "calculation": { "http://innovid.com/role/LEASESScheduleofOperatingLeaseLiabilityMaturitiesDetails": { "order": 2.0, "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for operating lease.", "label": "Lessee, Operating Lease, Liability, Undiscounted Excess Amount", "negatedTerseLabel": "Less: Interest" } } }, "localname": "LesseeOperatingLeaseLiabilityUndiscountedExcessAmount", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovid.com/role/LEASESScheduleofOperatingLeaseLiabilityMaturitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LesseeOperatingLeasesTextBlock": { "auth_ref": [ "r643" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for operating leases of lessee. Includes, but is not limited to, description of operating lease and maturity analysis of operating lease liability.", "label": "Lessee, Operating Leases [Text Block]", "terseLabel": "LEASES" } } }, "localname": "LesseeOperatingLeasesTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovid.com/role/LEASES" ], "xbrltype": "textBlockItemType" }, "us-gaap_Liabilities": { "auth_ref": [ "r25", "r238", "r326", "r357", "r358", "r359", "r360", "r361", "r362", "r363", "r364", "r365", "r580", "r581", "r582", "r605", "r755", "r842", "r898", "r899" ], "calculation": { "http://innovid.com/role/CONSOLIDATEDBALANCESHEETS": { "order": 1.0, "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.", "label": "Liabilities", "totalLabel": "TOTAL LIABILITIES" } } }, "localname": "Liabilities", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovid.com/role/CONSOLIDATEDBALANCESHEETS" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilitiesAndStockholdersEquity": { "auth_ref": [ "r20", "r172", "r184", "r784", "r810", "r832", "r889" ], "calculation": { "http://innovid.com/role/CONSOLIDATEDBALANCESHEETS": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.", "label": "Liabilities and Equity", "totalLabel": "TOTAL LIABILITIES AND STOCKHOLDERS\u2019 EQUITY" } } }, "localname": "LiabilitiesAndStockholdersEquity", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovid.com/role/CONSOLIDATEDBALANCESHEETS" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilitiesAndStockholdersEquityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Liabilities and Equity [Abstract]", "terseLabel": "LIABILITIES AND STOCKHOLDER\u2019 EQUITY" } } }, "localname": "LiabilitiesAndStockholdersEquityAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovid.com/role/CONSOLIDATEDBALANCESHEETS" ], "xbrltype": "stringItemType" }, "us-gaap_LiabilitiesCurrent": { "auth_ref": [ "r28", "r205", "r238", "r326", "r357", "r358", "r359", "r360", "r361", "r362", "r363", "r364", "r365", "r580", "r581", "r582", "r605", "r784", "r842", "r898", "r899" ], "calculation": { "http://innovid.com/role/CONSOLIDATEDBALANCESHEETS": { "order": 2.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.", "label": "Liabilities, Current", "totalLabel": "Total current liabilities" } } }, "localname": "LiabilitiesCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovid.com/role/CONSOLIDATEDBALANCESHEETS" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilitiesFairValueDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Liabilities, Fair Value Disclosure [Abstract]", "terseLabel": "Liabilities:" } } }, "localname": "LiabilitiesFairValueDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovid.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESScheduleofFairValueAssetsandLiabilitiesMeasuredonRecurringBasisDetails" ], "xbrltype": "stringItemType" }, "us-gaap_LiabilitiesNoncurrent": { "auth_ref": [ "r3", "r4", "r5", "r8", "r9", "r238", "r326", "r357", "r358", "r359", "r360", "r361", "r362", "r363", "r364", "r365", "r580", "r581", "r582", "r605", "r842", "r898", "r899" ], "calculation": { "http://innovid.com/role/CONSOLIDATEDBALANCESHEETS": { "order": 1.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of obligation due after one year or beyond the normal operating cycle, if longer.", "label": "Liabilities, Noncurrent", "totalLabel": "Total non-current liabilities" } } }, "localname": "LiabilitiesNoncurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovid.com/role/CONSOLIDATEDBALANCESHEETS" ], "xbrltype": "monetaryItemType" }, "us-gaap_LineOfCredit": { "auth_ref": [ "r8", "r171", "r179" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The carrying value as of the balance sheet date of the current and noncurrent portions of long-term obligations drawn from a line of credit, which is a bank's commitment to make loans up to a specific amount. Examples of items that might be included in the application of this element may consist of letters of credit, standby letters of credit, and revolving credit arrangements, under which borrowings can be made up to a maximum amount as of any point in time conditional on satisfaction of specified terms before, as of and after the date of drawdowns on the line. Includes short-term obligations that would normally be classified as current liabilities but for which (a) postbalance sheet date issuance of a long term obligation to refinance the short term obligation on a long term basis, or (b) the enterprise has entered into a financing agreement that clearly permits the enterprise to refinance the short-term obligation on a long term basis and the following conditions are met (1) the agreement does not expire within 1 year and is not cancelable by the lender except for violation of an objectively determinable provision, (2) no violation exists at the BS date, and (3) the lender has entered into the financing agreement is expected to be financially capable of honoring the agreement.", "label": "Long-Term Line of Credit", "terseLabel": "Line of credit outstanding" } } }, "localname": "LineOfCredit", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovid.com/role/LONGTERMDEBTDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LineOfCreditFacilityCommitmentFeeAmount": { "auth_ref": [ "r22" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of the fee for available but unused credit capacity under the credit facility.", "label": "Line of Credit Facility, Commitment Fee Amount", "terseLabel": "Commitment fee amount" } } }, "localname": "LineOfCreditFacilityCommitmentFeeAmount", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovid.com/role/LONGTERMDEBTDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LineOfCreditFacilityInterestRateDuringPeriod": { "auth_ref": [ "r22" ], "lang": { "en-us": { "role": { "documentation": "The effective interest rate during the reporting period.", "label": "Line of Credit Facility, Interest Rate During Period", "terseLabel": "Interest rate during period" } } }, "localname": "LineOfCreditFacilityInterestRateDuringPeriod", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovid.com/role/LONGTERMDEBTDetails" ], "xbrltype": "percentItemType" }, "us-gaap_LineOfCreditFacilityLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Line of Credit Facility [Line Items]", "terseLabel": "Line of Credit Facility [Line Items]" } } }, "localname": "LineOfCreditFacilityLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovid.com/role/LONGTERMDEBTDetails" ], "xbrltype": "stringItemType" }, "us-gaap_LineOfCreditFacilityTable": { "auth_ref": [ "r22", "r809" ], "lang": { "en-us": { "role": { "documentation": "A table or schedule providing information pertaining to short-term or long-term contractual arrangements with lenders, including letters of credit, standby letters of credit, and revolving credit arrangements, under which borrowings can be made up to maximum amount as of any point in time conditional on satisfaction of specified terms before, as of and after the date of drawdowns on the line.", "label": "Line of Credit Facility [Table]", "terseLabel": "Line of Credit Facility [Table]" } } }, "localname": "LineOfCreditFacilityTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovid.com/role/LONGTERMDEBTDetails" ], "xbrltype": "stringItemType" }, "us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The fee, expressed as a percentage of the line of credit facility, for available but unused credit capacity under the credit facility.", "label": "Line of Credit Facility, Unused Capacity, Commitment Fee Percentage", "terseLabel": "Commitment fee percentage" } } }, "localname": "LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovid.com/role/LONGTERMDEBTDetails" ], "xbrltype": "percentItemType" }, "us-gaap_LineOfCreditMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "A contractual arrangement with a lender under which borrowings can be made up to a specific amount at any point in time, and under which borrowings outstanding may be either short-term or long-term, depending upon the particulars.", "label": "Line of Credit [Member]", "terseLabel": "Line of Credit" } } }, "localname": "LineOfCreditMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovid.com/role/LONGTERMDEBTDetails" ], "xbrltype": "domainItemType" }, "us-gaap_LongTermDebtCurrent": { "auth_ref": [ "r24" ], "calculation": { "http://innovid.com/role/CONSOLIDATEDBALANCESHEETS": { "order": 1.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount, after unamortized (discount) premium and debt issuance costs, of long-term debt, classified as current. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.", "label": "Long-Term Debt, Current Maturities", "terseLabel": "Current portion of long-term debt" } } }, "localname": "LongTermDebtCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovid.com/role/CONSOLIDATEDBALANCESHEETS" ], "xbrltype": "monetaryItemType" }, "us-gaap_LongTermDebtNoncurrent": { "auth_ref": [ "r213" ], "calculation": { "http://innovid.com/role/CONSOLIDATEDBALANCESHEETS": { "order": 2.0, "parentTag": "us-gaap_LiabilitiesNoncurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount, excluding unamortized premium (discount) and debt issuance cost, of long-term debt classified as noncurrent. Excludes lease obligation.", "label": "Long-Term Debt, Excluding Current Maturities", "terseLabel": "Long-term debt" } } }, "localname": "LongTermDebtNoncurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovid.com/role/CONSOLIDATEDBALANCESHEETS" ], "xbrltype": "monetaryItemType" }, "us-gaap_MajorPropertyClassAxis": { "auth_ref": [ "r197" ], "lang": { "en-us": { "role": { "documentation": "Amount of property owned but leased or available for lease to third parties, by major property class.", "label": "Major Property Class [Axis]", "terseLabel": "Major Property Class [Axis]" } } }, "localname": "MajorPropertyClassAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovid.com/role/LEASESScheduleOfCommitmentsUnderNonCancelableOperatingLeasesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_MajorPropertyClassDomain": { "auth_ref": [ "r197" ], "lang": { "en-us": { "role": { "documentation": "The major classes of assets leased or available for lease to third parties under operating lease agreements as of the balance sheet date.", "label": "Major Property Class [Domain]", "terseLabel": "Major Property Class [Domain]" } } }, "localname": "MajorPropertyClassDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovid.com/role/LEASESScheduleOfCommitmentsUnderNonCancelableOperatingLeasesDetails" ], "xbrltype": "domainItemType" }, "us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock": { "auth_ref": [ "r0", "r149" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for business combinations, including leverage buyout transactions (as applicable), and divestitures. This may include a description of a business combination or divestiture (or series of individually immaterial business combinations or divestitures) completed during the period, including background, timing, and assets and liabilities recognized and reclassified or sold. This element does not include fixed asset sales and plant closings.", "label": "Mergers, Acquisitions and Dispositions Disclosures [Text Block]", "terseLabel": "TRANSACTION" } } }, "localname": "MergersAcquisitionsAndDispositionsDisclosuresTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovid.com/role/TRANSACTION" ], "xbrltype": "textBlockItemType" }, "us-gaap_NetCashProvidedByUsedInFinancingActivities": { "auth_ref": [ "r232" ], "calculation": { "http://innovid.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "order": 3.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.", "label": "Net Cash Provided by (Used in) Financing Activities", "totalLabel": "Net cash provided by financing activities" } } }, "localname": "NetCashProvidedByUsedInFinancingActivities", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovid.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Net Cash Provided by (Used in) Financing Activities [Abstract]", "terseLabel": "Cash flows from financing activities:" } } }, "localname": "NetCashProvidedByUsedInFinancingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovid.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "stringItemType" }, "us-gaap_NetCashProvidedByUsedInInvestingActivities": { "auth_ref": [ "r232" ], "calculation": { "http://innovid.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "order": 2.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.", "label": "Net Cash Provided by (Used in) Investing Activities", "totalLabel": "Net cash used in investing activities" } } }, "localname": "NetCashProvidedByUsedInInvestingActivities", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovid.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Net Cash Provided by (Used in) Investing Activities [Abstract]", "terseLabel": "Cash flows from investing activities:" } } }, "localname": "NetCashProvidedByUsedInInvestingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovid.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "stringItemType" }, "us-gaap_NetCashProvidedByUsedInOperatingActivities": { "auth_ref": [ "r52", "r54", "r57" ], "calculation": { "http://innovid.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "order": 1.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0 } }, "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.", "label": "Net Cash Provided by (Used in) Operating Activities", "totalLabel": "Net cash used in operating activities" } } }, "localname": "NetCashProvidedByUsedInOperatingActivities", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovid.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Net Cash Provided by (Used in) Operating Activities [Abstract]", "terseLabel": "Cash flows from operating activities:" } } }, "localname": "NetCashProvidedByUsedInOperatingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovid.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "stringItemType" }, "us-gaap_NetIncomeLoss": { "auth_ref": [ "r38", "r57", "r175", "r187", "r203", "r224", "r225", "r229", "r238", "r249", "r253", "r254", "r256", "r257", "r261", "r262", "r273", "r299", "r302", "r307", "r310", "r326", "r357", "r358", "r359", "r360", "r361", "r362", "r363", "r364", "r365", "r596", "r605", "r756", "r842" ], "calculation": { "http://innovid.com/role/BASICANDDILUTEDNETLOSSPERSHAREBasicandDilutedNetlossPerShareDetails": { "order": 1.0, "parentTag": "us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic", "weight": 1.0 }, "http://innovid.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "order": 9.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 }, "http://innovid.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": { "order": 2.0, "parentTag": "us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.", "label": "Net Income (Loss) Attributable to Parent", "terseLabel": "Net loss", "totalLabel": "Net loss" } } }, "localname": "NetIncomeLoss", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovid.com/role/BASICANDDILUTEDNETLOSSPERSHAREBasicandDilutedNetlossPerShareDetails", "http://innovid.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS", "http://innovid.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS", "http://innovid.com/role/STATEMENTSOFCHANGESINTEMPORARYEQUITYANDSTOCKHOLDERSEQUITYDEFICIT" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetIncomeLossAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Net Income (Loss) Attributable to Parent [Abstract]", "terseLabel": "Numerator:" } } }, "localname": "NetIncomeLossAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovid.com/role/BASICANDDILUTEDNETLOSSPERSHAREBasicandDilutedNetlossPerShareDetails" ], "xbrltype": "stringItemType" }, "us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic": { "auth_ref": [ "r253", "r254", "r256", "r257", "r264", "r265", "r274", "r277", "r299", "r302", "r307", "r310", "r756" ], "calculation": { "http://innovid.com/role/BASICANDDILUTEDNETLOSSPERSHAREBasicandDilutedNetlossPerShareDetails": { "order": null, "parentTag": null, "root": true, "weight": null }, "http://innovid.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities; of income (loss) available to common shareholders.", "label": "Net Income (Loss) Available to Common Stockholders, Basic", "totalLabel": "Net loss attributable to common stockholders, basic" } } }, "localname": "NetIncomeLossAvailableToCommonStockholdersBasic", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovid.com/role/BASICANDDILUTEDNETLOSSPERSHAREBasicandDilutedNetlossPerShareDetails", "http://innovid.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted": { "auth_ref": [ "r266", "r269", "r270", "r271", "r272", "r274", "r277" ], "calculation": { "http://innovid.com/role/BASICANDDILUTEDNETLOSSPERSHAREBasicandDilutedNetlossPerShareDetails": { "order": null, "parentTag": null, "root": true, "weight": null }, "http://innovid.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities, and addition from assumption of issuance of common shares for dilutive potential common shares; of income (loss) available to common shareholders.", "label": "Net Income (Loss) Available to Common Stockholders, Diluted", "totalLabel": "Net loss attributable to common stockholders, diluted" } } }, "localname": "NetIncomeLossAvailableToCommonStockholdersDiluted", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovid.com/role/BASICANDDILUTEDNETLOSSPERSHAREBasicandDilutedNetlossPerShareDetails", "http://innovid.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS" ], "xbrltype": "monetaryItemType" }, "us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "New Accounting Pronouncements or Change in Accounting Principle [Line Items]", "terseLabel": "New Accounting Pronouncements or Change in Accounting Principle [Line Items]" } } }, "localname": "NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovid.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESScheduleofReclassificationDetails" ], "xbrltype": "stringItemType" }, "us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable": { "auth_ref": [ "r66", "r198", "r199", "r200", "r201", "r202", "r248", "r249", "r250", "r251", "r252", "r256", "r263", "r281", "r324", "r325", "r327", "r328", "r329", "r330", "r331", "r332", "r527", "r528", "r529", "r554", "r555", "r556", "r557", "r575", "r576", "r577", "r586", "r587", "r588", "r589", "r590", "r591", "r592", "r593", "r594", "r595", "r596", "r597", "r606", "r607", "r608", "r609", "r610", "r611", "r612", "r613", "r622", "r623", "r626", "r627", "r628", "r629", "r644", "r645", "r646", "r647", "r648", "r649", "r661", "r662", "r663", "r686", "r687", "r688", "r689", "r690", "r691", "r692", "r693", "r694", "r695", "r696", "r697" ], "lang": { "en-us": { "role": { "documentation": "Summarization of the changes in an accounting principle or a new accounting pronouncement, including the line items affected by the change and the financial effects of the change on those particular line items.", "label": "Accounting Standards Update and Change in Accounting Principle [Table]", "terseLabel": "Accounting Standards Update and Change in Accounting Principle [Table]" } } }, "localname": "NewAccountingPronouncementsOrChangeInAccountingPrincipleTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovid.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESScheduleofReclassificationDetails" ], "xbrltype": "stringItemType" }, "us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.", "label": "New Accounting Pronouncements, Policy [Policy Text Block]", "terseLabel": "Recently Adopted Accounting Pronouncements and Recently issued accounting pronouncements not yet adopted by the Company" } } }, "localname": "NewAccountingPronouncementsPolicyPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovid.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_NoncashInvestingAndFinancingItemsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Noncash Investing and Financing Items [Abstract]", "terseLabel": "Non-cash transactions" } } }, "localname": "NoncashInvestingAndFinancingItemsAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovid.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "stringItemType" }, "us-gaap_NoncashOrPartNoncashAcquisitionValueOfLiabilitiesAssumed1": { "auth_ref": [ "r61", "r62", "r63" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The total amount of [all] liabilities that an Entity assumes in acquiring a business or in consideration for an asset received in a noncash (or part noncash) acquisition. Noncash is defined as transactions during a period that affect recognized assets or liabilities but that do not result in cash receipts or cash payments in the period. \"Part noncash\" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.", "label": "Noncash or Part Noncash Acquisition, Value of Liabilities Assumed", "terseLabel": "Accrued acquisition liability" } } }, "localname": "NoncashOrPartNoncashAcquisitionValueOfLiabilitiesAssumed1", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovid.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "monetaryItemType" }, "us-gaap_NoncurrentAssets": { "auth_ref": [ "r314" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Long-lived assets other than financial instruments, long-term customer relationships of a financial institution, mortgage and other servicing rights, deferred policy acquisition costs, and deferred tax assets.", "label": "Long-Lived Assets", "terseLabel": "Long-lived tangible assets" } } }, "localname": "NoncurrentAssets", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovid.com/role/SEGMENTREPORTINGRevenueandPropertyandEquipmentbyGeographicalAreasDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_NumberOfOperatingSegments": { "auth_ref": [ "r830" ], "lang": { "en-us": { "role": { "documentation": "Number of operating segments. An operating segment is a component of an enterprise: (a) that engages in business activities from which it may earn revenues and incur expenses (including revenues and expenses relating to transactions with other components of the same enterprise), (b) whose operating results are regularly reviewed by the enterprise's chief operating decision maker to make decisions about resources to be allocated to the segment and assess its performance, and (c) for which discrete financial information is available. An operating segment may engage in business activities for which it has yet to earn revenues, for example, start-up operations may be operating segments before earning revenues.", "label": "Number of Operating Segments", "terseLabel": "Number of operating segments" } } }, "localname": "NumberOfOperatingSegments", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovid.com/role/SEGMENTREPORTINGNarrativeDetails" ], "xbrltype": "integerItemType" }, "us-gaap_NumberOfReportingUnits": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of reporting units tested for impairment of goodwill. A reporting unit is an operating segment or one level below an operating segment.", "label": "Number of Reporting Units", "terseLabel": "Number of reporting units" } } }, "localname": "NumberOfReportingUnits", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovid.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails" ], "xbrltype": "integerItemType" }, "us-gaap_OperatingExpensesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Operating Expenses [Abstract]", "terseLabel": "Operating expenses:" } } }, "localname": "OperatingExpensesAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovid.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESScheduleofReclassificationDetails" ], "xbrltype": "stringItemType" }, "us-gaap_OperatingIncomeLoss": { "auth_ref": [ "r299", "r302", "r307", "r310", "r756" ], "calculation": { "http://innovid.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": { "order": 1.0, "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The net result for the period of deducting operating expenses from operating revenues.", "label": "Operating Income (Loss)", "totalLabel": "Operating (loss) profit" } } }, "localname": "OperatingIncomeLoss", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovid.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeaseCost": { "auth_ref": [ "r635", "r783" ], "calculation": { "http://innovid.com/role/LEASESScheduleOfLeaseCostsRecognizedInTheConsolidatedStatementOfEarningsDetails": { "order": 2.0, "parentTag": "us-gaap_LeaseCost", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of single lease cost, calculated by allocation of remaining cost of lease over remaining lease term. Includes, but is not limited to, single lease cost, after impairment of right-of-use asset, calculated by amortization of remaining right-of-use asset and accretion of lease liability.", "label": "Operating Lease, Cost", "terseLabel": "Operating lease cost" } } }, "localname": "OperatingLeaseCost", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovid.com/role/LEASESScheduleOfLeaseCostsRecognizedInTheConsolidatedStatementOfEarningsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeaseLiability": { "auth_ref": [ "r631" ], "calculation": { "http://innovid.com/role/LEASESScheduleofOperatingLeaseLiabilityMaturitiesDetails": { "order": 1.0, "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue", "weight": 1.0 }, "http://innovid.com/role/LEASESScheduleofleaseliabilityDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease.", "label": "Operating Lease, Liability", "terseLabel": "Lease liabilities", "totalLabel": "Total lease liabilities", "verboseLabel": "Total lease liabilities - operating" } } }, "localname": "OperatingLeaseLiability", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovid.com/role/LEASESScheduleofOperatingLeaseLiabilityMaturitiesDetails", "http://innovid.com/role/LEASESScheduleofleaseliabilityDetails", "http://innovid.com/role/LEASESScheduleofoperatingROUassetsandleaseliabilitiesDetails", "http://innovid.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESScheduleofOperatingLeaseLiabilitiesandROUAssetsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeaseLiabilityCurrent": { "auth_ref": [ "r631" ], "calculation": { "http://innovid.com/role/CONSOLIDATEDBALANCESHEETS": { "order": 3.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 }, "http://innovid.com/role/LEASESScheduleofleaseliabilityDetails": { "order": 1.0, "parentTag": "us-gaap_OperatingLeaseLiability", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.", "label": "Operating Lease, Liability, Current", "terseLabel": "Lease liabilities - current portion", "verboseLabel": "Current lease liabilities" } } }, "localname": "OperatingLeaseLiabilityCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovid.com/role/CONSOLIDATEDBALANCESHEETS", "http://innovid.com/role/LEASESScheduleofleaseliabilityDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeaseLiabilityNoncurrent": { "auth_ref": [ "r631" ], "calculation": { "http://innovid.com/role/CONSOLIDATEDBALANCESHEETS": { "order": 3.0, "parentTag": "us-gaap_LiabilitiesNoncurrent", "weight": 1.0 }, "http://innovid.com/role/LEASESScheduleofleaseliabilityDetails": { "order": 2.0, "parentTag": "us-gaap_OperatingLeaseLiability", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.", "label": "Operating Lease, Liability, Noncurrent", "terseLabel": "Lease liabilities - non-current portion", "verboseLabel": "Non-current lease liabilities" } } }, "localname": "OperatingLeaseLiabilityNoncurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovid.com/role/CONSOLIDATEDBALANCESHEETS", "http://innovid.com/role/LEASESScheduleofleaseliabilityDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList": { "auth_ref": [ "r632" ], "lang": { "en-us": { "role": { "documentation": "Indicates line item in statement of financial position that includes noncurrent operating lease liability.", "label": "Operating Lease, Liability, Noncurrent, Statement of Financial Position [Extensible Enumeration]", "terseLabel": "Operating Lease, Liability, Noncurrent, Statement of Financial Position [Extensible Enumeration]" } } }, "localname": "OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovid.com/role/OTHERNONCURRENTLIABILITIESDetails" ], "xbrltype": "enumerationSetItemType" }, "us-gaap_OperatingLeasePayments": { "auth_ref": [ "r633", "r638" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.", "label": "Operating Lease, Payments", "terseLabel": "Cash paid for amounts included in the measurement of lease liabilities" } } }, "localname": "OperatingLeasePayments", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovid.com/role/LEASESupplementaryCashFlowInformationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeaseRightOfUseAsset": { "auth_ref": [ "r630" ], "calculation": { "http://innovid.com/role/CONSOLIDATEDBALANCESHEETS": { "order": 5.0, "parentTag": "us-gaap_AssetsNoncurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's right to use underlying asset under operating lease.", "label": "Operating Lease, Right-of-Use Asset", "netLabel": "ROU assets", "terseLabel": "Operating lease right of use asset" } } }, "localname": "OperatingLeaseRightOfUseAsset", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovid.com/role/CONSOLIDATEDBALANCESHEETS", "http://innovid.com/role/LEASESScheduleofoperatingROUassetsandleaseliabilitiesDetails", "http://innovid.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESScheduleofOperatingLeaseLiabilitiesandROUAssetsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent": { "auth_ref": [ "r640", "r783" ], "lang": { "en-us": { "role": { "documentation": "Weighted average discount rate for operating lease calculated at point in time.", "label": "Operating Lease, Weighted Average Discount Rate, Percent", "terseLabel": "Operating lease, weighted average discount rate, percent" } } }, "localname": "OperatingLeaseWeightedAverageDiscountRatePercent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovid.com/role/LEASESNarrativeDetails" ], "xbrltype": "percentItemType" }, "us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1": { "auth_ref": [ "r639", "r783" ], "lang": { "en-us": { "role": { "documentation": "Weighted average remaining lease term for operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.", "label": "Operating Lease, Weighted Average Remaining Lease Term", "terseLabel": "Operating lease, weighted average remaining lease term" } } }, "localname": "OperatingLeaseWeightedAverageRemainingLeaseTerm1", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovid.com/role/LEASESNarrativeDetails" ], "xbrltype": "durationItemType" }, "us-gaap_OperatingLeasedAssetsLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Operating Leased Assets [Line Items]", "terseLabel": "Operating Leased Assets [Line Items]" } } }, "localname": "OperatingLeasedAssetsLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovid.com/role/LEASESScheduleOfCommitmentsUnderNonCancelableOperatingLeasesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_OperatingLeasesFutureMinimumPaymentsDue": { "auth_ref": [ "r194", "r195" ], "calculation": { "http://innovid.com/role/LEASESScheduleOfCommitmentsUnderNonCancelableOperatingLeasesDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of required minimum rental payments for leases having an initial or remaining non-cancelable letter-terms in excess of one year.", "label": "Operating Leases, Future Minimum Payments Due", "totalLabel": "Total" } } }, "localname": "OperatingLeasesFutureMinimumPaymentsDue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovid.com/role/LEASESScheduleOfCommitmentsUnderNonCancelableOperatingLeasesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent": { "auth_ref": [ "r194", "r195" ], "calculation": { "http://innovid.com/role/LEASESScheduleOfCommitmentsUnderNonCancelableOperatingLeasesDetails": { "order": 1.0, "parentTag": "us-gaap_OperatingLeasesFutureMinimumPaymentsDue", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of required minimum rental payments for operating leases having an initial or remaining non-cancelable lease term in excess of one year due in the next fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.", "label": "Operating Leases, Future Minimum Payments Due, Next 12 Months", "terseLabel": "2022" } } }, "localname": "OperatingLeasesFutureMinimumPaymentsDueCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovid.com/role/LEASESScheduleOfCommitmentsUnderNonCancelableOperatingLeasesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFourYears": { "auth_ref": [ "r194", "r195" ], "calculation": { "http://innovid.com/role/LEASESScheduleOfCommitmentsUnderNonCancelableOperatingLeasesDetails": { "order": 4.0, "parentTag": "us-gaap_OperatingLeasesFutureMinimumPaymentsDue", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of required minimum rental payments for operating leases having an initial or remaining non-cancelable lease term in excess of one year due in the fourth fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.", "label": "Operating Leases, Future Minimum Payments, Due in Four Years", "terseLabel": "2025" } } }, "localname": "OperatingLeasesFutureMinimumPaymentsDueInFourYears", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovid.com/role/LEASESScheduleOfCommitmentsUnderNonCancelableOperatingLeasesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeasesFutureMinimumPaymentsDueInThreeYears": { "auth_ref": [ "r194", "r195" ], "calculation": { "http://innovid.com/role/LEASESScheduleOfCommitmentsUnderNonCancelableOperatingLeasesDetails": { "order": 3.0, "parentTag": "us-gaap_OperatingLeasesFutureMinimumPaymentsDue", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of required minimum rental payments for operating leases having an initial or remaining non-cancelable lease term in excess of one year due in the third fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.", "label": "Operating Leases, Future Minimum Payments, Due in Three Years", "terseLabel": "2024" } } }, "localname": "OperatingLeasesFutureMinimumPaymentsDueInThreeYears", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovid.com/role/LEASESScheduleOfCommitmentsUnderNonCancelableOperatingLeasesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears": { "auth_ref": [ "r194", "r195" ], "calculation": { "http://innovid.com/role/LEASESScheduleOfCommitmentsUnderNonCancelableOperatingLeasesDetails": { "order": 2.0, "parentTag": "us-gaap_OperatingLeasesFutureMinimumPaymentsDue", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of required minimum rental payments for operating leases having an initial or remaining non-cancelable lease term in excess of one year due in the second fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.", "label": "Operating Leases, Future Minimum Payments, Due in Two Years", "terseLabel": "2023" } } }, "localname": "OperatingLeasesFutureMinimumPaymentsDueInTwoYears", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovid.com/role/LEASESScheduleOfCommitmentsUnderNonCancelableOperatingLeasesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLossCarryforwards": { "auth_ref": [ "r133" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of operating loss carryforward, before tax effects, available to reduce future taxable income under enacted tax laws.", "label": "Operating Loss Carryforwards", "terseLabel": "Operating loss carryforwards" } } }, "localname": "OperatingLossCarryforwards", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovid.com/role/INCOMETAXESOperatingLossCarryforwardsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLossCarryforwardsLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Operating Loss Carryforwards [Line Items]", "terseLabel": "Operating Loss Carryforwards [Line Items]" } } }, "localname": "OperatingLossCarryforwardsLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovid.com/role/INCOMETAXESNarrativeDetails", "http://innovid.com/role/INCOMETAXESOperatingLossCarryforwardsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_OperatingLossCarryforwardsTable": { "auth_ref": [ "r134" ], "lang": { "en-us": { "role": { "documentation": "Schedule reflecting pertinent information, such as tax authority, amounts, and expiration dates, of net operating loss carryforwards, including an assessment of the likelihood of utilization.", "label": "Operating Loss Carryforwards [Table]", "terseLabel": "Operating Loss Carryforwards [Table]" } } }, "localname": "OperatingLossCarryforwardsTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovid.com/role/INCOMETAXESNarrativeDetails", "http://innovid.com/role/INCOMETAXESOperatingLossCarryforwardsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Organization, Consolidation and Presentation of Financial Statements [Abstract]", "terseLabel": "Organization, Consolidation and Presentation of Financial Statements [Abstract]" } } }, "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock": { "auth_ref": [ "r1", "r150" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for organization, consolidation and basis of presentation of financial statements disclosure.", "label": "Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block]", "terseLabel": "DESCRIPTION OF BUSINESS" } } }, "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovid.com/role/DESCRIPTIONOFBUSINESS" ], "xbrltype": "textBlockItemType" }, "us-gaap_OriginationOfNotesReceivableFromRelatedParties": { "auth_ref": [ "r45" ], "calculation": { "http://innovid.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "order": 6.0, "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow for a loan, supported by a promissory note, granted to related parties where one party can exercise control or significant influence over another party; including affiliates, owners or officers and their immediate families, pension trusts, and so forth.", "label": "Origination of Notes Receivable from Related Parties", "negatedTerseLabel": "Founders\u2019 note receivable" } } }, "localname": "OriginationOfNotesReceivableFromRelatedParties", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovid.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherAccruedLiabilitiesCurrent": { "auth_ref": [ "r26" ], "calculation": { "http://innovid.com/role/ACCRUEDEXPENSESANDOTHERCURRENTLIABILITIESDetails": { "order": 4.0, "parentTag": "us-gaap_AccruedLiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of expenses incurred but not yet paid classified as other, due within one year or the normal operating cycle, if longer.", "label": "Other Accrued Liabilities, Current", "terseLabel": "Accrued expenses" } } }, "localname": "OtherAccruedLiabilitiesCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovid.com/role/ACCRUEDEXPENSESANDOTHERCURRENTLIABILITIESDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherAccruedLiabilitiesNoncurrent": { "auth_ref": [ "r30" ], "calculation": { "http://innovid.com/role/OTHERNONCURRENTLIABILITIESDetails": { "order": 1.0, "parentTag": "us-gaap_OtherLiabilitiesNoncurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of expenses incurred but not yet paid classified as other, due after one year or the normal operating cycle, if longer.", "label": "Other Accrued Liabilities, Noncurrent", "verboseLabel": "Accrued lease liability" } } }, "localname": "OtherAccruedLiabilitiesNoncurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovid.com/role/OTHERNONCURRENTLIABILITIESDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherAssetsCurrent": { "auth_ref": [ "r219", "r784" ], "calculation": { "http://innovid.com/role/PREPAIDANDOTHERCURRENTASSETSDetails": { "order": 4.0, "parentTag": "us-gaap_PrepaidExpenseAndOtherAssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of current assets classified as other.", "label": "Other Assets, Current", "terseLabel": "Other current assets" } } }, "localname": "OtherAssetsCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovid.com/role/PREPAIDANDOTHERCURRENTASSETSDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherAssetsDisclosureTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for other assets. This disclosure includes other current assets and other noncurrent assets.", "label": "Other Assets Disclosure [Text Block]", "terseLabel": "PREPAID AND OTHER CURRENT ASSETS" } } }, "localname": "OtherAssetsDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovid.com/role/PREPAIDANDOTHERCURRENTASSETS" ], "xbrltype": "textBlockItemType" }, "us-gaap_OtherAssetsNoncurrent": { "auth_ref": [ "r211" ], "calculation": { "http://innovid.com/role/CONSOLIDATEDBALANCESHEETS": { "order": 1.0, "parentTag": "us-gaap_AssetsNoncurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of noncurrent assets classified as other.", "label": "Other Assets, Noncurrent", "terseLabel": "Other non-current assets" } } }, "localname": "OtherAssetsNoncurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovid.com/role/CONSOLIDATEDBALANCESHEETS" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherIncomeAndExpensesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Other Income and Expenses [Abstract]" } } }, "localname": "OtherIncomeAndExpensesAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_OtherIntangibleAssetsNet": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount after accumulated amortization of finite-lived and indefinite-lived intangible assets classified as other.", "label": "Other Intangible Assets, Net", "terseLabel": "Other intangible assets" } } }, "localname": "OtherIntangibleAssetsNet", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovid.com/role/TRANSACTIONNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherLiabilitiesCurrent": { "auth_ref": [ "r26", "r784" ], "calculation": { "http://innovid.com/role/ACCRUEDEXPENSESANDOTHERCURRENTLIABILITIESDetails": { "order": 2.0, "parentTag": "us-gaap_AccruedLiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of liabilities classified as other, due within one year or the normal operating cycle, if longer.", "label": "Other Liabilities, Current", "terseLabel": "Other current liabilities" } } }, "localname": "OtherLiabilitiesCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovid.com/role/ACCRUEDEXPENSESANDOTHERCURRENTLIABILITIESDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherLiabilitiesDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Other Liabilities Disclosure [Abstract]" } } }, "localname": "OtherLiabilitiesDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_OtherLiabilitiesDisclosureTextBlock": { "auth_ref": [ "r27" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for other liabilities.", "label": "Other Liabilities Disclosure [Text Block]", "terseLabel": "OTHER NON-CURRENT LIABILITIES" } } }, "localname": "OtherLiabilitiesDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovid.com/role/OTHERNONCURRENTLIABILITIES" ], "xbrltype": "textBlockItemType" }, "us-gaap_OtherLiabilitiesNoncurrent": { "auth_ref": [ "r30" ], "calculation": { "http://innovid.com/role/CONSOLIDATEDBALANCESHEETS": { "order": 4.0, "parentTag": "us-gaap_LiabilitiesNoncurrent", "weight": 1.0 }, "http://innovid.com/role/OTHERNONCURRENTLIABILITIESDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.", "label": "Other Liabilities, Noncurrent", "terseLabel": "Other non-current liabilities", "totalLabel": "Other non-current liabilities" } } }, "localname": "OtherLiabilitiesNoncurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovid.com/role/CONSOLIDATEDBALANCESHEETS", "http://innovid.com/role/OTHERNONCURRENTLIABILITIESDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherNoncurrentLiabilitiesTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of other noncurrent liabilities.", "label": "Other Noncurrent Liabilities [Table Text Block]", "terseLabel": "Schedule of Other Noncurrent Liabilities" } } }, "localname": "OtherNoncurrentLiabilitiesTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovid.com/role/OTHERNONCURRENTLIABILITIESTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_OtherSundryLiabilitiesNoncurrent": { "auth_ref": [ "r10", "r170", "r182" ], "calculation": { "http://innovid.com/role/OTHERNONCURRENTLIABILITIESDetails": { "order": 2.0, "parentTag": "us-gaap_OtherLiabilitiesNoncurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Obligations not otherwise itemized or categorized in the footnotes to the financial statements that are expected to be paid after one year (or the normal operating cycle, if longer), from the balance sheet date.", "label": "Other Sundry Liabilities, Noncurrent", "terseLabel": "Other non-current liabilities" } } }, "localname": "OtherSundryLiabilitiesNoncurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovid.com/role/OTHERNONCURRENTLIABILITIESDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_PayablesAndAccrualsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Payables and Accruals [Abstract]" } } }, "localname": "PayablesAndAccrualsAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_PaymentsForUnderwritingExpense": { "auth_ref": [ "r53" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Cash paid for expenses incurred during underwriting activities (the process to review insurance applications, evaluate risks, accept or reject applications, and determine the premiums to be charged) for insurance companies.", "label": "Payments for Underwriting Expense", "negatedTerseLabel": "Less: Deferred underwriting fee paid" } } }, "localname": "PaymentsForUnderwritingExpense", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovid.com/role/TRANSACTIONTransactiontoCashFlowandChangesinTemporaryEquityandStockholdersEquityDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsOfMergerRelatedCostsFinancingActivities": { "auth_ref": [ "r51" ], "calculation": { "http://innovid.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "order": 1.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow for financing costs associated with business combinations.", "label": "Payments of Merger Related Costs, Financing Activities", "negatedTerseLabel": "Payment of SPAC merger transaction costs" } } }, "localname": "PaymentsOfMergerRelatedCostsFinancingActivities", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovid.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsToAcquireBusinessesGross": { "auth_ref": [ "r46", "r578" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow associated with the acquisition of business during the period. The cash portion only of the acquisition price.", "label": "Payments to Acquire Businesses, Gross", "terseLabel": "Payments to acquire business" } } }, "localname": "PaymentsToAcquireBusinessesGross", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovid.com/role/ACQUISITIONNarrativeDetails", "http://innovid.com/role/DESCRIPTIONOFBUSINESSDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired": { "auth_ref": [ "r46" ], "calculation": { "http://innovid.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "order": 1.0, "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow associated with the acquisition of a business, net of the cash acquired from the purchase.", "label": "Payments to Acquire Businesses, Net of Cash Acquired", "negatedTerseLabel": "Acquisitions of businesses, net of cash acquired" } } }, "localname": "PaymentsToAcquireBusinessesNetOfCashAcquired", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovid.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsToAcquirePropertyPlantAndEquipment": { "auth_ref": [ "r47" ], "calculation": { "http://innovid.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "order": 7.0, "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.", "label": "Payments to Acquire Property, Plant, and Equipment", "negatedTerseLabel": "Purchase of property and equipment" } } }, "localname": "PaymentsToAcquirePropertyPlantAndEquipment", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovid.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsToDevelopSoftware": { "auth_ref": [ "r47" ], "calculation": { "http://innovid.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "order": 5.0, "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow associated with the development or modification of software programs or applications for internal use (that is, not to be sold, leased or otherwise marketed to others) that qualify for capitalization.", "label": "Payments to Develop Software", "negatedTerseLabel": "Internal use software capitalization" } } }, "localname": "PaymentsToDevelopSoftware", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovid.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "monetaryItemType" }, "us-gaap_PlanNameAxis": { "auth_ref": [ "r850", "r851", "r852", "r853", "r854", "r855", "r856", "r857", "r858", "r859", "r860", "r861", "r862", "r863", "r864", "r865", "r866", "r867", "r868", "r869", "r870", "r871", "r872", "r873", "r874", "r875" ], "lang": { "en-us": { "role": { "documentation": "Information by plan name for share-based payment arrangement.", "label": "Plan Name [Axis]", "terseLabel": "Plan Name [Axis]" } } }, "localname": "PlanNameAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovid.com/role/STOCKBASEDCOMPENSATIONNarrativeDetails", "http://innovid.com/role/STOCKBASEDCOMPENSATIONStockOptionActivityUnderPlanDetails" ], "xbrltype": "stringItemType" }, "us-gaap_PlanNameDomain": { "auth_ref": [ "r850", "r851", "r852", "r853", "r854", "r855", "r856", "r857", "r858", "r859", "r860", "r861", "r862", "r863", "r864", "r865", "r866", "r867", "r868", "r869", "r870", "r871", "r872", "r873", "r874", "r875" ], "lang": { "en-us": { "role": { "documentation": "Plan name for share-based payment arrangement.", "label": "Plan Name [Domain]", "terseLabel": "Plan Name [Domain]" } } }, "localname": "PlanNameDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovid.com/role/STOCKBASEDCOMPENSATIONNarrativeDetails", "http://innovid.com/role/STOCKBASEDCOMPENSATIONStockOptionActivityUnderPlanDetails" ], "xbrltype": "domainItemType" }, "us-gaap_PostemploymentBenefitPlansPolicy": { "auth_ref": [ "r422" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for postemployment benefits. Postemployment benefits are benefits provided to former or inactive employees, their beneficiaries, and covered dependents after employment but before retirement, except for: a) benefits provided through a pension or postretirement benefit plan, b) individual deferred compensation arrangements, c) special or contractual termination benefits, and d) stock compensation plans.", "label": "Postemployment Benefit Plans, Policy [Policy Text Block]", "terseLabel": "Accrued post-employment benefits" } } }, "localname": "PostemploymentBenefitPlansPolicy", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovid.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_PostemploymentRetirementBenefitsMember": { "auth_ref": [ "r113", "r114" ], "lang": { "en-us": { "role": { "documentation": "Special and contractual termination benefits provided in connection with termination of employment and payable upon retirement, but not payable from defined benefit plan. Excludes benefits payable upon termination from defined benefit pension and other postretirement plan, and postemployment benefits payable before retirement.", "label": "Postemployment Retirement Benefits [Member]", "terseLabel": "Postemployment Retirement Benefits" } } }, "localname": "PostemploymentRetirementBenefitsMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovid.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_PreferredStockAccretionOfRedemptionDiscount": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The amount of accretion of the preferred stock redemption discount during the period.", "label": "Preferred Stock, Accretion of Redemption Discount", "negatedTerseLabel": "Accretion of preferred stocks to redemption value" } } }, "localname": "PreferredStockAccretionOfRedemptionDiscount", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovid.com/role/STATEMENTSOFCHANGESINTEMPORARYEQUITYANDSTOCKHOLDERSEQUITYDEFICIT" ], "xbrltype": "monetaryItemType" }, "us-gaap_PreferredStockConvertibleConversionRatio": { "auth_ref": [ "r395" ], "lang": { "en-us": { "role": { "documentation": "Number of common shares issuable upon conversion for each share of preferred stock to be converted.", "label": "Preferred Stock, Convertible, Conversion Ratio", "terseLabel": "Exchange ratio" } } }, "localname": "PreferredStockConvertibleConversionRatio", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovid.com/role/BASICANDDILUTEDNETLOSSPERSHARENarrativeDetails", "http://innovid.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONSParenthetical", "http://innovid.com/role/STOCKHOLDERSEQUITYNarrativeDetails", "http://innovid.com/role/TRANSACTIONNarrativeDetails" ], "xbrltype": "pureItemType" }, "us-gaap_PreferredStockRedemptionPremium": { "auth_ref": [ "r282" ], "calculation": { "http://innovid.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": { "order": 1.0, "parentTag": "us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The excess of (1) fair value of the consideration transferred to the holders of the preferred stock over (2) the carrying amount of the preferred stock in the registrant's balance sheet, during the accounting period.", "label": "Preferred Stock Redemption Premium", "negatedTerseLabel": "Accretion of preferred stock to redemption value" } } }, "localname": "PreferredStockRedemptionPremium", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovid.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS" ], "xbrltype": "monetaryItemType" }, "us-gaap_PrepaidExpenseAndOtherAssetsCurrent": { "auth_ref": [ "r805" ], "calculation": { "http://innovid.com/role/CONSOLIDATEDBALANCESHEETS": { "order": 1.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 }, "http://innovid.com/role/PREPAIDANDOTHERCURRENTASSETSDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.", "label": "Prepaid Expense and Other Assets, Current", "totalLabel": "Total", "verboseLabel": "Prepaid expenses and other current assets" } } }, "localname": "PrepaidExpenseAndOtherAssetsCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovid.com/role/CONSOLIDATEDBALANCESHEETS", "http://innovid.com/role/PREPAIDANDOTHERCURRENTASSETSDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_PrepaidExpenseCurrent": { "auth_ref": [ "r218", "r334", "r335", "r748" ], "calculation": { "http://innovid.com/role/PREPAIDANDOTHERCURRENTASSETSDetails": { "order": 3.0, "parentTag": "us-gaap_PrepaidExpenseAndOtherAssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits within a future period of one year or the normal operating cycle, if longer.", "label": "Prepaid Expense, Current", "verboseLabel": "Prepaid expenses" } } }, "localname": "PrepaidExpenseCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovid.com/role/PREPAIDANDOTHERCURRENTASSETSDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_PrimeRateMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Interest rate charged by financial institutions to their most creditworthy borrowers.", "label": "Prime Rate [Member]", "terseLabel": "Prime Rate" } } }, "localname": "PrimeRateMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovid.com/role/LONGTERMDEBTDetails" ], "xbrltype": "domainItemType" }, "us-gaap_PrivatePlacementMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "A private placement is a direct offering of securities to a limited number of sophisticated investors such as insurance companies, pension funds, mezzanine funds, stock funds and trusts.", "label": "Private Placement [Member]", "terseLabel": "Private Placement" } } }, "localname": "PrivatePlacementMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovid.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails", "http://innovid.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESScheduleofWarrantsFollowsatInitialMeasurementDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ProceedsFromContributedCapital": { "auth_ref": [ "r48" ], "calculation": { "http://innovid.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "order": 2.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The cash inflow associated with the amount received by a corporation from a shareholder during the period.", "label": "Proceeds from Contributed Capital", "terseLabel": "Capital contributions" } } }, "localname": "ProceedsFromContributedCapital", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovid.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromIssuanceInitialPublicOffering": { "auth_ref": [ "r48" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The cash inflow associated with the amount received from entity's first offering of stock to the public.", "label": "Proceeds from Issuance Initial Public Offering", "terseLabel": "Gross proceeds" } } }, "localname": "ProceedsFromIssuanceInitialPublicOffering", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovid.com/role/TRANSACTIONNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromIssuanceOfLongTermDebt": { "auth_ref": [ "r49" ], "calculation": { "http://innovid.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "order": 6.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The cash inflow from a debt initially having maturity due after one year or beyond the operating cycle, if longer.", "label": "Proceeds from Issuance of Long-Term Debt", "terseLabel": "Proceeds from loans" } } }, "localname": "ProceedsFromIssuanceOfLongTermDebt", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovid.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromIssuanceOfPrivatePlacement": { "auth_ref": [ "r48" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The cash inflow associated with the amount received from entity's raising of capital via private rather than public placement.", "label": "Proceeds from Issuance of Private Placement", "verboseLabel": "Cash - PIPE Investment, net of Secondary Sale Amount of $68,855" } } }, "localname": "ProceedsFromIssuanceOfPrivatePlacement", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovid.com/role/TRANSACTIONTransactiontoCashFlowandChangesinTemporaryEquityandStockholdersEquityDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromLinesOfCredit": { "auth_ref": [ "r49", "r809" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow from contractual arrangement with the lender, including but not limited to, letter of credit, standby letter of credit and revolving credit arrangements.", "label": "Proceeds from Lines of Credit", "terseLabel": "Proceeds from line of credit" } } }, "localname": "ProceedsFromLinesOfCredit", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovid.com/role/LONGTERMDEBTDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment": { "auth_ref": [ "r44" ], "calculation": { "http://innovid.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "order": 3.0, "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The cash inflow from the sale of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale.", "label": "Proceeds from Sale of Property, Plant, and Equipment", "terseLabel": "Proceeds from sale of property and equipment" } } }, "localname": "ProceedsFromSaleOfPropertyPlantAndEquipment", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovid.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromStockOptionsExercised": { "auth_ref": [ "r48", "r123" ], "calculation": { "http://innovid.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "order": 7.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow from exercise of option under share-based payment arrangement.", "label": "Proceeds from Stock Options Exercised", "terseLabel": "Proceeds from exercise of options" } } }, "localname": "ProceedsFromStockOptionsExercised", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovid.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "monetaryItemType" }, "us-gaap_PropertyPlantAndEquipmentAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Property, Plant and Equipment [Abstract]" } } }, "localname": "PropertyPlantAndEquipmentAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_PropertyPlantAndEquipmentByTypeAxis": { "auth_ref": [ "r98" ], "lang": { "en-us": { "role": { "documentation": "Information by type of long-lived, physical assets used to produce goods and services and not intended for resale.", "label": "Long-Lived Tangible Asset [Axis]", "terseLabel": "Long-Lived Tangible Asset [Axis]" } } }, "localname": "PropertyPlantAndEquipmentByTypeAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovid.com/role/PROPERTYANDEQUIPMENTNETDetails", "http://innovid.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails", "http://innovid.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESScheduleofPropertyPlantandEquipmentDetails" ], "xbrltype": "stringItemType" }, "us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock": { "auth_ref": [ "r101", "r702", "r703", "r704" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections.", "label": "Property, Plant and Equipment Disclosure [Text Block]", "terseLabel": "PROPERTY AND EQUIPMENT, NET" } } }, "localname": "PropertyPlantAndEquipmentDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovid.com/role/PROPERTYANDEQUIPMENTNET" ], "xbrltype": "textBlockItemType" }, "us-gaap_PropertyPlantAndEquipmentEstimatedUsefulLives": { "auth_ref": [ "r93" ], "lang": { "en-us": { "role": { "documentation": "Describes the periods of time over which an entity anticipates to receive utility from its property, plant and equipment (that is, the periods of time over which an entity allocates the initial cost of its property, plant and equipment).", "label": "Property, Plant and Equipment, Estimated Useful Lives", "terseLabel": "Useful lives (in years)" } } }, "localname": "PropertyPlantAndEquipmentEstimatedUsefulLives", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovid.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_PropertyPlantAndEquipmentGross": { "auth_ref": [ "r96", "r207" ], "calculation": { "http://innovid.com/role/PROPERTYANDEQUIPMENTNETDetails": { "order": 2.0, "parentTag": "us-gaap_PropertyPlantAndEquipmentNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.", "label": "Property, Plant and Equipment, Gross", "terseLabel": "Total cost" } } }, "localname": "PropertyPlantAndEquipmentGross", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovid.com/role/PROPERTYANDEQUIPMENTNETDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_PropertyPlantAndEquipmentLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Property, Plant and Equipment [Line Items]", "terseLabel": "Property, Plant and Equipment [Line Items]" } } }, "localname": "PropertyPlantAndEquipmentLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovid.com/role/PROPERTYANDEQUIPMENTNETDetails", "http://innovid.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESScheduleofPropertyPlantandEquipmentDetails" ], "xbrltype": "stringItemType" }, "us-gaap_PropertyPlantAndEquipmentNet": { "auth_ref": [ "r98", "r185", "r681", "r784" ], "calculation": { "http://innovid.com/role/CONSOLIDATEDBALANCESHEETS": { "order": 4.0, "parentTag": "us-gaap_AssetsNoncurrent", "weight": 1.0 }, "http://innovid.com/role/PROPERTYANDEQUIPMENTNETDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.", "label": "Property, Plant and Equipment, Net", "terseLabel": "Property and equipment, net", "totalLabel": "Depreciated cost" } } }, "localname": "PropertyPlantAndEquipmentNet", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovid.com/role/CONSOLIDATEDBALANCESHEETS", "http://innovid.com/role/PROPERTYANDEQUIPMENTNETDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_PropertyPlantAndEquipmentPolicyTextBlock": { "auth_ref": [ "r98", "r702", "r703" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections.", "label": "Property, Plant and Equipment, Policy [Policy Text Block]", "terseLabel": "Property and equipment, net" } } }, "localname": "PropertyPlantAndEquipmentPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovid.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_PropertyPlantAndEquipmentTextBlock": { "auth_ref": [ "r98" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.", "label": "Property, Plant and Equipment [Table Text Block]", "terseLabel": "Schedule of Property, Plant and Equipment" } } }, "localname": "PropertyPlantAndEquipmentTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovid.com/role/PROPERTYANDEQUIPMENTNETTables", "http://innovid.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_PropertyPlantAndEquipmentTypeDomain": { "auth_ref": [ "r96" ], "lang": { "en-us": { "role": { "documentation": "Listing of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale. Examples include land, buildings, machinery and equipment, and other types of furniture and equipment including, but not limited to, office equipment, furniture and fixtures, and computer equipment and software.", "label": "Long-Lived Tangible Asset [Domain]", "terseLabel": "Long-Lived Tangible Asset [Domain]" } } }, "localname": "PropertyPlantAndEquipmentTypeDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovid.com/role/PROPERTYANDEQUIPMENTNETDetails", "http://innovid.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails", "http://innovid.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESScheduleofPropertyPlantandEquipmentDetails" ], "xbrltype": "domainItemType" }, "us-gaap_PropertyPlantAndEquipmentUsefulLife": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Useful life of long lived, physical assets used in the normal conduct of business and not intended for resale, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Examples include, but not limited to, land, buildings, machinery and equipment, office equipment, furniture and fixtures, and computer equipment.", "label": "Property, Plant and Equipment, Useful Life", "terseLabel": "Years" } } }, "localname": "PropertyPlantAndEquipmentUsefulLife", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovid.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESScheduleofPropertyPlantandEquipmentDetails" ], "xbrltype": "durationItemType" }, "us-gaap_RealEstateMember": { "auth_ref": [ "r848" ], "lang": { "en-us": { "role": { "documentation": "Property consisting of land, land improvement and buildings.", "label": "Real Estate [Member]", "terseLabel": "Real Estate" } } }, "localname": "RealEstateMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovid.com/role/LEASESScheduleofoperatingROUassetsandleaseliabilitiesDetails", "http://innovid.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESScheduleofOperatingLeaseLiabilitiesandROUAssetsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.", "label": "Reconciliation of Unrecognized Tax Benefits, Excluding Amounts Pertaining to Examined Tax Returns [Roll Forward]", "terseLabel": "Reconciliation of Unrecognized Tax Benefits, Excluding Amounts Pertaining to Examined Tax Returns [Roll Forward]" } } }, "localname": "ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovid.com/role/INCOMETAXESIncomeTaxContingenciesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_RelatedPartyDomain": { "auth_ref": [ "r469", "r650", "r651" ], "lang": { "en-us": { "role": { "documentation": "Related parties include affiliates; other entities for which investments are accounted for by the equity method by the entity; trusts for benefit of employees; and principal owners, management, and members of immediate families. It also may include other parties with which the entity may control or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests.", "label": "Related Party [Domain]", "terseLabel": "Related Party [Domain]" } } }, "localname": "RelatedPartyDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovid.com/role/TRANSACTIONNarrativeDetails", "http://innovid.com/role/TRANSACTIONTransactiontoCashFlowandChangesinTemporaryEquityandStockholdersEquityDetails" ], "xbrltype": "domainItemType" }, "us-gaap_RelatedPartyTransactionLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Related Party Transaction [Line Items]", "terseLabel": "Related Party Transaction [Line Items]" } } }, "localname": "RelatedPartyTransactionLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovid.com/role/TRANSACTIONNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_RelatedPartyTransactionsByRelatedPartyAxis": { "auth_ref": [ "r469", "r650", "r665", "r666", "r667", "r668", "r669", "r670", "r671", "r672", "r673", "r674", "r675", "r676", "r897" ], "lang": { "en-us": { "role": { "documentation": "Information by type of related party. Related parties include, but not limited to, affiliates; other entities for which investments are accounted for by the equity method by the entity; trusts for benefit of employees; and principal owners, management, and members of immediate families. It also may include other parties with which the entity may control or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests.", "label": "Related Party [Axis]", "terseLabel": "Related Party [Axis]" } } }, "localname": "RelatedPartyTransactionsByRelatedPartyAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovid.com/role/TRANSACTIONNarrativeDetails", "http://innovid.com/role/TRANSACTIONTransactiontoCashFlowandChangesinTemporaryEquityandStockholdersEquityDetails" ], "xbrltype": "stringItemType" }, "us-gaap_RepaymentsOfLinesOfCredit": { "auth_ref": [ "r50", "r809" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of cash outflow for payment of an obligation from a lender, including but not limited to, letter of credit, standby letter of credit and revolving credit arrangements.", "label": "Repayments of Lines of Credit", "terseLabel": "Repayment of line of credit" } } }, "localname": "RepaymentsOfLinesOfCredit", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovid.com/role/LONGTERMDEBTDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_RepaymentsOfLongTermDebt": { "auth_ref": [ "r50" ], "calculation": { "http://innovid.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "order": 4.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow for debt initially having maturity due after one year or beyond the normal operating cycle, if longer.", "label": "Repayments of Long-Term Debt", "negatedLabel": "Loan repayment" } } }, "localname": "RepaymentsOfLongTermDebt", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovid.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "monetaryItemType" }, "us-gaap_ResearchAndDevelopmentExpense": { "auth_ref": [ "r128", "r190", "r906" ], "calculation": { "http://innovid.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": { "order": 1.0, "parentTag": "us-gaap_OperatingIncomeLoss", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use.", "label": "Research and Development Expense", "terseLabel": "Research and development" } } }, "localname": "ResearchAndDevelopmentExpense", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovid.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS", "http://innovid.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESScheduleofReclassificationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ResearchAndDevelopmentExpenseMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Primary financial statement caption in which the reported facts about research and development expense have been included.", "label": "Research and Development Expense [Member]", "terseLabel": "Research and development" } } }, "localname": "ResearchAndDevelopmentExpenseMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovid.com/role/STOCKBASEDCOMPENSATIONStockOptionActivityUnderPlanDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ResearchAndDevelopmentExpensePolicy": { "auth_ref": [ "r128" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for costs it has incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process.", "label": "Research and Development Expense, Policy [Policy Text Block]", "terseLabel": "Research and development" } } }, "localname": "ResearchAndDevelopmentExpensePolicy", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovid.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_ResearchDevelopmentAndComputerSoftwarePolicyTextBlock": { "auth_ref": [ "r90", "r91", "r190" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for its research and development and computer software activities including the accounting treatment for costs incurred for (1) research and development activities, (2) development of computer software for internal use, (3) computer software to be sold, leased or otherwise marketed as a separate product or as part of a product or process and (4) in-process research and development acquired in a purchase business combination.", "label": "Research, Development, and Computer Software, Policy [Policy Text Block]", "terseLabel": "Software development costs" } } }, "localname": "ResearchDevelopmentAndComputerSoftwarePolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovid.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_RestrictedCash": { "auth_ref": [ "r802", "r807", "r907", "r908" ], "calculation": { "http://innovid.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "order": 2.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash restricted as to withdrawal or usage. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits.", "label": "Restricted Cash", "terseLabel": "Long-term restricted deposits" } } }, "localname": "RestrictedCash", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovid.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "monetaryItemType" }, "us-gaap_RestrictedStockUnitsRSUMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Share instrument which is convertible to stock or an equivalent amount of cash, after a specified period of time or when specified performance conditions are met.", "label": "Restricted Stock Units (RSUs) [Member]", "terseLabel": "RSUs outstanding", "verboseLabel": "Restricted Stock Units (RSUs)" } } }, "localname": "RestrictedStockUnitsRSUMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovid.com/role/BASICANDDILUTEDNETLOSSPERSHARESecuritiesExcludedfromComputationofEarningsPerShareDetails", "http://innovid.com/role/STOCKBASEDCOMPENSATIONNarrativeDetails", "http://innovid.com/role/STOCKBASEDCOMPENSATIONRestrictedStockUnitActivityDetails" ], "xbrltype": "domainItemType" }, "us-gaap_RestructuringCostAndReserveAxis": { "auth_ref": [ "r346", "r347", "r349", "r350" ], "lang": { "en-us": { "role": { "documentation": "Information by type of restructuring cost.", "label": "Restructuring Type [Axis]", "terseLabel": "Restructuring Type [Axis]" } } }, "localname": "RestructuringCostAndReserveAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovid.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_RetainedEarningsAccumulatedDeficit": { "auth_ref": [ "r17", "r109", "r183", "r692", "r697", "r784" ], "calculation": { "http://innovid.com/role/CONSOLIDATEDBALANCESHEETS": { "order": 3.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.", "label": "Retained Earnings (Accumulated Deficit)", "terseLabel": "Accumulated deficit" } } }, "localname": "RetainedEarningsAccumulatedDeficit", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovid.com/role/CONSOLIDATEDBALANCESHEETS" ], "xbrltype": "monetaryItemType" }, "us-gaap_RetainedEarningsMember": { "auth_ref": [ "r200", "r245", "r246", "r247", "r250", "r259", "r262", "r330", "r527", "r528", "r529", "r556", "r557", "r594", "r688", "r690" ], "lang": { "en-us": { "role": { "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.", "label": "Retained Earnings [Member]", "terseLabel": "Accumulated deficit" } } }, "localname": "RetainedEarningsMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovid.com/role/STATEMENTSOFCHANGESINTEMPORARYEQUITYANDSTOCKHOLDERSEQUITYDEFICIT" ], "xbrltype": "domainItemType" }, "us-gaap_RetirementPlanTypeAxis": { "auth_ref": [ "r113", "r114", "r423", "r424", "r425", "r426", "r427", "r428", "r429", "r430", "r431", "r432", "r433", "r434", "r435", "r436", "r437", "r438", "r439", "r440", "r441", "r442", "r443", "r444", "r445", "r446", "r447", "r448", "r449", "r450", "r451", "r452", "r453", "r454", "r455", "r456", "r457", "r458", "r459", "r460", "r461", "r462", "r463", "r464", "r465", "r466", "r467", "r468", "r469", "r470", "r471", "r472", "r473", "r474", "r475", "r476", "r477", "r478", "r479", "r480", "r481", "r482", "r483", "r484", "r487", "r771", "r772", "r773", "r774", "r775", "r776", "r777", "r778" ], "lang": { "en-us": { "role": { "documentation": "Information by type of retirement benefit plan. Includes, but is not limited to, retirement benefit arrangement for defined benefit pension and other postretirement plans, retirement benefit arrangement for defined contribution pension and other postretirement plans, and special and contractual termination benefits payable upon retirement.", "label": "Retirement Plan Type [Axis]", "terseLabel": "Retirement Plan Type [Axis]" } } }, "localname": "RetirementPlanTypeAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovid.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_RetirementPlanTypeDomain": { "auth_ref": [ "r113", "r114", "r423", "r424", "r425", "r426", "r427", "r428", "r429", "r430", "r431", "r432", "r433", "r434", "r435", "r436", "r437", "r438", "r439", "r440", "r441", "r442", "r443", "r444", "r445", "r446", "r447", "r448", "r449", "r450", "r451", "r452", "r453", "r454", "r455", "r456", "r457", "r458", "r459", "r460", "r461", "r462", "r463", "r464", "r465", "r466", "r467", "r468", "r469", "r470", "r471", "r472", "r473", "r474", "r475", "r476", "r477", "r478", "r479", "r480", "r481", "r482", "r483", "r484", "r487", "r771", "r772", "r773", "r774", "r775", "r776", "r777", "r778" ], "lang": { "en-us": { "role": { "documentation": "Type of plan designed to provide participants with retirement benefits. Includes, but is not limited to, retirement benefit arrangement for defined benefit pension and other postretirement plans, retirement benefit arrangement for defined contribution pension and other postretirement plans, and special and contractual termination benefits payable upon retirement.", "label": "Retirement Plan Type [Domain]", "terseLabel": "Retirement Plan Type [Domain]" } } }, "localname": "RetirementPlanTypeDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovid.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax": { "auth_ref": [ "r295", "r296", "r301", "r305", "r306", "r312", "r313", "r316", "r419", "r420", "r659" ], "calculation": { "http://innovid.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": { "order": 6.0, "parentTag": "us-gaap_OperatingIncomeLoss", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.", "label": "Revenue from Contract with Customer, Excluding Assessed Tax", "terseLabel": "Revenues" } } }, "localname": "RevenueFromContractWithCustomerExcludingAssessedTax", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovid.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS", "http://innovid.com/role/SEGMENTREPORTINGRevenueandPropertyandEquipmentbyGeographicalAreasDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_RevenueFromContractWithCustomerPolicyTextBlock": { "auth_ref": [ "r411", "r412", "r413", "r414", "r415", "r416", "r417", "r418", "r421", "r753" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for revenue from contract with customer.", "label": "Revenue from Contract with Customer [Policy Text Block]", "terseLabel": "Revenue recognition and Cost of revenues" } } }, "localname": "RevenueFromContractWithCustomerPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovid.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Revenues from External Customers and Long-Lived Assets [Line Items]", "terseLabel": "Revenues from External Customers and Long-Lived Assets [Line Items]" } } }, "localname": "RevenuesFromExternalCustomersAndLongLivedAssetsLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovid.com/role/SEGMENTREPORTINGRevenueandPropertyandEquipmentbyGeographicalAreasDetails" ], "xbrltype": "stringItemType" }, "us-gaap_RevolvingCreditFacilityMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Arrangement in which loan proceeds can continuously be obtained following repayments, but the total amount borrowed cannot exceed a specified maximum amount.", "label": "Revolving Credit Facility [Member]", "terseLabel": "Revolving Credit Facility" } } }, "localname": "RevolvingCreditFacilityMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovid.com/role/LONGTERMDEBTDetails" ], "xbrltype": "domainItemType" }, "us-gaap_SaleOfStockConsiderationReceivedOnTransaction": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Cash received on stock transaction after deduction of issuance costs.", "label": "Sale of Stock, Consideration Received on Transaction", "terseLabel": "Aggregate value" } } }, "localname": "SaleOfStockConsiderationReceivedOnTransaction", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovid.com/role/TRANSACTIONNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_SaleOfStockNameOfTransactionDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Sale of the entity's stock, including, but not limited to, initial public offering (IPO) and private placement.", "label": "Sale of Stock [Domain]", "terseLabel": "Sale of Stock [Domain]" } } }, "localname": "SaleOfStockNameOfTransactionDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovid.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESScheduleofWarrantsFollowsatInitialMeasurementDetails", "http://innovid.com/role/TRANSACTIONNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The number of shares issued or sold by the subsidiary or equity method investee per stock transaction.", "label": "Sale of Stock, Number of Shares Issued in Transaction", "terseLabel": "Shares issued in transaction (in shares)" } } }, "localname": "SaleOfStockNumberOfSharesIssuedInTransaction", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovid.com/role/TRANSACTIONNarrativeDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_SaleOfStockPricePerShare": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Per share amount received by subsidiary or equity investee for each share of common stock issued or sold in the stock transaction.", "label": "Sale of Stock, Price Per Share", "terseLabel": "Per unit price (in dollars per share)" } } }, "localname": "SaleOfStockPricePerShare", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovid.com/role/TRANSACTIONNarrativeDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_SalesRevenueNetMember": { "auth_ref": [ "r316", "r829" ], "lang": { "en-us": { "role": { "documentation": "Revenue from sale of product and rendering of service and other sources of income, when it serves as benchmark in concentration of risk calculation.", "label": "Revenue Benchmark [Member]", "terseLabel": "Revenue Benchmark" } } }, "localname": "SalesRevenueNetMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovid.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESScheduleofConcentrationRiskDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the components of accrued liabilities.", "label": "Schedule of Accrued Liabilities [Table Text Block]", "terseLabel": "Schedule of Accrued Liabilities" } } }, "localname": "ScheduleOfAccruedLiabilitiesTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovid.com/role/ACCRUEDEXPENSESANDOTHERCURRENTLIABILITIESTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable": { "auth_ref": [ "r67" ], "lang": { "en-us": { "role": { "documentation": "Schedule for securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by Antidilutive Securities.", "label": "Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]", "terseLabel": "Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]" } } }, "localname": "ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovid.com/role/BASICANDDILUTEDNETLOSSPERSHARESecuritiesExcludedfromComputationofEarningsPerShareDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock": { "auth_ref": [ "r67" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by antidilutive securities.", "label": "Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block]", "terseLabel": "Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share" } } }, "localname": "ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovid.com/role/BASICANDDILUTEDNETLOSSPERSHARETables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable": { "auth_ref": [ "r140", "r141", "r573" ], "lang": { "en-us": { "role": { "documentation": "Schedule reflecting each material business combination (or series of individually immaterial business combinations) completed during the period, including background, timing, and recognized assets and liabilities.", "label": "Schedule of Business Acquisitions, by Acquisition [Table]", "terseLabel": "Schedule of Business Acquisitions, by Acquisition [Table]" } } }, "localname": "ScheduleOfBusinessAcquisitionsByAcquisitionTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovid.com/role/ACQUISITIONFairValuesoftheAssetsAcquiredandLiabilitiesAssumedDetails", "http://innovid.com/role/ACQUISITIONNarrativeDetails", "http://innovid.com/role/ACQUISITIONUnauditedProFormaFinancialInformationDetails", "http://innovid.com/role/DESCRIPTIONOFBUSINESSDetails", "http://innovid.com/role/TRANSACTIONCommonStockinInnovidCorpDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock": { "auth_ref": [ "r136" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the components of income tax expense attributable to continuing operations for each year presented including, but not limited to: current tax expense (benefit), deferred tax expense (benefit), investment tax credits, government grants, the benefits of operating loss carryforwards, tax expense that results from allocating certain tax benefits either directly to contributed capital or to reduce goodwill or other noncurrent intangible assets of an acquired entity, adjustments of a deferred tax liability or asset for enacted changes in tax laws or rates or a change in the tax status of the entity, and adjustments of the beginning-of-the-year balances of a valuation allowance because of a change in circumstances that causes a change in judgment about the realizability of the related deferred tax asset in future years.", "label": "Schedule of Components of Income Tax Expense (Benefit) [Table Text Block]", "terseLabel": "Schedule of Components of Income Tax Expense (Benefit)" } } }, "localname": "ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovid.com/role/INCOMETAXESTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock": { "auth_ref": [ "r132" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the components of net deferred tax asset or liability recognized in an entity's statement of financial position, including the following: the total of all deferred tax liabilities, the total of all deferred tax assets, the total valuation allowance recognized for deferred tax assets.", "label": "Schedule of Deferred Tax Assets and Liabilities [Table Text Block]", "terseLabel": "Schedule of Deferred Tax Assets and Liabilities" } } }, "localname": "ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovid.com/role/INCOMETAXESTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock": { "auth_ref": [ "r828" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.", "label": "Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]", "terseLabel": "Schedule of Basic and Diluted Net Loss Per Share" } } }, "localname": "ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovid.com/role/BASICANDDILUTEDNETLOSSPERSHARETables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock": { "auth_ref": [ "r130" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the reconciliation using percentage or dollar amounts of the reported amount of income tax expense attributable to continuing operations for the year to the amount of income tax expense that would result from applying domestic federal statutory tax rates to pretax income from continuing operations.", "label": "Schedule of Effective Income Tax Rate Reconciliation [Table Text Block]", "terseLabel": "Schedule of Effective Income Tax Rate Reconciliation" } } }, "localname": "ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovid.com/role/INCOMETAXESTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable": { "auth_ref": [ "r121", "r124" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about amount recognized for award under share-based payment arrangement. Includes, but is not limited to, amount expensed in statement of income or comprehensive income, amount capitalized in statement of financial position, and corresponding reporting line item in financial statements.", "label": "Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Table]", "terseLabel": "Share-based Payment Arrangement, Expensed and Capitalized, Amount [Table]" } } }, "localname": "ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovid.com/role/STOCKBASEDCOMPENSATIONStockOptionActivityUnderPlanDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock": { "auth_ref": [ "r121" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of allocation of amount expensed and capitalized for award under share-based payment arrangement to statement of income or comprehensive income and statement of financial position. Includes, but is not limited to, corresponding line item in financial statement.", "label": "Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Table Text Block]", "terseLabel": "Schedule Share Based Compensation Expenses" } } }, "localname": "ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovid.com/role/STOCKBASEDCOMPENSATIONTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock": { "auth_ref": [ "r598", "r599" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of assets and liabilities, including [financial] instruments measured at fair value that are classified in stockholders' equity, if any, that are measured at fair value on a recurring basis. The disclosures contemplated herein include the fair value measurements at the reporting date by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3).", "label": "Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Table Text Block]", "terseLabel": "Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis" } } }, "localname": "ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovid.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable": { "auth_ref": [ "r82", "r86", "r660" ], "lang": { "en-us": { "role": { "documentation": "Schedule of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.", "label": "Schedule of Finite-Lived Intangible Assets [Table]", "terseLabel": "Schedule of Finite-Lived Intangible Assets [Table]" } } }, "localname": "ScheduleOfFiniteLivedIntangibleAssetsTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovid.com/role/INTANGIBLEASSETSNETIntangibleAssetsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock": { "auth_ref": [ "r82", "r86" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of assets, excluding financial assets and goodwill, lacking physical substance with a finite life, by either major class or business segment.", "label": "Schedule of Finite-Lived Intangible Assets [Table Text Block]", "terseLabel": "Schedule of Finite-Lived Intangible Assets" } } }, "localname": "ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovid.com/role/INTANGIBLEASSETSNETTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock": { "auth_ref": [ "r196" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of future minimum payments required in the aggregate and for each of the five succeeding fiscal years for operating leases having initial or remaining noncancelable lease terms in excess of one year and the total minimum rentals to be received in the future under noncancelable subleases as of the balance sheet date.", "label": "Schedule of Future Minimum Rental Payments for Operating Leases [Table Text Block]", "terseLabel": "Schedule of Future Minimum Lease Commitments" } } }, "localname": "ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovid.com/role/LEASESTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock": { "auth_ref": [ "r811" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of income before income tax between domestic and foreign jurisdictions.", "label": "Schedule of Income before Income Tax, Domestic and Foreign [Table Text Block]", "terseLabel": "Schedule of Income (Loss) before Income Tax, Domestic and Foreign" } } }, "localname": "ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovid.com/role/INCOMETAXESTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfOperatingLeasedAssetsTable": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Schedule of long-lived, depreciable assets that are subject to a operating lease agreements and are used in the normal conduct of business to produce goods and services. Examples may include land, buildings, machinery and equipment, and other types of furniture and equipment including, but not limited to, office equipment, furniture and fixtures, and computer equipment and software.", "label": "Schedule of Operating Leased Assets [Table]", "terseLabel": "Schedule of Operating Leased Assets [Table]" } } }, "localname": "ScheduleOfOperatingLeasedAssetsTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovid.com/role/LEASESScheduleOfCommitmentsUnderNonCancelableOperatingLeasesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfPropertyPlantAndEquipmentTable": { "auth_ref": [ "r98" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.", "label": "Property, Plant and Equipment [Table]", "terseLabel": "Property, Plant and Equipment [Table]" } } }, "localname": "ScheduleOfPropertyPlantAndEquipmentTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovid.com/role/PROPERTYANDEQUIPMENTNETDetails", "http://innovid.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESScheduleofPropertyPlantandEquipmentDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock": { "auth_ref": [ "r144" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the amounts recognized as of the acquisition date for each major class of assets acquired and liabilities assumed. May include but not limited to the following: (a) acquired receivables; (b) contingencies recognized at the acquisition date; and (c) the fair value of noncontrolling interests in the acquiree.", "label": "Schedule of Recognized Identified Assets Acquired and Liabilities Assumed [Table Text Block]", "terseLabel": "Schedule of Fair Values of the Assets Acquired and Liabilities Assumed" } } }, "localname": "ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovid.com/role/ACQUISITIONTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock": { "auth_ref": [ "r40", "r77" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of information concerning material long-lived assets (excluding financial instruments, customer relationships with financial institutions, mortgage and other servicing rights, deferred policy acquisition costs, and deferred taxes assets) located in identified geographic areas and/or the amount of revenue from external customers attributed to that country from which revenue is material. An entity may also provide subtotals of geographic information about groups of countries.", "label": "Schedule of Revenue from External Customers and Long-Lived Assets, by Geographical Areas [Table Text Block]", "terseLabel": "Schedule of Revenue and Property and Equipment, by Geographical Areas" } } }, "localname": "ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovid.com/role/SEGMENTREPORTINGTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable": { "auth_ref": [ "r36", "r77" ], "lang": { "en-us": { "role": { "documentation": "Schedule of material long-lived assets (excluding financial instruments, customer relationships with financial institutions, mortgage and other servicing rights, deferred policy acquisition costs, and deferred taxes assets) located in identified geographic areas and/or the amount of revenue from external customers attributed to that country from which revenue is material. An entity may also provide subtotals of geographic information about groups of countries.", "label": "Schedule of Revenues from External Customers and Long-Lived Assets [Table]", "terseLabel": "Schedule of Revenues from External Customers and Long-Lived Assets [Table]" } } }, "localname": "ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovid.com/role/SEGMENTREPORTINGRevenueandPropertyandEquipmentbyGeographicalAreasDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable": { "auth_ref": [ "r488", "r490", "r492", "r493", "r494", "r496", "r497", "r498", "r499", "r500", "r501", "r502", "r503", "r504", "r505", "r506", "r507", "r508", "r509", "r510", "r511", "r512", "r513", "r516", "r517", "r518", "r519", "r520" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about share-based payment arrangement.", "label": "Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table]", "terseLabel": "Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]" } } }, "localname": "ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovid.com/role/STOCKBASEDCOMPENSATIONFairValueofEachOptiononTheDateofGrantDetails", "http://innovid.com/role/STOCKBASEDCOMPENSATIONNarrativeDetails", "http://innovid.com/role/STOCKBASEDCOMPENSATIONRestrictedStockUnitActivityDetails", "http://innovid.com/role/STOCKBASEDCOMPENSATIONStockOptionActivityDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock": { "auth_ref": [ "r116", "r117", "r118" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value.", "label": "Share-Based Payment Arrangement, Option, Activity [Table Text Block]", "terseLabel": "Schedule of Share Based Payment Arrangement, Option, Activity" } } }, "localname": "ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovid.com/role/STOCKBASEDCOMPENSATIONTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock": { "auth_ref": [ "r120" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the significant assumptions used during the year to estimate the fair value of stock options, including, but not limited to: (a) expected term of share options and similar instruments, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions.", "label": "Schedule of Share-Based Payment Award, Stock Options, Valuation Assumptions [Table Text Block]", "terseLabel": "Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions" } } }, "localname": "ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovid.com/role/STOCKBASEDCOMPENSATIONTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfShortTermDebtTable": { "auth_ref": [ "r23" ], "lang": { "en-us": { "role": { "documentation": "A table or schedule providing information pertaining to borrowings under which repayment was required in less than twelve months (or normal operating cycle, if longer) after its issuance. It may include: (1) description of the short-term debt arrangement; (2) identification of the lender or type of lender; (3) repayment terms; (4) weighted average interest rate; (5) carrying amount of funds borrowed under the specified short-term debt arrangement as of the balance sheet date and measures of the maximum and average amount outstanding during the period; (6) description of the refinancing of a short-term obligation when that obligation is excluded from current liabilities in the balance sheet; and (7) amount of a short-term obligation that has been excluded from current liabilities in the balance sheet because of a refinancing of the obligation.", "label": "Schedule of Short-Term Debt [Table]", "terseLabel": "Schedule of Short-Term Debt [Table]" } } }, "localname": "ScheduleOfShortTermDebtTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovid.com/role/FINANCEEXPENSESINCOMENETDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfStockholdersEquityTableTextBlock": { "auth_ref": [ "r107" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of changes in the separate accounts comprising stockholders' equity (in addition to retained earnings) and of the changes in the number of shares of equity securities during at least the most recent annual fiscal period and any subsequent interim period presented is required to make the financial statements sufficiently informative if both financial position and results of operations are presented.", "label": "Schedule of Stockholders Equity [Table Text Block]", "terseLabel": "Schedule of Stockholders Equity" } } }, "localname": "ScheduleOfStockholdersEquityTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovid.com/role/STOCKHOLDERSEQUITYTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock": { "auth_ref": [ "r782", "r879" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the change in unrecognized tax benefits.", "label": "Schedule of Unrecognized Tax Benefits Roll Forward [Table Text Block]", "terseLabel": "Schedule of Unrecognized Tax Benefits Roll Forward" } } }, "localname": "ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovid.com/role/INCOMETAXESTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock": { "auth_ref": [ "r86" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the amount of amortization expense expected to be recorded in succeeding fiscal years for finite-lived intangible assets.", "label": "Schedule of Finite-Lived Intangible Assets, Future Amortization Expense [Table Text Block]", "terseLabel": "Schedule of Finite-Lived Intangible Assets, Future Amortization Expense" } } }, "localname": "ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovid.com/role/INTANGIBLEASSETSNETTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_SchedulesOfConcentrationOfRiskByRiskFactorTextBlock": { "auth_ref": [ "r69", "r71", "r72", "r73", "r159", "r161" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the nature of a concentration, a benchmark to which it is compared, and the percentage that the risk is to the benchmark.", "label": "Schedules of Concentration of Risk, by Risk Factor [Table Text Block]", "terseLabel": "Schedules of Concentration of Risk, by Risk Factor" } } }, "localname": "SchedulesOfConcentrationOfRiskByRiskFactorTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovid.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_SegmentReportingAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Segment Reporting [Abstract]" } } }, "localname": "SegmentReportingAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_SegmentReportingDisclosureTextBlock": { "auth_ref": [ "r292", "r293", "r294", "r299", "r300", "r304", "r308", "r309", "r310", "r311", "r312", "r315", "r316", "r317" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments.", "label": "Segment Reporting Disclosure [Text Block]", "terseLabel": "SEGMENT REPORTING" } } }, "localname": "SegmentReportingDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovid.com/role/SEGMENTREPORTING" ], "xbrltype": "textBlockItemType" }, "us-gaap_SellingAndMarketingExpense": { "auth_ref": [], "calculation": { "http://innovid.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": { "order": 5.0, "parentTag": "us-gaap_OperatingIncomeLoss", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The aggregate total amount of expenses directly related to the marketing or selling of products or services.", "label": "Selling and Marketing Expense", "terseLabel": "Sales and marketing" } } }, "localname": "SellingAndMarketingExpense", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovid.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS", "http://innovid.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESScheduleofReclassificationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_SellingAndMarketingExpenseMember": { "auth_ref": [ "r39" ], "lang": { "en-us": { "role": { "documentation": "Primary financial statement caption encompassing selling and marketing expense.", "label": "Selling and Marketing Expense [Member]", "terseLabel": "Sales and marketing" } } }, "localname": "SellingAndMarketingExpenseMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovid.com/role/STOCKBASEDCOMPENSATIONStockOptionActivityUnderPlanDetails" ], "xbrltype": "domainItemType" }, "us-gaap_SellingGeneralAndAdministrativeExpensesPolicyTextBlock": { "auth_ref": [ "r127" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for inclusion of significant items in the selling, general and administrative (or similar) expense report caption.", "label": "Selling, General and Administrative Expenses, Policy [Policy Text Block]", "terseLabel": "General and administrative" } } }, "localname": "SellingGeneralAndAdministrativeExpensesPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovid.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_SeveranceCosts1": { "auth_ref": [ "r56" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of expenses for special or contractual termination benefits provided to current employees involuntarily terminated under a benefit arrangement associated exit or disposal activities pursuant to an authorized plan. Excludes expenses related to one-time termination benefits, a discontinued operation or an asset retirement obligation.", "label": "Severance Costs", "terseLabel": "Severance costs" } } }, "localname": "SeveranceCosts1", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovid.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ShareBasedCompensation": { "auth_ref": [ "r55" ], "calculation": { "http://innovid.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "order": 6.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of noncash expense for share-based payment arrangement.", "label": "Share-Based Payment Arrangement, Noncash Expense", "terseLabel": "Stock-based compensation" } } }, "localname": "ShareBasedCompensation", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovid.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "monetaryItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1": { "auth_ref": [ "r780" ], "lang": { "en-us": { "role": { "documentation": "Period over which grantee's right to exercise award under share-based payment arrangement is no longer contingent on satisfaction of service or performance condition, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, combination of market, performance or service condition.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Period", "terseLabel": "Vesting period" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovid.com/role/STOCKBASEDCOMPENSATIONNarrativeDetails" ], "xbrltype": "durationItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod": { "auth_ref": [ "r509" ], "lang": { "en-us": { "role": { "documentation": "The number of equity-based payment instruments, excluding stock (or unit) options, that were forfeited during the reporting period.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeited in Period", "negatedTerseLabel": "Forfeited (in shares)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovid.com/role/STOCKBASEDCOMPENSATIONRestrictedStockUnitActivityDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue": { "auth_ref": [ "r509" ], "lang": { "en-us": { "role": { "documentation": "Weighted average fair value as of the grant date of equity-based award plans other than stock (unit) option plans that were not exercised or put into effect as a result of the occurrence of a terminating event.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value", "terseLabel": "Forfeited (in USD per share)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovid.com/role/STOCKBASEDCOMPENSATIONRestrictedStockUnitActivityDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod": { "auth_ref": [ "r507" ], "lang": { "en-us": { "role": { "documentation": "The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period", "verboseLabel": "Granted (in shares)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovid.com/role/STOCKBASEDCOMPENSATIONRestrictedStockUnitActivityDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue": { "auth_ref": [ "r507" ], "lang": { "en-us": { "role": { "documentation": "The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value", "verboseLabel": "Granted (in USD per share)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovid.com/role/STOCKBASEDCOMPENSATIONRestrictedStockUnitActivityDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber": { "auth_ref": [ "r504", "r505" ], "lang": { "en-us": { "role": { "documentation": "The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number", "periodEndLabel": "Outstanding at the ending of the year (in shares)", "periodStartLabel": "Outstanding at the beginning of the year (in shares)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovid.com/role/STOCKBASEDCOMPENSATIONRestrictedStockUnitActivityDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]", "terseLabel": "Number of share units" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovid.com/role/STOCKBASEDCOMPENSATIONRestrictedStockUnitActivityDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue": { "auth_ref": [ "r504", "r505" ], "lang": { "en-us": { "role": { "documentation": "Per share or unit weighted-average fair value of nonvested award under share-based payment arrangement. Excludes share and unit options.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value", "periodEndLabel": "Outstanding at the ending of the year (in USD per share)", "periodStartLabel": "Outstanding at the beginning of the year (in USD per share)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovid.com/role/STOCKBASEDCOMPENSATIONRestrictedStockUnitActivityDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]", "terseLabel": "Weighted average grant date fair value" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovid.com/role/STOCKBASEDCOMPENSATIONRestrictedStockUnitActivityDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate": { "auth_ref": [ "r518" ], "lang": { "en-us": { "role": { "documentation": "The estimated dividend rate (a percentage of the share price) to be paid (expected dividends) to holders of the underlying shares over the option's term.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Dividend Rate", "terseLabel": "Expected dividends" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovid.com/role/STOCKBASEDCOMPENSATIONFairValueofEachOptiononTheDateofGrantDetails", "http://innovid.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESScheduleofWarrantsFollowsatInitialMeasurementDetails" ], "xbrltype": "percentItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate": { "auth_ref": [ "r517" ], "lang": { "en-us": { "role": { "documentation": "The estimated measure of the percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Volatility Rate", "terseLabel": "Expected volatility" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovid.com/role/STOCKBASEDCOMPENSATIONFairValueofEachOptiononTheDateofGrantDetails", "http://innovid.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESScheduleofWarrantsFollowsatInitialMeasurementDetails" ], "xbrltype": "percentItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate": { "auth_ref": [ "r519" ], "lang": { "en-us": { "role": { "documentation": "The risk-free interest rate assumption that is used in valuing an option on its own shares.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Risk Free Interest Rate", "terseLabel": "Risk-free interest rate" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovid.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESScheduleofWarrantsFollowsatInitialMeasurementDetails" ], "xbrltype": "percentItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The maximum risk-free interest rate assumption that is used in valuing an option on its own shares.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Maximum", "terseLabel": "Risk free interest rate, maximum" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovid.com/role/STOCKBASEDCOMPENSATIONFairValueofEachOptiononTheDateofGrantDetails" ], "xbrltype": "percentItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The minimum risk-free interest rate assumption that is used in valuing an option on its own shares.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Minimum", "terseLabel": "Risk free interest rate, minimum" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovid.com/role/STOCKBASEDCOMPENSATIONFairValueofEachOptiononTheDateofGrantDetails" ], "xbrltype": "percentItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]", "terseLabel": "Share-based Compensation Arrangement by Share-based Payment Award [Line Items]" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovid.com/role/STOCKBASEDCOMPENSATIONFairValueofEachOptiononTheDateofGrantDetails", "http://innovid.com/role/STOCKBASEDCOMPENSATIONNarrativeDetails", "http://innovid.com/role/STOCKBASEDCOMPENSATIONRestrictedStockUnitActivityDetails", "http://innovid.com/role/STOCKBASEDCOMPENSATIONStockOptionActivityDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Additional Disclosures [Abstract]", "terseLabel": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Additional Disclosures" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovid.com/role/STOCKBASEDCOMPENSATIONStockOptionActivityDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber": { "auth_ref": [ "r498" ], "lang": { "en-us": { "role": { "documentation": "The number of shares into which fully or partially vested stock options outstanding as of the balance sheet date can be currently converted under the option plan.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Number", "periodEndLabel": "Exercisable options at the end of the period (in shares)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovid.com/role/STOCKBASEDCOMPENSATIONStockOptionActivityDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice": { "auth_ref": [ "r498" ], "lang": { "en-us": { "role": { "documentation": "The weighted-average price as of the balance sheet date at which grantees can acquire the shares reserved for issuance on vested portions of options outstanding and currently exercisable under the stock option plan.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Exercise Price", "terseLabel": "Exercisable exercise price at the end of the period (in USD per share)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovid.com/role/STOCKBASEDCOMPENSATIONStockOptionActivityDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod": { "auth_ref": [ "r503" ], "lang": { "en-us": { "role": { "documentation": "Number of options or other stock instruments for which the right to exercise has lapsed under the terms of the plan agreements.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Expirations in Period", "negatedTerseLabel": "Expired (in shares)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovid.com/role/STOCKBASEDCOMPENSATIONStockOptionActivityDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod": { "auth_ref": [ "r502" ], "lang": { "en-us": { "role": { "documentation": "The number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures in Period", "negatedTerseLabel": "Forfeited (in shares)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovid.com/role/STOCKBASEDCOMPENSATIONStockOptionActivityDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross": { "auth_ref": [ "r500" ], "lang": { "en-us": { "role": { "documentation": "Gross number of share options (or share units) granted during the period.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Gross", "terseLabel": "Granted (in shares)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovid.com/role/STOCKBASEDCOMPENSATIONNarrativeDetails", "http://innovid.com/role/STOCKBASEDCOMPENSATIONStockOptionActivityDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue": { "auth_ref": [ "r122" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount by which the current fair value of the underlying stock exceeds the exercise price of options outstanding.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Intrinsic Value", "periodEndLabel": "Outstanding intrinsic value at the end of the period", "periodStartLabel": "Outstanding intrinsic value at the beginning of the period" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovid.com/role/STOCKBASEDCOMPENSATIONStockOptionActivityDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber": { "auth_ref": [ "r496", "r497" ], "lang": { "en-us": { "role": { "documentation": "Number of options outstanding, including both vested and non-vested options.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number", "periodEndLabel": "Outstanding at the end of the period (in shares)", "periodStartLabel": "Outstanding at the beginning of the period (in shares)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovid.com/role/STOCKBASEDCOMPENSATIONStockOptionActivityDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding [Roll Forward]", "terseLabel": "Number of options" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovid.com/role/STOCKBASEDCOMPENSATIONStockOptionActivityDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice": { "auth_ref": [ "r496", "r497" ], "lang": { "en-us": { "role": { "documentation": "Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price", "periodEndLabel": "Outstanding at the end of the period (in USD per share)", "periodStartLabel": "Outstanding at the beginning of the period (in USD per share)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovid.com/role/STOCKBASEDCOMPENSATIONStockOptionActivityDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Abstract]", "terseLabel": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Abstract]" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovid.com/role/STOCKBASEDCOMPENSATIONStockOptionActivityDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain": { "auth_ref": [ "r492", "r493", "r494", "r496", "r497", "r498", "r499", "r500", "r501", "r502", "r503", "r504", "r505", "r506", "r507", "r508", "r509", "r510", "r511", "r512", "r513", "r516", "r517", "r518", "r519", "r520" ], "lang": { "en-us": { "role": { "documentation": "Award under share-based payment arrangement.", "label": "Award Type [Domain]", "terseLabel": "Award Type [Domain]" } } }, "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovid.com/role/STOCKBASEDCOMPENSATIONNarrativeDetails", "http://innovid.com/role/STOCKBASEDCOMPENSATIONRestrictedStockUnitActivityDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice": { "auth_ref": [ "r501" ], "lang": { "en-us": { "role": { "documentation": "Weighted average price at which option holders acquired shares when converting their stock options into shares.", "label": "Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price", "terseLabel": "Exercised (in USD per share)" } } }, "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovid.com/role/STOCKBASEDCOMPENSATIONStockOptionActivityDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice": { "auth_ref": [ "r503" ], "lang": { "en-us": { "role": { "documentation": "Weighted average price at which grantees could have acquired the underlying shares with respect to stock options of the plan that expired.", "label": "Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Expirations in Period, Weighted Average Exercise Price", "terseLabel": "Expired (in USD per share)" } } }, "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovid.com/role/STOCKBASEDCOMPENSATIONStockOptionActivityDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice": { "auth_ref": [ "r502" ], "lang": { "en-us": { "role": { "documentation": "Weighted average price at which grantees could have acquired the underlying shares with respect to stock options that were terminated.", "label": "Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price", "terseLabel": "Forfeited (in USD per share)" } } }, "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovid.com/role/STOCKBASEDCOMPENSATIONStockOptionActivityDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice": { "auth_ref": [ "r500" ], "lang": { "en-us": { "role": { "documentation": "Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options.", "label": "Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Grants in Period, Weighted Average Exercise Price", "terseLabel": "Granted (in USD per share)" } } }, "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovid.com/role/STOCKBASEDCOMPENSATIONStockOptionActivityDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy": { "auth_ref": [ "r495", "r514", "r515", "r516", "r517", "r520", "r530", "r531" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for award under share-based payment arrangement. Includes, but is not limited to, methodology and assumption used in measuring cost.", "label": "Share-Based Payment Arrangement [Policy Text Block]", "terseLabel": "Stock-based compensation" } } }, "localname": "ShareBasedCompensationOptionAndIncentivePlansPolicy", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovid.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_ShareBasedPaymentArrangementEmployeeMember": { "auth_ref": [ "r490", "r492", "r493", "r494", "r496", "r497", "r498", "r499", "r500", "r501", "r502", "r503", "r504", "r505", "r506", "r507", "r508", "r509", "r510", "r511", "r512", "r513", "r516", "r517", "r518", "r519", "r520" ], "lang": { "en-us": { "role": { "documentation": "Recipient, of award granted under share-based payment arrangement, over whom grantor exercises or has right to exercise sufficient control to establish employer-employee relationship based on law of pertinent jurisdiction. Includes, but is not limited to, nonemployee director treated as employee when acting as member of board of directors, if elected by grantor's shareholders or appointed to board position to be filled by shareholder election when existing term expires.", "label": "Share-Based Payment Arrangement, Employee [Member]", "terseLabel": "Employees" } } }, "localname": "ShareBasedPaymentArrangementEmployeeMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovid.com/role/STOCKBASEDCOMPENSATIONRestrictedStockUnitActivityDetails", "http://innovid.com/role/STOCKBASEDCOMPENSATIONStockOptionActivityDetails", "http://innovid.com/role/STOCKBASEDCOMPENSATIONStockOptionActivityUnderPlanDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ShareBasedPaymentArrangementNonemployeeMember": { "auth_ref": [ "r488", "r492", "r493", "r494", "r496", "r497", "r498", "r499", "r500", "r501", "r502", "r503", "r504", "r505", "r506", "r507", "r508", "r509", "r510", "r511", "r512", "r513", "r516", "r517", "r518", "r519", "r520" ], "lang": { "en-us": { "role": { "documentation": "Recipient, of award granted under share-based payment arrangement, over whom grantor does not exercise nor has right to exercise sufficient control to establish employer-employee relationship based on law of pertinent jurisdiction. Excludes nonemployee director treated as employee when acting as member of board of directors, if elected by grantor's shareholders or appointed to board position to be filled by shareholder election when existing term expires.", "label": "Share-Based Payment Arrangement, Nonemployee [Member]", "terseLabel": "Consultants" } } }, "localname": "ShareBasedPaymentArrangementNonemployeeMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovid.com/role/STOCKBASEDCOMPENSATIONNarrativeDetails", "http://innovid.com/role/STOCKBASEDCOMPENSATIONRestrictedStockUnitActivityDetails", "http://innovid.com/role/STOCKBASEDCOMPENSATIONStockOptionActivityDetails" ], "xbrltype": "domainItemType" }, "us-gaap_SharePrice": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Price of a single share of a number of saleable stocks of a company.", "label": "Share Price", "terseLabel": "Initial public offering per share (in dollars per share)" } } }, "localname": "SharePrice", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovid.com/role/WARRANTSDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod": { "auth_ref": [ "r781" ], "lang": { "en-us": { "role": { "documentation": "Period from grant date that an equity-based award expires, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Expiration Period", "terseLabel": "Expiration period" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovid.com/role/STOCKBASEDCOMPENSATIONNarrativeDetails" ], "xbrltype": "durationItemType" }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1": { "auth_ref": [ "r516" ], "lang": { "en-us": { "role": { "documentation": "Expected term of award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Term", "terseLabel": "Expected term (in years)" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovid.com/role/STOCKBASEDCOMPENSATIONFairValueofEachOptiononTheDateofGrantDetails", "http://innovid.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESScheduleofWarrantsFollowsatInitialMeasurementDetails" ], "xbrltype": "durationItemType" }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1": { "auth_ref": [ "r122" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of difference between fair value of the underlying shares reserved for issuance and exercise price of vested portions of options outstanding and currently exercisable.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Intrinsic Value", "periodEndLabel": "Outstanding exercisable intrinsic value at the end of the period" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovid.com/role/STOCKBASEDCOMPENSATIONStockOptionActivityDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1": { "auth_ref": [ "r122" ], "lang": { "en-us": { "role": { "documentation": "Weighted average remaining contractual term for vested portions of options outstanding and currently exercisable or convertible, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Remaining Contractual Term", "terseLabel": "Outstanding exercisable, weighted average remaining contractual term (in years)" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovid.com/role/STOCKBASEDCOMPENSATIONStockOptionActivityDetails" ], "xbrltype": "durationItemType" }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2": { "auth_ref": [ "r119" ], "lang": { "en-us": { "role": { "documentation": "Weighted average remaining contractual term for option awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term", "terseLabel": "Outstanding option, weighted average remaining contractual term (in years)" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovid.com/role/STOCKBASEDCOMPENSATIONStockOptionActivityDetails" ], "xbrltype": "durationItemType" }, "us-gaap_SharesIssued": { "auth_ref": [ "r107" ], "lang": { "en-us": { "role": { "documentation": "Number of shares of stock issued as of the balance sheet date, including shares that had been issued and were previously outstanding but which are now held in the treasury.", "label": "Shares, Issued", "terseLabel": "Shares issued (in shares)" } } }, "localname": "SharesIssued", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovid.com/role/STOCKHOLDERSEQUITYNarrativeDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_SharesOutstanding": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of shares issued which are neither cancelled nor held in the treasury.", "label": "Shares, Outstanding", "terseLabel": "Shares outstanding (in shares)" } } }, "localname": "SharesOutstanding", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovid.com/role/STOCKHOLDERSEQUITYNarrativeDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShortTermDebtLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Short-Term Debt [Line Items]", "terseLabel": "Short-Term Debt [Line Items]" } } }, "localname": "ShortTermDebtLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovid.com/role/FINANCEEXPENSESINCOMENETDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ShortTermLeaseCost": { "auth_ref": [ "r636", "r783" ], "calculation": { "http://innovid.com/role/LEASESScheduleOfLeaseCostsRecognizedInTheConsolidatedStatementOfEarningsDetails": { "order": 3.0, "parentTag": "us-gaap_LeaseCost", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of short-term lease cost, excluding expense for lease with term of one month or less.", "label": "Short-Term Lease, Cost", "terseLabel": "Short term lease cost" } } }, "localname": "ShortTermLeaseCost", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovid.com/role/LEASESScheduleOfLeaseCostsRecognizedInTheConsolidatedStatementOfEarningsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_SignificantAccountingPoliciesTextBlock": { "auth_ref": [ "r65", "r235" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for all significant accounting policies of the reporting entity.", "label": "Significant Accounting Policies [Text Block]", "terseLabel": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES" } } }, "localname": "SignificantAccountingPoliciesTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovid.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIES" ], "xbrltype": "textBlockItemType" }, "us-gaap_SoftwareAndSoftwareDevelopmentCostsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Purchased software applications and internally developed software for sale, licensing or long-term internal use.", "label": "Software and Software Development Costs [Member]", "terseLabel": "Software development costs" } } }, "localname": "SoftwareAndSoftwareDevelopmentCostsMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovid.com/role/PROPERTYANDEQUIPMENTNETDetails", "http://innovid.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_StateAndLocalJurisdictionMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Designated tax department of a state or local government entitled to levy and collect income taxes from the entity.", "label": "State and Local Jurisdiction [Member]", "terseLabel": "Domestic NOLs (state and local)" } } }, "localname": "StateAndLocalJurisdictionMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovid.com/role/INCOMETAXESOperatingLossCarryforwardsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_StatementClassOfStockAxis": { "auth_ref": [ "r214", "r215", "r216", "r238", "r267", "r268", "r275", "r277", "r285", "r286", "r326", "r357", "r359", "r360", "r361", "r364", "r365", "r393", "r394", "r398", "r402", "r408", "r605", "r717", "r799", "r808", "r827" ], "lang": { "en-us": { "role": { "documentation": "Information by the different classes of stock of the entity.", "label": "Class of Stock [Axis]", "terseLabel": "Class of Stock [Axis]" } } }, "localname": "StatementClassOfStockAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovid.com/role/CoverPage" ], "xbrltype": "stringItemType" }, "us-gaap_StatementEquityComponentsAxis": { "auth_ref": [ "r34", "r107", "r200", "r227", "r228", "r229", "r245", "r246", "r247", "r250", "r259", "r262", "r284", "r330", "r410", "r527", "r528", "r529", "r556", "r557", "r594", "r614", "r615", "r616", "r617", "r618", "r619", "r649", "r688", "r689", "r690" ], "lang": { "en-us": { "role": { "documentation": "Information by component of equity.", "label": "Equity Components [Axis]", "terseLabel": "Equity Components [Axis]" } } }, "localname": "StatementEquityComponentsAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovid.com/role/FINANCEEXPENSESINCOMENETDetails", "http://innovid.com/role/STATEMENTSOFCHANGESINTEMPORARYEQUITYANDSTOCKHOLDERSEQUITYDEFICIT", "http://innovid.com/role/STOCKHOLDERSEQUITYNarrativeDetails", "http://innovid.com/role/TRANSACTIONNarrativeDetails", "http://innovid.com/role/WARRANTSDetails" ], "xbrltype": "stringItemType" }, "us-gaap_StatementLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Statement [Line Items]", "terseLabel": "Statement [Line Items]" } } }, "localname": "StatementLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovid.com/role/STATEMENTSOFCHANGESINTEMPORARYEQUITYANDSTOCKHOLDERSEQUITYDEFICIT" ], "xbrltype": "stringItemType" }, "us-gaap_StatementOfCashFlowsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Statement of Cash Flows [Abstract]", "terseLabel": "Statement of Cash Flows [Abstract]" } } }, "localname": "StatementOfCashFlowsAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_StatementOfFinancialPositionAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Statement of Financial Position [Abstract]", "terseLabel": "Statement of Financial Position [Abstract]" } } }, "localname": "StatementOfFinancialPositionAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_StatementOfStockholdersEquityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Statement of Stockholders' Equity [Abstract]", "terseLabel": "Statement of Stockholders' Equity [Abstract]" } } }, "localname": "StatementOfStockholdersEquityAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_StatementTable": { "auth_ref": [ "r245", "r246", "r247", "r284", "r659" ], "lang": { "en-us": { "role": { "documentation": "Schedule reflecting a Statement of Income, Statement of Cash Flows, Statement of Financial Position, Statement of Shareholders' Equity and Other Comprehensive Income, or other statement as needed.", "label": "Statement [Table]", "terseLabel": "Statement [Table]" } } }, "localname": "StatementTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovid.com/role/LEASESScheduleofoperatingROUassetsandleaseliabilitiesDetails", "http://innovid.com/role/STATEMENTSOFCHANGESINTEMPORARYEQUITYANDSTOCKHOLDERSEQUITYDEFICIT" ], "xbrltype": "stringItemType" }, "us-gaap_StockIssuedDuringPeriodSharesAcquisitions": { "auth_ref": [ "r14", "r15", "r109" ], "lang": { "en-us": { "role": { "documentation": "Number of shares of stock issued during the period pursuant to acquisitions.", "label": "Stock Issued During Period, Shares, Acquisitions", "terseLabel": "Stock Issued During Period, Shares, Acquisitions (in shares)" } } }, "localname": "StockIssuedDuringPeriodSharesAcquisitions", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovid.com/role/STATEMENTSOFCHANGESINTEMPORARYEQUITYANDSTOCKHOLDERSEQUITYDEFICIT" ], "xbrltype": "sharesItemType" }, "us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities": { "auth_ref": [ "r33", "r107", "r108", "r109", "r383" ], "lang": { "en-us": { "role": { "documentation": "Number of shares issued during the period as a result of the conversion of convertible securities.", "label": "Stock Issued During Period, Shares, Conversion of Convertible Securities", "terseLabel": "Conversion of redeemable convertible preferred stock into common stock (in shares)" } } }, "localname": "StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovid.com/role/STATEMENTSOFCHANGESINTEMPORARYEQUITYANDSTOCKHOLDERSEQUITYDEFICIT", "http://innovid.com/role/TRANSACTIONCommonStockinInnovidCorpDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans": { "auth_ref": [ "r14", "r15", "r107", "r109" ], "lang": { "en-us": { "role": { "documentation": "Number of shares issued during the period as a result of an employee stock purchase plan.", "label": "Stock Issued During Period, Shares, Employee Stock Purchase Plans", "terseLabel": "Shares issued under ESPP (in shares)" } } }, "localname": "StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovid.com/role/STOCKBASEDCOMPENSATIONNarrativeDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised": { "auth_ref": [ "r14", "r15", "r107", "r109", "r501" ], "lang": { "en-us": { "role": { "documentation": "Number of share options (or share units) exercised during the current period.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period", "negatedTerseLabel": "Exercised (in shares)", "terseLabel": "Stock options exercised (in shares)", "verboseLabel": "Stock options exercised (in shares)" } } }, "localname": "StockIssuedDuringPeriodSharesStockOptionsExercised", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovid.com/role/STATEMENTSOFCHANGESINTEMPORARYEQUITYANDSTOCKHOLDERSEQUITYDEFICIT", "http://innovid.com/role/STOCKBASEDCOMPENSATIONStockOptionActivityDetails", "http://innovid.com/role/TRANSACTIONCommonStockinInnovidCorpDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_StockIssuedDuringPeriodValueAcquisitions": { "auth_ref": [ "r34", "r107", "r109" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Value of stock issued pursuant to acquisitions during the period.", "label": "Stock Issued During Period, Value, Acquisitions", "terseLabel": "Common stock and equity awards issued for acquisition of TVS" } } }, "localname": "StockIssuedDuringPeriodValueAcquisitions", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovid.com/role/STATEMENTSOFCHANGESINTEMPORARYEQUITYANDSTOCKHOLDERSEQUITYDEFICIT" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities": { "auth_ref": [ "r34", "r107", "r109" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The gross value of stock issued during the period upon the conversion of convertible securities.", "label": "Stock Issued During Period, Value, Conversion of Convertible Securities", "terseLabel": "Conversion of redeemable convertible preferred stock into common stock" } } }, "localname": "StockIssuedDuringPeriodValueConversionOfConvertibleSecurities", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovid.com/role/STATEMENTSOFCHANGESINTEMPORARYEQUITYANDSTOCKHOLDERSEQUITYDEFICIT" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised": { "auth_ref": [ "r34", "r107", "r109" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Value of stock issued as a result of the exercise of stock options.", "label": "Stock Issued During Period, Value, Stock Options Exercised", "terseLabel": "Stock options exercised" } } }, "localname": "StockIssuedDuringPeriodValueStockOptionsExercised", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovid.com/role/STATEMENTSOFCHANGESINTEMPORARYEQUITYANDSTOCKHOLDERSEQUITYDEFICIT" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockholdersEquity": { "auth_ref": [ "r15", "r18", "r19", "r78", "r784", "r810", "r832", "r889" ], "calculation": { "http://innovid.com/role/CONSOLIDATEDBALANCESHEETS": { "order": 3.0, "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.", "label": "Stockholders' Equity Attributable to Parent", "periodEndLabel": "Balance", "periodStartLabel": "Balance", "totalLabel": "TOTAL STOCKHOLDERS\u2019 EQUITY" } } }, "localname": "StockholdersEquity", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovid.com/role/CONSOLIDATEDBALANCESHEETS", "http://innovid.com/role/STATEMENTSOFCHANGESINTEMPORARYEQUITYANDSTOCKHOLDERSEQUITYDEFICIT" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockholdersEquityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Stockholders' Equity Attributable to Parent [Abstract]", "terseLabel": "STOCKHOLDERS\u2019 EQUITY:" } } }, "localname": "StockholdersEquityAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovid.com/role/CONSOLIDATEDBALANCESHEETS" ], "xbrltype": "stringItemType" }, "us-gaap_StockholdersEquityNoteDisclosureTextBlock": { "auth_ref": [ "r112", "r237", "r394", "r397", "r398", "r399", "r400", "r401", "r402", "r403", "r404", "r405", "r406", "r407", "r410", "r585" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income.", "label": "Stockholders' Equity Note Disclosure [Text Block]", "verboseLabel": "STOCKHOLDERS\u2019 EQUITY" } } }, "localname": "StockholdersEquityNoteDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovid.com/role/STOCKHOLDERSEQUITY" ], "xbrltype": "textBlockItemType" }, "us-gaap_SubsequentEventMember": { "auth_ref": [ "r620", "r653" ], "lang": { "en-us": { "role": { "documentation": "Identifies event that occurred after the balance sheet date but before financial statements are issued or available to be issued.", "label": "Subsequent Event [Member]", "terseLabel": "Subsequent Event" } } }, "localname": "SubsequentEventMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovid.com/role/LONGTERMDEBTDetails" ], "xbrltype": "domainItemType" }, "us-gaap_SubsequentEventTypeAxis": { "auth_ref": [ "r620", "r653" ], "lang": { "en-us": { "role": { "documentation": "Information by event that occurred after the balance sheet date but before financial statements are issued or available to be issued.", "label": "Subsequent Event Type [Axis]", "terseLabel": "Subsequent Event Type [Axis]" } } }, "localname": "SubsequentEventTypeAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovid.com/role/LONGTERMDEBTDetails" ], "xbrltype": "stringItemType" }, "us-gaap_SubsequentEventTypeDomain": { "auth_ref": [ "r620", "r653" ], "lang": { "en-us": { "role": { "documentation": "Event that occurred after the balance sheet date but before financial statements are issued or available to be issued.", "label": "Subsequent Event Type [Domain]", "terseLabel": "Subsequent Event Type [Domain]" } } }, "localname": "SubsequentEventTypeDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovid.com/role/LONGTERMDEBTDetails" ], "xbrltype": "domainItemType" }, "us-gaap_SubsidiarySaleOfStockAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Information by type of sale of the entity's stock.", "label": "Sale of Stock [Axis]", "terseLabel": "Sale of Stock [Axis]" } } }, "localname": "SubsidiarySaleOfStockAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovid.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESScheduleofWarrantsFollowsatInitialMeasurementDetails", "http://innovid.com/role/TRANSACTIONNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_SummaryOfOperatingLossCarryforwardsTextBlock": { "auth_ref": [ "r134" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of pertinent information, such as tax authority, amounts, and expiration dates, of net operating loss carryforwards, including an assessment of the likelihood of utilization.", "label": "Summary of Operating Loss Carryforwards [Table Text Block]", "terseLabel": "Summary of Operating Loss Carryforwards" } } }, "localname": "SummaryOfOperatingLossCarryforwardsTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovid.com/role/INCOMETAXESTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_SupplementalCashFlowInformationAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Supplemental Cash Flow Information [Abstract]", "terseLabel": "Supplemental disclosure of cash flows activities:" } } }, "localname": "SupplementalCashFlowInformationAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovid.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "stringItemType" }, "us-gaap_TaxesPayableCurrent": { "auth_ref": [ "r24" ], "calculation": { "http://innovid.com/role/ACCRUEDEXPENSESANDOTHERCURRENTLIABILITIESDetails": { "order": 1.0, "parentTag": "us-gaap_AccruedLiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying value as of the balance sheet date of obligations incurred and payable for statutory income, sales, use, payroll, excise, real, property and other taxes. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).", "label": "Taxes Payable, Current", "terseLabel": "Tax payables" } } }, "localname": "TaxesPayableCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovid.com/role/ACCRUEDEXPENSESANDOTHERCURRENTLIABILITIESDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_TechnologyBasedIntangibleAssetsMember": { "auth_ref": [ "r145" ], "lang": { "en-us": { "role": { "documentation": "Technology-based intangible assets, including, but not limited to, patented technology, unpatented technology, and developed technology rights.", "label": "Technology-Based Intangible Assets [Member]", "terseLabel": "Technology", "verboseLabel": "Acquired technology" } } }, "localname": "TechnologyBasedIntangibleAssetsMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovid.com/role/ACQUISITIONFairValuesoftheAssetsAcquiredandLiabilitiesAssumedDetails", "http://innovid.com/role/ACQUISITIONNarrativeDetails", "http://innovid.com/role/INTANGIBLEASSETSNETIntangibleAssetsDetails", "http://innovid.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_TemporaryEquityAccretionToRedemptionValue": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Value of accretion of temporary equity to its redemption value during the period.", "label": "Temporary Equity, Accretion to Redemption Value", "terseLabel": "Accretion of preferred stocks to redemption value" } } }, "localname": "TemporaryEquityAccretionToRedemptionValue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovid.com/role/STATEMENTSOFCHANGESINTEMPORARYEQUITYANDSTOCKHOLDERSEQUITYDEFICIT" ], "xbrltype": "monetaryItemType" }, "us-gaap_TemporaryEquityByClassOfStockTable": { "auth_ref": [ "r2", "r105" ], "lang": { "en-us": { "role": { "documentation": "Table of capital stock that is classified as temporary equity. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer. This table may include a description by series, value, shares authorized, shares issued and outstanding, redemption price per share and subscription receivable.", "label": "Temporary Equity, by Class of Stock [Table]", "terseLabel": "Temporary Equity, by Class of Stock [Table]" } } }, "localname": "TemporaryEquityByClassOfStockTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovid.com/role/STOCKHOLDERSEQUITYNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_TemporaryEquityCarryingAmountAttributableToParent": { "auth_ref": [ "r357", "r359", "r360", "r361", "r364", "r365" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying amount, attributable to parent, of an entity's issued and outstanding stock which is not included within permanent equity. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. Includes stock with a put option held by an ESOP and stock redeemable by a holder only in the event of a change in control of the issuer.", "label": "Temporary Equity, Carrying Amount, Attributable to Parent", "periodEndLabel": "Ending balance", "periodStartLabel": "Beginning balance" } } }, "localname": "TemporaryEquityCarryingAmountAttributableToParent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovid.com/role/STATEMENTSOFCHANGESINTEMPORARYEQUITYANDSTOCKHOLDERSEQUITYDEFICIT" ], "xbrltype": "monetaryItemType" }, "us-gaap_TemporaryEquityDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Temporary Equity Disclosure [Abstract]" } } }, "localname": "TemporaryEquityDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_TemporaryEquityLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Temporary Equity [Line Items]", "terseLabel": "Temporary Equity [Line Items]" } } }, "localname": "TemporaryEquityLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovid.com/role/STOCKHOLDERSEQUITYNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_TemporaryEquitySharesOutstanding": { "auth_ref": [ "r13" ], "lang": { "en-us": { "role": { "documentation": "The number of securities classified as temporary equity that have been issued and are held by the entity's shareholders. Securities outstanding equals securities issued minus securities held in treasury. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer.", "label": "Temporary Equity, Shares Outstanding", "periodEndLabel": "Ending balance (in shares)", "periodStartLabel": "Beginning balance (in shares)" } } }, "localname": "TemporaryEquitySharesOutstanding", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovid.com/role/STATEMENTSOFCHANGESINTEMPORARYEQUITYANDSTOCKHOLDERSEQUITYDEFICIT" ], "xbrltype": "sharesItemType" }, "us-gaap_TradeAndOtherAccountsReceivablePolicy": { "auth_ref": [ "r191", "r192", "r193", "r320", "r321", "r323" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for accounts receivable.", "label": "Accounts Receivable [Policy Text Block]", "terseLabel": "Trade receivable, net" } } }, "localname": "TradeAndOtherAccountsReceivablePolicy", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovid.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_TradeNamesMember": { "auth_ref": [ "r146" ], "lang": { "en-us": { "role": { "documentation": "Rights acquired through registration of a business name to gain or protect exclusive use thereof.", "label": "Trade Names [Member]", "terseLabel": "Trade name" } } }, "localname": "TradeNamesMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovid.com/role/ACQUISITIONFairValuesoftheAssetsAcquiredandLiabilitiesAssumedDetails", "http://innovid.com/role/ACQUISITIONNarrativeDetails", "http://innovid.com/role/INTANGIBLEASSETSNETIntangibleAssetsDetails", "http://innovid.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_TreasuryStockCommonMember": { "auth_ref": [ "r110" ], "lang": { "en-us": { "role": { "documentation": "Previously issued common shares repurchased by the issuing entity and held in treasury.", "label": "Treasury Stock, Common [Member]", "terseLabel": "Treasury stocks" } } }, "localname": "TreasuryStockCommonMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovid.com/role/STATEMENTSOFCHANGESINTEMPORARYEQUITYANDSTOCKHOLDERSEQUITYDEFICIT", "http://innovid.com/role/STOCKHOLDERSEQUITYNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_TreasuryStockCommonShares": { "auth_ref": [ "r110" ], "lang": { "en-us": { "role": { "documentation": "Number of previously issued common shares repurchased by the issuing entity and held in treasury.", "label": "Treasury Stock, Common, Shares", "periodEndLabel": "Ending balance (in shares)", "periodStartLabel": "Beginning balance (in shares)" } } }, "localname": "TreasuryStockCommonShares", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovid.com/role/STATEMENTSOFCHANGESINTEMPORARYEQUITYANDSTOCKHOLDERSEQUITYDEFICIT" ], "xbrltype": "sharesItemType" }, "us-gaap_TypeOfAdoptionMember": { "auth_ref": [ "r198", "r199", "r200", "r201", "r202", "r249", "r250", "r251", "r252", "r263", "r324", "r325", "r327", "r328", "r329", "r330", "r331", "r332", "r527", "r528", "r529", "r554", "r555", "r556", "r557", "r575", "r576", "r577", "r586", "r587", "r588", "r589", "r590", "r591", "r592", "r593", "r594", "r595", "r596", "r597", "r606", "r607", "r608", "r609", "r610", "r611", "r612", "r613", "r622", "r623", "r626", "r627", "r628", "r629", "r644", "r645", "r646", "r647", "r648", "r649", "r661", "r662", "r663", "r686", "r687", "r688", "r689", "r690", "r691", "r692", "r693", "r694", "r695", "r696", "r697" ], "lang": { "en-us": { "role": { "documentation": "Amendment to accounting standards.", "label": "Accounting Standards Update [Domain]", "terseLabel": "Accounting Standards Update [Domain]" } } }, "localname": "TypeOfAdoptionMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovid.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESScheduleofOperatingLeaseLiabilitiesandROUAssetsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_TypeOfRestructuringDomain": { "auth_ref": [ "r346", "r347", "r349", "r350" ], "lang": { "en-us": { "role": { "documentation": "Identification of the types of restructuring costs.", "label": "Type of Restructuring [Domain]", "terseLabel": "Type of Restructuring [Domain]" } } }, "localname": "TypeOfRestructuringDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovid.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_UndistributedEarningsOfForeignSubsidiaries": { "auth_ref": [ "r176", "r189", "r532", "r568" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of undistributed earnings of foreign subsidiaries intended to be permanently reinvested outside the country of domicile.", "label": "Undistributed Earnings of Foreign Subsidiaries", "terseLabel": "Undistributed foreign subsidiaries" } } }, "localname": "UndistributedEarningsOfForeignSubsidiaries", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovid.com/role/INCOMETAXESNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_UnrecognizedTaxBenefits": { "auth_ref": [ "r533", "r541" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of unrecognized tax benefits.", "label": "Unrecognized Tax Benefits", "periodEndLabel": "Gross unrecognized tax benefits, ending balance", "periodStartLabel": "Gross unrecognized tax benefits, beginning balance", "terseLabel": "Unrecognized tax benefits" } } }, "localname": "UnrecognizedTaxBenefits", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovid.com/role/INCOMETAXESIncomeTaxContingenciesDetails", "http://innovid.com/role/INCOMETAXESNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions": { "auth_ref": [ "r542" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of decrease in unrecognized tax benefits resulting from tax positions taken in prior period tax returns.", "label": "Unrecognized Tax Benefits, Decrease Resulting from Prior Period Tax Positions", "negatedTerseLabel": "Decreases - prior year tax positions" } } }, "localname": "UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovid.com/role/INCOMETAXESIncomeTaxContingenciesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions": { "auth_ref": [ "r543" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of increase in unrecognized tax benefits resulting from tax positions that have been or will be taken in current period tax return.", "label": "Unrecognized Tax Benefits, Increase Resulting from Current Period Tax Positions", "terseLabel": "Increases - current year tax positions" } } }, "localname": "UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovid.com/role/INCOMETAXESIncomeTaxContingenciesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions": { "auth_ref": [ "r542" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of increase in unrecognized tax benefits resulting from tax positions taken in prior period tax returns.", "label": "Unrecognized Tax Benefits, Increase Resulting from Prior Period Tax Positions", "terseLabel": "Increases - prior year tax positions" } } }, "localname": "UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovid.com/role/INCOMETAXESIncomeTaxContingenciesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_UnrecognizedTaxBenefitsInterestOnIncomeTaxesAccrued": { "auth_ref": [ "r878" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of interest expense accrued for an underpayment of income taxes.", "label": "Unrecognized Tax Benefits, Interest on Income Taxes Accrued", "terseLabel": "Interest on income taxes accrued" } } }, "localname": "UnrecognizedTaxBenefitsInterestOnIncomeTaxesAccrued", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovid.com/role/INCOMETAXESNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_UseOfEstimates": { "auth_ref": [ "r74", "r75", "r76", "r287", "r288", "r290", "r291" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.", "label": "Use of Estimates, Policy [Policy Text Block]", "terseLabel": "Use of Estimates" } } }, "localname": "UseOfEstimates", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovid.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_VariableLeaseCost": { "auth_ref": [ "r637", "r783" ], "calculation": { "http://innovid.com/role/LEASESScheduleOfLeaseCostsRecognizedInTheConsolidatedStatementOfEarningsDetails": { "order": 1.0, "parentTag": "us-gaap_LeaseCost", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of variable lease cost, excluded from lease liability, recognized when obligation for payment is incurred for finance and operating leases.", "label": "Variable Lease, Cost", "terseLabel": "Variable lease cost" } } }, "localname": "VariableLeaseCost", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovid.com/role/LEASESScheduleOfLeaseCostsRecognizedInTheConsolidatedStatementOfEarningsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_VariableRateAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Information by type of variable rate.", "label": "Variable Rate [Axis]", "terseLabel": "Variable Rate [Axis]" } } }, "localname": "VariableRateAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovid.com/role/LONGTERMDEBTDetails" ], "xbrltype": "stringItemType" }, "us-gaap_VariableRateDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Interest rate that fluctuates over time as a result of an underlying benchmark interest rate or index.", "label": "Variable Rate [Domain]", "terseLabel": "Variable Rate [Domain]" } } }, "localname": "VariableRateDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovid.com/role/LONGTERMDEBTDetails" ], "xbrltype": "domainItemType" }, "us-gaap_WarrantMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Security that gives the holder the right to purchase shares of stock in accordance with the terms of the instrument, usually upon payment of a specified amount.", "label": "Warrant [Member]", "terseLabel": "Warrant", "verboseLabel": "Warrants outstanding" } } }, "localname": "WarrantMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovid.com/role/BASICANDDILUTEDNETLOSSPERSHARESecuritiesExcludedfromComputationofEarningsPerShareDetails", "http://innovid.com/role/CoverPage", "http://innovid.com/role/FINANCEEXPENSESINCOMENETDetails", "http://innovid.com/role/WARRANTSDetails" ], "xbrltype": "domainItemType" }, "us-gaap_WarrantsAndRightsOutstandingTerm": { "auth_ref": [ "r888" ], "lang": { "en-us": { "role": { "documentation": "Period between issuance and expiration of outstanding warrant and right embodying unconditional obligation requiring redemption by transferring asset at specified or determinable date or upon event certain to occur, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.", "label": "Warrants and Rights Outstanding, Term", "terseLabel": "Expiration term of warrant (in years)" } } }, "localname": "WarrantsAndRightsOutstandingTerm", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovid.com/role/TRANSACTIONNarrativeDetails", "http://innovid.com/role/WARRANTSDetails" ], "xbrltype": "durationItemType" }, "us-gaap_WeightedAverageInterestRateOfTimeDeposits100000OrMoreThreeMonthsOrLess": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The weighted average interest rate of domestic and foreign time deposits (including certificates of deposits, individual retirement accounts and open accounts) in denominations of $100,000 or more, with maturities of three months or less.", "label": "Weighted Average Interest Rate of Time Deposits, $100,000 or More, Three Months or Less", "terseLabel": "Weighted average interest rate of time deposits, three months or less" } } }, "localname": "WeightedAverageInterestRateOfTimeDeposits100000OrMoreThreeMonthsOrLess", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovid.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails" ], "xbrltype": "percentItemType" }, "us-gaap_WeightedAverageInterestRateOfTimeDeposits100000OrMoreThreeMonthsThroughSixMonths": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The weighted average interest rate of domestic and foreign time deposits (including certificates of deposits, individual retirement accounts and open accounts) in denominations of $100,000 or more, with maturities of three months through six months.", "label": "Weighted Average Interest Rate of Time Deposits, $100,000 or More, Three Months Through Six Months", "terseLabel": "Weighted average interest rate of time deposits, three months through six months" } } }, "localname": "WeightedAverageInterestRateOfTimeDeposits100000OrMoreThreeMonthsThroughSixMonths", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovid.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails" ], "xbrltype": "percentItemType" }, "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding": { "auth_ref": [ "r266", "r277" ], "lang": { "en-us": { "role": { "documentation": "The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.", "label": "Weighted Average Number of Shares Outstanding, Diluted", "verboseLabel": "Weighted-average number of stocks used in computing net loss per stock attributable to common stockholders, diluted (in shares)" } } }, "localname": "WeightedAverageNumberOfDilutedSharesOutstanding", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovid.com/role/BASICANDDILUTEDNETLOSSPERSHAREBasicandDilutedNetlossPerShareDetails", "http://innovid.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS" ], "xbrltype": "sharesItemType" }, "us-gaap_WeightedAverageNumberOfSharesOutstandingBasic": { "auth_ref": [ "r264", "r277" ], "lang": { "en-us": { "role": { "documentation": "Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.", "label": "Weighted Average Number of Shares Outstanding, Basic", "verboseLabel": "Weighted-average number of stocks used in computing net loss per stock attributable to common stockholders, basic (in shares)" } } }, "localname": "WeightedAverageNumberOfSharesOutstandingBasic", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovid.com/role/BASICANDDILUTEDNETLOSSPERSHAREBasicandDilutedNetlossPerShareDetails", "http://innovid.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS" ], "xbrltype": "sharesItemType" }, "us-gaap_WeightedAverageNumberOfSharesOutstandingBasicAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Weighted Average Number of Shares Outstanding, Basic [Abstract]", "terseLabel": "Weighted Average Number of Shares Outstanding, Basic [Abstract]" } } }, "localname": "WeightedAverageNumberOfSharesOutstandingBasicAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovid.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS" ], "xbrltype": "stringItemType" }, "us-gaap_WeightedAverageRateForeignDeposit": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Weighted average interest rate calculated at point in time for foreign deposit liability.", "label": "Weighted Average Rate, Interest-Bearing Foreign Deposits, Point in Time", "terseLabel": "Weighted average interest rate" } } }, "localname": "WeightedAverageRateForeignDeposit", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovid.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails" ], "xbrltype": "percentItemType" } }, "unitCount": 7 } }, "std_ref": { "r0": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "SubTopic": "20", "Topic": "205", "URI": "https://asc.fasb.org/subtopic&trid=2122178", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r1": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "205", "URI": "https://asc.fasb.org/topic&trid=2122149", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r10": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(24))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r100": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 5.CC)", "Topic": "360", "URI": "https://asc.fasb.org/extlink&oid=27011434&loc=d3e125687-122742", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r101": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "360", "URI": "https://asc.fasb.org/topic&trid=2155823", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r102": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "440", "URI": "https://asc.fasb.org/topic&trid=2144648", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r103": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "470", "URI": "https://asc.fasb.org/topic&trid=2208564", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r104": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "25", "SubTopic": "10", "Topic": "480", "URI": "https://asc.fasb.org/extlink&oid=109262497&loc=d3e20148-110875", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r105": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Topic": "480", "URI": "https://asc.fasb.org/extlink&oid=122040564&loc=d3e177068-122764", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r106": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 3.C)", "Topic": "480", "URI": "https://asc.fasb.org/extlink&oid=122040564&loc=d3e177168-122764", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r107": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21463-112644", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r108": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21475-112644", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r109": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.3-04)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r11": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(26)(a))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r110": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=6405813&loc=d3e23239-112655", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r111": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "50", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=6784392&loc=d3e188667-122775", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r112": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "505", "URI": "https://asc.fasb.org/topic&trid=2208762", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r113": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "15", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "712", "URI": "https://asc.fasb.org/extlink&oid=6410066&loc=d3e79218-111664", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r114": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "15", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "712", "URI": "https://asc.fasb.org/extlink&oid=6410066&loc=d3e79218-111664", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r115": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5047-113901", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r116": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r117": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r118": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r119": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)(1)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r12": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(26)(b))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r120": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r121": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(h)(1)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r122": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r123": { "Name": "Accounting Standards Codification", "Paragraph": "2A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=SL79508275-113901", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r124": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 14.F)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=122041274&loc=d3e301413-122809", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r125": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=126964447&loc=d3e11149-113907", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r126": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=126964447&loc=d3e11178-113907", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r127": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "35", "Subparagraph": "(a)", "Topic": "720", "URI": "https://asc.fasb.org/extlink&oid=6420018&loc=d3e36677-107848", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r128": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "730", "URI": "https://asc.fasb.org/extlink&oid=6420194&loc=d3e21568-108373", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r129": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=123427490&loc=d3e31931-109318", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r13": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(27)(b))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r130": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32687-109319", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r131": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32718-109319", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r132": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32537-109319", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r133": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32559-109319", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r134": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32559-109319", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r135": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32632-109319", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r136": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32639-109319", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r137": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 6.I.7)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r138": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "05", "SubTopic": "10", "Subparagraph": "(a)-(d)", "Topic": "805", "URI": "https://asc.fasb.org/extlink&oid=6909625&loc=d3e227-128457", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r139": { "Name": "Accounting Standards Codification", "Paragraph": "23", "Publisher": "FASB", "Section": "25", "SubTopic": "10", "Topic": "805", "URI": "https://asc.fasb.org/extlink&oid=123586518&loc=d3e1043-128460", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r14": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(28))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r140": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "805", "URI": "https://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r141": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "805", "URI": "https://asc.fasb.org/extlink&oid=79982066&loc=d3e1486-128463", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r142": { "Name": "Accounting Standards Codification", "Paragraph": "37", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "805", "URI": "https://asc.fasb.org/extlink&oid=123455525&loc=d3e2207-128464", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r143": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "805", "URI": "https://asc.fasb.org/extlink&oid=128092470&loc=d3e4845-128472", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r144": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "805", "URI": "https://asc.fasb.org/extlink&oid=128092470&loc=d3e4845-128472", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r145": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "805", "URI": "https://asc.fasb.org/extlink&oid=123410050&loc=d3e5227-128473", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r146": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "805", "URI": "https://asc.fasb.org/extlink&oid=123410050&loc=d3e5263-128473", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r147": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "805", "URI": "https://asc.fasb.org/extlink&oid=123410050&loc=d3e5333-128473", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r148": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(b)(4)", "Topic": "805", "URI": "https://asc.fasb.org/extlink&oid=126975305&loc=d3e6927-128479", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r149": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "805", "URI": "https://asc.fasb.org/topic&trid=2303972", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r15": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(29))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r150": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "810", "URI": "https://asc.fasb.org/topic&trid=2197479", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r151": { "Name": "Accounting Standards Codification", "Paragraph": "4B", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a),(c)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624163-113959", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r152": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "815", "URI": "https://asc.fasb.org/topic&trid=2229140", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r153": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(bbb)", "Topic": "820", "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r154": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "820", "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r155": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "820", "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r156": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "820", "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19279-110258", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r157": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "60", "SubTopic": "10", "Topic": "820", "URI": "https://asc.fasb.org/extlink&oid=7493716&loc=d3e21868-110260", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r158": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "825", "URI": "https://asc.fasb.org/extlink&oid=123594938&loc=d3e13279-108611", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r159": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "825", "URI": "https://asc.fasb.org/extlink&oid=123594938&loc=d3e13531-108611", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r16": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30)(a)(1))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r160": { "Name": "Accounting Standards Codification", "Paragraph": "21", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "825", "URI": "https://asc.fasb.org/extlink&oid=123594938&loc=d3e13537-108611", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r161": { "Name": "Accounting Standards Codification", "Paragraph": "21", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "825", "URI": "https://asc.fasb.org/extlink&oid=123594938&loc=d3e13537-108611", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r162": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "230", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=123444420&loc=d3e33268-110906", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r163": { "Name": "Accounting Standards Codification", "Paragraph": "4D", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)(2)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=SL51823488-111719", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r164": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "25", "SubTopic": "20", "Topic": "940", "URI": "https://asc.fasb.org/extlink&oid=126941158&loc=d3e41242-110953", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r165": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(1)(a))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r166": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(11))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r167": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(13))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r168": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(15)(1))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r169": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(15)(2))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r17": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30)(a)(3))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r170": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(15))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r171": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(16))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r172": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(23))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r173": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03.17)", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r174": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(15))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r175": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(22))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r176": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "740", "Subparagraph": "(b)", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=6479915&loc=d3e66715-112838", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r177": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "825", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=126941378&loc=d3e61044-112788", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r178": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(15)(b)(2))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r179": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(16))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r18": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r180": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(12))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r181": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(15)(b)(1))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r182": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(15))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r183": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r184": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(25))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r185": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(8))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r186": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03.(a),19)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r187": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(18))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r188": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(8))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r189": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "740", "Subparagraph": "(b)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=6487024&loc=d3e29054-158556", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r19": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(31))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r190": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "985", "URI": "https://asc.fasb.org/extlink&oid=6501960&loc=d3e128462-111756", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r191": { "Name": "Accounting Standards Codification", "Paragraph": "11B", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "310", "URI": "https://asc.fasb.org/extlink&oid=123577603&loc=SL6953423-111524", "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef" }, "r192": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "310", "URI": "https://asc.fasb.org/extlink&oid=123577603&loc=d3e5212-111524", "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef" }, "r193": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "310", "URI": "https://asc.fasb.org/extlink&oid=123577603&loc=d3e5093-111524", "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef" }, "r194": { "Name": "Accounting Standards Codification", "Paragraph": "40", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Subparagraph": "(Note 3)", "Topic": "840", "URI": "https://asc.fasb.org/extlink&oid=123403562&loc=d3e38371-112697", "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef" }, "r195": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "840", "URI": "https://asc.fasb.org/extlink&oid=123406913&loc=d3e41502-112717", "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef" }, "r196": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "840", "URI": "https://asc.fasb.org/extlink&oid=123406913&loc=d3e41502-112717", "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef" }, "r197": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "840", "URI": "https://asc.fasb.org/extlink&oid=123405975&loc=d3e41551-112718", "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef" }, "r198": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "105", "URI": "https://asc.fasb.org/extlink&oid=126987489&loc=SL124442142-165695", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r199": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "105", "URI": "https://asc.fasb.org/extlink&oid=126987489&loc=SL124442142-165695", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r2": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(27)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r20": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(32))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r200": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "105", "URI": "https://asc.fasb.org/extlink&oid=126987489&loc=SL124442142-165695", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r201": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "105", "URI": "https://asc.fasb.org/extlink&oid=126987489&loc=SL124442142-165695", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r202": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "105", "URI": "https://asc.fasb.org/extlink&oid=126987489&loc=SL124442142-165695", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r203": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "205", "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=SL51721683-107760", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r204": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r205": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6904-107765", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r206": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(1))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r207": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(13))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r208": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(14))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r209": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(15))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r21": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19(a))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r210": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(16))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r211": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(17))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r212": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(18))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r213": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(22))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r214": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(27)(b))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r215": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(28))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r216": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(29))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r217": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(4))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r218": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(7))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r219": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(8))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r22": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19(b),22(b))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r220": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(9))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r221": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=51824906&loc=SL20225862-175312", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r222": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=51824906&loc=SL20225862-175312", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r223": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=99393222&loc=SL20226008-175313", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r224": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669619-108580", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r225": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669625-108580", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r226": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL116659661-227067", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r227": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124442407-227067", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r228": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124442411-227067", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r229": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124452729-227067", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r23": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r230": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(25))", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r231": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3367-108585", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r232": { "Name": "Accounting Standards Codification", "Paragraph": "24", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3521-108585", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r233": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3536-108585", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r234": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4297-108586", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r235": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=126899994&loc=d3e18726-107790", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r236": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(c))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r237": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(e)(1))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r238": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(g)(1)(ii))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r239": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(h)(1))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r24": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19,20)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r240": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(h)(2))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r241": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(h))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r242": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(m)(1)(iii))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r243": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(m)(2)(ii))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r244": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.12-04(a))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e24072-122690", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r245": { "Name": "Accounting Standards Codification", "Paragraph": "23", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21914-107793", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r246": { "Name": "Accounting Standards Codification", "Paragraph": "24", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21930-107793", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r247": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21711-107793", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r248": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21728-107793", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r249": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(2)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r25": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19-26)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r250": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(3)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r251": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(4)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r252": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r253": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r254": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r255": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=SL124452830-107794", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r256": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22583-107794", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r257": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22595-107794", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r258": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r259": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r26": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.20)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r260": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r261": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22658-107794", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r262": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22663-107794", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r263": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 11.M.Q2)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=122038215&loc=d3e31137-122693", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r264": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1448-109256", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r265": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1377-109256", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r266": { "Name": "Accounting Standards Codification", "Paragraph": "16", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1505-109256", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r267": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1252-109256", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r268": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1278-109256", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r269": { "Name": "Accounting Standards Codification", "Paragraph": "40", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1930-109256", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r27": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.20,24)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r270": { "Name": "Accounting Standards Codification", "Paragraph": "40", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)(1)", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1930-109256", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r271": { "Name": "Accounting Standards Codification", "Paragraph": "40", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)(2)", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1930-109256", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r272": { "Name": "Accounting Standards Codification", "Paragraph": "40", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)(3)", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1930-109256", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r273": { "Name": "Accounting Standards Codification", "Paragraph": "60B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=SL5780133-109256", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r274": { "Name": "Accounting Standards Codification", "Paragraph": "60B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=SL5780133-109256", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r275": { "Name": "Accounting Standards Codification", "Paragraph": "60B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=SL5780133-109256", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r276": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1337-109256", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r277": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r278": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r279": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3630-109257", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r28": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.21)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r280": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=109243012&loc=SL65017193-207537", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r281": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=128363288&loc=d3e3842-109258", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r282": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=122038299&loc=d3e42851-122695", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r283": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "260", "URI": "https://asc.fasb.org/topic&trid=2144383", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r284": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "272", "URI": "https://asc.fasb.org/extlink&oid=125520817&loc=d3e70191-108054", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r285": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "272", "URI": "https://asc.fasb.org/extlink&oid=6373374&loc=d3e70434-108055", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r286": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "272", "URI": "https://asc.fasb.org/extlink&oid=6373374&loc=d3e70478-108055", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r287": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r288": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r289": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r29": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.22)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r290": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6161-108592", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r291": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6191-108592", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r292": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8657-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r293": { "Name": "Accounting Standards Codification", "Paragraph": "21", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8721-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r294": { "Name": "Accounting Standards Codification", "Paragraph": "21", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8721-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r295": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r296": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r297": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r298": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(h)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r299": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r3": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 201.5-02(24))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r30": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.24)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r300": { "Name": "Accounting Standards Codification", "Paragraph": "26", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8844-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r301": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r302": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r303": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r304": { "Name": "Accounting Standards Codification", "Paragraph": "31", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8924-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r305": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r306": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r307": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r308": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r309": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r31": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.25)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r310": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r311": { "Name": "Accounting Standards Codification", "Paragraph": "34", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8981-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r312": { "Name": "Accounting Standards Codification", "Paragraph": "40", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9031-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r313": { "Name": "Accounting Standards Codification", "Paragraph": "41", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9038-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r314": { "Name": "Accounting Standards Codification", "Paragraph": "41", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9038-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r315": { "Name": "Accounting Standards Codification", "Paragraph": "41", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9038-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r316": { "Name": "Accounting Standards Codification", "Paragraph": "42", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9054-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r317": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "280", "URI": "https://asc.fasb.org/topic&trid=2134510", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r318": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "310", "URI": "https://asc.fasb.org/extlink&oid=124259787&loc=d3e4428-111522", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r319": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "310", "URI": "https://asc.fasb.org/extlink&oid=124259787&loc=d3e4531-111522", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r32": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.29)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r320": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "310", "URI": "https://asc.fasb.org/extlink&oid=123577603&loc=d3e4975-111524", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r321": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "310", "URI": "https://asc.fasb.org/extlink&oid=123577603&loc=d3e5033-111524", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r322": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "310", "URI": "https://asc.fasb.org/extlink&oid=123577603&loc=d3e5074-111524", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r323": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "310", "URI": "https://asc.fasb.org/extlink&oid=84159169&loc=d3e10133-111534", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r324": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "310", "URI": "https://asc.fasb.org/extlink&oid=126986314&loc=SL124402458-218513", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r325": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "310", "URI": "https://asc.fasb.org/extlink&oid=126986314&loc=SL124402458-218513", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r326": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "323", "URI": "https://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r327": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "326", "URI": "https://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r328": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "326", "URI": "https://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r329": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "326", "URI": "https://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r33": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.29-30)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r330": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "326", "URI": "https://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r331": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(e)(3)", "Topic": "326", "URI": "https://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r332": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(e)(4)", "Topic": "326", "URI": "https://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r333": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Topic": "326", "URI": "https://asc.fasb.org/extlink&oid=124255206&loc=SL82895884-210446", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r334": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "05", "SubTopic": "10", "Topic": "340", "URI": "https://asc.fasb.org/extlink&oid=126905020&loc=d3e5879-108316", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r335": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "340", "URI": "https://asc.fasb.org/extlink&oid=6387103&loc=d3e6435-108320", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r336": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=99380562&loc=d3e13770-109266", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r337": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=99380562&loc=d3e13777-109266", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r338": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(e)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r339": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13854-109267", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r34": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.29-31)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r340": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r341": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(d)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r342": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)(1)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r343": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(d)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r344": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "SubTopic": "30", "Topic": "350", "URI": "https://asc.fasb.org/subtopic&trid=2144471", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r345": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "360", "URI": "https://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r346": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(1)", "Topic": "420", "URI": "https://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r347": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(2)", "Topic": "420", "URI": "https://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r348": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "420", "URI": "https://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r349": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 5.P.4(b)(1))", "Topic": "420", "URI": "https://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r35": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=99393222&loc=SL20226000-175313", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r350": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 5.P.4(b)(2))", "Topic": "420", "URI": "https://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r351": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "440", "URI": "https://asc.fasb.org/extlink&oid=123406679&loc=d3e25336-109308", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r352": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "440", "URI": "https://asc.fasb.org/extlink&oid=123406679&loc=d3e25336-109308", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r353": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "450", "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14435-108349", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r354": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "450", "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14557-108349", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r355": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "20", "Subparagraph": "(SAB Topic 5.Y.Q2)", "Topic": "450", "URI": "https://asc.fasb.org/extlink&oid=27011672&loc=d3e149879-122751", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r356": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "20", "Subparagraph": "(SAB Topic 5.Y.Q4)", "Topic": "450", "URI": "https://asc.fasb.org/extlink&oid=27011672&loc=d3e149879-122751", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r357": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(i))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r358": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(iii)(A))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r359": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(iv))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r36": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(1))", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r360": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(5))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r361": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(i))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r362": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r363": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r364": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(iv))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r365": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(5))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r366": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r367": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r368": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r369": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(e)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r37": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(10))", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r370": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(f)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r371": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(g)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r372": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(h)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r373": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(i)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r374": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r375": { "Name": "Accounting Standards Codification", "Paragraph": "1C", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495334-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r376": { "Name": "Accounting Standards Codification", "Paragraph": "1C", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495334-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r377": { "Name": "Accounting Standards Codification", "Paragraph": "1C", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495334-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r378": { "Name": "Accounting Standards Codification", "Paragraph": "1D", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r379": { "Name": "Accounting Standards Codification", "Paragraph": "1D", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r38": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(20))", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r380": { "Name": "Accounting Standards Codification", "Paragraph": "1D", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r381": { "Name": "Accounting Standards Codification", "Paragraph": "1E", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r382": { "Name": "Accounting Standards Codification", "Paragraph": "1E", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r383": { "Name": "Accounting Standards Codification", "Paragraph": "1E", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r384": { "Name": "Accounting Standards Codification", "Paragraph": "1E", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r385": { "Name": "Accounting Standards Codification", "Paragraph": "1F", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r386": { "Name": "Accounting Standards Codification", "Paragraph": "1F", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r387": { "Name": "Accounting Standards Codification", "Paragraph": "1F", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(1)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r388": { "Name": "Accounting Standards Codification", "Paragraph": "1F", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(2)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r389": { "Name": "Accounting Standards Codification", "Paragraph": "1I", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r39": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(4))", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r390": { "Name": "Accounting Standards Codification", "Paragraph": "1I", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r391": { "Name": "Accounting Standards Codification", "Paragraph": "1I", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r392": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466204&loc=SL6036836-161870", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r393": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r394": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r395": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r396": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r397": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(g)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r398": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(h)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r399": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(i)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r4": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 201.5-02(25))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r40": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.1)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r400": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r401": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496171-112644", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r402": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496171-112644", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r403": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496171-112644", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r404": { "Name": "Accounting Standards Codification", "Paragraph": "16", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496180-112644", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r405": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496189-112644", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r406": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496189-112644", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r407": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496189-112644", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r408": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21463-112644", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r409": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21475-112644", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r41": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.2)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r410": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.3-04)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r411": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130561-203045", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r412": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130563-203045", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r413": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130563-203045", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r414": { "Name": "Accounting Standards Codification", "Paragraph": "19", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130564-203045", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r415": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130566-203045", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r416": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130566-203045", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r417": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130566-203045", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r418": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130566-203045", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r419": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130543-203045", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r42": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.4)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r420": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130545-203045", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r421": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "606", "URI": "https://asc.fasb.org/topic&trid=49130388", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r422": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "712", "URI": "https://asc.fasb.org/topic&trid=2197446", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r423": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123453770&loc=d3e1703-114919", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r424": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r425": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)(1)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r426": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)(10)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r427": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)(2)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r428": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)(3)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r429": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)(4)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r43": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.8)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r430": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)(5)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r431": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)(6)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r432": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)(7)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r433": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)(8)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r434": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)(9)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r435": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r436": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(1)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r437": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(2)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r438": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(3)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r439": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(4)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r44": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3179-108585", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r440": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(5)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r441": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(6)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r442": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(7)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r443": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(8)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r444": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r445": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(i)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r446": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(ii)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r447": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(01)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r448": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(02)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r449": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(02)(A)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r45": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3213-108585", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r450": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(02)(B)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r451": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(02)(C)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r452": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(03)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r453": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(e)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r454": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(f)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r455": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(g)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r456": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(h)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r457": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(h)(1)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r458": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(h)(2)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r459": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(h)(3)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r46": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3213-108585", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r460": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(h)(4)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r461": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(h)(5)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r462": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(h)(6)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r463": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(h)(7)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r464": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(i)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r465": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(j)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r466": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(k)(1)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r467": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(k)(3)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r468": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(k)(4)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r469": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(n)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r47": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3213-108585", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r470": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(q)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r471": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e2410-114920", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r472": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e2709-114920", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r473": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)(1)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e2709-114920", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r474": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)(2)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e2709-114920", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r475": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)(3)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e2709-114920", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r476": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)(4)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e2709-114920", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r477": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)(5)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e2709-114920", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r478": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)(6)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e2709-114920", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r479": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)(7)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e2709-114920", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r48": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3255-108585", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r480": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e2709-114920", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r481": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e2919-114920", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r482": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "70", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=49170846&loc=d3e28014-114942", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r483": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "35", "SubTopic": "80", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=29639808&loc=d3e29008-114946", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r484": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "80", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450702-114947", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r485": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "80", "Subparagraph": "(d)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r486": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "80", "Subparagraph": "(f)(3)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r487": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "80", "Subparagraph": "(b)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450691-114947", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r488": { "Name": "Accounting Standards Codification", "Paragraph": "1D", "Publisher": "FASB", "Section": "35", "SubTopic": "10", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=126961718&loc=SL116886442-113899", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r489": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "35", "SubTopic": "10", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=126961718&loc=d3e4534-113899", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r49": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3255-108585", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r490": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "35", "SubTopic": "10", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=126961718&loc=d3e4549-113899", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r491": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r492": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(1)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r493": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(2)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r494": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(3)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r495": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r496": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(i)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r497": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(ii)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r498": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iii)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r499": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r5": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 201.5-02(26))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r50": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3291-108585", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r500": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(01)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r501": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(02)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r502": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(03)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r503": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(04)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r504": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(i)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r505": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(ii)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r506": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(iii)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r507": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(iii)(01)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r508": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(iii)(02)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r509": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(iii)(03)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r51": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3291-108585", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r510": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)(1)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r511": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)(2)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r512": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)(1)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r513": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)(2)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r514": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(1)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r515": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r516": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(i)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r517": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(ii)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r518": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(iii)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r519": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(iv)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r52": { "Name": "Accounting Standards Codification", "Paragraph": "24", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3521-108585", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r520": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(v)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r521": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(h)(1)(i)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r522": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(h)(1)(ii)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r523": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(h)(2)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r524": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(h)(2)(i)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r525": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(i)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r526": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(l)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r527": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128097895&loc=SL121327923-165333", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r528": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(f)(1)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128097895&loc=SL121327923-165333", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r529": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(f)(2)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128097895&loc=SL121327923-165333", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r53": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(g)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3536-108585", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r530": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 14.D.2.Q6)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=122041274&loc=d3e301413-122809", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r531": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "718", "URI": "https://asc.fasb.org/topic&trid=2228938", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r532": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "25", "SubTopic": "10", "Subparagraph": "(a)(1)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=126928070&loc=d3e28200-109314", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r533": { "Name": "Accounting Standards Codification", "Paragraph": "10B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=123427490&loc=SL37586934-109318", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r534": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=123427490&loc=d3e32247-109318", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r535": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=123427490&loc=d3e32280-109318", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r536": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=123427490&loc=d3e31917-109318", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r537": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=123427490&loc=d3e31931-109318", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r538": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32672-109319", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r539": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32687-109319", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r54": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3536-108585", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r540": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32705-109319", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r541": { "Name": "Accounting Standards Codification", "Paragraph": "15A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=SL6600010-109319", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r542": { "Name": "Accounting Standards Codification", "Paragraph": "15A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(1)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=SL6600010-109319", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r543": { "Name": "Accounting Standards Codification", "Paragraph": "15A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(2)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=SL6600010-109319", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r544": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32809-109319", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r545": { "Name": "Accounting Standards Codification", "Paragraph": "19", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32840-109319", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r546": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32537-109319", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r547": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32537-109319", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r548": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32537-109319", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r549": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32847-109319", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r55": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r550": { "Name": "Accounting Standards Codification", "Paragraph": "21", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32857-109319", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r551": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32639-109319", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r552": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32639-109319", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r553": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32639-109319", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r554": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=126983759&loc=SL121830611-158277", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r555": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=126983759&loc=SL121830611-158277", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r556": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)(2)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=126983759&loc=SL121830611-158277", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r557": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)(3)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=126983759&loc=SL121830611-158277", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r558": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB TOPIC 6.I.5.Q1)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r559": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB TOPIC 6.I.7)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r56": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r560": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 6.I.Fact.1)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r561": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 6.I.Fact.2)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r562": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 6.I.Fact.3)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r563": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 6.I.Fact.4)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r564": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 11.C)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330215-122817", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r565": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=123586238&loc=d3e38679-109324", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r566": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "270", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=6424409&loc=d3e44925-109338", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r567": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=6424122&loc=d3e41874-109331", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r568": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(b)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=6424122&loc=d3e41874-109331", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r569": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(c)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=6424122&loc=d3e41874-109331", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r57": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r570": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "740", "URI": "https://asc.fasb.org/topic&trid=2144680", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r571": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(h)(2)", "Topic": "805", "URI": "https://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r572": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(h)(3)", "Topic": "805", "URI": "https://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r573": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "805", "URI": "https://asc.fasb.org/extlink&oid=128092470&loc=d3e4946-128472", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r574": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "805", "URI": "https://asc.fasb.org/extlink&oid=128092470&loc=d3e4946-128472", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r575": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "65", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "805", "URI": "https://asc.fasb.org/extlink&oid=128092918&loc=SL128093175-196984", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r576": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "65", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "805", "URI": "https://asc.fasb.org/extlink&oid=128092918&loc=SL128093175-196984", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r577": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "65", "SubTopic": "20", "Subparagraph": "(d)", "Topic": "805", "URI": "https://asc.fasb.org/extlink&oid=128092918&loc=SL128093175-196984", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r578": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(b)(1)", "Topic": "805", "URI": "https://asc.fasb.org/extlink&oid=126975305&loc=d3e6927-128479", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r579": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r58": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3044-108585", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r580": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r581": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(bb)", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r582": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r583": { "Name": "Accounting Standards Codification", "Paragraph": "4A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5618551-113959", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r584": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "40", "Subparagraph": "(f)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=126731327&loc=d3e90205-114008", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r585": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "40", "Subparagraph": "(a)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=126731327&loc=SL126733271-114008", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r586": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(a)(1)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r587": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(a)(2)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r588": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(a)(3)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r589": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(b)(1)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r59": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4273-108586", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r590": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(b)(2)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r591": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(c)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r592": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(d)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r593": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(e)(2)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r594": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(e)(3)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r595": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(e)(4)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r596": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(f)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r597": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(a)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL126732908-238011", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r598": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "820", "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r599": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "820", "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r6": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(19))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r60": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4297-108586", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r600": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(bbb)(1)", "Topic": "820", "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r601": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(bbb)(2)", "Topic": "820", "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r602": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "820", "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r603": { "Name": "Accounting Standards Codification", "Paragraph": "6A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "820", "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=SL6742756-110258", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r604": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "825", "URI": "https://asc.fasb.org/extlink&oid=123594938&loc=d3e13433-108611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r605": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "825", "URI": "https://asc.fasb.org/extlink&oid=123596393&loc=d3e14064-108612", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r606": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "825", "URI": "https://asc.fasb.org/extlink&oid=126983955&loc=SL120254526-165497", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r607": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "825", "URI": "https://asc.fasb.org/extlink&oid=126983955&loc=SL120254526-165497", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r608": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "825", "URI": "https://asc.fasb.org/extlink&oid=126983955&loc=SL121967933-165497", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r609": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "825", "URI": "https://asc.fasb.org/extlink&oid=126983955&loc=SL121967933-165497", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r61": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4304-108586", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r610": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(c)(1)", "Topic": "825", "URI": "https://asc.fasb.org/extlink&oid=126983955&loc=SL121967933-165497", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r611": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(c)(2)", "Topic": "825", "URI": "https://asc.fasb.org/extlink&oid=126983955&loc=SL121967933-165497", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r612": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "825", "URI": "https://asc.fasb.org/extlink&oid=126983955&loc=SL122642865-165497", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r613": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "825", "URI": "https://asc.fasb.org/extlink&oid=126983955&loc=SL122642865-165497", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r614": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32136-110900", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r615": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(a)", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r616": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(b)", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r617": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(c)", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r618": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(d)", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r619": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=6450520&loc=d3e32583-110901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r62": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4313-108586", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r620": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=6450520&loc=d3e32618-110901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r621": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "830", "URI": "https://asc.fasb.org/topic&trid=2175825", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r622": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "832", "URI": "https://asc.fasb.org/extlink&oid=128342835&loc=SL128342857-244232", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r623": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "832", "URI": "https://asc.fasb.org/extlink&oid=128342835&loc=SL128342857-244232", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r624": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "835", "URI": "https://asc.fasb.org/extlink&oid=124429444&loc=SL124452920-239629", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r625": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=128293352&loc=SL77916155-209984", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r626": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=128293352&loc=SL126838806-209984", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r627": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=128293352&loc=SL126838806-209984", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r628": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=128293352&loc=SL126838806-209984", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r629": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)(1)", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=128293352&loc=SL126838806-209984", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r63": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4332-108586", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r630": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=123391704&loc=SL77918627-209977", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r631": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=123391704&loc=SL77918627-209977", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r632": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=123391704&loc=SL77918631-209977", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r633": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=123391704&loc=SL77918643-209977", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r634": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918666-209980", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r635": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918686-209980", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r636": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918686-209980", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r637": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918686-209980", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r638": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(g)(1)", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918686-209980", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r639": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(g)(3)", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918686-209980", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r64": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=SL98516268-108586", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r640": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(g)(4)", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918686-209980", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r641": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918686-209980", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r642": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918701-209980", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r643": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "SubTopic": "20", "Topic": "842", "URI": "https://asc.fasb.org/subtopic&trid=77888251", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r644": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "848", "URI": "https://asc.fasb.org/extlink&oid=125980421&loc=SL122150809-237846", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r645": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "848", "URI": "https://asc.fasb.org/extlink&oid=125980421&loc=SL125981372-237846", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r646": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(a)(1)", "Topic": "848", "URI": "https://asc.fasb.org/extlink&oid=125980421&loc=SL125981372-237846", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r647": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(a)(2)", "Topic": "848", "URI": "https://asc.fasb.org/extlink&oid=125980421&loc=SL125981372-237846", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r648": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(a)(3)(iii)(01)", "Topic": "848", "URI": "https://asc.fasb.org/extlink&oid=125980421&loc=SL125981372-237846", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r649": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(a)(3)(iii)(03)", "Topic": "848", "URI": "https://asc.fasb.org/extlink&oid=125980421&loc=SL125981372-237846", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r65": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "235", "URI": "https://asc.fasb.org/topic&trid=2122369", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r650": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "850", "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r651": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "850", "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r652": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "852", "URI": "https://asc.fasb.org/extlink&oid=124437977&loc=d3e55792-112764", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r653": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "855", "URI": "https://asc.fasb.org/extlink&oid=6842918&loc=SL6314017-165662", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r654": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(bb)(1)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r655": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(bb)(2)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r656": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(bb)(3)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r657": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)(1)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r658": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "910", "URI": "https://asc.fasb.org/extlink&oid=126937589&loc=SL119991595-234733", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r659": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 11.L)", "Topic": "924", "URI": "https://asc.fasb.org/extlink&oid=6472922&loc=d3e499488-122856", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r66": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r660": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "926", "URI": "https://asc.fasb.org/extlink&oid=120154696&loc=d3e54445-107959", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r661": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "926", "URI": "https://asc.fasb.org/extlink&oid=120154821&loc=SL120154904-197079", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r662": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "926", "URI": "https://asc.fasb.org/extlink&oid=120154821&loc=SL120154904-197079", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r663": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "926", "URI": "https://asc.fasb.org/extlink&oid=120154821&loc=SL120154904-197079", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r664": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "340", "Topic": "928", "URI": "https://asc.fasb.org/extlink&oid=6473545&loc=d3e61844-108004", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r665": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(a)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e61929-109447", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r666": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(b)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e61929-109447", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r667": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(a)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e62059-109447", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r668": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(b)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e62059-109447", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r669": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(a)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e62395-109447", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r67": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r670": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(b)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e62395-109447", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r671": { "Name": "Accounting Standards Codification", "Paragraph": "33", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(a)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e62479-109447", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r672": { "Name": "Accounting Standards Codification", "Paragraph": "33", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(b)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e62479-109447", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r673": { "Name": "Accounting Standards Codification", "Paragraph": "35A", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(a)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=SL6807758-109447", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r674": { "Name": "Accounting Standards Codification", "Paragraph": "35A", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(b)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=SL6807758-109447", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r675": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(c)(1)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e61872-109447", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r676": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(c)(2)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e61872-109447", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r677": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(10)(1))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r678": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(27))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r679": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "235", "Subparagraph": "(SX 210.9-05(b)(1))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=120399901&loc=d3e537907-122884", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r68": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3630-109257", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r680": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "235", "Subparagraph": "(SX 210.9-05(b)(2))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=120399901&loc=d3e537907-122884", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r681": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "360", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=124429447&loc=SL124453093-239630", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r682": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(23))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r683": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(3)(d))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r684": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(9))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r685": { "Name": "Accounting Standards Codification", "Paragraph": "7A", "Publisher": "FASB", "Section": "50", "SubTopic": "40", "Subparagraph": "(d)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=124506351&loc=SL117782755-158439", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r686": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(a)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r687": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(b)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r688": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(e)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r689": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(f)(1)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r69": { "Name": "Accounting Standards Codification", "Paragraph": "16", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6327-108592", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r690": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(f)(2)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r691": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(g)(1)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r692": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(g)(2)(i)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r693": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(g)(2)(ii)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r694": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(g)(2)(iii)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r695": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(g)(2)(iv)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r696": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(h)(1)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r697": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(h)(2)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r698": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "825", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=123600520&loc=SL75241803-196195", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r699": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "310", "Subparagraph": "(SX 210.12-29(Footnote 4))", "Topic": "948", "URI": "https://asc.fasb.org/extlink&oid=120402547&loc=d3e617274-123014", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r7": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(20))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r70": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6351-108592", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r700": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "310", "Topic": "954", "URI": "https://asc.fasb.org/extlink&oid=126942805&loc=d3e3115-115594", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r701": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "440", "Subparagraph": "(a)", "Topic": "954", "URI": "https://asc.fasb.org/extlink&oid=6491277&loc=d3e6429-115629", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r702": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "360", "Subparagraph": "(d)", "Topic": "958", "URI": "https://asc.fasb.org/extlink&oid=126982197&loc=d3e99779-112916", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r703": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "360", "Topic": "958", "URI": "https://asc.fasb.org/extlink&oid=126982197&loc=d3e99893-112916", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r704": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "360", "Topic": "958", "URI": "https://asc.fasb.org/extlink&oid=126982197&loc=SL120174063-112916", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r705": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Column B))", "Topic": "970", "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r706": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Column C))", "Topic": "970", "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r707": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Column D))", "Topic": "970", "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r708": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Column E))", "Topic": "970", "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r709": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Column F))", "Topic": "970", "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r71": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6351-108592", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r710": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Column G))", "Topic": "970", "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r711": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Column H))", "Topic": "970", "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r712": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Column I))", "Topic": "970", "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r713": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Footnote 2))", "Topic": "970", "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r714": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Footnote 4))", "Topic": "970", "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r715": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "310", "Subparagraph": "(c)", "Topic": "976", "URI": "https://asc.fasb.org/extlink&oid=6497875&loc=d3e22274-108663", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r716": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "310", "Subparagraph": "(b)", "Topic": "978", "URI": "https://asc.fasb.org/extlink&oid=126945304&loc=d3e27327-108691", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r717": { "Name": "Regulation S-K (SK)", "Number": "229", "Paragraph": "(a)", "Publisher": "SEC", "Section": "1402", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r718": { "Name": "Regulation S-K (SK)", "Number": "229", "Paragraph": "(b)", "Publisher": "SEC", "Section": "1402", "Subparagraph": "(1)", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r719": { "Name": "Regulation S-K (SK)", "Number": "229", "Paragraph": "(b)", "Publisher": "SEC", "Section": "1402", "Subparagraph": "(2)", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r72": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6404-108592", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r720": { "Name": "Regulation S-K (SK)", "Number": "229", "Paragraph": "(b)", "Publisher": "SEC", "Section": "1402", "Subparagraph": "(3)", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r721": { "Name": "Regulation S-K (SK)", "Number": "229", "Paragraph": "(b)", "Publisher": "SEC", "Section": "1402", "Subparagraph": "(4)", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r722": { "Name": "Regulation S-K (SK)", "Number": "229", "Paragraph": "(b)", "Publisher": "SEC", "Section": "1402", "Subparagraph": "(5)", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r723": { "Name": "Regulation S-K (SK)", "Number": "229", "Paragraph": "(c)", "Publisher": "SEC", "Section": "1402", "Subparagraph": "(1)(i)", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r724": { "Name": "Regulation S-K (SK)", "Number": "229", "Paragraph": "(c)", "Publisher": "SEC", "Section": "1402", "Subparagraph": "(1)(ii)", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r725": { "Name": "Regulation S-K (SK)", "Number": "229", "Paragraph": "(c)", "Publisher": "SEC", "Section": "1402", "Subparagraph": "(2)(i)", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r726": { "Name": "Regulation S-K (SK)", "Number": "229", "Paragraph": "(c)", "Publisher": "SEC", "Section": "1402", "Subparagraph": "(2)(ii)", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r727": { "Name": "Regulation S-K (SK)", "Number": "229", "Paragraph": "(c)", "Publisher": "SEC", "Section": "1402", "Subparagraph": "(2)(iii)", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r728": { "Name": "Regulation S-K (SK)", "Number": "229", "Publisher": "SEC", "Section": "1402", "Subsection": "Instruction 5", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r729": { "Name": "Regulation S-K (SK)", "Number": "229", "Paragraph": "(a)", "Publisher": "SEC", "Section": "1406", "Subparagraph": "(1)", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r73": { "Name": "Accounting Standards Codification", "Paragraph": "21", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6442-108592", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r730": { "Name": "Regulation S-K (SK)", "Number": "229", "Paragraph": "(a)", "Publisher": "SEC", "Section": "1406", "Subparagraph": "(2)", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r731": { "Name": "Regulation S-K (SK)", "Number": "229", "Paragraph": "(a)", "Publisher": "SEC", "Section": "1406", "Subparagraph": "(3)", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r732": { "Name": "Regulation S-K (SK)", "Number": "229", "Paragraph": "(a)", "Publisher": "SEC", "Section": "1406", "Subparagraph": "(4)", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r733": { "Name": "Regulation S-K (SK)", "Number": "229", "Paragraph": "(a)", "Publisher": "SEC", "Section": "1406", "Subparagraph": "(5)", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r734": { "Name": "Regulation S-K (SK)", "Number": "229", "Paragraph": "(c)", "Publisher": "SEC", "Section": "1406", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r735": { "Footnote": "2", "Name": "Regulation S-X (SX)", "Number": "210", "Publisher": "SEC", "Section": "12", "Subsection": "28", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r736": { "Footnote": "4", "Name": "Regulation S-X (SX)", "Number": "210", "Publisher": "SEC", "Section": "12", "Subsection": "28", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r737": { "Footnote": "4", "Name": "Regulation S-X (SX)", "Number": "210", "Publisher": "SEC", "Section": "12", "Subsection": "29", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r738": { "Name": "Regulation S-X (SX)", "Number": "210", "Paragraph": "Column B", "Publisher": "SEC", "Section": "12", "Subsection": "28", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r739": { "Name": "Regulation S-X (SX)", "Number": "210", "Paragraph": "Column C", "Publisher": "SEC", "Section": "12", "Subsection": "28", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r74": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6061-108592", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r740": { "Name": "Regulation S-X (SX)", "Number": "210", "Paragraph": "Column D", "Publisher": "SEC", "Section": "12", "Subsection": "28", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r741": { "Name": "Regulation S-X (SX)", "Number": "210", "Paragraph": "Column E", "Publisher": "SEC", "Section": "12", "Subsection": "28", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r742": { "Name": "Regulation S-X (SX)", "Number": "210", "Paragraph": "Column F", "Publisher": "SEC", "Section": "12", "Subsection": "28", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r743": { "Name": "Regulation S-X (SX)", "Number": "210", "Paragraph": "Column G", "Publisher": "SEC", "Section": "12", "Subsection": "28", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r744": { "Name": "Regulation S-X (SX)", "Number": "210", "Paragraph": "Column H", "Publisher": "SEC", "Section": "12", "Subsection": "28", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r745": { "Name": "Regulation S-X (SX)", "Number": "210", "Paragraph": "Column I", "Publisher": "SEC", "Section": "12", "Subsection": "28", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r746": { "Name": "Regulation S-X (SX)", "Number": "210", "Paragraph": "(m)", "Publisher": "SEC", "Section": "4", "Subparagraph": "(1)(iii)", "Subsection": "08", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r747": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r748": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(g)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r749": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6935-107765", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r75": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6132-108592", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r750": { "Name": "Accounting Standards Codification", "Paragraph": "16", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=99393222&loc=SL20226024-175313", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r751": { "Name": "Accounting Standards Codification", "Paragraph": "21", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=99393222&loc=SL20226049-175313", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r752": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=99393222&loc=SL20226052-175313", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r753": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=126899994&loc=d3e18823-107790", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r754": { "Name": "Accounting Standards Codification", "Paragraph": "52", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=128363288&loc=d3e4984-109258", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r755": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r756": { "Name": "Accounting Standards Codification", "Paragraph": "31", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8924-108599", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r757": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Subparagraph": "(e)", "Topic": "326", "URI": "https://asc.fasb.org/extlink&oid=124267575&loc=SL82921835-210448", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r758": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Subparagraph": "(e)(2)", "Topic": "326", "URI": "https://asc.fasb.org/extlink&oid=124267575&loc=SL82921835-210448", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r759": { "Name": "Accounting Standards Codification", "Paragraph": "24", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=122137925&loc=d3e14258-109268", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r76": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6143-108592", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r760": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r761": { "Name": "Accounting Standards Codification", "Paragraph": "69B", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466577&loc=SL123495735-112612", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r762": { "Name": "Accounting Standards Codification", "Paragraph": "69C", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466577&loc=SL123495737-112612", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r763": { "Name": "Accounting Standards Codification", "Paragraph": "69E", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466577&loc=SL123495743-112612", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r764": { "Name": "Accounting Standards Codification", "Paragraph": "69F", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466577&loc=SL123495745-112612", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r765": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r766": { "Name": "Accounting Standards Codification", "Paragraph": "91", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r767": { "Name": "Accounting Standards Codification", "Paragraph": "91", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r768": { "Name": "Accounting Standards Codification", "Paragraph": "91", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r769": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(ii)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r77": { "Name": "Accounting Standards Codification", "Paragraph": "41", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9038-108599", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r770": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(01)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r771": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123450688&loc=d3e4179-114921", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r772": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123450688&loc=d3e4587-114921", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r773": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "80", "Subparagraph": "(a)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450702-114947", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r774": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "80", "Subparagraph": "(b)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450702-114947", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r775": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "80", "Subparagraph": "(c)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450702-114947", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r776": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "80", "Subparagraph": "(a)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450673-114947", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r777": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "80", "Subparagraph": "(b)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450673-114947", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r778": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "80", "Subparagraph": "(c)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450673-114947", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r779": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "55", "SubTopic": "80", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=35742348&loc=SL14450788-114948", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r78": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 4.E)", "Topic": "310", "URI": "https://asc.fasb.org/extlink&oid=122038336&loc=d3e74512-122707", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r780": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(1)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r781": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(2)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r782": { "Name": "Accounting Standards Codification", "Paragraph": "217", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=126976462&loc=d3e36027-109320", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r783": { "Name": "Accounting Standards Codification", "Paragraph": "53", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=123414884&loc=SL77918982-209971", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r784": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "852", "URI": "https://asc.fasb.org/extlink&oid=84165509&loc=d3e56426-112766", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r785": { "Name": "Accounting Standards Codification", "Paragraph": "13H", "Publisher": "FASB", "Section": "55", "SubTopic": "40", "Subparagraph": "(a)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126561865&loc=SL117783719-158441", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r786": { "Name": "Accounting Standards Codification", "Paragraph": "13H", "Publisher": "FASB", "Section": "55", "SubTopic": "40", "Subparagraph": "(b)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126561865&loc=SL117783719-158441", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r787": { "Name": "Accounting Standards Codification", "Paragraph": "29F", "Publisher": "FASB", "Section": "55", "SubTopic": "40", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126561865&loc=SL117819544-158441", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r788": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r789": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b-2", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r79": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r790": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b-23", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r791": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "d1-1", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r792": { "Name": "Form 10-K", "Number": "249", "Publisher": "SEC", "Section": "310", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r793": { "Name": "Form 20-F", "Number": "249", "Publisher": "SEC", "Section": "220", "Subsection": "f", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r794": { "Name": "Form 40-F", "Number": "249", "Publisher": "SEC", "Section": "240", "Subsection": "f", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r795": { "Name": "Forms 10-K, 10-Q, 20-F", "Number": "240", "Publisher": "SEC", "Section": "13", "Subsection": "a-1", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r796": { "Name": "Regulation S-T", "Number": "232", "Publisher": "SEC", "Section": "405", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r797": { "Name": "Securities Act", "Number": "230", "Publisher": "SEC", "Section": "405", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r798": { "Name": "Securities Act", "Number": "7A", "Publisher": "SEC", "Section": "B", "Subsection": "2", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r799": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "272", "URI": "https://asc.fasb.org/extlink&oid=125520817&loc=d3e70229-108054", "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef" }, "r8": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(22))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r80": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=6388964&loc=d3e16212-109274", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r800": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "450", "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14615-108349", "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef" }, "r801": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "855", "URI": "https://asc.fasb.org/extlink&oid=6842918&loc=SL6314020-165662", "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef" }, "r802": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(1))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r803": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(20))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r804": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(8))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r805": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(9))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r806": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r807": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=SL98516268-108586", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r808": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(d))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r809": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(f))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r81": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=6388964&loc=d3e16225-109274", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r810": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(g)(1)(ii))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r811": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(h)(1)(Note 1))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r812": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.12-04(a))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e24072-122690", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r813": { "Name": "Accounting Standards Codification", "Paragraph": "23", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21914-107793", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r814": { "Name": "Accounting Standards Codification", "Paragraph": "24", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21930-107793", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r815": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21711-107793", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r816": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(2)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r817": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(3)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r818": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r819": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r82": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r820": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=SL124452830-107794", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r821": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22583-107794", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r822": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22595-107794", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r823": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r824": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r825": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22658-107794", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r826": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22663-107794", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r827": { "Name": "Accounting Standards Codification", "Paragraph": "55", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e2626-109256", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r828": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r829": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6351-108592", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r83": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)(3)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r830": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8672-108599", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r831": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "321", "URI": "https://asc.fasb.org/extlink&oid=126980263&loc=SL75117546-209714", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r832": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "323", "URI": "https://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r833": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(e)(3)", "Topic": "326", "URI": "https://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r834": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(e)(4)", "Topic": "326", "URI": "https://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r835": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r836": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(h)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r837": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(c)", "Topic": "410", "URI": "https://asc.fasb.org/extlink&oid=6393242&loc=d3e13237-110859", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r838": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "450", "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14557-108349", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r839": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "20", "Subparagraph": "(SAB Topic 5.Y.Q2)", "Topic": "450", "URI": "https://asc.fasb.org/extlink&oid=27011672&loc=d3e149879-122751", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r84": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r840": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "450", "URI": "https://asc.fasb.org/topic&trid=2127136", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r841": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(i))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r842": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(ii))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r843": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(iii))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r844": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(iv))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r845": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(iv))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r846": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r847": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130545-203045", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r848": { "Name": "Accounting Standards Codification", "Paragraph": "91", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r849": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(n)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r85": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "((a)(1),(b))", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r850": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(1)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r851": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(2)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r852": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(3)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r853": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(i)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r854": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(ii)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r855": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iii)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r856": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r857": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(01)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r858": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(02)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r859": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(03)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r86": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r860": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(04)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r861": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(i)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r862": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(ii)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r863": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(iii)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r864": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(iii)(01)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r865": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(iii)(02)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r866": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(iii)(03)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r867": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)(1)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r868": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)(2)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r869": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)(1)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r87": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)(1)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r870": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)(2)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r871": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(i)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r872": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(ii)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r873": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(iii)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r874": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(iv)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r875": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(v)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r876": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32672-109319", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r877": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32687-109319", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r878": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32718-109319", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r879": { "Name": "Accounting Standards Codification", "Paragraph": "15A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=SL6600010-109319", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r88": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)(2)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r880": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32537-109319", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r881": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32621-109319", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r882": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32639-109319", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r883": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32639-109319", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r884": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(h)(2)", "Topic": "805", "URI": "https://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r885": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(h)(3)", "Topic": "805", "URI": "https://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r886": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(e)(3)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r887": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(f)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r888": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(bbb)(2)", "Topic": "820", "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r889": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "825", "URI": "https://asc.fasb.org/extlink&oid=123596393&loc=d3e14064-108612", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r89": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)(3)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r890": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(g)(1)", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918686-209980", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r891": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918686-209980", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r892": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918701-209980", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r893": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(a)(3)(iii)(01)", "Topic": "848", "URI": "https://asc.fasb.org/extlink&oid=125980421&loc=SL125981372-237846", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r894": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(a)(3)(iii)(03)", "Topic": "848", "URI": "https://asc.fasb.org/extlink&oid=125980421&loc=SL125981372-237846", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r895": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "850", "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r896": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "850", "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r897": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "850", "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39603-107864", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r898": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "852", "URI": "https://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r899": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "852", "URI": "https://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r9": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(23))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r90": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "30", "SubTopic": "40", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=118172244&loc=d3e17916-109280", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r900": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)(1)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r901": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)(2)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r902": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)(3)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r903": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(1)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r904": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(2)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r905": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(3)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r906": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "25", "SubTopic": "730", "Topic": "912", "URI": "https://asc.fasb.org/extlink&oid=6472174&loc=d3e58812-109433", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r907": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(1)(a))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r908": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(2))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r909": { "Name": "Accounting Standards Codification", "Paragraph": "4H", "Publisher": "FASB", "Section": "50", "SubTopic": "40", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=116884468&loc=SL65671331-158438", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r91": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "25", "SubTopic": "50", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=16397303&loc=d3e19347-109286", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r910": { "Name": "Accounting Standards Codification", "Paragraph": "13H", "Publisher": "FASB", "Section": "55", "SubTopic": "40", "Subparagraph": "(c)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126561865&loc=SL117783719-158441", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r911": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "825", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=123600520&loc=SL75241803-196195", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r912": { "Name": "Regulation S-X (SX)", "Number": "210", "Publisher": "SEC", "Section": "11", "Subsection": "03", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r913": { "Name": "Regulation S-X (SX)", "Number": "210", "Paragraph": "(a)", "Publisher": "SEC", "Section": "12", "Subsection": "04", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r914": { "Name": "Regulation S-X (SX)", "Number": "210", "Paragraph": "(a)", "Publisher": "SEC", "Section": "13", "Subparagraph": "(4)(i)", "Subsection": "01", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r915": { "Name": "Regulation S-X (SX)", "Number": "210", "Paragraph": "(a)", "Publisher": "SEC", "Section": "13", "Subparagraph": "(4)(iv)", "Subsection": "01", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r916": { "Name": "Regulation S-X (SX)", "Number": "210", "Paragraph": "(a)", "Publisher": "SEC", "Section": "13", "Subparagraph": "(4)(iv)", "Subsection": "02", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r92": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "05", "SubTopic": "10", "Topic": "360", "URI": "https://asc.fasb.org/extlink&oid=109226317&loc=d3e202-110218", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r93": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "35", "SubTopic": "10", "Topic": "360", "URI": "https://asc.fasb.org/extlink&oid=126905813&loc=d3e1205-110223", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r94": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "360", "URI": "https://asc.fasb.org/extlink&oid=126905981&loc=d3e2420-110228", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r95": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "360", "URI": "https://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r96": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "360", "URI": "https://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r97": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "360", "URI": "https://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r98": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "360", "URI": "https://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r99": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "360", "URI": "https://asc.fasb.org/extlink&oid=109226691&loc=d3e2921-110230", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" } }, "version": "2.2" } ZIP 120 0001835378-23-000022-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001835378-23-000022-xbrl.zip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�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�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end

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